scarfre
regener
tissu
organ
occur
mani
fish
amphibian
mammal
restrict
certain
organ
embryon
earli
fetal
stage
regener
amput
appendag
zebrafish
urodel
amphibian
salamand
newt
involv
cellular
reprogram
prolifer
injuri
site
pattern
growth
regener
blastema
redifferenti
miss
tissu
unlik
organ
develop
embryo
regener
resembl
wound
repair
requir
transient
inflamm
produc
injuri
limb
blastema
growth
also
requir
factor
deriv
regrow
nerv
axon
repair
process
amput
mammalian
limb
transit
development
program
new
limb
remain
key
question
regen
biolog
anuran
amphibian
frog
toad
regener
develop
hindlimb
premetamorphosi
abil
lost
limb
complet
develop
larva
approach
metamorphosi
frog
xenopu
laevi
gradual
loss
regen
capac
begin
cell
adapt
immun
system
becom
function
analys
gene
express
proteom
chang
amput
hindlimb
xenopu
larva
indic
inflamm
resolut
upregul
strongli
persist
regenerationincompet
stage
younger
regener
limb
indic
chang
inflammatori
respons
may
interfer
import
aspect
limb
regener
immunosuppress
agent
knockdown
immun
cell
differenti
shown
restor
transient
loss
regen
abil
xenopu
tail
similar
agent
improv
regen
abil
larval
hindlimb
brief
exposur
amput
regenerationcompet
limb
solut
beryllium
persist
immun
adjuv
inhibit
regener
beryllium
caus
stronger
persist
upregul
gene
relat
inflamm
resolut
compar
control
regener
limb
limb
stump
treat
adjuv
also
normal
express
level
sever
marker
cellular
dedifferenti
reprogram
fail
express
key
gene
requir
normal
pattern
regener
blastema
work
review
along
import
studi
grow
bodi
evid
vertebr
cell
develop
immun
system
determin
capac
organ
appendag
regener
genet
approach
neurolog
disord
jagod
maja
scarfre
regener
tissu
organ
occur
mani
fish
amphibian
mammal
restrict
certain
organ
embryon
earli
fetal
stage
regener
amput
appendag
zebrafish
urodel
amphibian
salamand
newt
involv
cellular
reprogram
prolifer
injuri
site
pattern
growth
regener
blastema
redifferenti
miss
tissu
unlik
organ
develop
embryo
regener
resembl
wound
repair
requir
transient
inflamm
produc
injuri
limb
blastema
growth
also
requir
factor
deriv
regrow
nerv
axon
repair
process
amput
mammalian
limb
transit
development
program
new
limb
remain
key
question
regen
biolog
anuran
amphibian
frog
toad
regener
develop
hindlimb
premetamorphosi
abil
lost
limb
complet
develop
larva
approach
metamorphosi
frog
xenopu
laevi
gradual
loss
regen
capac
begin
cell
adapt
immun
system
becom
function
analys
gene
express
proteom
chang
amput
hindlimb
xenopu
larva
indic
inflamm
resolut
upregul
strongli
persist
regenerationincompet
stage
younger
regener
limb
indic
chang
inflammatori
respons
may
interfer
import
aspect
limb
regener
immunosuppress
agent
knockdown
immun
cell
differenti
shown
restor
transient
loss
regen
abil
xenopu
tail
similar
agent
improv
regen
abil
larval
hindlimb
brief
exposur
amput
regenerationcompet
limb
solut
beryllium
persist
immun
adjuv
inhibit
regener
beryllium
caus
stronger
persist
upregul
gene
relat
inflamm
resolut
compar
control
regener
limb
limb
stump
treat
adjuv
also
normal
express
level
sever
marker
cellular
dedifferenti
reprogram
fail
express
key
gene
requir
normal
pattern
regener
blastema
work
review
along
import
studi
grow
bodi
evid
vertebr
cell
develop
immun
system
determin
capac
organ
appendag
regener
genet
approach
neurolog
disord
jagod
maja
karolinska
institutet
dept
clinic
neurosci
center
molecular
medicin
stockholm
sweden
number
cellular
molecular
process
lead
pathogen
neuroinflamm
multipl
sclerosi
ms
howev
pinpoint
interact
caus
diseas
challeng
unbias
genet
approach
defin
evolutionari
conserv
gene
variant
pathway
crucial
diseas
pathogenesi
nevertheless
three
decad
genet
research
risk
gene
identifi
recent
year
mark
progress
made
human
genet
complex
diseas
includ
sequenc
human
genom
identif
catalog
variat
develop
highthroughput
afford
type
method
collect
larg
well
annot
casecontrol
materi
similarli
complex
diseas
led
robust
identif
sever
dozen
ms
risk
gene
thu
number
genet
regul
pathway
emerg
ms
mainli
involv
immun
respons
reaction
offer
better
understand
diseas
pathogenesi
therapeut
target
biomark
due
complex
human
diseas
experiment
model
experiment
autoimmun
encephalomyel
valuabl
understand
diseas
mechan
develop
therapi
special
valu
dissect
genet
control
neuroinflamm
owe
possibl
employ
control
design
breed
strategi
unlimit
sampl
size
limit
genet
heterogen
number
genomewid
linkag
scan
identifi
genom
loci
regul
experiment
neuroinflamm
special
conduct
cross
reveal
complex
involv
genegen
geneenviron
interact
well
parentoforigin
effect
recent
advanc
approach
addit
cell
bcell
function
microglia
activ
well
glutam
pathway
major
player
pathogenesi
ms
moreov
identif
antibodi
aquaporin
neuromyel
optica
good
exampl
identif
antigen
immun
mediat
provid
new
understand
pathogenesi
cn
white
matter
autoimmun
autoimmun
grey
matter
diseas
grau
francesc
neuroimmunolog
research
provid
robust
evid
neuron
may
target
autoimmun
attack
instanc
antibodi
synapt
protein
respons
neurolog
syndrom
may
may
associ
cancer
paraneoplast
limbic
enceph
le
present
consid
model
autoimmun
grey
matter
disord
le
initi
describ
clinicopatholog
entiti
character
inflammatori
process
mainli
involv
hippocampi
amygdala
present
le
divid
two
broad
categori
depend
target
antigen
onconeur
includ
hu
intracellular
antigen
relat
cancer
includ
gad
adenyl
kinas
patholog
studi
le
type
usual
show
promin
brain
infiltr
tcell
patient
poor
prognosi
bad
respons
immunotherapi
cell
surfac
antigen
synaps
includ
subunit
glutam
receptor
nmda
ampa
gaba
receptor
secret
synapt
protein
previous
coprecipit
voltageg
potassium
channel
unlik
le
first
group
antibodi
antigen
patrhogen
patient
respond
better
immunotherapi
patient
predominantli
men
develop
non
paraneoplast
le
contrast
patient
ampa
receptor
antibodi
femal
mani
develop
lung
breast
cancer
patient
le
gaba
receptor
antibodi
also
present
mani
case
associ
lung
cancer
particular
interest
enceph
associ
antibodi
extracellular
epitop
subunit
nmda
receptor
patient
syndrom
present
sever
psychiatr
symptom
seizur
dyskinesia
autonom
instabl
hypoventil
enceph
profil
differ
le
suggest
probabl
grey
matter
syndrom
await
character
autoimmun
physiolog
condit
astrocyt
abund
cell
central
nervou
system
cn
play
critic
role
regul
cn
homeostasi
synaps
format
develop
synapt
plastic
howev
follow
injuri
diseas
astrocyt
becom
reactiv
event
often
character
express
glial
fibrillari
acid
protein
gfap
activ
transcript
factor
nuclear
factorkappa
b
nfkb
product
immunoregulatori
molecul
cytokin
chemokin
reactiv
oxygen
speci
capac
astrocyt
form
import
compon
cn
innat
immun
play
import
role
neurorecoveri
neurodestruct
use
mice
nfkb
select
inactiv
gfap
express
cell
investig
contribut
astroglialnfb
cn
pathophysiolog
function
recoveri
model
spinal
cord
injuri
sci
experiment
autoimmun
encephalomyel
eae
lectur
present
evid
obtain
group
show
inhibit
astroglialnfkb
attenu
neuroinflamm
reduc
neuropatholog
improv
function
recoveri
model
sci
eae
discuss
potenti
mechan
action
possibl
therapeut
implic
studi
mechan
signal
transduct
regul
astrogli
microgli
function
campbel
iain
univers
sydney
sydney
australia
signal
transduct
protein
util
famili
cytokin
includ
lif
cntf
osm
bind
membran
bound
solubl
form
oligom
activ
pathway
implic
pathogenesi
variou
neurolog
disord
potent
activ
astroglia
microglia
limit
understand
commun
differ
cell
cn
activ
individu
signal
transduct
pathway
regul
mediat
action
astroglia
lack
respond
process
term
transsign
microglia
respond
via
classic
transsign
found
action
brain
involv
specif
molecular
cellular
respons
depend
transsign
highlight
import
transsign
mediat
mani
cn
effect
find
inhibit
transsign
reduc
sever
neuroinflammatori
diseas
induc
astrocytetarget
product
downstream
signal
intens
kinet
activ
jakstat
pathway
respons
transsign
similar
astrocyt
microgli
cell
signal
drive
increas
express
mani
gene
gene
regul
respons
signal
whose
primari
function
neg
regul
pathway
via
role
signal
glial
respons
neuron
injuri
determin
facial
nerv
axotomi
model
fna
use
mice
knockin
mutat
select
disabl
either
jakstat
pathway
studi
show
pathway
contribut
earli
activ
accumul
microglia
injur
facial
nerv
nucleu
fnn
ii
astrocyt
gfap
express
markedli
reduc
absenc
signal
howev
normal
level
glutamin
synthetas
brain
fnn
incompet
mice
suggest
astrocyt
develop
compromis
crucial
depend
pathway
summari
genet
dissect
commun
signal
transduct
provid
new
insight
key
mechanist
process
control
function
plastic
astroglia
microglia
vivo
approach
myasthenia
gravi
mg
antibodymedi
diseas
consider
clinic
serolog
heterogen
patient
separ
sever
group
accord
age
onset
hla
associ
thymic
patholog
serolog
earli
onset
mg
eomg
defin
year
onset
mainli
femal
high
incid
late
onset
mg
lomg
defin
year
onset
increasingli
recognis
peak
incid
patient
age
year
remain
patient
thymoma
overal
total
number
lomg
exceed
eomg
male
femal
mg
acetylcholin
receptor
achr
antibodi
muscl
specif
kinas
musk
antibodi
lowaffin
achr
antibodi
igg
patient
differ
antibodi
passiv
transfer
diseas
mice
indic
pathogen
activ
immunis
also
effect
musk
patient
often
sever
bulbar
symptom
reason
yet
clear
antibodi
may
act
pre
postsynapt
frequenc
musk
antibodi
appear
differ
latitud
suggest
environment
influenc
lambert
eaton
myasthen
syndrom
antibodi
voltageg
calcium
channel
vgcc
acquir
neuromyotonia
antibodi
voltageg
potassium
vgkc
channel
last
year
found
antibodi
protein
complex
vgkc
associ
central
nervou
system
dysfunct
morvan
syndrom
includ
peripher
nerv
hyperexcit
autonom
dysfunct
central
involv
recent
evid
show
mani
antibodi
patient
recognis
protein
tighli
complex
vgkc
neuron
tissu
often
associ
thymoma
antibodi
anoth
vgkccomplex
protein
found
patient
central
involv
memori
loss
seizur
identifi
novel
antiglycolipid
antibodi
target
use
combinatori
glycoarray
willison
hugh
glycolipid
act
plasma
membran
receptor
wide
rang
antibodi
lectin
microb
long
recognis
local
topographi
glycolipid
plasma
membran
critic
recognit
event
although
biolog
basi
rel
underinvestig
within
last
five
year
emerg
evid
indic
heterodimer
cluster
differ
glycolipid
form
highli
distinct
specif
epitop
antibodi
bind
human
autoimmun
neuropathi
sera
gangliosid
glycolipid
complex
compris
wide
rang
lipid
partner
either
dramat
enhanc
equal
well
inhibit
bind
neuropathyassoci
antibodi
present
describ
glycoarray
methodolog
allow
rapid
identif
divers
complex
far
demonstr
live
peripher
nerv
plasma
membran
complex
format
demonstr
either
enhanc
inhibit
antibodi
bind
subsequ
pathophysiolog
event
demonstr
complex
potenti
mechan
underli
effect
consid
although
much
remain
investig
explain
howev
implic
neurolog
autoimmun
widespread
rang
glycoarray
design
immunopatholog
consequ
glycolipid
complex
organis
neural
plasma
membran
actual
approv
diseas
modifi
drug
dmd
relapsingremit
multipl
sclerosi
includ
recombin
interferon
ifnbeta
glatiram
acet
ga
immunomodulatori
treatment
shown
reduc
frequenc
sever
relaps
well
reduc
progress
neurolog
disabl
howev
dmd
administ
parenter
need
frequent
inject
may
inconveni
uncomfort
patient
addit
patient
respond
adequ
common
side
effect
associ
therapi
may
reduc
adher
develop
drug
easier
administr
oral
agent
would
promot
adher
increas
patient
satisfact
therebi
improv
efficaci
two
phase
iii
clinic
trial
clariti
transform
provid
promis
result
cladribin
fingolimod
respect
result
clariti
studi
show
annual
shortcours
treatment
dose
mgkg
mgkg
cladribin
tablet
led
signific
reduct
rate
clinic
relaps
disabl
progress
brain
lesion
well
signific
increas
proport
patient
remain
relapsefre
overal
frequenc
advers
event
cladribin
treatment
group
compar
observ
placebo
group
dose
result
transform
studi
also
show
signific
reduct
annual
relaps
rate
mri
activ
studi
two
fatal
viral
infect
occur
moreov
freedom
studi
demonstr
signific
reduct
diseas
activ
dose
fingolimod
interferon
beta
avonex
safeti
profil
drug
open
concern
risk
herp
infect
cardiovascular
problem
oral
drug
earlier
phase
develop
includ
teriflunomid
laquinimod
three
drug
preliminari
efficaci
emerg
phase
ii
studi
phase
iii
studi
ongo
interferon
beta
ifnb
treatment
benefici
major
relapsingremit
multipl
sclerosi
rrm
patient
howev
signific
proport
patient
show
poor
clinic
respons
shown
baselin
ifnrespons
activ
serv
role
biomark
predict
clinic
respons
ifnb
hypothes
genet
variat
within
ifnpathway
particular
gene
associ
differenti
ifnrespons
gene
activ
clinic
respons
upon
ifnb
treatment
test
group
valid
group
patient
rrm
start
ifnb
therapi
genotyp
polymorph
ifnrespons
gene
activ
whole
blood
determin
baselin
start
therapi
qpcr
test
group
treatment
respons
ifnb
measur
absenceoccurr
new
lesion
magnet
reson
imag
mri
test
group
time
first
relaps
ifnb
treatment
valid
group
accord
previou
studi
poor
pharmacolog
respons
low
absent
induct
ifnrespons
gene
activ
observ
patient
elev
ifnrespons
gene
activ
baselin
poor
pharmacolog
respons
ifnb
associ
tt
aa
genotyp
p
p
accordingli
patient
either
tt
genotyp
aa
genotyp
develop
new
lesion
treatment
moreov
number
annual
lesion
higher
patient
tt
genotyp
p
clinic
relev
tt
genotyp
demonstr
associ
shorter
time
first
relaps
compar
genotyp
independ
group
p
find
indic
associ
pharmacolog
clinic
respons
ifnb
rrm
patient
homozyg
tallel
poor
clinic
respons
repres
frequent
develop
new
lesion
shorter
time
first
relaps
ifnb
treatment
identif
genet
factor
predispos
clinic
respons
ifnb
treatment
rrm
import
clinic
find
especi
current
avail
altern
drug
confirm
futur
prospect
studi
determin
genotyp
could
provid
addit
inform
treatment
decis
rrm
patient
thompson
sara
jone
joann
robertson
vicki
compston
alastair
cole
alasdair
univers
cambridg
cambridg
unit
kingdom
baff
b
cell
activ
factor
essenti
bcell
surviv
function
bind
three
receptor
baffreceptor
taci
calcium
modul
cyclophilin
ligand
interactor
bcma
bcell
matur
antigen
main
receptor
april
proliferationinduc
ligand
also
role
surviv
plasmablast
like
baff
member
tnfalpha
superfamili
gene
bind
taci
bcma
aim
studi
observ
chang
b
cell
surviv
marker
whether
correl
invers
b
cell
death
longitudin
studi
earli
relaps
remit
multipl
sclerosi
ms
patient
b
cell
survivaldifferenti
factor
prolifer
b
cell
death
measur
monthli
visit
diseas
activ
measur
edss
expand
disabl
statu
scale
mri
magnet
reson
imag
result
demonstr
baff
april
taci
mrna
increas
untreat
multipl
sclerosi
patient
compar
healthi
control
wherea
cell
death
lower
differ
seen
activ
inact
patient
preliminari
data
show
increas
b
cell
surviv
marker
correspond
decreas
b
cell
death
suggest
possibl
exagger
surviv
potenti
autoreact
b
cell
patient
could
therefor
implic
pathogen
ms
ci
sfasl
correl
invers
fa
measur
corpu
callosum
splenium
p
r
level
correl
invers
fa
measur
corpu
callosum
rostrum
p
r
rrm
sfasl
correl
invers
fa
measur
caudat
nucleu
p
r
posit
centrum
semioval
p
r
spm
mif
correl
significantli
adc
valu
centrum
semioval
p
r
adc
valu
capsula
interna
p
r
ppm
tnfa
correl
invers
fa
level
corpu
callosum
genu
p
r
posit
adc
level
corpu
callosum
genu
p
r
truncu
p
r
optic
radiat
p
r
thalamu
p
r
level
ifng
also
correl
posit
adc
valu
ppm
p
r
correl
immunolog
dti
find
differ
ms
subtyp
consist
evolut
pathophysiolog
diseas
cours
seem
immun
molecul
dti
paramet
evalu
us
might
util
biomark
ms
chanvillard
corali
swaminathan
bhairavi
alloza
iraid
vandenbroeck
koen
infanteduart
carmen
neurogenomik
ikerbasqu
universidad
del
vasco
upvehu
leioa
spain
experiment
neuroimmunolog
experiment
clinic
research
center
berlin
germani
known
receptor
fractalkin
chemokin
exist
solubl
surfacebound
form
mediat
chemotaxi
adhes
leucocyt
previou
data
gene
express
flow
cytometri
studi
demonstr
significantli
lower
express
natur
killer
nk
cell
ms
patient
compar
healthi
individu
suggest
diseas
activ
might
relat
express
explor
hypothesi
examin
genet
variant
possibl
associ
ms
clinic
welldefin
spanish
cohort
ms
patient
healthi
control
genotyp
singl
nucleotid
polymorph
snp
gene
use
fast
realtim
pcr
system
examin
snp
lead
respect
aminoacid
substitut
odd
ratio
snp
ms
suscept
calcul
cochranarmitag
test
use
plink
softwar
haploview
softwar
use
determin
haplotyp
ratio
correl
chisquar
test
pvalu
follow
analysi
whole
dataset
current
process
stratifi
data
base
ms
clinic
progress
primaryprogress
versu
relapsingremit
ms
well
gender
geographi
analys
screen
result
correl
diseas
suscept
clinic
phenotyp
gender
ethnic
allow
us
determin
whether
genet
variant
might
repres
biolog
marker
ms
detect
quantif
microrna
express
human
peripher
blood
microvesicl
multipl
sclerosi
patient
treat
thamilarasan
madhan
koczan
dirk
hermann
goertsch
robert
hecker
michael
thiesen
hansjuergen
zettl
uwe
klau
univers
rostock
rostock
germani
purpos
studi
investig
presenc
variou
microrna
speci
quantiti
peripher
blood
microvesicl
multipl
sclerosi
ms
patient
treat
aim
find
role
microrna
present
microvesicl
relat
prognosi
diseas
cours
normal
malign
cell
shed
surfac
membran
well
secret
endosom
membran
compart
circular
membran
fragment
call
microvesicl
mv
grow
experiment
evid
indic
mv
underappreci
compon
cell
environ
play
import
pleiotrop
role
mani
biolog
process
mv
contain
variou
bioactiv
molecul
may
directli
stimul
cell
kind
signal
complex
ii
transfer
membran
receptor
protein
mrna
organel
eg
mitochondria
cell
employ
appli
biosystem
low
densiti
realtim
micro
fluidic
card
eight
ms
patient
start
subcutan
therapi
three
healthi
control
monitor
four
differ
time
point
baselin
well
hour
peripher
blood
ms
patient
healthi
control
subject
differenti
centrifug
isol
mv
mirvana
kit
use
isol
microrna
mv
put
microrna
target
obtain
microcosm
databas
realtim
pcr
low
densiti
microrna
array
capabl
detect
differ
microrna
detect
bloodderiv
mv
ms
patient
treat
interferonbeta
upand
downregul
differ
microrna
eg
microrna
potenti
involv
regul
variou
process
among
predict
microrna
target
cell
adhes
molecul
esam
well
inflammatori
cytokin
eg
tnf
howev
experi
need
carri
valid
result
conclud
could
show
differenti
microrna
express
dynam
peripher
blood
mv
ms
patient
healthi
control
effort
need
associ
data
gene
regulatori
target
immun
cell
ii
clinic
data
includ
diseas
sever
progress
therapeut
outcom
current
underway
describ
prenat
stress
ps
stress
influenc
behavior
offspr
aim
work
investig
alter
behavior
neurotrophin
express
adult
anim
subject
ps
purpos
pregnant
mice
individu
restrain
hour
day
sinc
gestat
day
deliveri
stress
offspr
mice
n
test
age
togeth
control
match
mice
n
anim
group
n
submit
chronic
stress
result
shown
ps
induc
signific
alter
perform
open
field
altern
task
decreas
bndf
level
realtim
pcr
observ
hippocampu
moreov
bndf
level
decreas
lymphocyt
hand
anim
show
poorer
perform
altern
test
exposur
chronic
stress
respect
normal
anim
addit
import
decreas
bndf
level
clinic
manifest
intravascular
larg
bcell
lymphoma
ivl
vari
relat
organ
dysfunct
caus
occlus
small
vessel
ivl
show
cognit
dysfunct
spinal
cord
disord
cn
manifest
therefor
mimic
ms
necessari
pay
attent
ivl
neuroimmunolog
field
particularli
past
diagnosi
usual
recogn
autopsi
therefor
need
biomark
earli
diagnosi
b
cell
attract
factor
bca
cxc
chemokin
recent
prove
immunepatholog
lymphoma
b
cell
produc
clarifi
util
csf
biomark
earli
clinic
stage
ivl
studi
includ
patient
patholog
definit
ivl
show
differenti
clinic
type
follow
control
group
variou
neurolog
disord
includ
ms
select
measur
level
serum
csf
elisa
case
year
old
man
show
amnesia
three
month
cerebellar
ataxia
one
month
hospit
deterior
cours
hemophagocyt
syndrom
suggest
asian
variant
ivl
case
year
old
man
show
atax
gait
four
month
dementia
one
month
hospit
final
diagnos
classic
type
ivl
immunehistolog
examin
brain
biopsi
specimen
case
year
old
man
show
paraplegia
four
month
subsequ
pollakisuria
two
month
hospit
thorac
spine
mri
reveal
thorac
cord
involv
found
increas
csf
level
earli
clinic
stage
csf
level
ivl
respect
pgml
case
pg
ml
case
pgml
case
significantli
elev
addit
csf
case
reflect
diseas
activ
ivl
compar
paramet
contrast
csf
level
ms
nmo
cidp
ond
pgml
pg
ml
pgml
pgml
respect
signific
differ
serum
level
found
group
also
immunopatholog
studi
specimen
obtain
brain
biopsi
show
autocrin
malign
b
cell
vessel
recogn
signific
rise
csf
level
ivl
case
csf
could
diagnost
marker
ivl
earli
clinic
stage
myxoviru
mxa
protein
encod
gene
potent
antivir
activ
mxa
proven
sensit
measur
biolog
respons
interferonbeta
ifnb
treatment
activ
significantli
reduc
develop
neutral
antibodi
nab
nevertheless
use
mxa
biolog
marker
ifnb
treatment
multipl
sclerosi
ms
critic
lack
evid
role
diseas
pathogenesi
clinic
respons
ifnb
gene
express
microarray
affymetrix
human
genom
plu
perform
peripher
blood
mononuclear
cell
ms
patient
baselin
month
ifnb
treatment
four
patient
neg
nab
patient
develop
nab
andor
month
chang
gene
express
induc
ifnb
time
nab
posit
nab
neg
patient
analyz
nine
gene
follow
pattern
gene
express
time
similar
select
experi
gene
significantli
induc
ifnb
treatment
express
greatli
reduc
presenc
nab
chang
gene
express
select
gene
valid
real
time
pcr
vitro
experi
character
specif
induct
type
ifnb
ifnalfa
type
ii
ifngamma
ifn
current
progress
select
gene
potenti
new
biomark
ifnb
bioactiv
may
function
role
ms
clinic
respons
ifnb
idibap
hospit
clinic
depart
neurosci
barcelona
spain
neuroinflamm
myelin
degrad
accompani
debilit
brain
diseas
multipl
sclerosi
notori
hard
studi
human
due
logist
obstacl
vivo
imag
central
nervou
tissu
human
retina
past
year
access
via
new
imag
technolog
understood
window
brain
molecular
environ
mimic
brain
tissu
patholog
event
reason
use
nonreson
nearinfrar
raman
spectroscopi
imag
sever
key
molecul
implic
neuron
inflamm
isol
raman
spectra
nadh
fad
krebb
cycl
metabolit
marker
cellular
energi
product
ino
protein
respons
creation
cellular
free
radic
nitric
oxid
lactat
sourc
neuron
energi
report
glucos
metabol
neuron
cytochrom
c
protein
implic
mitochondri
function
trigger
apoptot
cascad
lglutam
major
factor
excitotox
nacetylaspart
neurotransmitt
use
marker
neuron
degrad
abcrystallin
molecular
chaperon
shown
upregul
earli
stage
ms
thought
myelin
antigen
moreov
obtain
raman
spectra
neural
tissu
use
organotyp
cultur
murin
retina
current
measur
level
metabolit
vitro
model
neuroinflamm
use
retin
organotyp
cell
cultur
challeng
lp
hsu
naijen
randal
philippa
keeton
roann
sebesho
boipelo
alli
nasiema
kellaway
lauriston
jacob
muazzam
pulmonari
tuberculosi
tb
primari
infect
tb
caus
gram
posit
bacilli
mycobacterium
tuberculosi
mtb
predomin
extrapulmonari
form
tb
tb
mening
tbm
rel
littl
known
pathogenesi
mechan
underli
neurolog
complic
immunolog
respons
tbm
although
known
microgli
cell
take
mtb
cell
close
relationship
neuron
may
induc
neuron
damag
interestingli
anoth
intracellular
pathogen
listeria
monocytogen
shown
vitro
internalis
neuron
interact
mtb
directli
neuron
cell
remain
larg
unexplor
vitro
infect
model
adopt
characteris
immunolog
tbm
nervou
system
primari
neuron
microglia
cultur
cultiv
hippocampu
cortex
day
old
embryo
primari
cultur
neural
celllin
includ
neuron
neuron
microgli
infect
differ
concentr
laboratori
mtb
differ
time
point
infect
cell
subject
ziehl
neelson
immunofluoresc
stain
analyz
use
microscopi
direct
associ
neuron
cell
multipl
infect
moi
observ
verifi
whether
bacilli
associ
neuron
also
internalis
neuron
confoc
microscopi
employ
gfpexpress
bacilli
clearli
found
insid
neuron
cytoplasm
label
phalloidin
marker
studi
show
neuron
act
target
cell
mtb
compar
seen
microglia
visualis
neuron
actual
show
uptak
mtb
introduc
new
dimens
studi
characterist
tbm
infect
neuron
respons
may
account
neurolog
morbid
seen
patient
suffer
tbm
subacut
scleros
panenceph
sspe
rare
persist
slow
viru
infect
central
nervou
system
cn
caus
measl
viru
mv
affect
children
sever
year
natur
measl
infect
defect
host
immun
respons
caus
mv
propos
possibl
mechan
diseas
develop
investig
regulatori
activ
cell
sspe
patient
stimul
isol
cell
sspe
patient
patient
inflammatori
diseas
icon
healthi
children
con
peptid
pool
mvp
ifng
granzym
b
grb
measur
cultur
supernat
multipl
cytokin
bead
assay
spontan
secret
level
cell
upon
stimul
significantli
higher
sspe
patient
icon
p
p
respect
level
stimul
also
significantli
upregul
compar
con
p
secret
costimul
alon
tcr
stimul
lower
sspe
patient
con
p
p
observ
differ
ifng
grb
level
group
higher
basal
level
higher
respons
mvp
implic
induct
mv
sspe
suppress
immun
respons
higher
secret
regulatori
subunit
name
stimul
sspe
patient
may
also
contribut
suppress
effect
viru
accord
decreas
level
cell
also
associ
suppress
cell
sspe
univers
ferrara
ferrara
itali
arcispedal
anna
ferrara
itali
although
epsteinbarr
viru
ebv
recent
receiv
increasingli
attent
potenti
caus
infecti
agent
multipl
sclerosi
ms
signific
ebvspecif
humor
immun
respons
ms
still
remain
clarifi
aim
studi
investig
csf
serum
level
presenc
intrathec
synthesi
antiebv
igg
ms
control
measur
elisa
techniqu
cerebrospin
fluid
csf
serum
level
antiebv
igg
relapsingremit
rr
ms
patient
group
accord
clinic
magnet
reson
imag
mri
evid
diseas
activ
patient
inflammatori
neurolog
disord
oind
patient
noninflammatori
neurolog
disord
nind
antiebv
nuclear
anti
viral
capsid
antigen
vca
igg
level
express
arbitrari
unit
quantit
intrathec
synthesi
antivca
igg
determin
antibodi
index
ai
presenc
ebvspecif
csf
oligoclon
igg
band
ocb
assess
ms
patient
antigenspecif
immunoblot
csf
concentr
higher
oind
ms
p
b
nind
p
b
antivca
igg
ms
nind
p
b
oind
nind
p
b
igg
serum
level
igg
elev
ms
oind
nind
p
b
serum
titer
igg
invers
p
b
correl
edss
intrathec
igg
product
antivca
igg
indic
antibodi
index
present
small
proport
ms
control
rang
ebvspecif
csfrestrict
ocb
detect
ms
patient
serum
level
antivca
igg
greater
ms
patient
without
ebvspecif
csf
ocb
find
argu
direct
pathogenet
role
ebvtarget
humor
immun
respons
ms
howev
intrathec
releas
ebvspecif
oligoclon
igg
occur
subset
patient
ms
ebv
brain
persist
infect
may
act
cofactor
develop
diseas
accordingli
serum
igg
respons
seem
mark
ms
patient
compar
inflammatori
non
inflammatori
condit
work
support
fism
programma
di
ricerca
fine
specif
b
cell
respons
potenti
link
multipl
sclerosi
infecti
mononucleosi
mechelli
rosella
anderson
jourdan
annibali
viviana
cannoni
stefania
vittori
danila
coarelli
giulia
aloisi
francesca
ristori
giovanni
jame
judith
salvetti
marco
sapienza
univers
rome
itali
oklahoma
medic
research
foundat
oklahoma
citi
unit
state
istituto
superior
di
rome
itali
togeth
epidemiolog
result
serolog
data
humor
respons
epsteinbarr
viru
ebv
multipl
sclerosi
ms
mainstay
associ
viru
diseas
varianc
work
character
diseaseassoci
cell
epitop
ebv
antigen
publish
work
within
humor
ebv
respons
ms
focus
rel
quantiti
antibodi
select
antigen
humor
epitop
order
provid
insight
molecular
mechan
may
link
ebv
ms
evalu
fine
specif
b
cell
respons
diseas
discord
monozygot
mz
twin
character
humor
respons
variou
pathogen
associ
risk
ms
mz
twin
pair
discord
ms
investig
serolog
ebv
human
human
cytomegaloviru
cmv
measl
viru
mv
varicella
zoster
vzv
herp
simplex
hsv
bordetella
pertussi
bp
mean
commerci
avail
assay
twin
pair
plu
healthi
mz
twin
pair
nontwin
ms
patient
healthi
subject
sera
evalu
antibodi
uniqu
maxim
overlap
octapeptid
epsteinbarr
nuclear
seropreval
differ
cmv
mv
vzv
bp
note
affect
unaffect
twin
seven
healthi
twin
ebv
seroneg
mix
result
obtain
twin
pair
retest
kit
differ
laboratori
fine
specif
experi
show
patient
control
produc
antibodi
recogn
glycinealaninerich
portion
expect
ebv
posit
individu
howev
ms
patient
consist
respond
addit
sequenc
near
middl
protein
region
antigen
healthi
ebv
seroposit
individu
surprisingli
pattern
similar
observ
patient
im
independ
respons
microb
well
histori
im
smoke
furthermor
identifi
epitop
fall
within
sequenc
describ
target
b
cell
respons
ms
patient
result
reflect
persist
imlik
humor
immun
respons
ebv
ms
support
epidemiolog
data
increas
risk
ms
individu
clinic
histori
im
suggest
unsatisfactori
control
ebv
infect
ms
p
ruuth
k
lundgren
e
antibodi
specif
domain
hla
interact
risk
factor
multipl
sclerosi
j
neuroimmunol
oct
genet
locu
chromosom
compos
immunerel
gene
regul
herp
enceph
rat
recombin
inbr
strain
abdelmagid
nada
bereczkyveress
biborka
toma
birgit
hubner
norbert
olsson
toma
pravenec
michal
diez
margarita
karolinska
institutet
stockholm
sweden
univers
sweden
maxdelbruckcent
molecular
medicin
berlin
germani
czech
academi
scienc
pragu
czech
republ
herp
simplex
enceph
hse
rare
diseas
high
mortal
signific
morbid
among
survivor
previous
shown
suscept
hse
hoststrain
depend
sever
lethal
hse
develop
inject
human
herp
simplex
type
viru
whisker
area
dark
agouti
da
rat
contrast
penetr
trigemin
ganglia
piebald
virol
glaxo
pvg
rat
remain
complet
asymptomat
aim
studi
identifi
genet
regul
hse
suscept
use
recombin
inbr
rat
strain
studi
suscept
hse
inbr
rat
strain
identifi
spontan
hypertens
rat
shr
suscept
hse
brown
norway
bn
rat
complet
resist
howev
contrari
resist
pvg
penetr
cn
clinic
resist
bn
rat
viru
enter
trigemin
ganglia
brain
stem
immunohistochemistri
reveal
lower
viru
spread
whisker
area
trigemin
ganglia
suscept
shr
compar
resist
bn
rat
although
brain
stem
viru
spread
pronounc
suscept
shr
rat
identifi
gene
respons
suscept
hse
rat
strain
infect
recombin
inbr
line
ril
shr
bn
two
ril
complet
resist
seven
line
show
intermedi
phenotyp
twenti
line
suscept
linkag
analysi
hxbbxh
ril
strain
reveal
signific
quantit
trait
locu
qtl
near
end
rat
chromosom
mb
lr
lod
score
associ
incid
weight
loss
onset
surviv
infect
qtl
compris
sever
immun
relat
gene
addit
sever
suggest
qtl
chromosom
identifi
identif
gene
underli
qtl
may
reveal
pathway
regul
hse
develop
possibl
new
target
therapeut
intervent
avail
data
support
role
viru
ms
pathogenesi
find
constitut
patholog
similar
virusinduc
demyelin
renew
research
interest
hhv
particularli
neurotrop
virus
herp
simplex
viru
varicella
zoster
viru
vzv
hhv
type
project
attempt
highlight
hsv
probabl
contribut
factor
ms
pathogenesi
order
pinpoint
toward
probabl
associ
tri
correl
serum
antibodi
titer
multipl
sclerosi
function
composit
msfc
scale
score
ms
patient
control
ms
group
studi
consist
case
women
men
analog
quit
similar
analog
gender
ms
popul
concern
diseas
type
case
rr
sp
ci
mean
age
particip
year
sd
min
max
mean
diseas
durat
year
sd
min
max
ms
group
particip
systemat
medic
mainli
use
pearson
chisquar
test
correct
fischer
exact
test
case
one
degre
freedom
perform
binomi
sequenti
logist
regress
analysi
discov
whether
capabl
msfc
scale
differenti
ms
patient
healthi
control
enhanc
presenc
igg
hsv
significantli
frequent
present
ms
particip
versu
control
group
particip
n
p
correct
classif
basi
msfc
score
alon
control
group
ms
one
overal
correct
classif
rate
addit
second
predictor
overal
correct
classif
rate
improv
reflect
success
rate
classif
control
ms
group
respect
result
add
current
knowledg
despit
limit
small
number
patient
control
examin
wide
rang
confid
interv
odd
ratio
preval
antibodi
seem
higher
ms
popul
compar
control
furthermor
serum
titer
seem
enhanc
predict
power
msfc
evalu
tool
multipl
sclerosi
natur
histori
higher
msfc
score
favor
better
function
vivo
vpr
molecular
divers
domainand
residuedepend
neuroimmun
neurodegener
na
hong
acharje
shaona
jone
gareth
vivithanaporn
pornpun
noorbakhsh
farshid
barsbi
nicola
maingat
ferdinand
ballanyi
klau
pardo
carlo
cohen
eric
power
christoph
univers
alberta
edmonton
canada
univers
calgari
calgari
canada
john
hopkin
univers
baltimor
unit
state
univers
montreal
montreal
canada
viral
molecular
divers
tissuespecif
inflamm
defin
properti
human
immunodefici
viru
hiv
biolog
pathogen
neuroinflamm
accompani
cytotox
viral
gene
express
repres
chief
effector
mechan
develop
hivassoci
neurovirul
previou
studi
indic
viral
protein
r
vpr
highli
neuropathogen
vitro
vivo
herein
investig
molecular
divers
within
vpr
relationship
neuroinflamm
ensu
neurovirul
divers
accessori
gene
vpr
examin
rna
sequenc
deriv
brain
blood
hivaid
patient
without
hivassoci
dementia
specif
mutat
identifi
amino
acid
residu
within
brainderiv
vpr
sequenc
distinguish
patient
nondement
nd
hivaid
patient
pb
clone
encod
stimul
higher
ifnalpha
transcript
level
human
astrocyt
rel
encod
viru
pb
likewis
vprtranfect
myeloid
cell
also
express
increas
level
ifnalpha
pb
vpr
peptid
amino
acid
contain
motif
induc
cytosol
calcium
flux
expos
human
neuron
human
glia
expos
peptid
show
higher
transcript
level
ifnalpha
prkra
rel
peptid
pb
vpr
contain
peptid
also
neurotox
concentrationdepend
manner
expos
human
neuron
p
b
stereotax
implant
full
length
vpr
peptid
basal
ganglia
mice
reveal
full
length
vpr
peptid
caus
greater
neurobehavior
abnorm
associ
neuron
loss
microgli
activ
compar
peptideimpl
anim
pb
observ
underscor
potent
neuropathogen
properti
vpr
also
impli
viral
divers
might
modul
innat
neuroimmun
neurodegener
uniqu
manner
permit
persist
viral
gene
express
develop
neurovirul
ebv
associ
increas
risk
develop
multipl
sclerosi
ms
mechan
underli
associ
understood
investig
whether
infus
autolog
blymphoblastoid
cell
blcl
induc
ebvrel
herpesviru
papio
puls
relev
peptid
induct
autoimmun
neuroinflamm
initi
central
nervou
system
target
autoimmun
respons
rhesu
monkey
three
group
anim
includ
group
receiv
three
intraven
infus
blcl
day
either
puls
encephalitogen
selfpeptid
myelinoligodendrocyt
glycoprotein
mog
group
mimicri
peptid
major
capsid
protein
cytomegaloviru
group
b
citrullin
group
c
group
b
receiv
day
singl
immun
miner
oil
ifa
group
c
monkey
euthan
day
prior
day
infus
blcl
induc
pbmc
prolifer
three
peptid
top
prolif
respons
blcl
prolifer
declin
termin
blcl
infus
could
sustain
immun
ifa
prolifer
pbmc
group
b
exclus
tcell
wherea
group
c
expans
tcell
observ
antimog
antibodi
form
mostli
boost
use
immunohistochem
stain
could
detect
brain
group
c
monkey
perivascular
infiltr
mainli
cell
togeth
cluster
cell
mening
structur
less
promin
group
b
clinic
sign
autoimmun
enceph
eae
weight
loss
observ
infus
herp
viru
infect
autolog
blcl
puls
mog
relat
peptid
particular
induc
cn
target
autoimmun
reaction
caus
earli
patholog
sign
ms
neuronalastrogli
interact
toxoplasma
gondii
cyst
brain
sandra
halonen
melzer
tyler
cranston
harlan
pitt
betsey
toxoplasma
gondii
protozoan
parasit
preval
human
result
chronic
infect
character
cyst
locat
predominantli
central
nervou
system
immunosuppress
host
aid
patient
infect
reactiv
cyst
brain
result
sever
potenti
fatal
enceph
recent
studi
also
suggest
chronic
infect
may
caus
cryptogen
epilepsi
gondii
infect
suggest
associ
schizophrenia
psychosi
suggest
chronic
infect
may
neuropatholog
effect
immunocompet
host
understand
cyst
stage
parasit
brain
import
chronic
toxoplasma
infect
immunocompet
host
neuron
known
harbor
cyst
vitro
studi
suggest
astrocyt
also
foster
develop
cyst
studi
address
question
whether
neuron
astrocyt
serv
host
cell
gondii
cyst
chronic
infect
mous
brain
mice
infect
gondii
intracellular
local
cyst
analyz
chronic
infect
month
postinfect
brain
infect
mice
fix
cryosect
stain
lectin
fitcdolicho
bifloran
identifi
toxoplasma
cyst
antibodi
gfap
identifi
neuron
astrocyt
respect
analyz
via
confoc
microscopi
cyst
found
occur
almost
exclus
neuron
throughout
chronic
infect
astrocyt
interact
neuronalcyst
frequent
observ
astrocyt
known
associ
neuron
synaps
bidirect
commun
neuron
astrocyt
know
occur
thought
disrupt
mechan
involv
astrocyteneuron
signal
may
result
involv
brain
diseas
astrocyt
associ
toxoplasma
cyst
neuron
observ
studi
suggest
mechan
cyst
affect
glial
cell
physiolog
chronic
toxoplasma
infect
immunocompet
host
previou
infect
murin
gamma
herpesviru
modifi
cours
eae
mice
univers
british
columbia
vancouv
canada
etiolog
ms
known
howev
epidemiolog
data
geograph
pattern
indic
ms
trigger
environment
factor
genet
suscept
individu
number
recent
find
identifi
epsteinbarr
viru
ebv
put
environment
trigger
ms
mechan
viru
caus
ms
remain
elus
inconsist
ebv
detect
brain
ms
patient
indic
ebv
could
trigger
diseas
without
directli
infect
cn
ebv
infect
restrict
human
use
murin
gamma
herpesviru
mghv
murin
homolog
ebv
examin
mghv
infect
could
aid
enhanc
autoimmun
reaction
cn
mice
infect
mghv
five
week
later
eae
induc
mice
previous
infect
mghv
develop
eae
earlier
sever
diseas
cours
show
sign
paralysi
neurolog
symptom
ataxia
mice
previous
infect
anoth
viru
lcmv
show
eae
cours
compar
uninfect
eae
mice
confirm
increas
eae
sever
phenomenon
specif
mghv
infect
intriguingli
mghv
infect
mice
show
cell
infiltr
spinal
cord
brain
parenchyma
wherea
cell
absent
brain
parenchyma
uninfect
eae
mice
cell
product
mog
restimul
vitro
detect
uninfect
eae
mice
absent
cell
mghv
eae
mice
fac
analysi
cell
activ
marker
show
increas
cell
activ
mghv
infect
mice
without
correl
paralysi
develop
serum
cytokin
chemokin
like
ifng
tnfa
significantli
increas
mghv
infect
mice
differ
time
point
post
eae
induct
howev
differ
correl
cell
infiltr
brain
date
result
show
previou
infect
mghv
enhanc
modifi
eae
symptom
absenc
product
infect
mice
suggest
diseas
might
trigger
differ
pathogen
cell
subset
typic
eae
experi
plan
analyz
composit
infiltr
brain
spinal
cord
well
assess
role
innat
immun
develop
eae
mghv
infect
mice
rare
minut
reactiv
jc
viru
natalizumab
longterm
treat
multipl
sclerosi
patient
cross
section
multicent
studi
retard
look
probabl
role
cmv
infect
psychomotor
develop
immunolog
mechan
involv
process
children
month
age
neurolog
disabl
unknown
caus
control
sexagematch
analyz
cmvspecif
igg
determin
enzymelink
immunosorb
assay
serumcerebrospin
fluid
pair
sampl
ai
quantifi
specif
anticmvigg
detect
patient
control
group
patient
suffer
psychomotor
retard
sinc
patholog
ai
also
found
patient
psychomotor
retard
one
patient
control
group
posit
ai
match
polymeras
chain
reaction
pcr
filter
paper
use
biochem
screen
kept
neonat
period
ai
data
avail
patient
pcr
simultan
posit
neg
seven
case
one
patient
belong
control
group
show
pcr
posit
ai
neg
main
clinic
manifest
patient
congenit
infect
seizur
chorioretin
hepatosplenomegali
microcephali
macrocephali
conclus
iggcmvai
consid
import
diagnost
tool
determin
cmv
infect
involv
patient
suffer
psychomotor
congenit
impair
trypanosoma
cruzi
parasit
protozoan
abl
colon
central
nervou
system
cn
induc
meningoenceph
restrict
acut
phase
infect
regardless
sever
chronic
myocard
observ
onethird
immunocompet
patient
cn
inflamm
parasit
selfresolv
chronic
phase
howev
immunosuppress
patient
cn
major
site
infect
reactiv
chronic
infect
lead
sever
frequent
fatal
meningoenceph
howev
remain
unknown
whether
cognit
behaviour
alter
cruzi
infect
sever
aspect
cn
abnorm
detect
chagas
patient
replic
cruziinfect
mice
model
parasit
infect
glial
cell
astrocyt
microglia
provok
sever
acut
meningoenceph
parallel
parasitemia
peak
parasit
scarc
meningoenceph
absent
chronic
infect
contrast
mice
cruzi
parasit
cn
selfresolv
absenc
inflamm
herein
analyz
cognit
deficit
learn
memori
behaviour
alter
anxieti
depress
adopt
infect
mice
resist
suscept
cruzielicit
meningoenceph
sever
test
includ
open
field
locomotoranxieti
inhibitori
avoid
shock
object
recognit
memori
well
tail
suspens
depress
perform
contrast
suscept
mice
resist
one
show
reduct
number
cross
number
rear
cruzi
infect
indic
alter
locomotorexploratori
activ
neither
differ
noninfect
infect
resist
suscept
mice
demonstr
stepdown
latenc
inhibitori
avoid
shock
test
howev
cruziinfect
anim
lineag
present
similar
time
laps
explor
familiar
novel
object
indic
inabl
form
memori
task
interestingli
tail
activin
act
member
tgfbeta
superfamili
multifunct
cytokin
involv
immun
system
inflammatori
respons
neuroprotect
properti
among
organ
act
found
central
nervou
system
elev
cerebrospin
fluid
patient
mening
act
releas
microgli
cell
upon
stimul
bacteri
tlragonist
shown
modul
releas
cytokin
microgli
cell
investig
whether
act
influenc
phagocytosi
escherichia
coli
caus
mening
microgli
cell
primari
mous
microgli
cell
stimul
differ
concentr
act
overnight
follow
costimul
agonist
tripalmitoylsglycerlcystein
lp
lipopolysaccarid
cpg
oligonucleotid
contain
unmethyl
cytosineguanosin
motif
hour
microgli
cell
challeng
cfuwel
e
coli
min
co
bacteri
exposur
extracellular
bacteria
kill
treatment
gentamicin
minut
cell
lyse
distil
water
number
intracellular
bacteria
determin
quantit
plate
serial
dilut
mannwhitneyutest
follow
bonferroni
multipl
comparison
test
use
analys
result
pretreat
act
influenc
phagocytosi
rate
unstimul
microgli
cell
concentr
nm
nm
nm
pretreat
act
increas
phagocytosi
rate
microgli
cell
activ
agonist
highest
effect
achiev
pretreat
nm
act
led
increas
phagocytosi
rate
microlgi
cell
stimul
p
increas
phagocytosi
rate
microgli
cell
stimul
lp
p
cpg
p
higher
concentr
nm
act
seem
inhibitori
effect
phagocytosi
pretreat
act
increas
phagocytosi
e
coli
murin
microglia
cell
activ
agonist
princip
tlr
involv
recognit
bacteria
find
provid
evid
role
act
defens
bacteri
infect
suggest
act
stimul
effect
phagocytosi
cn
infect
acut
stress
may
activ
microgli
cell
brain
via
modul
adren
corticosteron
sugama
shuei
takenouchi
takato
hiroshi
kitani
hashimoto
makoto
nippon
medic
school
tokyo
japan
nation
institut
agrobiolog
scienc
tsukuba
japan
nation
institut
agrobiolog
scienc
tsukuba
japan
tokyo
metropolitan
institut
neurosci
tokyo
japan
microglia
report
involv
variou
neurodegen
diseas
alzheim
parkinson
diseas
previou
studi
demonstr
stress
experi
could
induc
morpholog
microgli
activ
yet
mechan
stressinduc
microgli
activ
remain
elucid
present
studi
investig
mechan
acut
stress
induc
microgli
activ
rodent
brain
adrenalectom
rat
adx
shamoper
rat
shm
adx
plu
corticosteroneadminist
rat
adx
cort
expos
h
period
restraint
combin
water
immers
stress
prior
brain
analysi
immunohistochemistri
real
time
pcr
quantif
control
condit
morpholog
differ
immunoreact
microglia
observ
shamoper
shm
adx
adx
plu
corticosteron
adx
cort
rat
exposur
acut
stress
induc
morpholog
microgli
activ
significantli
adx
follow
adx
cort
shm
rat
addit
exposur
acut
stress
induc
mhc
class
ii
posit
microglia
cell
shm
rat
substanti
induc
hmc
class
iiposit
activ
microgli
cell
hippocampu
adx
rat
number
activ
microglia
slightli
decreas
administr
cort
furthermor
singl
session
acut
stress
increas
ino
brain
shm
rat
howev
adx
rat
acut
stress
significantli
induc
increas
express
ino
messag
wherea
significantli
decreas
adx
cort
cultur
microgli
cell
glucocorticoid
administr
significantli
suppress
sever
line
evid
indic
antibodi
serv
diseas
marker
also
play
pivot
role
pathogenesi
neuromyel
optica
nmo
anim
model
recent
provid
evid
pathogen
vivo
igg
reproduc
patholog
chang
strikingli
similar
nmo
patient
passiv
transfer
rat
experiment
autoimmun
encephalomyel
eae
although
observ
suggest
pathogen
nmo
still
remain
unclear
whether
antibodi
diseasemodifi
factor
primari
caus
diseas
present
studi
examin
whether
induc
astrocyt
cytotox
absenc
cn
antigenspecif
cell
treat
complet
freund
adjuv
cfa
alon
eightweekold
rat
given
daili
inject
purifi
igg
collect
nmo
control
patient
four
consecut
day
immunohistolog
examin
reveal
remark
swell
astrocyt
perivascular
loss
gfapand
ir
nmo
group
activ
lesion
nmo
group
accompani
perivascular
deposit
immunoglobulin
activ
complement
examin
pivot
role
complement
astrocyt
cytotox
recipi
rat
pretreat
cobra
venom
factor
inhibit
complement
cascad
addit
predomin
infiltr
granulocyt
observ
activ
lesion
nmo
group
accompani
remark
product
present
studi
show
rat
pretreat
complet
freund
adjuv
cfa
induc
pathogen
effect
absenc
cn
antigenspecif
cell
find
strongli
support
primari
role
pathogenesi
nmo
suggest
danger
signal
provid
nonspecif
inflamm
trigger
harbor
antibodi
develop
nmo
express
observ
lp
administr
focus
possibl
gender
differ
enzym
acut
immedi
neuroinflammatori
process
observ
septic
shock
analyz
influenc
intra
periton
lp
inject
mgkg
distribut
pattern
express
level
mrna
splice
variant
male
femal
mice
brain
character
cell
popul
involv
pde
alter
establish
doubl
situ
hybrid
histochemistri
immunohistochemistri
observ
mrna
level
show
clear
chang
femal
postinject
wherea
male
alter
express
less
evid
peak
treatment
furthermor
found
downregul
reflect
lower
percentag
olg
express
mrna
knowledg
mrna
express
mous
brain
sex
alter
provok
lp
administr
might
help
us
clarifi
sexrel
differ
suscept
autoimmun
diseas
osteopontin
opn
adhes
glycoprotein
link
varieti
pathophysiolog
process
neuroprotect
properti
ischem
injuri
investig
question
whether
opn
could
act
opsonin
diseas
model
brain
investig
postischem
express
local
opn
mrna
protein
rat
model
ischem
stroke
addit
character
subcellular
local
opn
protein
particular
relat
phagocytosi
ischem
core
use
ultrastructur
techniqu
middl
cerebr
arteri
rat
occlud
h
intralumin
thread
method
recircul
ischem
core
assess
fluorojad
stain
loss
cresylvioletstain
cell
microtubuleassoci
immunoreact
induct
opn
mrna
occur
activ
microglia
macrophag
ischem
core
day
one
reperfus
sustain
least
day
three
day
reperfus
opn
express
local
major
cell
larg
round
ameboidlik
brain
macrophag
opn
immunohistochemistri
show
homogen
label
profil
predomin
ischem
core
patchlik
area
devoid
opn
immunoreact
addit
concomit
induct
opn
hyaluron
acid
receptor
identifi
receptor
osteopontin
observ
ischem
core
ultrastructur
immunohistochemistri
show
opn
label
associ
membran
neuron
fragment
variou
size
scatter
ischem
core
addit
intens
label
observ
golgi
complex
peripheri
engulf
neuron
fragment
within
macrophag
data
indic
increas
immunoreact
opn
share
overlap
express
pattern
ischem
core
occur
surfac
neuron
fragment
opn
also
local
golgi
complex
neuron
fragment
intern
macrophag
suggest
opn
secret
macrophag
may
act
opsonin
therebi
facilit
phagocytosi
microgliamacrophag
ischem
core
rat
model
stroke
work
support
basic
scienc
research
program
nation
research
foundat
korea
nrf
fund
ministri
educ
scienc
technolog
bengurion
univers
negev
beersheva
israel
microglia
central
nervou
system
cn
leukocyt
compris
nonneuron
cell
popul
aris
hematopoiet
system
colon
cn
develop
adult
cn
microglia
provid
first
line
defens
pathogen
howev
grow
bodi
evid
point
uniqu
role
maintain
homeostasi
neuron
network
crucial
impact
neurodegen
process
cellular
molecular
mechan
microgli
phenotyp
gain
maintain
regul
healthi
diseas
brain
albeit
poorli
understood
herein
establish
exvivo
system
mous
hematopoiet
precursor
cell
bm
dendrit
cell
bmdc
cultur
organotyp
hippocamp
slice
cultur
ohsc
examin
dynam
differenti
microglialik
cell
studi
demonstr
place
cellular
milieu
brain
dc
adopt
microglia
ramifi
morpholog
process
last
approxim
seven
day
microgli
chemokin
receptor
involv
commun
neuron
slightli
induc
day
cultur
abundantli
express
major
differenti
cell
day
accompani
increas
express
microgli
calciumbind
protein
involv
cell
mobil
phagocytosi
concomitantli
adopt
microglialik
featur
dc
marker
mhc
class
ii
reduc
indic
attenu
dc
phenotyp
assum
differenti
process
impos
uniqu
complex
net
signal
provid
cellular
milieu
cn
exvivo
system
may
thu
serv
use
tool
studi
array
signal
provid
cn
milieu
induc
function
chang
develop
microglia
thu
shed
light
function
cell
healthi
diseas
brain
compar
analysi
gene
express
profil
microglia
demyelin
lesion
osmot
demyelin
syndrom
rat
model
ation
associ
local
inflamm
immun
cell
infiltr
mediat
cytokin
direct
effect
cytokin
oligodendrocyt
surviv
function
larg
unknown
develop
ex
vivo
model
function
myelin
util
organotyp
cerebellar
slice
cultur
studi
myelin
real
time
gener
slice
cultur
mice
express
green
fluoresc
protein
gfp
proteolipid
protein
plp
promot
gfp
express
oligodendrocyt
lineag
cell
includ
matur
cell
bodi
myelin
process
oligodendrocyt
progenitor
cell
slice
cultur
viabil
assess
propidium
iodid
uptak
dead
cell
viabl
cultur
maintain
robust
gfp
express
sever
week
myelin
tract
individu
oligodendrocyt
morpholog
identifi
allow
qualit
quantit
analysi
microscopi
fluoresc
signal
pattern
studi
direct
effect
immun
molecul
myelin
includ
proinflammatori
cytokin
ifng
tnfa
gmcsf
antiinflammatori
cytokin
individu
cytokin
cytokin
specif
combin
readili
induc
cell
death
slice
cultur
myelin
directli
enhanc
inhibit
specif
cytokin
slice
cultur
independ
overal
cell
viabil
next
assay
direct
effect
cytokin
myelin
deand
regener
follow
demyelin
insult
demyelin
indic
loss
gfp
signal
induc
slice
cultur
treatment
lysolecithin
de
novo
myelin
format
subsequ
observ
return
baselin
level
sever
day
individu
cytokin
cytokin
specif
combin
observ
inhibit
enhanc
myelin
regener
follow
demyelin
insult
cerebellar
slice
cultur
effect
mean
rapidli
object
assay
oligodendrocyt
surviv
function
myelin
real
time
treatment
demonstr
cytokin
modul
inflammatori
microenviron
cn
directli
enhanc
inhibit
myelin
degener
de
novo
format
delay
opposit
effect
kinin
astrocyt
prostaglandin
synthesi
bengurion
univers
beersheva
israel
shown
kinin
receptor
express
brain
pathophysiolog
condit
inflamm
howev
much
less
known
possibl
role
kinin
especi
bradykinin
brain
inflamm
although
kinin
thought
immedi
effect
peptid
may
also
exert
longer
protein
synthesi
depend
action
evalu
possibl
assess
regul
prostaglandin
synthesi
h
bradykinin
lysdesarg
bradykinin
receptor
agonist
treatment
rat
neonat
astrocyt
bradykinin
dose
depend
stimul
basal
lipopolysaccharid
lp
induc
prostaglandin
product
wherea
exposur
astrocyt
receptor
agonist
decreas
basal
lpsinduc
prostaglandin
releas
dosedepend
manner
measur
radioimmunoassay
ria
kinin
effect
synthesi
complet
abrog
actinomycind
cycloheximid
suggest
de
novo
synthesi
protein
bradykinin
also
increas
protein
level
receptor
agonist
decreas
protein
express
chang
protein
level
treatment
either
kinin
data
suggest
delay
feedback
regulatori
mechan
kinin
astrocyt
inflamm
wherebi
astrocyt
prostaglandin
synthesi
initi
enhanc
bradykinin
eventu
block
kinin
breakdown
product
act
receptor
least
part
presum
feedback
loop
could
mediat
de
novo
protein
synthesi
research
support
israel
scienc
foundat
grant
distinct
alter
glial
gap
junction
protein
normal
appear
multipl
sclerosi
brain
sargiannid
iren
markoulli
kyriaki
hadjisavva
andrea
reynold
richard
kleopa
kleopa
cypru
institut
neurolog
genet
nicosia
cypru
cypru
institut
neurolog
genet
nicosia
cypru
cypru
institut
neurolog
genet
nicosia
cypru
imperi
colleg
faculti
medicin
london
unit
kingdom
cypru
institut
neurolog
genet
nicosia
cypru
gap
junction
gj
defici
mice
well
patient
mutat
oligodendrocyt
astrocyt
gj
protein
present
differ
degre
transient
chronic
cn
demyelin
although
glial
gj
essenti
integr
cn
myelin
role
multipl
sclerosi
ms
patholog
remain
unknown
studi
examin
express
glial
gj
protein
postmortem
human
brain
tissu
ms
patient
control
kindli
provid
uk
ms
tissu
bank
unfix
brain
sampl
ms
nonm
control
brain
analyz
section
character
immunostain
antibodi
myelin
oligodendrocyt
glycoprotein
mog
microglia
marker
section
includ
normal
appear
cortex
nacx
normal
appear
white
matter
nawm
demyelin
lesion
white
matter
cortex
brain
averag
imag
nawm
nacx
differ
brain
area
per
case
evalu
studi
microglia
load
access
degre
inflamm
express
analyz
immunoblot
real
time
pcr
result
control
age
surprisingli
express
main
gj
protein
larg
myelin
fiber
increas
ms
nawm
compar
control
immunoblot
real
time
pcr
contrast
express
major
astrocyt
partner
oligodendrocyteastrocyt
gj
markedli
reduc
ms
nawm
compar
control
express
cell
bodi
proxim
process
oligodendrocyt
significantli
alter
group
studi
provid
evid
signific
alter
express
glial
gj
protein
ms
nawm
furthermor
glial
gj
protein
differenti
involv
may
play
distinct
role
inflammatori
environ
even
without
demyelin
dysfunct
gj
network
nawm
may
contribut
chronic
progress
ms
patholog
project
fund
cypru
research
promot
foundat
grant
cypru
telethon
injur
central
nervou
system
cn
astrocyt
appear
key
compon
reactiv
gliosi
reactiv
astrocytosi
defin
hypertrophi
often
hyperplasia
cell
associ
chang
gene
express
like
increas
synthesi
cytokin
notch
pathway
implic
mani
aspect
cn
develop
function
recent
notch
pathway
identifi
involv
inflammatori
event
cn
address
role
modul
ifngamma
induc
inflamm
astrocyt
use
sirna
mediat
silenc
notch
ligand
primari
astrocyt
cultur
treat
activ
ifng
rna
extract
perform
hour
hour
cell
activ
studi
use
affymetrix
rat
gene
st
array
gene
examin
alter
gene
express
astrocyt
treat
dna
microarray
data
filtrat
intens
signal
xfold
chang
pvalu
reveal
around
gene
vari
comparison
ctr
ifng
ifng
sever
cluster
gene
involv
variou
cellular
process
immun
respons
cell
signal
cell
adhes
mani
other
alter
inhibit
notch
pathway
previou
result
show
modul
jak
stat
pathway
could
confirm
microarray
studi
microarray
analysi
allow
us
identifi
sever
gene
pathway
ex
egf
chemokinesign
induc
ifngamma
implic
inflamm
regul
inhibit
moreov
realtim
pcrmicroarray
comparison
result
sever
target
gene
identifi
reveal
excel
correl
downregul
observ
sever
gene
includ
member
jakstatsoc
pathway
confirm
realtim
pcr
result
could
indic
possibl
crosstalk
signal
pathway
notch
pathway
overal
microarray
studi
highlight
import
notch
pathway
could
observ
import
gene
number
variat
induc
treatment
astrocyt
confirm
downregul
induc
decreas
express
element
characterist
inflamm
analysi
give
us
mean
identifi
possibl
link
major
pathway
multipl
sclerosi
ms
common
neurodegen
diseas
young
adult
hallmark
ms
autoimmun
attack
oligodendrocyt
myelin
cell
central
nervou
system
result
demyelin
ultim
caus
neuron
degener
remyelin
one
therapeut
strategi
amelior
diseas
progress
restor
neuron
function
requir
differenti
oligodendrocyt
progenitor
cell
opc
present
around
mslesion
surprisingli
antitnfa
therapi
known
regul
mediat
inflamm
suppos
reduc
autoimmun
attack
oligodendrocyt
caus
exacerb
mssymptom
may
least
partial
due
impair
repair
mechan
involv
activ
sinc
remyelin
inhibit
cuprizonetr
tnfreceptor
defici
mice
select
activ
human
design
singl
chain
tnf
oligomer
trimer
domain
tenascin
c
therebi
function
mimick
membranebound
tnf
determin
potenti
benefici
activ
select
activ
oligodendrocyt
precursor
cell
opc
prepar
primari
cultur
transgen
mice
express
human
mice
interestingli
human
predominantli
express
opc
later
stage
oligodendrocyt
develop
therefor
analyz
respons
activ
exclus
opc
result
indic
activ
protect
opc
apoptosi
induc
oxid
stress
find
accord
propos
neuroprotect
role
signal
support
futur
vivo
studi
remyelin
function
appropri
mous
model
multipl
sclerosi
clinic
experiment
neuroimmunolog
depart
neurolog
heinrichheineunivers
germani
matrix
metalloproteinas
mmp
repres
group
enzym
mediat
deleteri
effect
inflam
central
peripher
nervou
system
recent
evid
howev
indic
proteinas
also
crucial
involv
myelin
repair
estrogen
receptor
er
nongenom
receptor
mer
implic
mediat
neuroprotect
antiinflammatori
pathway
central
nervou
system
wherea
function
influenc
ligand
pn
suffici
studi
aim
studi
elucid
role
er
schwann
cell
sc
regul
express
mmp
dorsal
root
ganglia
drg
isol
rat
pup
cultiv
ex
vivo
model
conveni
studi
myelin
format
differenti
prolifer
glial
cell
physiolog
environ
furthermor
purifi
sc
neonat
rat
prepar
drg
well
sc
express
detect
protein
well
rnalevel
wherea
era
detect
sc
protein
level
membraneimperm
conjug
estradiolbsa
exhibit
signific
modifi
influenc
gene
express
thu
exist
nongenom
estrogen
signal
pathway
schwann
cell
assum
addit
sc
drg
treat
select
er
ligand
myelin
assess
western
blot
analysi
sudan
black
stain
express
activ
matrix
metalloproteinas
mmp
glia
associ
gene
measur
rtpcr
zymographi
stimul
specif
agonist
led
modif
pathway
concern
prolifer
differenti
myelin
synthesi
express
increas
lipopolysaccharid
stimul
modifi
well
depriv
intrins
estrogen
product
perform
aromatas
inhibit
formestan
reveal
opposit
effect
investig
reveal
genom
well
nongenom
act
er
function
express
sc
differenti
stimul
influenc
basic
glia
cell
pathway
includ
mmp
activ
myelin
whether
presum
neuroprotect
myelinform
properti
use
treatment
disord
peripher
nervou
system
current
studi
gammasecretas
import
microglia
activ
alzheim
diseas
farfara
dorit
trudler
dorit
segevamzaleg
niva
galron
ronit
frenkel
dan
telaviv
univers
telaviv
israel
cleavag
amyloid
precursor
protein
app
gammasecretas
play
import
role
pathogenesi
alzheim
diseas
ad
thu
gammasecretas
target
develop
ad
therapeut
specif
inhibitor
current
clinic
trial
nevertheless
work
aim
investig
role
gammasecretas
mediat
microglia
activ
toward
clear
brain
alzheim
amyloid
deposit
show
gammasecretas
inhibitor
impair
microglia
activ
seen
gene
express
protein
level
migrat
abil
result
reduct
solubl
betaamyloid
abeta
phagocytosi
moreov
adult
microglia
isol
presenilin
knock
mice
bear
specif
deplet
gammasecretas
catalyt
site
impair
clear
insolubl
abeta
ad
mous
brain
compar
microglia
wt
mice
work
suggest
first
time
role
gammasecretas
ad
regul
microglia
activ
import
clear
amyloid
deposit
thu
investig
gammasecretas
mediat
cellular
pathway
microglia
may
provid
use
therapeut
intervent
target
ad
neurodegen
diseas
demonstr
import
role
develop
malign
progress
astrocytoma
promot
angiogenesi
cell
prolifer
resist
apoptosi
radiat
control
express
level
cytokin
thu
essenti
retain
cell
homeostasi
prevent
malign
transform
guarante
transient
express
cytokin
contain
aurich
element
untransl
region
utr
mrna
element
confer
instabl
ensur
rapid
mrna
degrad
transcript
mrna
contain
six
line
describ
short
half
life
sever
cell
system
vari
minut
sever
extracellular
stimuli
describ
stabil
effect
mrna
among
other
beta
tnf
proven
sever
system
kinas
involv
mrna
stabil
induct
hand
protein
kinas
c
pkc
activ
associ
mrna
stabil
mrna
last
decad
insight
gain
physiolog
consequ
upregul
glioma
howev
molecular
mechan
involv
remain
larg
unclear
focu
molecular
mechan
lead
excess
product
human
astrocytoma
cell
line
cell
previous
shown
synergist
product
combin
betaadrenerg
tnfreceptor
trigger
cell
due
transcript
enhanc
mechan
describ
excess
product
tripl
induct
isoproterenol
proinflammatori
cytokin
tnf
beta
due
addit
molecular
mechan
involv
mrna
stabil
beta
surprisingli
effect
pkcbut
involv
hur
transloc
cytoplasm
involv
pkc
isoform
novel
subtyp
famili
base
pharmacolog
inhibitor
experi
conclus
mrna
stabil
effect
beta
human
astrocytoma
cell
abl
induc
potent
synergist
express
might
import
physiolog
consequ
immunochem
chang
neural
cell
ischem
rat
retina
evok
ischemiareperfus
injuri
venou
cauter
shin
jiman
lee
jonghyun
chun
myunghoon
oh
suja
understand
pathophysiolog
glaucomat
neural
degener
varieti
experiment
evok
ischem
model
use
present
studi
aim
investig
whether
attitud
neural
cell
differenti
appear
ischem
retina
evok
ischemiareperfus
injuri
ir
evok
venou
cauter
vc
ir
made
elev
intraocular
pressur
iop
iop
rais
maintain
pressur
mm
hg
hour
via
needl
cannul
anterior
chamber
reperfus
use
spraguedawley
rat
vc
made
electr
cauter
three
episcler
vein
attitud
neuron
cell
analyz
calbindin
nno
osteopontin
opn
immunohistochemistri
glial
cell
griffonia
simplicifolia
isolectin
gsi
gfap
immunohistochemistri
calbindin
express
horizont
cell
amacrin
cell
ganglion
cell
normal
state
ir
retina
calbindin
express
slightli
downregul
ganglion
cell
normal
vc
nno
express
amacrin
displac
amacrin
cell
rare
popul
bipolar
cell
normal
nno
express
bipolar
cell
slightli
increas
cell
number
vc
retina
opn
express
popul
ganglion
cell
normal
opn
express
slightli
increas
earlier
stage
vc
label
microgli
cell
appear
inner
plexiform
layer
ipl
near
blood
vessel
addit
endotheli
cell
normal
microgli
cell
popul
ipl
earlier
ir
retina
gfap
express
astrocyt
nerv
fiber
layer
ganglion
cell
layer
normal
gfap
express
ir
retina
appear
gradual
proxim
distal
radial
process
mueller
glial
cell
vc
similar
find
demonstr
larg
specif
chang
neuron
cell
attitud
remark
glial
cell
activ
rat
retina
respons
ir
injuri
vc
microgli
activ
appear
vigor
ir
retina
vitro
differenti
lineageneg
bone
marrow
cell
monocyt
microglialik
cell
microglia
believ
origin
hematopoiet
cell
invad
central
nervou
system
cn
develop
even
adulthood
hematopoieticderiv
cell
report
develop
resid
perivascular
macrophag
microglia
although
report
monocyt
invad
differenti
microglia
detail
mechan
differenti
transform
microgli
cell
fulli
understood
demonstr
murin
microgli
cell
show
morpholog
form
vitro
small
round
cell
express
trigger
receptor
express
myeloid
weakli
express
major
histocompat
complex
mhc
class
ii
larg
flat
cell
express
moreov
lineageneg
bone
marrow
ln
cell
cultur
primari
mix
glial
cultur
cell
could
differenti
small
round
microglialik
cell
despit
absenc
express
ln
cell
derivedsmal
round
cell
microglia
similar
term
cell
surfac
molecul
prolif
capac
furthermor
show
monocyt
also
differenti
small
round
microglialik
cell
cultur
primari
mix
glial
cultur
analysi
confoc
microscopi
reveal
ln
cell
derivedsmal
round
cell
posit
gfapposit
astrocyt
cellcel
contact
glial
cell
especi
astrocyt
may
necessari
maintain
small
round
shape
immatur
cell
express
induct
vascular
endotheli
growth
factor
mrna
glial
cell
follow
focal
cerebr
ischemia
rat
recent
studi
report
induct
vascular
endotheli
growth
factor
receptor
vegfr
receptor
vegfc
vegfd
implic
like
pathophysiolog
condit
includ
neuron
damag
glial
reaction
respons
cerebr
ischemia
howev
remain
unclear
whether
involv
pathophysiolog
stroke
identifi
whether
involv
pathophysiolog
stroke
investig
spatiotempor
regul
mrna
transient
focal
cerebr
ischemia
rat
focal
cerebr
ischemiareperfus
model
induc
middl
cerebr
arteri
occlus
use
investig
spatiotempor
regul
mrna
situ
hybrid
rtpcr
moreov
doubleand
triplelabel
techniqu
use
identifi
phenotyp
cell
express
identifi
origin
brain
macrophag
also
examin
cellular
local
mrna
organotyp
hippocamp
slice
cultur
subject
ischemialik
oxygenglucos
depriv
increas
express
ischem
core
could
attribut
brain
macrophag
wherea
periinfarct
region
predominantli
express
reactiv
astrocyt
ischem
core
induc
almost
brain
macrophag
larg
round
ameboidlik
brain
macrophag
contrast
small
proport
microgli
cell
periinfarct
region
express
receptor
doublelabel
cell
highli
activ
stellat
microgli
cell
subpopul
brain
macrophag
posit
proteoglycan
show
prolif
activ
addit
vitro
model
stroke
reveal
signific
induct
activ
microgli
cell
indic
infiltr
exogen
macrophag
express
focal
ischemia
data
demonstr
induc
reactiv
astrocyt
possibl
infiltr
bloodborn
macrophag
focal
ischemia
suggest
may
involv
glial
reaction
possibl
recruit
monocyt
macrophag
ischem
insult
work
support
korea
healthcar
technolog
r
project
ministri
health
welfar
famili
affair
grant
number
scholarship
seoul
scienc
fellowship
seoul
citi
shin
yj
injuri
peripher
gustatori
nerv
initi
central
immun
respons
brainstem
bartel
dianna
l
finger
thoma
e
chorda
tympani
nerv
ct
pure
sensorycel
bodi
lie
genicul
ganglion
peripher
process
innerv
lingual
tast
bud
central
process
extend
nucleu
solitari
tract
nt
ct
prone
injuri
variou
inner
ear
surgeri
result
destruct
peripher
process
ganglion
cell
central
project
remain
intact
though
nerv
success
reinnerv
tast
bud
within
week
damag
tast
disturb
persist
month
perceptu
disturb
may
indic
central
nervou
system
cn
alter
sinc
peripheri
appear
near
normal
reinnerv
trauma
mixedfunct
pure
motor
nerv
involv
retrograd
chang
motoneuron
cn
neuron
cell
death
inflammatori
respons
involv
resid
immun
cell
microglia
sought
test
whether
microglia
respond
nt
system
neuron
degener
occur
cn
despit
peripher
damag
adult
mice
ct
cut
unilater
middl
ear
anim
surviv
day
time
n
microglia
detect
nt
use
antibodi
microglia
injur
side
activ
morpholog
short
thick
process
rag
nuclei
uninjur
side
remain
rest
state
highli
ramifi
alreadi
day
post
lesion
microglia
evid
lesion
side
day
post
injuri
microglia
number
injur
side
control
level
return
normal
day
chang
number
intact
side
origin
addit
microglia
assess
chimer
bonemarrow
graft
anim
show
evid
inmigr
peripheri
nerv
injuri
stain
mitot
cell
show
day
post
lesion
microglia
within
nt
lesion
side
began
prolifer
cell
also
indic
matur
microglia
prolifer
gener
addit
cell
matur
microglia
nearbi
region
brain
also
seem
migrat
area
ct
termin
sinc
microgli
number
decreas
region
ventral
ct
fiber
day
post
injuri
summari
damag
pure
sensori
nerv
evok
rapid
chang
microglia
near
termin
zone
nerv
although
nerv
fiber
remain
intact
suggest
microglia
detect
signal
damag
nondegener
sensori
termin
liver
x
receptor
lxr
ligand
activ
nuclear
receptor
play
import
role
control
cellular
wholebodi
cholesterol
homeostasi
lxr
isoform
lxra
express
central
nervou
system
cn
involv
regul
brain
cholesterol
metabol
howev
presenc
oligodendrocyt
olg
function
olg
cholesterol
homeostasi
remain
larg
unknown
high
cholesterol
level
olg
essenti
myelin
membran
growth
matur
cn
order
gain
insight
cholesterol
homeostasi
olg
express
level
lxr
target
gene
investig
neonat
matur
rat
olg
cultur
use
quantit
real
time
pcr
lxr
well
lxr
target
gene
apo
ldlr
detect
primari
olg
cell
type
treatment
primari
neonat
rat
olg
lxr
agonist
induc
express
sever
establish
lxr
target
gene
includ
apo
lxra
furthermor
treatment
olg
result
enhanc
cholesterol
efflux
presenc
apolipoprotein
ai
high
densiti
lipoprotein
particl
lxr
activ
also
induc
morpholog
chang
data
show
lxr
target
gene
present
olg
regul
cholesterol
homeostasi
minocyclin
forc
microglia
earli
activ
stage
independ
activ
histori
bert
dri
eef
janssen
daniel
rigo
jeanmichel
microglia
consid
resid
macrophag
central
nervou
system
gener
accept
microgli
cell
shift
differ
activ
phenotyp
respons
variou
stimuli
depend
stimulu
microglia
execut
proinflammatori
antiinflammatori
action
term
eg
nitric
oxid
cytokin
product
investig
microgli
phenotyp
use
electrophysiolog
approach
previous
postul
rest
microglia
linear
currentvoltag
iv
relationship
upregul
inward
rectifi
potassium
kir
current
earli
activ
state
strong
activ
function
express
delay
rectifi
kdr
potassium
current
increas
addit
kir
current
aim
studi
discrimin
differ
activ
stage
proand
antiinflammatori
term
electrophysiolog
express
profil
microglia
ivrelationship
primari
cultur
rat
microglia
measur
use
wholecel
patchclamp
techniqu
ivrelationship
compar
control
lipopolysaccharidestimul
lp
ngml
minocyclinecondit
cell
control
condit
microglia
show
linear
ivrelationship
compar
previous
describ
rest
microglia
fifti
percent
control
cell
increas
express
kir
current
pa
mv
n
typic
earli
activ
microglia
presenc
kir
pa
mv
larg
kdr
pa
mv
n
current
lpsstimul
cell
agreement
previous
publish
result
minocylin
antibiot
antiinflammatori
drug
decreas
product
microglia
therefor
appli
minocyclin
lpsstimul
cell
order
bring
microglia
rest
condit
expect
minocyclinetreat
result
signific
decreas
kdr
current
lpstreat
microglia
n
interestingli
minocyclin
increas
kir
current
untreat
n
well
lpstreat
microglia
pa
n
result
suggest
potassium
channel
express
profil
consid
activ
marker
microglia
minocyclin
forc
microglia
earli
activ
state
phenotyp
independ
activ
histori
microglia
cn
specif
immun
cell
serv
patholog
sensor
respond
complex
activ
process
brain
damag
dysfunct
microglia
express
variou
subtyp
nucleotid
adenosin
receptor
control
ionic
conduct
membran
potenti
phagocytosi
migrat
gene
transcript
product
inflammatori
mediat
cell
surviv
studi
microgli
phagocyt
activ
two
situ
model
slice
adult
postnat
day
slice
earli
postnat
day
mice
first
model
studi
ramifi
microgli
cell
second
motil
ameboid
microglia
monitor
phagocyt
activ
appli
fluoresc
latex
bead
acut
brain
slice
koizumi
et
al
previous
shown
udp
facilit
phagocytosi
microglia
mediat
receptor
activ
agreement
found
stimul
utp
udp
increas
phagocyt
activ
ameboid
microgli
cell
contrast
acut
slice
adult
mice
udp
utp
stimul
caus
decreas
phagocyt
activ
ramifi
microglia
microgliaspecif
ectoenzym
hydrolyz
atp
releas
damag
tissu
adp
amp
wherea
utp
preferenti
hydrolyz
udp
zimmermann
found
basal
phagocyt
activ
ameboid
adult
ramifi
microglia
mice
higher
compar
wild
type
utp
udp
stimul
influenc
significantli
phagocyt
activ
microglia
second
approach
studi
motil
microgli
process
respons
laser
lesion
visual
microgli
motil
brain
slice
use
mice
express
egfp
microgliaspecif
promot
laser
lesion
caus
movement
microglia
process
toward
lesion
within
time
span
min
presum
mediat
atp
releas
damag
cell
davalo
et
al
studi
import
use
anim
crossbr
mice
express
egfp
microgliaspecif
promot
brain
slice
anim
respons
process
attract
laser
lesion
either
slow
complet
absent
conclud
microglia
respond
differ
purinerg
stimuli
depend
development
ameboid
versu
ramifi
activ
stage
wt
versu
ko
redlich
sandra
catharina
diesselberg
ribe
sandra
ebert
sandra
nau
roland
univers
depart
neurolog
germani
evangelisch
krankenhau
depart
geriatr
germani
microgli
cell
play
crucial
role
inflammatori
respons
phagocyt
kill
invad
pathogen
microglia
express
tolllik
receptor
tlr
recogn
pathogenassoci
molecular
pattern
pamp
lipopolysaccharid
lp
gramneg
bacteria
activ
tripalmitoylsglycerlcystein
activ
investig
whether
lp
influenc
phagocytosi
cryptococcu
neoforman
yeast
caus
mening
immunocompromis
patient
microgli
cell
vitro
primari
mous
microgli
cell
stimul
agonist
lp
hour
stimul
microgli
cell
wash
infect
cfuwel
cryptococcu
neoforman
min
extracellular
cryptococci
kill
incub
cultur
medium
dmem
contain
amphotericin
b
minut
microgli
cell
lyse
distil
water
number
intracellular
cryptococci
determin
quantit
plate
serial
dilut
sabouraud
agar
plate
data
present
mean
sd
anova
follow
bonferroni
multipl
comparison
test
use
compar
group
unstimul
microgli
cell
abl
ingest
low
number
cryptococci
pretreat
microgli
cell
lp
significantli
increas
phagocytosi
rate
approxim
p
b
pretreat
ml
also
led
increas
phagocytosi
rate
p
b
prestimul
lp
increas
phagocytosi
cryptococcu
neoforman
murin
microglia
cell
vitro
result
suggest
microgli
activ
tlr
agonist
might
prove
benefici
treatment
cryptococcu
neoforman
mening
immunocompromis
patient
product
function
central
nervou
system
kawanokuchi
jun
yasuoka
satoko
doi
yukiko
liang
jianfeng
noda
mariko
parajuli
bijay
sonob
yoshifumi
takeuchi
hideyuki
mizuno
tetsuya
suzumura
akio
riem
nagoya
univers
nagoya
japan
recent
identifi
function
ligand
novel
member
cytokin
famili
signal
describ
neg
regul
tolllik
receptor
signal
also
function
import
effector
molecul
respons
recent
studi
shown
pathogenassoci
molecular
pattern
significantli
increas
mrna
protein
express
central
nervou
system
cn
howev
function
cn
still
uncertain
thu
investig
express
function
cn
examin
express
function
cn
mean
rtpcr
western
blot
elisa
fac
brdu
cell
prolifer
assay
murin
brain
endotheli
celllin
cell
astrocyt
express
mrna
protein
microglia
lipopolysaccharid
lp
enhanc
express
astrocyt
tumor
necrosi
factoralpha
tnfalpha
suppress
express
cell
astrocyt
microglia
express
transmembran
isoform
receptor
secret
isoform
receptor
induc
microgli
prolifer
phagocytosi
induc
product
proinflammatori
cytokin
chemokin
microglia
howev
supernat
stimul
microglia
induc
neurotox
also
induc
product
antiinflammatori
cytokin
antioxid
molecul
neurotroph
factor
microglia
presenc
interferongamma
ifngamma
enhanc
mrna
express
antigen
present
cell
apc
relat
molecul
product
microglia
presenc
lp
ifngamma
microglia
stimul
induc
express
famili
cytokin
multifunct
cytokin
secret
astrocyt
endotheli
cell
act
microglia
exert
divers
biolog
effect
cn
regul
progranulin
express
human
microglia
astrocyt
implic
neuroinflammatori
diseas
suh
hyeonsook
choi
namjong
kraus
daniela
lee
sunhe
albert
einstein
colleg
medicin
ny
unit
state
progranulin
pgrn
rel
newli
discov
microgli
protein
divers
function
describ
peripheri
haploinsuffici
result
mutat
pgrn
caus
frontotempor
lobar
degener
ftld
although
neuron
microglia
astrocyt
less
frequent
known
express
pgrn
littl
known
regul
function
pgrn
cn
primari
cultur
human
fetal
microglia
astrocyt
studi
express
pgrn
use
standard
elisa
western
blot
analysi
microglia
releas
nanogram
level
pgrn
increas
follow
stimul
cytokin
cytokin
ifn
tolllik
receptor
ligand
poli
ic
lp
lp
poli
ic
often
suppress
pgrn
microglia
astrocyt
lower
nanogram
level
pgrn
releas
respons
inflammatori
stimuli
differ
microglia
poli
ic
stimulatori
interestingli
astrocyt
express
pgrn
close
resembl
secretori
leukocyt
proteas
inhibitor
slpi
known
inhibitor
progranulin
cleavag
inflammatori
granulin
result
suggest
pgrn
protein
involv
immunoregulatori
function
brain
immun
profil
suggest
pgrn
express
denot
altern
microgli
activ
rather
classic
activ
serotonin
modul
microgli
phagocytosi
motil
tessmann
grietj
matyash
vitali
katrin
kettenmann
helmut
cellular
neurosci
mdc
berlin
germani
microglia
brain
macrophag
repres
immun
cell
brain
insult
transform
ramifi
ameboid
cell
migrat
site
injuri
releas
neuroprotect
proinflammatori
substanc
shown
microgli
cell
express
neurotransmitt
receptor
gaba
norepinephrin
dopamin
whose
activ
modul
microgli
function
kettenmann
pocock
studi
impact
serotonin
microgli
phagocytosi
motil
quantifi
phagocytosi
activ
determin
uptak
serum
coat
latex
bead
cultur
microglia
newborn
nmri
anim
acut
brain
slice
prepar
day
old
mice
week
old
adult
nmri
mice
applic
mm
serotonin
reduc
significantli
phagocytosi
activ
primari
microglia
respect
sem
comparison
test
also
acut
isol
brain
slice
situ
model
studi
microglia
tissu
environ
mm
serotonin
stimul
result
decreas
phagocytosi
activ
sem
slice
taken
old
anim
wherea
slice
adult
mice
observ
signific
chang
phagocytosi
activ
n
second
set
experi
test
impact
serotonin
microgli
respons
insult
caus
laser
lesion
determin
quantifi
movement
process
lesion
acut
slice
mice
concentr
mm
serotonin
caus
increas
respons
microgli
process
toward
laser
lesion
stimul
serotonin
show
signific
effect
data
indic
microgli
cell
express
function
serotonin
receptor
control
microgli
execut
function
glial
respons
rodger
jane
miller
stephen
multipl
sclerosi
ms
tcell
mediat
autoimmun
demyelin
diseas
central
nervou
system
cn
myelinspecif
cell
character
major
contributor
ms
patholog
infiltr
cn
upon
reactiv
induc
local
inflamm
result
myelin
destruct
activ
cell
produc
signal
receptor
complex
consist
least
two
subunit
character
inflamm
affect
brain
resid
cell
glia
express
first
quantifi
astrocyt
microglia
oligodendrocyt
progenitor
cell
glia
express
upregul
diseas
mix
glia
cultur
purifi
opc
stimul
cytokin
product
prolifer
matur
studi
chemokin
monocyt
chemoattract
protein
keratinocyt
chemoattract
kc
produc
dose
timedepend
manner
oligodendrocyt
progenitor
cell
opc
major
sourc
remyelin
cell
thu
especi
necessari
understand
affect
understand
affect
glia
may
lead
effect
therapi
enhanc
remyelin
role
acid
tryptophan
metabolit
neuroprotect
agent
neuroinflamm
kraus
daniela
suh
hyeonsook
choi
namjong
zhao
mengliang
lee
sunhe
ludwigmaximilian
univers
munich
germani
alberteinstein
colleg
medicin
new
york
citi
unit
state
indoleamin
dioxygenas
ido
ifninduc
ratelimit
enzym
kynurenin
pathway
kp
tryptophan
metabol
activ
kp
lead
gener
variou
kynurenin
metabolit
depend
cell
type
cn
kynuren
acid
arm
kp
present
predominantli
astrocyt
wherea
arm
lead
gener
acid
quinolin
acid
present
exclus
microglia
addit
quinolin
acid
nmda
receptor
agonist
also
shown
neurotoxin
owe
prooxid
activ
base
observ
kp
enzym
kynurenin
monooxygenas
kmo
exampl
activ
target
drug
develop
neurodegen
diseas
huntington
diseas
howev
also
shown
inhibit
nitric
oxid
product
amelior
experiment
autoimmun
enceph
suggest
neuroprotect
activ
investig
role
modul
gene
express
neurotox
primari
cultur
human
fetal
brain
cell
cultur
stimul
ifn
tolllik
receptor
tlr
ligand
presenc
absenc
result
analyz
microarray
western
blot
elisa
vital
dye
exclus
test
found
suppress
glial
cytokin
chemokin
express
also
reduc
cytokineinduc
neuron
death
unexpectedli
also
found
highli
effect
induct
antioxid
cytoprotect
enzym
furthermor
express
astrocyt
microglia
human
cn
cultur
cytokin
tlr
ligand
neglig
effect
induc
compar
result
demonstr
novel
antiinflammatori
neuroprotect
activ
microgli
kynurenin
also
suggest
inhibitor
certain
kp
enzym
might
potenti
neuron
damag
chang
cn
inflammatori
redox
balanc
oligodendrocyt
form
one
highli
special
cellular
structur
bodi
myelin
sheath
allow
electr
insul
nerv
fibber
defect
myelin
insul
lead
sever
central
nervou
system
disord
interestingli
previou
studi
show
newborn
increas
total
serum
bilirubin
level
display
white
matter
abnorm
suggest
unconjug
bilirubin
ucb
may
compromis
myelin
henc
aim
investig
whether
ucb
determin
demis
oligodendrocyt
precursor
cell
opc
mix
glial
cultur
obtain
cerebr
cortex
neonat
rat
pup
day
vitro
div
opc
isol
shake
dislodg
microglia
enrich
opc
cultur
achiev
use
specif
prolifer
factor
div
cell
treat
ucb
plu
human
serum
albumin
h
puriti
opc
cultur
evalu
immunocytochemistri
use
antibodi
direct
opc
astrocyt
gfap
cell
viabil
assess
ldh
leakag
activ
use
specif
substrat
cleavag
mitochondri
abnorm
use
mitotrack
red
nm
endoplasm
reticulum
er
stress
activ
calciumdepend
calpain
use
specif
substrat
boclmcmac
approxim
enrich
opc
cultur
posit
less
gfap
posit
remain
oligodendrocyt
vari
stage
differenti
exposur
opc
ucb
led
first
mitochondri
dysfunct
h
p
b
follow
er
stress
determin
increas
calpain
activ
h
p
b
activ
preliminari
data
sequenti
event
trigger
cell
death
ruptur
plasma
membran
increas
ldh
releas
p
b
well
apoptosi
enhanc
activ
p
b
nuclear
fragment
tunel
label
preliminari
data
result
suggest
ucb
exert
cytotox
opc
lead
cascad
program
intracellular
event
includ
earli
signal
mitochondri
dysfunct
activ
calpain
ultim
result
death
necrosi
apoptosi
target
opc
dysfunct
ucb
may
lead
new
therapeut
strategi
aim
prevent
abnorm
myelin
follow
neonat
jaundic
white
matter
reactiv
astrocyt
express
nuclear
estrogen
receptor
alpha
experiment
autoimmun
encephalomyel
multipl
sclerosi
giraud
sebastien
n
mechan
action
estrogen
modul
inflamm
neuroprotect
neurodegen
disord
matter
great
debat
wherea
activ
astrocyt
involv
physiopatholog
neurodegen
neuroinflammatori
disord
emerg
glial
express
pattern
estrogen
receptor
er
multipl
sclerosi
ms
anim
model
experiment
autoimmun
encephalomyel
eae
remain
undefin
found
nuclear
eralpha
express
reactiv
astrocyt
white
matter
cord
chronic
eae
mice
estradiol
treatment
eae
onset
allevi
ongo
eae
symptom
associ
spinal
cord
white
matter
reduct
astrogli
reactiv
leukocyt
infiltr
axon
loss
order
investig
astrocyt
express
eralpha
ms
archiv
paraffin
section
frontal
cortex
secondari
progress
ms
patient
control
subject
use
doubl
immunocytochemistri
eralpha
hardli
detect
white
matter
tract
control
subject
around
blood
vessel
increas
gfap
stain
observ
control
subject
wegen
case
grey
matter
moder
eralpha
immunoreactivi
astrocyt
fiber
could
observ
layer
particularli
astrocyt
contact
dilat
blood
vessel
control
subject
otherwis
cortic
astrocyt
sever
process
close
proxim
blood
vessel
stain
eralpha
control
ms
subject
normal
appear
white
matter
ms
patient
astrocyt
express
rel
low
level
extranuclear
eralpha
compar
white
matter
rim
chronic
plaqu
identifi
lack
sudan
black
stain
reactiv
astrocyt
demyelin
white
matter
assess
lower
sudan
black
stain
immunoreact
adjac
section
exhibit
nuclear
eralpha
stain
wherea
eralpha
evidenc
chronic
plaqu
though
dens
gfap
immunoreact
fiber
detect
herein
show
first
time
eralpha
express
reactiv
astrocyt
ms
white
matter
nuclear
stain
could
observ
demyelin
lesion
data
support
white
matter
astroglia
import
direct
target
estrogen
antiinflammatori
action
ms
studi
interact
immun
nervou
system
actual
purpos
disclos
pathogenesi
search
new
approach
treatment
aim
studi
clinic
featur
laboratori
criteria
immunolog
indic
clinic
research
patient
age
year
carri
men
women
statist
data
process
spent
applic
parametr
nonparametr
method
statist
signific
clinic
sign
favor
forecast
presenc
posit
dynam
mild
express
disord
sensit
pain
syndrom
treatment
minimum
residu
phenomena
observ
patient
sever
result
immunolog
research
shown
authent
decreas
migratori
activ
leukocyt
peripher
blood
decreas
product
helper
lymphokin
factor
oppress
migrat
leukocyt
follow
criterion
decreas
function
activ
thelper
increas
activ
serum
lymphokin
patient
criterion
disord
immun
homeostasi
increas
level
gener
lymphocyt
lymphocyt
patient
criterion
sever
cours
diseas
reveal
prognost
criteria
promot
differenti
diagnost
correct
choic
medic
tactic
polymorph
promotor
gene
solubl
level
effect
biolog
respons
therapi
multipl
sclerosi
potenti
marker
macrophag
activ
may
modul
lpstrigger
apoptosi
regul
b
lymphocyt
function
elev
serum
level
found
associ
inflamm
report
act
neg
regul
cell
activ
human
tcell
report
c
exchang
posit
promotor
region
gene
lead
higher
level
addit
carrier
tt
genotyp
show
increas
express
aim
studi
evalu
polymorph
level
multipl
sclerosi
popul
assess
whether
level
promotor
gene
polymorph
may
reflect
therapeut
effect
multipl
sclerosi
control
includ
studi
ms
patient
group
accord
therapeut
respons
individu
either
relaps
rate
edss
deteriorationyear
describ
evid
lack
therapeut
respons
three
differ
band
pattern
obtain
cc
tt
ct
serum
level
elisa
also
measur
patient
immunemodul
immunosuppress
steroid
treatment
healthi
subject
studi
level
statist
differ
control
patient
howev
control
patient
group
femal
increas
level
compar
male
p
patient
control
genotyp
ct
patient
vs
control
tt
patient
control
cc
genotyp
differ
genotyp
frequenc
control
ms
patient
p
distribut
c
domin
genotyp
ccct
p
domin
genotyp
ttct
p
frequenc
similar
group
clinic
respons
ifnb
differ
c
domin
domin
genotyp
p
domin
patient
subgroup
level
significantli
lower
cc
genotyp
p
result
point
may
reliabl
marker
evalu
biolog
respons
therapi
secondli
larg
scale
patient
group
genotyp
differ
prove
influenc
therapeut
respons
detriment
role
emmprin
multipl
sclerosi
experiment
autoimmun
encephalomyel
agraw
smriti
silva
claudia
fan
yan
yong
v
wee
extracellular
matrix
metalloproteinas
induc
emmprin
member
immunoglobulin
ig
super
famili
upstream
induc
matrix
metalloproteinas
mmp
known
detriment
multipl
sclerosi
ms
result
cn
infiltr
inflammatori
cell
myelin
destruct
studi
investig
role
emmprin
ms
target
function
murin
experiment
autoimmun
encephalomyel
eae
use
immunofluores
stain
western
blot
flow
cytometri
mous
eae
control
tissu
found
upregul
emmprin
level
worsen
eae
diseas
sever
mark
increas
emmprin
level
observ
cn
infiltr
leukocyt
cn
resid
cell
interestingli
emmprin
level
observ
similarli
upregul
ms
plaqu
area
compar
adjac
white
matter
human
cn
sampl
function
treatment
eaeafflict
mice
block
antiemmprin
antibodi
decreas
cn
parenchym
infiltr
leukocyt
amelior
eae
clinic
sever
final
demonstr
reduct
eae
diseas
sever
antiemmprin
treat
mice
associ
reduc
mmp
proteolyt
activ
glia
limitan
final
barrier
infiltr
cn
parenchyma
result
first
emphas
earli
detriment
role
emmprin
eae
ms
mechan
involv
mmp
activ
emmprin
novel
therapeut
target
ms
amelior
neuroinflamm
patholog
present
strategi
treatment
multipl
sclerosi
ms
base
modul
immun
respons
lack
need
treatment
slow
diseas
progress
inhibit
inflammatori
degen
pathway
within
cn
result
demyelin
axon
damag
neuron
degener
activ
microglia
play
key
role
cours
inflammatori
demyelin
patholog
central
nervou
system
progress
form
ms
intim
associ
presenc
reactiv
microglia
postul
downregul
microglialmacrophag
activ
may
delay
halt
diseas
progress
grow
evid
modul
microgli
potassium
channel
good
approach
regul
activ
present
studi
demonstr
pharmacolog
regul
glial
inward
rectifi
potassium
channel
effect
improv
clinic
histolog
paramet
experiment
autoimmun
encephalomyel
eae
inducedmic
daili
oral
administr
reduc
clinic
score
eae
mice
decreas
microglia
activ
white
matter
demyelin
area
cell
infiltr
inhibit
inflammatori
respons
compar
control
anim
receiv
vehicl
tissu
integr
neuron
viabil
spinal
cord
also
better
preserv
treat
mice
taken
togeth
result
indic
inhibit
microgliamedi
neuroinflamm
glial
inward
rectifi
potassium
channel
regul
prospect
strategi
treat
cn
demyelin
disord
ms
could
also
combin
inmmunomodulatori
therapi
novel
strategi
microgliainduc
neurodegener
suzumura
akio
takeuchi
hideyuki
mizoguchi
hiroyuki
doi
yukiko
noda
mariko
sonob
yoshifumi
jin
shiji
mizuno
tetsuya
nagoya
univers
nagoya
japan
pathophysiolog
neuron
degener
still
remain
elucid
glutam
releas
activ
microglia
induc
exitoneurotox
like
contribut
noncel
autonom
neuron
death
neurodegen
diseas
includ
amyotroph
later
sclerosi
al
alzheim
diseas
ad
studi
examin
whether
pharmacolog
blockad
gap
junction
hemichannel
inhibit
glutam
releas
activ
microglia
significantli
amelior
symptom
mous
model
neurodegen
disord
synthes
sever
compound
effect
block
gapjunct
microglia
use
carbenoxolon
lead
compound
mean
vitro
screen
got
sever
compound
effect
suppress
glutam
releas
microglia
one
compound
significantli
amelior
clinic
symptom
mous
model
al
ad
without
detect
toxic
compound
may
provid
novel
strategi
varieti
neurodegen
disord
suppress
experiment
autoimmun
neuriti
lewi
rat
via
inhibit
cell
activ
zhu
wei
mix
eilhard
nennesmo
inger
zhu
jie
jilin
univers
changchun
china
karolinska
institut
stockholm
sweden
univers
rostock
rostock
germani
therapeut
effect
new
immunoregul
evalu
experiment
autoimmun
neuriti
ean
cellmedi
anim
model
syndrom
man
present
studi
investig
effect
cellmedi
autoimmun
ean
lewi
rat
induc
inocul
peripher
nerv
myelin
protein
peptid
togeth
complet
freund
adjuv
cfa
data
indic
two
differ
therapeut
regimen
activ
ean
passiv
transfer
ean
administ
daili
oral
effect
amelior
inhibit
clinic
patholog
sign
ean
suppress
ean
associ
mark
decreas
inflammatori
cell
infiltr
peripher
nervou
system
pn
insuffici
autoreact
cell
reflect
inhibit
peptidespecif
mononuclear
cell
prolifer
decreas
cell
subpopul
substanti
increas
number
macrophag
stimul
releas
thu
increas
apoptosi
autoreact
cell
conclud
insuffici
autoreact
cell
induc
pn
lymphoid
organ
may
contribut
absenc
inflammatori
cell
ean
lesion
amelior
diseas
effect
indic
strong
abil
inhibit
cell
respons
ean
may
therapeut
potenti
human
gb
previous
shown
phospholipas
play
role
onset
progress
remiss
phase
experiment
autoimmun
encephalomyel
eae
wide
use
anim
model
multipl
sclerosi
also
regul
product
prostaglandin
via
prostaglandin
mediat
either
proinflammatori
protect
effect
depend
type
receptor
bind
present
studi
assess
chang
express
prostaglandin
synthas
cpge
prostaglandin
receptor
relapsingremit
eae
rreae
rreae
induc
mice
subcutan
inject
complet
freund
adjuv
along
pertussi
toxin
spinal
cord
obtain
onset
peak
remiss
stage
eae
rtpcr
western
blot
fac
doubl
immunofluoresc
label
mrna
upregul
onset
peak
stage
eae
follow
declin
naiv
level
remiss
chang
seen
mrna
cpge
receptor
also
exhibit
mark
chang
mrna
express
throughout
cours
eae
mrna
level
elev
onset
eae
increas
peak
stage
follow
declin
normal
level
remiss
phase
chang
seen
mrna
level
immunoblot
reveal
chang
protein
level
increas
express
receptor
protein
express
decreas
onset
restor
normal
level
peak
remiss
fac
analysi
reveal
receptor
predominantli
express
monocytesneutrophil
macrophag
microglia
small
popul
b
lymphocyt
also
express
receptor
furthermor
synthas
also
express
primarili
leukocyt
doubl
immunofluoresc
label
eae
spinal
cord
tissu
section
show
addit
infiltr
immun
cell
also
express
astrocyt
near
eae
lesion
data
show
alter
occur
express
prostaglandin
synthas
receptor
cours
eae
infiltr
immun
cell
cn
resid
cell
suggest
receptormedi
pathway
may
modul
inflammatori
respons
eae
recent
evid
indic
dysregul
express
neuroimmun
factor
central
nervou
system
cn
contribut
neural
impair
associ
varieti
cn
condit
includ
infect
injuri
age
drug
abus
neurodegen
psychiatr
disord
howev
role
specif
neuroimmun
factor
normal
abnorm
cn
function
limit
studi
investig
cn
action
two
neuroimmun
factor
chemokin
cc
chemokin
ligand
previous
known
monocyt
chemoattract
cytokin
neuroimmun
factor
express
normal
cn
age
cn
disord
identifi
cn
action
condit
chronic
exposur
measur
synapt
transmiss
shortterm
plastic
acut
isol
hippocamp
slice
adult
transgen
mice
exhibit
elev
cn
express
huang
et
al
j
neurosci
campbel
et
al
pna
nontransgen
litterm
control
extracellular
field
potenti
electrophysiolog
record
schaffer
synaps
show
signific
reduct
magnitud
synapt
respons
hippocamp
slice
transgen
mice
compar
slice
nontransgen
litterm
control
contrast
synapt
transmiss
schaffer
synaps
transgen
mice
show
signific
increas
magnitud
synapt
respons
compar
slice
nontransgen
litterm
control
shortterm
synapt
plastic
posttetan
potenti
ptp
shortterm
potenti
stp
enhanc
hippocamp
slice
mice
hippocamp
slice
transgen
mice
longterm
synapt
plastic
longterm
potenti
ltp
alter
hippocamp
slice
compar
respect
nontransgen
litterm
control
slice
western
blot
analysi
hippocampu
mice
show
increas
level
astrocyt
protein
gfap
chang
level
neuron
specif
enolas
neuron
marker
cdllb
microglia
marker
result
show
neuroimmun
factor
known
chronic
produc
elev
level
within
cn
certain
disord
significantli
alter
neuron
function
show
differ
neuroimmun
factor
distinct
action
cn
synapt
function
support
multifoc
motor
neuropathi
patient
underdiagnos
epidemiolog
studi
amyotroph
later
sclerosi
al
report
multifoc
motor
neuropathi
mmn
remain
unknown
review
clinic
demograph
detail
mmnal
patient
major
neurolog
center
japan
diagnosi
mmn
made
basi
revis
efnspn
criteria
diagnos
al
use
el
escori
criteria
except
possibl
al
survey
gender
age
diagnosi
result
antiganglion
antibodi
studi
includ
patient
mmn
patient
al
median
number
patient
mmn
per
center
rang
per
center
influenc
method
use
detect
mild
occult
conduct
block
hospit
median
onset
age
mmn
year
rang
year
al
year
rang
year
femal
account
mmn
patient
al
patient
serum
antiganglion
antibodi
detect
mmn
patient
ratio
mmn
al
patient
larg
variat
number
patient
mmn
among
center
suggest
diagnost
sensit
depend
method
use
detect
conduct
block
axon
mitochondri
dysfunct
vitro
model
neuroinflamm
axon
degener
wallerian
degener
well
dyingback
degener
activ
phenomena
character
highli
regul
new
protein
synthesi
mechan
control
axon
dye
still
poorli
understood
investig
must
undertaken
establish
sequenc
molecular
event
involv
axon
degener
built
model
neuroinflamm
use
organotyp
cultur
cerebellum
challeng
lp
hour
model
reproduc
molecular
event
take
part
neuroinflammatori
neurodegen
diseas
like
ms
microgli
activ
demyelin
axon
damag
particular
observ
elisa
assay
increas
tnfalpha
hour
lp
stimul
respect
addit
observ
decreas
mbp
cnpase
format
multipl
axon
spheroid
suggest
axon
transport
impair
hour
lp
stimul
also
detect
increas
reactiv
oxygen
speci
ro
ino
hour
lp
stimul
respect
morpholog
analysi
use
electron
microscopi
show
alter
mitochondri
morpholog
enlarg
mitochondria
along
axon
current
assess
loss
mitochondri
membran
potenti
differ
probe
like
mitotrack
neuroinflamm
promot
axon
dysfunct
oxid
stress
mitochondri
morpholog
chang
axon
point
energet
failur
particip
axon
damag
model
ms
character
plasmacytoid
dendrit
cell
multipl
sclerosi
nakano
akiko
ifergan
igal
kebir
hania
prat
alexandr
multipl
sclerosi
ms
immunemedi
disord
central
nervou
system
cn
character
multifoc
area
leukocyt
infiltr
demyelin
axon
damag
typic
demyelin
associ
accumul
lymphocyt
macrophagesdendrit
cell
dc
aris
migrat
peripher
blood
immun
cell
across
cn
microvascular
endothelium
moreov
ms
lesion
format
thought
mediat
autoreact
lymphocyt
direct
myelin
peptid
sequenc
therefor
traffick
antigen
present
cell
apc
cn
thought
contribut
lymphocyt
reactiv
within
cn
compart
use
vitro
model
human
bbb
show
upon
migrat
across
bbbendotheli
cell
bbbec
monocyt
differenti
plasmacytoid
dc
pdc
show
cell
carri
marker
hladrhigh
lowinterm
dcsignneg
function
analysi
pdc
indic
lymphocyt
grown
presenc
pdc
tendenc
produc
lower
level
gmcsf
tnfa
ifng
higher
level
compar
cultur
monocyt
also
use
tissu
ms
patient
confirm
immunohistochemistri
abund
perivascular
pdc
within
acut
ms
lesion
close
associ
microvascular
bbbec
result
suggest
novel
popul
bbbassoci
pdc
play
antiinflammatori
role
cn
present
within
ms
lesion
correl
proinflammatori
cytokin
syndrom
role
matrix
metalloproteinas
mmp
cytokin
pathogenesi
syndrom
gb
larg
remain
unknown
studi
role
diseas
progress
recoveri
patient
gb
sixti
five
patient
gb
healthi
control
enrol
studi
serum
level
analyz
elisa
activ
mmp
measur
zymographi
express
higher
progress
phase
vs
p
b
vs
p
b
vs
p
b
lower
recoveri
phase
vs
p
b
vs
p
vs
p
gb
healthi
control
posit
correl
r
p
r
p
r
p
observ
progress
phase
gb
studi
show
upregul
along
proinflammatori
cytokin
earli
cours
appear
associ
immunemedi
diseas
progress
due
inflamm
pn
later
phase
downregul
proinflammatori
cytokin
implic
recoveri
diseas
effect
human
neuroblastoma
cell
line
proteom
neuropatholog
chang
alzheim
diseas
ad
brain
includ
extracellular
plaqu
intraneuron
neurofibrillari
tangl
compos
hyperphosphoryl
tauprotein
also
sign
chronic
inflamm
inflammatori
cytokin
larg
produc
brain
activ
microglia
previou
studi
suggest
may
impact
tau
kinas
relat
tau
phosphoryl
howev
link
ad
pathogenesi
still
poorli
understood
requir
studi
studi
want
studi
effect
differenti
human
neuronlik
cell
proteom
vitro
impact
differenti
human
neuronlik
cell
protein
profil
examin
differ
timepoint
h
use
twodimension
differencegelelectrophoresi
nontreat
differenti
cell
use
control
protein
exhibit
chang
cut
silver
stain
gel
ingel
digest
trypsin
identifi
use
mass
spectrometri
databas
search
signific
protein
chang
found
treatment
h
proteom
also
alter
h
h
treatment
compar
untreat
cell
number
protein
spot
greatest
h
mayb
indic
enhanc
modif
protein
altogeth
protein
exhibit
alter
identifi
relat
eg
cell
prolifer
andor
differenti
inflamm
regul
oxid
cell
signal
express
interest
protein
examin
western
blot
preliminari
data
suggest
timedepend
effect
proteom
profil
cell
detect
chang
may
link
upor
downregul
protein
express
wherea
alter
modif
current
examin
protein
chang
immunoblot
experiment
autoimmun
encephalomyel
absenc
lysophosphatid
acid
receptor
lysophosphatid
acid
lpa
endogen
phospholipid
involv
mani
differ
cellular
process
specif
gprotein
coupl
receptor
work
viabl
malaga
variant
mice
lack
receptor
demonstr
requir
receptor
normal
prolifer
differenti
neural
precursor
develop
adult
life
character
includ
myelin
glia
highli
express
receptor
myelin
point
mous
may
suitabl
model
studi
demyelin
diseas
multipl
sclerosi
absenc
decreas
number
oligodendrocyt
adult
gener
myelindefici
pattern
besid
lpa
also
act
neuroinflammatori
process
receptor
influenc
interleukin
secret
blood
brain
barrier
permeabl
microglia
activ
therefor
role
lpa
neuroinflammatori
demyelin
model
experiment
autoimmun
encephalomyel
eae
induc
immun
studi
respons
evalu
normal
mice
base
clinic
histolog
analysi
result
show
presenc
receptor
necessari
normal
immun
respons
although
genotyp
develop
similar
clinic
cours
display
relapsingremit
form
wild
type
mice
show
sever
symptom
null
anim
also
onset
diseas
delay
anim
lack
receptor
reflect
better
recoveri
relaps
mice
condit
delet
myeloid
lineag
cell
gener
studi
evalu
polar
macrophag
microglia
progress
eae
wildtyp
wt
mice
found
bone
marrowderiv
macrophag
microglia
stimul
express
higher
level
gene
relat
polar
tnfalpha
ino
mrna
protein
level
cell
compar
wt
mice
upon
lp
ifngamma
lp
plu
ifngamma
stimul
furthermor
delet
enhanc
lp
ifngammainduc
activ
signific
effect
lpsinduc
nfb
mapk
activ
experi
effect
eae
develop
investig
preliminari
result
suggest
mice
earlier
onset
sever
eae
wt
mice
function
macrophagemicroglia
treg
cell
differenti
test
pathogenesi
eae
studi
suggest
import
neg
regul
macrophagemicroglia
inflammatori
respons
specif
eae
model
spinal
cord
injuri
sci
character
mechan
disrupt
spinal
cord
tissu
ischemia
edema
follow
express
cytokin
chemokin
lesion
site
lead
recruit
peripher
blood
leukocyt
event
result
cell
death
denerv
paralysi
oligodendrocyt
one
sensit
cell
traumat
injuri
cn
loss
lead
demyelin
axon
injuri
concomit
loss
neurolog
function
previou
studi
use
transgen
mice
nfkb
specif
inhibit
astrocyt
gfapikbadn
tg
show
reduct
product
cytokin
chemokin
astrocyt
smaller
lesion
site
increas
white
matter
preserv
improv
locomotor
function
week
follow
sci
goal
gain
insight
molecular
mechan
lead
improv
function
behavior
increas
white
matter
preserv
perform
whole
mous
genom
microarray
analysi
spinal
cord
injur
wt
tg
mice
day
week
week
follow
sci
surprisingli
found
largest
number
differenti
regul
gene
week
postinjuri
gene
involv
inflammatoryimmun
respons
chemotaxi
axon
growth
cell
death
process
may
influenc
function
recoveri
also
found
number
gene
cnpase
significantli
upregul
week
suggest
increas
oligodendrogenesi
tg
mice
compar
wt
mice
moreov
kegg
pathway
analysi
reveal
wnt
signal
pathway
import
remyelin
significantli
activ
tg
mice
compar
wt
mice
also
found
signific
chang
rna
protein
level
number
cell
suggest
alter
innat
immun
respons
tg
mice
current
test
hypothesi
inhibit
astogli
nfkb
reduc
modifi
natur
inflammatori
respons
week
postinjuri
therefor
may
provid
permiss
environ
oligodendrocyt
progenitor
cell
develop
myelin
oligodendrocyt
imbal
bind
protein
ad
patient
real
marcella
iarlori
carla
bellant
veronica
di
nicola
marta
gambi
domenico
univers
g
dannunzio
chieti
pescara
chieti
itali
member
cytokin
famili
potent
induc
proinflammatori
cytokin
bind
protein
constitut
secret
protein
abl
bind
high
affin
provid
potenti
mechan
wherebi
activ
regul
previou
studi
confirm
imbal
versu
polar
favor
cell
subset
appear
key
pathogen
mechan
ad
aim
preliminari
studi
investig
express
product
may
involv
ad
ad
patient
clinic
diagnosi
accord
nincdsadrda
criteria
hc
subject
match
sex
age
enrol
plasma
level
assay
specif
enzymelink
immunosorb
assay
kit
accord
manufactur
instruct
rtpcr
perform
determin
mrna
espress
pbmc
studi
show
plasma
level
ad
group
significantli
higher
healthi
control
level
lower
healthi
control
p
b
increas
releas
observ
pbmc
ad
patient
compar
control
group
found
signific
increas
mrna
express
express
decreas
ad
patient
compar
healthi
control
il
potent
upstream
cytokin
antagon
lead
viciou
cycl
may
repres
import
contribut
pathogenesi
ad
one
interpret
suggest
lower
level
plasma
ad
patient
higher
mrna
level
pbmc
ad
group
compar
hc
bound
studi
suggest
serum
ad
patient
promot
upregul
cell
inhibit
cell
result
greater
imbal
aggrav
patient
ill
myelinphagocytos
macrophag
show
immunomodulatori
properti
bogi
jeroen
timmerman
silk
stinissen
piet
hell
niel
hendrik
jerom
multipl
sclerosi
ms
chronic
inflammatori
demyelin
diseas
central
nervou
system
cn
macrophag
play
pivot
role
nonetheless
remain
larg
unknown
macrophag
subpopul
induc
cn
inflamm
underli
cellular
mechan
govern
induct
macrophag
subset
contribut
ms
patholog
initi
macrophag
thought
mere
detriment
ms
intern
myelin
secret
toxic
proinflammatori
mediat
howev
recent
evid
suggest
may
also
protect
effect
especi
follow
myelin
phagocytosi
studi
demonstr
myelinphagocytos
macrophag
inhibit
lymphocyt
prolifer
pronounc
control
macrophag
inhibit
antigen
independ
mediat
alter
nitric
oxid
synthasearginas
balanc
addit
show
myelin
intern
macrophag
induc
express
liver
x
receptor
lxr
respons
gene
lxr
nuclear
receptor
involv
cholesterol
metabol
inflamm
prolong
lxr
activ
led
induct
secret
macrophag
possibl
explain
increas
product
myelin
phagocytosi
observ
suggest
myelin
phagocytosi
lead
alter
macrophag
phenotyp
modul
lymphocyt
respons
ms
research
need
elucid
immunomodulatori
role
myelinphagocytos
macrophag
essenti
increas
understand
neuroinflammatori
respons
diseas
like
ms
neuropeptid
modul
microgli
function
alzheim
diseas
fleisherberkovich
sigal
filipovichrimon
talia
benshmuel
sarit
gera
lajo
kummer
marku
heneka
michael
bengurion
univers
beersheva
israel
univers
colorado
denver
unit
state
univers
bonn
bonn
germani
microgli
inflamm
play
integr
role
develop
neurodegen
diseas
although
neuropeptid
bradykinin
bk
somatostatin
sst
endothelin
et
known
import
mediat
inflamm
peripheri
evid
similar
function
brain
scarc
aim
present
studi
examin
effect
neuropeptid
variou
aspect
microgli
activ
chemotaxi
phagocytosi
releas
proinflammatori
mediat
use
immunocytochemistri
show
express
receptor
bk
subtyp
et
eta
etb
subtyp
sst
sst
subtyp
microgli
cell
line
result
also
show
exposur
well
primari
neonat
rat
microgli
cell
bk
sst
increas
phagocytosi
cell
two
fold
dose
depend
manner
contrast
endothelin
decreas
phagocytosi
dose
depend
puls
chase
experi
confirm
neuropeptid
increas
overal
phagocytosi
affect
degrad
pathway
neuropeptid
increas
chemotact
activ
microglia
sever
fold
addit
show
express
gene
encod
proinflammatori
molecul
ino
microglia
inhibit
bk
et
also
significantli
decreas
express
monocyt
chemoattract
protein
result
suggest
neuropeptid
may
play
import
role
chemotaxi
clearanc
modul
brain
respons
neuroinflammatori
process
releas
inflammatori
factor
microgli
cell
neuropoiet
cytokin
oncostatin
osm
express
multipl
sclerosi
ms
lesion
effect
central
nervou
system
cn
lesion
develop
remain
unknown
osm
limit
neuron
death
induc
excitotox
nonneuron
diseas
model
arthriti
associ
inflamm
tissu
damag
studi
design
elucid
effect
local
osm
express
inflammatori
cn
lesion
develop
first
local
express
osm
induc
right
striatum
healthi
adult
mice
mean
stereotact
inject
lentivir
vector
encod
osm
osm
disrupt
bloodbrain
barrier
induc
local
inflammatori
respons
character
upregul
adhes
molecul
mhcii
express
infiltr
tcell
macrophag
otherwis
healthi
cn
indic
osm
express
suffici
induc
sever
aspect
characterist
inflammatori
cn
lesion
next
investig
osm
affect
underli
diseas
process
anim
model
ms
experiment
autoimmun
encephalomyel
eae
eae
induc
mice
local
express
osm
striatum
diseas
incid
clinic
symptom
significantli
reduc
agreement
find
significantli
less
inflammatori
lesion
detect
spinal
cord
osmtreat
mice
explain
osm
induc
inflammatori
lesion
site
express
inhibit
develop
eae
lesion
hypothes
immun
cell
attract
site
osmexpress
may
regulatori
immunosuppress
phenotyp
inde
immunohistochem
stain
reveal
mannos
receptor
posit
macrophag
site
osmexpress
marker
altern
activ
macrophag
moreov
osm
induc
shift
cytokin
profil
eaeanim
analys
mean
qpcr
vitro
studi
show
osm
reduc
noproduct
activ
macrophag
studi
demonstr
osm
import
regul
develop
inflammatori
cn
lesion
mitsugu
yamanaka
michael
heneka
alzheim
diseas
ad
character
chronic
deposit
amyloidbeta
abeta
microglialmedi
inflammatori
respons
peroxisom
proliferatoractiv
receptor
ppar
gamma
agonist
amelior
glucos
metabol
suppress
inflamm
type
diabet
patient
recent
evid
indic
mild
cognit
impair
human
may
improv
treatment
ppar
gamma
agonist
select
ppar
alphagamma
modul
current
clinic
develop
treatment
type
diabet
transactiv
assay
character
compar
valu
human
ppar
alpha
human
ppar
gamma
partial
activ
human
ppar
gmma
compar
pioglitazon
studi
investig
therapeut
potenti
ad
analyz
abeta
phagocytosi
use
rat
primari
microglia
perform
surfac
marker
analysi
microglia
transgen
mice
enhanc
uptak
abeta
rat
primari
microglia
note
effect
abolish
coincub
inhibitor
transcript
actinomycin
translat
cycloheximid
suggest
observ
effect
requir
de
novo
protein
synthesi
vivo
induc
express
surfac
marker
microglia
mice
ppar
heterodimer
rxr
subsequ
bind
specif
dna
respons
element
therebi
regul
express
target
gene
interestingli
combin
sever
rxr
agonist
includ
bexaroten
retino
acid
treatment
show
synergist
enhanc
uptak
abeta
microglia
concentrationdepend
manner
togeth
data
suggest
activ
ppar
alon
even
effect
concert
rxr
enhanc
microgli
phagocytosi
conclus
may
serv
therapeut
agent
ad
treatment
prenat
immun
challeng
promot
alzheim
diseaselik
neuropatholog
age
wildtyp
mice
krstic
dimitrij
doehner
jana
breu
karin
madhusudan
amrita
knuesel
iren
mani
ageassoci
degen
diseas
associ
abnorm
proteinac
aggreg
often
form
amyloid
deposit
alzheim
diseas
ad
amyloidbeta
abeta
peptid
major
plaqu
compon
rare
famili
ad
mutat
affect
proteolysi
amyloid
precursor
protein
lead
increas
product
aggregationpron
abeta
peptid
support
central
role
abeta
ad
pathophysiolog
grow
experiment
evid
suggest
critic
role
solubl
prefibrillari
oligom
abeta
speci
trigger
neuron
malfunct
cell
death
howev
current
unknown
whether
similar
mechan
also
underli
agingassoci
sporad
ad
report
previous
normal
age
rodent
primat
accompani
loss
reelinexpress
neuron
accumul
reelinposit
oligomer
aggreg
hippocamp
format
alter
correl
cognit
impair
mice
prenat
immun
challeng
result
acceler
plaqu
deposit
compar
control
suggest
role
earli
neurodevelopment
immunolog
abnorm
agingrel
neuropatholog
examin
monthsold
wild
type
mice
expos
utero
viral
mimic
polyinosin
polycytidyl
acid
polyi
c
use
biochem
immunohistochem
approach
combin
immunoelectron
microscopi
character
impact
prenat
infect
abeta
tau
patholog
confirm
format
thioflavinsposit
abetaimmunoreact
extracellular
deposit
select
hippocamp
format
polyi
cexpos
mice
month
area
cover
reelinand
abetaposit
deposit
significantli
enlarg
compar
control
month
aggrav
amyloid
patholog
associ
abnorm
level
phosphoryl
tau
observ
follow
polyi
cexposur
suggest
utero
infect
favor
adlik
neuropatholog
normal
wild
type
mice
program
cell
coinhibitori
receptor
express
activ
immun
cell
interact
ligand
suppress
immun
respons
experi
perform
anim
model
multipl
sclerosi
ms
shown
blockad
lead
earlier
onset
increas
diseas
sever
ligand
observ
infiltr
immun
cn
cell
model
cn
cell
type
express
molecul
fulli
resolv
data
human
cn
still
incomplet
goal
assess
express
human
cn
establish
whether
molecul
could
local
contribut
modul
immun
respons
investig
whether
express
human
primari
cn
cell
astrocyt
microglia
oligodendrocyt
neuron
brain
endotheli
cell
hbec
basal
inflammatori
condit
use
cytokin
treatment
ifngamma
tnf
astrocyt
microglia
oligodendrocyt
neuron
hbec
express
bare
detect
level
basal
condit
mrna
qpcr
protein
level
flow
cytometri
immunocytochemistri
howev
inflammatori
cytokin
treatment
increas
express
cell
especi
astrocyt
microglia
hbec
block
use
specif
sirna
express
astrocyt
led
signific
enhanc
alloreact
cell
respons
prolifer
cytokin
product
show
capac
human
glial
cell
modul
cell
respons
via
pdl
moreov
express
analyz
use
immunohistochemistri
postmortem
brain
tissu
ms
control
higher
express
detect
ms
brain
section
compar
control
coloc
astrocyt
microglia
specif
cell
marker
final
detect
subset
infiltr
cell
human
ms
brain
lesion
result
demonstr
although
bare
express
human
brain
cell
vitro
vivo
significantli
boost
inflam
environ
like
one
observ
ms
lesion
final
cnsprovid
pdl
molecul
capac
reduc
human
cell
respons
numer
cn
infiltr
cell
express
thu
insensit
attempt
inflam
cn
dampen
respons
role
chlamydia
pneumonia
antibodi
smoker
acut
ischem
stroke
indian
studi
bandaru
vc
srinivasarao
background
smoke
one
major
risk
factor
cerebrovascular
cardiovascular
diseas
sever
report
implic
chlamydia
pneumonia
c
pneumonia
caus
factor
atherosclerosi
stroke
limit
data
present
india
data
avail
associ
c
pneumonia
infect
smoker
acut
ischem
stroke
object
investig
role
c
pneumonia
antibodi
smoker
acut
ischem
stroke
methodolog
studi
conduct
nizam
institut
medic
scienc
tertiari
care
hospit
south
india
januari
consecut
patient
age
year
acut
ischem
stroke
admit
within
hour
stroke
onset
includ
patient
underw
stroke
workup
risk
factor
data
collect
patient
measur
creactiv
protein
crp
level
c
pneumonia
antibodi
igg
iga
microimmunofluoresc
techniqu
mif
patient
result
patient
acut
ischem
stroke
age
group
smoker
norsmok
c
pneumonia
seroposit
found
smoker
nonsmok
p
b
crp
elev
smoker
compar
nonsmok
p
b
smoker
multipl
logist
regress
test
adjust
variou
risk
factor
like
hypertens
odd
ci
diabet
mellitu
odd
ci
alcohol
odd
ci
c
pneumonia
seroposit
odd
ci
adjust
igg
antibodi
odd
ci
smoker
stroke
compar
iga
antibodi
odd
ci
c
pneumonia
igg
antibodi
independ
associ
acut
ischem
stroke
smoker
cell
specif
target
amyloid
plaqu
enhanc
plaqu
clearanc
mous
model
alzheim
diseas
bengurion
univers
beersheva
israel
patient
alzheim
diseas
ad
exhibit
substanti
accumul
amyloidbeta
abeta
plaqu
brain
examin
whether
abeta
vaccin
facilit
migrat
lymphocyt
specif
target
abeta
plaqu
consequ
enhanc
remov
use
new
mous
model
ad
show
immun
abeta
encephalitogen
proteolipid
protein
plp
result
accumul
cell
abeta
plaqu
brain
although
abetareact
plpreactiv
cell
similar
phenotyp
cell
secret
primarili
ifngamma
encephalitogen
cell
penetr
spinal
cord
caus
experiment
autoimmun
encephalomyel
eae
wherea
abeta
cell
accumul
primarili
abeta
plaqu
brain
spinal
cord
induc
almost
complet
clearanc
abeta
furthermor
singl
vaccin
abeta
result
upregul
phagocyt
marker
trigger
receptor
express
myeloid
signal
regulatori
brain
caus
downregul
proinflammatori
cytokin
tnfalpha
thu
suggest
abeta
deposit
hippocampu
area
priorit
target
abetareact
plpreactiv
cell
upon
vaccin
stimul
abetareact
cell
site
abeta
plaqu
result
ifngammainduc
chemotaxi
leukocyt
therapeut
clearanc
abeta
signal
myeloid
cell
experiment
autoimmun
encephalomyel
crucial
entranc
remiss
phase
trogrlic
ivana
malipiero
ursula
ackermann
friederik
suter
tobia
fontana
adriano
univers
hospit
zurich
zurich
switzerland
tgfbeta
potent
regulatori
cytokin
divers
effect
hematopoiet
cell
import
role
control
autoimmun
cellmedi
autoimmun
mostli
studi
experiment
autoimmun
encephalomyel
model
eae
shown
tgfbeta
increas
remiss
phase
treatment
mice
amelior
eae
wherea
antitgfbeta
antibodi
lead
exacerb
eae
dendrit
cell
dc
macrophag
mph
known
effector
cell
eae
whether
tgfbeta
also
essenti
control
eae
act
cell
also
regul
function
innat
immun
remain
establish
invitro
studi
show
tgfbeta
power
mph
deactiv
inhibit
proinflammatori
cytokin
tnfalpha
beta
furthermor
tgfbeta
impair
product
oxygen
radic
intermedi
gener
nitric
oxid
induc
synthas
order
dissect
role
tgfbeta
innat
immun
system
autoimmun
use
knockout
mice
target
delet
tgfbrii
gene
activ
phagocyt
myeloid
origin
found
absenc
tgfbrii
signal
myeloid
cell
chronic
phase
eae
take
sever
cours
mice
nt
go
remiss
phase
unexpectedli
phenotyp
associ
promin
express
ino
tnfalpha
mph
dc
microglia
deriv
tgfbrii
knockout
mice
rather
accumul
myeloid
cell
cn
anim
late
phase
eae
found
dendrit
cell
fold
increas
cn
knockout
anim
analysi
surfac
marker
like
integrin
molecul
involv
cell
migrat
extravas
show
differ
express
accumul
cell
activ
marker
cell
also
differ
express
compar
litterm
control
present
data
strongli
support
involv
tgfbeta
signal
myeloid
deriv
cell
remiss
phase
eae
current
investig
influenc
tgfbeta
cell
surviv
recruit
inflammatori
cell
cn
chemokin
receptor
critic
alzheimerlik
plaqu
format
transgen
mice
chemokin
famili
cytokin
structur
similar
chemoattract
properti
import
molecul
orchestr
inflammatori
process
abl
modul
cours
neuroinflammatori
neurodegen
diseas
descript
studi
brain
tissu
alzheim
patient
accord
anim
model
reveal
high
level
chemokin
argu
import
role
chemokin
pathogenesi
alzheim
diseas
ad
correspond
receptor
express
activ
cell
also
microglia
neuron
recent
function
studi
address
role
neurolog
diseas
present
data
argu
complex
role
chemokin
system
cnsdiseas
benefici
detriment
examin
studi
impact
signal
ad
progress
transgen
mice
coexpress
two
human
ad
mutat
amyloid
precursor
protein
appsw
mice
cross
mice
eight
month
old
mice
genotyp
wildtyp
mice
analys
amyloidbeta
deposit
app
process
express
inflammationrel
gene
furthermor
microgli
phagocytosi
assay
defici
wild
type
primari
microglia
use
analys
vitro
impact
microgli
phagocytosi
amyloidbeta
immunohistochem
abeta
stain
elisa
detect
amyloidbeta
brain
reveal
strongli
reduc
plaqu
burden
reduc
amyloidbeta
proteinlevel
defici
mice
compar
mice
morpholog
activ
periplaqu
accumul
microglia
diminish
app
compar
mice
moreov
defici
lead
decreas
rna
level
proinflammatori
cytokin
like
tnfalpha
ligand
brain
vitro
phagocytosi
assay
data
indic
increas
uptak
famlabel
fibrillar
amyloidbeta
microgli
cell
isol
mice
compar
control
conclus
critic
involv
adlik
plaqu
format
transgen
mice
data
suggest
reduct
amyloid
plaqu
mice
mediat
modul
microgli
function
due
argu
novel
promis
therapeut
target
ad
contribut
mapk
versu
mapk
microglia
cytokin
respons
lp
betaamyloid
adam
bachstett
linda
van
eldik
univers
kentucki
lexington
unit
state
activ
microglia
major
patholog
featur
alzheim
diseas
ad
microglia
activ
necessarili
detriment
mani
benefici
microglia
respons
sequest
remov
protein
aggreg
howev
activ
microglia
primari
sourc
proinflammatori
cytokin
brain
two
proinflammatori
cytokin
elev
ad
believ
contribut
neuron
damag
tnfalpha
mitogenactiv
protein
kinas
mapk
one
kinas
pathway
involv
product
tnfalpha
famili
consist
least
four
isoform
beta
gamma
delta
encod
separ
gene
isoform
express
signific
level
brain
commerci
avail
inhibitor
shown
inhibit
tnfalpha
biosynthesi
interact
isoform
rel
contribut
microgli
tnfalpha
biosynthesi
respons
variou
stimuli
address
address
question
isol
microglia
knockout
ko
mice
stimul
microglia
two
differ
activ
stimuli
lipopolysaccharid
lp
interestingli
found
quantit
differ
microglia
respons
lp
depend
isoform
ko
microglia
ko
mice
respons
lp
nearli
unrespons
diminish
detect
respons
stimuli
seen
defici
microglia
result
suggest
uniqu
function
may
attribut
isoform
activ
microglia
might
exploit
futur
develop
new
class
cnsactiv
isoformselect
inhibitor
effect
medicin
plant
neuroinflamm
neurolog
diseas
pragmat
random
ethnopharmacolog
survey
chapainawabganj
district
bangladesh
mollik
md
ari
haqu
peopl
integr
allianc
dhaka
bangladesh
epilepsi
malaria
sexual
transmit
diseas
preval
even
endem
variou
part
world
sinc
ancient
time
recent
year
attent
focus
diseas
emerg
drugresist
varieti
diseas
result
becom
imper
discov
novel
compound
treat
diseas
sinc
medicin
plant
form
one
best
sourc
obtain
pharmacolog
activ
constitu
use
remedi
diseas
like
epilepsi
malaria
sexual
transmit
diseas
object
present
studi
conduct
ethnopharmacolog
survey
amongst
tradit
health
practition
chapainawabganj
district
bangladesh
obtain
inform
medicin
plant
use
remedi
ailment
noteworthi
regard
abovement
ailment
preval
bangladesh
primarili
rural
popul
countri
reli
medicin
plant
plant
part
prescrib
tradit
health
practition
treat
ailment
interview
conduct
tradit
health
practition
help
semistructur
questionnair
medicin
plant
sampl
photograph
identifi
bangladesh
nation
herbarium
collect
inform
show
follow
medicin
plant
use
treat
epilepsi
citru
maxima
merr
bacopa
monnieri
l
pennel
datura
stramonium
l
calotropi
gigantea
l
wtaiton
nigella
sativa
l
bixa
orellana
l
carica
papaya
l
acoru
calamu
l
boerhavia
repen
l
antimalari
medicin
plant
includ
justicia
adhatoda
l
brassica
napu
l
ocimum
tenuiflorum
l
solanum
nigrum
l
saccharum
officinarum
l
piper
nigrum
l
momordica
charantia
descourt
coco
nucifera
l
citru
acida
roxb
medicin
plant
use
treat
sexual
transmit
diseas
includ
borassu
flabellif
l
terminalia
bellirica
gaertn
roxb
colocasia
esculenta
l
schott
melia
azadirachta
l
achyranth
aspera
l
cicer
arietinum
l
vitex
negundo
l
curcuma
longa
l
saraca
indica
l
bombax
ceiba
l
basella
alba
l
aconitum
napellu
l
sinc
rural
patient
bangladesh
appear
gener
satisfi
treatment
offer
medicin
plant
import
conduct
proper
scientif
studi
toward
discoveri
compound
interest
medicin
plant
use
safe
effect
medicin
inhibitori
neurotransmitt
glycin
gaba
amelior
diseas
cours
experiment
autoimmun
encephalomyel
carman
sofi
hendrik
jerom
rigo
jeanmichel
stinissen
piet
hell
niel
biom
hasselt
univers
diepenbeek
belgium
inhibitori
neurotransmitt
glycin
gammaaminobutyr
acid
gaba
shown
modul
peripher
immun
cell
respons
immunomodulatori
role
import
neuroinflammatori
diseas
like
multipl
sclerosi
ms
recent
demonstr
glycin
modul
macrophag
effector
function
implic
central
nervou
system
cn
inflamm
vitro
studi
vitro
effect
gaba
diseasecontribut
macrophag
function
explor
furthermor
role
glycin
gaba
diseas
process
ms
elucid
anim
model
experiment
autoimmun
encephalomyel
eae
mous
periton
macrophag
preincub
gaba
mm
hour
follow
lipopolysaccharid
ngml
stimul
hour
gaba
reduc
tumor
necrosi
factoralpha
product
concentrationdepend
manner
contrast
product
increas
low
gaba
concentr
effect
gaba
mediat
gabaa
gabab
receptor
respect
antagonist
gabazin
saclofen
revers
gabaevok
effect
addit
macrophag
capac
phagocytos
myelin
significantli
reduc
gaba
treatment
mm
hour
elucid
influenc
gaba
glycin
neuroinflamm
vivo
chronic
eae
induc
mice
anim
treat
daili
day
onward
glycin
mgkg
vigabatrin
mgkg
vigabatrin
gabatransaminas
inhibitor
result
increas
gaba
concentr
glycin
treatment
delay
eae
onset
reduc
clinic
symptom
vigabatrin
treatment
complet
prevent
eae
develop
find
demonstr
glycin
gaba
benefici
influenc
neuroinflamm
possibl
modul
macrophag
function
therefor
inhibitori
neurotransmitt
metabol
pathway
may
set
basi
develop
new
therapeut
agent
inflammatori
diseas
affect
cn
role
express
classic
activ
microglia
traumat
brain
injuri
kenji
dohi
hirokazu
ohtaki
kazu
satoh
tomoya
nakamachi
sachiko
yofu
kazuyuki
miyamoto
dandan
song
shohko
tsunawaki
seiji
shioda
tohru
aruga
showa
univers
tokyo
japan
nation
research
institut
child
health
develop
tokyo
japan
traumat
brain
injuri
tbi
associ
reactiv
oxygen
speci
ro
one
major
enzymat
sourc
superoxid
anion
product
brain
nadph
oxidas
one
catalyt
subunit
nadph
oxidas
enzym
nox
play
key
enzym
variou
neuron
diseas
hypothes
gener
superoxid
anion
major
caus
role
tbi
unilater
tbi
induc
knockout
wildtyp
mice
cci
express
role
tbi
investig
immunoblot
stain
mice
determin
situ
superoxid
anion
detect
oxid
metabolit
brain
activ
phenotyp
microglia
express
determin
microgli
cell
line
presenc
increas
h
h
ipsilater
hemispher
wildtyp
mice
cci
express
mainli
ameboidshap
microgli
cell
weakli
astrocyt
neuron
mice
less
contus
area
tunel
posit
cell
wildtyp
one
also
suppress
superoxid
radic
peroxynitrit
metabolit
presenc
ifngamma
cell
increas
ino
level
indic
classic
activ
phenotyp
drastic
increas
anoth
subunit
nadph
oxidas
decreas
presenc
contain
nadph
oxidas
express
classic
activ
like
microglia
promot
ro
format
import
role
brain
damag
tbi
modul
nadph
oxidas
ro
may
provid
new
therapeut
strategi
traumat
brain
injuri
therapeut
effect
alkyllysophospholipid
edelfosin
immun
cell
experiment
autoimmun
encephalomyel
cytostat
drug
edelfosin
synthet
analogu
lysophosphatidylcholin
edelfosin
incorpor
cell
act
cellular
membran
rather
dna
select
activ
cell
death
receptor
edelfosin
incorpor
effect
intracellular
concentr
highli
prolifer
cell
like
activ
immun
cell
tumor
cell
aim
studi
effect
edelfosin
immun
system
context
experiment
autoimmun
encephalomyel
eae
anim
model
multipl
sclerosi
addit
examin
impact
drug
human
cell
prolifer
order
analyz
antiinflammatori
properti
edelfosin
use
relapsingremit
mous
model
eae
sjl
mice
immun
proteolipid
protein
peptid
effect
edelfosin
eae
diseas
cours
evalu
clinic
histolog
analysi
daili
treatment
edelfosin
reduc
mean
eae
score
control
anim
pb
administr
mgkg
edelfosin
administr
eae
acut
phase
spinal
cord
immunohistolog
analysi
acut
phase
eae
reveal
reduc
well
cellular
infiltr
mice
treat
edelfosin
edelfosin
treatment
also
led
dosedepend
activ
caspas
cell
found
signific
differ
mgkg
edelfosin
pb
treatment
independ
cell
type
cell
tissu
lymph
node
spleen
examin
lymph
node
cell
edelfosinetr
mice
retain
prolif
function
upon
restimul
ex
vivo
reactiv
cell
result
edelfosin
dosedepend
prolif
respons
edelfosin
also
found
interfer
dosedepend
manner
activ
prolifer
specif
human
cell
result
impli
edelfosin
may
amelior
eae
act
diseasespecif
immun
cell
possibl
via
apoptosi
induct
result
point
dosedepend
interfer
edelfosin
specif
immun
cell
vivo
well
prolif
capac
restimul
experi
ex
vivo
experi
explor
therapeut
effect
edelfosin
start
eae
diseas
onset
well
effect
format
immunolog
synaps
ongo
support
herti
stiftung
year
old
libyan
ladi
present
left
eye
blur
vision
month
ago
resolv
within
week
oral
steroid
usag
three
month
later
got
bilater
lower
limb
numb
parenthes
follow
weak
urinari
retent
unsteadi
symptom
resolv
partial
usag
intraven
steroid
two
month
later
got
sever
neuropath
pain
allodynia
bodi
bilater
lower
limb
numb
resolv
partial
usag
intraven
steroid
oral
pregabalin
clinic
atax
paraparesi
brisk
reflex
bodi
bilater
lower
limb
hyposthesia
allodynia
level
lhermit
sign
investig
cervicodors
spine
mri
show
singl
continu
spinal
cord
lesion
extend
anoth
small
ovoid
cervic
spine
lesion
brain
mri
show
white
matter
demyelin
lesion
brain
disappear
steroid
csf
aquaporin
antibodi
neg
well
csf
oligoclon
band
normal
csf
igg
index
visual
evok
potenti
show
delay
respons
left
eye
somatosensori
evok
potenti
normal
conclus
patient
relapsingremit
neurolog
diseas
mri
brain
lesion
suggest
ms
singl
continu
gadolinium
enhanc
dorsal
spine
lesion
extend
presenc
long
spinal
cord
lesion
atyp
ms
suggest
devic
diseas
spite
neg
csf
aquaporin
antibodiesthi
case
highlight
challeng
diagnos
demyelint
diseas
import
implic
regard
patient
prognosi
therapi
diabet
ketoacidosi
increas
inflammatori
transcript
factor
activ
adhes
molecul
express
close
taylor
e
bezzina
kathryn
patterson
eric
k
cepinska
gedimina
fraser
dougla
univers
western
ontario
lonond
canada
diabet
ketoacidosi
dka
complic
diabet
requir
urgent
recognit
treatment
dka
therapi
children
high
risk
intracrani
complic
includ
edema
stroke
haemorrhag
caus
intracrani
complic
unknown
howev
blood
brain
barrier
bbb
compromis
neuroinflamm
may
contribut
factor
previous
shown
differ
immun
respons
system
cerebr
cortex
illustr
significantli
higher
level
cytokin
interleukin
kc
serum
dka
mice
howev
cerebr
cortex
decreas
increas
without
correspond
chang
aim
studi
investig
neuroinflammatori
respons
hypothes
transcript
factor
nuclear
factorkb
nfkb
activ
endotheli
cell
bbb
dka
nfkb
subsequ
increas
express
vascular
cell
adhes
investig
nfkb
activ
express
dka
use
juvenil
mice
inject
either
pancreat
betacel
toxin
streptozocin
alloxan
dka
vehicl
alon
control
spleen
cerebr
cortex
sampl
obtain
control
dka
mice
variou
time
point
hour
activ
nfkb
protein
level
spleen
cerebr
cortex
analyz
use
nfkb
transcript
factor
assay
mrna
express
cerebr
cortex
quantit
analyz
use
realtim
pcr
dka
confirm
mice
demonstr
significantli
higher
serum
glucos
betaohbutyr
level
weight
loss
compar
control
analysi
cerebr
cortex
reveal
significantli
increas
activ
nfkb
level
hour
spleen
signific
differ
control
dka
mice
upregul
cerebr
cortex
mrna
found
hour
mirror
nfkb
activ
find
yet
statist
signific
n
data
implic
inflammatori
respons
cerebr
cortex
dka
involv
nfkb
protein
activ
mrna
express
hour
without
correspond
respons
spleen
observ
neuroinflammatori
respons
may
contribut
intracrani
complic
observ
children
dka
result
mogtcr
mice
develop
lead
neuron
loss
monitor
longitudin
realtim
live
anim
therefor
offer
refin
previou
model
ms
classic
eae
new
model
invalu
studi
neuroprotect
repair
strategi
autoimmun
diseas
provid
direct
experiment
correl
studi
could
undertaken
human
mous
express
cell
receptor
tcr
transgen
specif
residu
myelin
oligodendrocyt
glycoprotein
mog
restrict
bett
et
al
j
exp
med
develop
spontan
approxim
follow
induct
combin
immun
adjuv
pertussi
toxin
mogspecif
monoclon
antibodi
give
coordin
incid
diseas
optic
neuriti
develop
absenc
clinic
histolog
eae
associ
extens
demyelin
axon
loss
optic
nerv
nerv
loss
quantifi
loss
rgc
retina
anim
cross
cfp
mice
express
cyan
fluoresc
protein
cfp
control
promot
limit
express
cfp
rgc
eye
feng
g
et
al
neuron
result
mogtcr
mice
develop
lead
neuron
loss
monitor
longitudin
realtim
live
anim
therefor
offer
refin
previou
model
ms
classic
eae
new
model
invalu
studi
neuroprotect
repair
strategi
autoimmun
diseas
provid
direct
experiment
correl
studi
could
undertaken
human
central
diabet
insipidu
associ
infiltr
mainli
tcell
pituitari
gland
infundibulum
possibl
hypothalamu
destruct
vasopressinexpress
neuron
lead
polydipsia
polyuria
pathophysiolog
role
tcell
subpopul
disord
still
unknown
could
studi
anim
model
studi
rel
contribut
tcell
cooper
cn
autoimmun
develop
mous
model
hemagglutinin
ha
express
neoself
antigen
neuron
camkha
mice
complementari
ha
tcrtransgen
mice
use
sourc
haspecif
tcell
address
individu
combin
contribut
differ
cell
subpopul
potenti
induc
damag
neuron
knockin
mous
ha
cdna
insert
locu
flox
stop
cassett
cross
camkicr
mice
express
cre
recombinas
control
neuronspecif
calmodulinkinas
iia
promot
adopt
transfer
vitro
activ
haspecif
cell
camkha
mice
control
camkha
mice
die
gener
myeloenceph
wherea
control
surviv
initi
phase
diseas
camkha
mice
show
sever
weight
loss
neurolog
sign
associ
trembl
hypoact
without
obviou
paralysi
histolog
day
detect
inflamm
spinal
cord
brain
predominantli
hypothalamu
brainstem
medulla
oblongata
initi
phase
surviv
mice
recov
full
mobil
normal
weight
howev
camkha
recipi
develop
day
onward
sign
diabet
insipidu
polydipsia
polyuria
high
amount
urin
time
control
could
reduc
inject
vasopressinanalog
suggest
destruct
hypothalam
vasopressinproduc
neuron
mice
inde
virtual
disappear
vassopressinexpress
neuron
shown
histolog
model
help
gener
novel
inform
regard
contribut
tcell
neural
tissu
injuri
protect
first
illustr
potenti
develop
new
model
diabet
insipidu
induc
autoreact
cytotox
tcell
underli
potenti
role
tcell
pathophysiolog
human
idiopath
diabet
insipidu
character
experiment
autoimmun
neuriti
model
induc
peptid
lipopeptid
lewi
rat
beaino
wissam
trifilieff
elisabeth
de
strasbourg
cnr
strasbourg
franc
thiopalmitoyl
ie
coval
attach
palmit
acid
via
thioester
linkag
cystein
residu
polypeptid
backbon
common
posttransl
modif
protein
previou
studi
shown
thiopalmitoyl
encephalitogen
tcell
epitop
central
nervou
myelin
proteolipid
protein
plp
occur
natur
vivo
enhanc
immun
respons
well
develop
chronic
experiment
autoimmun
encephalomyel
eae
anim
model
human
inflammatori
demyelin
diseas
multipl
sclerosi
ms
result
suggest
immun
respons
induc
endogen
thioacyl
peptid
releas
myelin
breakdown
may
play
role
develop
chronic
autoimmun
inflammatori
demyelin
diseas
confirm
hypothesi
studi
effect
thiopalmitoyl
immunogen
neuritogen
properti
protein
major
protein
peripher
nervou
system
pn
myelin
protein
thiopalmitoyl
cystein
candid
autoantigen
aidp
acut
inflammatori
demyelin
polyradiculoneuropathi
common
subtyp
syndrom
gb
human
inflammatori
demyelin
diseas
pn
valuabl
insight
immunopathogen
mechan
gb
gain
anim
model
experiment
autoimmun
neuriti
ean
induc
lewi
rat
inject
protein
peptid
synthes
palmitoyl
nonpalmitoyl
peptid
studi
compar
immunogen
neuritogen
properti
inject
lewi
rat
peptid
immunodomin
neuritogen
epitop
lewi
rat
use
control
peptid
cours
diseas
follow
clinic
assess
histopatholog
sciatic
nerv
preliminari
result
show
thiopalmitoyl
inde
import
effect
neuritogen
properti
peptid
cidplik
relaps
model
induc
palm
palm
seem
induc
amantyp
diseas
acut
motor
axon
neuropathi
role
musclespecif
kinas
musk
antibodi
ab
onset
myasthenia
gravi
mg
remain
disput
major
musk
ab
patient
shown
incap
activ
complement
lead
lysi
postsynapt
membran
neuromuscular
junction
nmj
order
reveal
whether
activ
complement
indispens
pathogen
mg
caus
musk
ab
complement
defici
mice
immun
musk
protein
investig
whether
mg
muskab
without
involv
complement
activ
inject
musk
protein
mice
twice
day
day
mous
strain
two
base
ta
delet
near
end
gene
caus
prematur
stop
translat
defici
mutat
gener
lytic
membran
attack
complex
mac
activ
complement
pathway
mice
demonstr
characterist
featur
electromyograpi
observ
patient
mg
also
abnorm
electrophysiolog
sign
record
patient
musk
mg
singl
inject
neostigmin
significantli
decreas
muscl
weak
muskinject
mice
sever
muscl
weak
revers
cmap
amplitud
decrement
neostigmin
treatment
record
stimul
anesthet
mice
within
mean
decrement
howev
one
mous
could
recov
cmap
within
decrement
preand
postsynapt
structur
neuromuscular
junction
nmj
significantli
degener
mice
examin
express
ach
collagen
q
colq
postsynapt
membran
nmj
mice
found
intens
ach
express
nmj
significantli
decreas
compar
uninjectedcontrol
mice
colq
achr
express
coordin
reduc
nmj
show
evid
muskab
caus
mg
without
involv
complement
activ
use
mice
strain
bear
mutat
complement
compon
domin
encephalitogen
peptid
direct
sustain
regul
model
multipl
sclerosi
induct
armour
treg
lin
youwei
sachiko
miyak
takashi
yamamura
nation
institut
neurosci
ncnp
tokyo
japan
immun
myelin
peptid
caus
varieti
inflammatori
reaction
central
nervou
system
collect
refer
experiment
autoimmun
encephalomyel
eae
though
model
may
repres
relapsingremit
diseas
rreae
resembl
multipl
sclerosi
other
would
follow
monophas
diseas
meae
surprisingli
prior
studi
address
mechanist
eae
model
would
exhibit
uniqu
diseas
cours
besid
refer
genet
factor
note
immun
sjlj
mice
overlap
myelin
proteolipid
protein
plp
residu
could
induc
quit
differ
diseas
meae
rreae
address
meae
rreae
differenti
regul
vivo
phenomenon
meae
could
never
develop
relaps
reinduct
wherea
rreae
could
compar
kinet
lymphoid
cell
mice
immun
either
peptid
found
highli
potent
regulatori
cell
express
induc
maintain
drain
lymph
node
meae
appear
encephalitogen
cell
regulatori
cell
function
efficaci
subset
cell
reflect
show
suppress
gene
signatur
uniqu
domin
cell
express
ico
gitr
much
higher
level
lower
level
produc
lap
enabl
resist
continu
peripher
expans
encephalitogen
cell
furthermor
elong
ntermini
truncat
cterminu
close
relat
domin
peptid
domin
peptid
possess
capac
develop
acut
eae
less
relaps
reinduct
eae
occur
correl
potenc
induc
activ
regulatori
cell
describ
result
indic
differenti
induct
efficaci
regulatori
cell
individu
domin
selfpeptid
tune
suppress
relev
pathogenesi
lead
differ
clinic
cours
prognosi
also
treatment
autoimmun
diseas
tumor
necrosi
factor
tnf
pleiotroph
cytokin
involv
normal
brain
function
associ
develop
inflamm
follow
traumat
injuri
neurolog
diseas
treatment
aim
elimin
excess
tnf
effect
therapi
number
inflammatori
autoimmun
diseas
rheumatoid
arthriti
multipl
sclerosi
howev
clinic
use
tnf
inhibitor
associ
increas
risk
infect
genet
studi
mice
suggest
inflamm
diseas
model
involv
soltnf
mainten
innat
immun
involv
transmembran
tnf
tmtnf
therefor
took
advantag
dominantneg
inhibitor
soltnf
select
inhibit
soltnf
compar
effect
wide
use
fctnf
receptor
fusion
protein
etanercept
inhibitor
soltnf
tmtnf
mous
model
spinal
cord
injuri
sci
behavior
test
mice
subject
sci
treat
either
etanercept
vehicl
either
directli
traumat
spinal
cord
via
microosmot
pump
continu
deliveri
day
subcutan
everi
day
week
show
mice
treat
display
obviou
improv
function
outcom
compar
etanercept
vehicl
howev
preliminari
data
stereolog
estim
lesion
size
show
mice
treat
deliv
directli
spinal
cord
smaller
lesion
size
day
sci
mice
treat
etanercept
vehicl
preliminari
data
indic
soltnf
inhibit
mainten
tmtnf
might
neuroprotect
follow
sci
express
quantit
trait
loci
identifi
candid
gene
regul
pathway
experiment
autoimmun
encephalomyel
hedreul
genomewid
associ
studi
success
identifi
mani
risk
gene
regul
complex
diseas
human
numer
quantit
trait
loci
qtl
modul
diseas
also
identifi
perform
genomewid
screen
experiment
anim
cross
howev
reach
singlegen
resolut
knowledg
diseas
risk
gene
truli
regul
diseas
incomplet
advanc
technolog
last
coupl
year
enabl
map
gene
express
level
eqtl
wholegenom
scale
import
complement
tradit
qtl
map
avail
full
transcriptom
even
enabl
coexpress
network
enrich
analysi
genet
risk
variant
provid
insight
diseas
pathogenesi
model
use
studi
complex
inflammatori
respons
experiment
autoimmun
encephalomyel
eae
anim
model
ms
studi
combin
classic
qtl
eqtl
map
facilit
candid
gene
identif
within
previous
known
eae
qtl
ciseqtl
resid
within
region
constitut
possibl
candid
gene
defin
diseas
pathway
regul
neuroinflamm
genom
wide
express
experi
affymetrix
rat
gene
st
array
perform
spleen
sampl
male
rat
da
backcross
day
post
immun
eae
confirm
mani
eae
qtl
previous
found
group
map
sever
ciseqtl
gain
knowledg
involv
regul
diseas
enceph
lethargica
el
affect
larg
number
peopl
pandem
earli
von
economo
whilst
consid
rare
disord
still
occur
sporad
frequenc
present
diseas
cours
treatment
respons
caus
unknown
typic
el
present
acut
ill
young
adult
initi
neuropsychiatr
featur
sleep
disturb
movement
disord
histolog
biochem
data
suggest
autoimmun
mechan
play
import
role
disord
recent
serum
antibas
ganglia
antibodi
abga
detect
affect
sporad
case
associ
evid
recent
streptococc
infectionabga
also
associ
neuropsychiatr
disord
like
sydenham
chorea
panda
tourett
syndrom
obsess
compuls
disord
abga
strongli
associ
recent
streptococc
infect
disord
repres
potenti
good
model
studi
molecular
mimicri
autoimmun
present
studi
demonstr
effect
immunopurifi
antibodi
el
patient
plasma
recombin
enzym
autoantigen
neuron
cell
function
follow
applic
purifi
autoantibodi
neuron
cell
cultur
decreas
enolas
activ
cell
viabil
metabol
activ
observ
togeth
increas
apoptosi
furthermor
preliminari
data
indic
calcium
influx
via
ltype
channel
significantli
depress
abga
patient
igg
lead
neurit
retract
apoptosi
thu
also
aim
determin
effect
purifi
monospecif
antibodi
kclevok
calcium
respons
well
nmda
stimul
calcium
respons
singl
cell
calcium
respons
measur
fluoresc
imag
poststreptococc
disord
still
poorli
understood
larg
due
lack
suitabl
anim
model
therefor
develop
anim
model
disord
passiv
transfer
el
patient
igg
activ
immun
group
streptococcu
homogen
human
basal
ganglia
recombin
protein
autoantigen
autoantibodi
mediat
diseas
respond
immunomodulatori
therapi
identifi
defin
pathogenesi
disord
import
patient
appropri
treat
establish
group
disord
true
autoimmun
diseas
cn
demonstr
abga
function
effect
establish
whole
new
paradigm
multipl
sclerosi
ms
immunemedi
demyelin
neurodegen
diseas
central
nervou
system
cn
use
experiment
autoimmun
encephalomyel
eae
model
ms
previous
demonstr
cannabinoid
system
control
autoimmun
neurodegen
symptomat
aspect
diseas
relat
action
two
cannabinoid
receptor
far
describ
identifi
orphan
g
protein
coupl
receptor
novel
lipidreceptor
stimul
lysophosphoinositol
importantli
cannabinoid
ligand
suggest
may
function
relationship
cannabinoid
system
use
quantit
polymeras
chain
reaction
situ
hybrid
show
weakli
express
nervou
immun
system
expect
absent
novel
defici
knockout
mous
develop
us
immunolog
phenotyp
relat
suscept
abh
mice
experiment
autoimmun
encephalomyel
respons
n
novel
symptom
modifi
agent
present
herp
simplex
viru
type
induc
central
nervou
system
cn
demyelin
mice
kastrukoff
lorn
lau
allen
thoma
eva
infect
oral
mucosa
novel
strain
lab
strain
result
develop
demyelin
lesion
throughout
brain
suscept
resist
mice
lesion
character
demyelin
inflammatori
mononuclear
cell
infiltr
rel
preserv
axon
develop
three
phase
month
earli
phase
last
day
postinfect
pi
correl
transient
spread
infecti
viru
throughout
brain
determin
viral
titer
studi
character
earli
phase
lesion
perform
histolog
immunohistochemistri
ihc
insitu
hybrid
solut
phase
pcr
studi
inbr
mice
infect
via
oral
mucosa
focal
area
viral
antigen
identifi
day
pi
brain
infect
mice
area
restrict
trigemin
root
entri
zone
resist
mice
develop
sequenti
throughout
brain
suscept
strain
infect
cell
focal
area
morpholog
characterist
neuron
glia
suscept
strain
number
size
demyelin
lesion
brain
correl
invers
resist
mous
strain
mortal
plj
n
ajn
sjljn
balbc
focal
area
viral
antigen
evolv
demyelin
lesion
clearanc
viru
site
despit
clearanc
infecti
viru
viral
cdna
posit
cell
remain
area
demyelin
solut
phase
pcr
studi
identifi
viral
dna
present
brain
suscept
strain
least
month
summari
specif
strain
induc
cn
demyelin
suscept
strain
mice
earli
phase
viru
replic
occur
focal
area
brain
latent
infect
establish
develop
demyelin
correl
clearanc
infecti
latent
viru
focal
area
viral
antigen
presenc
latent
viru
cn
beyond
earli
phase
may
play
role
develop
demyelin
occur
later
phase
hpa
axi
activ
influenc
suscept
develop
experiment
autoimmun
encephalomyel
gender
specif
manner
harpaz
idan
ben
gurion
univers
beer
sheva
israel
activ
hypothalamicpituitaryadren
hpa
axi
respons
stress
increas
releas
corticosteroid
adren
gland
maintain
homeostasi
howev
chronic
stress
prolong
activ
hpa
axi
may
interfer
normal
activ
turn
may
interfer
immun
homeostasi
reduc
abil
organ
cope
immun
challeng
given
differ
gender
suscept
experiment
autoimmun
encephalomyel
eae
investig
whether
mice
exposur
chronic
stress
affect
suscept
eae
genderspecif
manner
end
expos
male
femal
mice
chronic
stress
day
induc
eae
corticosteroid
secret
evalu
throughout
experi
show
basal
chronic
stress
condit
male
suscept
eae
compar
femal
effect
associ
poor
activ
hpa
axi
basal
chronic
stress
male
compar
femal
addit
chronic
stress
induc
anxietylik
behavior
weight
loss
reduc
frequenc
cell
gender
male
mice
show
exacerb
form
diseas
follow
exposur
chronic
stress
data
present
demonstr
hpaaxi
activ
respons
chronic
stress
differenti
regul
male
femal
phenomenon
directli
impact
regul
autoimmun
henc
suscept
progress
autoimmun
diseas
primari
syndrom
pss
chronic
autoimmun
diseas
affect
exocrin
gland
fatigu
common
major
caus
disabl
sick
behaviour
anim
adapt
respons
character
increas
sleep
social
withdraw
loss
appetit
mediat
proinflammatori
cytokin
interleukin
il
act
brain
cytokin
also
increas
human
cancer
relat
fatigu
group
recent
report
associ
activ
system
fatigu
pss
indic
might
signal
fatigu
sever
somat
diseas
object
current
studi
explor
effect
inhibit
fatigu
pss
doubleblind
placebocontrol
studi
patient
agre
particip
written
consent
receiv
four
week
treatment
patient
selfadminist
daili
inject
either
anakinraan
receptor
antagonistor
placebo
nacl
patient
examin
inclus
week
start
week
week
end
treatment
followup
week
patient
ask
rate
fatigu
visual
analogu
scale
va
baselin
characterist
age
diseas
durat
haematolog
biochem
test
level
fatigu
similar
anakinragroup
n
placebogroup
n
friedman
test
repeat
measur
use
test
differ
time
compar
baselin
chisquar
test
use
compar
number
patient
reach
reduct
fatigueva
week
compar
inclus
highli
signific
reduct
fatigueva
studi
anakinragroup
observ
placebogroup
median
fatigueva
inclus
rang
median
week
median
week
median
week
vs
median
inclus
median
week
median
week
median
week
p
vs
p
significantli
patient
reduct
fatigueva
week
anakinragroup
compar
placebogroup
p
inhibit
reduc
fatigu
significantli
patient
pss
may
due
decreas
signal
brain
observ
anim
studi
result
indic
system
biolog
factor
associ
fatigu
human
increas
express
rat
brain
pathogenesi
experiment
autoimmun
encephalomyel
yanji
jia
jingj
lu
yonglin
jia
lijun
jing
first
affili
hospit
zhengzhou
univers
zhengzhou
china
transient
receptor
potenti
trp
channel
larg
famili
protein
involv
wide
rang
process
rang
sens
thermal
chemic
signal
reload
intracellular
store
respond
extracellular
stimulu
convent
report
coldand
mentholsens
cation
channel
implic
thermosens
report
express
might
increas
greatli
rat
brain
pathogenesi
experiment
autoimmun
encephalomyel
eae
studi
firstli
establish
wistar
rat
model
eae
footpad
inject
guinea
pig
spinal
cord
homogen
cfa
express
protein
mrna
brain
tissu
extract
eae
rat
day
respect
measur
immunohistochem
stain
western
blot
rtpcr
correl
level
symptom
eae
also
investig
result
show
variou
degre
inflamm
demyelin
brain
found
eae
group
immun
observ
protein
mrna
express
low
level
brain
control
group
eae
induc
level
protein
mrna
express
brain
increas
gradual
develop
symptom
brain
patholog
eae
day
level
protein
mrna
express
brain
significantli
increas
level
time
clinic
symptom
patholog
eae
group
reach
peak
immunohistochem
stain
demonstr
express
protein
mainli
local
cell
membran
axon
region
lesion
foci
day
level
protein
mrna
express
reduc
gradual
parallel
gradual
allevi
part
clinic
symptom
patholog
lesion
eae
group
find
indic
may
play
import
role
pathogenesi
eae
inhibit
autoimmun
insuffici
stop
secondari
progress
experiment
autoimmun
encephalomyel
poor
translat
use
immunosuppress
agent
anim
model
treatment
multipl
sclerosi
ms
although
may
differ
diseas
pathogenesi
vast
major
studi
experiment
autoimmun
encephalomyel
eae
model
ms
examin
prophylact
treatment
regim
whilst
may
elucid
immun
mechan
probabl
limit
relev
therapeut
applic
studi
aim
investig
whether
potent
immunosuppress
could
inhibit
longestablish
progressiveautoimmun
diseas
cn
anim
ms
model
chronicrelaps
eae
induc
abh
mice
use
spinal
cord
antigen
complet
freund
adjuv
fingolimod
limit
relaps
ms
orallyadminist
variou
time
diseas
induct
influenc
motorfunct
assess
whilst
prophylact
inhibit
develop
diseas
importantli
inhibit
subsequ
relapsingdiseas
use
therapeut
relapsingea
facilit
recoveri
motorfunct
suggest
repair
relaps
diseas
halt
howev
follow
accumul
neurologicaldeficit
due
relaps
attack
slow
progressiveworsen
disabl
occur
expos
elimin
relapsingautoimmun
immunolog
toler
induct
use
transient
cell
delet
intraven
myelin
administr
month
diseas
induct
anim
randomis
vehicl
anticip
relaps
occur
signific
deterior
motor
function
group
suggest
immunosuppress
point
inhibit
progress
eae
earli
treatment
immunosuppress
agent
may
inhibit
gener
neurodegen
microenviron
longer
respons
potent
immunosuppress
howev
treatment
initi
late
diseaseprocess
progress
neurolog
diseas
continu
unab
suggest
immunosuppress
alon
never
insuffici
control
progress
neurodegener
anim
progress
ms
inhibit
neutrophil
elastas
attenu
neuroinflamm
axtel
robert
steinman
lawrenc
neuromyel
optica
nmo
neuroinflammatori
diseas
similar
relapsingremit
multipl
sclerosi
rrm
howev
nmo
differ
rrm
inflammatori
lesion
nmo
granulocyt
convent
rrm
treatment
effect
nmo
pathogen
mechan
neutrophil
nmo
larg
unknown
studi
demonstr
nmo
model
experiment
autoimmun
encephalomyel
eae
induc
diseas
attenu
target
enzym
found
granul
neutrophil
neutrophil
elastas
found
compar
rrm
nmo
increas
serum
level
groalpha
chemokin
recruit
activ
neutrophil
congruenc
nmo
eae
induc
cell
increas
level
groalpha
predomin
neutrophil
infiltr
compar
eae
induc
cell
addit
inhibit
enzym
found
granul
neutrophil
neutrophil
elastas
significantli
attenu
block
infiltr
neutrophil
central
nervou
system
data
demonstr
induc
eae
key
featur
resembl
nmo
furthermor
inhibit
neutrophil
elastas
effect
treat
eae
could
viabl
treatment
option
nmo
magnet
reson
imag
analysi
brain
lesion
mous
model
progress
multipl
sclerosi
levi
hilit
assaf
yaniv
frenkel
dan
tel
aviv
univers
tel
aviv
israel
multipl
sclerosi
ms
autoimmun
diseas
central
nervou
system
cn
character
damag
neuron
myelin
sheath
magnet
reson
imag
mri
noninvas
imag
tool
diagnos
character
ms
patholog
experiment
autoimmun
encephalomyel
eae
model
common
anim
model
studi
ms
nevertheless
eae
mous
model
neurolog
damag
mostli
affect
spinal
cord
limit
damag
brain
measur
mri
goal
investig
develop
brain
lesion
vivo
model
chronic
progress
ms
use
mri
analysi
done
human
work
describ
eae
cours
nod
mice
result
brain
spinal
cord
lesion
postgadolinium
mri
reveal
increas
bloodbrain
barrier
bbb
permeabl
brain
white
matter
specif
corpu
callosum
fimbria
intern
capsul
found
human
diffusiontensor
imag
dti
analysi
identifi
focal
area
abnorm
anisotropi
diffus
valu
immunohistolog
analysi
indic
dti
bbb
abnorm
also
character
demyelin
inflamm
furthermor
suggest
increas
astrocyt
toxic
eae
induc
nod
mice
may
link
brain
lesion
develop
propos
eae
model
suitabl
model
studi
ms
use
mri
method
toward
futur
drug
develop
delet
syndrom
common
hemizyg
microdelet
syndrom
occur
human
individu
show
varieti
neuroanatomicalpatholog
defect
particular
suffer
mani
brain
anomali
includ
reduc
size
cerebellum
cerebr
cortex
grey
white
matter
polymicrogyria
midlin
defect
cavum
septum
pellucidum
recent
shown
reduct
microrna
mirna
dosag
possibl
deriv
absenc
allel
part
molecular
machineri
involv
mirna
biogenesi
howev
real
contribut
mirna
diseas
outcom
far
come
mirna
contribut
forebrain
develop
test
inactiv
diceri
limit
enzym
mirna
biogenesi
act
downstream
sever
time
point
forebrain
develop
mediat
dicer
inactiv
occur
develop
forebrain
lead
substanti
derang
forebrain
develop
caus
radial
glial
rg
cell
death
produc
brain
cytoarchitectur
alter
howev
capabl
progress
cell
cycl
affect
contrast
later
dicer
inactivationi
mediat
gfapcr
occur
less
sever
apoptot
phenotyp
rg
cell
surviv
preserv
cortic
hippocamp
anlag
rg
cell
capabl
progress
cell
cycl
alter
inde
impair
dentat
gyru
cell
prolifer
produc
dramat
shrink
cko
dentat
gyru
cortic
rg
cell
prolifer
also
impair
start
signific
number
rg
cell
lose
phenotyp
acquir
featur
basal
progenitor
bp
cell
alter
balanc
rg
bp
cell
popul
lead
reduct
adult
neural
precursor
cell
anpc
dorsal
subventricular
zone
svz
forebrain
dicer
inactiv
lead
differ
phenotyp
depend
time
point
manipul
carri
cell
surviv
sever
affect
ablat
dicer
onset
neurogenesi
besid
cell
death
howev
find
alter
cell
cycl
progress
rg
cell
hand
later
dicer
inactivationi
onset
neurogenesisonli
partial
affect
cell
surviv
significantli
alter
cell
cycl
progress
dentat
gyru
progenitor
neuron
ppargknockout
caus
obes
peripher
insulin
resist
mice
peroxisom
proliferatoractiv
receptor
ppar
repres
ligandactiv
transcript
factor
belong
nuclear
receptor
superfamili
pparg
present
cell
type
mediat
multimod
function
includ
control
glucos
homeostasi
regul
system
insulin
sensit
cell
differenti
cholesterol
metabol
central
nervou
system
pparg
abundantli
express
neuron
function
less
clear
yet
studi
aim
investig
role
neuron
pparg
regul
bodi
weight
glucos
metabol
use
neuronspecif
ppargknockout
ko
mice
target
delet
pparg
neuron
induc
use
creloxp
technolog
take
advantag
nex
promot
achiev
neuron
specif
male
pparg
ko
wildtyp
wt
mice
fed
standard
diet
cd
highfat
diet
hfd
period
month
bodi
weight
daili
food
calori
intak
monitor
group
underw
glucos
toler
gtt
insulin
toler
test
itt
hfast
impact
pparg
defici
highfat
feed
insulin
signal
lipid
metabol
studi
blood
peripher
organ
hypothalam
rna
sampl
subject
whole
genom
array
brain
hemispher
use
histolog
analys
maintain
unrestrict
cd
pparg
ko
mice
show
signific
bodi
weight
gain
comparison
wt
mice
exhibit
glucos
intoler
insulin
resist
gtt
itt
month
find
exacerb
upon
highfat
feed
signific
increas
plasma
total
cholesterol
cdfed
pparg
ko
mice
compar
wt
control
along
sever
metabol
chang
neuroanatomi
pparg
ko
mice
demonstr
similar
neuron
architectur
densiti
control
reveal
hippocamp
cortic
neuron
morpholog
intact
microarray
show
upregul
carboxypeptidas
e
gene
cpe
hypothalamu
cdfed
pparg
ko
mice
compar
cdfed
wt
control
wherea
cpe
express
downregul
pparg
ko
mice
compar
control
hfd
condit
result
suggest
key
role
neuron
pparg
regul
peripher
insulin
sensit
bodi
weight
may
due
influenc
express
obes
suscept
gene
cpe
hypothalamu
addit
studi
requir
elucid
find
multipl
sclerosi
ms
immunemedi
demyelin
neurodegen
diseas
central
nervou
system
cn
loss
myelin
lead
develop
compens
mechan
reorganis
sodium
channel
along
axon
whilst
may
maintain
signal
transduct
shortterm
na
load
may
leav
nerv
vulner
gener
toxic
chemicalion
imbal
caus
metabol
demand
subsequ
death
may
mechan
neurodegener
underli
progress
ms
current
respond
immunosuppress
previou
studi
experiment
autoimmun
encephalomyel
eae
model
ms
suggest
na
channel
blocker
immunosuppress
nondemyelin
eae
howev
demonstr
na
channel
blocker
carbamazipin
oxcarbazepin
exhibit
mark
neuroprotectiveeffect
absenc
overt
immunosuppress
cellinduc
autoimmun
spinal
cord
homogen
complet
freund
adjuv
use
induc
eae
abh
mice
follow
initi
attack
establish
tissu
damag
synchron
relaps
induc
trigger
mark
nerv
damag
bolu
daili
administr
na
channel
blocker
dose
equival
lower
human
use
induc
immunosuppress
reduc
incid
immun
attack
maximum
sever
clinic
diseas
howev
drug
promot
better
recoveri
remiss
immuneattack
evidenc
clinic
score
motor
coordin
assess
rotarod
total
spinal
cord
nerv
content
assess
use
neurofila
elisa
neuroprotect
effect
evid
treatment
initi
onset
importantli
day
onset
paralyt
diseas
data
indic
defin
timewindow
follow
develop
attack
neuroprotect
agent
work
call
inflammatori
penumbra
analog
well
defin
ischaem
penumbra
stroke
inflammatori
penumbra
appear
correl
period
activ
bloodbrain
barrier
dysfunct
last
day
mice
week
ms
result
therapeut
indic
neuroprotect
strategi
ms
coadministr
na
channel
blocker
standard
immunosuppress
agent
steroid
lesion
format
evolut
may
provid
ad
benefit
limit
inflammatoryneurodegener
progress
diseas
multipl
sclerosi
ms
neurodegen
diseas
character
repeat
demyelin
event
accompani
inflamm
gliosi
axon
loss
remyelin
occur
mostli
earli
stage
diseas
diseas
progress
remyelin
fail
thu
mechan
behind
demyelin
relaps
remyelin
failur
consid
key
element
studi
ms
progress
system
inflamm
affect
central
ongo
inflammatori
process
induc
cytokin
express
within
central
nervou
system
cn
abl
modul
variou
aspect
cn
function
inflamm
posit
correl
demyelin
process
although
certain
circumst
play
dual
role
ms
progress
present
activ
ms
lesion
link
demyelin
relaps
howev
potenti
proremyelin
factor
neuroprotect
also
shown
therefor
precis
role
ms
progress
need
elucid
main
hypothesi
repeat
central
system
proinflammatori
stimuli
exacerb
previou
demyelin
due
central
demyelin
stimulu
previous
develop
chronic
inflammatori
rat
model
demyelin
chronic
express
striatum
caus
revers
demyelin
bloodbrain
barrier
breakdown
test
hypothesi
readminist
adenovir
vector
express
bgalactosidas
adbgal
control
striatum
iv
anim
receiv
system
inject
day
first
inject
remyelin
phase
show
exacerb
inflamm
demyelin
along
microgli
astrogli
activ
howev
second
stimulu
administ
central
lower
inflamm
demyelin
observ
compar
anim
receiv
uniqu
proinflammatori
stimulu
conclus
peripher
exacerb
inflammatori
demyelin
effect
previou
central
chronic
administr
repeat
central
stimulu
show
diminish
effect
compar
first
central
episod
model
show
peripher
inflamm
highli
signific
influenc
central
ongo
inflammatori
demyelin
lesion
inflammatori
respons
involv
camp
pharmacolog
manipul
camp
level
use
specif
phosphodiesteras
pde
inhibitor
provok
antiinflammatori
respons
experiment
autoimmun
encephalomyel
eae
anim
model
chronic
inflammatori
neurodegen
demyelin
diseas
multipl
sclerosi
ms
previous
demonstr
brain
spinal
cord
eae
rat
dramat
increas
mrna
express
level
isoenzym
sole
due
splice
mrna
variant
express
found
infiltr
tcell
macrophagemicroglia
microvessel
brain
parenchyma
present
result
alter
express
campspecif
sever
inflammatori
cytokin
mrna
brain
spinal
cord
eae
mice
model
neuroanatom
techniqu
doubl
situ
hybrid
histochemistri
immunohistochemistri
quantit
real
time
rtpcr
observ
mrna
upregul
onset
eae
model
signific
day
postimmun
chang
mrna
splice
variant
could
detect
doubl
situ
hybrid
immunohistochemistri
studi
show
cellular
infiltr
brain
spinal
cord
tissu
eae
mice
overexpress
isoform
found
mrna
splice
variant
overexpress
cell
macrophagesmicroglia
inflammatori
foci
find
support
import
distinct
role
differ
isoform
neuroinflammatori
respons
produc
eae
model
import
therapeut
target
treatment
neuroinflammatori
diseas
use
subtypeselect
inhibitor
rapid
injuri
steadi
recoveri
neuromuscular
nerv
termin
integr
applic
antigangliosid
antibodi
murin
model
syndrom
rupp
angi
willison
hugh
j
circul
antigangliosid
antibodi
consid
import
mediat
diseas
human
peripher
nerv
disord
syndrom
gb
recent
research
conduct
mous
model
gb
reveal
neuromuscular
junction
nmj
potenti
site
antigangliosid
antibodi
bind
complementmedi
injuri
gangliosid
composit
neural
glial
compon
nmj
determin
structur
injur
one
explan
rapid
onset
recoveri
occasion
observ
human
suffer
motor
axon
form
gb
aman
distal
motor
nerv
capabl
degener
function
regener
short
period
time
ventral
neck
muscl
mice
express
cytosol
fluoresc
protein
axon
cfp
schwann
cell
gfp
subject
singl
topic
applic
gangliosid
antibodi
follow
sourc
complement
chang
nmj
muscl
document
ex
vivo
qualit
quantit
imag
within
min
applic
sourc
complement
rapid
loss
cfp
overli
nmj
could
seen
gfp
signal
remain
stabl
control
anim
chang
either
gfp
cfp
observ
h
induct
injuri
superfici
sternohyoid
nmj
exhibit
cfp
cfploss
extend
proxim
axon
form
littl
bundl
recoveri
cfp
monitor
nmj
exhibit
cfp
day
auxiliari
investig
reveal
loss
cfp
nmj
correl
loss
nerv
termin
neurofila
return
cfp
nmj
accompani
return
neurofila
perisynapt
schwann
cell
affect
specif
antigangliosid
antibodi
mediat
injuri
howev
case
extend
process
beyond
normal
nmj
boundari
occasion
accompani
axon
sprout
result
describ
indic
follow
gangliosid
antibodymedi
attack
rapid
loss
nerv
termin
integr
observ
murin
nmj
follow
steadi
recoveri
nerv
termin
integr
next
day
occas
accompani
reactiv
chang
perisynapt
schwann
cell
data
support
notion
equival
mechan
may
account
rapid
recoveri
seen
clinic
case
aman
silenc
murin
express
vitro
lentivir
vectormedi
rna
interfer
approach
sinagra
melani
bun
rowena
bolton
chri
azzouz
mimoun
woodroof
nicola
sheffield
hallam
univers
sheffield
unit
kingdom
queen
mari
univers
london
london
unit
kingdom
univers
sheffield
sheffield
unit
kingdom
also
known
tumour
necrosi
factoralpha
tnfa
convert
enzym
tace
membranebound
enzym
belong
adam
disintegrin
metalloproteinas
famili
origin
identifi
abil
cleav
solubl
form
tnfa
major
immunomodulatori
cytokin
involv
central
nervou
system
cn
inflammatori
diseas
includ
multipl
sclerosi
ms
anim
model
experiment
autoimmun
encephalomyel
eae
also
respons
shed
sever
membranebound
protein
involv
pathogenesi
ms
includ
tnfa
receptor
cell
adhes
molecul
fractalkin
suggest
may
play
key
role
inflammatori
demyelin
disord
hypothesi
reinforc
fact
express
cn
ms
particularli
activ
plaqu
white
matter
wm
blood
vessel
endotheli
cell
astrocyt
activ
microglia
group
also
demonstr
express
upregul
inflammatori
macrophag
endotheli
astrocyt
cell
spinal
cord
wm
rat
eae
context
investig
put
role
ms
pathogenesi
use
lentivir
lv
vector
mediat
rna
interfer
rnai
approach
design
sever
short
hairpin
rna
sequenc
target
variou
site
mous
mrna
subsequ
construct
correspond
lentivirus
contain
interf
rna
order
knockdown
express
vitro
transduc
cell
mous
brain
astrocyt
endotheli
cell
line
respect
mrna
express
level
measur
use
quantit
realtim
pcr
assess
effici
lv
vectormedi
silenc
data
reveal
mrna
express
reduc
around
compar
control
lv
vector
cell
transduc
day
cell
lv
vector
induc
downregul
express
almost
lv
vectormedi
rnai
effici
reduc
express
murin
brain
endotheli
cell
astrocyt
vitro
silenc
approach
appli
determin
effect
biozzi
mous
model
eae
use
administ
intraven
elucid
role
cn
inflamm
recent
studi
cerebr
cortic
patholog
secondari
progress
multipl
sclerosi
ms
shown
presenc
extens
subpial
grey
matter
lesion
signific
proport
case
associ
subpial
lesion
ectop
bcell
folliclelik
structur
cerebr
mening
suggest
diffus
proinflammatori
cytokin
mening
brain
parenchyma
could
respons
patholog
test
hypothesi
establish
anim
model
mimick
cortic
patholog
observ
ms
femal
dark
agouti
rat
immun
mg
recombin
myelin
oligodendrocyt
glycoprotein
mog
incomplet
freund
adjuv
ifa
twenti
day
post
immun
anim
receiv
inject
tumour
necrosi
factor
tnf
interferongamma
ifng
subarachnoid
space
sagitt
sulcu
immunohistochemistri
reveal
area
subpial
demyelin
extend
sulcu
dorsal
surfac
cortex
encompass
layer
iiii
associ
extens
activ
microgliamacrophag
lesion
first
evid
day
post
inject
maxim
day
resolv
remyelin
day
extent
demyelin
correl
number
microgliamacrophag
cortic
parenchyma
cytotox
cell
observ
mening
corpu
callosum
scatter
throughout
grey
matter
wherea
cell
b
cell
restrict
mening
pattern
lymphocyt
infiltr
similar
seen
ms
postmortem
tissu
indic
model
potenti
model
ms
cortic
patholog
control
anim
ifa
immunis
inject
cytokin
increas
number
mening
macrophag
lymphocyt
compar
anim
demyelin
despit
microgli
activ
anim
immunis
mog
inject
phosphat
buffer
salin
show
increas
mening
macrophag
lymphocyt
demyelin
thu
subpial
demyelin
depend
preexist
immun
respons
myelin
protein
find
support
hypothesi
role
mening
inflamm
cortic
patholog
ms
describ
first
time
anim
model
use
studi
molecular
mechan
involv
pathway
involv
develop
symptom
allodynia
eae
distinct
mechan
peripher
central
role
fractalkin
fkn
member
fourth
class
chemokin
play
import
role
inflammatori
respons
pain
sole
receptor
constitut
express
cn
microglia
lymphocyt
includ
monocytesmacrophag
dendrit
cell
nk
cell
cytotoxiceffector
cell
report
antifkn
mab
show
inhibitori
effect
experiment
autoimmun
encephalomyel
eae
model
recent
also
demonstr
antifkn
mab
inhibit
allodynia
eae
studi
examin
mechan
inhibitori
effect
antifkn
mab
eae
symptom
allodynia
method
mog
myelin
oligodendrocyt
glycoprotein
induc
eae
model
antifkn
mab
mgmice
administ
everi
day
day
sensit
mog
peptid
allodynia
evalu
rat
mbpeae
model
ab
administ
mgsite
intrathec
day
sensit
rat
myelin
basic
protein
mbp
paw
withdraw
threshold
evalu
vonfrey
test
result
clarifi
role
express
cn
peripher
lymphocyt
establish
bone
marrow
transplant
bmt
mice
wt
ko
bmt
mice
wt
ko
show
eae
symptom
bmt
mice
ko
wt
administr
antifkn
mab
amelior
eae
symptom
wt
bmt
mice
wt
ko
affect
ko
mice
effect
antifkn
mab
migrat
lymphocyt
wt
ko
bmt
mice
follow
pattern
eae
result
regard
chronic
pain
eae
model
establish
allodynia
model
rat
mbpeae
model
model
intrathec
administr
ab
clearli
inhibit
allodynia
analyz
mechan
allodynia
immunohistochem
analysi
spinal
cord
perform
elev
mean
intens
observ
ab
administ
inhibit
elev
h
inject
ab
studi
effect
fkn
microglia
horizont
slice
spinal
cord
wt
ko
bmt
mice
stimul
fkn
ngml
result
fkn
induc
product
slice
wt
bmt
mice
ko
wt
pathway
play
key
role
eae
eae
induc
allodynia
result
suggest
involv
eae
migrat
immun
cell
spinal
cord
eaeinduc
allodynia
microglia
activ
profil
cytokin
express
involv
viru
persist
virusinduc
demyelin
ohara
yoshiro
himeda
toshiki
okuwa
takako
muraki
yasushi
depart
microbiolog
kanazawa
medic
univers
school
medicin
ishikawa
japan
theiler
murin
encephalomyel
viru
tmev
picornaviru
persist
spinal
cord
mice
follow
inflammatori
demyelin
diseas
late
chronic
demyelin
diseas
serv
experiment
model
human
demyelin
diseas
multipl
sclerosi
ms
viru
persist
key
determin
tmevinduc
demyelin
macrophag
thought
serv
site
tmev
persist
chronic
demyelin
phase
howev
key
factor
macrophag
cell
relat
viru
persist
demyelin
remain
poorli
understood
thought
establish
macrophag
cell
persist
infect
da
strain
tmev
use
investig
key
factor
macrophag
involv
viru
persist
virusinduc
demyelin
studi
establish
cell
analyz
cytokinechemokin
express
pattern
cell
dainfect
cell
show
continu
growth
subcultur
handl
cell
suggest
type
infect
cell
chronic
focal
infect
similar
type
dainfect
vivo
analysi
viral
antigenposit
rate
cell
viabil
product
infecti
viru
subsequ
analyz
cytokinechemokin
express
pattern
cell
use
rtpcr
anticytokin
antibodi
array
studi
upregul
downregul
ifnbeta
ifngamma
shown
cell
furthermor
upregul
blymphocyt
chemoattract
granulocyt
colonystimul
factor
gcsf
cell
first
demonstr
data
suggest
upregul
downregul
infbeta
ifngamma
may
contribut
tmev
persist
upregul
blc
gcsf
may
contribut
acceler
tmevinduc
demyelin
therefor
inhibit
blc
andor
gcsf
may
promis
novel
therapeut
approach
tmevinduc
demyelin
diseas
also
ms
role
regul
central
nervou
system
inflamm
hentschel
nicol
millward
jason
waiczi
sonia
schlickeis
stephan
sawitzki
birgit
infanteduart
carmen
berlin
berlin
germani
univers
malta
msida
malta
cell
surfac
glycan
play
import
role
regul
immun
respons
implic
inflammatori
diseas
glycosidas
remov
mannos
residu
process
protein
nglycosyl
initi
shift
highmannos
glycan
complex
glycan
shift
seem
crucial
discrimin
self
nonself
antigen
previous
show
express
reduc
patient
multipl
sclerosi
ms
respond
well
immunomodulatori
therapi
hand
transplant
blockad
inhibit
allograft
reject
indic
glycosidas
inhibit
may
antiinflammatori
effect
also
neuroinflamm
prove
appli
kifunensin
kif
potent
inhibitor
mice
suffer
experiment
autoimmun
encephalomyel
eae
anim
model
ms
show
vivo
administr
kif
biolog
effect
dendrit
cell
dc
cell
indic
signific
downregul
complex
glycan
upregul
highmannos
glycan
show
unexpectedli
administr
kif
intraperiton
induct
phase
eae
led
signific
eae
exacerb
howev
kif
administ
peak
diseas
effect
observ
thu
hypothesis
inhibit
may
affect
dc
enhanc
prime
capac
orand
perhap
diminish
potenti
induc
immun
regul
explor
examin
marker
associ
antigen
present
chemotaxi
dc
treat
vitro
inhibitor
preliminari
data
show
kif
treatment
significantli
affect
express
molecul
dc
gener
vitro
work
progress
extend
analysi
differ
dc
subset
analys
vivo
kif
applic
result
underscor
need
consid
regul
glycosyl
import
mediat
influenc
inflammatori
diseas
cn
multipl
sclerosi
ms
model
experiment
autoimmun
encephalomyel
eae
helper
cell
th
prime
peripheri
orchestr
pathogen
process
central
nervou
system
cn
recent
innat
immun
foremost
tolllik
receptor
tlr
found
crucial
shape
th
respons
howev
data
role
tlr
ms
limit
moreov
result
demonstr
relev
sever
tlr
eae
controversi
wherea
adapt
protein
tlr
signal
indispens
eae
develop
aim
studi
analyz
mrna
express
dark
agouti
da
albino
oxford
ao
rat
suscept
resist
eae
respect
rat
immun
spinal
cord
sc
homogen
complet
freund
adjuv
drain
lymph
node
dln
caudal
portion
sc
taken
total
realtimepcr
analysi
onset
first
neurolog
sign
peak
diseas
recoveri
phase
eaesuscept
da
strain
significantli
higher
mrna
express
sc
peak
diseas
eaeresist
ao
strain
exhibit
increas
express
sc
induct
phase
diseas
nevertheless
dln
mrna
assess
reveal
conclus
result
data
suggest
express
cn
correl
appear
clinic
sign
eae
wherea
signal
contribut
resist
diseas
onehundredeightyseven
ms
patient
ageand
sexmatch
healthi
individu
geograph
region
well
ms
patient
healthi
subject
includ
studi
result
show
tt
genotyp
allel
significantli
present
hc
compar
patient
genotyp
py
ic
confoc
microscopi
show
higher
intracellular
vdr
express
cell
tt
compar
cc
genotyp
carrier
statist
analysi
possibl
phenotyp
combin
tt
marker
entir
cohort
ms
patient
hc
multivari
analysi
confirm
interact
linkag
region
regul
vdr
express
via
mrna
stabil
vdr
tt
genotyp
individu
result
protect
ms
possibl
associ
increas
express
vdr
andor
find
offer
function
explan
interact
major
genet
hladrb
environment
vitamin
factor
involv
pathogenesi
ms
neuromyel
optica
nmo
inflammatori
diseas
central
nervou
system
cn
character
recurr
sever
attack
demyelin
myeliti
optic
neuriti
recent
biomark
nmo
nmoigg
identifi
diagnost
distinguish
nmo
typic
multipl
sclerosi
ms
bind
water
channel
express
astrocyt
foot
process
cn
may
particip
pathogenesi
nmo
microrna
mirna
short
noncod
singlestrand
rna
molecul
modul
gene
express
posttranscript
level
degrad
translat
repress
target
mrna
play
role
physiolog
develop
cell
differenti
prolifer
also
patholog
condit
like
autoimmun
disord
includ
lupu
ms
therefor
want
know
whether
mirna
put
mrna
target
involv
pathogenesi
nmo
perform
mirna
mrna
analys
postmortem
spinal
cord
sc
tissu
nmo
patient
agematch
control
use
luxol
fast
blue
stain
one
demyelin
sc
lesion
patient
normal
sc
section
form
control
select
rna
isol
qualiti
control
mirna
mrna
differ
mirna
mrna
express
determin
duplic
use
agil
microarray
system
unpair
ttest
benjaminihochberg
adjust
p
b
conduct
detect
chang
mirna
mrna
express
compar
demyelin
lesion
control
materi
differenti
express
mirna
select
assess
differenti
express
mrna
target
fc
p
b
express
level
mirna
mrna
determin
compar
control
materi
mirna
mrna
differenti
express
nmo
lesion
differenti
invers
express
put
mrna
target
assess
joint
analysi
target
known
involv
myelopoesi
tcell
dendrit
cell
differenti
cancerogenesi
adipogenesi
smooth
muscl
homeostasi
neural
differenti
brain
injuri
neurodegener
alter
mirna
mrna
target
express
demyelin
lesion
nmo
patient
compar
control
suggest
mirna
involv
pathogenesi
nmo
studi
requir
investig
target
function
involv
gain
insight
diseas
mechan
reveal
potenti
therapeut
target
alter
phosphoryl
statu
brain
protein
anim
model
multipl
sclerosi
vanheel
ann
daniel
ruth
stinissen
piet
noben
jeanpaul
hell
niel
multipl
sclerosi
ms
inflammatori
autoimmun
diseas
central
nervou
system
axon
myelin
damag
underli
molecular
process
remain
poorli
understood
crucial
search
new
therapeut
option
protein
phosphoryl
import
protein
function
may
involv
patholog
ms
experiment
autoimmun
encephalomyel
eae
anim
model
ms
identif
panel
differenti
express
phosphoryl
protein
along
diseas
cours
could
provid
valuabl
insight
global
diseas
process
eae
ms
protein
extract
bloodfre
brain
stem
control
eae
lewi
rat
separ
electrophoresi
detect
phosphoryl
protein
gel
stain
fluoresc
dye
proq
diamond
phosphoprotein
gel
stain
invitrogen
fluoresc
total
protein
stain
use
qualiti
control
thu
normal
phosphoprotein
signal
moreov
total
protein
stain
enabl
match
differ
gel
quantit
data
obtain
comparison
previou
twodimension
differ
ingel
electrophoresi
studi
differ
diseas
stage
control
onset
top
recoveri
three
biolog
replic
identifi
differenti
express
anova
protein
studi
check
possibl
phosphoryl
sensit
specif
proq
diamond
phosphoprotein
gel
stain
analyz
use
differ
concentr
peppermintstick
phosphoprotein
standard
invitrogen
background
stain
detect
make
difficult
distinguish
differ
phosphoryl
load
presenc
phosphoryl
differenti
express
protein
current
confirm
immunohistochemistri
ihc
western
blot
wb
techniqu
allow
us
determin
presenc
phosphoryl
protein
also
express
pattern
multipl
time
point
includ
global
overview
phosphoryl
diseas
invit
new
studi
unravel
complic
molecular
biolog
process
patholog
ms
csf
proteom
pattern
analysi
multipl
sclerosi
relat
disord
multipl
sclerosi
ms
relat
disord
recogn
inflammatori
autoimmun
diseas
central
nervou
system
report
previous
cerebrospin
fluid
csf
proteom
profil
use
magnet
beadbas
separ
combin
matrixassist
laser
desorptionion
timeofflight
malditof
mass
spectrometri
significantli
discrimin
ms
neuromyel
optica
nmo
extend
studi
increas
number
sampl
ms
relat
disord
neurolog
diseas
well
tri
appli
updat
statist
algorithm
csf
sampl
patient
relapseremit
ms
rrm
primari
progress
ms
ppm
antibodi
seroposit
nmo
spnmo
seroneg
nmo
snnmo
includ
control
neurolog
diseas
includ
amyotroph
later
sclerosi
al
also
enrol
studi
csf
sampl
separ
clinprot
systemtm
report
previous
magnet
bead
analyz
malditof
mass
spectrometri
autoflex
iitm
acquisit
mass
rang
mz
spectra
analyz
use
clinprotool
first
analyz
csf
clinprot
data
set
use
support
vector
machin
svm
cross
valid
discret
wavelet
transformationsupport
vector
machin
dwtsvm
algorithm
addit
appli
pattern
match
method
biotypertm
algorithm
data
set
make
conceptu
dendrogram
neurolog
diseas
base
csf
proteom
pattern
svm
gener
perform
well
csf
clinprot
data
set
confirm
distinct
spnmo
rrm
relaps
phase
previous
report
dendrogram
calcul
pattern
match
method
spnmo
snnmo
similar
proteom
pattern
relaps
remiss
spectral
differ
rrm
ppm
much
bigger
ppm
al
rais
possibl
ppm
rrm
bigger
differ
regard
inflammatori
neurodegen
featur
consid
proteom
pattern
analysi
promis
reliabl
biomark
strategi
neuroimmunolog
diseas
studi
repres
multifactori
aspect
ms
relat
disord
genderbas
system
biolog
multipl
sclerosi
unravel
distinct
blood
gene
signatur
common
epigenet
facet
multipl
sclerosi
ms
demyelin
disord
central
nervou
system
cn
characteris
presenc
inflammatori
cell
mediat
within
nervou
tissu
chronic
diseas
onset
young
adulthood
gender
bia
relapsingremit
rrm
form
diseas
although
ms
affect
cn
evid
alter
peripher
immun
ms
patient
investig
global
gene
express
peripher
blood
mononuclear
cell
rrm
patient
healthi
individu
contrast
convent
studi
whole
diseas
popul
compar
healthi
one
perform
genderbas
analys
approach
reduc
heterogen
human
popul
intriguingli
led
definit
distinct
msrelat
gene
signatur
women
men
despit
clinic
cours
genderbas
function
annot
system
biolog
studi
show
differenti
express
gene
share
molecular
function
particip
common
biolog
process
furthermor
reconstruct
genderrel
ms
interactom
demonstr
frequent
share
interactor
femal
male
gene
set
issu
regard
epigenet
control
gene
express
appear
common
basi
diseas
women
men
conclus
propos
genderbas
system
biolog
novel
tool
gain
fundament
inform
diseaseassoci
function
process
approach
highlight
distinct
gene
signatur
common
process
women
men
ms
intens
immunosuppress
follow
autolog
hematopoiet
stem
cell
transplant
potenti
treatment
option
subset
patient
suffer
multipl
sclerosi
ms
presum
autoaggress
immun
diseas
central
nervou
system
sever
gene
express
analys
peripher
blood
mononuclear
cell
ms
patient
shown
strong
differ
express
immun
gene
compar
healthi
control
howev
known
whether
immun
deviat
seen
ms
patient
develop
peripher
immun
system
later
stage
immun
develop
whether
chang
alreadi
imprint
hematopoiet
precursor
cell
highli
relev
manag
ms
patient
rational
autolog
hematopoiet
stem
cell
transplant
therapi
ms
depend
aim
compar
hematopoiet
stem
cell
ms
patient
healthi
donor
gene
express
analysi
epigenet
profil
hematopoiet
stem
cell
collect
apheresi
healthi
donor
n
mean
age
year
femal
mobil
gcsf
ms
patient
n
mean
age
year
femal
mobil
gcsf
ms
patient
n
mean
age
year
femal
mobil
gcsf
cyclophosphamid
cell
isol
graft
immunomagnet
separ
total
rna
genom
dna
isol
use
trizol
reagent
protocol
global
gene
express
analysi
appli
use
human
design
array
agil
technolog
allow
analys
express
known
human
gene
transcript
epigenet
analysi
done
use
affymetrix
platform
human
promot
array
gener
list
gene
differenti
express
ms
patient
healthi
donor
valid
candid
rtpcr
ongo
princip
compon
analysi
allow
clear
discrimin
posit
neg
cell
significantli
regul
gene
annot
biolog
process
accord
gene
ontolog
databas
analys
gene
express
cell
ms
patient
reveal
signific
deviat
immun
gene
previous
report
ms
summari
find
inflammatori
signatur
cell
ms
patient
thu
provid
evid
immun
deviat
seen
ms
patient
develop
peripheri
evolut
diseas
imprint
hematopoiet
precursor
cell
object
studi
infer
character
proteinprotein
interact
ppi
network
multipl
sclerosi
ms
antigen
mediat
immun
cell
respons
use
ingenu
pathway
analysi
http
wwwingenuitycom
select
candid
gene
differ
cell
type
involv
antigen
mediat
immun
respons
b
lymphocyt
lb
lymphocyt
lt
dendrit
cell
dc
macrophag
mph
also
gene
relat
immun
respons
gener
gir
mine
extern
genetodiseas
databas
extract
list
candid
gene
ms
identifi
networkand
processlevel
similar
ms
differ
immun
cell
type
immun
system
gener
construct
proteinprotein
interact
ppi
network
use
string
http
stringdb
org
experi
databas
select
interact
criteria
stringenc
score
biolog
process
enrich
score
david
http
davidabccncifcrfgov
topolog
analys
ppi
network
made
cytoscap
http
wwwcytoscapeorg
obtain
result
show
gene
relat
antigen
mediat
immun
respons
lb
lt
dc
mph
respect
gene
obtain
relat
gir
gene
ms
hand
number
gene
includ
ppi
network
lb
lt
dc
mph
gir
ms
respect
function
analys
overlap
gene
among
ms
immun
cell
type
reveal
involv
biolog
process
immun
system
process
immun
respons
apoptosi
signal
transduct
cell
differenti
inflammatori
respons
cellcel
signal
locomotori
behavior
respons
stimulu
homeostasi
regul
antibodi
isotyp
switch
among
other
fdrb
evalu
radial
node
central
index
ms
ppi
network
perform
function
analysi
relev
gene
obtain
differ
radial
found
ms
gene
involv
specif
function
process
alter
ms
mainli
locat
peripheri
network
hub
studi
develop
order
obtain
modular
ms
ppi
network
search
critic
ms
gene
candid
experiment
valid
multipl
sclerosi
ms
immunemedi
diseas
polygen
etiolog
character
individu
clinic
variabl
aim
present
investig
studi
associ
immun
respons
gene
polymorph
mainli
code
cytokin
network
compon
earli
clinic
featur
first
remiss
durat
frd
symptom
onset
may
provid
predict
valu
unrel
russian
women
men
relapsingremit
ms
studi
perform
complex
associ
analyz
polymorph
function
signific
region
follow
candid
gene
hla
class
ii
tumor
necrosi
factor
tnf
interferongamma
ifng
transform
growth
factorbeta
interferonbeta
interferonalphabeta
receptor
cc
chemokin
receptor
carriag
allelegenotyp
combin
associ
frd
symptom
onset
identifi
use
apsampl
softwar
base
bayesian
mcmc
method
provid
valid
mean
fisher
exact
test
reveal
reliabl
differ
mean
multipl
sclerosi
sever
score
among
patient
stratifi
frd
sfdr
short
month
vs
lfdr
long
month
p
b
symptom
ms
onset
sensit
visual
disturb
vs
initi
symptom
p
b
posit
associ
sfrd
tnf
gg
p
combin
allel
tnf
gg
c
tnf
gg
g
tnf
gg
ifng
p
found
correspondingli
allel
combin
includ
altern
allel
tnf
c
posit
associ
lfrd
women
subgroup
sfrd
associ
tnf
gg
p
c
p
combin
p
men
subgroupwith
combin
ifng
g
p
comparison
pvalu
tnf
separ
combin
show
evid
cooper
effect
gene
also
compar
allel
pattern
ms
patient
differ
symptom
ms
onset
initi
sensit
visual
disturb
consid
favor
prognost
factor
othersa
unfavor
one
observ
associ
unfavor
ms
cours
cc
p
b
combin
ifng
c
tnf
g
p
allel
variant
immunorespons
gene
associ
ms
earli
clinic
featur
provid
possibl
use
individu
genet
statu
patient
ms
prognosi
overlap
gene
autism
autoimmun
diseas
previou
studi
suggest
autoimmun
role
etiolog
patholog
autism
spectrum
disord
asd
although
role
fulli
character
molecular
level
object
studi
look
common
gene
express
signatur
asd
autoimmun
diseas
aid
first
select
list
aid
wwwaardaorg
mine
extern
genetodiseas
databas
build
rank
list
candid
gene
asd
aid
compar
analysi
asd
gene
aid
gene
conduct
favor
aid
gene
mean
common
asd
asd
sibl
diseas
analysi
rheumatoid
arthriti
ra
multipl
sclerosi
ms
system
lupu
erythematosu
sle
ulcer
coliti
uc
cardiomyopathi
cad
type
diabet
crohn
diseas
cd
endometriosi
em
identifi
networkand
processlevel
similar
asd
sibl
aid
construct
proteinprotein
interact
ppi
network
diseas
use
string
http
stringdborg
biolog
process
enrich
score
fdr
b
david
http
davidabccncifcrfgov
ppi
network
analysi
reveal
signific
overlap
asd
ra
ms
sle
gene
respect
indic
three
aid
close
relat
autism
seven
gene
involv
regul
antibodi
isotyp
switch
found
common
across
aid
network
gene
uniqu
asd
significantli
enrich
neurolog
process
synapt
transmiss
axon
guidanc
behavior
neurogenesi
final
also
obtain
gene
first
neighbor
overlap
gene
autism
aid
calcul
biolog
enrich
gene
set
process
compar
common
signific
biolog
function
asd
sibl
neurolog
diseas
wall
et
al
obtain
list
new
gene
candid
like
involv
asd
base
function
implic
neurolog
dysfunct
autoimmun
respons
preliminari
result
suggest
signific
molecular
signatur
autoimmun
autism
signatur
specif
set
aid
rather
autoimmun
gener
futur
work
focu
character
molecular
signatur
myasthenia
gravi
mg
like
autoimmun
diseas
multifactori
etiolog
determin
environment
genet
factor
advanc
human
genom
knowledg
along
new
systemat
search
tool
suggest
involv
autoimmun
process
gene
product
central
tcell
toler
induct
lymphocyt
activ
among
non
receptortyp
protein
tyrosin
phosphatas
activ
control
tcell
activ
neg
regul
src
famili
kinas
mediat
tcr
signal
sever
differ
singl
nucleotid
polymorph
snp
associ
differ
autoimmun
diseas
studi
focus
function
polymorph
report
data
allel
frequenc
italian
mg
popul
compar
ethnicallymatch
control
group
snp
allel
determin
use
snapshot
system
appli
biosystem
flank
segment
amplifi
pcr
genom
dna
extract
peripher
blood
leukocyt
analyz
control
italian
mg
subject
data
analyz
accord
age
onset
thymu
patholog
antiachr
antimusk
antibodi
presenc
snp
distribut
analysi
show
increas
frequenc
major
c
allel
mg
patient
compar
control
increment
higher
earli
onset
mg
patient
antiachr
antibodi
previou
studi
focus
cellmedi
system
autoimmun
diseas
suggest
protect
role
c
allel
compar
allel
gainoffunct
determin
amino
acid
substitut
present
report
confirm
differ
distribut
c
allel
italian
compar
northern
european
contrast
studi
northern
european
mg
patient
increas
frequenc
allel
found
increas
c
allel
find
explain
either
differ
role
autoimmun
process
ethnic
differ
popul
differ
pathogen
mechan
underli
mg
pure
antibodymedi
diseas
compar
autoimmun
diseas
find
togeth
give
new
element
debat
role
snp
mg
pathogenesi
valid
gene
multipl
sclerosi
spain
multipl
sclerosi
ms
disord
central
nervou
system
thought
chronic
inflammatori
diseas
autoimmun
basi
pathogenesi
multipl
sclerosi
yet
poorli
understood
amidst
plethora
data
gener
genom
wide
associ
studi
need
replic
studi
differenti
fals
posit
find
genuin
marker
underli
patholog
ms
studi
aim
replic
candid
gene
recent
report
associ
ms
collect
sampl
differ
cohort
across
spain
bilbao
madrid
san
total
ms
patient
healthi
control
found
signific
associ
p
cmh
ci
p
cmh
ci
ms
lowfrequ
code
nonsynonym
snp
display
trend
associ
p
cmh
ci
furthermor
analysi
data
snp
found
associ
combin
cohort
studi
collect
earlier
publish
data
p
valu
p
cmh
p
cmh
respect
also
detect
trend
associ
respons
ifnbeta
therapi
infect
conclus
emerg
studi
risk
factor
multipl
sclerosi
spain
spinal
cord
tissu
autopsi
ms
patient
compar
amyotroph
later
sclerosi
al
control
subject
activ
demyelin
ms
lesion
identifi
accord
presenc
phagocyt
contain
mbp
posit
myelin
degrad
product
inact
demyelin
lesion
classifi
accord
densiti
cell
macrophag
microglia
phenotyp
mening
parenchym
cell
distribut
determin
accord
lesion
stage
axon
damag
neuroaxon
chang
studi
immunoreact
ir
app
variabl
phosphoryl
neurofila
ventral
horn
neuron
chronic
demyelin
spinal
cord
show
alter
neurofila
phosphoryl
name
progress
loss
immunoreact
ir
upon
lesion
diseas
progress
axon
loss
spinal
white
matter
wm
lesion
anoth
progress
featur
inact
lesion
stage
correl
diseas
durat
sever
select
reduct
axon
phosphoryl
neurofila
nfh
took
place
acut
chronic
inact
wm
lesion
al
loss
neuron
ir
even
sever
wherea
rel
axon
reduct
resembl
observ
ms
progress
neuron
axon
neurofila
alter
context
chronic
inflammatori
demyelin
reflect
chang
neuroaxon
metabol
contribut
chronic
neuroaxon
dysfunct
axon
loss
like
substrat
clinic
progress
patholog
hallmark
multipl
sclerosi
format
chronic
demyelin
lesion
cn
although
remyelin
may
extens
patient
result
shadow
plaqu
remyelin
fail
other
lesion
fail
remyelin
unclear
cn
contain
endogen
repair
mechan
normal
act
ensur
rapid
essenti
complet
remyelin
goal
identifi
potenti
mechan
inhibit
remyelin
ms
lesion
fail
remyelin
use
frozen
autopt
tissu
identifi
shadow
plaqu
dissect
along
activ
chronic
inact
ms
lesion
perform
express
profil
use
quantit
pcr
low
densiti
array
therebi
detect
complex
alter
growth
differenti
factor
oligodendrocyt
lineag
cell
fgf
pdgf
semaphorin
igf
chemokin
famili
strike
upregul
subset
chronic
demyelin
lesion
none
remyelin
shadow
plaqu
potenti
function
implic
observ
investig
treat
myelin
rat
cn
cultur
exogen
experiment
set
inhibit
abil
matur
oligodendrocyt
myelin
ensheath
axon
effect
associ
correspond
decreas
transcript
encod
myelin
protein
myelin
relat
transcript
factor
express
pattern
factor
regul
oligodendrocyt
alter
complex
way
differ
type
ms
lesion
induct
chronic
demyelin
ms
lesion
might
one
inhibitori
mechan
account
failur
remyelin
immunopathogenesi
brain
lesion
nasuhakola
diseas
satoh
junichi
tabunoki
hiroko
kim
seung
u
meiji
pharmaceut
univers
tokyo
japan
univers
british
columbia
vancouv
canada
intern
medic
center
chiba
japan
hyogocyuo
nation
hospit
hyogo
japan
nation
center
neurolog
psychiatri
tokyo
japan
nasuhakola
diseas
nhd
also
design
polycyst
lipomembran
osteodysplasia
scleros
leukoencephalopathi
plosl
rare
autosom
recess
disord
distribut
worldwid
character
combin
progress
presenil
dementia
format
multipl
bone
cyst
nhd
caus
genet
mutat
express
myeloid
lymphoid
cell
includ
microglia
osteoclast
defect
signal
caus
impair
osteoclast
differenti
although
number
microglia
reduc
brain
mice
nat
immunol
remain
unknown
whether
microgli
differenti
activ
impair
nhd
brain
lesion
attempt
character
immunopathogenesi
nhd
brain
lesion
studi
brain
lesion
patient
immunohistochemistri
also
reanalyz
geo
microarray
dataset
gmcsfinduc
dendrit
cell
dc
nhd
patient
final
determin
express
pmaexpos
monocyt
leukemia
microgli
cell
realtim
rtpcr
identifi
massiv
infiltr
microglia
macrophag
cerebr
cortex
white
matter
lesion
nhd
substanti
number
microgliamacrophag
also
express
hladr
small
popul
macrophag
microglia
express
identifi
upregul
dc
share
defect
patient
follow
exposur
pma
upregul
substanti
express
activ
microgliamacrophag
might
induc
chronic
inflammationmedi
neuron
injuri
nhd
brain
lesion
support
view
signal
play
inhibitori
role
microgli
activ
cortisol
end
product
hypothalamuspituitaryadren
hpa
axi
routin
use
synthet
form
prednison
treat
multipl
sclerosi
ms
relaps
postmortem
vivo
studi
show
hpa
axi
chronic
activ
ms
interestingli
postmortem
studi
ms
brain
donor
recent
found
highli
signific
invers
relationship
respons
hpa
axi
sever
ms
reveal
group
donor
low
hpaaxi
activ
sever
ms
huitinga
et
al
ann
neurol
followup
studi
femal
ms
brain
donor
perform
determin
patholog
mechan
may
respons
observ
studi
clearli
confirm
sever
ms
associ
low
hpaaxi
activitya
indic
low
cortisol
level
donor
sever
ms
analysi
neuropatholog
report
ms
brain
donor
reveal
demyelin
less
remyelin
present
low
cortisol
donor
sever
ms
opposit
found
high
cortisol
donor
rel
mild
ms
identifi
molecular
mechan
underli
find
low
cortisol
donor
sever
ms
compar
high
cortisol
rel
mild
ms
gene
express
normal
appear
white
matter
nawm
highli
signific
cortisolassoci
express
found
sever
ms
gene
involv
inflamm
immunosuppress
myelin
bloodbrain
barrier
function
data
indic
high
level
endogen
cortisol
modul
varieti
molecular
mechan
nawm
ms
patient
therebi
render
less
vulner
new
ms
lesion
tissu
obtain
netherland
brain
bank
www
brainbanknl
studi
financ
dutch
foundat
ms
research
speci
differ
origin
reactiv
microglia
microglia
serv
homeostat
function
normal
cn
sens
threat
modul
neuron
function
injur
diseas
cn
present
understand
microgli
biolog
involv
diseas
influenc
observ
exogen
immigr
bone
marrow
bm
deriv
cell
may
contribut
reactiv
microgliosi
mous
set
investig
possibl
speciesdiffer
microgli
recruit
transform
bmderiv
cell
microglia
injur
cn
analyz
microgli
origin
brain
irradi
bm
chimer
mice
rat
subject
transient
global
cerebr
ischemia
known
elicit
predict
strong
microgli
reaction
speci
display
characterist
microgli
hyperplasia
rod
cell
transform
regio
superior
hippocampu
day
surgeri
mous
subpopul
lesionreact
microglia
origin
transform
bmderiv
cell
contrast
bm
chimer
rat
recruit
microgli
transform
bmderiv
cell
observ
result
suggest
reactiv
microglia
rat
origin
resid
microglia
mix
bmderiv
resid
origin
mous
stress
relat
cognit
deficit
hippocampu
limbic
area
involv
learn
memori
particularli
sensit
effect
chronic
stress
cytokin
shown
affect
behaviour
includ
memori
moreov
ifngamma
implic
psychiatr
disord
glatiram
acet
synthet
amino
acid
polym
weakli
crossreact
cnsresid
autoantigen
safe
simul
protect
repar
effect
autoreact
cell
aim
present
work
studi
copaxon
effect
behaviour
balanc
induc
chronic
stress
balbc
mice
found
balbc
mice
expos
chronic
stress
poor
learn
perform
respect
control
mice
altern
behaviour
ymaze
task
habitu
open
field
lymphoid
product
cytokin
analys
elisa
show
decreas
ifngamma
chang
increas
stress
balbc
mice
effect
induc
chronic
stress
revert
administr
copaxon
per
inject
sc
four
time
three
week
result
indic
copaxon
abl
revers
memori
impair
cytokin
balanc
result
suggest
respons
could
constitut
protect
mechan
prevent
behaviour
impair
support
pip
conicet
copaxon
gener
gift
laboratori
tevatuteur
argentina
effect
prenat
stress
immun
respons
acut
chronic
stress
exposur
pascuan
cecilia
gabriela
wald
miriam
ruth
palumbo
laura
genaro
ana
prenat
stress
ps
associ
chang
immun
respons
mechan
involv
fulli
elucid
aim
work
investig
alter
neuroimmun
interact
adult
anim
subject
ps
purpos
pregnant
mice
individu
restrain
h
day
sinc
gestat
day
deliveri
stress
offspr
mice
test
age
togeth
control
match
mice
group
anim
submit
acut
chronic
stress
result
shown
ps
induc
signific
chang
either
prolif
respons
vitro
antibodi
level
immun
vivo
lead
imbal
hand
observ
chang
corticosteron
catecholamin
level
howev
anim
lower
immun
respons
respect
control
mice
submit
acut
chronic
stress
moreov
ps
anim
respond
acut
stress
lower
level
corticosteron
signific
chang
observ
chronic
stress
hand
ps
anim
respond
acut
chronic
stress
similar
chang
catecholamin
level
control
anim
addit
increas
sensit
inhibitori
effect
corticosteron
found
lymphocyt
ps
anim
result
indic
ps
induc
disrupt
hyphothalamicpituitaryadren
axi
hpa
immun
interact
support
pip
conicet
univers
queensland
centr
clinic
research
brisban
australia
queensland
brain
institut
univers
queensland
brisban
australia
school
medicin
univers
queensland
brisban
australia
schizophrenia
global
popul
sever
debilit
psychiatr
disord
result
disrupt
neurotransmiss
evid
sever
research
group
suggest
may
immun
abnorm
present
peopl
schizophrenia
pw
includ
alter
cell
distribut
circul
cytokin
level
presenc
autoantibodi
direct
brain
aim
studi
investig
whether
autoantibodi
direct
brain
particularli
molecul
involv
neurotransmiss
elev
pw
identifi
antigen
target
serum
sampl
pw
ageand
sexmatch
healthi
control
screen
immunohistochemistri
reactiv
tissu
region
brain
commonli
affect
schizophrenia
approxim
sampl
pw
show
significantli
elev
level
reactiv
brain
tissu
compar
healthi
control
identifi
potenti
autoantigen
target
human
brain
tissu
separ
gel
electrophoresi
blot
probe
sera
spot
recogn
posit
sera
pw
control
sera
excis
protein
identifi
matrix
assist
laser
desorptionionizationtim
flight
malditof
mass
spectrometri
one
protein
frequent
identifi
neurofila
medium
nfm
dopamin
receptor
interact
protein
drip
drip
pivot
involv
regul
dopamin
receptor
signal
transduct
subsequ
sera
pw
healthi
control
test
elisa
nfm
addit
sera
pw
healthi
control
test
reactiv
extracellular
portion
muscarin
acetylcholin
receptor
previous
suggest
target
autoantibodi
schizophrenia
one
quarter
pw
significantli
elev
level
autoantibodi
one
protein
compar
unaffect
individu
subgroup
pw
show
extrem
high
reactiv
nfm
current
investig
whether
correl
strong
nfm
reactiv
specif
clinic
featur
result
provid
support
hypothesi
autoantibodi
neurotransmitt
receptor
molecul
involv
regul
neurotransmiss
may
pathogen
relev
subpopul
peopl
schizophrenia
gender
differ
correl
behavior
redox
immunolog
paramet
old
mice
age
complex
process
affect
mani
regulatori
system
includ
immun
system
agerel
neuroimmunolog
network
alter
lead
loss
homeostasi
may
contribut
progress
age
behavior
phenotyp
genderdepend
differ
also
known
contribut
statu
neuroimmunolog
network
aim
present
work
analyz
predict
valid
differ
behavior
test
correl
paramet
oxid
stress
immun
function
old
month
male
femal
mice
behavior
screen
assess
sever
aspect
sensorimotor
abil
locomot
neophobia
emot
respons
anxietylik
behavior
exploratori
behavior
noveltyseek
behavior
despair
thereaft
sever
paramet
redox
state
extracellular
anion
superoxid
level
activ
antioxid
enzym
catalas
immunolog
function
natur
killer
activ
phagocytosi
basal
concavalin
lpsinduc
lymphoprolif
respons
studi
periton
leukocyt
result
show
genderdepend
effect
redox
state
male
femal
correl
behavior
aspect
studi
differ
test
although
correl
evid
male
femal
contrast
immunolog
function
paramet
show
better
correspond
behavior
variabl
accord
function
gender
studi
gener
femal
show
higher
correl
male
regard
immunolog
function
nk
activ
phagocytosi
seem
relat
anxietylik
behavior
lymphoprolifer
correl
better
level
exploratori
noveltyseek
activ
exhibit
differ
test
conclus
result
reinforc
relev
take
gender
consider
assess
redox
state
neuroimmunolog
function
well
need
consid
behavior
trait
addit
typic
relat
anxieti
financi
support
ucm
research
group
reticef
neonat
matern
depriv
induc
longterm
increas
cytokin
plasma
level
modul
high
fat
diet
vivero
mariapaz
basi
divers
behaviour
neurochem
immunolog
endocrin
effect
propos
procedur
matern
depriv
md
neonat
rat
h
pnd
may
use
anim
model
studi
development
neuroimmunoendocrin
interact
present
studi
evalu
effect
md
andor
high
fat
diet
hfd
fat
control
fat
hfd
research
diet
brogaarden
wean
pnd
adulthood
pnd
level
divers
cytokin
plasma
adult
male
femal
wistar
rat
cytokin
measur
multiplex
elisa
use
luminex
machin
millipor
matern
depriv
induc
longterm
increas
plasma
level
proinflammatori
cytokin
male
femal
revers
high
fat
diet
matern
depriv
male
femal
also
show
signific
increas
tnf
level
also
case
effect
diminish
special
high
fat
diet
similar
trend
observ
respect
il
sexual
dimorph
found
level
il
il
control
femal
show
significantli
higher
content
cytokin
compar
control
male
femal
level
il
significantli
decreas
high
fat
diet
result
indic
cytokin
plasma
level
modul
neonat
stress
matern
depriv
appear
induc
longterm
increas
least
proinflammatori
cytokin
also
diet
high
fat
content
latter
factor
tend
counteract
md
effect
result
show
divers
sexual
dimorph
baselin
plasma
level
certain
cytokin
well
effect
two
treatment
matern
depriv
per
se
induc
decreas
bodi
weight
throughout
experiment
period
wherea
special
high
fat
diet
counteract
effect
moreov
adulthood
md
male
high
fat
diet
weigh
control
nondepriv
male
receiv
special
diet
individu
differ
premorbid
behaviour
exhibit
cours
infect
diseas
may
use
explain
individu
suscept
infect
underli
neuroimmunolog
mechan
help
get
better
predict
pharmacolog
reactiv
age
old
age
gender
male
also
consid
vulner
factor
present
work
locomotor
activ
emotion
anxieti
assess
adult
monthold
old
monthold
male
mice
prior
studi
lp
mgkg
ip
induc
sick
behavior
lethal
result
show
equal
neophob
respons
novelti
corner
test
corner
rear
respect
increas
freez
behavior
latenc
movement
vs
old
anim
confront
anxiogen
environ
openfield
test
also
differ
develop
sequenc
behavior
event
exploratori
activ
faster
reduc
age
measur
relat
anxieti
emotion
number
durat
groom
presenc
urin
show
also
increas
old
anim
compar
adult
mice
lpsinduc
sick
behavior
measur
locomotor
effect
min
group
develop
equal
activ
first
minut
test
activ
drop
reach
maximum
effect
next
min
old
group
motor
depress
effect
last
end
test
adult
anim
recoveri
horizont
vertic
locomotor
activ
experienc
last
min
interv
mortal
rate
record
everi
min
total
period
h
group
age
old
anim
mean
surviv
time
reduc
exactli
one
half
surviv
h
vs
respect
age
lpsinduc
sick
behaviour
mainli
horizont
activ
show
direct
correl
surviv
premorbid
behavior
individu
differ
predict
enough
reach
statist
signific
exclud
relat
surviv
tel
aviv
univers
tel
aviv
israel
oklahoma
univers
oklahoma
unit
state
group
streptococc
ga
infect
associ
spectrum
neuropsychiatr
disord
includ
sydenham
chorea
sc
obsessivecompuls
disord
tourett
syndrom
sc
classic
poststreptococc
neurolog
disord
character
involuntari
movement
neuropsychiatr
disturb
lead
hypothesi
suggest
anteced
ga
infect
induc
crossreact
immun
respons
direct
neuron
brain
determin
aim
present
project
identifi
neural
mechan
alter
antibodi
respons
gasrel
neuropsychiatr
disord
grnd
lead
neuropsychiatr
symptom
recent
develop
new
anim
model
grnd
disord
use
immun
rat
crude
ga
extract
immun
rat
show
increas
compuls
motor
disturb
autoantibodi
immun
rat
target
striatum
thalamu
two
brain
region
implic
pathophysiolog
grnd
sera
taken
rat
demonstr
strong
immunoreact
ga
antigen
neural
tissu
includ
dopamin
receptor
interestingli
level
antibodi
dopamin
receptor
correl
sever
behavior
symptom
base
result
current
test
whether
immun
lead
alter
differ
neurotransmiss
system
male
lewi
rat
inocul
ga
extract
follow
comprehens
behavior
examin
rat
compuls
behavior
evalu
induc
groom
assay
b
rat
motor
disturb
evalu
food
manipul
beam
walk
assay
subsequ
evalu
pathogen
chang
brain
immun
rat
assess
chang
mrna
actual
protein
level
use
rtpcr
western
blot
protein
dopaminerg
glutamaterg
serotonerg
cholinerg
gabaerg
system
base
result
found
brain
immun
rat
assess
correl
differ
biolog
measur
measur
behavior
dysfunct
project
provid
basi
develop
novel
therapi
grnd
improv
diagnosi
prevent
disord
understand
neural
mechan
underli
autoimmunerel
disord
provid
clue
pathogenesi
similar
movement
behavior
disord
autoimmun
singl
electr
stimul
bed
nucleu
stria
terminali
medial
septal
nucleu
increas
peripher
blood
natur
killer
cell
cytotox
rat
myslinska
dorota
plucinska
karolina
redzimska
dorota
ciepielewski
ziemowit
glac
wojciech
badtk
piotr
wrona
danuta
depart
anim
physiolog
univers
gdansk
gdansk
poland
previou
studi
found
electrolyt
lesion
bed
nucleu
stria
terminali
bst
well
medial
septal
nucleu
ms
caus
depress
peripher
blood
natur
killer
cell
cytotox
nkcc
number
leukocyt
rat
respect
sham
oper
group
mere
insert
electrod
bst
ms
evok
transient
enhanc
nkcc
probabl
result
mechan
stimul
brain
tissu
also
found
chronic
electr
stimul
bst
ms
caus
signific
augment
blood
nkcc
larg
granular
lymphocyt
lgl
number
present
studi
evalu
spleen
blood
nkcc
singl
electr
stimul
bst
ms
consciou
freeli
behav
rat
male
wistar
rat
implant
stimul
electrod
bst
n
ms
n
area
divid
group
subject
singl
electr
stimul
constant
current
ms
durat
cathod
puls
deliv
frequenc
hz
bst
n
ms
n
sham
stimul
control
n
n
respect
blood
sampl
collect
heart
punctur
halothan
anesthesia
seven
day
one
hour
stimul
nkcc
quantifi
use
releas
assay
target
cell
label
adjust
concentr
effector
cell
e
determin
experiment
exp
spontan
sp
maxim
max
releas
percentag
cytotox
obtain
follow
equat
exp
sp
max
sp
found
singl
electr
stimul
bst
caus
signific
nkcc
augment
blood
nkcc
p
b
comparison
sham
oper
group
baselin
similarli
singl
electr
stimul
ms
result
augment
blood
nkcc
comparison
sham
oper
group
p
b
baselin
p
b
vs
respect
effect
found
spleen
result
obtain
indic
bst
ms
belong
limbic
structur
involv
regul
immun
respons
lesion
caus
depress
stimul
caus
enhanc
cellular
immun
work
support
univers
gdansk
grant
known
depress
disord
associ
impair
immun
system
present
studi
investig
spleen
lymphocyt
subpopul
chronic
desipramin
dez
treatment
follow
acut
white
illumin
open
field
stress
order
induc
behavior
depress
rat
anim
use
experi
differ
spontan
locomotor
activ
may
reflect
differ
psychobehavior
type
human
fourteen
day
inject
dez
follow
exposur
acut
result
decreas
spleen
percentag
number
nk
cell
p
b
sd
subpopul
lymphocyt
p
b
nondivid
hr
lr
compar
salin
control
nk
respect
signific
influenc
stress
dez
inject
spleen
b
lymphocyt
behavior
differ
group
lower
level
percentag
vs
vs
observ
hr
dez
inject
control
compar
control
nk
cell
percentag
decreas
hr
vs
lr
vs
moreov
splenocyt
apoptosi
follow
stress
significantli
lower
dezinject
group
nondivid
hr
lr
compar
control
nondivid
hr
lr
result
obtain
suggest
individu
differ
locomotor
activ
novelti
play
import
role
immun
effect
desipramin
influenc
stressinduc
behavior
depress
work
support
research
grant
n
ministri
scientif
research
inform
technolog
former
state
committe
scientif
research
kbn
effect
salivari
biomark
awaken
respons
two
week
sleep
tutori
suguri
kazumichi
tanaka
hideki
okamoto
yuko
nomura
tomoyo
nomura
shusaku
nagaoka
univers
technolog
nagaoka
japan
hiroshima
intern
univers
higashihiroshima
japan
recent
develop
molecular
analysi
techniqu
enabl
scientist
studi
tini
amount
biochem
substanc
contain
varieti
secretori
fluid
reveal
close
relationship
secret
substanc
human
mental
state
among
grow
evid
suggest
magnitud
cortisol
awaken
respons
car
character
profound
increas
salivari
cortisol
awaken
plausibl
reflect
level
chronic
stress
social
stress
anxieti
etc
elev
awaken
also
report
varieti
biomark
howev
still
small
number
studi
field
littl
known
altern
magnitud
biomark
relev
car
investig
awaken
respons
cortisol
immunoglobulin
iga
start
end
two
week
sleep
tutori
anticip
tutori
would
bring
forth
posit
affect
better
sleep
manag
also
result
alter
car
illustr
differ
awaken
respons
endocrin
immun
system
eleven
healthi
student
age
voluntarili
particip
studi
instruct
individu
go
originallydevelop
tutori
take
good
sleep
go
bed
two
week
tutori
consist
literatur
materi
introduc
proper
sleep
time
diet
exercis
check
list
item
relat
materi
start
end
experi
salivari
cortisol
iga
assess
time
awaken
min
awaken
estim
awak
respons
biomark
note
subject
forc
chang
behavior
nevertheless
sleep
cycl
behavior
check
check
list
result
subject
chang
daili
sleep
diet
behavior
anticip
howev
awaken
respons
cortisol
car
significantli
increas
p
b
whilst
iga
chang
differ
awaken
respons
endocrin
immun
system
success
demonstr
studi
howev
higher
car
observ
studi
impli
procedur
experi
ie
tutori
everi
night
go
bed
might
mere
taken
stress
task
subject
neuroinflamm
neurolog
diseas
chair
baror
p
villoslada
accumul
evid
demonstr
inflammatori
oxid
process
togeth
play
fundament
role
onset
evolut
parkinson
diseas
pd
inde
inflammatori
process
associ
microgli
activ
cytokin
releas
suggest
human
postmortem
analys
anim
toxin
model
pd
overact
microglia
releas
damag
oxid
radic
superoxid
shown
toxic
midbrain
dopamin
da
neuron
present
propos
proinflammatori
cytokin
interferongamma
ifngamma
mediat
microgli
reactiv
releas
oxid
speci
respons
environment
toxin
exposur
immunohistochem
method
use
coloc
ifn
signal
factor
oxid
regulatori
element
upon
microglia
neuron
follow
exposur
pesticid
paraquat
similarli
rigor
stereolog
techniqu
enabl
quantif
loss
midbrain
da
neuron
follow
paraquat
exposur
rtpcr
western
blot
use
evalu
mrna
protein
chang
influenc
paraquat
exposur
ifngamma
defici
mice
wild
type
litterm
ifngamma
null
mice
found
resist
loss
da
neuron
enhanc
microgli
respons
provok
pesticid
paraquat
epidemiolog
link
pd
wild
type
litterm
parallel
neuroprotect
action
ifngamma
defici
mice
fail
display
increas
express
local
microglia
nadph
oxidas
subunit
requir
oxid
radic
product
evid
wild
type
addit
cytokin
signal
element
includ
jnk
also
elev
within
substantia
nigra
paraquat
expos
wild
type
mice
inhibit
ifngamma
delet
suggest
environment
toxin
paraquat
provok
loss
nigral
da
neuron
activ
ifngamma
pathway
regul
nadph
oxidas
activ
upon
local
microglia
data
import
implic
develop
novel
target
therapeut
action
pd
enhanc
understand
neuron
inflammatori
mechan
environment
toxin
act
promot
patholog
heinrichheineunivers
duesseldorf
germani
german
diabet
center
duesseldorf
germani
chronic
inflammatori
demyelin
polyneuropathi
cidp
autoimmun
mediat
damag
peripher
nerv
caus
chronic
progress
pares
sensori
impair
immunolog
target
remain
elus
studi
imped
lack
adequ
anim
model
search
adequ
anim
model
inflammatori
neuropathi
nonobes
diabet
nod
mous
strain
spontan
develop
autoimmun
diabet
nod
mice
defici
intercellular
adhes
molecul
mediat
costimul
endotheli
cell
adhesionar
protect
diabet
surprisingli
observ
defici
nod
miceinstead
diabetesdevelop
hind
limb
pares
gait
disturb
progress
age
predominantli
affect
femal
studi
defici
nod
mice
phenotyp
analysi
peripher
nerv
electrophysiolog
immunohistochemistri
semithin
section
analyz
lymphocyt
cytokin
express
perform
adopt
cell
transfer
studi
electrophysiolog
demonstr
sign
chronic
demyelin
neuropathi
correl
clinic
impair
histopatholog
cell
extract
peripher
nerv
reveal
cell
macrophag
infiltr
semithin
section
demonstr
consecut
loss
myelin
lesser
extent
axon
peripher
nervou
system
organ
includ
brain
spinal
cord
exhibit
abnorm
adopt
transfer
cell
induc
inflammatori
neuropathi
immunodefici
recipi
cell
neuropath
defici
nod
mice
exhibit
predomin
bia
conclud
mice
gener
prone
autoimmun
defici
shift
autoimmun
specif
endocrin
pancrea
peripher
nerv
introduc
novel
anim
model
human
cidp
may
allow
us
studi
mechan
test
preclin
treatment
chronic
inflammatori
neuropathi
futur
role
receptor
alpha
experiment
autoimmun
encephalomyel
jopek
ashbaugh
jessica
brambilla
roberta
malek
thoma
bethea
john
experiment
autoimmun
encephalomyel
eae
mous
model
multipl
sclerosi
ms
neurodegen
diseas
character
extens
inflamm
demyelin
axon
damag
recent
studi
ms
patient
shown
genet
linkag
diseas
mutat
interleukin
receptor
alpha
chain
locu
alpha
common
thymic
stromal
lymphopoietin
tslp
receptor
import
lymphocyt
develop
homeostasi
well
dendrit
cell
function
therefor
ultim
goal
studi
identifi
alpha
function
specif
cell
popul
eae
diseas
set
appli
therapeut
strategi
translat
clinic
set
studi
use
genet
alter
mice
express
alpha
thymu
show
signific
neuroprotect
myelin
oligodendrocyt
glycoprotein
mog
peptid
model
chronic
progress
eae
base
upon
result
genet
analysi
human
want
determin
target
alpha
signal
would
therapeut
eae
studi
show
system
blockad
alpha
via
neutral
antibodi
diseas
onset
promot
signific
decreas
eae
sever
lymphocyt
infiltr
central
nervou
system
accompani
increas
resid
microglia
popul
convers
vivo
neutral
show
protect
diseas
despit
abil
inhibit
function
vitro
next
perform
chimera
studi
whereupon
bone
marrow
bm
either
mice
wild
type
wt
control
transplant
workshop
irradi
rag
recipi
interestingli
diseas
sever
equival
group
taken
togeth
genet
therapeut
approach
system
block
alpha
reduc
eae
sever
howev
block
yield
protect
impli
altern
pathway
tslp
may
involv
addit
inhibit
alpha
specif
small
lymphocyt
suffici
promot
protect
observ
mice
suggest
leukocyt
andor
cell
nonhematopoiet
lineag
involv
alpha
mediat
neuroinflamm
multipl
sclerosi
ms
chronic
diseas
central
nervou
system
cn
character
inflamm
myelin
damag
axon
degener
ms
diseas
relaps
markedli
reduc
pregnanc
greatest
suppress
diseas
activ
observ
third
trimest
serum
factor
implic
respons
pregnancyassoci
diseas
suppress
exosom
small
lipidbound
vesicl
function
facilit
intercellular
commun
augment
serum
pregnanc
exosom
abl
modul
cell
immun
central
nervou
system
relay
molecular
signal
cell
origin
target
cell
bear
specif
adhes
molecul
therefor
goal
studi
elucid
role
serum
exosom
pregnancyassoci
suppress
ms
studi
pregnanc
murin
experiment
autoimmun
encephalomyel
eae
diseas
sever
significantli
reduc
pregnanc
induc
establish
eae
addit
observ
postpartum
flare
diseas
cours
diseas
suppress
observ
gestat
administ
pregnancyderiv
serum
exosom
mice
establish
eae
observ
reduc
clinic
sever
follow
exosom
treatment
shown
exosom
abl
suppress
activ
myelinspecif
cell
measur
reduct
prolifer
interferongamma
express
also
demonstr
role
serum
exosom
prolifer
matur
oligodendrocyt
precursor
cell
opc
vitro
vivo
determin
protein
express
pregnancyversu
controlderiv
exosom
perform
differenti
gel
electrophoresi
follow
mass
spectrometri
protein
enrich
pregnanc
exosom
facilit
local
action
corticosteron
scaveng
oxygenderiv
free
radic
inhibit
matrix
metalloproteas
provid
surviv
signal
oligodendrocyt
data
suggest
serum
exosom
critic
modul
immun
central
nervou
system
pregnanc
govern
pregnancyassoci
suppress
eae
ms
har
mechan
exosom
suppress
immun
enhanc
function
opc
consequ
suppress
clinic
eae
extraordinari
implic
therapi
develop
ms
macrophag
migrat
inhibitori
factor
promot
central
nervou
system
patholog
model
neuroinflamm
cox
gina
mavriki
alexand
j
kithcart
william
j
smith
k
shawler
satoskar
whitacr
cc
ohio
state
univers
columbu
oh
unit
state
multipl
sclerosi
ms
chronic
inflammatori
demyelin
diseas
central
nervou
system
cn
cerebrospin
fluid
collect
ms
patient
relaps
found
contain
greater
level
macrophag
migrat
inhibitori
factor
mif
sampl
collect
remiss
shown
induct
experiment
autoimmun
encephalomyel
eae
mifdefici
mice
result
reduc
clinic
sign
cn
inflammatori
infiltr
rel
wild
type
control
howev
differ
cell
function
peripheri
two
group
find
suggest
mif
act
within
cn
potenti
diseas
progress
potent
proinflammatori
properti
mif
well
establish
howev
precis
contribut
mif
neuroinflamm
well
defin
mif
express
mani
cell
type
cn
includ
infiltr
macrophag
resid
microglia
suggest
mif
may
enhanc
inflammatori
environ
ms
lesion
thu
sought
determin
rel
contribut
mif
neuroinflamm
identifi
mif
therapeut
target
treatment
ms
assess
contribut
mif
cn
inflamm
primari
microgli
cultur
treat
increas
dose
rmif
upregul
inflammatori
mediat
associ
ms
eae
tnfa
ino
addit
rmif
induc
morpholog
chang
microgli
cultur
dosedepend
manner
consist
activ
phenotyp
explor
role
mif
vivo
use
intraspin
model
neuroinflamm
stereotact
spinal
cord
microinject
rmif
perform
result
transient
microgli
reactiv
cellular
accumul
within
cn
current
util
model
explor
role
mif
progress
eae
studi
implic
mif
inflammatori
mediat
within
cn
suggest
mif
may
contribut
develop
mainten
ms
lesion
taken
togeth
data
suggest
inhibit
mif
may
serv
therapeut
strategi
resolv
cn
inflamm
interact
adhes
molecul
express
bloodbrain
barrier
endotheli
cell
bbbec
cognat
ligand
express
lymphocyt
promot
transmigr
inflammatori
cell
central
nervou
system
cn
earli
phenomenon
multipl
sclerosi
ms
lesion
format
melanoma
cell
adhes
molecul
adhes
molecul
reportedli
interact
identifi
proteom
use
lipid
raft
membran
microdomain
human
bbbec
grown
primari
cultur
goal
defin
role
mcam
bbbec
thu
cn
immun
infiltr
seen
ms
data
demonstr
mcam
express
subset
inflammatori
effector
memori
lymphocyt
coexpress
mcam
lymphocyt
also
express
rorg
granzym
b
mcamneg
cell
ex
vivo
vitro
activ
vitro
polar
induc
mcam
express
much
lymphocyt
mcam
lymphocyt
display
significantli
higher
prolifer
product
compar
mcamneg
cell
furthermor
proport
mcam
lymphocyt
higher
blood
ms
patient
healthi
control
enrich
csf
ms
patient
compar
mcam
cell
healthi
donor
mcam
lymphocyt
ms
patient
consist
produc
percentag
intens
addit
report
mcam
express
surfac
human
bbbec
vitro
situ
ms
lesion
coloc
lymphocyt
surfac
marker
diapedesi
preliminari
data
ms
eae
tissu
reveal
mcamlymphocyt
present
immun
infiltr
coloc
inflammatori
cytokin
especi
moreov
crosslink
mcam
induc
brief
calcium
influx
similar
obtain
data
show
mcam
antibodi
influenc
proport
activ
ifng
compar
control
mcam
neutral
restrict
migrat
inflammatori
lymphocyt
across
human
bbbec
data
indic
mcam
express
bbbec
subset
effector
memori
lymphocyt
potenti
adhes
molecul
entri
cn
ms
patient
mcam
engag
influenc
ifng
releas
product
multipl
sclerosi
ms
chronic
inflammatori
diseas
cn
associ
complex
antimyelin
autoimmun
number
cn
myelin
protein
myelin
basic
protein
mbp
proteolipid
protein
plp
myelin
oligodendrocyt
glycoprotein
mog
myelin
oligodendrocyt
basic
protein
mobp
oligodendrocyt
specif
protein
osp
implic
potenti
primari
target
antigen
ms
multipl
potenti
primari
target
antigen
ms
togeth
like
possibl
epitop
spread
wherebi
pathogen
autoimmun
expand
myelin
target
antigen
patient
diseas
progress
suggest
ms
associ
complex
pathogen
antimyelin
autoimmun
impos
major
difficulti
devis
immunespecif
therapeut
approach
ms
view
potenti
complex
aim
establish
new
anim
model
better
reflect
complex
autoimmun
associ
ms
present
novel
model
chronic
complex
eae
associ
well
defin
multipl
pathogen
antimyelin
autoreact
induc
mice
immun
mous
multiepitop
encephalitogen
protein
mmep
protein
product
synthet
gene
encod
tandem
diseaserel
epitop
mbp
plp
mog
mobp
osp
complex
eae
induc
mmep
associ
pathogen
autoreact
multipl
myelin
antigen
result
sever
chronic
clinic
manifest
accompani
massiv
inflamm
extens
demyelin
neuron
damag
cn
optic
nerv
overal
result
suggest
complex
eae
induc
mmep
better
simul
complex
pathogen
autoimmun
ms
use
model
devis
immunospecifictherapi
ms
total
old
femal
mice
inject
mous
recombin
myelin
oligodendrocyt
glycoprotein
rmmog
induc
eae
twenti
one
develop
clinic
diseas
symptom
start
day
post
immun
dpi
diseas
peak
dpi
show
partial
remiss
dpi
anim
relaps
dpi
mice
sacrif
differ
time
point
dpi
spinal
cord
examin
immunohistochemistri
immunoblot
realtim
pcr
dpi
eae
mice
show
demyelin
total
white
matter
area
twm
axon
loss
compar
control
inflammatori
microglia
cell
infiltr
twm
protein
level
reduc
wherea
rna
level
express
upregul
contrast
mark
downregul
express
remain
unchang
stage
dpi
demyelin
axon
loss
reach
respect
inflamm
diminish
overexpress
express
remain
downregul
level
gj
protein
reduc
dpi
demyelin
axon
loss
inflamm
increas
express
markedli
upregul
increas
protein
level
express
remain
slightli
upregul
increas
protein
level
compar
control
show
signific
chang
studi
show
distinct
alter
express
major
oligodendrocyt
astrocyt
gj
protein
differ
stage
inflammatori
demyelin
suggest
gj
protein
may
differenti
involv
process
impair
gj
connect
oligodendrocyt
oligodendrocyt
astrocyt
result
chang
may
signific
impact
outcom
eae
ms
patholog
project
fund
cypru
research
promot
foundat
grant
cypru
telethon
univers
oxford
oxford
unit
kingdom
nmethyl
daspart
receptor
nmdar
class
ionotroph
receptor
glutam
predomin
excitatori
neurotransmitt
central
nervou
system
implic
learn
memori
well
sever
diseas
nmdar
antibodi
nmdarab
princip
constitut
subunit
recent
detect
sera
patient
enceph
present
psychosi
memori
loss
seizur
usual
progress
reduct
level
conscious
mark
dyskinet
movement
disord
earli
immunotherapi
plasma
exchang
corticosteroid
intraven
immunoglobulin
result
clinic
improv
correl
reduct
disappear
nmdarab
dalmau
et
al
irani
et
al
nmdar
transmembran
heterom
extracellular
domain
access
circul
antibodi
nmdar
igg
antibodi
bind
hippocampu
rodent
brain
tissu
surfac
live
hippocamp
neuron
shown
decreas
number
nmdar
hippocamp
neuron
dalmau
et
al
howev
yet
shown
patient
nmdar
igg
antibodi
passiv
transfer
cognit
behaviour
chang
live
anim
purifi
igg
patient
nmdarab
healthi
individu
mice
code
test
forti
day
period
follow
singl
intracerebroventricular
inject
either
patient
control
igg
observ
observ
blind
presenc
speciestyp
behaviour
motor
activ
seizur
activ
cognit
perform
mice
display
normal
lightdark
activ
cycl
differ
motor
perform
rotarod
task
static
rod
howev
nmdarabinject
mice
display
visual
sign
seizur
exhibit
phenotyp
involv
dyskinet
hind
limb
clasp
suspend
tail
observ
control
mice
p
b
video
avail
cognit
abil
examin
throughout
day
use
tmaze
task
work
memori
assess
natur
tendenc
mice
altern
choic
goal
arm
spontan
altern
nmdarab
treat
mice
show
signific
impair
p
b
compar
mice
receiv
control
igg
first
evid
passiv
transfer
nmdarab
posit
igg
elicit
neurolog
phenotyp
mous
reflect
aspect
nmdarab
antibodi
enceph
multipl
sclerosi
ms
inflammatori
diseas
suscept
loci
identifi
goal
project
explor
function
consequ
suscept
loci
genomewid
rna
express
data
gener
peripher
blood
mononuclear
cell
pbmc
subject
ms
assess
data
ci
tran
effect
rna
express
valid
ms
loci
variant
dataset
consist
genom
wide
rna
express
data
pbmc
ms
subject
either
untreat
n
treat
immunomodulatori
drug
n
interferonbeta
n
glatiram
acet
analys
perform
use
linear
regress
addit
model
snp
independ
variabl
adjust
snptreatment
interact
identifi
robust
ci
associ
rna
express
variant
p
sever
signific
tran
associ
within
ms
loci
modul
suscept
snp
use
pathway
analys
ipa
ingenu
system
find
differ
loci
affect
rna
express
multipl
gene
signal
pathway
signal
tcr
signal
icosicosligand
signatur
exampl
affect
express
multipl
gene
pathway
p
show
remark
level
interconnected
among
subset
ms
suscept
loci
loci
affect
rna
express
within
suscept
loci
strike
multipl
differ
loci
broad
effect
signal
pathway
critic
cell
function
prolifer
observ
provid
strong
bridg
recent
genet
discoveri
ms
wealth
immunolog
data
accumul
diseas
multipl
sclerosi
chronic
inflammatori
autoimmun
diseas
central
nervou
system
exact
caus
work
mechan
diseas
known
make
specif
treatment
difficult
aim
studi
identifi
diseaserel
protein
help
us
unravel
fundament
diseas
process
identifi
differenti
express
protein
brain
stem
eaeanim
control
rat
differ
stage
diseas
quantit
studi
twodimension
differ
ingel
electrophoresi
perform
three
rat
cfa
inject
control
rat
immun
mbp
induc
acut
eae
eae
anim
divid
three
group
repres
onset
top
recoveri
diseas
anim
group
bloodfre
brain
stem
lewisrat
collect
detergentsolubl
brain
protein
extract
use
analysi
differenti
protein
select
thereaft
identifi
use
mass
spectrometri
found
differenti
express
protein
spot
four
condit
control
onset
top
recoveri
protein
spot
abl
discrimin
earli
late
group
control
onset
sampl
versu
top
recoveri
sampl
moreov
set
discrimin
protein
select
discrimin
analysi
classifi
abl
discrimin
four
group
ingenu
pathway
analysi
identifi
protein
perform
find
molecular
relationship
protein
analysi
reveal
role
protein
involv
neuron
signal
inflamm
bbb
damag
mitochondri
dysfunct
apart
commonli
identifi
differenti
express
protein
also
known
brain
marker
new
candid
interest
pathway
identifi
differenti
express
quantit
analysi
differenti
express
brain
protein
anim
model
multipl
sclerosi
first
success
step
identifi
interest
diseaserel
protein
may
target
fundament
research
brain
microrna
target
neurosteroidogenesi
multipl
sclerosi
mediat
demyelin
neurodegener
noorbakhsh
farshid
ellestad
kristofor
k
multipl
sclerosi
ms
prototyp
autoimmun
neurodegen
diseas
central
nervou
system
underli
diseas
mechan
remain
uncertain
neurosteroid
synthes
within
nervou
system
exert
divers
effect
brain
growth
repair
viabil
although
involv
neuroinflammatori
disord
previous
studi
use
multiplatform
approach
includ
autopsi
brain
tissu
vitro
cultur
ms
anim
model
experiment
autoimmun
enceph
eae
investig
microrna
profil
brainderiv
white
matter
ms
nonm
patient
base
princip
compon
gene
ontolog
analys
predict
target
dysregul
mirna
limit
specif
biolog
function
includ
neurosteroid
biosynthesi
show
target
bia
toward
induc
mirna
p
b
neurosteroid
allopregnanolon
allo
suppress
ms
brain
complement
diminish
neurosteroid
enzymat
machineri
transcript
protein
quantiti
brain
tissu
pb
transduct
human
astrocyt
select
mirna
suppress
enzym
express
respons
allo
synthesi
pb
exposur
oligodendrocyt
nonimmunosuppress
allo
protect
cytotox
effect
activ
macrophag
pb
reduc
allo
enzym
respons
synthesi
observ
mice
mog
ptxinduc
eae
pb
togeth
induct
mirna
neurosteroidspecif
enzym
treatment
eae
anim
allo
diminish
neuroinflamm
demyelin
axon
loss
togeth
suppress
neurobehavior
abnorm
pb
microrna
dysregul
potenti
contribut
ms
pathogenesi
alter
neurosteroid
express
lead
select
suppress
allo
express
ensu
advers
effect
oligodendrocyt
viabil
allo
repres
plausibl
neurorepar
therapi
ms
transcript
factor
ccaatenhanc
bind
protein
beta
c
ebpbeta
cebpdelta
regul
express
gene
often
associ
deleteri
effect
glial
activ
ie
tnfalpha
cebpbeta
cebpdelta
regul
express
gene
activ
glial
cell
inhibit
cebpbeta
andor
cebpdelta
could
result
attenu
less
neurotox
glial
activ
test
hypothesi
undertaken
studi
two
aim
studi
express
cebpbeta
cebpdelta
glial
activ
analyz
effect
inhibitionabs
cebpbeta
c
ebpdelta
proinflammatori
neurotox
profil
activ
glial
cell
use
primari
mix
glial
astrogli
microgli
murin
cortic
cultur
observ
tolllik
receptor
tlr
agonist
upregul
cebpbeta
cebpdelta
mrna
protein
level
effect
observ
astrocyt
particularli
strong
microglia
immunoprecipit
observ
associ
c
ebpbeta
cebpdelta
nuclear
fraction
activ
microgli
cell
indic
presenc
cebpbetadelta
heterodim
analyz
role
cebpbeta
cebpdelta
glial
activ
use
three
experiment
approach
overexpress
lip
domin
neg
form
cebpbeta
microgli
cell
b
primari
glial
cultur
cebpbeta
defici
mice
c
treatment
glial
cultur
chrysin
antiinflammatori
flavonoid
reduc
cebpdelta
express
affect
nfkappab
cebpbeta
nuclear
level
dnabind
three
paradigm
inhibit
absenc
cebp
markedli
reduc
proinflammatori
gene
express
induc
lp
lp
ifng
interestingli
absenc
cebpbeta
pharmacolog
reduct
cebpdelta
level
markedli
attenu
neurotox
effect
microgli
activ
microglialneuron
cocultur
result
indic
upregul
cebpbeta
c
ebpdelta
common
featur
tlrinduc
microgli
activ
also
suggest
transcript
factor
play
key
role
regul
proinflammatori
gene
express
glial
activ
consequ
inhibit
cebpbeta
cebpdelta
could
use
treatment
neurolog
disord
glial
activ
play
pathogen
role
support
isciii
type
interferon
signal
axon
injuryinduc
glial
respons
institut
molecular
medicin
univers
southern
denmark
odens
denmark
insult
central
nervou
system
cn
lead
initi
glial
respons
innat
cn
innat
glial
respons
critic
induct
cytokin
chemokin
direct
leukocyt
entri
injuri
site
respons
may
contribut
repair
process
damag
cn
may
also
exacerb
neurodegener
better
understand
process
import
studi
mechan
signal
glial
respons
injuri
glial
respons
may
involv
cytokin
type
interferon
known
regul
innat
immun
respons
viral
infect
signal
receptor
ifnar
involv
activ
interferon
regulatori
lead
activ
interferon
stimul
gene
includ
induct
enhanc
examin
involv
signal
hippocampu
transect
entorhin
affer
axon
injuri
induc
upregul
receptor
associ
signal
hippocampu
doubl
immunofluoresc
coloc
studi
show
induc
posit
macrophagesmicroglia
denerv
molecular
layer
dentat
gyru
hippocampu
addit
mrna
detect
facssort
microglia
lesionreact
hippocampi
induct
mrna
ifnardepend
furthermor
lack
ifna
signal
result
increas
leukocyt
infiltr
lesionreact
hippocampu
unlik
wt
mice
axon
lesion
induc
increas
induc
increas
matrix
metalloproteinas
gene
express
ifnarko
mice
find
point
role
type
ifn
signal
regul
innat
immun
respons
steril
injuri
microgli
cell
acut
eae
may
play
key
role
regul
lymphocyt
dynam
almolda
beatriz
costa
manuela
montoya
maria
gonzalez
berta
castellano
bernardo
experiment
autoimmun
encephalomyel
eae
wellestablish
model
multipl
sclerosi
characteris
microgli
activ
lymphocyt
infiltr
lymphocyt
activ
antigen
present
process
involv
two
main
signal
first
provid
tcrmhc
engag
second
bind
costimulatori
molecul
wide
number
report
describ
microgli
reactiv
tcell
infiltr
eae
howev
major
part
studi
focus
peak
less
known
aspect
take
place
induct
recoveri
phase
work
perform
detail
analysi
microgli
activ
tcell
dynam
along
acut
lewi
rat
eae
model
mbpinject
rat
sacrif
differ
phase
attend
exclus
clinic
score
spinal
cord
analys
flow
cytometri
immunohistochemistri
find
reveal
induct
phase
peak
microgli
cell
becam
activ
subpopul
display
immatur
dendriticcelllik
phenotyp
mhcclass
mhcclass
ii
parallel
high
infiltr
lymphocyt
phenotyp
take
place
first
sign
symptomatolog
peak
coincid
begin
clinic
improv
high
decreas
number
cell
occur
declin
mediat
mechan
apoptosi
induc
microgli
cell
immatur
dendrit
cell
phenotyp
discard
howev
cell
differenti
type
lymphocyt
recoveri
reduct
total
number
lymphocyt
cell
fact
recoveri
phase
found
import
increas
treg
cell
popul
also
recoveri
phase
microgli
cell
remain
highli
activ
found
neighbour
area
blood
vessel
display
mhcclass
mhcclass
ii
phenotyp
presenc
activ
microgli
cell
infiltr
lymphocyt
popul
extend
postrecoveri
phase
conclus
result
indic
microgli
cell
may
regul
dynam
lymphocyt
subpopul
may
involv
lead
resolut
patholog
process
also
induct
subsequ
toler
characterist
model
eae
enhanc
product
primari
astrocyt
mear
gordon
xiangyu
qin
hongwei
benvenist
etti
n
univers
alabama
birmingham
birmingham
unit
state
qilu
hospit
shandong
univers
jinan
china
multipl
sclerosi
ms
debilit
autoimmun
diseas
character
progress
select
destruct
myelin
sheath
subsequ
degener
axon
onset
ms
pathogen
cell
includ
produc
cell
invad
cn
contribut
demyelin
chemokin
includ
chemokin
cc
motif
ligand
bind
promot
migrat
cell
site
inflamm
astrocyt
import
role
regul
inflamm
within
cn
astrocyt
respond
number
cytokin
recent
demonstr
astrocyt
express
receptor
respond
enhanc
signal
nfkappab
mapkdepend
fashion
experiment
autoimmun
encephalomyel
eae
astrocyt
produc
howev
influenc
astrocyt
product
current
unknown
studi
examin
role
product
primari
mous
astrocyt
alon
alon
modest
effect
express
howev
combin
led
robust
increas
mrna
express
secret
astrocyt
measur
rtpcr
elisa
respect
increas
express
due
mrna
stabil
instead
increas
activationassoci
phosphoryl
nfkappab
inhibit
nfkappab
pathway
ablat
express
addit
chromatin
ip
chip
reveal
stimul
primari
astrocyt
increas
recruit
activ
nfkappab
promot
increas
bind
histon
acetyl
consist
transcript
activ
gene
interestingli
enhanc
product
uniqu
also
synerg
well
known
induc
increas
express
human
glioma
cell
line
collect
result
suggest
astrocyt
respons
may
shift
chemokin
product
favor
cell
recruit
cn
microglia
phenotyp
involv
central
nervou
system
deand
remyelin
olah
marta
biber
knut
boddek
erik
univers
medic
center
groningen
groningen
netherland
propos
microglia
resid
immun
cell
central
nervou
system
cn
multifacet
role
cn
disord
affect
white
matter
believ
critic
involv
demyelin
remyelin
phase
leukoencephalopathi
multipl
sclerosi
microglia
therefor
potenti
therapeut
target
demyelin
diseas
render
understand
exact
microglia
phenotyp
involv
deand
remyelin
highli
desir
aim
investig
role
adult
murin
microglia
process
deand
remyelin
cuprizon
model
protocol
recent
develop
laboratori
isol
microglia
brain
adult
mice
differ
time
point
cuprizon
diet
demyelin
phase
withdraw
cuprizon
remyelin
phase
microglia
total
rna
subject
gene
express
experi
use
illumina
bead
array
result
gene
express
analysi
reveal
microglia
phenotyp
involv
process
primari
demyelin
remyelin
central
nervou
system
microglia
phenotyp
associ
demyelin
characteris
express
mrna
protein
involv
phagocytosi
myelin
debri
apoptot
cell
nevertheless
remyelin
phase
microglia
highli
express
transcript
gene
involv
tissu
remodel
oligodendrocyt
precursor
cell
recruit
differenti
trophic
support
sinc
confirm
select
gene
express
result
protein
function
level
suggest
addit
microglia
phenotyp
involv
clearanc
specif
microglia
phenotyp
support
remyelin
process
exist
signal
central
nervou
system
glial
cell
regul
inflammatori
demyelin
balabanov
roumen
interferon
regulatori
factor
interferondepend
transcript
factor
implic
pathogenesi
multipl
sclerosi
ms
anim
model
experiment
autoimmun
encephalomyel
eae
present
studi
investig
involv
signal
mechan
inflammatori
demyelin
ms
eae
purpos
studi
employ
number
molecular
method
focus
express
interact
caspas
ms
eae
tissu
cell
cultur
addit
gener
bone
marrow
chimera
mice
differenti
express
central
nervou
system
cn
test
respons
eae
found
express
ms
eae
tissu
microglia
oligodendrocyt
astrocyt
mous
bone
marrow
chimera
experi
demonstr
mice
lack
cn
protect
eae
investig
signal
identifi
caspas
proinflammatori
proapoptot
gene
import
target
transcript
activ
base
result
conclud
signal
glial
cell
regul
inflammatori
demyelin
ms
eae
find
clinic
relev
may
provid
basi
develop
novel
therapeut
strategi
ms
nitric
oxid
synthas
no
present
wide
rang
brain
region
involv
modul
defens
adapt
behaviour
includ
dorsal
hippocampu
recent
evid
suggest
system
hippocamp
administr
nonselect
no
inhibitor
caus
anxiolyticand
antidepressantlik
effect
anim
model
howev
no
isoform
involv
effect
clearli
defin
consid
mediat
inflammatori
respons
well
upregul
product
induc
exposur
stress
aim
present
studi
investig
differenti
involv
hippocamp
induc
no
isoform
ino
neuron
no
isoform
nno
modul
defens
behavior
relat
depress
anxieti
use
forc
swim
test
fst
elev
plu
maze
epm
respect
male
wistar
rat
guidecannula
aim
dorsal
hippocampu
submit
fst
epm
fst
rat
submit
pretest
pt
min
swim
receiv
local
administr
npropyllarginin
npla
select
nno
inhibitor
w
select
ino
inhibitor
vehicl
one
day
later
immobl
time
regist
min
swim
test
epm
rat
receiv
hippocamp
administr
npla
w
vehicl
min
expos
epm
time
spent
open
enclos
arm
score
min
diazepam
mgkg
ip
use
posit
control
protocol
approv
local
ethic
committe
npla
w
reduc
fst
pb
antidepressantlik
effect
model
epm
treatment
npla
w
diazepam
increas
time
spent
open
arm
pb
indic
anxiolyticlik
effect
npla
w
diazepam
induc
signific
locomotor
effect
sinc
differ
treatment
detect
total
number
entri
arm
epm
result
indic
hippocamp
nno
ino
may
differenti
involv
regul
defens
behavior
relat
anxieti
depress
effect
chronic
stress
male
univers
student
final
examin
nomura
shusaku
morishima
mika
migita
masao
mizuno
tota
nozawa
akio
suzuki
ikuo
izawa
shuhei
imai
junichi
nagaoka
univers
technolog
nagaoka
japan
gifu
citi
women
colleg
gifu
japan
shiga
univers
hikon
japan
tokyo
polytechn
univers
atsugi
japan
meisei
univers
tokyo
japan
hokkaido
univers
sapporo
japan
nation
institut
occup
safeti
health
tokyo
japan
chiba
institut
technolog
chiba
japan
influenc
chronic
stress
immuneendocrin
system
male
univers
student
engag
graduat
examin
investig
recent
develop
molecular
analysi
techniqu
enabl
scientist
studi
tini
amount
biochem
substanc
contain
varieti
secretori
fluid
reveal
hormon
immun
substanc
elev
level
shortterm
acut
experiment
stressor
therefor
substanc
could
also
consid
possibl
biomark
human
mental
stress
level
howev
studi
investig
effect
chronic
stress
biomark
frequent
show
inconsist
result
discrep
might
attribut
difficulti
control
varieti
background
factor
durat
strength
chronic
stress
focus
male
univers
student
engag
graduat
examin
graduat
examin
consist
vital
oral
defens
end
follow
six
month
prepar
thu
durat
least
end
point
chronic
stress
level
caus
exam
would
highli
expect
parallelli
align
particip
forti
six
male
univers
finalyear
student
engag
graduat
examin
target
male
univers
student
second
grade
control
voluntarili
particip
studi
regard
biomark
salivari
secretori
substanc
immunoglobulin
iga
cortisol
chromogranin
cga
dehydroepiandrosteron
dhea
dehydroepiandrosteronesulf
dhea
testosteron
te
alphaamylas
ami
assess
seven
distinct
point
time
seri
three
month
two
month
month
two
week
week
oral
defens
week
two
week
oral
defens
develop
result
whole
period
observ
iga
cga
dhea
deha
significantli
higher
target
group
control
p
b
whilst
te
ami
significantli
lower
target
group
p
b
signific
differ
cortisol
conclus
differ
effect
chronic
stress
immuneendocrin
system
illustr
studi
variat
observ
biomark
studi
impli
might
differ
physiolog
reaction
mechan
chronic
stress
biomark
chair
c
whitacr
x
montalban
multipl
sclerosi
ms
clinic
cours
individu
patient
larg
unpredict
futur
develop
prognost
test
ms
via
biomark
identif
would
much
clinic
valu
would
allow
physician
tailor
treatment
regimen
patholog
individu
patient
gene
express
signatur
becom
one
promis
methodolog
identifi
biomark
complex
diseas
aim
project
develop
prognost
test
ms
use
dna
array
bioinformat
tool
first
perform
express
screen
use
plu
array
analyz
gene
express
pbmc
patient
aggress
ms
patient
benign
ms
control
without
patholog
identifi
gene
differenti
express
three
group
perform
valid
gene
real
time
pcr
prospect
cohort
ms
patient
classifi
good
relaps
chang
edss
bad
outcom
relaps
increas
edss
control
follow
two
year
abl
valid
gene
signatur
pattern
gene
use
creat
bayesian
classifi
diagnost
accuraci
distinguish
patient
good
bad
prognosi
mine
cell
mirnom
multipl
sclerosi
biomark
gueraudearellano
mireia
smith
kristen
godlewski
jakub
whitacr
carolin
lawler
sean
lovettrack
ami
rack
michael
k
myelinspecif
cell
present
peripher
blood
mononuclear
cell
pbmc
healthi
control
multipl
sclerosi
ms
patient
becom
pathogen
ms
patient
suggest
ms
cell
predispos
autoreact
activ
microrna
mir
regul
number
cellular
process
mrna
degrad
andor
translat
inhibit
hypothes
mirna
underli
suscept
ms
cell
autoimmun
activ
investig
role
mir
predispos
ms
determin
mir
profil
cell
healthi
relapsingremit
rrm
secondari
progress
spm
primari
progress
ppm
individu
realtim
pcr
taqman
array
assay
cover
describ
human
mir
mir
found
significantli
differ
ms
compar
healthi
control
rrm
spm
patient
almost
ident
mirna
profil
downregul
mir
predomin
contrast
ppm
patient
distinct
highli
uniqu
profil
domin
upregul
mir
ingenu
pathway
analysi
gene
predict
regul
upregul
mir
reveal
cooper
target
cell
differenti
includ
silenc
transcript
factor
favor
differenti
msassoci
mirtransfect
result
reduc
cell
express
result
identifi
mir
ms
biomark
biolog
signific
potenti
clinic
valu
reveal
new
possibl
therapeut
target
ms
children
present
initi
episod
acquir
demyelin
syndrom
ad
biomark
lack
predict
whose
ill
remain
monophas
develop
recurr
diseas
consist
diagnosi
multipl
sclerosi
ms
use
luminex
multiplex
system
investig
select
panel
immun
molecul
previous
implic
put
biomark
diseas
activ
adultm
serum
collect
time
ad
children
age
year
fm
follow
comprehens
standard
clinic
imag
studi
part
prospect
canadian
pediatr
demyelin
diseas
studi
averag
followup
year
ad
children
exhibit
clinic
imag
evid
recurr
diseas
ms
evid
recurr
diseas
monophasicad
compar
sampl
ad
onset
month
follow
ad
serum
level
mig
trail
vcam
increas
p
b
level
hgf
rant
decreas
p
b
though
differ
observ
group
howev
serum
level
osteopontin
p
eselectin
p
lower
time
ad
month
follow
ad
children
subsequ
diagnos
ms
p
p
respect
compar
remain
monophas
serum
level
also
higher
month
follow
ad
children
ms
p
b
sever
immun
molecul
previous
implic
establish
adult
ms
may
repres
nonspecif
marker
acut
inflamm
rather
earli
predictor
diseas
outcom
studi
warrant
confirm
whether
level
osteopontin
eselectin
serv
predict
biomark
distinguish
ms
monophasicad
switch
relaps
remiss
multipl
sclerosi
continu
inflammatori
respons
balanc
suppress
gurevich
michael
dolev
mark
magalashvili
david
achiron
anat
sheba
medic
center
ramatgan
israel
telaviv
univers
telaviv
israel
multipl
sclerosi
ms
character
patient
relapsingremit
diseas
cours
howev
trigger
relaps
transform
switch
remiss
clearli
understood
aim
evalu
key
molecular
pathway
oper
ms
relaps
ms
remiss
better
understand
associ
repair
mechan
microarray
geneexpress
analysi
affymetrix
array
appli
studi
peripher
blood
mononuclear
cell
pbmc
signatur
relapsingremit
ms
patient
patient
remiss
age
year
diseas
durat
year
f
edss
patient
acut
relaps
age
year
diseas
durat
year
f
edss
compar
data
healthi
subject
age
year
f
partek
wwwpartekcom
ingenu
softwar
www
ingenuitycom
appli
statist
analysi
signific
gene
mig
p
b
fold
chang
differenti
geneexpress
mig
distinguish
ms
patient
relaps
healthi
subject
mig
differ
ms
patient
remiss
healthi
subject
ms
relaps
signatur
character
suppress
gene
relat
caspaseapoptot
pathway
fadd
fasl
caspas
activ
enhanc
macrophag
penetr
bloodbrain
barrier
accord
stimul
cxcmodul
inflamm
known
recruit
macrophag
neutrophil
concert
intensifi
inflammatori
respons
identifi
suppress
respons
ifng
indic
initi
remiss
ms
remiss
signatur
character
suppress
respons
associ
activ
neg
regul
nfkb
depend
inflamm
cytokin
signal
soc
still
ongo
overexpress
proinflammatori
activ
promot
lymphocyt
chemotaxi
adhes
comparison
ms
relaps
remiss
demonstr
elev
level
neurotroph
factor
like
bdnf
downstream
signal
molecul
tnr
ms
relaps
ms
remiss
constitut
continu
process
transform
switch
occur
imbal
activ
cxcmodul
inflamm
relat
traffick
adhes
evid
relaps
suppress
neurotroph
activ
promin
remiss
type
interferon
ifn
crucial
antivir
cytokin
releas
respons
viral
infect
includ
herp
simplex
viru
type
studi
shown
children
unabl
produc
type
ifn
follow
brain
infect
highli
suscept
enceph
sought
elicit
role
ifn
cn
follow
infect
use
mice
lack
alpha
chain
type
ifn
receptor
follow
ocular
infect
found
signific
increas
viral
burden
cerebr
cortic
brain
stem
bs
mice
day
post
infect
pi
compar
wild
type
wt
control
lack
contain
mice
correl
decreas
nk
cell
infiltr
bs
seen
wt
mice
loss
nk
cell
recruit
mice
correspond
decreas
product
howev
signific
increas
express
chemoattract
bs
mice
correspond
increas
macrophag
order
evalu
bloodbrain
barrier
integr
matrix
metalloproteinas
level
determin
elisa
significantli
elev
compar
wt
mice
brain
bs
day
pi
use
magnet
reson
imag
found
signific
enlarg
later
ventricl
mice
day
pi
comparison
wt
counterpart
conclus
absenc
type
ifn
signal
result
rapid
dissemin
viru
throughout
cn
result
gross
morpholog
chang
associ
aberr
immun
respons
consequ
feel
excel
model
dissect
contribut
cell
solubl
factor
elicit
respons
viral
pathogen
ensu
neuropatholog
better
defin
viralmedi
enceph
cellular
molecular
level
consist
detect
ebv
rna
immun
infiltr
multipl
sclerosi
brain
use
combin
laser
captur
microdissect
realtim
rtpcr
rosicarelli
barbara
severa
martina
coccia
eliana
serafini
barbara
aloisi
francesca
istituto
superior
di
rome
itali
increas
number
epidemiolog
immunolog
studi
support
associ
epsteinbarr
viru
ebv
infect
multipl
sclerosi
ms
howev
mechan
link
ebv
infect
brain
patholog
still
unknown
possibl
ebv
establish
persist
infect
cn
reactiv
period
bolster
immunopatholog
respons
explor
sever
group
contrast
result
particular
inabl
detect
ebv
nucleic
acid
whole
ms
brain
section
could
due
absencelow
frequenc
cnsinfiltr
b
cell
main
viral
reservoir
andor
limit
sensit
convent
realtim
pcr
techniqu
use
brain
section
ms
case
establish
bcell
contain
immun
infiltr
tissu
sampl
obtain
uk
ms
tissu
bank
confirm
inabl
detect
ebv
latenc
lytic
transcript
use
convent
realtim
rtpcr
wherea
select
cdna
preamplif
allow
detect
ebv
latenc
transcript
sampl
highest
content
b
cell
assess
mrna
level
increas
sensit
assay
next
appli
laser
captur
microdissect
conjunct
realtim
rtpcr
select
cdna
preamplif
allow
perform
quantit
analysi
cellular
viral
gene
even
amount
start
rna
small
optim
techniqu
mrna
detect
immun
infiltr
analyz
perivascular
cuff
activ
chronic
activ
white
matter
lesion
mening
infiltr
bcell
follicl
wherea
mrna
detect
acut
lesion
bcell
follicl
thu
confirm
previou
immunohistochem
find
serafini
et
al
j
exp
med
ebv
transcript
detect
lasercut
normalappear
lesion
white
grey
matter
parenchyma
bcell
follicl
normal
lymph
node
without
sensit
laser
captur
microdissect
andor
preamplif
realtim
pcr
techniqu
expect
detect
ebv
nucleic
acid
would
unattain
ms
brain
sampl
lipocalin
ironsiderophor
bind
bacteriostat
factor
produc
host
innat
immun
respons
bacteri
infect
howev
unclear
whether
express
function
host
respons
viral
infect
addit
antimicrobi
action
may
also
regul
cellular
iron
metabol
apoptosi
littl
known
concern
function
cn
host
respons
therefor
investig
regul
function
cn
follow
system
lipopolysaccharid
lp
inject
west
nile
viru
wnv
enceph
although
undetect
physiolog
condit
mrna
protein
level
highli
induc
either
lp
inject
wnv
infect
choroid
plexu
epithelium
endotheli
cell
microglia
brain
mice
interestingli
protein
mrna
found
present
high
level
subset
neuron
consist
uptak
accumul
cell
although
cn
express
variou
cytokin
chemokin
inflammationassoci
gene
increas
brain
follow
system
lp
inject
signific
differ
marker
ironmetabol
wt
control
versu
ko
mice
howev
compar
wt
ko
mice
show
significantli
increas
mortal
follow
intranas
infect
low
dose
wnv
induc
strateg
key
gateway
cn
host
respons
bacteri
also
viral
infect
protein
distribut
brain
bacteri
viral
infect
suggest
neuron
dominantli
infect
cell
type
wnv
may
key
target
action
clear
function
role
establish
lpsinduc
inflammatori
respons
brain
data
suggest
import
protect
function
wnv
enceph
malaria
infecti
system
diseas
caus
protozoa
plasmodium
nitric
oxid
produc
larg
amount
enzym
ino
consid
play
major
role
malaria
howev
effect
controversi
malaria
pathogenesi
present
studi
aim
evalu
ino
role
cerebr
hepat
inflammatori
respons
mous
infect
plasmodium
berghei
anim
use
femal
mice
wildtyp
wt
defici
ino
inosko
week
old
mice
infect
intraperiton
ip
inject
parasitis
erythrocyt
parasitemia
level
monitor
giemsastain
blood
smear
surviv
rate
analyz
infect
leukocyteendotheli
interact
brain
hepat
microvasculatur
evalu
intravit
microscopi
wildtyp
inosko
also
anim
treat
ip
aminoguanidin
mgkg
ino
inhibitor
parasitemia
significantli
higher
inosko
n
compar
wildtyp
group
n
inosko
wt
p
b
postinfect
pi
inosko
wt
p
b
howev
surviv
rate
show
signific
differ
infect
wildtyp
infect
inosko
infect
mice
show
signific
increas
leukocyt
roll
adhes
brain
microvasculatur
compar
control
mice
howev
infect
inosko
infect
wildtyp
treat
ag
mice
show
signific
differ
compar
infect
wildtyp
mice
cerebr
leukocyt
recruit
hand
infect
inosko
exhibit
signific
increas
leukocyt
roll
roll
cell
min
p
b
adhes
adher
p
b
hepat
microvasculatur
compar
infect
wildtyp
adher
roll
cell
min
mice
treat
ag
also
present
signific
increas
roll
roll
cellsmin
p
b
adhes
adher
p
b
compar
wildtyp
treat
salin
roll
cellsmin
adher
higher
level
parasitemia
infect
inosko
mice
indic
nitric
oxid
inhibit
prolifer
plasmodium
berghei
addit
p
berghei
infect
abl
induc
leukocyt
recruit
brain
microcircul
howev
absenc
inhibit
ino
enzym
increas
leukocyt
roll
adhes
hepat
microvasculatur
suggest
import
role
ino
peripher
inflamm
p
berghei
infect
financi
support
cape
fapemig
bone
marrowderiv
cell
primari
sourc
regul
antigenspecif
cell
recruit
cn
univers
oklahoma
health
scienc
center
oklahoma
citi
unit
state
chemokin
crucial
control
viral
replic
regul
mobil
antigenspecif
cell
site
infect
highli
express
site
inflamm
well
constitut
within
lymphoid
organ
bone
marrow
bm
deriv
nonbm
deriv
cell
howev
rel
immunolog
import
express
diverg
sourc
differ
anatom
site
unknown
use
mous
chimera
reconstitut
either
wildtyp
defici
bone
marrow
bm
show
bmderiv
cell
domin
sourc
within
drain
lymph
node
spleen
follow
herp
simplex
viru
infect
nonlymphoid
organ
express
bmderiv
radiat
sensit
cell
regul
mobil
specif
cell
cn
provid
domin
contribut
toward
control
viru
result
establish
sitespecif
contribut
leukocyt
express
studi
also
challeng
view
chemokin
function
simpl
recruit
leukocyt
along
concentr
gradient
establish
product
nonbm
deriv
resid
cell
site
inflamm
whilst
contribut
microglia
pathogenet
pathway
associ
neuroinflamm
focu
intens
investig
astrocyt
larg
ignor
gener
assum
astrocyt
reactiv
secondari
microgli
one
despit
rapidli
accumul
evid
high
capabl
cell
instantan
robust
respons
chang
condit
well
commun
central
nervou
system
cell
type
therefor
order
improv
map
effector
pathway
trigger
neuroinflammatori
condit
multipl
sclerosi
ms
investig
time
natur
astrocyt
reactiv
relat
microgli
reactiv
experiment
autoimmun
encephalomyel
eae
ms
model
perform
nodlt
mous
myelin
oligodendrocyt
glycoprotein
peptid
neuroantigen
evalu
confoc
microscopi
preclin
stage
astrocyt
reactiv
evidenc
glial
fibrillari
acid
protein
gfap
observ
time
earliest
mening
accumul
inflammatori
cell
extend
across
grey
white
matter
manifest
differ
morpholog
chang
two
compart
promin
around
blood
vessel
neuron
cell
bodi
quantif
gfap
show
signific
increas
control
find
overlap
ident
microglia
coincid
earliest
parenchym
invas
direct
contact
cell
identifi
marker
seen
occur
least
two
form
firstli
interact
cell
astrocyt
process
protrus
appear
interlock
secondli
intim
associ
cell
bodi
latter
case
reconstruct
demonstr
contact
involv
substanti
area
cell
bodi
cell
becom
enfold
astrocyt
undergo
consider
morpholog
chang
current
investig
address
question
whether
interact
astrocyt
cell
restrict
sampl
environ
part
homeostat
role
astrocyt
evid
format
immunolog
synaps
cell
type
data
demonstr
preclin
astrocyt
reactiv
parallel
microglia
implic
develop
therapi
neuroinflamm
accumul
data
divers
high
throughput
platform
analysi
dataset
independ
part
solut
follow
axiom
whole
sum
part
hypothesi
much
knowledg
pathogenesi
complex
diseas
gain
thorough
systemat
creativ
combin
omic
result
empir
test
present
discuss
new
way
integr
genom
gene
express
imag
data
larg
cohort
ms
patient
control
also
present
analys
genet
similar
differ
ms
complex
diseas
use
origin
networkbas
approach
meaning
data
integr
becom
next
frontier
analysi
complex
dataset
learn
omic
transcriptom
proteom
lipidom
compar
genom
stanford
univers
ca
usa
shall
compar
learn
omic
learn
gwa
studi
date
obvious
need
omic
understand
ms
resourc
alloc
howev
key
time
research
budget
shrink
shall
argu
case
increas
fund
point
omic
besid
genom
brainblood
barrier
regul
brain
inflamm
chair
prat
elga
de
vri
novel
adhes
molecul
involv
preferenti
migrat
leukocyt
subset
cn
bloodbrain
barrier
bbb
protect
central
nervou
system
regul
molecular
cellular
exchang
brain
blood
bbb
made
network
tightli
adher
endotheli
cell
ec
surround
astrocyt
process
provid
factor
contribut
bbb
mainten
sever
proteom
basedprofil
human
anim
bbb
endotheli
cell
reveal
presenc
uniqu
regulatori
protein
involv
bbb
physiolog
transendotheli
leukocyt
migrat
other
found
human
bbbec
special
membran
microdomain
lipid
raft
enrich
protein
involv
cellular
adhes
cell
structur
bbb
develop
immun
defens
transport
traffick
signal
transduct
recent
work
use
anim
model
ms
spinal
cord
contus
well
human
vitro
situ
ex
vivo
analys
reveal
new
bbb
candid
protein
includ
alcam
hedgehog
pathway
mcam
involv
regul
immun
cell
traffick
across
vascular
structur
cn
importantli
interact
regul
traffick
lymphocyt
monocytesmacrophag
impact
recruit
lymphocyt
convers
express
restrict
cell
myeloid
lineag
regul
recruit
monocyt
dc
cn
final
mcam
express
primarili
lymphocyt
highli
express
within
activ
ms
eae
lesion
recent
data
base
proteom
analysi
human
bbbassoci
lipid
raft
membran
microdomain
identifi
novel
adhes
molecul
involv
recruit
specif
immun
cell
subset
cn
role
abc
transport
neuroinflammatori
event
bloodbrain
barrier
background
goal
bloodbrain
barrier
bbb
atp
bind
cassett
abc
transport
drive
cellular
exclus
varieti
compound
therebi
protect
brain
neurotox
compound
recent
describ
abc
transport
may
also
involv
remov
inflammatori
agent
immun
cell
varieti
neuroinflammatori
disord
includ
multipl
sclerosi
ms
defect
function
bbb
describ
base
structur
differ
howev
lower
express
abc
transport
bbb
may
lead
enhanc
exposur
brain
inflammatori
mediat
therebi
aggrav
inflammatori
process
vasculatur
method
result
therefor
set
studi
regul
abc
transport
bbb
ms
use
welldefin
postmortem
patient
materi
domin
loss
pglycoprotein
pgp
detect
activ
ms
lesion
moreov
identifi
interact
activ
tcell
brain
endotheli
cell
cultur
lead
reduct
pgp
express
function
regul
nfkb
signal
rout
kooij
et
al
j
autoimmun
data
therefor
indic
ms
structur
level
bloodbrain
barrier
alter
occur
also
endotheli
efflux
barrier
properti
affect
expos
brain
higher
level
inflammatori
agent
thursday
octob
th
concurr
symposia
strikingli
ms
lesion
reactiv
astrocyt
start
express
number
abc
transport
includ
multidrug
resist
pgp
express
sole
local
astrocyt
endfeet
contact
vasculatur
found
distribut
along
whole
cell
bodi
importantli
vitro
cultur
primari
human
astrocyt
deriv
ms
lesion
found
enhanc
function
pgp
compar
astrocyt
isol
nonneurolog
control
vitro
data
use
human
astrocyt
reveal
efflux
pump
involv
secret
monocyt
chemoattract
protein
found
act
lead
chemoattract
monocyt
recruit
across
bbb
block
activ
astrocyt
abc
transport
reduc
cellular
migrat
across
bbb
vitro
conclus
togeth
data
emphas
abc
transport
modulatori
role
inflamm
bbb
role
leukocyt
traffick
mechan
pathogenesi
epilepsi
seizur
paroxysm
hypersynchron
discharg
central
nervou
system
cn
neuron
repeat
seizur
lead
unknown
mechan
epilepsi
chronic
neurolog
disord
affect
percent
world
popul
leukocyt
recruit
hallmark
point
potenti
therapeut
intervent
tissu
inflamm
result
show
seizur
induc
elev
express
vascular
adhes
molecul
enhanc
leukocyt
roll
arrest
brain
venul
mediat
leukocyt
mucin
pselectin
glycoprotein
integrin
interestingli
intravit
microscopi
studi
show
cell
preferenti
adher
inflam
brain
venul
seizur
suggest
adapt
immun
may
role
epilepsi
inhibit
leukocytevascular
interact
either
block
antibodi
mice
genet
defici
function
dramat
reduc
seizur
lead
signific
decreas
neuron
cell
loss
vascular
leakag
known
enhanc
neuron
excit
induc
acut
seizur
activ
prevent
blockad
leukocytevascular
adhes
suggest
pathogenet
link
leukocytevascular
interact
vascular
damag
seizur
gener
leukocyt
motil
behavior
insid
cn
parenchyma
neurolog
diseas
leukocyt
interact
neural
cell
larg
unknown
adhes
molecul
abl
bind
leukocyt
counterreceptor
previous
shown
upregul
neural
cell
inflammatori
condit
suggest
potenti
adhes
interact
immun
cell
neural
cell
leukocyt
traffick
follow
insid
cn
parenchyma
use
twophoton
microscopi
show
cell
migrat
insid
brain
parenchyma
seizur
particularli
cell
display
enhanc
abil
penetr
insid
brain
parenchyma
exhibit
remark
motil
aptitud
capac
interact
neural
structur
seizur
conclus
identif
molecular
mechan
control
vascular
inflamm
phenomena
leukocyt
motil
behavior
cellcel
contact
neural
cell
insid
cn
parenchyma
experiment
model
epilepsi
open
new
avenu
understand
neural
damag
immun
respons
epilepsi
help
identifi
new
therapeut
approach
abl
complement
exist
antiepilept
drug
carman
christoph
v
inflamm
challeng
integr
endothelium
format
micronscal
discontinu
could
defin
microwound
requir
heal
order
maintain
homeostasi
microwound
produc
either
paracellular
gap
result
endotheli
contract
respons
inflammatori
mediat
eg
histamin
thrombin
either
paracellular
gap
transcellular
pore
gener
diapedesi
inflammatori
leukocyt
mechan
poregap
resolut
ie
microwound
heal
remain
poorli
character
show
first
time
lamellipodiumlik
structur
form
explicitli
ventral
aspect
endothelium
rapidli
reseal
poresgap
preced
either
pore
constrict
reanneal
adher
junction
lead
edg
novel
ventral
lamellipodialik
structur
vl
exhibit
strong
enrich
actin
cortactin
nadph
oxidas
subunit
hydrogen
peroxid
small
molecul
domin
neg
construct
demonstr
vl
requir
signal
rac
cortactin
lesser
extent
rhoa
furthermor
noxspecif
inhibitor
ro
scaveng
also
robustli
revers
inhibit
vl
format
find
defin
reactiv
oxygen
speciesdepend
vl
activ
critic
determin
mainten
recoveri
endotheli
integr
immunotherapi
high
grade
glioma
hgg
innov
treatment
approach
enter
clinic
practic
promis
perspect
understand
mechan
immun
respons
open
strategi
improv
antitumor
immunotherapeut
effect
clinic
observ
welldesign
clinic
trial
add
evid
make
immunotherapi
part
standard
treatment
approach
patient
hgg
orthotop
mous
model
use
unravel
immun
respons
upon
dc
vaccin
dc
load
tumor
antigen
cell
demonstr
role
effector
memori
regulatori
treg
cell
found
tumor
enrich
myeloidderiv
suppressor
cell
howev
mdsc
suppress
case
treg
deplet
prior
tumor
inocul
treg
observ
also
patient
sampl
express
infiltr
lymphocyt
correl
express
demonstr
function
activ
treg
clinic
practic
use
autolog
matur
dendrit
cell
load
autolog
tumor
lysat
dcmhggl
boost
vaccin
perform
hggl
patient
relaps
hgg
treat
cohort
comparison
trial
hgg
adult
relaps
hgg
group
accord
adapt
rpa
classif
reflect
integr
risk
factor
pf
os
differ
class
significantli
differ
twoyear
surviv
adult
observ
class
iiv
patient
treatment
feasibl
without
major
side
effect
next
immunotherapi
integr
multimod
primari
treatment
pilot
adult
median
pf
os
os
subsequ
patient
first
diagnosi
hgg
grade
iv
enrol
median
pf
os
pf
os
patient
per
definit
rpa
class
iiiv
addit
valu
immunotherapi
compar
histor
control
signific
class
iii
iv
patient
therapi
feasibl
without
major
side
effect
preclin
research
continu
support
strategi
improv
immunotherapi
efficaci
confirm
prospect
random
doubl
blind
clinic
trial
approach
immun
modul
look
base
insight
obtain
preclin
model
glioblastoma
gbm
remain
uniformli
fatal
convent
therapi
limit
nonspecif
damag
normal
brain
system
tissu
inher
biolog
specif
immunolog
reactiv
could
meet
clear
need
specif
precis
therapi
howev
immunotherapi
thwart
lack
tumorspecif
target
inabl
gener
potent
antitumor
immun
respons
context
profoundli
immunosuppress
host
environ
year
work
address
limit
toward
end
other
identifi
sever
potenti
target
egfrviii
mutant
antigen
cytomegaloviru
peptid
vaccin
target
egfrviii
led
nearli
univers
gener
egfrviiispecif
immun
respons
erad
egfrviiiexpress
tumor
cell
appar
prolong
progressionfre
overal
surviv
mutat
target
immunolog
repres
parallel
paradigm
except
mutant
protein
express
surfac
tumor
cell
predilect
lower
grade
glioma
mutat
may
signific
implic
approach
mutat
immunotherapeut
other
reproduc
confirm
presenc
multipl
cmv
antigen
gbin
almost
patient
gbm
conduct
two
clinic
trial
target
antigen
patient
gbm
trial
abl
increas
immun
respons
base
tetram
analysi
induct
polyfunct
cell
respons
proven
difficult
patient
gbm
appear
immunolog
deficit
specif
believ
gener
specif
immunolog
deficit
identifi
patient
gbm
result
multipl
immunosuppress
pathway
shown
regulatori
cell
level
significantli
elev
patient
glioblastoma
level
cell
dramat
diminish
recent
identifi
dramat
abil
enhanc
immun
respons
temozolomideinduc
lymphodeplet
also
seen
temozolomid
actual
increas
regulatori
cell
level
shown
anim
human
studi
antibodi
deplet
regulatori
cell
result
associ
dramat
prolong
pf
patient
gbm
virtu
vice
youth
age
immun
gene
express
malign
glioma
highgrad
glioma
hgg
outcom
improv
substanti
last
year
despit
advanc
noncn
tumor
novel
research
clinic
paradigm
thu
need
develop
better
hgg
therapi
patient
age
outweigh
metric
predict
surviv
treatment
sensit
prognost
favor
gene
express
pattern
glioma
previous
show
agedepend
outcom
chemosensit
human
hgg
link
level
agesensit
cell
domin
antitumor
respons
follow
dendrit
cell
dc
vaccin
therapi
sinc
agedepend
outcom
chemosensit
link
pattern
gene
express
examin
role
antitumor
cell
gener
cell
particular
glioma
gene
express
malign
found
nascent
cell
level
correl
invers
worst
prognost
group
mesenchym
major
subclass
hgg
immun
respons
dc
vaccin
patient
abrog
agedepend
surviv
properti
confer
favor
prognost
group
proneur
rais
possibl
cell
activ
might
direct
alter
subclassspecif
gene
express
glioma
consist
hgg
subject
standard
therapi
upregul
mesenchym
gene
wherea
subject
dc
vaccin
upregul
nonmesenchym
gene
direct
support
direct
alter
glioma
gene
express
cell
murin
hgg
model
exhibit
select
downregul
mesenchym
gene
immun
resist
invas
upon
exposur
wildtyp
cell
link
downregul
subset
master
transcript
activ
mesenchym
gene
moreov
prolif
subclass
gene
upregul
chemosensit
upon
exposur
endogen
cell
wherea
distinct
gene
stemlik
properti
enhanc
upon
exposur
vaccineinduc
antitumor
cell
thu
favor
well
potenti
unfavor
chang
agerel
gene
express
associ
phenotyp
elicit
differ
strength
antitumor
cell
glioma
elucid
master
regul
genet
program
help
optim
therapeut
synergi
enhanc
vaccin
respons
increas
benefit
hgg
patient
context
immunotherapi
three
distinct
inflammatori
myopathi
current
distinguish
dermatomyos
dm
inclus
bodi
myositi
ibm
polymyos
pm
infiltr
dm
muscl
contain
b
cell
plasma
cell
plasmacytoid
dendrit
cell
pathogenet
mechan
perimysi
atrophi
patholog
hallmark
dm
remain
controversi
one
hypothesi
assum
endotheli
antibodi
andor
immun
complex
deposit
caus
capillari
injuri
lead
perimysi
atrophi
anoth
hypothesi
base
observ
sever
interferoninduc
gene
eg
interferonstimul
gene
strongli
upregul
dm
muscl
trigger
cascad
pathogen
chang
ibm
pm
mechan
muscl
fiber
injuri
seem
differ
dm
ibm
common
inflammatori
myopathi
adult
wherea
pure
pm
rare
pm
especi
ibm
clonal
expand
cell
invad
nonnecrot
muscl
fiber
strongli
express
mhc
class
antigen
use
laserassist
microdissect
put
pathogen
autoimmun
cell
resurrect
inflammatori
lesion
muscl
biopsi
tissu
reviv
cell
use
probe
search
unknown
target
antigen
special
case
gammadelta
cellmedi
myositi
strategi
recent
allow
molecular
identif
novel
autoimmun
target
motif
express
sever
protein
translat
apparatu
includ
sever
aminoacyltrna
synthetas
plenari
symposium
stem
cell
crossroad
neuroimmunolog
chair
g
martino
role
neural
stem
cell
brain
regener
inflamm
degener
usual
patholog
process
occur
central
nervou
system
cn
appar
distinct
process
soon
patholog
process
becom
chronic
tendenc
becom
strictli
interrel
primari
neurodegener
trigger
secondari
inflammatori
reaction
primari
inflammatori
reaction
lead
neurodegen
phenomena
sever
molecular
cellular
event
sustain
intrins
brain
repair
mechanismsoccur
within
cn
consequ
chronic
inflammatori
andor
degen
processeshav
describ
far
divid
three
distinct
categori
inflammationdriven
process
cn
plastic
neuro
glio
genesi
one
hand
humor
cellular
inflammatori
compon
shift
sens
function
time
tissuedamag
mode
mode
promot
tissu
repair
eg
neurotroph
support
inflammatori
cell
hand
recruit
altern
nondamag
function
neuron
pathwaysoccur
mainli
via
axon
branch
synaptogenesistak
place
consequ
brain
damag
whether
extent
recapitul
precis
development
pathway
underli
whole
phenomenon
brain
plastic
still
matter
investig
final
endogen
neural
stemprecursor
cell
npc
selfrenew
multipot
cell
cn
capabl
drive
neurogenesi
gliogenesi
adult
lifemay
adapt
target
migrat
damag
area
promot
repair
via
sever
mechan
action
eg
neuro
gliogenesi
immunomodul
neuroprotect
recent
evid
suggest
intrins
repair
mechan
appar
distinct
process
immunolog
development
cellular
event
aim
restor
tissu
integr
within
cn
strictli
interrel
npc
cross
road
interrel
phenomena
understand
relationship
repair
mechan
reason
fail
time
chronic
cn
disord
consid
way
develop
altern
therapeut
approach
promot
brain
repair
mesenchym
stem
cell
brain
repair
neural
differenti
realli
matter
uccelli
antonio
mesenchym
stem
cell
msc
heterogen
subset
stromal
stem
cell
isol
expand
ex
vivo
mani
adult
tissu
includ
bone
marrow
differenti
mesoderm
tissu
despit
potenti
transdifferenti
recent
data
suggest
msc
therapeut
potenti
due
mostli
signific
paracrin
effect
celltocel
interact
msc
shown
interact
cell
innat
adapt
immun
modul
function
upon
intraven
administr
experiment
autoimmun
encephalomyel
msc
rapidli
leav
blood
flow
migrat
lymph
node
injur
central
nervou
system
engraft
short
time
rapidli
vanish
despit
fast
clearanc
tissu
msc
administr
induc
immedi
state
immun
toler
exert
signific
neuroprotect
effect
promot
surviv
damag
cell
paracrin
mechan
therapeut
plastic
sustain
strike
immunomodulatori
antioxid
trophic
antiapoptot
activ
evid
differenti
neural
cell
due
strike
therapeut
featur
rel
simplic
grow
vitro
rel
safeti
aris
hematooncolog
studi
msc
chosen
incom
intern
treatment
multipl
sclerosi
patient
refractori
convent
therapi
immunolog
brain
intracrani
immun
cell
part
function
brain
link
physiolog
patholog
weizmann
institut
scienc
rehovot
israel
background
decad
central
nervou
system
cn
view
autonom
unit
preserv
behind
wall
shield
immun
cell
pathogen
present
circul
accordingli
local
inflamm
seen
brain
patholog
consid
major
contributor
diseas
progress
mitig
therefor
conundrum
system
antiinflammatori
drug
fall
short
neurodegen
diseas
result
found
cn
critic
depend
circul
immun
cell
support
provid
monocyt
selfreact
cell
normal
function
repair
breakdown
dialogu
brain
circul
immun
cell
may
occur
level
start
immun
cell
composit
circul
natur
number
immun
cell
recruit
cell
border
cn
phenotyp
acquir
recruit
cell
locat
time
arriv
within
cn
territori
defect
process
impact
cognit
perform
resili
stress
emerg
development
neuropsycholog
disord
onset
progress
neurodegen
diseas
repair
follow
acut
injuri
concept
unifi
role
immun
cell
healthi
brain
manifest
function
support
neurogenesi
express
brainderiv
neurotroph
factor
express
growth
factor
synapseassoci
protein
patholog
condit
well
explain
role
protect
autoimmun
propos
base
experiment
evid
dialogu
cn
tissu
circul
immun
cell
occur
healthi
brain
discret
compart
within
brain
territori
within
parenchyma
mediat
select
subpopul
circul
immun
cell
oper
control
brain
milieu
conclus
find
introduc
new
principl
brain
immunolog
hitherto
acknowledg
call
redefinit
brain
immun
privileg
site
suggest
potenti
immunebas
mean
intervent
support
recoveri
injuri
cope
stress
depress
age
neurodegen
condit
schwartz
shechter
mol
psychiatri
schwartz
shechter
nat
rev
neurol
jun
brainblood
barrier
mechan
involv
initi
cell
interact
bloodbrain
barrier
experiment
autoimmun
encephalomyel
vivo
sathiyanadan
karthik
coisn
carolin
engelhardt
britta
multipl
sclerosi
ms
anim
model
experiment
autoimmun
encephalomyel
eae
circul
immun
cell
gain
access
central
nervou
system
cn
caus
inflamm
bloodbrain
barrier
bbb
breakdown
demyelin
immun
cell
recruit
across
bbb
recogn
major
pathophysiolog
hallmark
ms
vitro
vivo
studi
highlight
predomin
role
play
integrin
cell
traffick
cn
direct
visual
multistep
interact
cell
noninflam
spinal
cord
white
matter
microcircul
mean
intravit
fluoresc
videomicroscopi
ivm
allow
us
demonstr
cell
interact
healthi
bbb
uniqu
due
lack
roll
predomin
involv
integrin
mediat
gprotein
independ
captur
subsequ
gprotein
depend
adhes
encephalitogen
cell
spinal
cord
microvascular
wall
contrast
eae
saw
although
integrin
still
critic
involv
mediat
cell
adhes
inflam
spinal
cord
microvessel
integrin
longer
requir
initi
cell
interact
inflam
spinal
cord
microvasculatur
initi
roll
captur
thu
eae
addit
adhes
mechan
becom
avail
inflam
bbb
mediat
initi
step
defin
integrin
independ
mechan
involv
cell
captur
roll
bbb
eae
observ
cell
interact
inflam
spinal
cord
microvasculatur
eae
ivm
function
absenc
number
differ
adhes
molecul
pselectin
data
allow
delin
integrin
independ
molecular
mechan
involv
cell
captur
roll
inflam
bbb
eae
vivo
evalu
vascular
adhes
express
multipl
sclerosi
brain
involv
diseas
pathogenesi
eae
aira
laura
langen
barbara
dost
rita
thua
matia
smith
david
turku
univers
hospit
turku
finland
bioti
therapi
corp
turku
finland
two
put
rout
exist
entri
lymphoid
cell
cn
initi
contact
immun
system
cn
suggest
take
place
via
vessel
choroid
plexu
wherea
second
wave
activ
cell
like
enter
via
stimul
cerebr
blood
vessel
vascular
adhes
endotheli
adhes
molecul
capabl
mediat
lymphocyt
bind
migrat
vascular
vessel
wall
site
inflamm
goal
studi
evalu
express
inflam
human
brain
role
experiment
autoimmun
encephalomyel
mous
express
multipl
sclerosi
ms
brain
control
brain
studi
immunohistochemistri
frozen
tissu
section
postmortem
brain
seven
ms
patient
four
control
patient
obtain
uk
multipl
sclerosi
tissu
bank
section
stain
express
level
evalu
count
number
vessel
differ
microscop
field
size
field
mm
mous
model
ms
experiment
autoimmun
enceph
eae
use
studi
function
role
develop
cn
inflamm
studi
ms
patient
spm
lesion
examin
chronic
activ
lesion
strong
express
mening
choroid
plexu
vessel
seen
ms
brain
control
brain
ms
brain
parenchyma
rang
vessel
control
brain
vesselsmm
averag
vesselsmm
ms
brain
wherea
control
brain
densiti
vessel
differ
statist
highli
signific
p
b
eae
target
antibodi
reduc
diseas
activ
strongli
express
choroid
plexu
mening
vessel
ms
brain
control
brain
ms
brain
parenchyma
preval
blood
vessel
increas
compar
control
brain
data
eae
experi
suggest
might
contribut
immunopathogenesi
ms
inflamm
mediat
chang
blood
spinalcord
barrier
bscb
permeabl
follow
sciatic
nerv
injuri
echeverri
stefania
wu
zhang
ji
peripher
nerv
lesion
trigger
altern
spinal
cord
microenviron
contribut
pathogenesi
neuropath
pain
neuron
glia
implic
function
chang
remain
larg
unexplor
whether
bloodspin
cord
barrier
bscb
also
involv
patholog
event
potenti
role
neuropath
pain
develop
goal
studi
examin
function
bscb
follow
peripher
nerv
injuri
possibl
underli
mechan
consequ
chang
bscb
alter
bscb
permeabl
examin
day
partial
ligat
left
sciatic
nerv
use
evan
blue
eb
index
eb
content
within
spinal
cord
parenchyma
significantli
increas
day
nerv
injuri
increas
permeabl
confirm
leakag
plasma
protein
igg
fibronectin
spinal
parenchyma
import
neurontoglia
signal
molecul
spinal
cord
nerv
injuri
intrathec
administr
evok
increas
eb
spinal
parenchyma
naiv
anim
similar
seen
anim
day
postinjuri
intrathec
treatment
antiinflammatori
cytokin
day
block
eb
extravas
induc
peripher
nerv
lesion
explor
role
inflammatori
mediat
bscb
function
inject
system
rat
observ
dose
depend
increas
eb
extravas
signific
intraven
inject
ng
cytokin
addit
observ
low
poster
session
dose
ng
circul
abl
cross
compromis
bscb
associ
nerv
injuri
provid
new
pathway
neuroimmun
interact
assess
structur
integr
bscb
level
tightjunct
protein
express
also
evalu
use
western
blot
final
mechan
thermal
hypersensit
develop
nerv
injuri
assess
time
point
day
close
tempor
correl
bscb
disrupt
initi
neuropath
pain
result
suggest
sciatic
nerv
injuri
impair
permeabl
bscb
phenomenon
like
mediat
nerv
injuri
associ
inflammatori
respons
find
highlight
import
inflamm
bscb
function
potenti
consequ
bscb
disrupt
develop
neuropath
pain
cerebr
microvascular
endotheli
cell
cmec
constitut
physiolog
barrier
central
nervou
system
cn
number
transmembran
protein
occludin
integr
constitu
tight
junction
tj
cmec
restrict
free
passag
molecul
blood
brain
bloodbrain
barrier
bbb
dysfunct
result
alter
cmec
phenotyp
major
hallmark
neuroinflammatori
diseas
multipl
sclerosi
cellular
factor
releas
activ
leukocyt
andor
brainresid
cell
eg
tnfa
ifng
alter
tj
organ
lead
increas
bbb
permeabl
cmec
facilit
leukocyt
infiltr
cn
parenchyma
investig
chang
pattern
gene
microrna
mir
express
induc
inflammatori
stimuli
immort
human
cerebr
microvascular
endotheli
cell
line
transcriptom
analysi
perform
use
illumina
human
microarray
basal
condit
transcript
indentifi
cell
treatment
tnfa
ifng
increas
mrna
level
gene
fold
highest
increas
fold
observ
chemokin
adhes
molecul
decreas
mrna
level
gene
fold
mani
associ
regul
tj
cytokineinduc
chang
mrna
level
correl
increas
endotheli
permeabl
associ
decreas
level
occludin
increas
adhes
monocyt
cell
jurkat
cell
line
monolay
hypothesis
mir
may
involv
fine
tune
brain
endotheli
inflammatori
respons
mir
express
profil
cytokineactiv
analys
use
agil
microarray
identifi
mir
upregul
downregul
differ
time
point
follow
inflammatori
stimuli
alter
mir
level
might
play
import
role
regul
cmec
phenotyp
ultim
lead
bbb
breakdown
current
investig
whether
modul
mir
level
transfect
specif
premir
antimir
affect
bbb
permeabl
andor
leukocyt
adhes
migrat
understand
molecular
mechan
lead
cytokineinduc
bbb
breakdown
might
constitut
import
strategi
develop
new
therapeut
target
neuroinflammatori
disord
nascent
multipl
sclerosi
lesion
associ
earli
disturb
bloodbrain
barrier
alvarez
jorg
godschalk
alisha
terouz
simon
prat
alexandr
earli
chang
normal
appear
white
matter
multipl
sclerosi
ms
patient
preced
appear
gadoliniumenhanc
lesion
brain
magnet
reson
imag
mri
scan
although
mri
studi
suggest
breakdown
bloodbrain
barrier
bbb
import
featur
ms
pathogenesi
limit
inform
avail
patholog
chang
occur
bbb
lesion
genesi
henc
work
design
studi
differenti
chang
bbb
compon
particularli
earli
stage
lesion
format
ms
lesion
n
donor
categor
nascent
activ
chronic
activ
chronic
inact
section
immunostain
distinct
cellular
marker
gfap
bbb
disrupt
determin
evalu
express
pattern
fibrinogen
laminin
gfap
junction
protein
occludin
vecadherin
acatenin
addit
correl
bbb
disrupt
endotheli
activ
express
cell
adhes
molecul
cam
alcam
studi
nascent
lesion
display
moder
leukocyt
infiltr
limit
demyelin
moder
gliosi
discret
basement
membran
protein
abnorm
consider
chang
express
junction
protein
increas
express
cam
bbb
junction
protein
basement
membran
compon
sever
disrupt
activ
lesion
compar
nascent
lesion
express
pattern
junction
compon
partial
reestablish
chronic
activ
inact
lesion
patholog
find
indic
presenc
earli
disturb
express
junction
cam
basement
membran
protein
level
bbb
nondemyelin
ms
specimen
earli
vascular
chang
coincid
perivascular
immun
cell
infiltr
bring
patholog
support
import
bbb
disrupt
first
stage
lesion
format
ms
prior
demyelin
netrin
regul
bloodbrain
barrier
function
podjaski
cornelia
lebeurri
nathali
antel
jack
p
microvasculatur
central
nervou
system
complex
highli
structur
order
maintain
proper
brain
function
specialis
endothelium
gener
highli
select
dynam
physic
bloodbrainbarri
bbb
small
number
factor
regul
barrier
function
identifi
sever
studi
show
netrin
express
endotheli
cell
contribut
embryon
develop
vasculatur
hypothesis
netrin
best
known
axon
guidanc
cue
express
endotheli
cell
ec
human
adult
bbb
govern
regulatori
function
bbb
screen
primari
human
brainderiv
endotheli
cell
bbbec
netrin
netrin
receptor
express
quantit
real
time
pcr
demonstr
bbbec
express
multipl
netrin
netrinreceptor
netrin
express
regul
differenti
barrierpromot
astrocyt
destabil
condit
tumor
necrosi
factor
alpha
netrin
express
confirm
western
blot
immunochemistri
coloc
microvasculatur
adult
human
brain
section
function
signific
netrin
bbb
determin
character
express
tight
junction
molecul
evalu
diffus
tracermolecul
use
vitro
transwel
model
bbb
netrintreat
promot
function
decreas
bbbpermeabl
upregul
tight
junction
molecul
summari
netrin
receptor
express
special
brain
microvasculatur
regul
junction
complex
control
bloodbrain
barrier
permeabl
propos
netrin
novel
bbb
regulatori
molecul
import
mainten
properli
function
bbb
role
angiotensin
ii
receptor
control
bbb
integr
macrophag
entri
brain
laila
groth
rasmussen
maria
tofthansen
henrik
khorooshi
reza
owen
trevor
bloodbrain
barrier
bbb
complex
endotheli
glial
barrier
control
passag
cell
solut
blood
central
nervou
system
cn
interest
whether
reninangiotensinsystem
involv
bbb
breakdown
express
type
angiotensin
receptor
astrocyt
increas
hippocampu
dentat
gyru
mice
stereotact
transect
entorhin
affer
systemicallyappli
candesartan
block
receptor
led
increas
macrophag
infiltr
dentat
gyru
day
axon
transect
tcell
infiltr
known
increas
lesion
affect
blockad
discern
effect
microgli
astrogli
respons
induct
bbb
breakdown
horseradish
peroxidas
hrp
leakag
chang
express
chemokin
known
control
leukocyt
entri
system
correl
increas
macrophag
entri
also
studi
type
angiotensin
receptor
use
two
model
brain
inflamm
distinguish
solut
versu
cellular
barrier
function
leukocyt
hrp
accumul
perivascular
space
transgen
mice
express
chemokin
cn
indic
select
endotheli
effect
cellular
infiltr
hrp
leakag
across
glia
limitan
parenchyma
induc
pertussi
toxin
treatment
contrast
detect
hrp
leakag
hippocampu
dentat
gyru
transect
axon
affer
despit
leukocyt
infiltr
site
immunoreact
increas
glia
limitan
astrocyt
pertussi
toxintr
wherea
immunostain
induc
lesionreact
dentat
gyru
result
suggest
control
bbb
integr
leukocyt
entri
brain
influenc
macrophag
infiltr
wherea
induct
correl
solut
leakag
rather
cellular
infiltr
tetinduc
express
brain
endothelium
reduc
edema
format
clinic
diseas
anim
model
multipl
sclerosi
engelhardt
britta
pfeiffer
friederik
julia
tauber
silk
deutsch
urban
theodor
kocher
institut
univers
bern
bern
switzerland
experiment
autoimmun
encephalomyel
eae
anim
model
multipl
sclerosi
leukocyt
migrat
across
bloodbrain
barrier
bbb
caus
central
nervou
system
cn
inflamm
edema
format
contribut
disabl
clinic
pictur
diseas
paracellular
permeabl
bbb
regul
level
complex
tight
junction
tj
concert
action
seem
maintain
tj
integr
eae
loss
bbb
tj
correl
cellular
infiltr
focal
bbb
leaki
leukocyt
diapedesi
leav
tj
morpholog
intact
hypothes
modul
tj
integr
affect
immun
cell
recruit
across
bbb
eae
may
control
edema
format
establish
transgen
mous
model
allow
tetinduc
endotheli
cellspecif
express
absent
tj
cn
parenchym
microvessel
sever
chronic
eae
significantli
reduc
doubl
transgen
mice
compar
singl
transgen
control
mice
immunofluoresc
analysi
brain
spinal
cord
section
mice
chronic
eae
reveal
express
tetinduc
bbb
influenc
number
size
cellular
infiltr
within
cn
rather
vascular
permeabl
found
significantli
reduc
around
cn
microvessel
tetinduc
find
show
tetinduc
reseal
bbb
tj
cn
autoimmun
inflamm
taken
togeth
studi
demonstr
possibl
mediat
reseal
bbb
junction
inflamm
suggest
claudin
good
therapeut
target
control
bbb
permeabl
cn
autoimmun
inflamm
studi
adhes
molecul
via
novel
modifi
migrat
assay
model
bloodbrain
barrier
loss
bloodbrain
barrier
bbb
integr
associ
increas
traffick
leukocyt
central
nervou
system
cn
hallmark
multipl
sclerosi
ms
howev
mechan
cell
gain
access
cn
still
fulli
understood
previou
report
shown
bbb
dysfunct
associ
upregul
cell
adhes
molecul
cam
selectin
integrin
member
immunoglobulin
famili
allow
reciproc
attach
bloodborn
leukocyt
bbb
endotheli
cell
bbbec
crucial
step
infiltr
cell
order
better
understand
molecular
mechan
underli
recruit
transmigr
immun
cell
cn
develop
new
vitro
model
human
bbb
allow
research
novel
cam
model
consist
modifi
migrat
assay
human
immun
cell
migrat
occur
across
human
primari
cultur
bbbec
hbbbec
pressurecontrol
flow
adequ
recapitul
vivo
condit
migrat
experi
perform
use
differ
cam
ligandsantibodi
combin
immun
cell
abil
cell
adher
hbbbec
veloc
assess
use
volocitytm
softwar
abl
corrobor
import
recruit
lymphocyt
across
human
bbbec
found
increas
veloc
diminut
adhes
cell
follow
blockad
latter
combin
addit
explor
influenc
new
cam
melanoma
cell
adhes
molecul
activ
leukocyt
cell
adhes
molecul
well
adhes
migrat
lymphocyt
monocyt
across
brain
endothelium
data
show
increas
veloc
reduct
adhes
monocyt
follow
steric
inhibit
mcam
preliminari
data
use
antibodi
neutral
reveal
increas
veloc
human
cell
min
flow
condit
new
experiment
human
dynam
setup
allow
us
studi
role
human
cam
migrat
specif
immun
cell
subset
system
allow
us
studi
new
potenti
therapeut
target
block
entri
specif
human
immun
cell
across
hbbbec
order
reduc
neuroinflammatori
process
multipl
sclerosi
ms
demyelin
diseas
acut
chronic
inflamm
associ
glial
scar
neuroaxon
damag
earli
phase
diseas
inflamm
caus
mononuclear
cell
infiltr
central
nervou
system
promin
patholog
featur
cannabinoid
system
consist
endogen
endocannabinoid
exogen
natur
synthet
cannabinoid
receptor
enzym
cannabinoid
mediat
physiolog
effect
basic
activ
specif
receptor
cannabinoid
receptor
mainli
express
cn
cannabinoid
receptor
express
predominantli
immun
cell
accord
rank
order
b
cell
n
nk
cell
n
monocyt
n
polymorphonuclear
leukocyt
n
cell
mani
data
suggest
exogen
cannabinoid
might
benefici
treatment
ms
symptom
like
spastic
tremor
ataxia
bladder
control
pain
beyond
symptomat
relief
increas
bodi
evid
support
involv
cannabinoid
system
immunosuppress
neuroprotect
consid
import
immun
respons
ms
extens
express
immun
cell
possibl
exist
cannabinoid
system
might
regul
part
extent
immun
respons
cn
peripheri
would
mediat
modul
autoreact
cell
via
investig
decid
examin
use
realtim
quantit
pcr
express
pattern
immun
cell
patient
activ
ms
well
effect
interferon
beta
therapi
express
show
differenti
express
b
nk
cell
report
although
rank
order
express
cell
popul
similar
patient
healthi
control
ms
patient
increas
express
b
nk
cell
compar
control
furthermor
observ
interferon
beta
therapi
induc
signific
progress
decreas
express
cell
differenti
express
mrna
ms
patient
point
relev
role
cannabinoid
system
immun
respons
diseas
better
understand
cannabinoid
system
particular
might
result
develop
new
drug
therapeut
potenti
ms
consequ
immun
complex
format
brain
pathogen
antibodi
exist
sever
neuropatholog
condit
littl
inform
exist
infiltr
brain
initi
cn
tissu
damag
antibodi
mediat
cell
death
either
direct
signal
recruit
cytotox
effector
cell
via
fc
receptor
fcr
complement
activ
develop
novel
mous
model
character
antibodymedi
inflamm
brain
investig
underli
mechan
neurolog
complic
mediat
antibodi
balbc
mice
immun
ovalbumin
ova
follow
intracerebr
ova
challeng
braintissu
analyz
immunohistochemistri
presenc
immun
complex
inflamm
fcg
chain
defici
mice
use
studi
role
fcr
complement
antibodymedi
brain
inflamm
inflammatori
respons
characterist
immun
complex
detect
inject
site
around
blood
vessel
within
cortex
mening
increas
express
sever
macrophag
microgli
activ
marker
neutrophil
activ
detect
brain
inflammatori
respons
absent
fc
defici
mice
defici
mice
differ
wild
type
mice
apart
histopatholog
chang
detect
week
show
immun
complex
induc
transient
neurobehaviour
chang
reactiv
follow
system
inflamm
also
found
increas
microglia
activ
express
fcr
particular
fcriv
increas
level
igg
brain
mice
chronic
neurodegener
lupu
experiment
acut
enceph
result
show
immun
complex
form
brain
induc
inflamm
behaviour
chang
initi
fcr
therefor
addit
direct
attack
neuron
cell
brainspecif
auto
antibodi
recruit
activ
microglia
activ
fcr
result
releas
proinflammatori
cytokin
induc
neuron
damag
observ
import
implic
use
therapeut
antibodi
exampl
antiabeta
possibl
explain
side
effect
observ
anim
model
clinic
trial
propos
immun
senesc
ageassoci
restructur
chang
immun
function
particip
rate
age
modul
oxiinflammag
moreov
agerel
chang
immun
system
biolog
age
marker
predictor
longev
gender
differ
oxid
statu
immun
function
observ
rat
male
show
higher
oxid
immun
senesc
femal
age
estrogen
sex
hormon
activ
particip
modul
mammalian
immun
function
therefor
agerel
impair
immun
respons
drastic
acceler
femal
menopaus
transit
ovariectomi
rodent
constitut
good
model
mimick
human
estrogen
loss
thu
menopaus
situat
recent
shown
deleteri
effect
estrogen
loss
sever
function
leukocyt
immun
organ
rat
mice
addit
ovariectom
rat
show
similar
level
immun
function
male
aim
present
work
studi
mous
periton
macrophag
lymphocyt
old
sham
ovariectom
femal
well
male
age
sever
function
well
inflammatori
oxid
stress
paramet
follow
paramet
studi
chemotaxi
phagocytosi
intracellular
ro
level
lymphocyt
prolifer
respons
mitogen
secret
natur
killer
cytotox
antioxid
defenc
reduc
glutathion
gsh
level
glutathion
peroxidas
activ
oxid
oxid
glutathion
gssg
gssggsh
ratio
lipid
peroxid
damag
result
show
femal
higher
immun
respons
lower
oxid
inflamm
male
appear
similar
male
paramet
studi
lost
estrogen
ovariectomi
thu
data
support
posit
role
estrogen
immun
function
age
process
financi
support
mcinn
ucm
research
group
reticef
old
mice
treat
puls
highenergi
potentialvortic
improv
behavior
immun
cell
function
paramet
reach
similar
level
adult
anim
puls
highenergi
potentialvortic
nanopuls
sinc
produc
natur
thunderstorm
lightn
suppli
cell
energi
thu
affect
mani
cellular
physiolog
function
although
antiinflammatori
analges
action
nanopuls
known
effect
immun
function
behavior
especi
regard
age
process
yet
unclear
age
consequ
oxid
inflamm
stress
affect
cell
special
nervou
immun
system
recent
propos
immun
senesc
involv
rate
age
sever
immun
function
marker
biolog
age
aim
present
work
studi
possibl
posit
effect
special
nanopuls
treatment
possibl
technolog
medic
instrument
sever
behavior
immun
function
paramet
old
mice
three
group
femal
mice
use
group
old
mice
month
age
old
treat
group
ot
receiv
session
nanopuls
frequenc
pulsesmin
min
twice
week
week
use
anoth
group
old
mice
given
handl
receiv
treatment
old
control
group
oc
group
adult
mice
month
use
age
control
week
anim
perform
explor
test
tmaze
behavior
test
vertic
activ
percentag
anim
perform
rear
number
rear
horizont
activ
exploratori
effici
analyz
periton
suspens
obtain
phagocytosi
capac
macrophag
level
superoxid
anion
prolifer
capac
lymphocyt
basal
respons
mitogen
antitumor
nk
activ
studi
result
show
improv
ot
mice
exploratori
paramet
respect
oc
anim
moreov
immun
function
studi
improv
reach
valu
similar
obtain
adult
mice
conclus
treatment
special
nanopuls
seem
good
strategi
improv
nervou
immun
system
old
mice
sinc
immun
function
studi
marker
health
biolog
age
predictor
longev
treatment
could
use
maintain
younger
biolog
age
consequ
better
longer
longev
thank
mr
f
pricci
pulsartec
slu
financi
support
reticef
viscer
leishmaniasi
vl
anthropozoonosi
caus
parasit
protozoan
leishmania
donovani
complex
studi
focus
neurolog
manifest
leishmania
infect
dog
report
sign
gener
central
nervou
system
cn
involv
microglia
consid
first
line
defenc
within
cn
stimul
inflammatori
mediat
becom
activ
activ
microglia
identifi
morpholog
pattern
relat
chang
immunophenotyp
function
twenti
mixedbre
adult
dog
select
control
zoonosi
center
paulo
state
brazil
endem
area
vl
sampl
nervou
tissu
cerebrospin
fluid
csf
dog
posit
diagnosi
vl
assess
elisa
parasitolog
test
infect
group
n
dog
neg
diagnosi
control
group
n
collect
csf
titer
antileishmania
antibodi
detect
elisa
brain
sampl
store
buffer
formalin
submit
identif
microgli
cell
use
lectinhistochemistri
microgli
reactiv
observ
light
microscopi
quantifi
use
softwar
imagepro
plu
signific
differ
group
determin
student
test
welch
correct
valu
p
b
consid
statist
signific
infect
group
present
higher
level
antibodi
titer
csf
control
group
p
concern
microgli
reactiv
signific
differ
infect
control
group
detect
p
b
infect
group
microgli
cell
subependym
area
intens
detect
cortic
area
p
posit
correl
microglia
antibodi
titer
detect
p
perivascular
cell
includ
microglia
act
interfac
blood
brain
bring
inflammatori
stimuli
peripheri
presenc
circul
antibodi
within
nervou
milieu
may
activ
microglia
contribut
establish
inflammatori
process
describ
immun
degen
diseas
cn
result
present
herein
indic
proinflammatori
statu
brain
strongli
suggest
microgli
involv
pathogenesi
brain
lesion
associ
viscer
leishmaniasi
dog
human
apolipoprotein
e
apo
glycoprotein
three
isoform
experiment
autoimmun
neuriti
ean
anim
model
syndrom
immunemedi
experiment
disord
pn
increas
suscept
ean
apo
ko
mice
previous
found
elucid
isoformdepend
effect
apo
ean
use
human
apo
transgen
tg
mice
immun
peptid
induc
ean
along
macrophag
cultur
cell
prolifer
test
flow
cytometri
elisa
etc
investig
effect
apo
isoform
function
macrophag
cell
naiv
condit
ean
clinic
sign
ean
cours
sever
mice
tg
mice
follow
tg
mice
least
sever
tg
mice
wt
n
n
p
b
nadir
either
spleen
weight
mix
cell
prolifer
test
stimul
peptid
interleukin
il
line
clinic
sever
ean
prolifer
test
purifi
naiv
cell
stimul
cona
show
isoformspecif
differ
wt
n
p
b
macrophag
naiv
ean
mice
produc
nitric
oxid
upon
inflammatori
stimul
lp
ifn
poli
c
combin
thereof
isoformdepend
manner
wt
n
n
p
b
furthermor
gener
intervent
w
specif
induc
nitric
oxid
synthas
ino
inhibitor
could
significantli
suppress
clinic
cours
ean
wt
mice
well
human
tg
mice
preliminari
data
support
subtypedepend
effect
apo
ean
might
due
isoformspecif
effect
apo
macrophag
function
andor
cell
function
contribut
distinct
clinic
sever
ean
cannabi
compound
cannabinoid
shown
exert
antiinflammatori
activ
certain
experiment
model
inflammatori
cn
degen
diseas
main
obstacl
clinic
applic
materi
psychoact
properti
evalu
effect
nonpsychoact
cannabinoid
cannabidiol
cbd
myelin
oligodendrocyt
glycoprotein
mog
induc
eae
murin
model
multipl
sclerosi
ms
determin
mechan
underli
properti
specif
microgli
cell
observ
peripher
given
cbd
administ
time
diseas
onset
amelior
clinic
eae
symptom
evalu
use
behavior
patholog
score
histochem
analysi
spinal
cord
moginject
eae
mice
treat
cbd
vs
mogonli
treat
mice
reveal
cbd
regul
infiltr
prolifer
stain
activ
stain
macrophag
microglia
spinal
cord
white
matter
use
mous
microgli
cell
line
lipopolysaccharid
induc
inflammatori
respons
screen
intracellular
mechan
might
involv
cbd
antiinflammatori
activ
observ
cbd
decreas
releas
interleukin
il
proinflammatori
cytokin
activ
microgli
cell
cbd
inhibit
activ
proinflammatori
transcript
factor
upregul
factor
element
homeostat
mechan
induc
antiinflammatori
event
conclus
observ
cbd
exert
antiinflammatori
activ
vivo
use
eae
model
ms
well
vitro
use
microgli
cell
activ
may
mediat
via
stat
depend
pathway
relat
prolong
stress
develop
psychiatr
disord
depress
anxieti
well
establish
ader
cohen
given
role
hpa
axi
depress
recent
work
miller
et
al
suggest
critic
role
endocannabinoid
system
regul
aim
present
work
studi
effect
restraint
stress
neuroimmunoendocrin
behavior
endocannabinoid
paramet
restraint
stress
appli
adult
spraguedawley
rat
two
hour
daili
consecut
day
behavior
test
open
field
elev
plu
maze
blood
sampl
collect
hippocampi
dissect
total
mrna
protein
level
analyz
real
time
pcr
western
blot
respect
result
show
stress
anim
increas
cannabinoid
receptor
type
total
mrna
protein
level
hippocampu
oxytocin
corticosteron
plasma
level
increas
well
adren
gland
weight
also
anim
show
reduc
habitu
open
field
test
chang
anxieti
paramet
find
suggest
possibl
interact
neuroimmunoendocrin
endocannabinoid
system
present
stress
paradigm
bidocrar
cognitiveenhanc
antidepress
effect
chronic
celecoxib
memantin
treatment
obx
rat
model
alzheim
diseas
borr
yuliya
lemstra
susan
oost
ronald
olivi
berend
utrecht
univers
utrecht
netherland
immun
dysfunct
play
role
pathogenesi
variou
neurodegen
disord
increas
proinflammatori
cytokin
alzheim
diseas
ad
associ
cognit
deficit
depress
symptom
remov
olfactori
bulb
obx
laboratori
rat
lead
longlast
behavior
neurochem
chang
deficit
learn
memori
obx
may
model
certain
aspect
ad
obx
report
elev
level
proinflammatori
cytokin
use
studi
relationship
immun
dysfunct
behavioralcognit
abnorm
present
studi
obx
use
assess
whether
chronic
celecoxib
memantin
administr
start
presurgeri
would
preventdelay
abnorm
behavior
cognit
develop
pharmacolog
effect
antidementia
drug
memantin
uncompetit
nmda
receptor
antagonist
celecoxib
inhibitor
evalu
obx
induc
cognit
impair
chronic
administr
memantin
mgkg
celecoxib
mgkg
start
day
obx
surgeri
continu
week
attenu
passiv
avoid
pa
memori
deficit
normal
hyperact
open
field
associ
obx
yet
effect
spatial
memori
measur
holeboard
test
week
treatment
cessat
celecoxib
treat
obx
anim
still
show
improv
pa
memori
comparison
obx
treat
vehicl
sham
oper
control
peripher
interleukin
level
measur
variou
time
point
post
chronic
drug
administr
possibl
mechan
celecoxib
memantin
improv
pa
memori
hyperact
obx
rat
may
result
suppress
inflamm
normal
glutamaterg
system
celecoxib
found
reduc
blood
brain
concentr
decreas
blood
level
result
attenu
pa
memori
deficit
normal
hyperact
mediat
obx
memantin
antagonist
properti
diminish
sustain
increas
extracellular
glutam
level
may
result
cognit
protect
prevent
patholog
microgli
activ
find
suggest
pharmacolog
intervent
earli
phase
neuroinflamm
develop
rescu
behavior
cognit
abnorm
also
slow
progress
cognit
impair
idiopath
intracrani
hypertens
iih
neurolog
condit
whose
aetiolog
unknown
factor
thought
contribut
rais
intracrani
pressur
includ
oversecret
impair
absorpt
cerebrospin
fluid
csf
studi
investig
composit
csf
iih
condit
commonli
use
noninflammatori
control
show
find
may
challeng
assumpt
noninflamm
compar
cytokin
csf
patient
iih
patient
neurolog
diseas
includ
multipl
sclerosi
ms
inflammatori
neurolog
diseas
chronic
inflammatori
demyelin
polyneuropathi
cidp
neurosarcoidosi
function
ill
use
combin
multiplex
array
elisa
cytokin
chosen
suggest
import
cell
differenti
function
focuss
treg
cell
csf
significantli
elev
iih
popul
compar
ms
function
group
interferongamma
also
significantli
higher
iih
group
ms
group
howev
significantli
lower
iih
group
compar
neuroinflamm
group
cidp
neurosarcoidosi
signific
differ
seen
group
level
tumour
necrosi
factoralpha
transform
growth
factorbeta
osteopontin
compar
posit
correl
seen
level
certain
cytokin
csf
includ
interferongamma
interferongamma
unclear
whether
dysregul
cytokin
iih
csf
causal
consequ
rais
intracrani
pressur
howev
rais
interest
question
possibl
pathogen
mechan
whether
target
inflamm
may
fact
futur
treatment
potenti
disabl
condit
increas
studi
shown
patient
diabet
mellitu
increas
risk
cognit
impair
dementia
neurodegener
inflamm
recogn
promin
featur
patholog
diabet
mellitu
alzheim
diseas
present
studi
design
evalu
effect
danshensu
diabetesassoci
learn
memori
declin
mice
diabet
induc
singl
intraperiton
inject
streptozotocin
mgkg
bodi
weight
mice
anim
blood
glucos
level
exceed
mmoll
select
diabet
mice
mice
administ
danshensu
dose
mgkg
intragastr
administr
day
week
continu
afterward
effect
danshensu
diabetesassoci
learn
memori
declin
mice
investig
evalu
mean
escap
latenc
time
spent
target
quadrant
tnfa
content
acetylcholinesteras
activ
level
hippocampu
assay
western
blot
use
analyz
express
ino
result
show
diabet
mellitu
induc
signific
learn
memori
declin
administr
danshensu
dose
mg
kg
reduc
mean
escap
latenc
also
increas
spent
time
target
quadrant
furthermor
danshensu
decreas
acetylcholinesteras
activ
tnfa
level
hippocampu
compar
diabet
group
express
ino
significantli
decreas
danshensu
group
studi
demonstr
danshensu
could
attenu
diabetesassoci
learn
memori
declin
mice
mechan
may
relat
antiinflammatori
action
danshensu
common
phenotyp
multipl
sclerosi
ms
relapsingremit
rr
form
characteris
recurr
acuteonset
episod
neurolog
dysfunct
follow
complet
partial
recoveri
longterm
prognosi
rrm
usual
unfavour
sinc
patient
enter
socal
secondari
progress
sp
phase
diseas
accumul
irrevers
neurolog
disabl
differ
diseas
pattern
primari
progress
pp
ms
seen
patient
show
progress
cours
onset
even
rarer
form
diseas
call
benign
ms
bm
latter
case
absent
minim
neurolog
impair
mani
year
diseas
onset
cours
rrm
appear
larg
driven
inflammatori
process
convers
neurodegener
least
part
develop
independ
inflamm
drive
chronic
brain
injuri
patient
pp
spm
antiinflammatori
therapi
immun
modul
shown
benefici
effect
rrm
patient
discrep
could
explain
differ
pathogenet
mechan
act
differ
diseas
phenotyp
investig
immunolog
correl
divers
diseas
manifest
attempt
clarifi
pathogenesi
ms
thu
perform
extens
immunophenotyp
function
analys
mbpstimul
lymphocyt
bm
rrm
spm
ppm
patient
compar
result
obtain
group
healthi
control
hc
result
show
trascript
factor
cytokin
associ
activ
cell
significantli
upregul
rr
spm
patient
wherea
ppm
associ
increas
marker
alon
thu
mbpstimul
well
rorg
upregul
rr
spm
tbet
upregul
ppm
interestingli
signific
differ
observ
bm
compar
hc
data
herein
reinforc
pivot
role
inflamm
pathogenesi
ms
first
time
show
differ
pattern
diseas
associ
activ
differ
helper
cell
subset
offer
explan
biolog
clinic
peculiar
ppm
vs
distinct
macrophag
subset
diverg
phenotyp
function
properti
murin
brain
abscess
richter
lydia
held
josephin
alexandra
meisen
michael
heppner
frank
l
stenzel
werner
macrophag
activ
call
classic
altern
pathway
give
rise
least
two
differ
phenotyp
differ
function
properti
interferon
gammainduc
classic
activ
macrophag
main
effector
cell
acut
infect
bactericid
function
via
product
reactiv
oxygen
speci
macrophag
primarili
hostprotect
properti
collater
damag
within
certain
organ
certain
situat
may
also
detriment
hand
helper
cell
abl
induc
altern
pathway
macrophag
activ
via
product
theoret
reduc
excess
inflamm
macrophag
studi
intens
chronic
fungal
worm
parasit
induc
diseas
knowledg
never
studi
bacteri
infect
cn
use
wellestablish
model
murin
brain
abscess
promin
acut
phase
character
sever
cerebr
sepsislik
ill
follow
chronic
heal
phase
format
fibrou
capsul
delimit
process
border
healthi
cn
tissu
earli
phase
diseas
macrophag
promin
coexpress
ino
marker
altern
activ
late
phase
macrophag
coexpress
weak
ino
produc
result
confirm
mrna
level
capsul
format
subsequ
upregul
evid
collagen
vi
fibroblast
maxim
day
show
differ
macrophag
subset
distinct
function
properti
activ
brain
abscess
develop
heal
probabl
broad
spectrum
macrophag
divers
accord
immunolog
necess
explor
mechan
axon
neuron
damag
caus
cell
chevali
gregoir
suberbiel
elsa
liblau
roland
gonzalezdunia
daniel
inserm
centr
de
physiopathologi
de
toulous
purpan
toulous
franc
cytotox
cell
ctl
increasingli
recogn
key
player
variou
neuroinflammatori
neurodegen
diseas
multipl
sclerosi
rasmussen
enceph
alzheim
diseas
ctl
believ
contribut
neuron
damag
diseas
although
precis
contribut
remain
unclear
inde
possibl
neuron
could
repres
target
ctl
still
controversi
part
due
pauciti
major
histocompat
complex
mhc
class
express
neuron
therefor
better
understand
mechan
underli
neuron
axon
attack
ctl
much
want
object
bring
new
inform
mechan
neuron
injuri
caus
ctl
address
question
use
model
cellmedi
neuroinflamm
induc
neurotrop
borna
diseas
viru
bdv
ctl
ex
vivo
purifi
brain
bdvinfect
anim
coincub
primari
cultur
cortic
neuron
infect
bdv
assess
dynam
consequ
ctl
interact
neuron
use
livecel
imag
timelaps
microscopi
techniqu
observ
bdv
infect
induc
mhc
class
express
neuron
render
suscept
ctl
attack
upon
incub
infect
neuron
ex
vivo
ctl
mobil
dramat
reduc
mhc
class
idepend
manner
suggest
specif
interact
neuron
analysi
use
calcein
stain
reveal
chang
neuron
permeabl
within
minut
ctl
contact
surprisingli
neuron
appear
resist
quit
well
initi
ctl
contact
sinc
activ
detect
h
coincub
moreov
record
electr
activ
use
microelectrod
array
mea
reveal
neuron
network
remain
function
activ
period
taken
togeth
data
suggest
dynam
ctlneuron
interact
may
quit
differ
classic
ctl
target
aim
project
character
vitamin
influenc
inflammatori
cell
mediat
multipl
sclerosi
ms
emphasi
epigenet
regul
gene
hla
complex
recent
data
indic
high
level
sunlight
vitamin
protect
ms
howev
known
protect
function
molecular
basi
sever
data
implic
epigenet
chang
mediat
influenc
vitamin
ms
rat
fed
special
diet
without
vitamin
subsequ
eae
anim
model
ms
induc
lymphnod
harvest
methyl
dna
purifi
use
methyl
dna
immunoprecipit
medip
differ
methyl
pattern
hla
complex
gene
genomewid
assess
hybrid
dna
promotor
cpg
specif
array
data
confirm
use
rtpcr
differenti
methyl
gene
subsequ
valid
human
ms
sampl
epigenet
modif
shown
revers
exampl
defici
folat
lead
genom
hypomethyl
caus
open
neural
tube
defect
howev
folat
therapi
restor
normal
methyl
pattern
revers
epigenet
modif
valuabl
ms
prevent
possibl
therapi
sever
diseas
vitamin
establish
main
environment
trigger
ms
supplementari
administr
vitamin
could
reduc
risk
develop
ms
especi
countri
low
level
winter
sunlight
sweden
therefor
elucid
molecular
mechan
follow
epigenet
chang
occur
vitamin
defici
vitro
anim
model
lead
new
therapeut
approach
cure
ms
patient
genet
determin
betachemokin
express
regul
neuroinflamm
rat
ms
believ
autoimmun
diseas
trigger
unspecif
environment
factor
genet
suscept
individu
therefor
approach
aim
identif
natur
occur
genet
variant
predispos
diseas
pinpoint
causal
candid
gene
investig
basic
inflammatori
mechan
earli
stage
neuroinflamm
perpetu
diseas
congen
rat
strain
dapvgccl
natur
occur
genet
variant
predispos
regul
neuroinflamm
backcross
popul
betachemokin
cluster
implic
underli
genet
caus
one
major
eaeregul
qtl
design
initi
identifi
daxaci
cross
furthermor
sever
ms
studi
show
evid
associ
diseas
initi
result
confirm
display
less
sever
diseas
respons
mog
immun
experi
minim
congen
dapvgccl
compris
indic
effect
map
chemokin
cluster
furthermor
express
chemokin
lymph
node
day
immun
correl
genotyp
locu
indic
genet
variant
chemokin
partial
govern
express
level
associ
studi
scandinavian
materi
show
evid
associ
ms
higher
level
demonstr
csf
ms
patient
compar
control
classic
hypothesisdriven
research
focus
investig
molecul
distinguish
differ
regard
molecul
caus
consequ
diseas
process
togeth
diseas
heterogen
complex
could
account
slow
progress
treatment
develop
accordingli
approach
aim
identif
diseaseregul
gene
provid
primari
candid
mechan
might
suitabl
target
drug
develop
genomewid
profil
micro
rna
associ
suscept
experiment
neuroinflamm
bergman
petra
gillett
alan
goga
supic
larsson
kristina
kvist
ander
jagod
maja
karolinska
intitutet
stockholm
sweden
uppsala
univers
uppsala
sweden
lund
univers
lund
sweden
dysregul
express
micro
rna
mirna
variou
tissu
associ
varieti
diseas
sought
profil
mirna
associ
suscept
develop
pathogen
neuroinflamm
order
detect
differ
relev
suscept
associ
induct
neuroinflamm
compar
mirna
profil
activ
lymph
node
suscept
resist
inbr
rat
strain
highthroughput
deepsequenc
technolog
solexa
illumina
first
appli
identifi
quantifi
mirna
furthermor
adapt
tag
uniqu
index
sequenc
allow
multiplex
sampl
identifi
known
mirna
sever
novel
candid
mirna
taqman
rodent
micro
rna
array
appli
biosystem
compris
uniqu
rat
mirna
confirm
number
differenti
express
mirna
detect
solexa
pass
fdr
sinc
everi
mirna
potenti
regul
hundr
target
gene
next
use
data
differenti
express
mrna
strain
tissu
affymetrix
elucid
mirna
mrna
target
pathway
dysregul
suscept
strain
solexa
sequenc
also
enabl
identif
sever
novel
mirna
upregul
resist
strain
differenti
express
mirna
target
implic
pathway
associ
suscept
neuroinflamm
involv
prolifer
innat
immun
respons
tlr
signal
tumor
suppress
neurodegener
inflamm
play
import
role
cerebr
ischemia
interleukin
il
antiinflammatori
cytokin
immun
system
explor
chang
gene
transient
global
cerebr
ischemia
model
global
cerebr
ischemia
induc
occlud
common
carotid
arteri
withdraw
ml
blood
tail
vein
mice
three
day
later
gene
express
hippocamp
tissu
cerebr
ischemia
mice
examin
use
realtim
pcr
result
show
gene
upregul
least
two
fold
transient
global
cerebr
ischemia
result
made
interest
observ
subject
mice
ischemia
significantli
upregul
gene
express
probabl
one
selfneuroprotect
mechan
mice
inflamm
cerebr
ischemia
experiment
autoimmun
encephalomyel
eae
mous
model
multipl
sclerosi
ms
autoimmun
inflammatori
diseas
central
nervou
system
cn
imbal
proinflammatori
versu
antiinflammatori
cytokin
key
determin
develop
autoimmun
express
proinflammatori
cytokin
ifnand
tnfa
correl
increas
diseas
suscept
hand
cytokin
shown
import
prevent
amelior
diseas
deliveri
antiinflammatori
molecul
cn
one
possibl
approach
treat
eae
demonstr
deliveri
helperdepend
adenovir
vector
induc
clinic
function
recoveri
eae
new
member
famili
cytokin
promot
respons
eae
chronic
mous
model
regul
develop
autoimmun
inflamm
mediat
cell
studi
show
gene
therapi
modul
relapsingremit
rr
eae
mous
model
briefli
investig
effect
therapi
rreae
intrathec
inject
rreaesjl
mice
lentiviru
onset
first
diseas
remiss
follow
clinic
outcom
day
express
lentiviru
infect
ependym
cell
along
entir
ventricular
space
shown
antiha
immunostain
cerebro
spinal
fluid
brain
homogen
contain
protein
demonstr
elisa
assay
moreov
also
abl
upregul
mrna
express
cn
measur
real
timepcr
despit
result
gene
therapi
effect
clinic
patholog
featur
eae
evalu
respect
diseas
clinic
score
number
inflammatori
infiltr
percentu
axon
myelin
damag
spinal
cord
section
analyz
elisa
assay
amount
protein
brain
homogen
rreae
sjl
inject
mice
vs
rreae
sjl
uninject
mice
conclus
data
suggest
unlik
data
eae
chronic
mous
model
gene
deliveri
rreae
sjl
mice
effect
clinic
patholog
featur
diseas
even
abl
exert
biolog
function
alter
express
profil
amyloid
precursor
protein
cleav
enzym
cell
alzheim
diseas
ad
involv
neuron
loss
amyloidbeta
compos
plaqu
neurofibrillari
tangl
nft
contain
tau
protein
variou
region
neocortex
presenc
inflamm
inflammatori
cytokin
eg
interleukin
produc
mainli
activ
microglia
brain
import
role
nerv
cell
degener
eg
enhanc
product
plaqu
earlier
studi
show
coloc
plaqu
nft
contain
neuron
induc
express
kinas
involv
hyperphosphoryl
tau
studi
examin
effect
amyloid
precursor
protein
app
process
enzym
neuronlik
differenti
human
neuroblastoma
cell
gener
evalu
role
plaqu
format
cell
expos
bioactiv
recombin
chang
detect
immunoblot
immunohistochemistri
use
paraffin
section
brain
sampl
ad
patient
treat
neuronlik
cell
show
increas
protein
level
betaamyloid
cleav
enzym
h
h
treatment
compar
untreat
control
increas
abolish
simultan
treatment
neutral
bind
protein
express
profil
cleavag
product
app
show
also
alter
treatment
ihc
detect
surprisingli
also
receptor
associ
plaqu
thu
seem
enhanc
plaqu
format
induc
express
may
role
plaqu
clearanc
interact
plaqu
local
plaqu
may
function
bind
site
complex
may
inhibit
plaqu
uptak
extracellular
space
glial
cell
interact
cell
membran
enhanc
progress
ad
shown
beta
accumul
brain
key
featur
alzheim
diseas
ad
revers
beta
immunotherapi
effect
mediat
least
part
phagocytosi
microglia
studi
aim
improv
understand
role
microglia
play
ad
patholog
outcom
beta
immunis
neuropatholog
ad
patient
activ
immunis
beta
peptid
iad
elan
pharmaceut
explor
express
microgli
protein
immunis
control
ad
subject
order
defin
microgli
profil
relat
patholog
featur
diseas
beta
tau
protein
immunohistochemistri
hladr
antigenpres
complex
phagocyt
activ
complement
fc
gamma
ri
fc
gamma
rii
igg
perform
frontal
tempor
pariet
lobe
significantli
higher
load
observ
immunis
case
compar
nonimmunis
control
p
addit
within
immunis
group
load
show
signific
correl
beta
load
p
quantif
hladr
load
show
signific
differ
iad
case
vs
ad
control
p
preliminari
result
microgli
marker
suggest
signific
chang
level
igg
complement
decreas
express
fc
gamma
ri
ii
iad
case
compar
ad
control
case
beta
immunis
effect
function
microglia
increas
capac
beta
phagocytosi
correl
load
beta
load
immunis
case
lack
correl
control
group
highlight
point
presenc
microglia
rather
target
specif
profil
determin
role
ad
patholog
far
found
evid
increas
overal
humour
autoimmun
activ
kruppel
like
factor
novel
transcript
factor
microgli
activ
subsequ
neuroinflamm
kaushik
deepak
basu
anirban
nation
brain
research
center
gurgaon
india
activ
microglia
resid
macrophag
cn
sever
neurodegen
diseas
like
alzheim
parkinson
multipl
sclerosi
patholog
condit
associ
cn
infect
often
associ
neuron
death
therefor
understand
inflammatori
mechan
lead
activ
becom
indispens
part
studi
focus
neurodegener
nuclear
factorkappa
b
nfkappa
b
one
import
transcript
factor
known
associ
macrophag
microgli
activ
involv
mediat
upregul
induc
nitricoxid
synthas
ino
proinflammatori
cytokin
howev
inflamm
complex
event
coactiv
transcript
factor
known
play
key
role
process
recent
kruppel
like
factor
one
zincfing
transcript
factor
report
play
import
role
inflamm
peripher
macrophag
shown
regul
ino
express
potenti
interact
pnfkappa
b
therefor
investig
role
neuroinflamm
studi
microgli
cell
primari
microglia
treat
salmonella
enterica
lipopolysaccharid
lp
chang
express
observ
found
transloc
nucleu
express
increas
dose
timedepend
manner
upon
lp
stimul
studi
reveal
requir
upregul
ino
express
mrna
protein
level
significantli
reduc
within
h
lp
stimul
knockdown
potenti
bind
promot
element
microgli
cell
confirm
promot
bind
assay
transcript
factor
also
found
import
upregul
key
proinflammatori
cytokin
includ
tnfalpha
upon
lp
treatment
data
suggest
respons
upregul
proinflammatori
mediat
cytokin
microgli
cell
upon
endotoxin
stimul
detail
mechan
transcript
factor
involv
neuroinflamm
subject
studi
alzheim
diseas
microgli
respons
thought
occur
without
signific
leukocyt
infiltr
evalu
microglialleukocyt
dynam
neocortex
young
age
wildtyp
wt
amyloid
precursor
protein
app
transgen
tg
mice
stereolog
estim
cell
show
increas
microgli
number
age
mice
neocortex
occupi
amyloid
plaqu
neuron
loss
occur
microgli
number
significantli
differ
young
wt
mice
young
mice
amyloid
deposit
detect
similar
result
obtain
quantif
microgli
cell
use
flow
cytometri
flow
cytometr
analys
also
reveal
signific
infiltr
cell
increas
number
high
macrophag
age
mice
leukocyt
recruit
coincid
emerg
microgli
macrophag
subpopul
express
high
level
mhc
class
age
mice
consist
immunohistochem
stain
show
leukocytelik
cell
postmortem
brain
tissu
patient
alzheim
diseas
despit
increas
number
myeloid
cell
rate
microgli
macrophag
prolifer
measur
h
period
immedi
prior
perfus
unchang
age
express
instead
rate
microgli
macrophag
apoptosi
increas
age
mice
exvivo
analysi
show
microglia
macrophag
ingest
amyloid
vivo
like
undergo
apoptosi
less
like
prolifer
cell
data
demonstr
amyloid
patholog
elicit
greater
leukocyt
infiltr
previous
anticip
suggest
apoptosi
phagocyt
cell
lead
failur
amyloid
clearanc
plaqu
deposit
may
therefor
increas
rate
microgli
macrophag
cell
death
exce
rate
cellular
recruit
loss
astrocyt
connexin
significantli
alter
suscept
sever
experiment
autoimmun
encephalomyel
mice
lutz
sarah
e
rain
cedric
brosnan
celia
f
adult
brain
astrocyt
express
connexin
cx
form
gap
junction
channel
astrocyt
astrocyt
oligodendrocyt
astrocyt
myelin
glial
syncytium
facilit
distribut
metabol
substrat
glucos
lactat
spatial
buffer
ionic
potassium
glutam
express
alter
number
patholog
condit
includ
site
inflamm
experiment
autoimmun
encephalomyel
eae
anim
model
multipl
sclerosi
ms
furthermor
recent
publish
proteom
analys
indic
alter
express
human
ms
lesion
han
et
al
natur
goal
studi
determin
astrocyt
gap
junction
affect
inflamm
central
nervou
system
cn
mice
mgfapcr
astrocytetarget
delet
singl
knockout
sko
doubl
knockout
dko
sensit
eae
use
sko
dko
mice
clinic
sign
diseas
slightli
increas
compar
control
genotyp
p
b
howev
lesion
load
suscept
differ
area
cn
inflamm
similar
genotyp
moreov
differ
note
bloodbrain
barrier
bbb
permeabl
evan
blue
dye
tissu
wet
weight
axon
patholog
gliosi
demyelin
explor
potenti
relev
find
human
diseas
examin
express
ms
lesion
use
immunohistochemistri
western
blot
normal
appear
white
matter
wide
express
associ
myelin
chronic
activ
ms
lesion
restrict
perivascular
endfeet
golgi
compart
coloc
suggest
alter
traffick
chronic
silent
lesion
exhibit
detect
protein
summari
observ
slight
exacerb
eae
sko
mice
genotyp
observ
differ
group
measur
lesion
load
inflamm
demyelin
bbb
permeabl
human
ms
lesion
associ
chang
express
level
subcellular
distribut
conclud
genet
loss
astrocyt
meaning
chang
express
eae
contribut
bbb
breakdown
clinic
relev
alter
regul
ms
remain
unclear
microparticl
releas
reactiv
microglia
potenti
biomark
neuroinflammatori
neurodegen
diseas
shed
vesicl
microparticl
shed
plasma
membran
respons
cell
activ
injuri
andor
apoptosi
cn
suppos
fundament
way
intercellular
signal
commun
immun
neuron
system
microglia
immun
cell
cn
mediat
inflammatori
immun
respons
respond
neuron
damag
shown
releas
microparticl
contain
cytokin
atp
stimul
chronic
activ
microglia
shown
detriment
benefici
role
neurodegen
diseas
debat
current
clinic
diagnost
criteria
alzheim
diseas
ad
requir
patient
dementia
diagnosi
made
clinic
method
avail
identifi
prodrom
ad
patient
mild
cognit
impair
mci
aim
character
presenc
microgli
shed
vesicl
csf
patient
differ
neurolog
diseas
order
detect
possibl
alter
number
content
associ
neurodegener
fortyf
patient
examin
recruit
sinc
septemb
depart
neurolog
san
raffael
scientif
institut
patient
underw
neuropsycholog
assess
mri
csf
analysi
cohort
patient
includ
total
alzheim
diseas
patient
age
mean
sd
year
mild
cognit
impair
mci
patient
age
year
relaps
remit
multipl
sclerosi
patient
peripher
nerv
diseas
patient
cephalalg
patient
underli
parenchym
diseas
csf
sampl
collect
lumbar
punctur
perform
vertebr
interspac
first
ml
csf
collect
steril
screw
top
leakproof
tube
csf
sampl
split
two
part
one
directli
analyz
flow
cytometri
stain
annexinv
detect
microparticl
centrifug
sever
differenti
centrifug
obtain
pellet
store
gene
express
analysi
result
found
increas
number
shed
vesicl
microgli
origin
csf
ad
patient
ms
patient
comparison
mci
control
patient
shed
vesicl
myeloid
origin
csf
may
repres
novel
biomark
microgli
activ
use
tool
investig
immunopathogenesi
neuroinflamm
neurodegener
parkinson
diseas
pd
neurodegen
disord
character
progress
massiv
loss
dopaminerg
neuron
dn
ventral
part
mesencephalon
ie
substantia
nigra
result
motor
disturb
accumul
evid
suggest
noncel
autonom
mechan
involv
neurodegener
pd
line
recent
shown
peripher
cell
invad
brain
pd
patient
mptptreat
mice
experiment
model
pd
activ
particip
neuron
cell
death
suggest
therapeut
strategi
aim
prevent
lymphocyt
extravas
may
interest
brochard
et
al
jci
yet
molecular
mechan
underli
infiltr
still
larg
unknown
major
aim
unravel
mechan
particular
adhes
chemotact
factor
involv
process
sinc
lymphocyt
infiltr
reach
pick
day
mptp
intox
mice
sacrif
half
time
point
dissect
ventral
mesencephalon
mous
total
mrna
extract
panel
cellular
marker
eg
tyrosin
hydroxylas
th
fibrillari
acid
protein
test
real
time
rtpcr
individu
n
per
time
point
present
pronounc
inflammatori
reaction
decreas
th
use
low
densiti
array
studi
chang
chemokin
adhes
molecul
express
gene
total
impact
correspond
chemokin
receptor
defici
lymphocyt
infiltr
dopaminerg
cell
death
follow
mptp
challeng
test
use
knockout
anim
result
indic
chemokin
known
stimul
cell
tactism
particular
overexpress
ventral
mesencephalon
mptp
treatment
yet
mice
defici
either
two
major
chemokin
receptor
involv
cell
traffick
found
display
much
dopaminerg
cell
loss
brain
infiltr
cell
wildtyp
litterm
mptp
although
one
exclud
possibl
involv
cell
brain
extravas
mptp
mous
model
pd
data
could
also
suggest
compensatori
andor
redund
mechan
may
underlin
neg
result
investig
therefor
need
test
hypothesi
form
alzheim
diseas
ad
increas
level
interleukin
il
monocyt
chemoattract
protein
brain
tissu
reliabl
diseas
predictor
present
studi
design
determin
whether
addit
inflammatori
mediat
significantli
differ
brain
level
cellular
express
ad
patient
mutat
presenilin
gene
versu
common
sporad
diseas
determin
relationship
two
patholog
solubl
brain
extract
analys
level
cytokin
chemokin
simultan
use
multiplex
analysi
biorad
immunohistochemistri
carri
use
specif
antibodi
tumour
necrosi
factora
tnfa
abeta
tau
quantit
analysi
densiti
immunoreact
glia
tnfa
neurofibrillari
tangl
tau
core
noncor
plaqu
abeta
proport
neuron
contain
tnfa
tau
immunoreact
carri
stepwis
logist
regress
model
show
increas
level
solubl
tnfa
reliabl
predict
diagnosi
ad
versu
sporad
diseas
p
b
similar
model
tissu
patholog
identifi
proport
tnfa
immunoreact
neuron
reliabl
factor
differenti
sporad
ad
across
group
increas
neuron
tnfa
immunoreact
correl
densiti
tnfaimmunoreact
glia
neurofibrillari
tangl
stage
importantli
differ
unrel
densiti
abeta
plaqu
patholog
data
demonstr
mutant
protein
enhanc
specif
inflammatori
mediat
ad
brain
beyond
expect
due
increas
abeta
plaqu
patholog
find
import
implic
model
ad
role
inflammatori
process
neuromyel
optica
nmo
also
name
devic
diseas
demyelin
disord
central
nervou
system
though
involv
confin
optic
nerv
spinal
cord
definit
asymptomat
brain
lesion
occasion
found
magnet
reson
imag
symptomat
brain
lesion
first
manifest
nmo
well
inform
clinic
implic
treatment
issu
woman
present
dizzi
dysarthria
sensori
disturb
neurolog
examin
show
bilater
spontan
upbeat
nystagmu
left
facial
hyperalgesia
brisk
deep
tendon
reflex
pronounc
right
side
magnet
reson
imag
mri
reveal
diffus
high
signal
intens
lesion
lower
medulla
upper
cervic
spinal
cord
diagnosi
brainstem
glioma
patient
underw
craniectomi
biopsi
patholog
find
diffus
demyelin
axon
injuri
scatter
macrophag
consist
ischem
demyelin
diseas
month
new
abnorm
hyperintens
lesion
brainstem
note
follow
mri
diagnos
multipl
sclerosi
start
interferonbeta
despit
diseas
modifi
treatment
sever
attack
long
segment
transvers
myeliti
optic
neuriti
correct
diagnosi
neuromyel
optica
nmo
remain
relapsefre
state
follow
month
treatment
highdos
corticosteroid
azathioprin
nmo
patient
initi
misdiagnos
brainstem
glioma
due
diffus
extens
brainstem
lesion
clinician
mind
possibl
demyelin
diseas
diagnost
approach
diffus
brainstem
lesion
differenti
diagnosi
depend
mr
imag
limit
earli
accur
diagnosi
critic
proper
treatment
inflammatori
diseas
central
nervou
system
cn
often
lead
neurolog
deficit
paralysi
autonom
cognit
dysfunct
onset
inflamm
tissu
infiltr
peripher
immun
cell
may
caus
local
tissu
destruct
resolut
cn
inflamm
ineffect
inher
neuroprotect
repair
mechan
result
widespread
accumul
degener
axon
later
diseas
cours
may
loss
specif
axon
tract
corticospin
tract
cst
control
motor
activ
point
neurolog
disabl
becom
irrevers
develop
neuroprotect
intervent
limit
axon
loss
critic
better
prognosi
prevent
perman
neurolog
disabl
recapitul
patholog
cn
inflamm
induc
experiment
autoimmun
encephalomyel
eae
mice
ifng
cytokin
involv
establish
inflamm
peripher
immun
organ
interestingli
data
studi
other
shown
ifng
ifngr
mice
eae
suffer
increas
neurolog
sever
compar
wild
type
control
addit
eae
induct
absenc
ifngifngr
result
induct
set
neurolog
deficit
typic
observ
control
deficit
includ
axial
rotat
head
tilt
balanc
impair
suggest
malfunct
vestibular
system
protect
effect
previous
attribut
inhibit
gener
pathogen
cell
ifng
howev
data
show
gener
rate
cell
ifng
mice
eae
transient
higher
control
taken
togeth
data
suggest
benefici
effect
ifn
may
exert
cn
promot
neuroprotect
mechan
examin
case
induc
eae
irradi
bone
marrow
chimer
mice
ifngr
absent
cn
present
peripher
immun
cell
vice
versa
degre
acut
axonopathi
spinal
cord
reveal
stain
loss
cst
count
small
diamet
axon
dorsal
funiculu
data
show
absenc
ifng
signal
specif
cn
resid
cell
suffici
onset
atyp
neurolog
deficit
increas
clinic
sever
axon
loss
conclud
ifng
signal
inflam
cn
contribut
preserv
axon
limit
tissu
atrophi
mausberg
ann
k
dorok
mareik
dehmel
thoma
kieseier
bernd
c
chronic
inflammatori
demyelin
polyneuropathi
cidp
autoimmun
mediat
disord
affect
peripher
nerv
caus
motor
weak
sensori
symptom
sign
precis
pathophysiolog
cidp
remain
uncertain
although
cell
recogn
self
antigen
believ
trigger
inflamm
peripher
nerv
nerv
root
current
neither
target
antigen
specif
cell
popul
respons
pathogenesi
cidp
identifi
elucid
role
contribut
cell
cell
receptor
tcr
repertoir
cell
peripher
blood
patient
cidp
analyz
use
spectratyp
control
healthi
ageand
sexmatch
individu
control
noninflammatori
polyneuropathi
also
includ
tcr
length
distribut
almost
alter
v
beta
element
popul
cidp
patient
display
impress
spectrum
oligoclon
expans
analyz
v
beta
element
vast
prolifer
differ
cell
clone
indic
broad
activ
cell
especi
popul
public
expans
distinct
tcr
length
one
v
beta
element
within
major
affect
patient
detect
strike
heterogen
respons
activ
either
caus
epitop
spread
proceed
diseas
andor
impli
multipl
peptid
potent
induc
autoimmun
mediat
diseas
interestingli
cytotox
cell
demonstr
much
broader
activ
helper
regulatori
cell
find
point
potenti
crucial
role
cell
immunopathogenesi
cidp
underlin
import
cellcontact
direct
destruct
peripher
nerv
pathogenesi
chronic
inflammatori
neuropathi
univers
glasgow
glasgow
unit
kingdom
nagoya
univers
school
medicin
nagoya
japan
univers
edinburgh
edinburgh
unit
kingdom
axon
variant
syndrom
gb
antibodi
complex
gangliosid
frequent
found
evid
show
antibodi
pathogen
effect
structur
function
neuromuscular
junction
nmj
node
ranvier
mous
model
diseas
confound
fact
wild
type
wt
mice
express
normal
complement
gangliosid
immunolog
toler
immunis
exogen
gangliosid
convers
nacetylgalactosaminyltransferas
knockout
galnact
mice
lack
complex
gangliosid
produc
high
affin
antibodi
respons
complex
gangliosid
immunis
develop
neuropatholog
lack
target
antigen
current
model
therefor
reli
passiv
immunis
wt
mice
antigangliosid
antibodi
gener
galnact
mice
overcom
doubl
step
assess
tolerogen
effect
gangliosid
sole
express
axon
cross
transgen
mous
express
galnact
driven
axon
neurofilamentlight
nfl
promot
onto
galnact
background
creat
galnact
tgko
mice
rescu
neuron
gangliosid
express
demonstr
thin
layer
chromatographi
brain
glycolipid
immunofluoresc
stain
neuromuscular
tissu
use
gangliosid
antibodi
sensit
transgen
nmj
antibodi
complement
mediat
injuri
first
establish
use
ex
vivo
prepar
hemidiaphragm
antibodi
bound
presynapt
membran
fix
complement
led
membran
attack
complex
deposit
galnact
tgko
wt
mice
galnact
mice
vivo
passiv
transfer
studi
intraperiton
ip
antibodi
plu
complement
galnact
tgko
mice
develop
respiratori
compromis
wherea
galnact
mice
furthermor
immunis
transgen
anim
complex
liposom
produc
vigor
antibodi
respons
indistinguish
seen
galnact
mice
compar
blunt
respons
wt
mice
provid
sourc
complement
deliv
ip
immunis
transgen
mice
develop
diaphragmat
paralysi
model
demonstr
local
axon
express
gangliosid
induc
system
immunolog
toler
allow
product
activ
immunis
model
motor
axon
gb
singl
mous
line
resensitis
axon
antibodi
mediat
injuri
mani
neurodegen
diseas
underpin
dysregul
inflammatori
respons
central
nervou
system
cn
howev
imper
process
tightli
control
inappropri
chronic
deploy
inflammatori
system
lead
loss
protect
repar
function
emerg
destruct
forc
pathogen
process
multipl
sclerosi
ms
alzheim
diseas
cn
notch
pathway
implic
mani
aspect
cellular
develop
function
recent
studi
led
recognit
role
notch
pathway
neurodegen
diseas
other
show
notch
play
critic
role
steer
immun
respons
toward
inflamm
regul
express
variou
cytokin
proinflammatori
compound
reexpress
notch
compon
neurodegen
diseas
seem
creat
environ
induc
neuron
death
aim
studi
understand
implic
notch
pathway
adult
cn
neurodegen
process
previous
shown
vitro
inhibit
notch
ligand
inhibit
inflammatori
reaction
astrocyt
use
mous
model
valid
method
modul
vivo
notch
ligand
express
given
previou
result
decid
studi
effect
silenc
model
induc
gliosi
forebrain
mice
mechan
lesion
inject
simultan
differ
type
sirna
lesion
crude
cholesterollabel
use
combin
without
transfect
reagent
variou
concentr
determin
effici
inhibit
kinet
studi
realiz
studi
modul
express
lesion
month
stab
wound
injuri
vivo
strategi
enabl
us
observ
major
modul
inflammatori
process
cn
inhibit
modul
microgli
activ
astrogliosi
within
lesion
result
show
play
import
role
control
inflammatori
reaction
could
thu
allow
develop
new
therapeut
strategi
help
diminish
gliosi
inflammatori
respons
cn
chitinas
express
broad
spectrum
inflammatori
condit
cancer
previous
report
level
elev
cerebrospin
fluid
csf
macaqu
human
lentivir
enceph
current
studi
transcript
express
evalu
varieti
acut
chronic
human
neurolog
condit
well
anim
model
traumat
brain
injuri
experiment
autoimmun
encephalomyel
eae
csf
analysi
reveal
signific
elev
multipl
sclerosi
patient
well
patient
traumat
brain
injuri
situ
hybrid
show
transcript
mostli
associ
reactiv
astrocyt
pronounc
inflammatori
condit
like
simian
viru
enceph
multipl
sclerosi
comparison
express
differ
stage
brain
infarct
show
abundantli
express
astrocyt
acut
phase
diminish
low
level
chronic
infarct
similarli
transcript
primarili
associ
reactiv
astrocyt
pericontusion
cortex
control
cortic
impact
area
reactiv
gliosi
mous
model
eae
taken
togeth
find
demonstr
induc
astrocyt
neuroinflammatori
condit
adjunct
minocyclin
therapi
affect
antiabeta
antibodi
induc
microhemorrhag
progress
mice
vasilevko
vitali
quir
daniel
cribb
david
cerebr
vascular
patholog
elderli
increas
risk
microhemorrhag
vasogen
edema
respons
antiabeta
immunotherapi
ad
patient
investig
whether
antiinflammatori
drug
minocyclin
attenu
abetaantibodi
immun
complexinduc
microhemorrhag
passiv
immun
mice
twenti
one
month
old
app
mice
mild
moder
caa
mening
pial
vessel
extens
parenchym
patholog
passiv
immun
pi
ctermin
specif
monoclon
antibodi
isotyp
mice
dose
weekli
ip
mgkg
per
mous
week
minocyclin
supplement
gkg
control
diet
con
given
mice
ad
libitum
start
day
first
passiv
inject
mice
per
group
begin
experi
mice
group
end
experi
adlik
amyloid
patholog
analyz
plaqu
load
microgli
activ
marker
microhemorrhag
comparison
neuropatholog
frontal
cortex
hippocampu
mice
show
signific
clearanc
amyloid
plaqu
passiv
immun
howev
frontal
cortex
group
significantli
lower
plaqu
load
minocyclin
similar
result
observ
hippocampu
versu
passiv
immunotherapi
alon
reduc
posit
microgli
activ
combin
minocyclin
demonstr
even
pronounc
effect
pi
group
extens
vascular
caa
antibodi
induc
microhemorrhag
minocyclin
intervent
chang
number
microhemorrhag
decreas
size
patholog
lesion
chronic
antiinflammatori
therapi
reduc
immunotherapyinduc
microhemorrhag
progress
mice
howev
minocyclin
also
attenu
plaqu
clearanc
data
suggest
microgli
involv
antibodi
mediat
plaqu
clearanc
older
mice
progress
microhemorrhag
lesion
pregabalin
new
agent
use
treatment
pheripher
neuropath
pain
studi
month
period
aim
investig
advers
effect
pregabalin
neuropath
pain
patient
examin
patient
pain
policlin
advers
effect
ask
first
control
pregabalin
advers
effect
determin
patient
admit
policlin
advers
effect
dizzi
vertigo
somnol
nausea
vomit
hypotens
headach
weak
hallucin
extrem
edema
constip
pregabalin
advers
effect
importantli
determin
use
long
time
chronic
pain
patient
studi
pregabalin
advers
effect
detect
import
pregabalin
administr
patient
ceas
recent
proteasom
inhibitor
bortezomib
report
reduc
autoantibodi
titer
improv
clinic
condit
mice
suffer
lupuslik
diseas
neubert
et
al
bortezomib
deplet
short
longliv
plasma
cell
normal
surviv
standard
immunosuppress
treatment
find
encourag
us
test
potenti
effect
bortezomib
experiment
autoimmun
myasthenia
gravi
eamg
model
lewi
rat
immun
salin
control
n
torpedo
achr
eamg
n
complet
freund
adjuv
first
week
experiment
period
eight
week
immun
rat
receiv
twice
week
subcutan
inject
salin
solut
untreat
bortezomib
mgkg
salin
prevent
eamg
combin
salin
first
four
week
bortezomib
rest
experi
treatment
eamg
clinic
condit
eamg
model
significantli
improv
bortezomib
prevent
group
compar
untreat
group
p
treatment
group
also
slight
amelior
observ
correl
observ
bortezomib
effici
reduc
product
anti
achr
antibodi
titer
prevent
group
treatment
group
improv
neuromuscular
transmiss
prevent
group
final
bortezomib
induc
apoptosi
bone
marrow
cell
spleen
thymu
reduc
amount
plasma
cell
bone
marrow
reduct
peripher
blood
reduct
result
indic
bortezomib
improv
eamg
symptom
significantli
reduc
autoantibodi
titer
therefor
proteasom
inhibit
promis
therapeut
strategi
target
plasma
cell
mg
celecoxib
analogu
lack
inhibitori
activ
suppress
inflammatori
disord
inhibit
inflammatori
cytokin
previous
report
celecoxib
trifluoromethyl
analogu
celecoxib
tfmcelecoxib
lack
activ
induc
cellular
retent
cytokin
involv
autoimmun
inflammatori
diseas
ask
whether
tfmcelecoxib
suppress
anim
model
human
autoimmun
diseas
method
experiment
autoimmun
encephalomyel
eae
induc
mice
immun
complet
freund
adjuv
cfa
contain
mycobacterium
tuberculosi
follow
pertussi
toxin
administr
shortli
immun
h
later
induc
collageninduc
arthriti
cia
mice
immun
bovin
type
ii
collagen
cii
g
cfa
day
cii
g
ifa
day
antibodyinduc
arthriti
aia
induc
mice
inject
anticii
antibodi
follow
lipopolysaccharid
lp
administr
day
later
mice
receiv
tfmcelecoxib
celecoxib
everi
day
day
eae
aia
experi
everi
day
day
cia
experi
control
anim
inject
vehicl
alon
splenic
dendrit
cell
dc
mice
treat
tfmcelecoxib
celecoxib
day
earlier
stimul
lp
vitro
result
tfmcelecoxib
celecoxib
treatment
suppress
clinic
featur
eae
tfmcelecoxib
treatment
suppress
cell
infiltr
demyelin
spinal
cord
compar
vehicl
treatment
although
lymph
node
cell
form
tfmcelecoxib
celecoxibtr
mice
produc
less
rechalleng
mog
vitro
inhibitori
effect
tfmcelecoxib
recal
respons
potent
celecoxib
sever
clinic
patholog
featur
cia
aia
reduc
tfmcelecoxib
celecoxib
group
howev
tfmcelecoxib
treatment
show
stronger
suppress
effect
arthriti
obviou
aia
tfmcelecoxib
treatment
suppress
lpsinduc
product
inflammatori
cytokin
includ
dc
compar
celecoxib
vehicl
testament
may
explain
profound
diseas
inhibitori
effect
tfmcelecoxib
aia
model
tfmcelecoxib
possess
abil
inhibit
inflammatori
diseas
model
decreas
product
cell
also
suppress
inflammatori
cytokin
innat
immun
cell
report
glycogen
synthas
inhibitor
lithium
therapeut
acut
relapsingremit
experiment
autoimmun
encephalomyel
eae
relapsingremit
multipl
sclerosi
rrm
segreg
helper
type
diseas
helper
type
diseas
goal
studi
determin
lithium
differenti
regul
versu
diseas
order
determin
therapeut
effect
lithium
eae
versu
eae
perform
passiv
transfer
studi
transfer
encephalitogen
tcell
lithiumtr
untreat
recipi
determin
lithium
treatment
effect
attenu
eae
induc
encephalitogen
tcell
cell
exvivo
analysi
prolifer
assay
elisa
cell
indic
hyperprolifer
secret
presenc
lithium
recent
identifi
novel
cooper
relationship
type
type
interferon
ifn
immunopathogenesi
eae
therefor
dissect
mechan
lithium
protect
eae
evalu
develop
progress
eae
mice
lack
ifnab
signal
mice
lack
ifng
signal
mice
lack
ifnab
ifng
signal
mice
treat
lithium
onset
diseas
compar
untreat
mice
found
lithium
administ
onset
clinic
diseas
equal
suppress
eae
mice
mice
wild
type
mice
contrast
mice
lithium
reduc
partial
sever
initi
phase
eae
complet
ineffect
chroniceffector
progress
phase
diseas
data
suggest
cooper
type
type
ifn
involv
lithiumdepend
therapeut
effect
eae
importantli
lithium
select
inhibitor
suppress
chronicprogress
eae
ifng
mediat
signal
abl
suppress
diseas
mice
find
crucial
implic
identifi
type
ms
patient
mostli
benefit
therapi
encapsul
polyethyleneglycolco
longcircul
liposom
strategi
increas
efficaci
alter
therapeut
profil
pharmaceut
activ
drug
recent
work
demonstr
approach
also
promis
glucocorticoid
gc
mainstay
treatment
acut
relaps
multipl
sclerosi
ms
patient
use
experiment
autoimmun
encephalomyel
eae
explor
mechan
may
account
superior
therapeut
efficaci
liposom
gc
compar
free
compound
treatment
eae
mice
singl
inject
liposom
prednisolon
potent
applic
tenfold
higher
dose
free
dexamethason
three
consecut
day
nevertheless
drug
prepar
similarli
act
classic
cytosol
gc
receptor
gr
shown
use
gr
knockout
mice
interestingli
condit
mutagenesi
gr
demonstr
modul
cell
function
stringent
prerequisit
therapeut
efficaci
liposom
gc
find
contrast
previou
observ
peripher
cell
essenti
target
free
dexamethason
analysi
reveal
major
featur
macrophag
function
cytokin
chemokin
express
product
mhc
class
ii
surfac
level
strongli
affect
liposom
gc
consequ
specif
delet
gr
myeloid
cell
also
partial
impair
eae
therapi
liposomeencapsul
free
gc
liposomeencapsul
gc
similar
side
effect
certain
paramet
liver
metabol
compar
higher
dose
free
gc
indic
new
formul
may
reduc
advers
effect
gc
therapi
collect
find
demonstr
liposom
encapsul
gc
alter
therapeut
target
treatment
cn
autoimmun
may
allow
focus
stringent
gc
therapi
ms
patient
statin
hmg
coenzym
reductas
inhibitor
known
reduc
serum
lowdens
lipoprotein
wide
use
treatment
hypercholesterolemia
associ
myasthenia
gravi
mg
statin
describ
case
report
small
case
seri
conclud
stain
safe
case
might
aggrav
mg
retrospect
investig
mg
patient
japanes
elav
achr
antibodi
treat
chiba
univers
hospit
among
patient
use
statin
histori
statin
use
previou
report
defin
statininduc
mg
worsen
happen
within
month
statin
use
investig
patient
histori
mg
worsen
within
month
statin
use
mg
worsen
occur
cours
steroid
reduct
high
dose
steroid
take
therapi
month
thymectomi
reincreas
dosag
steroid
togeth
cyclosporina
continu
statin
use
mg
worsen
ceas
achiev
steroid
reduct
ordin
cours
thu
consid
worsen
caus
steroid
reduct
statin
use
hypercholesterolemia
caus
steroid
therapi
still
common
among
mg
patient
statin
effect
solut
consid
statin
could
use
posit
mg
patient
hypercholesterolemia
sinc
statin
use
might
littl
relationship
mg
worsen
investig
glatiram
acet
ga
therapi
multipl
sclerosi
ms
consid
lead
system
alter
circul
monocyt
aim
infer
accessori
regulatori
pathway
appli
drug
human
ms
blood
monocyt
henc
genom
wide
interrog
monocyt
messeng
rna
transcript
time
offer
substanti
view
complex
ms
potenti
impact
ga
elucid
molecular
interact
specif
transcript
factor
bind
site
tfb
promot
region
garespons
gene
aim
character
employ
affymetrix
array
eight
ms
patient
monitor
ex
vivo
receiv
subcutan
ga
peripher
blood
sampl
process
treatment
correspondingli
upcom
inject
one
day
one
four
eight
week
magnet
activ
cell
sort
appli
isol
monocyt
cell
fraction
transcriptom
analys
includ
gene
express
intens
correct
filter
maid
gene
function
analysi
gene
ontologygo
construct
molecular
interact
network
use
r
softwar
packag
pathway
studio
algorithm
infer
gene
regulatori
network
integr
tfb
tilar
two
month
treatment
differenti
express
gene
deg
attain
consist
detect
significantli
alter
support
previou
evid
respect
ga
activ
properti
marker
monocyt
activ
initi
downregul
patient
note
upregul
gene
consid
essenti
cell
differenti
dna
bind
motif
transcript
factor
function
molecular
switch
antivir
activ
overrepres
gene
promot
region
eg
link
deg
eg
ido
oasl
sever
othernatur
tf
also
assign
immun
system
relat
group
function
relat
gene
go
categori
significantli
chang
coordinatedli
time
gene
interact
explor
analysi
use
deg
reveal
time
dynam
network
high
connect
center
biolog
import
gene
oxt
pam
prkca
vcam
war
signific
chang
monocyt
rna
profil
time
reveal
hitherto
unrecogn
gaaffect
transcript
key
regul
contribut
mechan
action
ms
muramoto
kenzo
daun
jane
zheng
wanjun
shirota
hiroshi
gusovskey
fabian
hishinuma
ieharu
kobayashi
seiichi
eisai
co
ltd
tsukubashi
japan
eisai
inc
boston
unit
state
key
protein
kinas
regul
activ
involv
cytokin
product
upregul
adhes
molecul
includ
novel
potent
select
inhibitor
shown
good
efficaci
inhibit
sever
inflammatori
cytokin
adhes
molecul
multipl
sclerosi
demyelin
diseas
exacerb
migrat
leukocyt
central
nervou
system
adhes
molecul
chemokin
inhibit
tnfinduc
express
human
umbil
vein
endotheli
cell
activ
cell
induc
product
mice
microglia
evalu
model
ms
administ
prophylact
mog
myelinoligodendrocyteglycoprotein
induc
eae
model
significantli
inhibit
develop
eae
symptom
start
dose
mgkg
histolog
analysi
demonstr
inhibit
infiltr
leukocyt
spinal
cord
fac
analysi
infiltr
leukocyt
reveal
cell
dendrit
cell
reduc
spinal
cord
administr
furthermor
therapeut
administr
plp
proteolipid
protein
induc
eae
model
show
decreas
diseas
sever
determin
affect
induct
cell
mogea
model
splenocyt
mogimmun
mice
activ
vitro
mog
peptid
secret
ifng
reduc
splenocyt
anim
compar
vehicletr
anim
result
suggest
inhibit
antigendepend
differenti
model
potenti
promis
therapeut
treatment
multipl
sclerosi
earli
aggress
treatment
iapp
ivmp
combin
therapi
nmoclin
efficaci
combin
therapi
serum
ohji
satoru
kubota
akihiro
kojima
miki
isaki
shoko
nomura
kyoichi
depart
neurolog
saitama
medic
center
saitama
medic
univers
saitama
japan
purpos
plasmapheresi
recent
becom
avail
therapi
neuromyel
optica
nmo
report
chang
serum
cytokin
immunoadsorpt
plasmapheresi
iapp
patient
activ
phase
nmo
serum
level
increas
immedi
iapp
treatment
compar
iapp
remov
antibodi
iapp
induc
clinic
improv
howev
increas
serum
level
iapp
might
promot
reexacerb
increas
product
antibodi
present
studi
perform
intraven
methylpredonisolon
ivmp
treatment
iapp
addit
earli
aggress
treatment
studi
clinic
efficaci
combin
therapi
chang
serum
cytokin
combin
therapi
compar
iapp
therapi
method
six
combin
therapi
perform
patient
activ
phase
nmo
clinic
efficaci
estim
neurolog
examin
symptom
serum
level
cytokin
measur
use
bead
array
method
treatment
treatment
combin
therapi
result
discuss
studi
clinic
efficaci
neurolog
examin
symptom
improv
earlier
combin
therapi
iapp
therapi
studi
chang
serum
cytokin
serum
level
increas
immedi
iapp
therapi
decreas
ivmp
treatment
earlier
neurolog
improv
might
provid
remov
anti
antibodi
iapp
also
suppress
serum
ivmp
conclus
earli
aggress
treatment
combin
therapi
iapp
ivmp
might
provid
earli
neurolog
improv
compar
iapp
therapi
increas
serum
iapp
suppress
combin
ivmp
treatment
interferon
beta
therapi
accept
firstlin
treatment
patient
multipl
sclerosi
ms
howev
proport
patient
show
poor
clinic
respons
hand
ramatroban
known
thromboxan
receptor
antagonist
suppress
express
monocyt
chemoattract
adhes
molecul
endotheli
cell
ramatroban
prevent
exacerb
inflamm
block
mention
molecul
investig
whether
administr
ramatroban
could
prevent
relaps
ms
via
inhibitoin
lymphocyt
macrophag
invas
blood
brain
barrier
bbb
central
nervou
system
cn
total
patient
ms
clinic
confirm
accord
mcdonald
criteria
enrol
openlabel
studi
patient
treat
administr
ramatroban
mgday
po
addit
convent
ms
therapi
number
relaps
use
primari
outcom
measur
patient
monitor
develop
advers
effect
patient
ramatroban
therapi
discontinu
acut
erupt
result
drug
allergi
howev
patient
ramatroban
treatment
continu
without
develop
advers
effect
case
patient
complet
year
therapi
signific
differ
mean
standard
deviat
sd
annual
relaps
rate
note
year
treatment
respect
ramatroban
might
use
addit
therapi
decreas
clinic
laboratori
exacerb
found
reason
safe
japanes
patient
ms
potent
select
pegyl
small
molecul
integrin
inhibitor
current
evalu
treatment
multipl
sclerosi
expect
inhibit
leukocyt
entri
inflam
central
nervou
system
blockad
transendotheli
migrat
bind
guinea
pig
human
leukocyt
similar
affin
thu
sought
determin
efficaci
guinea
pig
model
experiment
autoimmun
encephalomyel
eae
mimic
sever
patholog
process
associ
multipl
sclerosi
guinea
pig
eae
induc
inject
spinal
cord
homogen
complet
freund
adjuv
weekli
subcutan
inject
mgkg
administ
chronic
phase
guinea
pig
eae
result
rapid
signific
reduct
clinic
score
compar
vehicletr
group
interim
period
weekli
dose
clinic
score
reduct
sustain
mgkg
group
last
day
mgkg
group
consist
low
drug
plasma
level
observ
trough
low
dose
anim
histopatholog
examin
spinal
cord
end
treatment
period
reveal
inflammatori
cell
infiltr
microgli
activ
significantli
reduc
group
compar
vehicl
group
conclud
efficaci
guinea
pig
eae
model
potent
inhibitor
integrinmedi
human
leukocyt
adhes
vitro
garrido
carolin
mao
jennif
xu
yizheng
nguyen
van
yednock
ted
bard
elan
pharmaceut
south
san
francisco
unit
state
potent
select
pegyl
small
molecul
integrin
inhibitor
current
evalu
treatment
multipl
sclerosi
entri
inflammatori
leukocyt
central
nervou
system
vascular
transmigr
highli
depend
interact
integrinexpress
leukocyt
endotheli
cell
integrinmedi
leukocyt
adhes
thought
play
major
role
patholog
process
observ
preferenti
bind
integrin
integrin
integrinexpress
human
whole
blood
lymphocyt
addit
inhibit
adhes
jurkat
cell
immobil
human
nm
inhibit
adhes
cell
immobil
human
madcamfc
nm
inhibit
adhes
cell
human
adhes
cell
human
fibronectin
thu
specif
potent
inhibitor
integrinmedi
leukocyt
adhes
character
fold
greater
potenc
toward
integrin
properti
may
provid
novel
mean
treat
ms
patient
specif
inhibit
leukocyt
traffick
cn
preserv
traffick
function
multipl
sclerosi
ms
autoimmun
inflammatori
demyelin
diseas
central
nervou
system
current
treatment
ms
nonspecif
action
signific
side
effect
normal
immun
function
antigenspecif
immunotherapeut
agent
chang
respons
pathogen
cell
could
help
reduc
side
effect
best
way
target
cell
specif
use
modifi
peptid
target
interact
cell
receptor
mhc
howev
peptidebas
reagent
typic
poorli
immunogen
work
aim
enhanc
bioavail
effect
immunomodulatori
peptid
modul
cell
potenti
therapeut
applic
ms
use
well
establish
alter
peptid
ligand
apl
model
shown
therapeut
effect
experiment
autoimmun
encephalomyel
eae
test
efficaci
approach
myelin
proteolipid
protein
plp
specif
apl
modifi
attach
palmit
acid
via
thioester
bond
cystein
residu
peptid
abil
thiopalmitoyl
spalm
apl
modul
pathogen
immun
respons
vitro
show
clinic
efficaci
sjlj
mous
model
ms
compar
nonacyl
apl
control
serum
halflif
spalm
apl
approxim
longer
apl
alon
furthermor
spalmapl
induc
stronger
prolif
respons
apl
induc
greater
number
regulatori
cell
differ
induc
increas
product
antiinflammatori
cytokin
interleukin
compar
apl
alon
therapeut
spalmapl
use
lower
concentr
effect
apl
prevent
diseas
anim
model
addit
spalmapl
also
effect
treat
establish
diseas
result
full
recoveri
day
sooner
apl
treat
mice
spalm
apl
retain
improv
benefici
effect
apl
vitro
vivo
good
potenti
method
enhanc
therapeut
effect
specif
peptidebas
agent
diseas
ms
genet
engin
solubl
tumor
necrosi
factor
receptor
select
tnf
membran
tnf
mimet
activ
multipl
sclerosi
character
autoimmun
respons
oligodendrocyt
myelin
cell
central
nervou
system
cn
result
demyelin
consecut
neurodegener
repair
demyelin
tissu
requir
de
novo
differenti
oligodendrocyt
progenitor
cell
form
new
myelin
sheet
access
axon
regen
role
cn
postul
tumor
necrosi
factor
receptor
induc
oligodendrocyt
precursor
prolifer
accordingli
tnf
variant
select
activ
could
potenti
use
therapeut
regimen
neurodegen
diseas
solubl
recombin
tnf
strong
mediat
inflamm
predominantli
activ
solubl
tnf
suffici
activ
contrast
membran
bound
form
tnf
memtnf
fulli
activ
therefor
specif
therapeut
need
compli
two
basic
requir
mimicri
memtnf
receptor
select
order
avoid
dose
limit
sever
inflammatori
respons
trimer
stabil
oligomer
statu
crucial
determin
tnf
receptor
activ
basi
construct
membran
mimet
select
tnf
variant
use
singlechain
tnf
sctnf
molecul
consist
three
tnf
monom
fuse
short
peptid
linker
previous
shown
sctnf
possess
increas
stabil
vitro
vivo
comparison
wildtyp
tnf
introduc
two
amino
acid
exchang
sctnf
variant
result
loss
affin
retens
bind
mimic
memtnf
link
receptor
select
singl
chain
tnf
tenascinc
tnc
trimer
domain
result
stabil
nonam
respect
tnf
domain
vitro
could
demonstr
mimic
memtnf
exclus
activ
evid
complex
format
recruit
nfkb
activ
ongo
studi
vivo
properti
present
investig
particular
appropri
diseas
model
transgen
mice
reveal
use
potenti
therapeut
neurodegen
diseas
immunodomin
epitop
properti
pyroglutamatemodifi
abetaspecif
antibodi
perezgarmendia
roxanna
ibarrabracamont
vanessa
vasilevko
vitali
jose
mena
raul
govezenski
tzipe
manoutcharian
karen
cribb
david
gevorkian
goar
institut
memori
impair
neurolog
disord
univers
california
irvin
irvin
unit
state
instituto
de
investigacion
biomedica
universidad
nacion
autonoma
de
mexico
mexico
mexico
depart
neurosci
cinvestavipn
mexico
mexico
ntruncatedmodifi
form
amyloid
beta
peptid
found
diffus
dens
core
plaqu
alzheim
diseas
ad
syndrom
patient
well
transgen
mous
model
ad
previou
studi
demonstr
peptid
significantli
resist
degrad
aggreg
rapidli
vitro
exhibit
similar
case
increas
toxic
hippocamp
neuron
cultur
compar
fulllength
peptid
thu
ntermin
truncatedmodifi
peptid
repres
highli
desir
abund
therapeut
target
present
studi
focus
ntruncatedmodifi
peptid
bear
aminotermin
pyroglutam
posit
pe
produc
pe
specif
polyclon
antibodi
rabbit
identifi
epitop
recogn
antibodi
use
librari
random
heptapeptid
display
fusion
minor
coat
protein
phage
two
bcell
epitop
recogn
pe
antibodi
determin
first
one
locat
aminotermin
part
second
one
central
part
peptid
peptid
insert
select
posit
phage
clone
mimick
antigen
properti
epitop
addit
demonstr
pe
antibodi
inhibit
pe
induc
cytotox
differenti
neuroblastoma
cell
recogn
natur
occur
amyloid
aggreg
present
brain
sampl
ad
patient
importantli
pe
rabbit
polyclon
antibodi
bound
also
ntruncat
modifi
pe
suggest
three
peptid
may
share
common
bcell
epitop
immun
select
mimotop
may
induc
crossreact
antibodi
bind
three
major
form
understand
antigen
immunogen
properti
mimotop
select
studi
may
help
elicit
bcell
respons
mimick
pe
one
repres
promis
immunotherapeut
approach
diseas
treatment
andor
prevent
believ
result
potenti
import
develop
novel
immunogen
target
ntruncatedmodifi
aggreg
sinc
commonli
use
immunogen
major
vaccin
studi
ad
shown
induc
antibodi
recogn
ntermin
immunodomin
epitop
efrh
full
length
absent
namino
truncat
peptid
antigenspecif
therapi
multipl
sclerosi
hold
promis
inhibit
autoimmun
respons
without
affect
global
immun
function
main
autoantigen
ms
includ
myelin
basic
protein
mbp
proteolipid
protein
plp
myelin
oligodendrocyt
protein
mog
experiment
model
ms
myelin
peptid
appli
epicutan
induc
antigenspecif
immun
toler
studi
treat
relapsingremit
ms
patient
mixtur
three
myelin
peptid
placebo
appli
week
skin
throughout
studi
patient
assess
immun
respons
skin
lymph
node
peripher
blood
immun
cell
found
use
immunocytochemistri
myelin
peptid
activ
dendrit
langerhan
cell
skin
site
immun
local
lymph
node
epicutan
treatment
myelin
peptid
induc
uniqu
popul
granular
dendrit
cell
peripheri
epicutan
immun
myelin
peptid
led
gener
produc
type
regulatori
cell
suppress
myelinspecif
cell
prolifer
suppress
ifngamma
tgfbeta
product
show
first
time
epicutan
immun
myelin
peptid
induc
immun
toler
inhibit
autoimmun
ms
patient
neuroprotect
autoimmun
alemtuzumab
treatment
multipl
sclerosi
mose
suzann
jone
joann
anderson
jane
phuah
chial
webber
daniel
compston
alastair
cole
alasdair
phase
clinic
trial
shown
lymphocytedeplet
humanis
monoclon
antibodi
alemtuzumab
highli
effect
treatment
earli
relapsingremit
multipl
sclerosi
reduc
risk
relaps
accumul
disabl
compar
interferon
furthermor
treat
alemtuzumab
lost
disabl
cours
trial
associ
increas
brain
volum
imag
suggest
tissu
restor
unpreced
observ
led
us
hypothesis
alemtuzumab
promot
brain
repair
enhanc
neuroprotect
autoimmun
product
neurotrophin
lymphocyt
interrog
hypothesi
exvivo
peripher
blood
mononuclear
cell
pbmc
cultur
patient
alemtuzumab
analys
neurotrophin
product
elisa
supernat
ii
brainderiv
neurotroph
factor
bdnf
secret
intracellular
flow
cytometri
iii
express
growth
factor
mrna
semiquantit
rtpcr
separ
cell
popul
iv
function
effect
pbmc
condit
media
vitro
rodent
neuron
oligodendrocyt
precursor
cell
opc
cultur
pbmc
regener
alemtuzumab
secret
increas
level
bdnf
pgml
vs
baselin
p
plateletderiv
growth
factor
pgml
vs
baselin
p
ciliari
neurotroph
factor
cntf
pgml
vs
undetect
baselin
p
stimul
myelin
basic
protein
mbp
intracellular
flow
cytometri
identifi
cell
main
sourc
bdnf
bdnf
also
found
produc
lesser
extent
cell
b
cell
monocyt
cell
b
cell
monocyt
bdnf
mrna
express
increas
alemtuzumab
particularli
respons
mbp
cntf
produc
cell
posttreat
deriv
pbmccondit
media
increas
surviv
rat
neuron
fold
surviv
fold
matur
oligodendrocyt
precursor
cell
cultur
compar
pretreat
deriv
media
p
b
effect
partial
revers
block
antibodi
bdnf
cntf
find
support
hypothesi
alemtuzumab
promot
neuroprotect
autoimmun
increas
secret
neurotrophin
thu
improv
disabl
alemtuzumab
may
part
explain
increas
cell
deliveri
neurotrophin
central
nervou
system
proper
treatment
protect
axon
loss
associ
neuroinflammatori
diseas
multipl
sclerosi
ms
still
remain
mysteri
survivin
member
iap
famili
protein
whose
neuroprotect
effect
explor
yet
paper
appli
survivin
bir
motif
mutant
demonstr
neuroprotect
role
cytotox
effect
granzymeb
deriv
activ
tcell
first
show
granzym
b
respons
toxic
activ
tcell
activ
apoptosi
pathway
next
found
pretreat
protect
neuron
cell
lead
reduc
popul
dead
cell
decreas
level
mitochondri
depolar
express
also
balanc
cytosol
homeostasi
find
suggest
promis
treatment
protect
neuron
cell
granzym
b
cytotox
open
new
window
treatment
neuroinflammatori
diseas
besid
strong
antioxid
properti
broad
rang
biolog
effect
benefici
human
health
eg
antiinflammatori
antithrombot
anticarcinogen
properti
develop
neuroprotect
therapi
multipl
sclerosi
ms
repres
one
import
goal
ms
treatment
research
project
examin
neuroprotect
effect
hydroxytyrosol
primari
cortic
cultur
mice
neuronspecif
viabil
assay
could
show
preincub
hyt
h
significantli
promot
neuron
surviv
oxid
stress
condit
model
neuroinflammatori
stress
ie
cocultur
activ
human
neutrophil
basi
result
perform
genomewid
express
analysi
wholegenom
microarray
hyttreat
cortic
cell
oxid
stress
condit
control
cell
analysi
reveal
preincub
hyt
activ
sever
compon
antioxid
defens
system
ia
enzym
glutathion
metabol
gclm
antioxid
enzym
thu
prime
cell
follow
oxid
stress
treatment
hand
hyt
lead
downregul
import
cell
cycl
factor
eg
aspm
cenpf
therebi
presum
enhanc
prosurviv
repair
mechan
rather
proapoptot
damagerespons
base
data
sinc
hyt
oral
avail
cross
bloodbrainbarri
appear
favor
safeti
profil
consid
interest
candid
futur
neuroprotect
therapi
trial
optimis
regulatori
macrophag
activ
phenotyp
immunotherapi
autoimmun
diseas
parsa
roham
andresen
pernilla
harri
robert
macrophag
import
antigenpres
cell
abil
surfac
express
secret
varieti
effector
molecul
either
drive
modul
pathogenesi
recent
year
nonclass
regulatori
phenotyp
describ
repres
new
immunotherapeut
opportun
treatment
chronic
autoimmun
diseas
thu
investig
induct
regulatori
properti
nonclass
state
use
cytokin
modulatori
agent
dexamethason
vitamin
either
alon
combin
order
discern
optim
regulatori
macrophag
activ
regimen
readout
includ
surfac
receptor
express
cytokin
releas
enzymat
cell
suppress
activ
determin
combin
yield
optim
regulatori
macrophag
phenotyp
interestingli
stabil
phenotyp
enhanc
addit
toll
receptor
agonist
subsequ
appli
consequ
signific
increas
secret
stimul
necessari
order
induc
signific
secret
activ
cell
distinct
profil
surfac
express
could
effici
suppress
antigenspecif
cell
recal
prolifer
also
investig
immunotherapeut
use
perform
adopt
transfer
regulatori
macrophag
experiment
model
autoimmun
diseas
found
new
way
induc
regulatori
macrophag
phenotyp
research
keep
elucid
possibl
immunotherapeut
use
therapi
autoimmun
diseas
universti
foggia
foggia
itali
univers
bari
bari
itali
background
atp
cognat
receptor
involv
inflammatori
process
particular
purinerg
receptor
thought
play
import
role
macrophag
microgli
function
regul
cytokin
product
apoptosi
known
upregul
inflamm
antagonist
receptor
may
serv
novel
antiinflammatori
agent
experiment
evid
show
certainli
involv
multipl
sclerosi
ms
patholog
aim
investig
express
ectoapyras
peripher
blood
monocyt
ms
patient
see
whether
glatiram
acet
ga
therapeut
effect
ms
may
possibl
mediat
mechan
interf
interact
henc
induct
atp
activ
modul
patient
method
twelv
rr
treatmentfre
ms
patient
select
peripher
blood
monocyt
obtain
express
monocyt
investig
qrtpcr
thereaft
vitro
effect
ga
express
bzatp
potent
agonist
stimulatedmonocyt
evalu
monocyt
without
ga
condit
final
check
bax
express
qrtpcr
order
rule
apoptosi
process
ten
healthi
donor
hd
similarli
investig
result
actual
differ
found
express
patient
control
ms
bzatp
stimulatedmonocyt
ga
condit
clearli
abl
downregul
p
express
also
express
even
differ
reach
statist
signific
convers
express
show
trend
p
increas
similarli
hd
p
p
downregul
ga
wherea
show
upregul
even
statist
signific
moreov
proapoptot
bax
vs
antiapoptot
ratio
express
monocyt
modifi
ga
condit
either
ms
hd
conclus
monocyt
either
ms
control
express
togeth
ga
immun
modul
seem
interfer
also
express
monocyt
patient
control
apoptot
phenomena
induc
cultur
monocyt
ga
condit
therefor
observ
chang
seem
repres
ga
net
effect
preclin
studi
anim
model
demonstr
cholesterollow
statin
promot
immun
modul
may
benefici
treatment
autoimmun
diseas
clinic
trial
data
suggest
treatment
statin
reduc
risk
develop
new
brain
lesion
patient
cn
demyelin
diseas
statin
inhibit
hmgcoa
reductas
known
bind
affin
pharmacokinet
properti
differ
influenc
potenc
treatment
hypercholesterolemia
therefor
possibl
immunodulatori
potenti
statin
differ
certain
statin
may
benefici
treatment
multipl
sclerosi
ms
goal
examin
rel
potenc
individu
statin
eae
treatment
compar
capabl
modul
cell
signal
differenti
oral
simvastatin
lovastatin
atorvastatin
rosuvastatin
test
plp
eae
sjlj
mice
mice
treat
least
day
rosuvastatin
atorvastatin
prevent
eae
develop
lovastatin
simvastatin
delay
clinic
onset
four
statin
suppress
prolifer
encephalitogen
cell
rosuvastatin
atorvastatin
treatment
also
promot
signific
cell
secret
wherea
low
level
antiinflammatori
cytokin
detect
cell
vivo
treatment
lovastatin
simvastatin
concord
polar
rosuvastatin
atorvastatin
cytokin
ifng
reduc
treatment
two
statin
lovastatin
simvastatin
vivo
treatment
rosuvastatin
atorvastatin
associ
greater
redistribut
farnesyl
ra
geranylgeranyl
rhoa
gtpase
membran
cytosol
cell
accordingli
differenti
ra
rho
inhibit
block
erk
mapk
activ
requir
transactiv
repress
data
demonstr
oral
administr
individu
statin
vari
markedli
clinic
immunodulatori
potenti
result
support
evalu
atorvastatin
rosuvastatin
ms
therapi
predictor
efficaci
plasmapheresisimmunoadsorpt
myasthenia
gravi
kitazono
hisao
konno
shingo
murata
mayumi
nakazora
hiroshi
nomoto
nobuatsu
sugimoto
hideki
nemoto
hiroshi
fujioka
toshiki
toho
univers
ohashi
medic
centr
tokyo
japan
antiacetyl
cholin
receptor
antibodi
achrab
profoundli
involv
develop
myasthenia
gravi
mg
thu
immunomodulatori
therapi
could
suppress
antibodi
product
mainstay
treatment
strategi
plasmapheresi
pp
immunoadsorpt
ia
directli
depriv
autoantibodi
ppia
employ
mainli
case
crisi
japan
howev
mg
patient
respond
goal
present
studi
evalu
predict
paramet
success
treatment
ppia
mg
review
medic
record
patient
mg
underw
ppia
institut
year
one
patient
seroneg
mg
indic
ppia
myasthen
crisi
two
patient
gener
sever
weak
without
respiratori
failur
present
patient
receiv
immunoglobulin
develop
hypoiggemia
seri
ppia
exclud
studi
japan
ppia
approv
perform
time
per
week
time
per
month
studi
ppia
carri
accord
approv
program
mgadl
score
achrab
titer
igg
valu
sequenc
ppia
evalu
resveratrol
natur
polyphenol
compound
red
wine
resveratrol
report
effect
axon
protect
although
becom
controversi
recent
resveratrol
also
exhibit
antiinflammatori
antivir
activ
modul
product
interleukin
il
propos
critic
develop
ms
resveratrol
suggest
benefici
immunemedi
diseas
well
neurolog
diseas
includ
stroke
alzheim
diseas
without
mark
advers
effect
investig
whether
resveratrol
could
therapeut
multipl
sclerosi
ms
use
anim
model
ms
experiment
autoimmun
encephalomyel
eae
theiler
murin
encephalomyel
viru
tmev
induc
demyelin
diseas
tmevidd
mice
sensit
myelin
oligodendrocyt
glycoprotein
mog
peptid
mice
fed
control
diet
control
diet
contain
resveratrol
mgkgday
prior
diseas
onset
earli
day
diseas
progress
late
day
whole
cours
day
sjlj
mice
infect
da
strain
tmev
mice
fed
diet
contain
resveratrol
acut
stage
day
late
stage
day
tmev
infect
resveratrol
treatment
exacerb
clinic
sign
moginduc
eae
earli
resveratrol
treatment
result
sever
eae
mean
clinic
score
day
control
earli
p
b
resveratrol
alter
cytokin
product
antimog
immun
respons
similarli
chronic
phase
tmev
infect
level
clinic
sign
demyelin
mice
treat
resveratrol
late
stage
greater
control
despit
reduc
product
result
resveratrol
treatment
axon
protect
seen
resveratroltr
mice
hand
mice
treat
resveratrol
acut
stage
tmev
infect
recov
acut
encephalomyel
rapidli
control
mice
sinc
resveratrol
treatment
result
detriment
effect
eae
tmevidd
red
wine
polyphenol
compon
may
potenti
detriment
effect
immunemedi
demyelin
diseas
includ
ms
support
nih
previous
report
infus
murin
bone
marrow
cell
bmc
transduc
autoantigen
nonmyeloabl
recipi
induc
toler
autoantigen
prevent
improv
experiment
autoimmun
encephalomyel
eae
even
absenc
engraft
hypothes
tolerogen
effect
mediat
subpopul
transduc
cell
gener
ex
vivo
bmc
cultur
end
investig
phenotyp
bmc
undergo
retrovir
transduct
sort
candid
cell
subpopul
analyz
suppress
effect
vitro
murin
bmc
transduc
use
standard
condit
medium
fc
condit
media
contain
murin
stem
cell
factor
exposur
supernat
contain
retrovir
vector
day
vast
major
transduc
cell
either
phenotyp
two
myeloid
cell
subpopul
correspond
two
monocytelik
granulocytelik
respect
subtyp
myeloidderiv
suppressor
cell
mdsc
report
character
function
analyz
abil
transduc
total
bmc
sort
candid
cell
subpopul
suppress
prolif
respons
splenocyt
mice
eae
autoantigen
challeng
transduct
total
bmc
myeloid
cell
subpopul
suppress
prolif
cell
respons
dosedepend
manner
addit
found
monocytelik
cell
significantli
suppress
granulocytelik
counterpart
suppress
also
significantli
higher
cell
transduc
autoantigen
control
vector
cell
subpopul
suggest
nonspecif
antigenspecif
mechan
contribut
suppress
effect
observ
vitro
moreov
cell
popul
display
higher
level
nitric
oxid
synthas
activ
upon
stimul
cell
subpopul
test
report
mdsc
best
knowledg
first
report
demonstr
gener
mdsc
standard
hematopoiet
transduct
cultur
result
also
suggest
particip
antigenspecif
mdsc
model
toler
induct
eae
potenti
therapeut
use
autoimmun
diseas
helper
cell
appear
central
import
develop
autoimmun
inflamm
neuromyel
optica
nmo
recent
shown
associ
increas
level
cell
rituximab
monoclon
antibodi
direct
use
treatment
sever
case
nmo
lead
bcell
deplet
decreas
cell
along
clinic
improv
treatment
rituximab
report
patient
suffer
rheumatoid
arthriti
aim
elucid
effect
rituximab
thelper
cell
nmo
patient
year
old
caucasian
woman
develop
sever
bilater
optic
nerv
neuriti
loss
vision
mri
show
lesion
within
brain
spine
bilater
gdenhanc
optic
nerv
lumbar
punctur
reveal
cell
normal
protein
level
intrathec
synthesi
igg
neg
oligoclon
band
serum
posit
antibodi
support
diagnosi
aquaporin
antibodyposit
nmo
patient
respond
treatment
steroid
slight
improv
achiev
cycl
plasma
exchang
therefor
decid
initi
treatment
rituximab
administ
dosag
mg
twice
day
purpos
treatment
monitor
follow
b
cell
level
respons
vitro
peripher
blood
mononuclear
cell
pbmc
activ
cultur
day
cytokin
analysi
th
type
cell
done
flow
cytometri
intracellular
stain
shortli
therapi
rituximab
cell
identifi
lymphocyt
gate
cell
bcell
level
monitor
routin
diagnost
method
patient
visual
acuiti
improv
normal
month
first
cycl
rituximab
number
bcell
check
regular
interv
show
expect
deplet
bcell
cell
respons
elev
therapi
remark
rituximab
administr
observ
signific
declin
produc
cell
decreas
interestingli
time
coincid
patient
clinic
improv
observ
suggest
import
role
cell
bcelltcel
axi
pathogenesi
nmo
may
provid
use
insight
mechan
action
rituximab
shortand
longterm
differenti
gene
express
chang
multipl
sclerosi
patient
treat
subcutan
hecker
michael
goertsch
robert
h
purpos
studi
character
genomewid
transcript
effect
subcutan
ifnbeta
treatment
patient
relapsingremit
multipl
sclerosi
ms
identifi
express
signatur
correl
individu
clinic
outcom
beyond
aim
analyz
transcript
factor
bind
site
tfb
promot
region
ifnbetarespons
gene
elucid
molecular
interact
affect
therapi
use
affymetrix
plu
dna
microarray
obtain
ms
patient
express
level
peripher
blood
mononuclear
cell
baselin
well
two
day
one
month
one
year
two
year
start
ifnbeta
therapi
rebif
merck
serono
upand
downregul
gene
ascertain
use
maidscor
regulatori
region
these
gene
analyz
use
tfb
predict
provid
three
differ
databas
ucsc
tfbsconssit
cisr
human
swissregulon
use
express
data
tfb
inform
construct
gene
interact
model
use
tilar
novel
integr
network
infer
algorithm
identifi
set
gene
significantli
modul
observ
period
mainli
demonstr
upregul
type
ifn
signatur
compris
eg
also
contain
known
downregul
gene
eg
howev
remark
express
differ
patient
two
day
one
month
therapi
eight
patient
show
increas
ifnbetarespons
gene
ii
marker
monocyt
activ
upregul
patient
higher
baselin
diseas
activ
tfb
ifn
regulatori
factor
significantli
overrepres
promot
upregul
gene
bind
site
repressor
ifnbeta
gene
express
enrich
regulatori
region
upand
downregul
gene
compris
ms
patient
show
differ
express
dynam
ifnbeta
therapi
may
explain
individu
advers
benefici
therapeut
outcom
result
promot
network
analys
indic
posit
neg
feedback
mechan
affect
express
known
novel
ifnbetarespons
gene
structur
insight
molecular
chaperon
depend
therapeut
function
small
heat
shock
protein
autoimmun
demyelin
brownel
sara
rothbard
jonathan
steinman
lawrenc
small
heat
shock
protein
shsp
highli
dynam
kda
oligom
wide
recogn
intracellular
molecular
chaperon
function
ten
human
small
heat
shock
protein
although
divers
express
pattern
share
abil
molecular
chaperon
although
commonli
recogn
function
bind
unfold
protein
shown
antiinflammatori
antiapoptot
function
suggest
might
therapeut
treat
autoimmun
diseas
arrigo
et
al
steinman
recent
shown
one
small
heat
shock
protein
alpha
b
crystallin
amelior
experiment
autoimmun
encephalomyel
eae
predomin
mous
model
multipl
sclerosi
ousman
et
al
primari
aim
studi
determin
small
heat
shock
protein
therapeut
eae
present
studi
shown
member
whole
famili
human
small
heat
shock
protein
therapeut
eae
mice
treat
peak
diseas
amelior
clinic
score
accompani
decreas
peripher
immun
activ
fewer
immun
cell
present
brain
spinal
cord
significantli
discov
therapeut
efficaci
shsp
due
common
molecular
chaperon
function
use
natur
occur
point
mutat
impair
proper
fold
thu
molecular
chaperon
activ
shown
mutat
also
disrupt
therapeut
efficaci
eae
final
taken
structurefunct
approach
investig
particular
region
identifi
specif
peptid
fragment
also
therapeut
eae
peptid
fragment
previous
establish
literatur
capabl
molecular
chaperon
activ
provid
evid
small
heat
shock
protein
depend
molecular
chaperon
activ
therapeut
effect
eae
small
heat
shock
protein
therapeut
autoimmun
demyelin
use
peptidebas
structurefunct
approach
found
therapeut
function
depend
molecular
chaperon
abil
shsp
alzheim
diseas
ad
accompani
accumul
neuron
cell
death
brain
patient
current
ad
therapeut
provid
mainli
symptomat
shortterm
benefit
rather
target
diseas
mechan
immunotherapi
advanc
clinic
trial
subset
patient
develop
meningoenceph
thu
develop
new
effect
way
ad
therapi
requir
propos
new
approach
ad
therapi
use
antibodi
receptor
one
hypothes
ad
neuropatholog
involv
high
affin
bind
acetylcholin
receptor
achr
cell
lysi
amyloid
plaqu
format
recent
find
also
identifi
cellular
prion
protein
one
receptor
consid
antibodi
either
achr
prion
protein
would
prevent
bind
would
protect
neuron
develop
neurodegen
process
investig
therapeut
effect
antibodi
neuron
receptor
chose
olfactori
bulbectom
obx
nmri
mice
show
impair
learn
memori
loss
neuron
cortex
hippocampu
increas
level
brain
amyloid
precursor
protein
induc
antibodi
format
mice
select
fragment
achr
prion
protein
case
achr
synthet
fragment
reveal
immunogen
free
nonconjug
form
nmri
mice
demonstr
vaccin
fragment
restor
spatial
memori
obx
mice
fourfold
decreas
level
brain
compar
nonimmun
obx
mice
passiv
immun
either
mous
blood
sera
contain
antibodi
peptid
affin
purifi
antibodi
fragment
also
restor
memori
obx
anim
induc
antibodi
prion
protein
synthet
fragment
chosen
synthes
shown
fragment
low
immunogen
nonconjug
form
therefor
investig
effect
immun
protein
conjug
fragment
obx
mice
show
immun
fragment
conjug
carrier
protein
restor
spatial
memori
obx
anim
decreas
level
brain
result
obtain
provid
new
immunotherapeut
approach
treatment
ad
base
vaccin
fragment
either
achr
prion
protein
recent
molecular
mechan
action
sever
specif
ba
defin
inhibit
either
cathepsin
g
microsom
prostaglandin
synthas
mpeg
dual
inhibit
cathepsin
g
one
main
enzym
neutrophil
involv
migrat
inflam
lesion
rank
among
highli
overexpress
gene
inflammatori
multipl
sclerosi
ms
lesion
product
one
major
key
player
inflamm
neurodegen
diseas
consid
tripl
inhibit
cathepsin
g
promis
novel
antiinflammatori
treatment
approach
relapsingremit
ms
studi
far
gener
mechanist
data
studi
design
test
safeti
toler
efficaci
mechan
action
ba
phase
iia
proofofconcept
baselinetotreat
studi
relapsingremit
ms
patient
standard
frankincens
extract
mechan
action
ba
sever
function
neutrophil
test
biomark
shall
aid
dosefind
vivo
assess
pharmacodynam
ba
identifi
dose
find
assess
toler
efficaci
contrastenhanc
mri
lesion
trial
accompani
mechanist
studi
address
ex
vivo
vitro
experi
treatment
frankincens
extract
affect
enzym
pharmacodynam
effect
sever
line
evid
suggest
involv
neutrophil
earli
step
ms
lesion
evolut
therefor
block
neutrophil
activ
ba
oral
avail
success
test
clinic
trial
sever
autoimmun
diseas
show
good
toler
appear
interest
opportun
two
clinic
trial
show
dimethyl
fumar
dmf
novel
treatment
multipl
sclerosi
ms
significantli
reduc
gadolinium
enhanc
lesion
relapsingremit
multipl
sclerosi
rrm
howev
neither
molecular
mechan
possibl
neuroprotect
properti
fulli
investig
hypothesi
dmf
exert
therapeut
effect
immun
system
central
nervou
system
cn
heme
oxygenas
induct
bonemarrow
deriv
dendrit
cell
bmdc
stimul
lpsifng
ngml
presenc
absenc
dmf
cytokin
analyz
h
stimul
result
suggest
dmf
significantli
reduc
proinflammatori
cytokin
product
eg
order
determin
chang
dc
phenotyp
lead
alter
antigen
present
subsequ
cell
activ
cocultur
system
util
stimulatori
dc
treat
dmf
vehicl
h
supernat
wash
dc
cocultur
myelinspecif
cell
receptor
tcr
transgen
cell
presenc
mbp
h
cocultur
result
show
cell
cocultur
dmf
treat
dc
express
lower
level
encephalitogen
marker
name
ifng
tbet
addit
h
thymidin
incorpor
assay
demonstr
cell
incub
dmf
treat
dc
prolifer
less
compar
nontreat
dc
addit
immunoregulatori
properti
dmf
possibl
neuroprotect
effect
also
investig
use
excitotox
model
induc
ampa
microinject
mice
pretreat
dmf
mgkg
vehicl
day
follow
ampa
inject
spinal
cord
result
demonstr
dmf
pretreat
reduc
neuron
damag
improv
behavior
outcom
compar
vehicletr
mice
indic
possibl
neuroprotect
effect
dmf
studi
show
dmf
upregul
express
dc
cn
data
suggest
dmf
inhibit
cell
encephalitogen
protect
neuron
damag
caus
excitotox
potenti
induct
effect
dietari
antioxid
gelatinas
activ
cultur
rat
astrocyt
implic
complementari
treatment
multipl
sclerosi
investig
whether
natur
antioxid
compound
might
repres
complementari
therapi
patient
multipl
sclerosi
ms
abl
modul
matrix
metalloproteinas
mmp
activ
express
primari
astrocyt
cultur
mmp
key
mediat
tissu
damag
cours
ms
primari
cultur
rat
astrocyt
activ
exposur
lp
simultan
treat
differ
dose
antioxid
resveratrol
rsv
nacetylcystein
nac
quercetin
qrc
prepar
tyrosol
hydroxytyrosol
oliplu
green
tea
extract
gte
lycopen
lyc
cultur
supernat
collect
astrocyt
h
incub
subject
gelatin
zymographi
assess
gelatinas
gelatinas
b
level
total
rna
extract
astrocyt
subject
rtpcr
assess
mrna
express
rsv
nac
qrc
oliplu
lyc
gte
dosedepend
inhibit
lpsinduc
level
cell
cultur
supernat
assess
rtpcr
rsv
oliplu
significantli
inhibit
express
antioxid
also
test
abil
inhibit
directli
mmp
activ
zymograph
run
ingel
experi
result
qrc
gte
nac
potent
inhibitor
ingel
zymograph
activ
wherea
oliplu
partial
effect
lyc
rsv
fail
inhibit
ingel
gelatinas
activ
result
suggest
bioactiv
dietari
molecul
test
studi
exert
inhibitori
effect
mmp
display
differ
mechan
action
therefor
combin
use
low
concentr
molecul
may
use
effect
complementari
dietari
supplement
wellb
ms
patient
convent
therapi
support
ms
project
grant
italian
multipl
sclerosi
foundat
fism
potenti
neuroprotect
neurogenesi
immunomodulatori
treatment
glatiram
acetat
aharoni
rina
eilam
raya
arnon
ruth
weizmann
institut
pf
scienc
rehovot
israel
background
multipl
sclerosi
ms
anim
model
experiment
autoimmun
encephalomyel
eae
complex
diseas
involv
inflamm
well
oligodendrocyt
neuron
patholog
treatment
strategi
aim
affect
cn
reduc
inflamm
induc
neuroprotect
repair
process
tcell
produc
major
contributor
pathogenesi
wherea
regulatori
tcell
treg
play
role
suppress
autoimmun
therapeut
effect
glatiram
acet
ga
attribut
immunomodul
inflammatori
toward
antiinflammatori
pathway
object
identifi
cell
popul
relev
pathogenesi
repair
within
injur
cn
explor
whether
immunomodulatori
treatment
lead
neuroprotect
situ
method
daili
inject
ga
initi
follow
diseas
induct
diseas
develop
two
eae
model
relapsingremit
plpand
chronic
moginduc
eae
treg
identifi
express
respect
incid
within
cn
local
injuri
site
analyz
prolifer
marker
brdu
inject
concurr
ga
incorpor
progenitor
cell
express
variou
development
marker
detect
neuron
myelin
damag
identifi
use
electron
microscopi
immunohistochemistri
result
cn
mice
either
relapsingremit
chronic
eae
tcell
activ
microglia
express
appar
local
within
region
myelin
loss
ga
treat
mice
cn
inflamm
occurr
drastic
reduc
parallel
elev
treg
indic
immunomodulatori
consequ
ga
treatment
situ
furthermor
ga
treatment
result
reduct
neuron
myelin
damag
augment
three
process
characterist
neurogenesisneuron
prolifer
migrat
differenti
newborn
neuron
migrat
exist
dormant
pathway
injuri
site
brain
region
normal
undergo
neurogenesi
differenti
matur
neuron
phenotyp
ga
treatment
induc
also
prolifer
differenti
toward
oligodendrocyt
lineag
immunomodulatori
treatment
may
counteract
neurodegen
diseas
cours
point
direct
linkag
neuroprotect
therapeut
activ
cn
use
abetahsp
conjug
novel
vaccin
approach
alzheim
diseas
activ
vaccin
amyloid
beta
peptid
abeta
shown
remark
effect
clear
cerebr
abeta
improv
cognit
function
mous
model
alzheim
diseas
ad
howev
emulsifi
adjuv
abeta
vaccin
induc
meningoenceph
ad
patient
phase
clinic
trial
presum
result
pathogen
activ
immun
system
abeta
studi
gener
novel
heat
shock
protein
hsp
base
vaccin
contain
abeta
bcell
epitop
abeta
peptid
abeta
vaccin
demonstr
wherea
conjug
abetahsp
vaccin
promot
mild
tcell
respons
human
mous
model
ad
carri
allel
humor
respons
suffici
promot
signific
reduct
cerebr
amyloid
burden
well
associ
inflammatori
respons
analyz
antibodi
isotyp
evok
follow
abetahsp
vaccin
reveal
predomin
isotyp
rel
low
titer
indic
activ
immun
respons
type
vaccin
combin
gradual
increas
antibodi
product
accompani
mild
tcell
respons
like
due
uniqu
adjuv
properti
self
hsp
peptid
use
tlr
ligand
tcell
epitop
possibl
provid
safer
efficaci
approach
ad
vaccin
multipl
sclerosi
ms
chronic
demyelin
autoimmun
diseas
central
nervou
system
current
ms
therapi
decreas
frequenc
relaps
modestli
accumul
disabl
prevent
progress
diseas
definit
altern
approach
ms
treatment
need
toler
induct
selfantigen
promis
therapeut
strategi
autoimmun
dendrit
cell
dc
main
antigen
present
cell
dc
therapi
tumour
infect
immunolog
longli
investig
potenti
tool
induc
immunorespons
situat
aim
induc
toler
ms
patient
use
tolerogen
dc
load
myelin
deriv
peptid
sourc
specif
antigen
peripher
blood
cell
obtain
donor
n
patient
relapsingremit
ms
n
monocytederiv
dc
mddc
obtain
follow
convent
protocol
presenc
gmcsf
matur
induc
proinflamatori
cytokin
cocktail
absenc
matdc
presenc
toldc
tolerogen
induc
agent
differenti
monocyt
mddc
evalu
morpholog
viabil
phenotyp
cytokin
product
induct
cell
prolifer
mddc
differenti
healthi
subject
ms
patient
exhibit
similar
yield
viabil
function
particular
toldc
express
reduc
level
hladr
compar
matdc
produc
lower
level
additt
prolifer
allogen
cell
induc
toldc
also
lower
analysi
cytokin
found
cocultur
supernat
reveal
reduc
secret
proinflammatori
mediat
tnfalfa
ifngamma
addit
toldc
resist
subsequ
matur
stimulu
induc
lp
final
bind
myelin
peptid
mddc
shown
immunofluoresc
competit
assay
myelin
peptideload
matdc
induc
prolifer
autolog
cell
obtain
ms
patient
thu
confirm
specif
assay
conclus
demonstr
toldc
may
gener
monocyt
ms
patient
toldc
induc
hyporespons
allogen
cell
thu
suggest
tolerogen
potenti
consequ
load
toldc
myelin
peptid
might
effect
tool
induc
antigenspecif
hyporespons
ms
patient
lead
toler
induct
follow
spinal
cord
injuri
sci
neuropath
chronic
pain
major
caus
disabl
recent
evid
suggest
express
sci
might
involv
develop
neuropath
pain
aim
present
studi
test
effect
novel
inhibitor
evok
field
potenti
ep
longterm
potenti
ltp
dorsal
horn
area
spinal
cord
rat
suffer
sci
spinal
cord
transact
level
adult
rat
behaviour
data
collect
sci
rat
reveal
sensori
motor
deficit
week
spinal
cord
slice
obtain
sci
well
control
rat
bioelectr
activ
record
dorsal
horn
lamina
iiii
electr
stimul
appli
bipolar
platinum
electrod
attach
dorsal
root
condit
tetan
stimul
deliv
dorsal
root
spinal
cord
slice
follow
puls
stimul
paramet
ident
control
amplitud
evok
potenti
dh
spinal
cord
slice
decreas
p
b
p
b
initi
valu
within
min
addit
bath
medium
concentr
respect
applic
concentr
min
tetan
stimul
significantli
inhibit
ltp
induct
slice
control
p
result
suggest
possibl
analges
effect
neuropath
pain
sci
keyword
inhibitor
nneuropath
pain
injur
spinal
cord
recent
evid
indic
proinflammatori
cytokin
play
import
role
inflammationinduc
cachexia
via
mechan
interact
hypothalam
neuron
circuit
regul
appetit
adjuv
arthriti
aa
rat
use
model
inflammatori
cachexia
character
anorexia
increas
metabol
rate
bodi
mass
loss
mimic
pathophysiolog
human
rheumatoid
arthriti
aim
studi
investig
whether
chronic
inflammatori
process
aa
affect
mrna
express
neuropeptid
involv
control
appetit
along
circul
level
leptin
ghrelin
insulin
corticosteron
adiponectin
condit
overunderand
normofeed
hypothalam
arcuat
nucleu
arc
mrna
express
orexigen
neuropeptid
npi
agoutirel
protein
agrp
anorexigen
proopiomelanocortin
pomc
cocaineand
amphetaminerel
transcript
cart
quantifi
use
quantit
realtim
pcr
plasma
hormon
level
determin
ria
elisa
bodi
mass
leptin
adiponectin
decreas
ghrelin
corticosteron
increas
aa
dietari
regim
insulin
reduc
aa
underf
rat
express
npi
agrp
enhanc
cart
reduc
pomc
unchang
aa
dietari
modul
group
howev
underfeed
aa
led
profound
bodi
mass
loss
reduc
leptin
insulin
increas
ghrelin
corticosteron
level
well
enhanc
express
npi
agrp
reduc
express
pomc
cart
compar
overand
normofeed
aa
result
demonstr
aa
independ
underand
normofeed
associ
overexpress
arc
may
involv
inflammatori
cachexia
rather
anorexigen
neuropeptid
cart
pomc
whose
express
reduc
unaffect
aa
dietari
regim
moreov
overexpress
orexigen
npi
agrp
aa
dietari
regim
indic
import
maintain
energi
homeostasi
neg
energi
balanc
underf
aa
rat
stronger
respons
orexigen
neuropeptid
weaker
respons
anorexigen
neuropeptid
line
previous
attribut
role
bodi
weight
homeostasi
lower
express
may
reflect
milder
inflamm
underf
rat
support
antinmdar
enceph
complement
activ
tumor
brain
anti
receptor
nmdar
enceph
sever
potenti
lethal
treatment
respons
disord
well
defin
set
clinic
featur
presenc
underli
tumor
mostli
teratoma
vari
accord
sex
gender
recent
report
experi
demonstr
nmdar
autoantibodi
pathogen
effect
caus
select
revers
decreas
nmdar
surfac
densiti
synapt
local
mechan
crosslink
intern
nmdar
antibodi
subtyp
work
explor
complement
cytotox
could
second
pathogen
mechan
examin
activ
complement
cultur
embryon
rat
hippocamp
neuron
expos
patient
csf
determin
whether
complement
deposit
tumor
ovarian
teratoma
pancreat
testicular
breast
tumor
brain
biopsi
autopsi
patient
antinmdar
enceph
hippocampu
rat
previous
infus
patient
antibodi
week
complement
compon
membran
attack
complex
mac
detect
linear
deposit
cell
membran
neuron
incub
fresh
frozen
serum
healthi
donor
complement
deposit
found
tumor
patient
tumor
control
teratoma
linear
vascular
pattern
contrast
complement
deposit
seen
control
hippocampu
patient
brain
sampl
examin
mac
stain
granular
pattern
seen
one
patient
biopsi
taken
necrot
cystic
lesion
tempor
lobe
visibl
brain
mri
similar
radiolog
patholog
find
found
patient
antinmdar
enceph
studi
laboratori
mac
immunostain
absent
hippocampu
rat
infus
patient
csf
studi
show
antibodi
patient
antinmdar
enceph
activ
complement
deposit
complement
detect
tumor
brain
current
data
coupl
previou
studi
show
revers
loss
nmdarmedi
synapt
function
suggest
main
pathogen
mechan
antibodymedi
neuron
dysfunct
complementmedi
neuron
lysi
purpos
studi
determin
associ
polymorph
clinic
characterist
mg
chines
han
nation
polymorph
determin
pcrrflp
method
sporad
mg
patient
unrel
healthi
control
without
evid
common
autoimmun
diseas
frequenc
genotyp
allel
compar
mg
group
control
group
among
differ
subgroup
classifi
gender
age
onset
osserman
type
maxim
sever
patholog
thymu
mg
patient
relationship
genotyp
allel
mgfa
score
maxim
sever
followup
shortterm
effici
glucocorticoid
also
explor
patient
requir
immunolog
treatment
includ
studi
treat
mediumdos
glucocorticoid
initi
treatment
effici
determin
rel
score
proport
differ
absolut
score
treatment
absolut
score
treatment
absolut
score
treatment
satisfactori
shortterm
effici
defin
rel
score
within
month
regular
treatment
glucocorticoid
dose
equival
prednison
less
signific
differ
frequenc
genotyp
allel
mg
group
control
among
subgroup
gender
age
onset
ocular
gener
mg
patholog
thymu
mg
pn
differ
mean
age
onset
mean
maxim
mgfa
score
among
differ
genotyp
allel
group
p
n
unsatisfactori
shortterm
effici
glucocorticoid
gener
mg
patient
preval
ocular
mg
patient
p
patient
thymoma
preval
patient
without
thymoma
p
mean
pretreat
mgfa
score
higher
patient
unsatisfactori
effici
glucocorticoid
p
effici
relat
age
onset
pretreat
durat
diseas
pn
logist
regress
analysi
reveal
higher
pretreat
mgfa
score
wors
effici
glucocorticoid
mg
patient
p
signific
correl
polymorph
suscept
mg
maxim
sever
shortterm
glucocorticoid
effici
cathol
univers
roma
itali
b
lymphocyt
induc
matur
transcript
repressor
play
crucial
role
differenti
function
b
lymphocyt
b
lymphocyt
requir
antigendepend
termin
differenti
b
cell
immunoglobulinsecret
plasmablast
plasma
cell
lymphocyt
induc
express
repress
gene
transcript
inhibit
cell
prolifer
influenc
gener
memori
precursor
effector
cell
central
memori
cell
multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
usual
consid
autoimmun
diseas
even
recent
studi
underlin
new
crucial
role
cell
also
b
cell
studi
evalu
flow
cytometri
mean
fluoresc
intens
mfi
cell
b
cell
percentag
cell
b
cell
peripher
blood
untreat
relaps
remit
multipl
sclerosi
patient
rrm
relaps
remiss
healthi
subject
hs
also
stimul
cell
day
cellcultur
experi
differ
dose
without
observ
higher
percentag
circul
b
cell
rrm
patient
relaps
remiss
also
found
mfi
significantli
lower
cell
ms
patient
compar
hs
mfi
significantli
lower
cell
relaps
ms
patient
hs
furthermor
percentag
cell
higher
relaps
patient
hs
stimul
cell
differ
amount
observ
high
dose
induc
express
cell
day
express
remain
stabl
day
low
dose
induc
express
day
cultur
ad
cultur
proinflammatori
cytokin
clearli
inhibit
express
cell
rrm
patient
hs
even
presenc
high
dose
demonstr
plasma
cell
plasmablast
may
involv
acut
phase
rrm
dysregul
express
present
cell
relaps
ms
patient
data
suggest
consid
potenti
new
target
ms
therapi
potent
tool
use
identifi
character
receptor
among
tool
neurotoxin
use
studi
function
role
ionic
channel
mainli
n
k
channel
bind
neurotoxin
receptor
induc
specif
pharmacolog
properti
type
channel
neurotoxin
act
k
channel
kaliotoxin
ktx
purifi
neurotoxin
androctonu
australi
hector
venom
scorpion
exhibit
high
affin
k
channel
mammalian
nervou
system
toxic
action
differ
mainli
chosen
rout
inject
well
known
specif
target
ktx
locat
central
nervou
system
mode
inocul
could
essenti
fixat
specif
target
neuropatholog
effect
aim
studi
investig
involv
potassium
channel
regul
variou
biolog
system
analysi
tissu
damag
biochem
modif
inflammatori
respons
carri
mice
experiment
envenom
use
intracerebroventricular
icv
subcutan
sc
rout
result
show
inocul
ktx
icv
induc
sever
disturb
cerebr
cortex
oedema
hemorrhag
necrosi
toxin
induc
also
inflammatori
respons
mark
increas
inflammatori
cell
anim
brain
respons
accompani
signific
increas
protein
marker
inflamm
epo
mpo
albumin
globulin
fraction
alpha
alpha
globulin
beta
gamma
globulin
indic
infiltr
eosinophil
neutrophil
organ
anim
system
cardiorespiratori
endocrin
also
alter
dysfunct
result
tissu
damag
correl
high
level
biochem
paramet
inocul
ktx
subcutan
sc
rout
provok
effect
result
report
present
studi
suggest
involv
k
channel
variou
regul
nervou
cardiorespiratori
hormon
system
dysfunct
could
lead
neurolog
diseas
keyword
k
channel
kaliotoxin
nervou
system
inflamm
endocrin
function
multipl
sclerosi
ms
immunemedi
demyelin
diseas
central
nervou
system
cn
wellcharacter
anim
model
experiment
autoimmun
encephalomyel
eae
major
focu
mseae
immunolog
cell
sever
report
other
us
show
cell
play
import
role
diseas
role
cnsspecif
autoreact
cell
ms
eae
pathogenesi
still
unclear
focu
studi
use
sensit
flow
cytometrybas
suppress
assay
saw
cn
autoantigenspecif
cell
specif
control
antigen
exhibit
regulatori
abil
suppress
cell
prolifer
antigenspecif
tcell
line
confirm
cnsspecif
cell
suppress
cell
control
antigenspecif
cell
suppress
abil
depend
hla
class
present
tnfa
secret
note
cell
ms
patient
acut
exacerb
defici
suppress
cnsspecif
cell
respons
compar
healthi
subject
untreat
quiescent
ms
patient
mice
cell
abl
suppress
eae
novel
unexpect
function
requir
vivo
class
imedi
present
cognat
antigen
depend
ifnand
perforin
product
cell
regulatori
cell
abl
kill
mogload
cell
well
apc
vivo
suggest
cytotoxicsuppressor
mechan
regul
diseas
associ
modul
apc
function
well
decreas
mogspecif
cell
respons
result
demonstr
cnsspecif
cell
import
regulatori
role
ms
diseas
perturb
immun
regul
understand
arm
adapt
immun
system
offer
promis
strategi
immunotherapeut
intervent
futur
studi
support
grant
award
nih
nation
ms
societi
includ
harri
weaver
neurosci
scholar
award
nmss
local
tissuedrain
lymph
node
vital
gener
immun
respons
infect
autoimmun
diseas
also
maintain
immun
toler
self
antigen
tissu
antigen
reach
drain
lymph
node
lymphat
howev
lymphat
vessel
lack
cn
parenchyma
despit
uniqu
anatom
featur
cn
antigen
reach
cnsdrain
cervic
lymph
node
cln
lumbar
lymph
node
lln
henc
cln
lln
like
control
cn
inflamm
therefor
investig
access
cn
compound
cln
function
outcom
use
human
tissu
anim
model
show
myelin
neuron
antigen
transfer
cln
ms
eae
mice
well
rhesu
monkey
marmoset
monkey
self
antigen
present
function
distinct
antigen
present
cell
cell
characterist
macrophagesmicroglia
dendrit
cell
myelinspecif
cell
respons
occur
cln
eaeaffect
anim
hypothes
cnsdrain
lymph
node
involv
eae
diseas
progress
eae
test
surgic
remov
superfici
cln
deep
cln
lln
mice
eae
induct
use
three
model
clinic
differ
eae
cours
demonstr
remov
cn
drain
lymph
node
affect
first
acut
phase
diseas
howev
anim
cln
lln
surgic
remov
develop
less
sever
relaps
compar
shamoper
indic
cnsdrain
lymph
node
pivot
fulli
develop
relaps
collect
data
demonstr
cln
eae
involv
immun
toler
control
autoaggress
respons
cln
function
support
relaps
develop
support
concept
cnsdrain
lymph
node
may
interest
target
therapeut
intervent
ms
clarifi
function
signific
cn
gener
transgen
mous
line
astrocyterestrict
express
gene
transgen
mice
develop
normal
show
sign
neurolog
dysfunct
howev
histolog
character
reveal
substanti
astrocytosi
mild
activ
microglia
morpholog
criteria
observ
sign
demyelin
neurodegener
promin
tissu
damag
scatter
calcif
small
intraparenchymat
vessel
histolog
facsanalysi
show
absenc
parenchym
infiltr
immun
cell
cn
transgen
mice
investig
act
synergist
proinflammatori
stimuli
system
treat
mice
wild
type
control
lp
observ
flow
cytometri
pronounc
microgli
activ
increas
amount
microglia
mice
compar
control
furthermor
quantif
mrna
level
reveal
upregul
proinflammatori
cytokin
gene
like
tnfa
substanti
higher
mice
compar
wild
type
control
result
demonstr
chronic
astrogli
synthesi
cn
induc
astrocytosi
microgli
activ
sever
tissu
damag
directli
promot
infiltr
hematogen
cell
data
argu
key
role
mediat
tissu
damag
neuroinflamm
like
act
modul
factor
network
induc
cytokin
novel
mous
model
use
tool
character
role
neuroinflammatori
diseas
model
demonstr
transgen
mous
model
cnstarget
product
cytokin
cytokin
peripher
blood
natur
killer
cell
cytotox
crosstalk
restraint
stress
influenc
stress
genotyp
pig
ciepielewski
ziemowit
stojek
wojciech
glac
wojciech
myslinska
dorota
lewandowska
danuta
aim
studi
evalu
peripher
blood
natur
killer
cell
cytotox
nkcc
plasma
level
two
cytokin
play
crucial
role
regulatori
mechan
nkcc
interleukin
interleukin
stress
pig
differ
genet
base
stress
vulner
restraint
special
construct
hammock
use
stress
model
experi
perform
chronic
catheteris
pietrain
crossbr
male
pig
divid
molecular
analysi
screen
singl
aminoacid
mutat
ryanodin
receptor
gene
group
stress
suscept
homozygotesnn
stress
resist
heterozygotesnn
homozygotesnn
found
mean
baselin
plasma
elisa
level
well
nkcc
essay
differ
significantli
ryr
genotyp
highest
baselin
level
cytokin
observ
stress
gene
carrier
nn
anim
differ
pattern
chang
emerg
particular
cytokin
stress
period
signific
amplitud
chang
observ
nn
stress
suscept
anim
compar
stress
resist
nn
nn
pig
nn
group
plasma
level
increas
stress
reach
two
separ
peak
first
one
min
maxim
increas
second
min
plasma
level
increas
earli
phase
stress
peak
min
maxim
increas
nn
anim
return
baselin
valu
min
genotyp
group
similarli
highest
level
nkcc
observ
stress
suscept
nn
pig
stress
period
restraint
also
evok
biphas
chang
nkcc
shortlast
enhanc
min
genotyp
pronounc
nn
pigsincreas
follow
subsequ
suppress
min
decreas
stress
resist
nn
pig
data
suggest
time
depend
differ
respons
stress
could
contribut
stressinduc
stimulatori
effect
blood
nkcc
moreov
intensif
reactiv
differ
compart
immun
system
stress
could
depend
stress
suscept
statu
anim
probabl
involv
hitherto
unknown
mechan
underli
gene
depend
modul
individu
stress
respons
neuromyel
optica
nmo
sever
demyelin
diseas
subject
increas
interest
sinc
discoveri
highli
specif
serum
biomark
nmoigg
target
antigen
water
channel
protein
astrocyt
endfeet
express
form
full
length
shorter
isoform
previou
data
group
confirm
presenc
sera
nmo
high
risk
patient
also
indic
conform
epitop
primari
target
base
result
intend
investig
abil
induc
cellular
complement
mediat
cytotox
cdc
transfect
cell
expos
heat
inactiv
sampl
nmo
patient
control
addit
activ
complement
complement
depend
cytotox
cdc
analyz
presenc
termin
complement
complex
tcc
use
live
cell
stain
immunofluoresc
assay
flow
cytometri
result
show
cell
bound
compon
activ
complement
cascad
cell
incub
high
titer
posit
sampl
healthi
control
patient
multipl
sclerosi
besid
cdc
antibodi
depend
cellular
cytotox
adcc
current
evalu
incub
transfect
cell
surfacebound
patient
human
nk
cell
cell
death
transfect
cell
activ
statu
nk
cell
examin
flow
cytometri
analysi
cdc
adcc
mediat
human
antibodi
might
provid
new
insight
role
antibodi
nmo
sever
studi
report
cytotox
mechan
mani
patholog
event
accident
patholog
like
scorpion
envenom
complex
immun
respons
reaction
releas
activ
inflammatori
mediat
cellular
infiltr
observ
pharmacolog
action
scorpion
venom
north
africa
rel
scarc
direct
action
crude
venom
assess
use
cell
cultur
model
work
investig
toxic
venom
cell
cultur
mice
undertaken
vivo
effect
androctonu
australi
hector
aah
venom
macrophag
spleen
cell
examin
addit
obtain
periton
macrophag
male
balbc
mice
cultur
cell
stimul
vitro
aah
venom
show
aah
venom
induc
cytotox
activ
macrophag
splenocyt
determin
cytotox
test
crystal
violet
stain
h
incub
concentr
venom
vivo
venom
biochem
studi
also
conduct
evalu
oxid
stress
caus
venom
mediat
oxid
balanc
measur
malondialdehyd
index
lipid
peroxid
glutathion
h
stimul
increas
product
malondialdehyd
observ
splenocyt
compar
control
cell
lipid
peroxid
either
caus
effect
toxic
reaction
induc
scorpion
venom
inde
increas
lipid
peroxid
correl
increas
product
hydrogen
peroxid
signific
releas
also
obtain
activ
periton
macrophag
low
dose
aah
venom
furthermor
increas
intracellular
glutathion
marker
antioxid
balanc
highlight
spleen
cell
macrophag
activ
cell
line
increas
dose
venom
caus
maximum
product
glutathion
low
dose
venom
mechan
action
led
venom
complex
involv
inflammatori
cell
mediat
process
cytotox
remain
unclear
differ
cellular
immun
associ
activ
diseas
patient
ms
nmo
matsui
makoto
hashiba
naomi
araya
shinichi
inada
hiroyuki
nagayama
shigemi
tanaka
keiko
konishi
tetsuro
kanazawa
medic
univers
uchinada
japan
utano
nation
hospit
kyoto
japan
ongo
discuss
regard
whether
multipl
sclerosi
ms
neuromyel
optica
nmo
consid
distinct
diseas
entiti
repres
spectrum
demyelin
diseas
address
differ
pathogenesi
ms
nmo
patient
import
compar
inflammatori
event
occur
system
circul
well
cerebrospin
fluid
csf
relaps
activ
diseas
state
investig
cellular
immunolog
event
blood
csf
sampl
obtain
patient
activ
ms
nmo
use
flow
cytometri
system
fifteen
patient
ms
women
men
nmo
women
enrol
studi
ms
patient
typic
ms
plaqu
brain
fulfil
barkhof
criteria
long
spinal
cord
lesion
lcl
encompass
vertebr
segment
neg
contrast
nmo
patient
lcl
posit
antibodi
none
subject
receiv
immunomodulatori
drug
time
studi
examin
relaps
activ
stage
diseas
magnet
reson
imag
mri
scan
show
gadolinium
enhanc
brain
spinal
cord
blood
csf
sampl
obtain
day
measur
use
flow
cytometri
perform
determin
percentag
cell
b
cell
function
subset
includ
high
regulatori
cell
cell
subset
includ
cytotox
cell
cell
addit
level
csf
protein
albumin
igg
well
igg
index
determin
peripher
blood
patient
nmo
cell
popul
significantli
decreas
compar
ms
group
vs
protein
level
significantli
increas
csf
nmo
group
vs
mgdl
assess
relev
lesion
format
optic
nerv
spinal
cord
data
obtain
patient
spinal
opticspin
ms
n
nmo
patient
n
compar
indic
antibodi
posit
contribut
decreas
cell
csf
result
suggest
relaps
nmo
patient
background
system
immunoregulatori
disturb
conspicu
ms
patient
furthermor
antibodi
effect
cellular
immun
central
nervou
system
antiinflammatori
cytokin
help
restor
femal
cycl
integr
immunolog
challeng
barad
zsuzsanna
klaudia
kiss
endr
dorottya
gabriella
ctr
neuroendocrinolog
dept
physiol
univ
otago
dunedin
new
inst
med
scienc
univ
aberdeen
aberdeen
unit
kingdom
dept
immunol
eotvo
lorand
univ
budapest
hungari
well
known
peripher
immun
challeng
interfer
reproduct
femal
immuneinflammatori
stress
disrupt
estru
cycl
affect
sever
level
hypothalamuspituitarygonad
hpg
axi
previou
research
shown
peripher
lp
inject
abl
alter
pulsatil
gonadotrophin
releas
hormon
gnrh
secret
gonadotrophin
releas
hormon
neuron
gnrh
neuron
medial
preoptic
area
mpoa
femal
rat
aim
experi
test
effect
celldepend
antigen
fluorescein
isothiocyan
conjug
keyhol
limpet
hemocyanin
fitcklh
cellindepend
antigen
fitc
conjug
dextran
gnrh
neuron
upon
immun
femal
knockout
ko
mice
measur
phosphoryl
extracellular
signalregul
kinas
index
intracellular
chang
gnrh
neuron
detect
mean
doublelabel
immunohistochemistri
differ
time
point
immun
celldepend
antigeninduc
immun
challeng
led
signific
increas
p
b
gnrh
neuron
day
maximum
increas
day
contrast
fitcdextran
administr
fail
effect
phosphoryl
gnrh
neuron
interestingli
elev
level
antiinflammatori
cytokin
pb
hypothalamu
fitcklh
challeng
mice
show
strong
synchron
increas
gnrh
neuron
proinflammatori
cytokin
tnfa
prostaglandin
detect
hypothalamu
immun
mice
time
role
evalu
use
ko
mice
immun
ko
mice
show
increas
gnrh
neuron
day
complet
abolish
effect
immun
cycl
integr
assess
analyz
vagin
smear
daili
least
week
prior
administr
fitcklh
found
initi
disrupt
cycl
integr
might
caus
immun
challeng
restor
day
wild
type
mice
ko
anim
show
highli
irregular
cycl
perturb
immun
taken
togeth
result
suggest
releas
immun
respons
time
antigen
depend
manner
may
regul
gnrh
neuron
function
induc
phosphoryl
therebi
contribut
integr
hpg
axi
background
multipl
sclerosi
ms
relapsingremit
demyelin
diseas
despit
evid
support
idea
ms
cellmedi
autoimmun
diseas
involv
autoantigenspecif
regulatori
effector
lymphocyt
fulli
understood
remain
establish
object
assess
dynam
autorreact
effector
teff
regulatori
treg
lymphocyt
progress
experiment
autoimmun
encephalomyel
eae
anim
model
multipl
sclerosi
also
made
screen
balanc
popul
method
induc
eae
ia
b
perform
quantit
analysi
use
mhc
class
ii
tetram
tetram
use
track
autoantigenspecif
regulatori
effector
cell
diseas
detect
character
antigenspecif
cell
realiz
spleen
lymphat
node
peripher
blood
cn
tissu
progress
eae
analyz
flow
cytometri
result
observ
increas
popul
teff
treg
specif
mog
induct
diseas
current
perform
analysi
popul
brain
tissu
addit
observ
subpopul
crossreact
mog
tetram
go
character
conclus
better
understand
effector
regulatori
cell
dynam
allow
improv
knowledg
pathogenesi
autoimmun
diseas
studi
requir
order
find
new
therapi
target
granulocytemacrophag
colonystimul
factor
gmcsf
signatur
cytokin
autoimmun
pathogen
cell
known
absolut
requir
gener
encephalitogen
cell
respons
mechan
action
begin
becom
unravel
includ
prime
effector
phase
respons
found
intracerebr
product
gmcsf
healthi
mice
suffic
recruit
ident
dendrit
cell
dc
popul
eae
cn
popul
consist
minor
lymphoid
dc
major
myeloid
inflammatori
dc
eae
intracerebr
gmcsf
treatment
dc
found
within
cn
prove
origin
function
properti
lymphoid
myeloid
dc
almost
exclus
bloodderiv
wherea
inflammatori
dc
constitut
bloodand
cnsderiv
cell
furthermor
lymphoid
myeloid
dc
found
stimul
cell
prolifer
cytokin
secret
strongli
peripher
inflammatori
dc
inferior
function
contrast
cnsderiv
inflammatori
dc
well
microgli
cell
treat
vitro
gmcsf
found
abl
inhibit
cell
prolifer
despit
capac
gmcsf
induc
cnsderiv
inhibitori
infldc
administr
gmcsf
mice
eae
result
exacerb
diseas
gmcsf
dual
role
cn
direct
cnsderiv
dc
toward
inhibitori
phenotyp
recruit
peripher
dc
exhibit
proinflammatori
function
addit
cnsspecif
effector
function
investig
discuss
vascular
cell
adhes
molecul
shown
key
factor
initi
step
leukocyt
extravas
ms
lesion
serv
ligand
express
leukocyt
consecut
solubl
form
svcam
upregul
endotheli
activ
inflammatori
diseas
natalizumab
recombin
monoclon
antibodi
direct
downregul
cellular
traffick
across
blood
brain
barrier
effect
blockag
counterpart
investig
vivo
want
investig
serum
level
affect
natalizumab
treatment
compar
variou
control
group
level
may
serv
marker
natalizumab
bioavail
investig
effect
natalizumab
serum
level
measur
elisa
ms
patient
sampl
compar
variou
control
group
includ
ten
healthi
person
untreat
well
interferonbeta
treat
ms
patient
sampl
subset
patient
control
express
measur
fluoresc
activ
cell
sort
lymphocyt
monocyt
neutral
antibodi
nab
natalizumab
interferonbeta
determin
standard
method
median
serum
concentr
significantli
lower
sampl
natalizumab
treat
patient
compar
control
sampl
vs
ngml
signific
differ
control
sampl
nab
posit
natalizumab
sampl
vs
ngml
signific
differ
nab
posit
versu
nab
neg
sampl
vs
ngml
concentr
less
ngml
indic
natalizumab
treatment
sensit
specif
concentr
followup
sampl
natalizumab
treat
patient
chang
time
express
present
nearli
lymphocyt
monocyt
control
almost
entir
block
natalizumab
treat
patient
believ
studi
result
indic
dual
role
natalizumab
block
downregul
mechan
may
involv
reduc
cell
traffick
cn
lead
clinic
effect
natalizumab
also
rare
albeit
evid
advers
event
progress
multifoc
leukoencephalopathi
observ
ms
patient
treatment
appear
good
biomark
natalizumab
bioactiv
might
use
therapi
monitor
ms
chronic
inflammatori
demyelin
diseas
central
nervou
system
also
regard
cellsmedi
autoimmun
diseas
natur
killer
nk
cell
major
compon
innat
immun
system
capabl
kill
target
cell
without
prior
immun
sever
report
suggest
protect
role
nk
cell
ms
patient
nk
cell
kill
autolog
cell
defin
far
goal
current
studi
identifi
mechan
util
nk
cell
kill
autolog
cell
use
polyclon
activ
cell
isol
peripher
blood
mononuclear
cell
pbmc
daclizumabtr
ms
patient
neg
select
target
cell
target
cell
effect
kill
autolog
nk
cell
e
ratio
modifi
flowcytometri
base
kill
assay
demonstr
predomin
degranul
oppos
nk
cell
contrast
rest
cell
kill
order
identifi
mechan
kill
sever
block
reagent
appli
egta
inhibit
degranul
nk
cell
block
effect
zvadfmk
pancaspas
inhibitor
block
effect
kill
neutral
antifa
ab
trail
effect
confoc
microscopi
observ
transfer
granzym
gzm
b
k
effector
cell
activ
cell
within
h
cocultur
quantit
gzm
k
almost
complet
absent
activ
cell
highest
fold
increas
granzym
includ
gzma
gzmb
gzmk
kill
target
cell
induc
mitochondri
dysfunct
reactiv
oxygen
speci
ro
measur
mitochondri
transmembran
potenti
intracellular
ro
format
found
significantli
impair
activ
cell
upon
cocultur
nk
cell
granul
exocytosi
pathway
contribut
nk
cellsmedi
kill
autolog
cell
multipl
sclerosi
chemokin
receptor
origin
describ
chemotact
cytokin
involv
leucocyt
traffick
howev
research
shown
chemokin
receptor
restrict
leucocyt
one
receptor
regul
traffick
effector
function
cell
macrophag
nk
cell
immatur
dendrit
cell
common
delet
code
region
gene
origin
truncat
nonfunct
receptor
reduc
express
cell
surfac
multipl
sclerosi
ms
patient
elev
percentag
blood
cell
express
compar
healthi
control
suggest
genet
polymorph
could
modul
diseas
suscept
progress
investig
whether
delet
associ
suscept
andor
sever
portugues
ms
patient
total
ms
patient
ethnicallymatch
control
studi
subset
patient
diseas
durat
least
year
divid
group
accord
sever
patient
consid
benign
ms
edss
b
aggress
ms
edss
n
kaplanmei
surviv
analysi
distribut
time
reach
mild
edss
sever
disabl
edss
perform
differ
distribut
test
use
log
rank
test
signific
differ
observ
allel
frequenc
patient
control
ms
vs
control
p
concern
diseas
sever
frequenc
significantli
higher
aggress
group
benign
ms
vs
aggress
ms
p
edss
end
point
median
progress
time
year
posit
patient
year
neg
p
reach
edss
median
progress
time
year
posit
group
year
group
p
studi
ms
patient
carri
delet
appear
wors
prognosi
agreement
previou
studi
gadeandavolu
colleagu
genet
med
report
strong
associ
delet
earli
death
delet
may
protect
develop
ms
although
could
confirm
studi
howev
diseas
diagnos
carrier
may
progress
rapidli
advanc
edss
suggest
possibl
dual
effect
delet
object
confirm
differenti
gene
express
ms
patient
hd
use
realtim
pcr
ii
studi
put
role
ms
pathogenesi
gene
express
determin
real
timepcr
fresh
frozen
peripher
blood
mononuclear
cell
pbmc
relapsingremit
rr
ms
patient
hd
contrast
previou
result
express
fresh
pbmc
rrm
patient
significantli
increas
compar
hd
n
per
group
fold
chang
p
express
induc
stress
condit
previou
studi
use
fresh
frozen
pbmc
analyz
whether
freez
could
modifi
express
explain
controversi
observ
data
howev
express
significantli
chang
compar
fresh
frozen
pbmc
either
hd
fold
p
rrm
patient
n
fold
chang
p
howev
gene
express
increas
rrm
patient
associ
chang
protein
express
cell
monocyt
studi
put
role
ms
induc
experiment
autoimmun
encephalomyel
eae
ko
mice
two
independ
studi
clinic
histopatholog
differ
ko
mice
found
compar
wildtyp
mice
even
though
differ
statist
signific
eae
incid
reduct
vs
increas
diseas
sever
maximum
score
vs
observ
ko
mice
present
studi
previou
data
deriv
microarray
studi
regard
express
ms
patient
could
confirm
use
rtpcr
approach
convers
gene
express
found
increas
rrm
patient
compar
hd
data
suggest
relat
enhanc
immun
respons
addit
studi
need
gain
insight
biolog
relev
ms
pathogenesi
virusprim
memori
cell
protect
immunodefici
scid
recipi
follow
cn
infect
neurotrop
coronaviru
jhmv
wherea
ifng
defici
gko
donor
cell
result
rapid
mortal
although
viru
replic
remain
uncontrol
without
demyelin
control
infect
mice
recipi
group
control
viru
replic
exhibit
similar
demyelin
howev
distinct
wt
cell
recipi
mortal
gko
recipi
associ
massiv
cn
neutrophil
infiltr
detect
mrna
determin
interplay
ifng
neutrophil
diseas
sever
equal
popul
wt
gko
cell
cotransf
scid
mice
despit
spars
accumul
wt
versu
gko
cell
cn
vs
minor
popul
abrog
detriment
effect
gko
cell
cn
neutrophil
infiltr
decreas
coincid
reduc
neutrophilattract
chemokin
diseas
sever
amelior
promot
surviv
protect
role
ifng
limit
cn
neutrophil
recruit
support
rapid
lethal
associ
massiv
cn
neutrophil
infiltr
wtgko
cell
recipi
treat
antiifng
surprisingli
howev
wt
recipi
treat
antiifng
spare
acceler
mortal
despit
substanti
cn
neutrophil
infiltr
analysi
express
cn
suggest
rapid
fatal
diseas
outcom
observ
ifng
defici
recipi
express
mrna
inhibit
gko
recipi
inde
revert
lethal
phenotyp
despit
retent
elev
neutrophil
demonstr
ifng
afford
protect
inhibit
mediat
proinflammatori
respons
data
demonstr
ifng
downregul
neutrophil
accumul
independ
howev
neutrophil
dysregul
absenc
ifng
overt
clinic
consequ
environ
express
importantli
condit
express
ifng
ifng
overrid
otherwis
detriment
effector
respons
impact
neutrophil
tcell
respons
murin
brain
abscess
held
josephin
richter
lydia
meisen
michael
heppner
frank
l
stenzel
werner
brain
abscess
sever
inflammatori
condit
cn
character
differ
phase
orchestr
immun
respons
elicit
cell
peripher
immun
system
well
cnsderiv
cell
recent
analyz
variou
aspect
neutrophil
respons
tcell
respons
well
role
macrophag
microgli
cell
context
sinc
recruit
activ
cell
regul
mainli
constitut
respons
use
genetarget
mice
defici
mention
cytokin
understand
sequenti
impact
kinet
adapt
innat
immun
process
cours
abscess
develop
resolut
especi
known
partial
play
role
neutrophil
recruit
also
produc
recent
describ
subset
helper
cell
cell
thu
impact
earli
phase
character
domin
neutrophil
influx
well
later
phase
brain
abscess
adapt
immun
respons
activ
work
provid
evid
import
mediat
brain
abscess
develop
discuss
sequenti
role
cytokin
famili
compar
role
initi
vs
late
phase
diseas
impair
respons
gut
microb
gliadin
splenocyt
mice
alter
stressrel
behavior
prematur
immun
senesc
stress
associ
impair
bidirect
commun
nervou
immun
system
lead
loss
homeostasi
might
play
relev
role
diseas
risk
celiac
diseas
cd
chronic
inflammatori
disord
small
intestin
caus
abnorm
immun
respons
gluten
protein
gliadin
genet
predispos
individu
ingest
gluten
main
trigger
diseas
whose
typic
case
often
present
earli
life
gluten
introduct
diet
howev
preval
cd
adulthood
increas
suggest
factor
gluten
intak
involv
present
disord
moreov
cd
recent
associ
alter
gut
microbiota
composit
may
also
favour
develop
diseas
ongo
inflamm
small
intestin
mucosa
aim
studi
assess
whether
splenocyt
prematur
age
mice
pam
model
base
alter
stressrel
behavior
respons
immun
senesc
show
differ
respons
gliadin
intestin
bacteri
strain
includ
potenti
probiot
pathogen
cell
nonprematur
age
mice
npam
two
group
femal
adult
outbr
mice
pam
npam
obtain
accord
differ
behavior
tmaze
test
use
splenocyt
anim
incub
h
follow
stimuli
lp
bovin
serum
albumin
bsa
gliadin
fragment
differ
bacteri
strain
cfuml
bifidobacterium
longum
subsp
infanti
b
longum
e
coli
lactobacillu
casei
level
cytokin
tnfalpha
secret
determin
supernat
elisa
splenocyt
pam
releas
significantli
higher
level
tnfalpha
npam
stimul
lp
bifidobacteria
p
well
one
bifidobacteria
b
longum
p
addit
stimul
gliadin
pam
splenocyt
secret
significantli
higher
level
tnfalpha
smaller
cell
npam
p
immun
cell
adult
pam
mice
alter
stressrel
behavior
show
inflammatori
stress
respons
gliadin
could
lead
higher
risk
develop
cd
nuyt
amber
cool
nathali
van
camp
kirsten
lender
kevin
stein
barbara
nagel
guy
dhoogh
mari
beatric
willeken
barbara
berneman
zwi
n
dendrit
cell
dc
special
popul
white
blood
cell
play
import
role
modul
immun
system
present
studi
hypothes
alter
function
dc
result
disturb
balanc
immun
toler
multipl
sclerosi
ms
monocytederiv
dc
mspatient
male
femal
gener
compar
ageand
gendermatch
healthi
control
n
next
evalu
phenotyp
cytokin
express
profil
immatur
dc
idc
cytokin
cocktailmatur
dc
mdc
capac
dc
induc
regulatori
tcell
ntreg
potenc
activ
autolog
myelinspecif
tcell
vitro
show
upon
matur
mdc
mspatient
display
signific
lower
express
level
mhc
class
ii
costimulatori
migratori
molecul
compar
mdc
healthi
control
addit
mdc
mspatient
secret
lower
amount
tnfalpha
compar
mdc
healthi
control
moreov
induc
significantli
lower
number
ntreg
compar
mdc
healthi
control
contrast
differ
induct
myelinspecif
ifngammaproduc
tcell
found
conclus
result
show
phenotyp
function
mdc
impair
mspatient
influenc
induct
ntreg
observ
import
implic
regard
develop
dcbase
vaccin
strategi
ms
immunologist
look
past
cell
differenti
oneway
process
lead
termin
irrevers
commit
one
cell
phenotyp
face
concept
plastic
impli
cell
includ
cell
may
chang
fate
accord
need
impos
environ
consequ
epigenet
stimuli
induc
relapsingremit
eae
sjlj
mice
cell
express
fluoresc
function
fusion
protein
allow
identif
sort
live
gfp
express
treg
cell
investig
polar
th
cell
differenti
stimuli
allow
simultan
express
differ
lineag
marker
sort
mice
cell
peak
diseas
cell
drain
lymph
node
cultur
presenc
polyclon
stimulu
cytokin
block
antibodi
induc
differenti
toward
itreg
cell
surprisingli
found
mrna
express
background
h
stimul
untreat
cultur
cultur
treat
becom
cell
sort
cell
sjlj
mice
measur
cultur
condit
express
rorc
ifng
confirm
cell
express
earli
time
point
untreat
differ
rreae
also
cultur
later
time
point
h
howev
upregul
expect
itreg
cultur
unexpect
find
upregul
rorc
itreg
cell
final
ifng
especi
express
untreat
cultur
mrna
appear
transcrib
condit
remain
express
although
appar
low
level
longterm
cultur
condit
thu
appear
earli
activ
polyclon
stimulu
independ
cultur
condit
possibl
detect
cell
marker
effector
cytokin
supposedli
differ
lineag
inde
found
cell
autoimmun
mice
express
differ
lineagespecif
nuclear
transcript
factor
first
hour
upon
activ
suggest
data
produc
past
revisit
accord
concept
mix
ident
celiac
diseas
enteropathi
trigger
ingest
cereal
gluten
protein
gliadin
genet
predispos
individu
disord
also
associ
alter
composit
gut
microbiota
vitro
seem
contribut
induc
cytokin
profil
characterist
diseas
aim
work
studi
possibl
role
intestin
bacteria
bifidobacteria
gramneg
bacteria
phenotyp
function
matur
dendrit
cell
dc
presenc
gliadin
monocytederiv
dc
stimul
potenti
probiot
bacteri
strain
bifidobacterium
longum
bifidobacterium
bifidum
gramneg
bacteri
strain
isol
gut
microbiota
cd
patient
e
coli
shigella
alon
cocultur
intestin
epitheli
cell
surfac
protein
express
cytokin
product
dc
evalu
effect
bacteri
strain
alon
combin
gliadin
elisa
flow
cytometri
gramneg
bacteria
induc
higher
secret
type
cytokin
tnfalpha
ifngamma
two
bifidobactei
strain
test
induct
express
dc
also
higher
presenc
gramneg
bacteria
presenc
two
bifidobacteri
strain
cocultiv
monocyt
deriv
dc
cell
result
reduc
cytokin
secret
dc
two
gramneg
bacteria
exert
proinflammatori
effect
cytokin
product
costimulatori
protein
express
dc
could
influenc
specif
compon
gut
microbiota
togeth
gliadin
may
also
influenc
interact
effector
tcell
polar
immun
respons
studi
evalu
percentag
cell
cell
cell
dim
bright
nk
cell
peripher
blood
untreat
relaps
remit
rr
relaps
remiss
untreat
secondari
progress
sp
untreat
primari
progress
pp
multipl
sclerosi
patient
age
sex
match
healthi
subject
percentag
circul
cell
perforin
mean
fluoresc
intens
mfi
cell
higher
rrm
patient
relaps
remiss
spm
ppm
patient
control
percentag
circul
cell
significantli
higher
spm
ppm
patient
control
increas
rrm
patient
without
reach
signific
valu
ppm
patient
show
higher
percentag
dim
nk
cell
rrm
patient
relaps
remiss
control
wherea
differ
percentag
perforin
bright
nk
cell
among
differ
group
patient
control
percentag
circul
cell
dim
nk
cell
posit
correl
month
confirm
edss
score
ms
patient
ms
patient
confirm
edss
show
higher
percentag
cell
dim
nk
cell
patient
edss
studi
demonstr
increas
percentag
perforin
cell
dim
nk
cell
peripher
blood
ms
patient
correl
confirm
disabl
cell
perforin
dim
nk
cell
may
play
role
ms
disabl
progress
partial
tradit
tempor
order
multipl
sclerosi
ms
lesion
develop
start
activ
lesion
follow
chronic
activ
lesion
macrophag
accumul
rim
myelin
centr
progress
remov
final
lesion
die
leav
hypocellular
scarlik
inact
lesion
still
intrigu
issu
remain
question
ms
lesion
realli
start
earliest
patholog
sign
damag
ms
cluster
activ
microglia
normalappear
white
matter
term
preactiv
lesion
given
frequenc
preactiv
lesion
suggest
probabl
spontan
resolv
without
progress
activ
demyelin
stage
microglia
activ
stage
may
therefor
reflect
immuneregulatori
immunesuppress
rather
proinflammatori
activ
goal
examin
preactiv
lesion
aris
small
heat
shock
protein
shsp
may
play
key
role
preactiv
lesion
sinc
shown
alpha
b
crystallin
cryab
accumul
oligodendrocyt
preactiv
ms
lesion
cryab
directli
contact
microgli
surfac
vitro
cryab
activ
human
microglia
induc
immuneregulatori
phenotyp
typifi
product
tgfbeta
tnfalpha
suppress
consist
previous
demonstr
antiinflammatori
effect
shsp
anim
model
vitro
cryab
unregul
stress
oligodendrocyt
follow
treatment
monoclon
antibodi
mab
direct
myelin
oligodendrocyt
glycoprotein
mog
mab
augment
clinic
diseas
demyelin
mice
eae
moreov
antibodi
mog
mab
myelin
protein
induc
stress
oligodendrocyt
induc
repartit
mog
chang
intracellular
signal
cell
morpholog
paper
present
hypothesi
ms
antibodi
direct
mog
could
deriv
ebv
infect
b
cell
ms
antibodi
initi
stress
oligodendrocyt
upregul
cryab
protect
mechan
express
cryab
howev
trigger
activ
microglia
ms
lead
format
preactiv
lesion
therefor
hypothes
preactiv
lesion
reflect
mild
form
revers
neuroinflamm
govern
predominantli
immuneregulatori
neuroprotect
process
believ
preactiv
lesion
thu
hold
key
understand
natur
mechan
immun
regul
repair
human
cn
mannos
bind
lectin
syndrom
uchibori
ayumi
chiba
atsuro
kyorin
univers
tokyo
japan
background
syndrom
gb
suggest
complement
activ
import
mechan
postinfecti
immunemedi
peripher
nerv
damag
mannosebind
lectin
mbl
recogn
sugar
structur
mannos
nacetylglucosamin
surfac
pathogen
activ
complement
system
report
relat
sever
gb
object
elucid
role
mbl
pathogenesi
exacerb
gb
investig
chronolog
chang
serum
mbl
concentr
especi
earli
period
neurolog
onset
method
peripher
blood
sampl
serial
obtain
patient
igg
antibodyposit
variant
gb
millerfish
syndrom
gb
ophthalmoplegia
serum
mbl
concentr
determin
elisa
use
mannan
ligand
result
patient
widerang
serum
mbl
concentr
studi
serial
sampl
mbl
concentr
reach
peak
around
time
bottom
clinic
symptom
decreas
four
patient
one
patient
peak
mbl
concentr
neurolog
onset
two
patient
measur
symptomat
worsen
phase
mbl
concentr
increas
mbl
concentr
increas
gradual
decreas
diseas
day
case
take
sever
clinic
cours
point
nadir
unclear
two
case
mbl
concentr
unchang
throughout
clinic
cours
conclus
serial
studi
chronolog
chang
mbl
concentr
show
similar
tendenc
mbl
concentr
level
increas
clinic
exacerb
reach
maximum
level
around
bottom
clinic
symptom
decreas
gradual
result
suggest
complement
activ
mediat
mbl
could
associ
patholog
condit
gb
especi
extent
nerv
damag
mbl
might
anoth
target
point
therapeut
approach
prevent
progress
diseas
map
corticotropinreleas
factor
crf
famili
peptid
receptor
fibroblastslik
synoviocyt
osteoarthrosi
rheumatoid
arthriti
patient
well
known
presenc
hormon
neurotransmitt
includ
neuropeptid
joint
patient
rheumat
diseas
includ
osteoarthrosi
oa
rheumatoid
arthriti
ra
origin
could
central
peripher
nervou
system
produc
local
level
cell
joint
sens
recent
demonstr
differenti
express
vip
receptor
oafl
rafl
crfucn
system
includ
four
peptid
corticotropin
releas
factor
crf
urocortin
urocortin
urocortin
two
receptor
express
nervou
peripher
tissu
includ
immun
system
crf
system
crucial
regul
mammalian
stress
inflammatori
respons
also
involv
disord
anxieti
depress
drug
addict
hypothalam
crf
produc
immunosuppress
antiinflammatori
effect
endogen
glucocorticoid
releas
activ
hypothalamuspituitaryadren
hpa
axi
moreov
peripher
site
crf
system
promot
direct
inflammatori
immunostimulatori
action
local
product
peripher
crf
demonstr
experiment
model
ra
includ
streptococc
cell
walland
adjuvantinduc
arthrit
joint
rat
joint
patient
oa
ra
thu
crh
system
could
contribut
pathophysiolog
rheumat
diseas
howev
date
data
crf
receptor
ra
establish
role
system
play
pathophysiolog
crucial
identifi
cellular
type
involv
express
present
studi
describ
presenc
crf
fl
oa
ra
patient
express
mrna
protein
level
detect
real
time
pcr
enzym
immunoassay
eia
immunocytochemistri
moreov
receptor
express
oaand
rafl
show
express
receptor
crf
abund
ra
oa
express
oa
regard
receptor
express
similar
fl
patholog
summari
studi
show
ra
pattern
crf
peptid
human
fl
increas
express
proinflammatori
peptid
crf
decreas
express
predominantli
antiinflammatori
peptid
midkin
exacerb
experiment
autoimmun
encephalomyel
suppress
expans
regulatori
dendrit
cell
yoshifumi
sonob
hua
li
hideyuki
takeuchi
tetsuya
mizuno
akio
suzumura
nagoya
univers
nagoya
japan
shown
previous
rna
aptam
midkin
heparinbind
growth
factor
attenu
experiment
autoimmun
encephalomyel
eae
anim
model
multipl
sclerosi
expans
regulatori
cell
treg
howev
precis
mechan
remain
unclear
show
inhibit
midkin
expand
regulatori
dendrit
cell
dcreg
capac
induc
differenti
cell
treg
result
attenu
eae
dcreg
stimul
midkin
decreas
allogen
treg
expans
midkin
impair
phosphoryl
dcreg
induc
product
induct
src
homolog
inhibit
cancel
suppress
effect
midkin
treg
differenti
suggest
midkin
induc
product
via
dephosphoryl
dcreg
attenu
dcreginduc
treg
differenti
administr
midkinestimul
dcreg
eae
worsen
symptom
diseas
accompani
decreas
treg
compar
administr
dcreg
antimidkin
rna
aptam
attenu
eae
doe
treg
expans
mrna
express
level
dc
downregul
lymph
node
treat
mice
result
indic
midkin
inhibit
dcreg
expans
increas
product
via
dephosphoryl
result
suppress
treg
differenti
black
jennif
freedman
mark
univers
ottawa
ottawa
canada
ottawa
hospit
ottawa
canada
neurofascin
nf
integr
nodal
protein
serv
structur
role
well
involv
neurotransmiss
antibodi
ab
specif
nf
detect
sera
multipl
sclerosi
ms
patient
ms
patientderiv
fcrexpress
gamma
delta
gd
tcell
shown
exert
antibodydepend
cellular
cytotox
adcc
frequenc
subset
gd
tcell
increas
ms
progress
find
led
us
propos
possibl
role
antinf
ab
gd
tcell
pathogenesi
ms
use
enzymelink
immunosorb
assay
antinf
ab
detect
cerebrospin
fluid
csf
sera
ms
patient
csf
titr
greatest
rrm
patient
p
b
vs
control
wherea
revers
observ
sera
highest
titr
detect
patient
progress
form
diseas
p
b
p
b
spm
ppm
respect
vs
control
initi
investig
possibl
role
antinf
pathogenesi
ms
first
screen
seri
neuron
cell
line
use
western
blot
flow
cytometri
immunohistochemistri
identifi
express
nf
screen
reveal
human
teratocarcinoma
cell
express
nf
retino
acidinduc
differenti
cell
variou
condit
result
deriv
heterogen
popul
classic
neuron
astrocyt
addit
neuriteexpress
neurospher
continu
express
nf
commerci
mspatientderiv
antinf
antibodi
mixtur
recogn
bound
cell
axon
cell
bodi
current
establish
system
wherebi
examin
cytotox
gd
tcell
target
toward
cell
neuron
lineag
context
adcc
studi
help
determin
gd
tcell
injur
neuron
cell
ms
direct
indirect
cytotox
mechan
oppos
diseas
stage
specif
activ
interferon
gamma
eae
modul
type
interferon
signal
raman
chander
nave
rodrigo
singh
simer
preet
cashman
kevin
axtel
robert
steinman
lawrenc
de
sarno
patrizia
univers
alabama
birmingham
birmingham
unit
state
stanford
univers
palo
alto
unit
state
physiolog
activ
interferon
gamma
ifng
experiment
autoimmun
encephalomyel
eae
multipl
sclerosi
ms
remain
controversi
addit
recent
report
interferon
gamma
ifng
signal
necessari
immunosuppress
activ
ifnbeta
ifnb
experiment
autoimmun
encephalomyel
eae
studi
resolv
controversi
role
ifng
eae
integr
biolog
activ
type
ifn
ifnab
signal
perform
comprehens
analysi
determin
extent
cooper
type
interferon
ifna
ifnb
type
ii
interferon
ifng
depend
signal
develop
progress
experiment
autoimmun
encephalomyel
eae
onset
sever
myelin
peptideinduc
eae
ifnab
receptor
null
mice
wildtyp
wt
mice
similar
contrast
eae
mice
lack
ifng
receptor
ifngr
delay
onset
significantli
sever
remark
mice
lack
receptor
ifnab
ifng
ifnabgr
develop
milder
form
eae
result
infer
ifng
diseas
promot
induct
phase
protect
chronic
phase
type
ifnact
absenc
ifng
signal
exacerb
diseas
order
directli
test
oppos
activ
ifng
eae
wt
mice
inject
recombin
ifng
rifng
daili
day
start
induct
diseas
onset
diseas
symptom
ifng
treatment
induct
phase
worsen
diseas
remark
treatment
onset
clinic
symptom
complet
suppress
diseas
progress
suppress
effect
rifng
treatment
depend
transcript
factor
integr
type
type
ii
ifnreceptor
signal
function
ifnab
receptor
wt
mice
adopt
transfer
encephalitogen
tcell
type
type
ii
doubl
ifnreceptor
defici
anim
reveal
type
type
ii
ifn
requir
persist
diseas
diseas
importantli
function
loss
either
ifnab
signal
ifng
signal
led
sever
diseas
data
reveal
ifng
oppos
diseas
stage
specif
activ
pathogenesi
eae
show
system
administr
rifng
activ
diseas
therapeut
activ
depend
type
ifnsign
perri
justin
han
sungpil
kennedi
luci
boyc
bibiana
bielekova
object
studi
use
unbias
approach
determin
full
mechan
action
moa
daclizumab
dac
multipl
sclerosi
ms
combin
clinic
trial
select
immunomodul
dac
invivo
immun
provid
power
tool
studi
human
immun
studi
chang
immun
subpopul
induc
influenza
haemagglutinin
fluha
immun
ms
patient
dac
therapi
versu
agesex
match
control
multicolor
flow
cytometri
corrobor
find
analyz
cryopreserv
peripher
blood
mononuclear
cell
pbmc
nih
dac
trial
final
perform
extens
function
studi
purifi
immun
subpopul
determin
mechan
underli
observ
chang
identifi
significantli
lower
proport
adult
lti
cell
dactreat
patient
vs
control
fluha
immun
exagger
postimmun
confirm
dac
therapi
diminish
lti
number
earli
month
posttreat
declin
lti
cell
correl
previouslyreport
expans
nk
cell
furthermor
analyz
lymph
node
ln
biopsi
specimen
demonstr
observ
declin
circul
lti
cell
dactreat
patient
due
increas
home
ln
hypothes
dac
induc
enhanc
differenti
nk
cell
adult
lti
cell
promot
develop
chronic
inflamm
induct
tertiari
lymphoid
follicl
target
tissu
contrast
nk
cell
inhibit
immun
respons
demonstr
two
molecul
genet
link
ms
regul
differenti
hpc
toward
lti
versu
nk
cell
lineag
thu
small
differ
signal
lead
profound
chang
outcom
immun
respons
proinflammatori
tolerancepromot
phenotyp
may
underli
develop
autoimmun
ms
sonia
adibessalem
sassia
samimerah
amina
mendi
djelila
hammouditriki
fatima
larabadjebari
usthb
univers
algier
algeria
voltageg
na
nav
channel
neurotoxin
import
compon
scorpion
venom
main
agent
respons
toxic
effect
scorpion
envenom
induc
massiv
releas
neurotransmitt
inflammatori
modul
mediat
lead
cascad
patholog
event
central
nervou
cardiorespiratori
system
involv
mechan
immunolog
inflammatori
respons
extens
evalu
aim
investig
differ
type
mediat
involv
experiment
scorpion
envenom
androctonu
australi
hector
use
select
antiinflammatori
drug
indomethacin
hydrocortison
adrenerg
antagonist
metoprolol
find
show
inflammatori
process
induc
scorpion
venom
character
hyperleucocytosi
neutrophil
eosinophil
lymphocyt
elev
product
inflammatori
cytokin
tnfa
peripher
blood
tissu
anim
migrat
neutrophil
eosinophil
lung
confirm
releas
reactiv
oxygen
speci
myeloperoxydas
mpo
pulmonari
eosinophil
peroxidas
epo
hypoalbuminemia
hyperglobulinemia
hypergammaglobulinemia
accompani
signific
activ
complement
system
also
predomin
abnorm
found
envenom
anim
inflammatori
disturb
result
lung
heart
exud
plasma
protein
fluid
tissu
form
pulmonari
myocard
edema
treat
anim
drug
interfer
arachidon
acid
metabol
pathway
prior
envenom
reduc
significantli
hyperleucocytosi
cellular
peroxidas
activ
epo
mpo
reduct
fluid
accumul
lung
heart
normal
seric
protein
level
compar
anim
envenom
also
observ
metoprolol
betaadrenerg
blocker
effect
reduc
edema
heart
lung
confirm
structur
analysi
tissu
howev
antagonist
prevent
increas
rate
inflammatori
mediat
serum
protein
level
result
suggest
edema
induc
androctonu
australi
hector
venom
could
mediat
mainli
cellular
mediat
neutrophil
also
multipl
molecular
mediat
includ
eicosanoid
partial
betaadrenoceptor
explor
role
serotonin
anim
model
msexperiment
autoimmun
encephalomyel
eae
use
fluoxetin
increas
serotonerg
activ
show
previous
fluoxetin
amelior
paralysi
significantli
eae
explor
mechan
effect
find
vitro
fluoxetin
decreas
cytokin
product
spleen
cell
respons
inflammatori
stimuli
major
effect
cell
pure
cultur
vitro
fluoxetin
decreas
cell
prolifer
increas
fasdepend
activationinduc
cell
death
cell
cell
express
sert
wellknown
site
action
fluoxetin
howev
prolifer
cell
primarili
depend
upon
subtyp
receptor
also
known
bind
fluoxetin
therefor
hypothes
fluoxetin
may
function
block
signal
howev
ad
exogen
serotonin
flow
cytometr
purifi
cell
rescu
effect
fluoxetin
high
dose
explor
mechan
use
anoth
ssri
citalopram
sert
knockout
anim
fluoxetin
amelior
eae
part
due
immunomodul
specif
affect
cell
prolifer
apoptosi
signific
effect
vivo
unknown
warrant
explor
multipl
sclerosi
ms
demyelin
diseas
complex
unknown
aetiolog
associ
ms
haplotyp
proven
strong
molecular
basi
link
remain
unclear
vitamin
receptor
vdr
gene
variant
propos
modul
associ
although
link
ill
remain
controversi
face
problem
follow
object
set
test
whether
hla
ii
gene
express
could
affect
haplotyp
test
associ
vdr
variant
ms
check
whether
variant
modul
risk
confer
studi
whether
vdr
variant
affect
hla
ii
gene
express
peripher
blood
ms
patient
healthi
control
obtain
dna
sampl
total
rna
patient
control
extract
peripher
blood
mononuclear
cell
gene
express
measur
genotyp
perform
qpcr
use
specif
taqman
probe
vdr
variant
genotyp
pcrrflp
posit
sampl
show
signific
overexpress
p
b
p
b
p
patient
p
p
b
also
overexpress
control
data
confirm
haplotyp
confer
higher
risk
suffer
ms
odd
ratio
ci
associ
found
vdr
variant
ms
apai
variant
shown
modul
risk
confer
anyway
hla
ii
gene
express
differ
found
among
vdr
variant
result
suggest
hla
ii
gene
express
differ
could
part
molecular
mechan
upon
ms
associ
reli
moreov
apai
variant
vdr
gene
seem
modul
risk
confer
although
effect
seem
happen
via
gene
express
regul
presenc
myeloid
suppressor
cell
relat
lymphocyt
apoptosi
multipl
sclerosi
multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
relapsingremit
msrr
frequent
variant
character
relaps
phase
inflammatori
cell
infiltr
remit
period
patient
partial
recov
howev
immunosuppressor
cell
type
involv
process
well
character
myeloid
deriv
suppressor
cell
mdsc
form
heterogen
popul
immatur
cell
capac
suppress
inflammatori
respons
cell
act
among
mechan
arginasei
argi
tcell
activ
previou
studi
show
increment
argi
activ
spleen
mdsc
immunosupressor
role
cell
cancer
infect
relaps
phase
eae
howev
natur
argi
cell
within
cn
identifi
studi
aim
detect
identifi
argi
cell
spinal
cord
eae
time
cours
onset
dpi
peak
day
postimmunizationdpi
remit
period
dpi
chronic
phase
dpi
result
indic
presenc
densiti
argi
cell
eae
mice
parallel
differ
diseas
period
fact
number
highest
dpi
significantli
decreas
dpi
complet
disappear
dpi
onward
argi
cell
detect
demyelin
plaqu
periplaqu
alway
show
characterist
mdsc
phenotyp
addit
apoptot
cell
exclus
detect
stage
mdsc
present
frequent
appear
contact
proxim
argi
cell
inde
apoptot
dpi
dpi
cell
present
signific
direct
opposit
correl
respect
number
mdsc
observ
within
around
demyelin
plaqu
data
show
import
role
play
mdsc
transit
relaps
remit
phase
ms
immunosuppress
cell
favour
antiinflammatori
respons
subsequ
rel
recoveri
within
diseas
modul
mdsc
popul
could
therapeut
altern
msrr
favour
immunosuppress
therefor
acceler
return
remit
phase
multipl
sclerosi
ms
chronic
inflammatori
neurodegen
diseas
thought
autoimmun
origin
elev
level
antibodi
present
cerebrospin
fluid
brain
patient
ms
howev
target
antigen
antibodi
yet
fulli
characteris
posttransl
modif
myelin
basic
protein
mbp
cnsspecif
protein
includ
citrullin
arginin
residu
result
conform
chang
protein
lead
increas
degrad
proteas
exposur
new
epitop
may
caus
product
autoantibodi
target
myelin
sheath
citrullin
carri
famili
enzym
call
peptidylarginin
deiminas
pad
report
present
brain
excess
citrullin
occur
ms
mbp
ms
white
matter
highli
citrullin
control
white
matter
context
investig
express
primari
human
astrocyt
human
brain
endotheli
cell
line
inflammatori
condit
express
colocalis
citrullin
protein
ms
control
tissu
provid
better
understand
process
citrullin
cn
inflamm
possibl
role
ms
pathogenesi
cell
treat
vitro
proinflammatori
cytokin
h
follow
quantit
realtim
pcr
determin
mrna
express
mrna
decreas
tnf
ifng
primari
human
astrocyt
mrna
increas
human
brain
endotheli
cell
line
mrna
express
undetect
cell
type
protein
express
assess
immunocytochemistri
immunohistochemistri
ihc
preliminari
data
indic
presenc
primari
astrocyt
vitro
ms
control
tissu
ihc
show
increas
citrullin
protein
ms
lesion
normal
appear
white
matter
nawm
compar
control
tissu
mrna
downregul
primari
human
astrocyt
upregul
human
brain
endotheli
cell
line
inflammatori
condit
protein
detect
primari
human
astrocyt
ms
control
tissu
stain
ms
lesion
nawm
show
increas
citrullin
compar
control
white
matter
data
indic
may
role
pathogenesi
ms
increas
citrullin
cn
protein
multipl
sclerosi
ms
chronic
inflammatori
demyelin
diseas
central
nervou
system
cn
mainli
affect
young
adult
uptak
apoptot
cell
dendrit
cell
dc
involv
tolerogenesi
also
immun
activ
differ
autoimmun
diseas
treatment
cell
chemic
crosslink
ecdi
shown
promot
toler
sever
anim
model
autoimmun
diseas
analyz
whether
uptak
apoptot
autolog
blood
mononuclear
cell
pbmc
affect
matur
activ
human
monocytederiv
dc
describ
immunostimulatori
capac
compar
differ
method
induc
apoptosi
dc
gener
untouch
posit
cell
presenc
gmcsf
day
cell
stimul
either
ecditr
uv
gammairradi
without
autolog
pbmc
next
day
cell
stimul
lp
defin
matur
cocktail
consist
variou
proinflammatori
cytokin
cell
activ
differenti
analyz
express
cell
surfac
marker
eg
hladr
concentr
variou
proand
antiinflammatori
cytokin
chemokin
eg
correspond
cell
cultur
supernat
furthermor
immunostimulatori
capac
apoptoticcel
load
dc
assess
allogen
mix
leukocyt
reaction
mlr
found
differ
strategi
induc
apoptosi
profound
influenc
matur
activ
dc
detail
dc
stimul
ecditr
pbmc
show
impair
matur
reveal
express
surfac
marker
reduc
capac
promot
allogen
cell
prolifer
result
indic
immunomodulatori
effect
ecditr
pbmc
dc
like
alter
matur
reduc
immunostimulatori
capac
allogen
mlr
result
provid
evid
import
dc
antigen
specif
toler
ecditr
antigencoupl
cell
novel
therapeut
approach
ms
human
cytomegaloviru
hcmv
common
viral
infect
transmit
mother
unborn
child
signific
infecti
caus
development
cn
disord
industri
nation
neurolog
deficit
result
cmv
infect
well
document
yet
mechan
respons
remain
unknown
develop
newborn
mous
model
cmv
infect
mimic
mani
characterist
human
infect
includ
cerebellar
deficit
cmv
infect
newborn
mice
result
focal
enceph
howev
cn
damag
global
symmetr
therefor
hypothes
cn
deficit
follow
cmv
infect
result
host
inflammatori
respons
viral
replic
furthermor
hypothes
damag
develop
cn
limit
treat
infect
mice
antiinflammatori
dexamethason
mcmv
infect
newborn
mice
result
alter
cerebellar
develop
mcmv
infect
analyz
situ
hybrid
well
stain
histolog
stain
use
analyz
cerebellar
morpholog
area
volum
treatment
dexamethason
attenu
mcmv
induc
cn
inflamm
group
treat
dose
dexamethason
pnd
dose
pnd
express
ifn
stimul
gene
analyz
quantit
realtim
pcr
qpcr
viral
titer
determin
reversetranscript
pcr
dexamethason
treatment
decreas
activ
cn
macrophag
mcmv
infect
mice
activ
microglia
analyz
immunofluoresc
mononuclear
cell
isol
brain
stain
analyz
flow
cytometri
mhcii
express
analyz
flow
cytometri
dexamethason
normal
alter
development
prolif
marker
mcmv
infect
mice
qpcr
use
assay
differ
development
gene
phosphohiston
analyz
cyclin
activ
analyz
western
blot
analysi
treatment
mcmv
infect
newborn
mice
dexamethason
attenu
inflamm
normal
express
development
regul
gene
within
cn
find
support
hypothesi
cerebellar
deficit
mcmv
infect
mice
secondari
host
inflammatori
respons
viral
infect
result
suggest
modul
inflamm
follow
mcmv
infect
limit
cerebellar
damag
howev
better
understand
inflammatori
mechan
lead
abnorm
necessari
dendrit
cell
control
toler
eae
via
induct
treg
signal
pathway
dendrit
cell
dc
consid
effici
antigenpres
cell
initi
immun
respons
condit
absenc
danger
signal
toll
like
receptor
tlr
ligand
dc
steadi
state
shown
import
toler
mainten
natur
regulatori
cell
ntreg
pool
experiment
autoimmun
encephalomyel
eae
dc
thought
play
first
role
prime
phase
later
central
nervou
system
cn
infiltr
phase
sever
dcdeplet
model
previous
develop
want
analyz
role
dc
play
differ
phase
eae
progress
major
goal
find
whether
eae
induct
possibl
absenc
dc
primari
role
dc
eae
immun
toler
use
three
distinct
genet
mean
deplet
dc
mice
first
use
model
second
use
new
model
mice
model
deplet
dc
induc
inject
diphtheria
toxin
dt
third
model
use
mice
mice
dt
express
dc
birth
onward
lead
mice
lack
dc
constitut
model
use
mice
peptid
induc
express
present
dc
surpis
eae
could
induc
dcdeplet
model
system
even
eae
develop
system
enhanc
compar
litterm
control
test
whether
tolerogen
role
dc
promin
prime
role
use
mice
found
eae
nearli
fulli
prevent
express
induc
also
induct
eae
result
hint
critic
role
dc
induct
treg
found
dc
induc
upregul
antigen
specif
cell
itreg
differenti
show
dc
lead
itreg
differenti
depend
manner
recombin
pdligand
complement
lack
dc
itreg
differenti
first
data
show
activ
immun
either
extrem
low
number
dc
cell
dc
abl
prime
encephalitogen
cell
dc
also
fulfil
regulatori
role
prime
phase
probabl
via
induct
regulatori
cell
herebi
pathway
seem
play
predomin
role
interferon
beta
ifnbeta
antiinflammatori
drug
first
choic
treatment
relapseremit
multipl
sclerosi
ms
though
mechan
action
ifnbeta
ms
unclear
suppos
antivir
effect
inhibit
immun
cell
traffick
across
bloodbrain
barrier
regul
tcell
activ
etc
half
ms
patient
show
signific
posit
respons
ifn
treatment
discov
predict
biomark
respons
ifnbeta
treatment
extrem
import
main
object
research
perform
mathemat
model
ifnbeta
signal
pathway
predict
behavior
key
molecul
pathway
upon
ifnbeta
treatment
system
biolog
methodolog
use
perform
kinet
model
ifnbeta
signal
pathway
use
ordinari
differenti
equat
ode
pathway
includ
main
molecul
jakstat
signal
pathway
ifnbeta
isom
protein
phosphoryl
inhibitor
mrna
protein
level
measur
pcr
elisa
western
blot
flow
cytometri
vitro
experi
raw
mous
macrophag
cell
line
stimul
lp
ifnbeta
differ
time
identifi
oscil
concentr
ifnbeta
protein
mrna
involv
ifnbeta
signal
pathway
mathemat
model
abl
reproduc
oscillatori
behavior
identifi
neg
feedback
provid
critic
element
type
ifn
pathway
tightli
control
neg
feedback
provid
kinet
chang
ifn
pathway
might
indic
respons
ifnbeta
therapi
ms
alzheim
diseas
ad
sever
neurodegen
disord
character
progress
loss
memori
cognit
function
accord
amyloid
hypothesi
format
accumul
peptid
initi
caus
pathogen
lesion
vaccin
target
repres
promis
therapeut
option
activ
immun
provid
encourag
result
experiment
mous
model
lesser
extent
subsequ
clinic
trial
howev
trial
interrupt
due
occurr
meningoenceph
treat
patient
sever
side
effect
attribut
proinflammatori
cell
respons
preclin
murin
model
show
evid
cellrel
side
effect
addit
sever
report
suggest
cell
may
implic
natur
cours
ad
could
strong
therapeut
potenti
well
henc
better
understand
adapt
cell
respons
crucial
develop
innov
vaccin
strategi
ad
prerequisit
deciph
immunobiolog
cell
respons
cours
ad
character
paramet
control
cell
respons
normal
mice
independ
patholog
set
data
indic
cell
respons
highli
heterogen
mous
strain
differ
haplotyp
sjl
mice
display
strong
respons
mice
show
weak
respons
previous
report
surprisingli
mice
congen
haplotyp
display
permiss
mhcii
allel
present
immunodomin
epitop
show
weak
cell
respons
similar
mice
suggest
mhcindepend
factor
downmodul
cell
respons
background
transient
deplet
regulatori
cell
treg
indic
cell
respons
significantli
enhanc
mice
upon
treg
deplet
tregdeplet
sjl
mice
display
unalt
cell
respons
altogeth
result
suggest
magnitudestrength
cell
respons
control
mhcdepend
independ
factor
mice
latter
includ
overal
abil
develop
treg
cell
respons
kondo
takayuki
matsuya
nemu
komori
mika
nomura
kyouichi
matsuo
hidenori
kitano
hospit
tazuk
kofukai
foundat
medic
research
institut
osaka
japan
nation
hospit
organ
nagasaki
kawatana
medic
center
nagasaki
japan
kyoto
univers
kyoto
japan
saitama
medic
center
kawago
japan
neuromyel
optica
nmo
inflammatori
diseas
central
nerv
system
cn
autoimmun
pathogenesi
evidenc
antiaquaporin
aqp
play
crucial
role
pathogenesi
nmo
contrast
role
cell
nmo
remain
establish
yet
studi
succeed
reveal
particip
cell
nmo
pathogenesi
nmo
patient
seroposit
relapsingremit
ms
patient
healthi
subject
hs
enrol
three
nmo
monitor
cell
activ
vivo
relaps
remiss
flow
cytometri
use
antibodi
isothiocyan
fitc
pe
frequenc
activ
cell
shown
increas
relaps
next
analyz
antigenspecif
cell
respons
purpos
overlap
peptid
myelin
peptid
prepar
insolubl
exclud
studi
remain
peptid
use
stimul
antigen
final
concentr
mixtur
peptid
adjust
final
concentr
pbmc
freshli
isol
seed
cultur
well
atbottom
cultur
plate
antigen
ad
well
day
cultur
rest
sampl
incub
antigen
hour
thereaft
cell
analyz
flow
cytometri
assay
determin
three
time
increas
cell
posit
eight
nmo
show
posit
two
ms
none
hs
respond
significantli
nine
nmo
respond
induc
posit
respons
ms
patient
hs
two
ms
hs
react
observ
indic
nmospecif
cell
epitop
unexpectedli
seven
nmo
show
respons
plp
hand
one
ms
one
hs
show
posit
demonstr
cell
immun
plp
increas
nmo
taken
togeth
demonstr
evid
antibodi
specul
cell
b
cell
essenti
develop
nmo
autoaggress
cell
autoantibodi
thought
attack
central
nervou
system
diseas
multipl
sclerosi
ms
autoimmun
condit
character
inflamm
demyelin
around
axon
brain
spinal
cord
despit
intens
work
immunopathogenesi
ms
still
unknown
particular
molecular
target
recogn
autoaggress
cell
still
unidentifi
group
recent
succeed
reviv
autoaggress
cell
frozen
biopsi
sampl
ms
patient
first
investig
cell
repertoir
autoimmun
tissu
lesion
identifi
clonal
expans
spectratyp
second
identifi
autoaggress
cell
human
biopsi
tissu
cell
receptor
tcr
specif
antibodi
third
character
antigen
specif
tcr
alphaand
betachain
multiplex
pcr
fourth
function
express
tcr
molecul
mous
hybridoma
cell
lastli
investig
antigen
far
identifi
four
cell
receptor
biopsi
tissu
one
ms
patient
sequenc
analysi
primari
structur
tcr
point
converg
antigen
recognit
motif
share
amongst
reconstruct
function
express
autoaggress
tcr
current
investig
antigenrecognit
properti
use
autolog
ebvtransform
b
cell
mononuclear
cell
hlamatch
donor
present
cell
found
recogn
peptid
candid
antigen
mbp
mog
ebv
current
screen
cdna
librari
sever
sourc
age
sex
match
healthi
subject
ms
patient
rr
type
noninflammatori
neurolog
diseas
nind
patient
enrol
studi
simultan
stain
chemokin
receptor
memori
cell
pb
csf
perform
frequenc
cell
subset
etc
measur
flow
cytometri
pb
particular
memori
cell
subset
increas
ms
compar
hs
nind
irrespect
diseas
state
next
compar
frequenc
cell
subset
csf
pb
relaps
ms
patient
nind
patient
interestingli
group
patient
frequenc
cell
lower
csf
pb
notabl
ms
nind
patient
frequenc
cell
higher
csf
pb
suggest
preferenti
recruit
inflam
cn
polyclon
activ
produc
ifng
frequenc
ifng
cell
measur
intracellular
cytokin
stain
also
higher
subset
subset
matrix
metalloproteinas
degrad
collagen
extracellular
matrix
assum
play
role
breakdown
blood
brain
barrier
found
express
level
well
activ
measur
zymographi
significantli
higher
subset
cell
subset
moreov
express
level
osteopontin
whose
transcript
abundantli
express
activ
ms
lesion
also
significantli
higher
subset
identifi
uniqu
cell
subset
enrich
csf
relaps
ms
subset
cell
produc
ifng
also
equip
tissu
invas
machineri
target
subset
novel
therapeut
approach
immun
surveil
uninflam
brain
interf
import
differ
cell
subset
pathogenesi
multipl
sclerosi
ms
anim
model
experiment
autoimmun
encephalomyel
eae
controversi
induct
chronic
autoimmun
cn
inflamm
eae
shown
depend
involv
gener
cell
wherea
role
cell
eae
still
unclear
investig
requir
gener
highli
encephalitogen
myelin
oligodendrocyt
glycoprotein
mog
specif
cell
eae
induct
effect
presenc
cell
eae
cours
reconstitut
mice
andor
cell
induc
activ
eae
mog
restimul
protocol
induct
passiv
eae
vitrogener
mogspecif
cell
deriv
cell
receptor
transgen
mice
establish
correl
diseas
cours
flow
cytometr
profil
ex
vivo
isol
cell
activ
induc
eae
mice
reconstitut
without
cell
compar
sever
presenc
absenc
cell
reconstitut
cell
alon
howev
induc
lowlevel
clinic
diseas
infiltr
mainli
consist
ifng
produc
cell
contrast
sever
disabl
anim
cell
reconstitut
mice
show
brain
infiltr
cell
highlight
correl
presenc
cell
clinic
sever
order
induc
stabl
highli
encephalitogen
popul
vitro
repetit
stimul
cell
essenti
transfer
adopt
mice
even
low
cell
number
induc
fulmin
sever
progress
eae
diseas
induct
correl
enrich
transfer
cell
cn
affect
anim
taken
togeth
found
effector
cell
minor
pathogen
potenti
moginduc
eae
even
lymphopen
host
shown
lowlevel
clinic
diseas
even
presenc
profus
cell
infiltr
cn
contrast
alreadi
low
number
cell
suffici
induc
sever
often
atyp
nonremit
neurolog
deficit
led
rapid
death
cn
damag
find
underlin
relev
cell
differenti
quantiti
qualiti
neurolog
deficit
autoimmun
neuroinflamm
gonzalez
hugo
prado
carolina
barriento
magali
pacheco
rodrigo
fundacion
ciencia
para
la
vida
santiago
chile
fundacion
ciencia
para
la
vida
santiago
chile
despit
role
dopamin
da
central
nervou
system
well
character
recent
studi
reveal
immun
cell
tcell
express
dopamin
receptor
dar
howev
littl
known
impact
regul
mediat
da
function
tcell
studi
aim
character
immunobiolog
effect
dar
stimul
murin
tcell
accordingli
first
analyz
dar
express
flow
cytometri
rtpcr
result
show
express
unstimul
tcell
importantli
dar
differenti
express
upon
tcell
activ
specif
receptor
upregul
receptor
downmodul
tcell
activ
wherea
express
receptor
upregul
upon
activ
tcell
function
analysi
tcell
respons
evalu
effect
da
tcell
activ
secret
stimul
result
show
da
inhibit
tcell
activ
dosedepend
way
moreov
signal
pathway
analysi
show
stimul
dopamin
receptor
agonist
elicit
increas
intracellular
calcium
level
tcell
measur
hand
stimul
receptor
select
agonist
promot
decreas
product
camp
forskolintr
tcell
conclus
data
show
tcell
express
function
dopamin
receptor
activationdepend
manner
wherea
stimul
elicit
intracellular
calcium
mobil
coupl
inhibit
adenil
cyclas
moreov
dar
stimul
regul
activ
tcell
summari
result
suggest
da
may
exert
complex
regul
tcell
physiolog
understand
role
stimul
dar
tcell
could
help
design
therapi
treatment
autoimmun
immunodefici
cancer
pbmc
also
sever
studi
suggest
involv
compart
ms
line
hypothes
possibl
link
ms
ebv
could
ascertain
studi
frequenc
ebvspecif
cell
ms
patient
differ
stage
time
point
diseas
compar
healthi
donor
aim
stain
pbmc
mhc
pentam
coupl
known
antigen
latent
lytic
ebv
infect
multipl
surfac
marker
care
defin
ebvspecif
cell
subset
data
show
frequenc
cell
specif
antigen
express
latent
phase
viru
significantli
higher
ci
patient
ms
patient
shorter
diseas
durat
compar
ms
patient
healthi
donor
frequenc
cell
specif
antigen
express
lytic
phase
viru
significantli
higher
patient
undergo
clinic
relaps
compar
patient
stabl
phase
diseas
healthi
donor
perform
detail
character
ebv
specif
cell
use
polychromat
flow
cytometri
multipl
surfac
marker
function
assay
thu
carri
order
monitor
qualiti
immun
respons
direct
ebv
cmv
specif
rel
proport
cytotox
cytokineproduc
cell
subset
within
ebv
specif
cell
antigen
lytic
phase
latent
phase
viru
infect
analyz
found
subset
cytotox
perforin
cell
confin
cell
specif
antigen
latent
phase
cmvspecif
cell
wherea
cell
specif
antigen
lytic
phase
contain
granzym
b
produc
larg
amount
cytokin
result
advanc
understand
relationship
distinct
immun
respons
differ
stage
infect
differ
stage
ms
diseas
prematur
immunosenesc
link
mani
autoimmun
diseas
multipl
sclerosi
ms
rheumatoid
arthriti
ra
particular
cell
gain
aberr
possibl
cytotox
function
repeat
antigen
stimul
homeostat
prolifer
absenc
use
marker
senesc
cell
howev
marker
present
surfac
cell
greatli
benefit
isol
character
subset
cell
therefor
phenotyp
character
cell
perform
use
flow
cytometri
sever
marker
significantli
upregul
p
b
cell
either
healthi
control
hc
n
patient
ms
n
ra
n
comparison
cell
interestingli
fractalkin
receptor
present
vast
major
cell
hc
ms
ra
mostli
absent
cell
hc
ms
ra
demonstr
cell
migrat
toward
fractalkin
transwel
system
therebi
prove
function
cell
moreov
immunofluoresc
stain
ms
brain
lesion
demonstr
presenc
cell
brain
donor
test
target
tissu
cell
might
exert
cytotox
properti
preliminari
result
show
cell
degranul
tcr
stimul
well
stimul
ms
relat
antigen
mbp
mog
result
indic
cell
contribut
pathogenesi
autoimmun
diseas
ms
ra
particular
found
number
treg
cell
express
ectonucleotidas
significantli
reduc
peripher
blood
mononuclear
cell
pbmc
ms
patient
compar
healthi
donor
sinc
express
confin
cell
endow
power
suppress
abil
reduct
cell
ms
patient
point
deregul
balanc
pathogen
effector
protect
regul
analys
role
plasmacytoid
pdc
myeloid
mdc
dendrit
cell
establish
tregulatoryteffector
cell
balanc
stimul
purifi
pdc
mdc
healthi
donor
ms
patient
tlr
agonist
cocultur
naiv
memori
cell
studi
frequenc
effector
regulatori
cell
day
cocultur
found
stimul
pdc
potent
induc
cell
regulatori
properti
mdc
induc
high
level
cell
produc
effector
cytokin
result
indic
pdc
mdc
differenti
role
maintain
balanc
regulatori
effector
cell
ms
knowledg
import
design
new
therapeut
approach
aim
shift
balanc
toward
antiinflammatori
immun
respons
ms
patient
multipl
sclerosi
ms
central
nervou
system
cn
direct
inflammatori
diseas
leukocyt
found
lesion
lymphocyt
lymphocyt
b
lymphocyt
antigenpres
cell
role
cell
ms
anim
model
experiment
autoimmun
encephalomyel
eae
extens
studi
nevertheless
recent
studi
shown
cell
capac
access
cn
cell
found
parenchyma
activ
lesion
ms
patient
eae
anim
also
clonal
expand
lymphocyt
found
ms
lesion
cerebrospin
fluid
csf
ms
patient
howev
phenotyp
origin
rout
entri
lymphocyt
found
ms
eae
lesion
yet
identifi
object
evalu
phenotyp
migrat
lymphocyt
mechan
cell
cross
bloodbrain
barrier
bbb
use
csf
relapsingremit
ms
patient
spinal
cord
mog
induc
eae
coronavirusinduc
enceph
demonstr
flow
cytometri
immunostain
lymphocyt
mostli
effector
memori
em
phenotyp
granzymebhi
show
purifi
human
tem
lymphocyt
transmigr
readili
across
bbb
endotheli
cell
nonem
lymphocyt
bbb
endothelium
promot
select
recruit
em
lymphocyt
furthermor
provid
evid
select
recruit
ifngand
lymphocyt
human
mous
bbb
endothelium
vitro
vivo
final
show
vitro
vivo
migrat
lymphocyt
cn
depend
integrin
studi
provid
evid
activ
role
bbb
recruit
tem
lymphocyt
cn
defin
integrin
major
contributor
lymphocyt
entri
brain
effect
glucocorticoid
adrenomedullin
express
cell
adrenomedullin
novel
vasodilatatori
peptid
act
primarili
calcitonin
receptorlik
receptor
clr
combin
either
receptoractivitymodifyingprotein
ramp
receptor
respect
shown
play
import
yet
unclear
role
inflamm
increas
follow
cytokin
treatment
promot
macrophag
action
situ
proinflammatori
also
downregul
tnfalpha
increas
express
macrophag
antiinflammatori
inde
specif
previous
demonstr
elev
develop
neuroinflammatori
lesion
anim
model
multipl
sclerosi
furthermor
constitut
express
cell
highli
express
hypox
condit
exert
import
role
cell
adapt
perform
low
oxygen
concentr
final
immunosuppress
glucocorticoid
gc
shown
regul
varieti
cell
clr
mrna
product
previous
detect
jurkat
leukaemia
cell
normox
condit
receptor
compon
protein
level
never
studi
studi
present
examin
express
compon
part
receptor
primari
human
cell
effect
gc
express
clr
express
examin
primari
human
cell
pcr
flow
cytometri
receptor
compon
found
physiolog
express
unstimul
cell
intracellularli
cell
surfac
phastimul
appear
decreas
receptor
protein
significantli
clr
p
b
follow
treatment
h
express
significantli
decreas
unstimul
cell
p
b
contrari
gc
treatment
h
affect
stimul
cell
increas
intracellular
ramp
level
p
b
find
indic
close
relationship
express
activ
state
cell
potenti
novel
mechan
sens
cell
environ
receptor
discuss
gendron
steve
prat
alexandr
multipl
sclerosi
ms
character
immun
cell
infiltr
central
nervou
system
cn
particularli
cell
lineag
one
import
event
infiltr
transmigr
cell
bloodbrain
barrier
bbb
mainli
constitut
endotheli
cell
extracellular
matrix
ecm
protein
th
cell
transmigr
larg
attribut
integrin
famili
express
surfac
cell
integrin
known
import
integrin
process
blockad
complet
abrog
ms
eae
symptom
data
lab
suggest
effector
cell
express
integrin
integrin
never
describ
cell
goal
studi
character
express
integrin
thelper
cell
whether
integrin
involv
transmigr
lymphocyt
bbb
experiment
autoimmun
encephalomyel
eae
ms
western
blot
rtpcr
analysi
demonstr
integrin
found
human
cell
strikingli
upregul
higher
express
lymphocyt
well
found
nephronectin
npnt
main
ligand
integrin
produc
primari
cultur
human
brain
endotheli
cell
hbec
express
vascular
structur
human
rodent
cn
preliminari
data
specif
role
integrin
migrat
thelper
lymphocyt
across
brain
vsacular
structur
address
use
known
rgdbase
block
peptid
interact
invitro
invivo
eae
work
aim
identifi
potenti
new
interact
patholog
cell
express
integrin
npnt
express
brain
endotheli
cell
interact
might
lead
identif
novel
therapeut
target
treatment
ms
erasmu
mc
univers
medic
center
rotterdam
netherland
introduct
one
first
valid
singl
nucleotid
polymorph
associ
increas
risk
multipl
sclerosi
howev
limit
inform
avail
express
receptor
differ
lymphocyt
subset
possibl
differenti
signal
capac
ms
compar
healthi
control
hc
aim
studi
determin
whether
frequenc
express
level
function
tcell
subset
differ
ms
patient
healthi
control
moreov
function
differ
signal
upon
stimul
test
ms
patient
method
flowcytometr
studi
pbmc
ms
patient
remiss
healthi
control
b
memori
c
effector
popul
stain
express
moreov
stimul
sort
tcell
perform
studi
function
paramet
result
expect
percentag
memori
tcell
significantli
increas
ms
patient
interestingli
signific
increas
frequenc
effector
memori
found
ms
ms
hc
p
moreov
express
level
significantli
increas
tcell
subset
except
memori
tcell
memori
tcell
ms
patient
p
b
ms
patient
show
significantli
stronger
increas
phophoryl
tcell
compar
healthi
control
p
b
stimul
independ
membran
express
ms
hc
stimul
tcell
lead
increas
express
gene
involv
cytotox
granzym
b
signific
specif
ms
patient
upregul
granzym
express
observ
p
discuss
axi
activ
ms
patient
possibl
relat
mainten
memori
tcell
pool
recent
shown
ms
lesion
produc
lower
threshold
induc
cytotox
ms
patient
may
enhanc
pathogen
tcell
appear
special
interest
light
demyelin
cytotox
effect
granzym
neuromyel
optica
nmo
associ
specif
antibodi
human
celldepend
antibodi
subclass
suggest
cell
may
particip
nmo
pathogenesi
possibl
support
observ
antibodi
alon
pathogen
absenc
cn
inflamm
order
understand
potenti
role
cell
nmo
pathogenesi
develop
model
nmo
studi
cell
recognit
nmo
patient
mice
goal
investig
identifi
cell
determin
sjlj
mice
scan
cell
reactiv
use
intact
overlap
peptid
encompass
entir
sequenc
mous
human
mice
immun
peptid
intact
complet
freund
adjuv
prolifer
measur
incorpor
direct
immun
peptid
mice
cell
determin
identifi
within
peptid
p
sjl
j
mice
cell
determin
situat
cell
determin
identifi
strain
locat
within
put
cytoplasm
domain
mhc
iirestrict
cell
line
specif
individu
determin
prolifer
respons
intact
howev
immun
intact
recal
strongest
strain
indic
region
contain
natur
process
immunodomin
cell
epitop
cell
secret
ifng
use
truncat
peptid
within
cell
determin
character
cell
sjlj
mice
recogn
respect
preliminari
data
prolifer
tetram
analysi
indic
cell
nmo
patient
also
recogn
determin
residu
contain
immunogen
mhc
iirestrict
cell
determin
sjlj
mice
contain
immunodomin
determin
within
intact
unlik
recognit
b
cell
antibodi
frequent
recogn
extracellular
domain
protein
cell
determin
locat
within
cytoplasm
domain
data
may
use
investig
develop
nmo
model
vivo
visual
antigen
present
cn
kawakami
naoto
ingo
pesic
marija
odoardi
francesca
christian
alexand
wekerl
hartmut
max
planck
institut
neurobiolog
martinsri
germani
univers
germani
experiment
autoimmun
encephalomyel
eae
well
multipl
sclerosi
cell
seem
central
role
clinic
outcom
acut
phase
adopt
transfer
eae
autoreact
cell
infiltr
cn
massiv
cell
highli
reactiv
produc
inflammatori
cytokin
recruit
immun
cell
eg
macrophag
b
cell
ask
question
cell
infiltr
cn
start
use
intravit
two
photon
microscopi
visual
genet
gfp
label
posit
mbp
specif
cell
tmbpgfp
cell
infiltr
procedur
entir
eae
period
onset
tmbpgfp
cell
appear
leptomening
vessel
spinal
cord
tmbpgfp
cell
crawl
intra
lumin
surfac
extravas
interestingli
cell
penetr
cn
parenchyma
extravas
continu
scan
ablumin
surfac
vessel
hypothes
antigen
present
happen
perivascular
locat
sinc
perivascularmening
macrophag
locat
mark
perivascularmening
macrophag
potenti
antigen
present
cell
apc
intrathec
inject
fluorochromedextran
conjug
altern
apc
mark
bone
marrow
transplant
bone
marrow
cell
deriv
gfp
transgen
rat
graft
irradi
recipi
observ
shortand
longlast
contact
cell
apc
seem
repres
antigen
recognit
gene
profil
analysi
support
observ
tmbpgfp
cell
activ
mening
compar
spleen
blood
interestingli
mening
apc
satur
endogen
antigen
exogen
mbp
hyperactiv
tmbpgfp
cell
cn
exagger
eae
furthermor
show
import
antigen
present
cn
mening
use
ova
specif
cell
small
number
tovagfp
cell
appear
cn
mening
penetr
cn
parenchyma
intrathec
inject
ovapuls
mening
apc
chang
situat
dramat
higher
number
tovagfp
cell
recruit
cn
show
stationari
behavior
seem
repres
antigen
recognit
show
antigen
present
cn
mening
critic
step
cell
penetr
cn
current
studi
relationship
durat
contact
cell
activ
furthermor
character
mening
apc
depth
schneider
raphael
yaneva
teodora
beauseigl
dian
prat
alexandr
arbour
nathali
cytokin
famili
shown
exhibit
proand
antiinflammatori
properti
wherea
favor
develop
respons
also
inhibit
respons
sever
studi
document
capac
suppress
experiment
autoimmun
encephalomyel
eae
murin
astrocyt
microglia
report
produc
moreov
promot
prolifer
cytotox
function
mous
lymphocyt
whether
similar
effect
human
cell
elucid
final
whether
human
cn
cell
could
local
provid
explor
goal
investig
impact
human
cell
function
identifi
cellular
sourc
human
central
nervou
system
cn
use
peripher
blood
mononuclear
cell
pbmc
isol
cell
healthi
donor
perform
phenotyp
function
assay
first
determin
subset
human
cell
express
complet
receptor
express
increas
upon
polyclon
activ
induc
rapid
phosphoryl
signal
transduc
activ
transcript
stat
enhanc
protein
express
cell
furthermor
upon
treatment
human
cell
express
suppressor
cytokin
signal
soc
mrna
importantli
effect
attenu
inhibit
signal
addit
activ
cell
significantli
increas
transcript
factor
tbet
express
level
cell
prolifer
ifngamma
granzym
b
product
cell
lead
increas
cellmedi
cytotox
detect
immunohistochemistri
human
brain
tissu
section
indic
microglia
brain
endotheli
cell
potenti
local
sourc
addit
detect
supernat
obtain
primari
cultur
human
brain
endotheli
cell
treat
proinflammatori
stimuli
support
notion
secret
cell
inflam
environ
result
demonstr
proinflammatori
impact
human
cell
mediat
via
lead
boost
cytotox
effector
cell
furthermor
human
microglia
brain
endotheli
cell
could
local
provid
henc
impact
infiltr
human
cell
goal
studi
presenc
regulatori
treg
regulatorysuppressor
ts
cell
subset
effector
cell
csf
peripher
blood
pb
ms
patient
first
relaps
twentyf
patient
first
clinic
relaps
later
diagnos
ms
consecut
studi
csf
pb
sampl
ms
patient
analyz
parallel
multiparametr
flowcytometri
proport
ts
significantli
higher
csf
pb
p
p
p
ns
respect
contrari
cell
count
elev
peripheri
p
treg
frequenc
also
higher
csf
pb
p
p
p
indic
specif
recruit
cell
toward
csf
ms
relaps
interestingli
found
surfac
express
significantli
reduc
treg
cell
csf
compar
peripheri
mean
fluoresc
intens
mfi
p
b
mfi
p
b
expect
cell
percentag
lower
csf
pb
pb
p
respect
memori
p
effectormemori
p
effector
p
cell
higher
csf
effectormemori
p
effector
cell
higher
csf
memori
cell
higher
pb
p
observ
specif
intrathec
enrich
regulatori
cell
togeth
effectormemori
effector
cell
within
csf
cohort
ms
patient
first
ms
relaps
interestingli
downmodul
costimulatori
signal
cell
induct
forkhead
transcript
factor
express
treg
ts
suggest
attempt
inhibit
selfantigen
effector
specif
respons
thu
control
inflammatori
activ
diseas
smith
kristen
gueraudearellano
mireia
bottoni
arianna
rack
michael
lovettrack
ami
whitacr
carolin
multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
cn
affect
million
worldwid
autoreact
thelper
th
cell
phenotyp
implic
ms
pathogenesi
microrna
mir
class
small
noncod
rna
neg
regul
posttranscript
gene
express
dicerdefici
cell
lack
express
mir
produc
inflammatori
cytokin
upon
stimul
howev
mir
respons
modul
cell
program
defin
studi
implic
specif
mir
regul
respons
make
mir
potenti
biomark
ms
use
target
predict
algorithm
found
predict
target
two
key
compon
differenti
tbet
ifng
importantli
tbet
identifi
factor
necessari
cell
infiltr
cn
target
tbet
ifng
posit
control
program
function
encephalitogen
valid
target
tbet
ifng
use
gainand
lossoffunct
experi
human
murin
cell
consist
role
develop
express
increas
follow
polar
induct
correl
ifng
product
addit
purifi
cell
treat
ifng
upregul
result
indic
induc
ifng
signal
act
neg
feedback
loop
control
amplitud
respons
therefor
hypothes
ms
patient
would
alter
level
purifi
cell
ms
patient
lower
basal
level
rel
healthi
control
suggest
fundament
dysregul
ms
patient
may
contribut
diseas
pathogenesi
data
identifi
axi
initi
cell
control
inflamm
axi
disrupt
ms
patient
predispos
individu
develop
robust
respons
order
return
immun
system
homeostat
state
ms
treatment
may
work
part
normal
express
hypothesi
activ
investig
ultim
result
studi
could
lead
develop
biomark
cellmedi
diseas
ms
peripher
opioidinduc
analgesia
associ
adapt
cell
respons
boue
jerom
blanpi
catherin
brousset
pierr
vergnol
nathali
dietrich
gill
pain
sensat
hallmark
inflammatori
respons
induc
pathogen
tissu
damag
larg
spectrum
molecul
releas
within
inflam
tissu
includ
neuropeptid
prostaglandin
proteas
induc
pain
stimul
primari
affer
neuron
situ
activ
primari
sensit
fiber
counteract
peripher
endogen
regulatori
mechan
involv
local
opioid
releas
leukocyt
infiltr
inflammatori
site
studi
show
inflammatori
pain
relief
occur
spontan
day
antigen
challeng
caus
opioid
releas
antigenprim
cell
site
inflamm
within
drain
lymph
node
specif
antigen
prime
upregul
opioid
synthesi
lymphocyt
taken
togeth
data
demonstr
lymphocyt
acquir
antinocicept
effector
properti
specif
prime
antigen
adapt
immun
respons
hail
yohann
turner
dian
bleackley
chri
giuliani
fabrizio
regulatori
cell
treg
play
unequivoc
role
modul
divers
array
immunolog
respons
maintain
peripher
toler
nevertheless
contradictori
report
regard
role
treg
impair
multipl
sclerosi
ms
activ
cytotox
cell
releas
serin
proteas
granzym
b
grb
induc
neurotox
degrad
myelin
andor
axon
neurodegen
diseas
ms
howev
separ
effect
cell
subset
term
grb
express
subsequ
neurotox
explor
studi
aim
character
level
grb
express
assess
cytotox
effect
cell
subset
human
neuron
special
emphasi
treg
human
lymphocyt
activ
antibodi
negativeposit
select
cell
subset
use
magnet
separ
grb
express
measur
realtim
pcr
flow
cytometri
human
cortic
fetal
neuron
cultur
alon
cocultur
unactivatedactiv
cell
subset
neuron
viabil
assess
immunocytochemistri
microtubul
associ
ifngamma
measur
cytokineelisa
suppress
assay
perform
quantif
incorpor
cell
rtpcr
reveal
activ
cell
express
fold
grb
compar
unactiv
cell
confirm
fac
cell
induc
signific
amount
grb
ifngamma
treg
induc
sever
neurotox
compar
cell
separ
activ
cell
significantli
enhanc
grb
express
fold
compar
cell
fail
suppress
prolifer
effector
cell
current
paradigm
consid
treg
benefici
autoimmun
respons
potent
suppress
immunemedi
tissu
damag
contrari
find
show
cell
neurotox
activ
loss
suppress
function
ifngamma
express
indic
shift
toward
phenotyp
grb
induc
target
cell
apoptosi
thu
neuron
death
might
mediat
presenc
high
level
grb
express
cell
data
provid
import
insight
limit
treg
cell
therapeut
applic
requir
seriou
caution
use
treg
diseas
intervent
strategi
tcell
macrophag
play
crucial
role
primari
immun
attack
inflamm
also
associ
remyelin
acut
ms
plaqu
anim
model
sinc
inflamm
occur
concurr
remyelin
howev
difficult
isol
benefici
effect
inflamm
remyelin
previous
shown
adopt
transfer
tcell
infiltr
zone
axon
lesion
devoid
autoimmun
demyelin
investig
extent
infiltr
cell
factor
releas
cell
activ
microgliamacrophag
affect
oligodendrocyt
precursor
cell
opc
prolifer
oligodendrocyt
format
method
group
mice
subject
adopt
transfer
proteolipid
proteinspecif
tcell
tplp
axon
lesion
tplp
ovalbuminspecif
tcell
tova
axon
lesion
tova
axon
lesion
alon
mice
inject
prolifer
marker
brdu
tissu
process
cell
count
cell
opc
cnpase
oligodendrocyt
along
doubl
stain
brdu
sprout
calretinerg
axon
examin
areal
estim
express
cytokin
evalu
quantit
pcr
situ
hybrid
techniqu
result
found
tplp
mice
axon
lesion
show
signific
increas
prolifer
opc
day
post
lesion
format
new
cnpase
oligodendrocyt
day
post
lesion
compar
lesion
tova
mice
presenc
tplp
cell
also
enhanc
clearanc
myelin
debri
increas
sprout
respons
intact
calretinerg
fibr
within
dentat
gyru
markedli
rais
express
key
inflammatori
cytokin
ifn
tnfa
along
receptor
conclus
data
show
presenc
myelinreact
cell
may
stimulatori
effect
opc
prolifer
differenti
affect
sever
paramet
alon
combin
facilit
induc
myelin
result
suggest
spite
patholog
role
myelinreact
tcell
ms
cell
may
also
associ
benefici
effect
regen
process
brain
mucin
pselectin
glycoprotein
express
leukocyt
main
ligand
endotheli
selectin
involv
leukocyt
traffick
physiolog
patholog
condit
wherea
role
emerg
cell
homeostasi
controversi
result
obtain
anim
model
autoimmun
diseas
goal
clarifi
role
mucin
cell
respons
experiment
autoimmun
encephalomyel
eae
eae
induc
activ
immun
sever
mice
wherea
myelin
oligodendrocyt
glycoprotein
mog
cell
obtain
mice
transfer
sever
diseas
wt
cell
suggest
role
regulatori
mechan
eae
cell
isol
form
wt
mice
display
similar
prolif
respons
proinflammatori
cytokin
product
studi
role
suppressor
activ
exert
regulatori
treg
cell
eae
use
twophoton
laser
microscopi
tplm
aim
visual
behavior
encephalitogen
cell
presenc
absenc
treg
intact
drain
lymph
node
earli
day
postimmun
late
day
postimmun
preclin
phase
eae
tplm
experi
show
cell
move
slower
lower
motil
coeffici
enhanc
arrest
coeffici
display
less
random
movement
compar
cell
ovalbuminprim
cell
show
signific
increas
speed
decreas
arrest
coeffici
presenc
wt
treg
drain
lymph
node
immun
mice
interestingli
treg
fail
modul
motil
behavior
prolifer
cell
late
earli
preclin
phase
eae
addit
treg
mice
present
reduc
migrat
capac
cn
preclin
phase
eae
compar
wt
treg
display
dramat
decreas
adhes
interact
inflam
brain
microcircul
final
defici
treg
reduc
capac
suppress
eae
compar
wt
cell
data
suggest
key
role
treg
function
eae
mediat
cellcel
contact
requir
effici
suppress
vivo
control
treg
migrat
inflam
brain
organspecif
autoimmun
diseas
trigger
often
tissuespecif
autoreact
lymphocyt
experiment
autoimmun
encephalomyel
eae
serv
anim
model
multipl
sclerosi
eae
induc
passiv
transfer
cn
antigen
specif
cell
stimul
vitro
howev
suscept
clinic
outcom
eae
strongli
strain
antigen
depend
lewi
rat
myelin
basic
protein
mbp
specif
cell
tmbp
cell
trigger
sever
neurolog
diseas
cell
specif
myelin
oligodendrocyt
glycoprotein
mog
tmog
cell
induc
mild
diseas
despit
cell
infiltr
cn
interestingli
context
differ
genotyp
dark
agouti
da
rat
tmog
cell
induc
sever
mbplike
eae
use
retrovir
gfp
label
cn
antigen
specif
cell
intravit
two
photon
microscopi
compar
behavior
encephalitogen
cell
relat
pathogen
observ
low
well
highli
encephalitogen
cell
infiltr
leptomening
area
spinal
cord
cascad
roll
crawl
extravas
blood
vessel
howev
highli
encephalitogen
tmbp
cell
crawl
phenotyp
domin
low
encephalitogen
tmog
cell
roll
crawl
equal
observ
nevertheless
tmog
cell
attach
intralumin
surfac
blood
vessel
crawl
long
highli
encephalitogen
tmbp
cell
extravas
low
encephalitogen
tmog
cell
made
rel
short
contact
local
apc
compar
highli
encephalitogen
tmbp
cell
tmog
cell
activ
cn
penetr
deep
cn
parenchyma
intrathec
inject
apc
vitro
puls
mog
protein
chang
situat
dramat
apc
recruit
tmog
cell
within
cn
parenchyma
induc
significantli
sever
clinic
symptom
result
suggest
low
encephalitogen
tmog
cell
abl
get
activ
signal
local
apc
consequ
fail
infiltr
cn
parenchyma
current
explor
highli
encephalitogen
tmog
cell
behavior
da
rat
lead
us
better
understand
structur
involv
cell
home
antigen
present
potenti
qualifi
new
select
therapeut
target
brain
autoimmun
diseas
paradox
role
effector
cell
autoimmun
chronic
inflamm
harrington
lauri
mani
autoimmun
chronic
inflammatori
diseas
includ
multipl
sclerosi
previous
report
disord
howev
recent
data
suggest
cell
respons
diseas
paradox
principl
cytokin
appear
necessari
diseas
key
transcript
factor
tbet
requir
conundrum
propel
us
investig
regul
transcript
factor
effector
cell
function
well
role
cell
autoimmun
address
question
employ
well
describ
mous
model
multipl
sclerosi
experiment
autoimmun
encephalomyel
eae
follow
onset
eae
observ
preferenti
upregul
tbet
effector
cell
within
cn
secondari
lymphoid
organ
cell
capabl
produc
ifngamma
fraction
abl
make
ifngamma
contrast
cell
produc
primarili
low
tbet
express
keep
nonessenti
role
tbet
differenti
next
examin
requir
promot
cytokin
ifngamma
induct
cell
eae
absenc
cytokin
signific
popul
cell
still
upregul
tbet
consist
data
found
cell
ifngamma
reporterifngamma
defici
mice
eae
express
report
molecul
indic
presenc
cell
even
absenc
cardin
cytokin
ifngamma
conclus
data
demonstr
cell
highli
associ
onset
eae
moreov
data
indic
tbet
effector
cell
aris
nontyp
polar
condit
suggest
altern
mechan
regul
tbet
express
chronic
inflamm
role
glycolipid
pathogenesi
multipl
sclerosi
bigg
nanci
j
pon
robert
search
etiolog
antigen
multipl
sclerosi
ms
chronic
inflammatori
demyelin
diseas
central
nervou
system
cn
focus
hostderiv
protein
autoantigen
relat
microorganismderiv
protein
andor
genet
motifsal
littl
success
carbohydr
form
glycolipid
repres
addit
class
antigen
richli
express
within
cn
poorli
studi
role
ms
pathogenesi
studi
describ
method
assess
relationship
use
materi
deriv
human
peripher
blood
pb
cerebrospin
fluid
csf
accomplish
expand
character
cell
sensit
glycolipid
presenc
autolog
express
dendrit
cell
dc
along
examin
antibodi
bind
profil
panel
defin
glycolipid
antigen
major
present
element
glycolipid
antigen
found
isoform
express
level
monocytederiv
dc
sensit
medium
compon
b
c
express
poor
medium
contain
human
oppos
bovin
serum
express
rel
unaffect
sinc
express
direct
bear
strateg
expans
patient
deriv
glycolipid
reactiv
cell
significantli
present
brain
deriv
glycolipid
within
cn
matter
investig
interestingli
human
plasma
oppos
serum
neg
affect
express
cultur
contain
csf
enhanc
level
often
observ
condit
primari
expans
protocol
establish
use
mix
pool
bovin
glycolipid
lead
establish
immort
sever
ms
patient
cell
line
character
cell
line
reveal
glycolipid
reactiv
cytokin
releas
thymidin
uptak
assay
ongo
screen
glycolipid
antibodi
present
within
patient
csf
pb
detect
rel
strong
level
antibodi
vari
compart
assay
patient
sampl
summari
method
establish
comprehens
examin
role
brain
glycolipid
play
immunopathogenesi
ms
studi
address
frequenc
glycolipid
reactiv
cell
blood
csf
ms
neurolog
diseas
control
possibl
correl
antiglycolipid
antibodi
level
two
pore
domain
potassium
channel
constitut
express
human
cell
pathophysiolog
relev
neuroinflamm
shown
upregul
especi
cell
relapsingremit
multipl
sclerosi
patient
better
understand
channel
function
could
provid
basi
select
target
pathophysiolog
relev
cell
assum
contribut
compens
k
efflux
upon
cell
stimul
necessari
endur
cell
activ
demonstr
overexpress
lead
fold
increas
cell
prolifer
cytokin
product
contrast
pharmacolog
inhibit
result
decreas
prolifer
cytokin
product
prolifer
basic
cell
function
reli
progress
cell
cycl
tightli
regul
sever
promot
inhibitor
cell
cycl
inhibit
follow
arrest
cell
could
shown
cyclin
cell
cycl
promot
express
inhibit
wherea
inhibitor
cell
cycl
transit
upregul
blockad
channel
function
understand
role
cell
function
also
import
point
regul
channel
blockad
differ
intracellular
signal
pathway
result
compar
inhibit
upregul
mrna
level
upon
cell
stimul
seem
also
regul
protein
level
western
blot
data
show
pool
intracellular
locat
protein
well
plasmamembran
local
protein
fraction
result
point
essenti
function
key
integr
extracellular
signal
molecular
level
dynam
interplay
pool
plasma
membran
intracellular
open
possibl
rapid
express
plasmamembran
immedi
adapt
extracellular
signal
enigmat
lymphocyt
display
effector
well
immunoregulatori
function
involv
pathogenes
autoimmun
diseas
estim
pathogenet
role
experiment
autoimmun
encephalomyel
eae
multipl
sclerosi
ms
peripher
blood
mononuclear
cell
pbmc
lymph
node
intraepitheli
lymphocyt
intestin
splenocyt
thymocyt
wistar
rat
induc
eae
control
anim
well
pbmc
patient
relapsingremit
ms
healthi
donor
use
materi
quantiti
myelininduc
activ
prolifer
cfselabel
subset
presenc
absenc
cell
remov
cell
cultur
magnet
separ
monitor
flow
cytometri
analysi
investig
lymphoid
organ
show
redistribut
peripher
blood
lymph
node
eae
rat
correl
clinic
find
diseas
similarli
ms
patient
number
reduc
among
pbmc
estim
influenc
home
myelininduc
activ
vitro
reveal
hold
check
shed
surfac
pb
control
express
p
b
tcell
subset
cultur
autoantigen
ms
patient
healthi
donor
moreov
presenc
suppress
spontan
autoantigeninduc
prolifer
p
b
healthi
donor
perform
therebi
immunoregulatori
role
contrari
ms
patient
promot
increas
tcell
myelinspecif
prolifer
p
b
assum
particip
autoantigen
present
thelper
obtain
data
confirm
myelinspecif
prolifer
absenc
potenti
antigenpres
cell
pbmc
cultur
ms
patient
involv
pathogenesi
ms
confirm
eae
model
regul
home
activ
myelinspecif
differ
way
affect
subset
prolifer
respons
specif
autoantigen
ms
patient
healthi
donor
make
perspect
target
pathogenet
therapi
experiment
autoimmun
encephalomyel
eae
central
nervou
system
target
autoimmun
diseas
primari
anim
model
multipl
sclerosi
ms
use
eae
smallsiz
neotrop
primat
common
marmoset
callitrix
jacchu
unravel
cellular
mechan
demyelin
anim
model
relev
due
clinic
patholog
similar
ms
high
genet
immunolog
proxim
human
aim
research
assess
phenotyp
function
newli
discov
subset
autoreact
cytotox
tcell
mediat
demyelin
absenc
autoantibodi
involv
besid
also
identifi
mhcpeptid
complex
target
tcell
eae
induc
immun
unrel
marmoset
synthet
peptid
repres
peptid
human
myelin
oligodendrocyt
glycoprotein
emulsifi
incomplet
freund
adjuv
ifa
anim
develop
neurolog
deficit
demyelin
lesion
brain
spinal
cord
fac
analysi
cell
cfse
dilut
upon
stimul
coexpress
moreov
cell
display
specif
cytolyt
activ
allogen
autolog
bcell
minim
tcell
epitop
within
sequenc
bcell
exchang
experi
show
cytotox
peptid
specif
target
cell
independ
indic
peptid
may
present
invari
mhc
class
allel
caja
homologu
human
hlae
normal
repertoir
marmoset
monkey
contain
memorytyp
tcell
vivo
activ
adjuv
ifa
without
innat
antigen
receptor
ligand
strike
capac
tcell
induc
demyelin
cn
white
grey
matter
associ
epitop
within
sequenc
caja
restrict
cytotox
hypothes
featur
causal
relat
ortlieb
guerreirocacai
andr
beyeen
amennai
jagod
maja
olsson
thoma
depart
clinic
neurosci
neuroimmunolog
unit
karolinska
institutet
stockholm
sweden
member
famili
guanin
nucleotid
exchang
factor
gef
rho
famili
gtp
bind
protein
import
hematopoiesi
also
play
role
tcell
bcell
develop
activ
tissu
home
effector
function
found
within
rat
quantit
trait
locu
qtl
regul
experiment
autoimmun
encephalomyel
eae
model
multipl
sclerosi
ms
overlap
sever
qtl
immunemedi
diseas
analysi
extens
human
cohort
also
demonstr
associ
certain
haplotyp
within
first
intron
gene
ms
increas
level
mrna
found
peripher
blood
cerebrospin
fluid
ms
patient
compar
match
control
publish
result
attempt
character
function
context
develop
autoimmun
use
intervalspecif
congen
rat
line
carri
diseas
predispos
protect
variant
show
immun
recombin
rat
myelin
oligodendrocyt
glycoprotein
mog
incomplet
freund
adjuv
diseas
predispos
variant
promot
develop
high
proinflammatori
state
higher
number
cell
higher
number
doubl
posit
cell
cell
show
increas
express
activ
marker
increas
brdu
incorpor
indic
cell
cycl
upon
antigenspecif
vitro
restimul
cell
diseas
predispos
variant
exhibit
phenotyp
increas
product
tnf
cell
strain
protect
variant
show
increas
level
well
higher
overal
level
cell
especi
within
subset
conclud
play
central
role
control
inflammatori
immun
respons
rat
model
eae
studi
aim
pinpoint
stage
immun
respons
specif
control
nucleotid
exchang
factor
eae
also
prevent
oral
toler
mbp
howev
although
oral
toler
myelin
antigen
achiev
multipl
sclerosi
ms
patient
benefici
effect
patient
recent
found
oral
toler
egg
ovalbumin
also
occur
liver
mediat
specif
plasmacytoid
dendrit
cell
system
toler
involv
delay
type
hypersensit
respons
plasmacytoid
dendrit
cell
demonstr
eae
lesion
plasma
cell
identifi
use
specif
marker
cd
confin
perivascular
space
ms
patient
present
brain
parenchyma
cell
parenchyma
extens
rough
endoplasm
reticulum
previous
describ
plasma
cell
probabl
plasmacytoid
dendrit
cell
need
confirm
use
specif
mark
order
produc
anim
model
nonlepromat
leprosi
dutch
bantam
englishlop
rabbit
inject
homogen
human
sensori
peripher
nerv
plu
adjuv
skin
test
dilut
concentr
sensori
nerv
variou
human
nonmyelin
antigen
rabbit
develop
state
granulomat
hypersensit
ie
plasmalik
cell
extens
rough
endoplasm
reticulum
accumul
skin
test
site
dermi
also
endoneurium
axon
damag
thin
myelin
sheath
plasmalik
cell
may
plasmacytoid
dendrit
cell
activ
compon
human
sensori
nerv
induc
granulomat
respons
deoxycholateextract
membran
fraction
nuclear
pellet
sensori
nerv
myelin
remov
may
possibl
induc
oral
toler
use
specif
antigen
order
confirm
whether
toler
occur
absenc
plasmalik
cell
endoneurium
dermal
nerv
axon
damag
skintest
site
follow
challeng
membran
fraction
sensit
rabbit
although
antigen
effect
microgram
protein
purif
necessari
localis
similar
antigen
central
nervou
system
may
possibl
induc
toler
antigen
case
vaccin
could
develop
prevent
disabl
ms
activ
receptor
axi
respons
anoxia
primari
rat
astrocyt
fischer
iri
nichol
anthoni
alliod
chantal
frossard
mari
pouli
sandrin
ischemictyp
lesion
cn
characterist
hallmark
multipl
sclerosi
ms
like
particip
neurodegen
process
diseas
hypoxia
shown
lead
increas
permeabl
disrupt
bbb
hypoxia
astrocyt
retract
end
feet
process
microvessel
result
increas
permeabl
prolifer
may
lead
format
glial
scar
activ
astrocyt
respons
hypox
stress
also
shown
induc
proangiogen
factor
vascular
endotheli
growth
factor
vegf
major
target
gene
activ
hypoxia
other
shown
enzym
sphingosin
kinas
induc
low
oxygen
level
cell
line
deriv
human
glioblastoma
led
increas
level
final
crosstalk
vegf
demonstr
upregul
express
receptor
associ
enhanc
intracellular
signal
respons
goal
present
studi
thu
investig
combin
oxygenglucos
depriv
ogd
subsequ
reoxygen
activ
receptor
axi
primari
rat
astrocyt
lead
transactiv
vegf
primari
cultur
rat
astrocyt
expos
ogd
h
follow
reoxygen
h
regul
mrna
level
receptor
measur
well
influenc
erkand
aktsign
receptor
specif
signal
investig
use
cellkey
technolog
allow
measur
bioimped
modul
induc
upon
receptor
activ
chang
cell
shape
furthermor
product
vegf
measur
ogd
follow
reoxygen
induc
upregul
mrna
level
addit
erksign
elev
h
ogd
reoxygen
wherea
aktsign
elev
reoxygen
final
specif
signal
via
increas
reoxygen
correl
increas
vegf
level
preliminari
data
demonstr
ischem
stress
follow
reoxygen
activ
receptor
axi
cultur
primari
rat
astrocyt
experi
attempt
elucid
possibl
involv
pathway
product
vegf
nmoigg
autoantibodi
consid
use
serum
biomark
neuromyel
optica
nmo
seri
clinic
patholog
observ
suggest
nmoigg
may
play
central
role
nmo
physiopatholog
aim
vitrobas
studi
character
molecular
function
consequ
interact
nmoigg
astrocyt
primari
cultur
three
nmoigg
posit
nmo
patient
neuroimmunolog
ramo
mejia
hospit
argentina
select
control
includ
serum
nmoigg
neg
healthi
control
primari
cultur
rat
astrocyt
incub
heatinactiv
control
nmo
patient
sera
dilut
h
h
immunofluoresc
studi
well
water
permeabl
measur
fluoresc
videomicroscopi
perform
fluoresc
quantifi
densitometr
analysi
use
imagej
softwar
immunofluoresc
studi
show
cell
exposit
nmo
patient
sera
h
restrict
membran
fluiditi
result
igg
bind
plasma
membran
linear
pattern
coloc
serum
igg
control
bind
significantli
contrast
exposur
h
nmo
patient
sera
contain
specif
igg
result
disappear
fluoresc
plasma
membran
control
sera
effect
express
even
h
exposit
astrocyt
nmoigg
chang
water
permeabl
indic
water
pore
affect
bind
igg
h
exposit
nmoigg
clearli
induc
signific
reduct
water
permeabl
time
constant
water
transport
control
vs
nmoigg
sera
vs
p
b
nmo
patientssera
igg
select
pathogen
effect
cell
membran
express
demonstr
nmoigg
bind
astrocyt
alter
express
decreas
permeabl
vartak
neha
borgmann
kathleen
tang
lin
ghorpad
anuja
human
immunodefici
viru
hiv
dementia
highli
debilit
neurocognit
disord
occur
untreat
individu
astrocyt
abund
cell
brain
play
crucial
role
progress
outcom
recent
rapid
subtract
hybrid
approach
rash
determin
differenti
express
gene
infect
astrocyt
identifi
novel
gene
astrocyt
elev
tumor
necrosi
factor
tnf
induc
transcript
subsequ
also
shown
elev
subset
malign
glioma
hepatocellular
breast
carcinoma
identifi
oncogen
respons
metastasi
anchorageindepend
growth
resist
chemotherapeut
drug
although
primarili
identifi
induc
gene
astrocyt
role
infect
studi
far
astrocyt
crucial
regul
brain
homeostasi
focu
research
long
time
therefor
would
benefici
studi
role
astrocyt
respons
orchestr
infect
brain
propos
crucial
contribut
factor
progress
modul
astrocyt
respons
inflamm
injuri
stress
gener
pathogenesi
activ
downstream
nuclear
factor
nf
kb
pathway
preliminari
data
show
hadrelev
stimuli
tnfa
upregul
express
mrna
protein
level
primari
human
astrocyt
correspond
decreas
excitatori
amino
acid
transport
eaat
mrna
level
increas
chemokin
product
characterist
phenomenon
also
observ
suggest
probabl
role
modul
express
protein
mrna
level
immunocytochem
studi
show
local
cytoplasm
nucleu
primari
human
astrocyt
respons
hadrelev
inflammatori
stimuli
nucleolu
respons
injuri
oxid
stress
distinct
intracellular
local
respons
differ
hadrelev
stimuli
suggest
involv
regul
astrocyt
behavior
develop
progress
rheumatoid
arthriti
system
autoimmun
diseas
bring
except
pain
often
impair
logic
memori
attent
deficit
far
experiment
correl
could
suffici
explain
possibl
prevent
problem
aim
present
studi
analyz
neuroendcrin
inflammatori
chang
circul
mrna
express
paramet
oxid
stress
hippocampu
clinic
manifest
inflammatori
diseas
day
cfa
administr
control
male
lewi
rat
cfa
administ
intraderm
base
tail
acth
corticosteron
creactiv
protein
assay
plasma
specif
ria
elisa
albumin
measur
spectrophotometr
base
format
bromcresol
green
complex
mrna
oxidas
oxidas
induc
syntas
ino
hippocampu
assay
quantit
realtim
pcr
use
taqman
probe
primer
express
arbitrari
unit
relat
betaactin
express
cfo
measur
immunohistochem
lumbar
spinal
cord
slice
find
enhanc
cfo
fiber
lumbar
spinal
cord
indic
activ
pain
relat
neuron
hind
paw
preclin
stage
diseas
found
enhanc
circul
level
acth
corticosteron
creactiv
protein
reduc
level
albumin
hippocampu
found
overexpress
mrna
unchang
furthermor
express
mrna
well
ino
upregul
microglia
upon
immun
activ
known
enhanc
activ
consequ
induc
well
product
product
give
rise
highli
neurotox
proooxid
peroxynitrit
onooand
may
lead
synaps
loss
base
result
assum
chang
found
earli
phase
inflammatori
diseas
may
progress
induc
oxid
stress
neuron
furthermor
result
show
oxidativeinflammatori
chang
preced
clinic
manifest
treatment
antioxid
may
possibl
help
slower
process
support
gacr
apvv
chang
neuromuscular
junction
peripher
nerv
associ
acut
chronic
exposit
antibodi
antigangliosid
antibodi
one
frequent
autoantibodi
associ
immun
mediat
neuropathi
almost
gb
patient
demonstr
serum
reactiv
glucolipid
chronic
polineuropathi
show
lower
associ
frequenc
although
antibodi
recogn
gangliosid
like
frequent
found
mechan
implic
nerv
damag
possibl
interfer
gangliosid
function
axon
neuromuscular
junction
littl
studi
studi
effect
human
igm
monoclon
antibodi
recogn
specif
carbohydr
sequenc
shear
nerv
neuromuscular
junction
presenc
complement
without
neuromuscular
junction
nmj
studi
perform
mous
levat
auri
longu
muscl
nerv
conduct
studi
perform
sciatic
rat
nerv
perform
immunohistochem
studi
local
antibodi
fixat
complement
activ
structur
chang
nmj
nerv
b
methylen
blue
studi
analyz
structur
chang
nerv
c
electron
microscopi
evalu
ultrastructur
chang
intracellular
record
electrofisiolog
studi
perform
evalu
nmj
convent
motor
neurographi
electromyographi
evalu
rat
sciatic
nerv
nmj
found
acut
chronic
neurotransmitt
releas
blockag
without
complement
implic
voltagedepend
calcium
channel
vdcc
involv
effect
immunoglobulin
chronic
appli
vivo
provok
termin
axon
retract
spout
express
vdcc
type
l
without
complement
activ
passiv
intra
nerv
immunoglobulin
transfer
induc
acut
complement
depend
partial
conduct
block
chronic
treatment
result
complement
depend
mix
axonaldemielin
electrophysiolog
morpholog
chang
antibodi
affect
neuromuscular
transmiss
without
complement
activ
howev
nerv
conduct
alter
need
membran
structur
damag
gangliosid
involv
reciproc
schwann
cellnerv
termin
interact
includ
structur
stabil
neurotransmiss
introduct
inflammatori
mechan
play
key
role
pathophysiolog
postischem
inflamm
follow
stroke
resid
microgli
cell
invad
immun
cell
major
contributor
postischem
inflamm
differ
immun
cell
subpopul
integr
complex
cytokin
network
compos
proand
antiinflammatori
cytokin
goal
studi
elucid
immunolog
mechan
underli
activ
immun
system
ischem
brain
method
intracellular
cytokin
product
analyz
fluoresc
activ
cell
sort
fac
analysi
immun
cell
subpopul
follow
temporari
occlus
middl
cerebr
arteri
mcao
subsequ
purif
immun
cell
brain
homogen
result
day
cytokin
product
cell
domin
interferon
gamma
infg
tnf
alpha
posit
cell
day
gamma
delta
cell
gd
cell
emerg
ischem
hemispher
major
produc
follow
posit
cell
nkt
cell
produc
smaller
amount
regard
antigenpres
cell
apc
macrophag
microgli
cell
major
produc
tnf
alpha
wherea
neutrophil
contribut
substanti
amount
next
util
lymphocyt
defici
mice
analyz
interplay
cell
apc
accord
publish
data
rag
mice
exhibit
smaller
infarct
volum
day
post
stroke
addit
defici
lymphocyt
result
substanti
decreas
tnf
product
macrophag
wherea
microgliaderiv
tnf
product
unaffect
conclus
initi
cytokin
milieu
ischem
hemispher
domin
infg
tnf
alpha
produc
cell
atyp
cell
produc
invad
ischem
hemispher
parallel
macrophag
microgli
cell
produc
larg
amount
tnf
remark
cell
seem
play
central
role
alreadi
orchestr
initi
immun
respons
sinc
activ
proinflammatori
macrophag
decreas
rag
mice
character
immunolog
mechan
postischem
inflamm
provid
valuabl
insight
role
differ
immun
cell
popul
activ
modul
cytokin
pathway
cumul
autoimmun
myelinspecif
cell
corecognis
neurofilamentmedium
despit
extens
effort
antigenspecif
inflammatori
respons
drive
multipl
sclerosi
ms
remain
poorli
defin
determin
hinder
presenc
cnsspecif
cell
healthi
individu
fact
immun
respons
ms
composit
vari
time
myelin
oligodendrocyt
glycoprotein
mog
candid
autoantigen
ms
posit
outermost
lamella
render
mog
directli
access
pathogen
immunoglobulin
found
within
csf
ms
patient
aim
explor
pathogen
trait
mogspecif
cell
respons
make
use
tcrtransgen
mice
cell
specif
ia
use
mice
made
paradox
observ
spontan
eae
persist
even
absenc
target
antigen
mog
mice
cross
mogdefici
background
preserv
incid
spontan
eae
mog
suffici
mice
use
proteom
approach
could
identifi
altern
target
cell
respons
neurofila
medium
nfm
cytoskelet
protein
exclus
express
neuron
shown
share
tcr
bind
residu
present
context
iab
could
stimul
cell
mice
vitro
nfm
altern
target
pathogen
specif
cell
respons
adopt
transfer
pathogen
mogspecif
cell
syngen
recipi
lack
mog
nfm
mog
nfm
doubledefici
mice
fail
induc
diseas
assess
individu
contribut
either
mog
nfm
diseas
sever
use
mog
nfm
singl
defici
mice
recipi
pathogen
cell
absenc
mog
express
observ
diseas
character
delay
onset
similar
maximum
sever
hand
mice
lack
nfm
develop
diseas
similar
onset
reduc
diseas
sever
furthermor
recent
observ
mice
preserv
diseaseincid
spontan
eae
wildtyp
mice
mice
data
reveal
molecular
mimicri
neural
antigen
aggrav
autoimmun
diseas
permit
clonal
cell
respons
target
one
cognat
autoantigen
simultan
coin
observ
cumul
autoimmun
macrophag
play
import
role
pathogenesi
multipl
sclerosi
ms
benefici
detriment
effect
sever
studi
found
correl
macrophag
axon
damag
elimin
infiltr
macrophag
reduc
axon
damag
clinic
sign
eae
ii
correl
found
number
infiltr
macrophag
axon
damag
link
macrophag
axon
regener
repair
report
macrophag
phagocytos
myelin
debri
growth
inhibit
ii
macrophag
infiltr
correspond
upregul
express
level
growthassoci
marker
axon
growth
hypothesi
differ
effect
macrophag
axon
damag
repair
due
differ
subtyp
macrophag
extrem
subtyp
macrophag
classic
activ
ca
macrophag
cytotox
altern
activ
aa
macrophag
growth
promot
investig
effect
differenti
activ
macrophag
neuron
integr
differ
activ
macrophag
gener
day
exposur
lp
ifng
induc
ca
macrophag
induc
aa
macrophag
mous
primari
neuron
cultur
expos
either
differ
activ
macrophag
condit
medium
effect
neuron
vital
morpholog
determin
determin
three
aspect
macrophag
function
migrat
induct
damag
phagocytosi
first
attract
ca
aa
macrophag
differ
cn
cell
type
determin
neuron
condit
medium
attract
aa
macrophag
significantli
higher
number
compar
ca
macrophag
ca
macrophag
attract
toward
astrocyt
condit
medium
next
investig
induct
neuron
damag
neuron
expos
either
ca
macrophag
ca
condit
medium
reduct
neuron
vital
found
exposur
aa
macrophag
aa
condit
medium
reduc
neuron
vital
final
determin
capac
phagocytosi
differ
activ
macrophag
ca
macrophag
effici
phagocytos
neuron
neuron
fragment
compar
aa
macrophag
influenc
phagocytosi
neuron
fragment
myelin
phagocytosi
significantli
reduc
summari
ca
macrophag
damag
neuron
abl
clear
debri
effici
compar
aa
macrophag
member
tnf
receptor
famili
elicit
wide
rang
biolog
respons
includ
cell
death
cell
prolifer
inflamm
differenti
cytotox
effect
receptor
mediat
activ
apoptot
cell
death
program
fa
associ
death
domain
protein
fadd
key
adaptor
protein
facilit
recruit
receptor
shown
crucial
target
inactiv
fadd
mice
result
earli
embryon
lethal
sign
cardiac
failur
hemorrhag
fibroblast
fadd
knockout
mice
complet
resist
death
receptor
dr
mediat
apoptosi
thymocyt
fadd
knockout
chimer
mice
display
reduc
prolifer
respons
mitogen
indic
faddsign
pathway
also
play
role
cell
develop
activ
sinc
oligodendrocyt
thought
die
apoptosi
cours
multipl
sclerosi
ms
main
anim
model
experiment
autoimmun
encephalomyel
eae
sought
elucid
role
fadd
eae
fadd
defici
mice
die
utero
gener
condit
fadd
allel
use
creloxp
recombin
system
allow
studi
role
fadd
adult
mice
investig
role
fadd
patholog
ms
gener
mice
lack
fadd
oligodendroct
cross
faddflfl
mice
knockin
line
express
cre
control
endogen
oligodendrocytespecif
myelin
oligodendrocyt
glycoprotein
promot
mogicr
result
mice
lack
fadd
specif
oligodendrocyt
faddolgko
eae
induc
faddolgko
mice
order
evalu
role
fadddepend
death
signal
oligodendrocyt
develop
progress
eae
mice
protect
eae
reflect
milder
clinic
diseas
cours
well
reduc
inflammatori
infiltr
spinal
cord
otherwis
typic
hallmark
eae
furthermor
reduc
inflammatori
phenotyp
result
aberr
peripher
immun
respons
faddolgko
mice
previou
report
point
role
oligodendrocyt
apoptosi
eae
result
present
indic
dr
signal
fadd
oligodendrocyt
crucial
develop
progress
eae
mikael
al
nimer
faiez
lindblom
rickard
piehl
fredrik
neurodegener
import
featur
neurolog
disord
multipl
sclerosi
alzheim
al
parkinson
diseas
common
form
diseas
caus
complex
interact
genet
environment
factor
appli
unbias
genet
dissect
use
mechan
nerv
injuri
model
ventral
root
avuls
vra
identifi
factor
respons
differ
neurodegener
among
differ
rat
strain
qtl
regul
nerv
cell
death
previous
found
da
pvg
intercross
effect
reproduc
fine
map
congen
strain
advanc
intercross
line
combin
da
pvg
intercross
global
gene
express
profil
use
affymetrix
rat
exon
chip
perform
anim
subject
vra
day
injuri
linkag
analysi
region
display
four
cisregul
eqtl
one
certainti
includ
smallest
congen
fragment
effect
plot
independ
verif
rtpcr
demonstr
lower
express
da
strain
display
lower
motorneuron
surviv
neuroinflamm
activ
microglia
lead
product
reactiv
oxygen
speci
ro
subsequ
lipid
peroxid
highli
reactiv
endproduct
lipid
peroxid
extrem
high
catalyt
effici
reduc
conjug
glutathion
react
protein
form
stabl
adduct
alter
protein
function
found
elev
level
sever
neurodegen
diseas
also
present
ms
lesion
studi
effect
traumat
brain
injuri
tbi
experiment
autoimmun
encephalomyel
eae
congen
rat
strain
tbi
lead
higher
express
brain
lower
level
histidineconjug
cerebrospin
fluid
csf
measur
elisa
pilot
moginduc
eae
experi
regul
diseas
sever
level
also
found
elev
csf
subpopul
patient
ms
togeth
data
suggest
natur
occur
genet
variabl
may
regul
suscept
neurodegener
trauma
autoimmun
neuroinflamm
multipl
sclerosi
ms
associ
cognit
deficit
develop
independ
motor
disord
deficit
manifest
neuron
damag
studi
use
experiment
model
msautoimmun
encephalomyel
eae
investig
whether
eae
result
damag
hippocamp
neuron
select
deficit
learn
memori
investig
morri
water
maze
test
lewi
femal
rat
month
old
inject
million
antimbp
cell
evok
eae
anim
suffer
tail
hind
limb
paresi
recov
complet
day
post
inocul
dpi
cell
infiltr
spinal
cord
mani
brain
region
includ
hippocampu
demonstr
decreas
pyramid
neuron
region
evalu
stereolog
measur
dpi
preced
prolong
glial
activ
well
rise
proinflammatori
cytokin
mrna
express
tnf
alfa
increas
express
cytokin
mrna
observ
also
dpi
howev
contrari
hypothesi
differ
water
maze
test
detect
eae
control
group
neither
dpi
dpi
antimbp
cell
capabl
injur
hippocamp
pyramid
neuron
eae
probabl
secret
proinflammatori
cytokin
also
activ
glial
cell
howev
studi
condit
hippocamp
neurodegener
caus
cell
result
memori
disturb
support
grant
ministri
scientif
research
inform
technolog
poland
stimul
neurit
outgrowth
primari
neuron
organotyp
brain
slice
vidal
vera
lemmen
evi
boato
francesco
nelissen
sofi
vangansewinkel
tim
hendrix
sven
increas
evid
inflammatori
process
spinal
cord
injuri
sci
may
exert
detriment
well
benefici
effect
previou
studi
indic
helper
type
cell
may
influenc
axon
regener
via
secret
antiinflammatori
cytokin
insid
famili
biolog
function
resembl
mostli
share
receptor
achain
thought
respons
function
characterist
cytokin
investig
effect
recombin
neurit
outgrowth
outgrowth
assay
base
neuron
cell
cultur
organotyp
brain
slice
cortic
primari
neuron
cultur
significantli
increas
averag
axon
length
get
closer
vivo
situat
also
analyz
effect
entorhin
cortex
explant
embed
three
dimension
collagen
matrix
twoold
wildtyp
mice
well
entorhin
cortic
deriv
enhanc
green
fluoresc
proteinposit
mice
cocultur
hippocampu
wildtyp
litterm
model
found
potent
stimul
neurit
outgrowth
dosedepend
manner
analys
use
mtt
assay
primari
neuron
cultur
indic
chang
metabol
activ
suggest
neuroprotect
toxic
effect
respons
increas
neurit
outgrowth
conclus
result
suggest
potent
promot
axon
regener
vitro
occur
independ
neuron
cell
surviv
proinflammatori
cytokin
beta
consid
exert
detriment
effect
context
brain
trauma
eg
induc
neuron
cell
death
consist
concept
demonstr
suppress
neurotrophinmedi
neuron
cell
surviv
therefor
investig
whether
similar
impact
neurotrophininduc
neurit
growth
analyz
neurit
densiti
length
organotyp
brain
spinal
cord
slice
cultur
influenc
neurotrophin
nerv
growth
factor
ngf
brainderiv
neurotroph
factor
bdnf
significantli
promot
neurit
growth
increas
number
slice
display
maxim
growth
similarli
promot
neurit
densiti
extens
well
number
slice
show
maxim
growth
brain
slice
knockout
mice
reveal
endogen
crucial
spontan
neurit
growth
coadministr
still
significantli
stimul
neurit
densiti
length
well
number
slice
display
maxim
neurit
growth
effect
appear
brainspecif
sinc
spinal
cord
slice
stimul
ngf
coadministr
factor
thu
contrast
inhibitori
effect
neurotrophinmedi
neuron
cell
surviv
stimul
neurit
growth
impair
neurit
growth
data
suggest
antiinflammatori
treatment
may
prevent
neuron
cell
death
cost
neurit
regener
hail
yohann
simmen
katia
touret
nicola
simmen
thoma
bleackley
chri
giuliani
fabrizio
multipl
sclerosi
ms
inflammatori
diseas
central
nervou
system
cn
character
demyelin
neurodegener
infiltr
cell
macrophag
constitu
ms
lesion
activ
cytotox
cell
ctl
releas
serineproteas
granzym
b
grb
shown
induc
neurotox
ctlsmediat
neuron
microtubul
disrupt
report
anim
model
ms
experiment
autoimmun
encephalomyel
recent
studi
also
show
alphatubulin
one
main
constitu
microtubul
new
target
grb
therefor
object
studi
investig
mechan
grbmediat
neuron
injuri
human
cortic
foetal
neuron
hfn
cultur
alon
treat
grb
cocultur
unactiv
anti
cell
polyornithin
coat
cultur
plate
viabil
assay
perform
use
immunocytochemistri
microtubul
associ
assess
surviv
neuron
express
grb
cell
measur
rtpcr
confoc
microscopi
use
follow
interact
cell
neuron
intern
grb
neuron
induct
apoptosi
cleavag
alphatubulin
grb
substrat
evalu
use
western
blot
viabil
hfn
significantli
low
cultur
treat
activ
cell
grb
mous
system
activ
cell
grb
knock
mice
fail
kill
mous
neuron
grb
enter
neuron
via
receptor
induc
perforinindepend
neuron
apoptosi
western
blot
show
caspasedepend
cleavag
alphatubulin
presenc
grb
activ
cell
studi
show
grb
intern
neuron
independ
perforin
occur
mediat
addit
grb
destabil
cytoskelet
protein
induc
caspasedepend
neuron
apoptosi
data
show
grb
new
potenti
target
neuroprotect
strategi
ms
treatment
nicotin
acetylcholin
receptor
nachr
wellknown
mediat
inflamm
activ
nachr
express
macrophag
suppress
synthesi
releas
proinflammatori
cytokin
includ
tnfalpha
remain
possibl
immun
system
reciproc
regul
function
nachr
microglia
astrocyt
neuron
brain
furthermor
inflamm
brain
associ
multipl
disord
includ
autism
spectrum
disord
asd
henc
understand
function
consequ
potenti
bidirect
crosstalk
immun
system
nachr
import
laboratori
interest
relationship
nachr
asd
genomewid
associ
studi
link
nachr
asd
postmortem
analys
specif
region
asd
patient
brain
show
increas
nachr
level
identifi
function
associ
nachr
neurexin
presynapt
cell
adhes
molecul
bidirect
interact
neurexin
postsynapt
bind
partner
neuroligin
promot
synaps
matur
recruit
specif
preand
postsynapt
molecul
includ
nicotin
receptor
synaps
delet
mutat
neurexin
neuroligin
gene
strongli
link
asd
studi
examin
associ
nachr
specif
neurexin
isoform
rat
hippocamp
neuron
cotransfect
nachr
neurexin
isoform
cocultur
nonneuron
tsa
cell
transfect
neuroligin
isoform
nachr
express
alon
neuron
target
tsa
cell
howev
coexpress
target
tsa
cell
small
percentag
neuron
examin
cultur
data
suggest
neurexin
influenc
target
nachr
specif
subset
neuron
whose
ident
investig
thu
dysfunct
either
inflammatori
process
andor
synaps
matur
could
promot
chang
express
nachr
observ
asd
brain
consequ
behavior
deficit
associ
disord
parkinson
diseas
pd
patient
impair
spatial
work
memori
problem
organ
use
new
materi
well
appli
strategi
striatal
dopamin
da
defici
sole
respons
genesi
nonmotor
symptom
present
studi
mptp
administr
influenc
neurodegener
memori
impair
studi
one
year
old
male
mice
receiv
mptp
mgkg
control
group
receiv
nacl
order
evalu
learn
memori
abil
morri
water
maze
wm
behavior
test
provid
brain
concentr
da
norepinephrin
ne
glutam
glu
estim
use
highperform
liquid
chromatographi
hplc
ratio
metabolit
mhpg
hva
parent
amin
select
brain
region
estim
neuronspecif
nuclear
protein
neun
immunohistochemistri
unbias
stereolog
method
use
determin
total
number
neuron
subregion
hippocamp
format
statist
signific
decreas
level
monoamin
notic
mptp
mice
group
striatum
da
ne
hippocampu
ne
prefront
cortex
da
ne
content
day
month
intox
statist
signific
differ
ne
content
hippocampu
p
b
prefront
cortex
p
b
remain
also
month
intox
mhpgne
ratio
increas
hippocampu
p
b
prefront
cortex
p
b
hvada
ratio
increas
day
intox
striatum
prefront
cortex
p
b
notic
subtl
differ
longterm
memori
test
provid
month
mptp
intox
compar
control
mptp
group
mice
spent
less
time
target
quadrant
se
intox
control
mice
swim
distanc
reach
hidden
platform
neg
correl
na
content
hippocampu
r
p
b
result
evid
acut
system
administr
mptp
lead
seriou
altern
ne
neurotransmiss
acceler
turnov
da
ne
absenc
declin
number
cell
bodi
may
indic
exist
compens
mechan
differ
spatial
longterm
memori
also
make
suggest
noradrenerg
function
requir
hippocamp
cortic
depend
memori
increas
evid
suggest
inflammatori
process
spinal
cord
injuri
sci
may
caus
detriment
well
benefici
effect
previou
studi
indic
cell
may
influenc
axon
regener
via
secret
antiinflammatori
cytokin
antiinflammatori
cytokin
multipl
function
common
share
receptor
achain
thought
respons
function
characterist
current
studi
investig
therapeut
potenti
recombin
administ
local
gelfoam
bead
lesion
select
time
point
sci
singl
administr
recombin
immedi
day
injuri
significantli
improv
locomotor
restor
assess
two
behavior
test
openfield
basso
mous
scale
bm
locomot
rotarod
treadmil
experi
histolog
analysi
reveal
recombin
significantli
stimul
axon
regrowth
lesion
spinal
cord
vivo
surprisingli
immedi
local
administr
recombin
worsen
clinic
outcom
sci
summari
result
indic
acut
treatment
recombin
significantli
promot
function
recoveri
sci
exert
oppos
effect
thu
impair
clinic
outcom
sci
vivo
although
cytokin
share
role
fibroblast
growth
chronic
demyelin
multipl
sclerosi
lesion
multipl
sclerosi
ms
lead
caus
nontraumat
neurolog
disabl
among
young
adult
north
america
western
europ
patholog
hallmark
inflammatori
demyelin
diseas
format
chronic
demyelin
plaqu
gliotic
scar
tissu
central
nervou
system
cn
lesion
fail
remyelin
unclear
endogen
repair
mechan
normal
act
ensur
rapid
essenti
complet
remyelin
cn
sever
report
suggest
failur
remyelin
ms
may
due
overor
underexpress
factor
influenc
oligodendrocyt
progenitor
cell
opc
migrat
andor
differenti
experiment
studi
identifi
numer
potenti
candid
may
affect
opc
function
ms
clinic
relev
remain
unclear
lowdens
microarray
studi
investig
growth
factor
cytokin
receptor
ms
lesion
develop
perform
max
planck
institut
neuroimmunologymohan
meinl
reveal
associ
failur
remyelin
upregul
express
investig
function
signific
observ
treat
myelin
cn
cultur
exogen
experiment
set
inhibit
abil
matur
oligodendrocyt
myelin
axon
dose
depend
manner
effect
associ
correspond
decreas
transcript
encod
myelin
protein
myelin
relat
transcript
factor
howev
genomewid
microarray
analysi
reveal
addit
neg
effect
myelin
also
significantli
enhanc
express
gene
implic
neuroprotect
neuron
surviv
account
hundr
gene
highli
upregul
hypothes
mediat
neuroprotect
effect
contribut
surviv
axon
travers
persist
demyelin
gliotic
plaqu
ms
albeit
expens
impair
remyelin
understand
molecular
basi
divers
effect
may
lead
improv
neuroprotect
therapi
ms
japanes
enceph
je
lead
form
viral
enceph
world
caus
japanes
enceph
viru
jev
belong
famili
flavivirida
evas
peripher
immun
system
facilit
entri
viru
central
nervou
system
cn
caus
neuron
death
result
inflammatori
milieu
gener
cn
due
microgli
activ
peripher
macrophag
constitut
import
part
immun
surveil
propos
entri
bodi
viru
may
carri
cn
peripher
immun
cell
macrophag
act
trojan
hors
jev
shown
persist
within
macrophag
long
enough
carri
cn
shown
earlier
bloodbrain
barrier
critic
compromis
je
result
massiv
infiltr
peripher
cell
cn
howev
unclear
whether
accumul
virusinfect
peripher
macrophag
cn
also
contribut
death
potenti
viabl
neuron
use
periton
macrophag
model
peripher
macrophag
shown
upon
infect
jev
significantli
increas
releas
proinflammatori
cytokin
well
reactiv
oxygen
nitrogen
speci
express
transcript
factor
associ
proinflammatori
cytokin
gene
express
also
found
elev
macrophag
follow
jevinfect
addit
cultur
media
jevinfect
macrophag
primari
cortic
neuron
significantli
reduc
surviv
observ
compar
neuron
media
mockinfect
macrophag
ad
annexinpi
stain
show
number
necrot
late
apoptot
neuron
cell
also
increas
along
level
proapoptot
marker
addit
specif
inhibitor
nacetyl
cystein
celecoxib
aminoguanidin
macrophag
post
jev
infect
led
reduct
level
proinflammatori
solubl
factor
macrophag
addit
condit
media
macrophag
neuron
result
significantli
higher
surviv
thu
seem
possibl
jevinfect
macrophag
add
bystand
death
neuron
je
result
activ
microglia
resid
macrophag
cn
activ
microglia
infiltr
immun
cell
promin
patholog
featur
amyotroph
later
sclerosi
al
transgen
mice
wildtyp
microglia
neuroprotect
microglia
absenc
tcell
associ
faster
diseas
progress
shorten
surviv
increas
spinal
cord
express
marker
microgli
activ
tnfa
transplant
bone
marrow
restor
cell
attenu
microgli
activ
slow
diseas
progress
data
suggest
tcell
may
neuroprotect
suppress
injuri
microglia
goal
defin
specif
subpopul
tcell
involv
potenti
mechan
attenu
microglialmedi
toxic
use
flow
cytometri
rtpcr
tcell
increas
blood
lymph
node
spinal
cord
earli
stage
diseas
significantli
decreas
late
stage
diseas
transgen
mice
passiv
transfer
earli
stage
tcell
effect
slow
diseas
progress
prolong
surviv
mice
microglia
vivo
well
isol
spinal
cord
earli
stage
manifest
hallmark
neuroprotect
phenotyp
use
rtpcr
balanc
shift
toxic
phenotyp
microglia
vivo
well
isol
rapid
progress
phase
diseas
vitro
earli
stage
tregcel
isol
spleen
lymph
node
mice
cultur
adult
microglia
suppress
express
marker
teff
cell
minim
effect
vitro
suppress
effect
tregcel
mediat
block
ab
tcell
present
earli
stabl
phase
effect
slow
diseas
progress
possibl
secret
therebi
maintain
neuroprotect
microgli
phenotyp
mark
decreas
treg
cell
late
diseas
associ
injuri
microgli
phenotyp
result
suggest
treg
cell
may
sustain
microgli
phenotyp
therebi
provid
motoneuron
protect
use
regulatori
tcell
enhanc
microgli
neuroprotect
may
offer
novel
therapeut
option
al
critic
pathogen
aspect
multipl
sclerosi
ms
influx
immunomodulatori
cell
central
nervou
system
cn
induc
inflamm
demyelin
axon
damag
caus
neurolog
deficit
current
therapi
ms
reduc
cell
infiltr
induc
immunosuppress
addit
disturb
immun
balanc
illustr
need
local
act
drug
treat
ms
tissu
transglutaminas
enzym
ubiquit
express
becom
local
activ
upon
inflamm
known
act
coreceptor
subunit
involv
cytoskelet
remodel
enzym
could
interest
immun
cell
adhes
migrat
process
occur
ms
therefor
perform
studi
determin
possibl
role
activ
cellular
process
contribut
ms
demonstr
ms
anim
model
chronic
relaps
experiment
autoimmun
encephalomyel
creae
level
significantli
increas
reduct
activ
specif
inhibitor
creae
anim
dramat
attenu
clinic
deficit
neuropatholog
treatment
clearli
reduc
infiltr
mhc
ii
posit
cell
monocyt
resid
blood
vessel
lumen
perivascular
space
migrat
cn
tissu
parenchyma
addit
vitro
experi
support
role
monocyt
adhes
migrat
reduc
migrat
monocyt
cn
due
attenu
monocyt
cytoskelet
flexibl
rhoa
gtpase
activ
possibl
consequ
reduc
number
activ
monocyt
present
cn
reduct
tnfa
express
cn
spleen
treat
creae
anim
found
could
explain
attenu
demyelin
observ
treat
creae
anim
interestingli
express
level
variou
inflammatori
gene
affect
either
cn
spleen
compar
untreat
creae
anim
conclud
select
block
monocyt
migrat
cn
monocyt
adhes
brain
endothelium
inhibit
activ
result
less
demyelin
open
new
avenu
therapeut
intervent
ms
seemingli
complic
disturb
peripher
cytokin
respons
new
player
neuroinflamm
critic
lymphocyt
motil
emerg
potenti
peripher
indic
inflamm
lymphocyt
motil
crucial
tissu
invas
neuroinflamm
intim
regul
chemoattract
includ
chemokin
identifi
phosphoprotein
immun
cell
demonstr
role
tlymphocyt
polar
migrat
vincent
et
al
ji
level
express
elev
blood
immun
cell
patient
suffer
retrovirusinduc
neuroinflamm
also
lymph
nodeand
brainisol
immun
cell
mice
infect
neurotrop
virus
vuaillat
et
al
jni
led
us
investig
mechan
underli
function
immun
cell
motil
potenti
marker
neuroinflamm
contrast
neural
cell
respond
semaphorin
signal
appear
novel
transduc
chemokin
signal
tworkshop
lymphocyt
chemokin
induc
dynam
reloc
uropod
flexibl
structur
motil
lymphocyt
increas
bind
cytoskeleton
protein
vimentin
mutat
strategi
lymphocyt
show
crucial
role
phosphoryl
protein
function
examin
phosphoryl
statu
chemokin
signal
modifi
balanc
site
yestarget
site
site
mutat
strongli
reduc
tlymphocyt
motil
evidenc
function
import
newli
report
phosphosit
investig
blood
immun
cell
healthi
control
multipl
sclerosi
patient
show
divers
express
lymphocyt
natur
killer
monocyt
subtyp
antibodi
direct
form
show
upregul
activ
hladr
lymphocyt
specif
presenc
neuroinflammatori
situat
includ
multipl
sclerosi
conclud
tlymphocyt
migrat
requir
integr
sever
process
also
involv
phosphoprotein
downstream
chemokin
signal
data
also
suggest
modul
chemokin
brain
origin
could
crucial
diver
step
lead
immun
cell
neuroinvas
neuroinflamm
infiltr
bloodderiv
monocyt
requir
diseas
progress
experiment
autoimmun
encephalomyel
eae
microglia
princip
immun
cell
central
nervou
system
cn
exquisit
sensit
cn
injuri
diseas
fuel
reactivest
call
microgliosi
use
parabiosi
surgic
procedur
allow
creation
peripher
blood
chimera
without
transplant
show
unlik
tissueresid
macrophag
reli
circul
bloodborn
precursor
replac
microglia
capabl
selfrenew
within
cn
also
show
bloodborn
monocyt
exclud
cn
murin
model
denerv
neurodegener
ajami
et
al
natur
neurosci
contrast
certain
inflammatori
patholog
condit
multipl
sclerosi
murin
model
experiment
autoimmun
encephalomyel
eae
known
lead
recruit
inflammatori
monocyt
cn
entri
cell
normal
exclud
cn
causal
factor
diseas
progress
address
question
develop
new
experiment
model
base
parabiosi
differenti
bone
marrow
irradi
allow
precis
distinct
peripher
bloodderiv
monocytemacrophag
resid
microglia
thu
enabl
us
investig
kinet
microglia
activ
blood
born
monocyt
entri
cn
differenti
macrophag
eae
progress
data
reveal
dynam
interplay
macrophag
microglia
strongli
support
causal
link
myelomonocyt
cell
invas
diseas
progress
inde
specif
block
circul
inflammatori
monocyt
enter
cn
prevent
progress
beyond
diseas
stage
experi
final
abl
demonstr
presenc
bloodborn
cell
cn
parenchyma
transient
even
success
invad
cn
cell
contribut
microgli
pool
summari
data
identifi
invas
circul
monocyt
cn
parenchyma
major
advers
event
eae
progress
support
therapeut
strategi
specif
aim
inhibit
migrat
myelomonocyt
cell
rather
leukocyt
gener
petermann
franziska
rothhamm
veit
claussen
malt
c
haa
jan
experiment
autoimmun
encephalomyel
eae
cell
mediat
autoimmun
diseas
serv
anim
model
multipl
sclerosi
classic
eae
thought
mediat
mhc
class
iirestrict
cell
reactiv
central
nervou
system
cn
deriv
autoantigen
howev
recent
much
evid
suggest
nonconvent
gd
cell
tgd
may
also
contribut
pathogenesi
eae
subset
tgd
constitut
express
receptor
respond
vigor
produc
inflammatori
cytokin
use
gfp
report
mous
approach
investig
role
tgd
eae
vivo
upon
immun
emulsifi
cfa
tgd
expand
secondari
lymphoid
tissu
accumul
cn
peak
diseas
interestingli
control
myelin
antigen
specif
cell
regulatori
cell
treg
cn
oper
contract
tgd
popul
suggest
tgd
inhibit
treg
respons
inde
supernat
tgd
abrog
treg
mediat
suppress
effector
cell
moreov
tgd
extrem
potent
produc
factor
inhibit
tgfdriven
convers
convent
cell
treg
vitro
vivo
consequ
cell
receptor
delta
tcrd
ko
mice
lack
tgd
cell
exhibit
exagger
treg
respons
attenu
develop
eae
deplet
treg
tcrd
ko
mice
restor
full
susceptibl
eae
anim
conclus
provid
evid
arm
tgd
inhibit
treg
respons
thu
fast
kinet
tgd
respons
creat
environ
product
adapt
cell
respons
unfold
uninhibit
manner
result
point
driven
pathogen
properti
tgd
might
particularli
relev
epitheli
surfac
neuroectoderm
tissu
recent
identifi
gene
express
signatur
cell
individu
clinic
isol
syndrom
ci
highli
correl
rapid
progress
ms
signatur
includ
upregul
gene
promot
cell
activ
well
downregul
gene
promot
quiescenc
among
antiprolif
gene
downregul
hypothes
defici
mice
show
earlier
eae
onset
sever
phenotyp
studi
immunolog
neurodevelopment
properti
mice
character
cell
prolifer
express
wt
counterpart
mice
experienc
earlier
onset
sever
eae
analysi
motoneuron
function
apoptosi
suggest
earlier
onset
associ
neural
toxic
anim
evalu
potenti
independ
role
cn
measur
express
myelin
insitu
hybrid
immunostain
myelin
antigen
interestingli
mice
show
signific
delay
spinal
cord
myelin
compar
wt
mice
final
found
hdac
inhibitor
tsa
increas
express
vitro
amelior
eae
strikingli
mice
eae
show
improv
tsa
administr
suggest
express
requir
benefici
effect
tsa
confirm
result
invitro
experi
result
suggest
dual
role
cn
peripheri
found
requir
keep
quiescenc
cell
peripheri
may
also
critic
oligodendrocyt
myelin
axon
time
manner
requir
tsa
exert
benefici
effect
eae
suppress
cell
prolifer
vitro
thu
potenti
therapeut
target
eae
ms
thu
play
import
role
maintain
balanc
immun
toler
studi
investig
phenotyp
tcell
stimulatori
capac
standard
immatur
dc
immatur
dc
respect
antigenspecif
product
cytokin
express
regulatori
tcell
marker
observ
diminish
express
compar
indic
pronounc
immatur
phenotyp
suppress
cmvspecif
ifnproduct
cmv
lymphocyt
compar
stimul
lymphocyt
alon
importantli
antigenspecif
ifnproduct
autolog
lymphocyt
myelinassoci
antigen
mbpmog
diminish
cocultur
well
could
demonstr
differ
suppress
potenti
neither
observ
differ
capac
induc
treg
howev
idc
subject
inflammatori
cytokinecocktail
less
prone
upregul
matur
marker
hladr
compar
indic
stabl
immatur
dc
phenotyp
current
use
immatur
dc
therapeut
intervent
downmodul
exuber
immun
respons
eg
diabet
graftversushost
diseas
investig
studi
demonstr
effect
suppress
viral
immun
respons
well
msassoci
pathogen
respons
howev
might
interest
clinic
use
sinc
tolerogen
phenotyp
stabl
compar
establish
toler
multipl
sclerosi
etim
investigatoriniti
cell
therapi
earli
multipl
sclerosi
put
vitro
mechan
action
multipl
sclerosi
ms
devast
autoimmun
inflammatori
diseas
brain
spinal
cord
current
therapi
ms
inhibit
autoimmun
respons
nonspecif
manner
moder
effect
signific
side
effect
adopt
promis
toler
strategi
employ
autolog
peptidecoupl
antigen
present
cell
tolerogen
therapi
proven
excel
efficaci
anim
model
ms
differ
cellmedi
autoimmun
diseas
start
appli
toler
regimen
ms
patient
assess
safeti
efficaci
open
label
mricontrol
phase
iiia
clinic
trial
aim
analys
invitro
mechan
action
novel
toler
strategi
use
autolog
antigencoupl
fix
antigenpres
cell
invitro
mechan
action
edctreat
cell
tpbmc
analys
pbmc
healthi
donor
inhibitori
capac
tpbmc
cell
analys
use
cell
clone
obtain
ms
patient
prolif
capac
cell
assess
thymidin
incorpor
cfse
dilut
assay
analys
effect
tpbmc
phenotyp
matur
cytokin
express
dendrit
cell
monocyt
proven
capac
edc
coupl
peptid
surfac
cell
data
suggest
peptid
bound
unspecif
surfac
cell
besid
coupl
reaction
treatment
pbmc
edc
lead
caspas
activ
apoptot
cell
death
use
well
character
cell
clone
demonstr
tpbmc
effect
inhibit
cell
prolifer
inhibit
doseand
cellcel
contactdepend
find
presenc
tpbmc
affect
matur
dendrit
cell
monocytesmacrophag
measur
express
dendrit
cell
monocyt
incub
presenc
tpbmc
produc
consider
amount
tgfbeta
toler
edccoupl
cell
involv
sever
direct
indirect
mechan
action
includ
caspasedepend
apoptot
cell
death
uptak
dead
cell
antigen
present
cell
plasmacytoid
dendrit
cell
pdc
emerg
possibl
therapeut
tool
within
complex
immunomodulatori
network
autoimmun
diseas
contrast
classic
dc
pdc
may
essenti
initi
immun
respons
crucial
regul
sever
extent
qualiti
autoimmun
diseas
studi
provid
strong
evid
prevent
therapeut
adopt
transfer
cell
potenti
modul
eae
mice
focus
properti
two
distinct
pdc
subset
pdc
subpopul
character
differenti
express
pattern
antigen
recogn
specif
interferon
type
secret
pdc
antibodi
pdcipc
addit
abund
typic
pdc
marker
differ
comparison
pdc
pdc
express
wherea
express
siglech
lectin
exclus
found
pdc
specif
interferon
type
secret
pdc
ipc
decreas
furthermor
express
costimulatori
molecul
like
mhc
class
ii
reduc
indic
less
activ
state
pdc
vivo
experi
reveal
prevent
therapeut
intraven
inject
pdc
amelior
eae
effect
pdc
vitro
mix
cultur
demonstr
lack
prolifer
mogspecif
respond
cell
presenc
pdc
contrast
pdc
ad
antifasl
abrog
unrespons
wherea
ad
neither
antiicosl
display
effect
howev
addit
pdcstimul
tlr
ligand
cpg
result
overal
inhibit
prolifer
mayb
due
induct
secret
furthermor
sinc
apoptosi
necrosi
rate
compar
set
cell
death
may
explain
decreas
potenti
encephalitogen
cell
thu
studi
rather
lead
conclus
eae
immunomodulatori
function
pdc
associ
regulatori
cell
well
reduc
proinflammatori
condit
investig
subpopul
pdc
may
increas
efficaci
therapeut
potenti
support
bmbf
gz
weber
clinic
data
indic
b
cell
deplet
may
effect
treatment
multipl
sclerosi
ms
goal
investig
influenc
b
cell
cell
activ
differenti
eae
mechan
immun
modul
induc
b
cell
deplet
examin
two
murin
eae
model
one
b
cell
particip
eae
pathogenesi
one
requir
b
cell
eae
induct
eae
induc
either
recombin
myelin
oligodendrocyt
glycoprotein
rmog
mog
peptid
p
b
cellindepend
eae
model
immun
mog
protein
promot
expans
activ
b
cell
serv
antigen
present
cell
apc
activ
b
cell
effici
present
mog
protein
mog
peptid
naiv
mog
cell
promot
differenti
b
cell
deplet
prevent
revers
establish
mog
proteininduc
eae
associ
less
cn
inflamm
elimin
mening
b
cell
reduct
mogspecif
cell
contrast
b
cell
mice
immun
mog
becom
activ
similar
naiv
b
cell
could
present
mog
peptid
mog
protein
mog
cell
although
mog
bind
mhc
ii
directli
unactiv
naiv
b
cell
use
apc
b
cell
effici
promot
differenti
eae
induc
mog
treatment
exacerb
eae
alter
develop
cell
irrespect
eae
model
use
b
cell
deplet
reduc
frequenc
regulatori
cell
treg
deplet
remain
myeloid
apc
produc
tnf
less
serv
apc
promot
develop
encephalitogen
cell
find
suggest
b
cell
may
regul
apc
studi
highlight
distinct
role
b
cell
pathogenesi
regul
cn
autoimmun
diseas
activ
mogspecif
b
cell
naiv
unactiv
b
cell
effici
apc
capabl
induc
differenti
proinflammatori
myelinspecif
cell
clinic
benefit
observ
deplet
mog
proteininduc
eae
may
relat
primarili
elimin
proinflammatori
b
cell
apc
function
howev
certain
clinic
set
elimin
unactiv
b
cell
particip
regul
cell
apc
may
undesir
multifoc
motor
neuropathi
mmn
autoimmun
disord
peripher
nerv
caus
muscl
weak
wast
intraven
immunoglobulin
ivig
standard
treatment
howev
effect
shortliv
halt
long
term
progress
trial
immunomodulatori
agent
shown
benefit
date
mmn
known
antibodymedi
diseas
patient
posit
glycolipid
antibodi
anim
model
antibodymedi
neuropathi
requir
complement
activ
neural
destruct
complet
inhibit
nerv
damag
display
termin
complement
activ
inhibit
eculizumab
humanis
monoclon
antibodi
specif
prevent
cleavag
thu
termin
complement
activ
eculizumab
licens
treat
paroxysm
nocturn
haemoglobinuria
pnh
trial
eculizumab
autoimmun
condit
ongo
howev
trial
yet
conduct
neurolog
diseas
ongo
ivig
treatment
trial
patient
mmn
given
eculizumab
week
primari
outcom
safeti
eculizumab
group
concurr
receiv
ivig
major
secondari
outcom
chang
ivig
dose
frequenc
monthli
treatment
interv
subject
assess
efficaci
measur
includ
mrc
grade
dynamometri
peg
test
subject
score
electrophysiolog
perform
baselin
end
treatment
period
treatment
emerg
sign
symptom
highest
first
four
week
treatment
common
headach
account
advers
event
headach
also
common
side
effect
ivig
treatment
patient
discontinu
treatment
due
advers
event
shown
eculizumab
safe
use
conjunct
ivig
treatment
period
patient
ivig
mainten
continu
requir
dose
ivig
two
patient
intertreat
interv
lengthen
day
half
group
subject
respond
includ
patient
receiv
ivig
individu
improv
clinic
electrophysiolog
paramet
group
signific
overal
trend
toward
sustain
improv
use
complement
inhibitor
treat
immun
mediat
neuropathi
merit
investig
howev
may
efficaci
hyperacut
phase
disord
multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
cn
major
current
use
ms
medic
target
inflammatori
aspect
diseas
treatment
induc
remyelin
lack
multipl
natur
neuroinflamm
increasingli
recogn
inflammatori
cell
molecul
one
hand
damag
neural
element
benefici
aspect
neuroinflamm
promot
repair
also
occur
challeng
har
benefici
aspect
neuroinflamm
avoid
potenti
detriment
consequ
given
increas
evid
activ
monocytoid
cell
macrophag
microglia
role
cn
repair
test
hypothesi
medic
stimul
monocytoid
cell
use
stimul
remyelin
sought
first
identifi
medic
could
stimul
monocytoid
cell
use
cytokin
product
human
microglia
initi
screen
test
collect
compound
alreadi
clinic
use
variou
indic
found
singl
medic
amphotericin
b
ampb
microglia
activ
facilit
transit
mous
model
vivo
test
found
ampb
similarli
increas
activ
macrophag
cultur
bone
marrow
mice
activ
determin
express
tolllik
receptor
tlr
scaveng
receptor
cytokin
moreov
increas
activ
cultur
mous
macrophag
ampb
enhanc
simultan
treatment
anoth
agent
known
effect
monocytoid
cell
macrophagecoloni
stimul
factor
mcsf
next
produc
demyelin
mous
spinal
cord
local
inject
lipiddisrupt
agent
lysolecithin
dorsal
column
region
three
day
signific
demyelin
spinal
cord
accompani
elev
sever
marker
monocytoid
activ
importantli
system
inject
combin
ampb
mcsf
elev
monocytoid
marker
moreov
tissu
process
day
lysolecithin
insult
lesion
volum
gratio
analys
found
combin
treatment
ampb
mcsf
improv
remyelin
comparison
singl
control
treatment
result
support
concept
benefit
neuroinflamm
show
stimul
monocytoid
cell
amphotericin
b
mcsf
enhanc
remyelin
inclus
bodi
myositi
ibm
common
acquir
myopathi
beyond
age
histolog
hallmark
nonnecrot
myofib
attack
tcell
contrast
myofib
healthi
individu
attack
nonattack
myofib
patient
ibm
express
high
level
human
leukocyt
antigen
hla
classi
hlai
molecul
hlai
express
prerequisit
antigen
present
cell
subgroup
hlai
myofib
attack
other
spare
identifi
chang
specif
attack
myofib
appli
laser
microdissect
separ
analys
healthi
control
myofib
b
nonattack
ibm
myofib
c
attack
ibm
myofib
immunohistochemistri
ihc
classifi
myofib
five
patient
ibm
attack
nonattack
depend
presenc
adjoin
cell
microdissect
intracellular
content
healthi
control
myofib
nonattack
myofib
attack
myofib
pool
microdissect
materi
three
differ
group
analys
microarray
hybrid
quantit
pcr
hlai
upregul
present
attack
nonattack
ibm
myofib
wherea
healthi
control
fiber
neg
hlai
contrast
induc
chain
ifng
receptor
number
ifnginduc
gene
upregul
attack
myofib
compar
nonattack
fiber
healthi
control
ihc
verifi
express
protein
level
confoc
microscopi
show
segment
upregul
membran
attack
myofib
posit
correl
number
adjac
tcell
result
suggest
amplif
loop
hypothesi
inflamm
ibm
muscl
first
unknown
etiolog
factor
lead
ubiquit
upregul
hlaclass
myofib
next
cell
recogn
unknown
antigen
display
surfac
hlai
myofib
initi
rare
chanc
event
subsequ
activ
immun
cell
produc
proinflammatori
cytokin
induc
local
express
well
major
downstream
effector
ifng
signal
pathway
attack
myofib
thu
attack
fiber
stimul
releas
factor
attract
inflammatori
cell
amplifi
focal
inflammatori
chang
multipl
sclerosi
ms
chronic
inflammatori
respons
constitu
central
nervou
system
known
regulatori
cell
treg
play
key
role
autoimmun
balanc
improp
function
may
facilit
expans
autoaggress
cell
clone
recent
microrna
mirna
involv
autoimmun
disord
lossoffunct
immun
cell
shown
facilit
system
autoimmun
disord
analyz
mirna
express
profil
treg
msrr
assess
mirna
genomewid
express
profil
microarray
analysi
regulatori
cell
ms
relapsingremit
patient
stabl
condit
healthi
control
order
valid
result
perform
quantit
rtpcr
cell
found
human
mirna
differenti
express
treg
cell
ms
patient
versu
healthi
donor
among
deregul
mirna
member
cluster
found
upregul
ms
patient
compar
healthi
donor
previous
shown
modul
signal
pathway
action
involv
regulatori
cell
differenti
matur
therefor
upregul
mirna
cluster
may
alter
regulatori
cell
activ
cours
ms
block
biolog
function
function
type
interferon
ifn
signal
critic
host
respons
virus
cellular
respons
type
ifn
depend
larg
studi
effect
host
respons
viral
infect
cn
wildtyp
wt
mice
mice
lack
ko
infect
intracrani
lymphocyt
choriomening
viru
lcmv
wt
mice
lethal
lymphocyt
choriomening
lcm
occur
day
characterist
cerebr
seizur
lcmv
larg
confin
cn
contrast
lcmvinfect
ko
mice
caus
transient
nonfat
clinic
diseas
viru
spread
peripher
organ
viral
rna
level
decreas
slowli
time
becam
undetect
peripher
organ
liver
spleen
remain
detect
cn
day
cn
site
viral
infect
associ
foci
activ
microgliamacrophag
multinucl
giant
cell
moder
tcell
infiltr
presenc
viru
immun
patholog
cn
peripher
organ
parallel
significantli
increas
express
variou
cytokin
mrna
includ
ifngamma
tnf
well
coinhibitori
molecul
mrna
conclus
find
indic
absenc
prevent
lethal
lcm
result
persist
infect
chronic
inflamm
cn
presenc
tcell
slow
decreas
viral
rna
level
cn
peripher
organ
argu
retard
rather
exhaust
incapacit
antivir
respons
treg
subsequ
alter
diseas
cours
inform
human
leukocyt
e
hlae
restrict
cell
limit
studi
aim
elucid
involv
hlae
restrict
cell
immunoregulatori
alter
observ
ms
first
regul
hlae
surfac
express
differ
immun
subset
studi
hlae
express
transient
upregul
cell
type
upon
polyclon
activ
b
cell
exhibit
significantli
higher
upregul
ms
patient
compar
healthi
control
p
b
addit
proinflammatori
cytokin
ifnand
antiinflammatori
cytokin
induc
increas
hlae
express
cell
surfac
cell
find
indic
activ
immun
cell
proinflammatori
condit
ms
upregul
hlae
second
part
ms
associ
studi
hlae
polymorph
perform
hc
n
ms
patient
n
plink
option
analysi
identifi
significantli
higher
frequenc
gc
haplotyp
ms
patient
compar
hc
p
condit
reveal
associ
mere
reflect
well
describ
effect
ms
suscept
still
ms
patient
carri
gc
haplotyp
show
significantli
lower
p
b
potenti
upregul
hlae
surfac
express
b
cell
activ
final
part
hlae
restrict
tcell
character
base
express
major
ligand
name
number
cell
differ
hc
ms
patient
frequenc
cell
significantli
lower
ms
patient
p
b
moreov
regulatori
marker
significantli
regul
p
b
cell
ms
patient
compar
control
cocultur
experi
cell
point
whether
phenotyp
differ
correl
suppress
capac
cell
studi
identifi
immunolog
alter
hlae
restrict
cell
ms
function
consequ
actual
role
diseas
process
need
investig
kawachi
izumi
toyoshima
yasuko
yanagawa
kaori
saji
etsuji
kakita
akiyoshi
takahashi
hitoshi
nishizawa
masatoyo
brain
research
institut
niigata
univers
niigata
japan
neuromyel
optica
nmo
demyelin
syndrom
character
myeliti
optic
neuriti
crucial
role
humor
immun
nmo
pathogenesi
suggest
detect
highli
specif
serum
autoantibodi
nmo
immunoglobulin
g
bind
water
channel
pronounc
deposit
immunoglobulin
coloc
product
complement
activ
vasculocentr
pattern
nmo
lesion
howev
level
sever
cytokin
interleukin
il
increas
cerebrospin
fluid
human
nmo
patient
inject
human
antibodi
rodent
model
tcellmedi
brain
inflamm
induc
acut
nmo
lesion
find
indic
cellular
immun
respons
may
play
role
induct
effect
phase
nmo
lesion
combin
humor
element
detail
immunopatholog
featur
cellular
element
nmo
remain
elus
therefor
investig
humor
cellular
immun
respons
nmo
patient
clinic
immunolog
patholog
studi
radiolog
find
patient
nmo
patholog
find
autopsi
case
nmo
demonstr
graymatterpredomin
lesion
well
subpial
whitematterpredomin
lesion
longitudin
extens
spinal
cord
moreov
confirm
nmo
lesion
accompani
infiltr
immun
cell
cell
leptomening
membran
around
radial
vessel
patholog
studi
bcell
follicl
detect
mening
infiltr
pattern
lymphocyt
nmo
cord
lesion
might
similar
rodent
model
tcellmedi
experiment
autoimmun
encephalomyel
myelin
antigenspecif
cell
arrest
leptomening
vessel
immedi
monitor
lumin
surfac
continu
scan
ablumin
vascular
surfac
underli
leptomening
membran
encount
phagocyt
effect
present
antigen
produc
inflammatori
mediat
provid
format
inflammatori
infiltr
cellular
element
patient
nmo
might
aid
b
cell
antibodi
product
break
bloodbrain
barrier
due
access
antibodi
extracellular
domain
astrocyt
foot
process
suspect
humor
also
cellular
immun
respons
might
play
critic
role
nmo
pathogenesi
oestradiol
enhanc
perforin
express
human
regulatori
cell
implic
multipl
sclerosi
teijeiro
roseta
valor
larissa
faur
florenc
de
clara
tejeraalhambra
marta
alonso
eduardo
silvia
dept
immunolog
hospit
gener
universitario
gregorio
madrid
spain
inserm
institut
curi
pari
franc
dept
neurolog
hospit
gener
universitario
gregorio
madrid
spain
regulatori
tcell
treg
suppress
immun
respons
autoantigen
divers
antigen
mainli
cell
contactdepend
mechan
yet
fulli
defin
report
human
natur
induc
treg
exert
cytotox
activ
autolog
target
cell
suggest
perforingranzym
pathway
may
relev
candid
mechan
suppress
function
treg
pregnanc
oestradiol
markedli
increas
previou
report
shown
modul
treg
percentag
function
propos
potenti
modul
multipl
sclerosi
ms
main
goal
quantifi
treg
proport
perforin
express
treg
ms
healthi
women
pregnanc
menstrual
cycl
secondli
determin
effect
treg
function
perforin
express
ex
vivo
cultur
studi
ms
pregnant
healthi
pregnant
ms
healthi
nonpregn
women
day
menstrual
cycl
treg
perforin
ex
vivo
express
multiparametr
flowcytometri
perform
suppress
experi
autolog
respond
cell
treg
purif
see
effect
treg
function
degranul
assay
express
treg
also
done
found
statist
higher
proport
circul
treg
ms
healthi
pregnant
compar
ms
healthi
nonpregn
women
respect
p
p
respect
p
p
b
respect
ns
p
respect
express
perforin
treg
significantli
higher
third
trimest
ms
healthi
pregnant
p
p
respect
addit
stimulatedrespond
induc
significantli
higher
treg
phenotyp
compar
nonstimul
respond
p
tcr
stimul
respond
alon
p
treg
effect
express
b
similar
way
ctl
cell
treg
expand
express
higher
perforin
level
pregnanc
healthi
women
set
ms
although
lower
level
later
one
show
vitro
expand
treg
enhanc
treg
function
induc
treg
phenotyp
activ
respond
tcell
increas
express
perforin
treg
found
surfac
express
treg
sign
cell
degranul
therefor
cytotox
cell
inflammatori
myopathi
chronic
diseas
skelet
muscl
typic
autoaggress
attack
mhc
class
posit
muscl
fiber
destroy
target
cell
case
tcell
oligoclon
expand
express
alphabetatcellreceptor
tcr
molecul
rare
form
polymyos
myocytotox
tcell
express
gammadeltatcr
gdtcr
gdtcr
recogn
antigenslik
antibodiesin
mhcnonrestrict
way
one
patient
monoclon
gdt
cell
expans
observ
therefor
gdtcr
chain
could
clone
easili
express
thybridoma
cell
line
lack
endogen
tcr
chain
previou
experi
found
gdtcr
recogn
enigmat
antigen
express
human
muscl
fiber
also
tissu
speci
therefor
surmis
gdtcr
might
recogn
defin
epitop
rather
evolutionari
conserv
motif
describ
molecular
characteris
antigen
motif
pathogen
gdtcr
found
sever
protein
associ
rna
translat
apparatu
human
cell
bacteria
recogn
candid
protein
coat
microtit
well
incub
gdtcr
transfect
secret
measur
strikingli
sever
trnasynthetas
includ
wellknown
myositisantigen
recogn
use
small
solubl
translat
initi
factor
e
coli
paradigm
show
sitedirect
mutagenesi
gdtcr
recogn
conform
antigen
motif
consist
four
amino
acid
motif
locat
alphahel
segment
surfaceexpos
loop
use
gdtcr
transfect
defin
amino
acid
exchang
differ
posit
tcr
chain
show
motif
recogn
specif
depend
way
antigen
motif
describ
repres
first
motif
pathogen
human
gdtcr
found
human
microbi
protein
surprisingli
motif
recogn
gdtcr
present
sever
trnasynthetas
known
elicit
b
cell
respons
myositi
patient
provid
unexpect
link
pathogen
gd
cell
respons
consid
relat
innat
immun
system
myositisassoci
antiaar
autoantibodi
usual
undergon
extens
affin
matur
koutrolo
michail
bartholomaeu
ingo
kawakami
naoto
sparwass
tim
krishnamoorthi
gurumoorthi
wekerl
hartmut
max
planck
institut
neurobiolog
martinsri
germani
technisch
munich
germani
regulatori
treg
cell
shown
play
pivot
role
control
autoimmun
respons
import
treg
cell
extens
studi
activ
induc
experiment
autoimmun
encephalomyel
eae
model
studi
investig
function
role
treg
cell
spontan
opticospin
eae
mous
model
develop
follow
interact
myelin
oligodendrocyt
glycoprotein
mog
specif
b
cell
use
doubletransgen
tcrmog
ighmog
mous
strain
spontan
develop
opticospin
eae
ose
mous
high
frequenc
bred
ose
mice
transgen
strain
express
diphtheria
toxin
dtx
receptoregfp
fusion
protein
dereg
mice
treg
cell
allow
select
deplet
treg
cell
dtx
inject
b
fluoresc
treg
report
mous
express
egfp
control
promot
track
visual
treg
cell
interact
immun
cell
vivo
found
chronic
deplet
treg
cell
dereg
mice
treat
dtx
start
onset
spontan
eae
increas
diseas
incid
burden
next
monitor
frequenc
gfp
treg
cell
spontan
eae
ose
mice
fac
found
peripher
immun
system
fraction
treg
cell
low
remain
stabl
irrespect
diseas
statu
howev
clinic
eae
numer
treg
cell
accumul
cn
infiltr
frequenc
alter
throughout
entir
diseas
episod
find
confirm
immunocytochemistri
furthermor
proport
mogspecif
tgtcrexpress
treg
cell
elev
significantli
cn
compar
peripheri
fraction
mogspecif
tgtcrexpress
teff
cell
decreas
initi
observ
use
intravit
spinal
cord
imag
suggest
treg
cell
accumul
perivascular
milieu
move
low
veloc
mening
mice
chronic
spontan
eae
show
spontan
eae
model
frequenc
mogspecif
treg
cell
remain
stabl
peripheri
increas
abundantli
cn
indic
possibl
role
cell
within
target
tissu
importantli
deplet
treg
cell
onset
diseas
seem
increas
diseas
incid
suggest
protect
role
treg
cell
spontan
eae
effectormemori
cell
specif
myelin
antigen
perpetu
central
nervou
system
cn
inflamm
multipl
sclerosi
ms
becom
activ
peripheri
cell
cross
bloodbrain
barrier
enter
uniqu
microenviron
cnsan
environ
design
limit
deleteri
inflamm
primarili
nonregen
organ
cn
cell
reactiv
creat
inflammatori
microenviron
caus
damag
myelin
sheath
axon
lead
clinic
neurolog
impair
although
signific
effort
describ
effect
cytokin
cell
much
less
known
abil
influenc
antigenexperienc
effector
cell
multifunct
cytokin
present
healthi
inflam
cn
wellcharacter
suppress
effect
cell
function
howev
abil
influenc
effector
cell
well
defin
use
myelinspecif
tcr
transgen
mice
experiment
autoimmun
encephalomyel
eae
model
demonstr
elicit
differenti
effect
versu
effector
cell
show
exposur
secondari
stimul
effector
cell
enhanc
cellular
activ
prolifer
cytokin
productiona
respons
differ
seen
cell
interestingli
cell
exhibit
reduct
encephalitogen
adopt
transfer
wildtyp
mice
demonstr
promot
selfregul
induc
popul
cell
respons
reduct
encephalitogen
silenc
smallinterf
rna
technolog
restor
diseas
sever
data
demonstr
uniqu
mechan
abl
reduc
pathogen
myelinspecif
cell
base
differenti
state
target
cell
although
semaphorin
initi
identifi
axon
guidanc
cue
determin
direct
migrat
neuron
neurogenesi
cumul
evid
indic
import
function
immun
cell
migrat
recent
secretedtyp
class
semaphorin
shown
regul
immun
cell
migrat
signal
receptor
respect
sinc
emerg
cell
traffick
cn
play
critic
role
relaps
multipl
sclerosi
investig
role
migrat
cell
develop
eae
first
examin
mrna
express
level
effector
cell
found
markedli
increas
naiv
cell
differenti
cell
investig
role
interact
tcell
cross
lckcre
transgen
mice
mice
gener
tcell
specif
mice
perform
chemotaxi
assay
cell
ad
recombin
upper
chamber
presenc
chemokin
chemotaxi
wildtyp
cell
enhanc
addit
upper
chamber
effect
cancel
mice
induc
eae
tcell
specif
defici
mice
immun
mogpeptid
clinic
onset
mutant
mice
significantli
delay
compar
wildtyp
mice
howev
maximum
clinic
score
eae
mutant
mice
statist
differ
wildtyp
mice
collect
data
suggest
particip
pathogenesi
eae
promot
cell
migrat
cn
calcium
signal
play
crucial
role
cell
activ
prolifer
calcium
respons
involv
influx
calcium
channel
locat
within
plasma
membran
open
channel
requir
continu
releas
intracellular
pool
mediat
three
differ
mobil
second
messeng
name
dmyoinositol
cyclic
adpribos
cadpr
nicotin
acid
adenin
dinucleotid
phosphat
naadp
due
lack
biocompat
specif
inhibitor
function
impact
distinct
second
messeng
poorli
understood
use
recent
develop
inhibitor
select
interfer
naadpmedi
releas
explor
role
naadp
autoreact
effector
cell
experiment
autoimmun
encephalomyel
eae
neuriti
ean
anim
model
multipl
sclerosi
guillain
syndrom
respect
molecular
analys
reveal
naadp
signal
influenc
cell
reactiv
upon
arriv
nervou
tissu
naadp
inhibitor
treatment
significantli
reduc
level
proinflammatori
cytokin
ifn
live
two
photon
imag
show
chang
cell
motil
go
togeth
function
chang
eae
lesion
effector
cell
display
characterist
locomot
pattern
infiltr
cell
stationari
phase
antigen
recognit
wherea
remain
cell
motil
move
high
speed
cn
tissu
naadp
inhibitor
treatment
higher
fraction
cell
motil
invas
capac
reduc
accordingli
clinic
symptom
eae
ean
amelior
vitro
antigentrigg
cell
prolifer
cytokin
product
evenli
suppress
remark
longliv
memori
cell
target
significantli
less
naadp
inhibitor
differenti
suscept
correl
express
put
receptor
naadptrigg
signal
cell
upregul
effector
cell
compar
memori
cell
data
indic
naadpcalcium
signal
pathway
essenti
recruit
activ
autoaggress
tcell
within
target
organ
interfer
pathway
suppress
autoimmun
inflammatori
lesion
format
thu
might
qualifi
novel
strategi
treatment
cellmedi
autoimmun
diseas
vivo
imag
lymphocyt
cn
reveal
differ
behaviour
naiv
cell
health
autoimmun
autoimmun
central
nervou
system
cn
inflamm
suppos
mediat
perivascular
accumul
mononuclear
cell
preced
actual
infiltr
cn
parenchyma
myelinspecif
cell
contribut
regulatori
cell
phenotyp
complex
process
still
unclear
therefor
investig
navig
regulatori
cell
vivo
live
brain
tissu
could
show
intravit
two
photon
microscopi
eae
cell
highli
motil
compar
mean
track
veloc
n
lymphoid
tissu
get
hint
drive
cell
travel
compact
cn
parenchyma
migratori
signal
exist
brain
cell
use
slice
model
sinc
healthi
mice
hardli
cell
find
slice
model
circumv
bbb
see
cell
migratori
capac
per
se
brain
tissu
could
hardli
find
migratori
cell
contrast
observ
effector
cell
found
depend
compartmentalis
around
vessel
also
regulatori
cell
show
migrat
pattern
highli
dynam
natur
perivascular
area
similar
cell
indic
domin
role
area
immuneregul
result
visual
even
though
cell
migratori
capac
lymph
node
find
suffici
migratori
signal
cn
parenchyma
noninflam
condit
seem
undergo
kind
activ
brain
eae
affect
mice
lymph
node
known
cell
migrat
along
reticular
fiber
detect
shg
signal
inflam
brain
could
also
observ
reticular
structur
shg
signal
healthi
brain
brain
slice
suggest
inflamm
induc
structur
may
also
provid
migratori
signal
need
naiv
cell
migrat
within
cn
identif
molecular
origin
reticular
network
signal
navig
cell
aim
futur
investig
refer
siffrin
v
brandt
u
radbruch
h
herz
j
boldakowa
n
leuenberg
werr
j
hahner
schulzetopphoff
u
nitsch
r
et
al
increasingli
recogn
excess
intracellular
cation
particularli
contribut
neuron
glial
cell
injuri
underpin
patholog
develop
longterm
disabl
multipl
sclerosi
ms
recent
evid
experiment
autoimmun
encephalomyel
eae
anim
model
ms
suggest
acid
sens
ion
channel
activ
acidot
tissu
condit
found
inflammatori
lesion
flux
contribut
axon
injuri
howev
express
studi
ms
tissu
extent
cellular
distribut
express
neuron
glia
inflammatori
lesion
unknown
show
signific
upregul
axon
associ
injuri
within
acut
eae
activ
ms
lesion
also
demonstr
parallel
find
oligodendrocyt
show
blockad
myeloprotect
neuroprotect
moreov
daili
administr
amilorid
licens
clinicallysaf
blocker
asic
commenc
diseas
onset
first
relaps
amelior
disabl
mice
chronicrelaps
eae
creae
togeth
find
suggest
blockad
offer
novel
dual
neuroand
myeloprotect
benefit
justifi
trial
amilorid
blocker
treatment
patient
ms
vivo
imag
partial
revers
neuron
dysfunct
cours
encephalomyel
neuron
damag
autoimmun
neuroinflamm
correl
longterm
disabl
patient
suffer
multipl
sclerosi
ms
although
assum
autoimmun
neuroinflamm
primari
immun
respons
direct
myelin
sheath
axon
neuron
injuri
alreadi
promin
earli
diseas
stage
like
determin
degre
longterm
disabl
patient
provid
evid
cell
studi
alreadi
shown
associ
clinic
deficit
eae
ivanov
et
al
play
domin
role
direct
neuron
injuri
diseas
cours
investig
role
immun
cell
earli
neuron
damag
process
anim
model
ms
monitor
autoimmun
neuroinflamm
use
twophoton
microscopi
live
anaesthet
mice
brainstem
detect
longlast
interact
immun
cell
neuron
process
especi
diseas
peak
direct
interact
mogspecif
neuron
cell
demyelin
lesion
associ
extens
axon
damag
longlast
contact
led
sever
local
partial
revers
fluctuat
neuron
intracellular
concentr
import
indic
neuron
dysfunct
demonstr
mice
increas
could
block
nmdareceptor
antagonist
indic
excitotox
relev
featur
immunemedi
neuron
damag
process
especi
cell
capabl
induc
apoptosi
cultur
neuron
irrespect
antigen
specif
contactdepend
manor
thu
data
indic
import
role
effector
phenotyp
neuron
dysfunct
clinic
deficit
chronic
neuroinflamm
arriv
cn
activ
cell
particular
abl
directli
contact
neuron
well
axon
induc
chang
antigenindepend
manner
target
organ
cell
liveimag
diseas
character
neuron
dysfunct
earli
potenti
revers
suggest
immunemedi
disturb
neuron
compart
caus
relaps
remit
disabl
patient
multipl
sclerosi
addit
conduct
block
result
chang
myelin
sheath
devic
neuromyel
optica
dnmo
inflammatori
demyelin
disord
restrict
optic
nerv
spinal
cord
sinc
identif
specif
autoantibodi
nmoigg
direct
aquaporin
astrocyt
water
channel
protein
dnmo
consid
entiti
distinct
multipl
sclerosi
recent
find
indic
antibodi
pathogen
role
complementdepend
astrocyt
toxic
howev
link
demyelin
remain
elus
hypothes
antibodi
impair
astrocyt
function
secondarili
lead
demyelin
rat
astrocyt
oligodendrocyt
primari
cultur
rat
optic
nerv
expos
longterm
h
igg
absenc
complement
igg
purifi
serum
dnmo
patient
either
antibodi
posit
neg
healthi
control
flow
cytometri
analysi
show
reduct
membran
glutam
transport
astrocyt
follow
contact
igg
purifi
antibodi
posit
serum
activ
glutamin
synthetas
decreas
parallel
indic
astrocyt
dysfunct
igg
antibodi
posit
sera
also
reduc
oligodendrocyt
cell
process
approxim
die
deleteri
effect
confirm
ex
vivo
isol
optic
nerv
igg
antibodi
seroneg
patient
healthi
control
similar
effect
antibodi
directli
injur
oligodendrocyt
cultur
without
astrocyt
toxic
bystand
effect
astrocyt
damag
antibodi
oligodendrocyt
identifi
progress
accumul
glutam
cultur
medium
glial
cell
support
hypothesi
glutamatemedi
excitotox
death
oligodendrocyt
model
moreov
glutam
receptor
nmda
subunit
detect
oligodendrocyt
cotreat
glial
cultur
antibodi
acid
competit
antagonist
nmda
receptor
partial
protect
oligodendrocyt
rat
model
demonstr
direct
effect
nmoigg
antibodi
astrocyt
independ
complement
indirect
effect
oligodendrocyt
mediat
damag
astrocyt
possibl
glutamatemedi
mechan
excitotox
oligodendrocyt
cc
chemokin
receptor
essenti
role
develop
autoimmun
encephalomyel
express
requir
dendrit
cell
cell
cc
chemokin
receptor
ligand
contribut
pathogenesi
allerg
respons
infecti
autoimmun
diseas
direct
lymphocyt
traffick
inflammatori
site
howev
role
cn
autoimmun
remain
unknown
provid
evid
critic
implic
pathogenesi
experiment
autoimmun
encephalomyel
eae
sinc
knockout
mice
exhibit
eae
resist
immun
myelin
oligodendrocyt
glycoprotein
cooper
role
ligand
eae
support
fact
cn
immigr
dendrit
cell
express
produc
dendrit
cell
concert
macrophagesmicroglia
adopt
transfer
defici
cell
still
abl
induc
eae
mice
indic
cell
dispens
diseas
induct
instead
diseas
suscept
restor
bonemarrow
chimera
express
myeloid
cell
intracerebr
microinject
dendrit
cell
identifi
cell
key
mediat
eae
develop
data
clearli
demonstr
novel
nonredund
role
dendrit
cell
regul
effector
phase
eae
thu
therapi
target
function
dendrit
cell
may
repres
import
strategi
develop
treatment
autoimmun
cn
diseas
use
transect
model
sci
spinal
cord
cut
axial
vertebra
use
mice
wild
type
wt
knockout
ko
type
examin
motor
function
use
basso
mous
scale
bm
locomot
day
post
oper
dpo
sagitt
section
spinal
cord
obtain
dpo
stain
immunohistochemistri
area
surround
gfap
marker
astrocyt
posit
cell
measur
injur
area
softwar
olympu
homogen
sampl
spinal
cord
obtain
dpo
examin
chemistri
use
elisa
kit
motor
function
significantli
improv
ko
mice
dpo
compar
wt
mice
area
surround
gfap
posit
cell
significantli
decreas
ko
mice
dpo
compar
wt
mice
peak
dpo
decreas
gradual
dpo
wt
mice
express
marker
mgmf
posit
cell
tnfa
also
increas
sci
kept
high
level
dpo
wt
mice
significantli
decreas
mice
dpo
compar
wt
mice
significantli
higher
ko
mice
dpo
compar
wt
mice
posit
cell
tend
accumul
around
injuri
site
ko
mice
addit
express
marker
mgmf
posit
cell
conclus
studi
endogen
influenc
activ
mgmf
sci
moreov
could
take
part
differ
mgmf
activ
sci
bloodbrain
barrier
bbb
compos
tightli
bound
endotheli
cell
ec
perivascular
astrocyt
regul
central
nervou
system
cn
homeostasi
recent
studi
indic
compon
hedgehog
hh
pathway
play
import
role
vascular
prolifer
differenti
tissu
repair
adult
tissu
bbb
disrupt
observ
earli
neuroinflammatori
condit
multipl
sclerosi
ms
studi
aim
demonstr
astrocytesecret
sonic
hh
shh
contribut
mainten
bbb
function
includ
immun
quiescenc
herein
show
astrocyt
express
secret
sonic
hedgehog
shh
bbbec
bear
hh
receptor
downstream
transcript
factor
vitro
vivo
experi
show
activ
hh
pathway
restrict
bbb
permeabl
hh
neutral
impact
bbb
format
stabil
fetal
develop
adulthood
demonstr
shh
promot
immun
quiescenc
bbbec
decreas
secret
proinflammatori
chemokin
surfac
express
cell
adhes
molecul
well
adhes
migrat
immun
cell
phenomenon
dysregul
neuroinflamm
addit
vitro
stimul
bbbec
tnfa
ifng
deregul
hh
signal
pathway
prevent
barrier
stabil
properti
hh
final
shh
found
impact
cytokin
product
adhes
molecul
express
helper
th
lymphocyt
data
suggest
hh
pathway
provid
barrierpromot
effect
endogen
antiinflammatori
balanc
cnsdirect
immun
attack
occur
ms
chronic
neurodegen
diseas
alzheim
diseas
parkinson
diseas
prion
diseas
may
evolv
mani
year
prior
present
clinic
symptom
associ
accumul
misfold
protein
slow
degener
neuron
process
microglia
resid
macrophag
cn
take
activ
morpholog
increas
number
cell
innat
immun
system
contribut
diseas
progress
present
unclear
murin
model
prion
diseas
demonstr
presenc
misfold
protein
slow
degener
neuron
microglia
associ
atyp
antiinflammatori
profil
domin
microglia
longliv
popul
tissu
macrophag
thu
retain
innat
immun
memori
ongo
tissu
degener
phenotyp
switch
robust
proinflammatori
phenotyp
system
inflamm
turn
lead
exagger
symptom
sick
behaviour
increas
neuron
degener
acceler
diseas
progress
cunningham
et
al
system
inflamm
shown
exacerb
neuron
degener
number
model
chronic
neurodegener
sinc
system
inflamm
switch
microglia
phenotyp
preclin
model
investig
whether
system
inflamm
affect
diseas
progress
patient
alzheim
diseas
find
patient
rais
serum
level
tumour
necrosi
factoralpha
tnf
indic
chronic
system
inflamm
contract
acut
system
infect
show
greater
rate
cognit
declin
patient
low
level
tnf
system
infect
holm
et
al
propos
system
inflamm
infect
contribut
rate
progress
chronic
neurodegen
diseas
switch
microglia
proinflammatori
tissu
damag
phenotyp
microglialmedi
neuroinflammatori
process
involv
alzheim
diseas
ad
addit
recent
report
suggest
crucial
role
invad
bloodderiv
monocyt
cell
bdmc
pathogenesi
cerebr
amyloidosi
transgen
mice
establish
novel
protocol
allow
condit
ablat
microglia
administr
ganciclovir
gcv
transgen
tk
mice
cross
tk
mice
variou
app
transgen
mice
found
microgli
ablat
four
week
effect
format
mainten
amyloid
patholog
grathwohl
et
al
nat
neurosci
recent
util
tk
mice
establish
irradiationindepend
assay
repopul
entir
mous
brain
bdmc
follow
microglia
cell
deplet
taken
advantag
mous
model
determin
consequ
microgli
ablat
bdmc
invas
normal
brain
function
well
pathogenesi
amyloid
lesion
transgen
mous
model
possibl
role
system
environ
modul
brain
age
neurodegener
grow
evid
link
neurodegener
alter
immun
respons
brain
peripheri
well
addit
age
main
risk
factor
sporad
form
neurodegen
diseas
age
peripher
organ
may
affect
brain
function
system
environ
affect
brain
health
larg
unknown
interact
may
involv
cell
enter
nervou
tissu
like
mani
mediat
solubl
factor
use
antibodybas
microarray
luminex
technolog
measur
rel
level
secret
signal
protein
includ
cytokin
growth
factor
plasma
human
mice
correl
molecular
cellular
chang
brain
use
method
identifi
exampl
protein
strongli
neuroprotect
administ
mice
system
agerel
factor
regul
neurogenesi
neuroinflamm
find
point
system
chang
immun
respons
cellular
signal
factor
age
neurodegener
may
relev
understand
diagnosi
agerel
neurodegener
also
support
use
focus
proteom
approach
studi
cellular
signal
protein
collect
call
communicom
mean
understand
pathophysiolog
physiolog
chang
brain
talk
want
summar
recent
insight
pathogenesi
immunemedi
axon
damag
vivo
immunemedi
axon
damag
play
crucial
role
inflammatori
diseas
central
nervou
system
cn
like
multipl
sclerosi
ms
ms
immun
cell
infiltr
brain
spinal
cord
attack
axon
surround
myelin
sheet
know
number
axon
damag
immun
cell
critic
determin
clinic
disabl
ms
patient
howev
still
understand
littl
process
lead
axon
damag
use
vivo
imag
approach
investig
pathogenesi
immunemedi
axon
damag
anim
model
multipl
sclerosi
timelaps
imag
fluoresc
label
axon
could
follow
slow
spatial
restrict
degener
axon
inflammatori
cn
lesion
focal
axon
degener
appear
novel
type
axon
degener
differenti
posttraumat
form
axon
degener
like
wallerian
degener
eg
limit
extens
slow
speed
progress
could
identifi
intermedi
stage
focal
axon
degener
persist
sever
day
progress
either
degener
full
recoveri
affect
axon
interestingli
demyelin
appear
prerequisit
induct
axon
damag
contrast
mitochondri
damag
appear
earliest
ultrastructur
sign
axon
damag
earli
stage
focal
axon
degener
often
associ
persist
macrophag
contact
suggest
macrophagederiv
mediat
play
crucial
role
induct
process
current
tri
identifi
molecular
mediat
induc
degener
process
reveal
intraaxon
mechan
lead
axon
fragment
hope
work
improv
understand
immunemedi
tissu
damag
multipl
sclerosi
pave
way
toward
develop
target
neuroprotect
therapi
vivo
imag
neuron
recoveri
neuroinflamm
gan
wanbiao
parkhurst
christoph
hay
scott
gan
wenbiao
murin
model
experiment
autoimmun
encephalomyel
eae
wide
use
studi
effect
inflamm
central
nervou
system
cn
eae
mous
model
reveal
neuropatholog
spinal
cord
brainstem
cerebellum
impact
eae
cerebr
cortex
remain
poorli
understood
use
vivo
transcrani
twophoton
microscopi
examin
dendrit
spine
plastic
microgli
activ
somatosensori
cortex
mous
model
eae
induc
immun
myelinoligodendrocyteglycoprogein
mog
found
mice
moginduc
eae
display
signific
increas
dendrit
spine
turnov
least
day
onset
neurolog
symptom
concomit
dendrit
spine
instabl
microglia
display
reactiv
phenotyp
includ
chang
morpholog
distribut
dendrit
spine
instabl
microgli
activ
continu
peak
stage
eae
subsid
month
eaeinduc
mog
inject
observ
indic
moginduc
eae
profoundli
disrupt
synapt
connect
cortex
also
suggest
microgli
activ
may
play
import
role
pathogenesi
eae
sever
proinflammatori
cytokin
produc
activ
microglia
tnfalpha
known
regul
synapt
plastic
present
studi
microgli
activ
increas
proinflammatori
cytokin
product
contribut
eaeassoci
synapt
patholog
recoveri
cortex
sever
novel
autoantibodi
discov
field
neurolog
due
outstand
signific
diagnosi
therapi
rapidli
translat
clinic
patient
care
among
import
marker
autoantibodi
direct
nmdatyp
glutam
receptor
also
call
nmda
receptor
detect
antibodi
serum
cerebrospin
fluid
determin
fate
affect
patient
autoantibodi
found
patient
neuromyel
optica
nmo
also
known
devic
syndrom
subform
earli
aggress
immunosuppress
therapi
decis
futur
diseas
cours
detect
antibodi
allow
differenti
nmo
multipl
sclerosi
particularli
import
nmo
ms
treat
differ
drug
addit
antibodi
discrimin
small
signific
subgroup
patient
neuropsychiatr
sle
primari
syndrom
therapeut
strategi
nmo
need
appli
autoantibodi
nmda
receptor
characterist
antinmda
receptor
enceph
current
still
wide
underdiagnos
autoimmun
diseas
first
describ
young
patient
ovarian
teratoma
howev
antinmda
receptor
enceph
also
increasingli
diagnos
older
femal
patient
women
without
teratoma
well
men
children
diseas
often
start
flulik
preliminari
stage
follow
psychiatr
symptom
anxieti
excit
strang
behaviour
delus
hallucin
therefor
larg
proport
patient
initi
admit
psychiatr
ward
within
week
epilept
attack
cloud
conscious
occur
eventu
lead
coma
final
diagnosi
antinmda
receptor
enceph
base
detect
antibodi
glutam
receptor
type
nmda
serum
csf
patient
principl
antinmda
receptor
enceph
curabl
even
long
intens
medic
treatment
longterm
ventil
prerequisit
howev
rapid
diagnosi
earli
therapi
complet
remov
tumour
present
novel
highli
specif
autoantibodi
patient
limbic
enceph
compris
antibodi
direct
gababreceptor
novel
antigen
target
previous
attribut
vkkc
also
discuss
respons
interferonbeta
treatment
multipl
sclerosi
pharmacogenom
studi
comabella
manuel
centr
desclerosi
de
catalunya
cemcat
unitat
de
neuroimmunologia
hospit
universitari
vall
barcelona
spain
mechan
underli
heterogen
respons
treatment
multipl
sclerosi
ms
complet
understood
although
genet
factor
like
play
import
role
moreov
given
complex
natur
diseas
heterogen
probabl
explain
contribut
multipl
gene
diseas
modifi
therapi
dmt
mainstay
treatment
relapsingremit
ms
demonstr
benefici
effect
diseas
activ
howev
dmt
partial
effect
longterm
impact
diseas
progress
remain
elus
addit
patient
respond
current
dmt
increas
number
new
therapi
ms
potenti
risk
lack
respons
andor
seriou
advers
reaction
make
individu
therapi
highprior
ms
pharmacogenom
appli
technolog
gene
express
profil
singl
nucleotid
polymorph
snp
screen
proteom
order
predict
respons
treatment
toxic
drug
although
pharmacogenom
hold
great
promis
individu
therapi
ms
big
effort
first
made
identifi
marker
treatment
efficaci
talk
focu
current
statu
futur
direct
pharmacogenom
studi
ms
mainli
relat
interferonbeta
treatment
multipl
sclerosi
ms
heterogen
complex
autoimmun
demyelin
diseas
tissu
damag
repair
process
occur
simultan
central
nervou
system
highthroughput
analys
gene
protein
antibodi
undertaken
elucid
molecular
signatur
ms
proteom
analysi
microarray
studi
brain
lesion
cerebrospin
fluid
immun
cell
ms
patient
reveal
unexpect
molecul
pathway
involv
diseas
pathogenesi
identifi
new
target
therapi
howev
techniqu
limit
due
half
life
target
molecul
compartment
within
cell
limit
platform
moreov
direct
comparison
transcriptom
proteom
databas
differ
group
complic
due
lack
standard
platform
due
heterogen
tissu
analyz
present
differ
proteom
technolog
util
studi
ms
tissu
benefit
defici
approach
find
also
discuss
compar
proteom
transcriptom
analysi
tissu
multipl
sclerosi
brain
lesion
final
compar
proteom
studi
ms
tissu
similar
demeylin
diseas
nmo
combin
multilevel
integr
approach
illumin
molecular
pathogenesi
ms
identifi
potenti
target
therapi
immunolog
lectur
convers
tissu
cell
nih
bethesda
md
usa
immun
system
two
question
must
answer
face
potenti
threat
shall
respond
kind
respons
make
three
quarter
centuri
immunologist
tri
discov
immun
system
answer
first
question
base
theori
experi
fundament
belief
immun
system
answer
question
discrimin
self
nonself
thought
taught
system
perfect
would
attack
everyth
nonself
total
toler
anyth
self
abandon
belief
suggest
instead
immun
system
concern
danger
distinct
self
nonself
model
start
idea
immun
system
defin
danger
anyth
caus
tissu
stress
destruct
model
antigenpres
cell
activ
alarm
signal
stress
damag
tissu
without
activ
primari
immun
respons
occur
show
recent
evid
favor
discuss
implic
also
present
new
idea
second
question
thu
far
immunolog
concert
attempt
find
model
immun
system
determin
effector
class
particular
respons
current
wide
taught
effector
class
tailor
pathogen
drive
immun
respons
exampl
make
ige
worm
infect
killer
cell
viru
longer
believ
although
pathogen
certainli
influenc
immun
respons
made
usual
find
way
modifi
respons
like
believ
fundament
underli
system
control
believ
ultim
control
immun
tissu
immun
system
design
protect
injur
tissu
emit
alarm
signal
initi
immun
respons
injur
tissu
present
antigen
releas
pass
dc
present
cell
order
induc
toler
moreov
immun
respons
occur
tissu
send
signal
direct
immun
system
tailor
respons
effector
class
elimin
pathogen
without
caus
damag
tissu
must
stop
think
immun
system
independ
group
cell
patrol
bodi
keep
free
foreign
base
think
view
immun
system
extend
famili
constantli
commun
cell
tissu
accept
harmless
benefici
entiti
fight
harm
one
open
new
window
suggest
new
experi
build
new
understand
complex
wonder
power
system
cnsimmun
system
interact
danc
chang
develop
age
experi
neuroinflamm
trigger
system
inflamm
occur
critic
period
cn
develop
hypothes
contribut
develop
andor
pathogenesi
mani
neurodevelopment
disord
includ
cerebr
palsi
schizophrenia
autism
adult
cn
type
magnitud
microgli
activ
macrophag
influx
trigger
system
inflamm
well
character
yet
littl
known
microgli
phenotyp
chang
critic
period
cn
develop
associ
synaptogenesi
oligodendrocyt
develop
use
flow
cytometri
dual
situ
hybrid
immunohistochemistri
show
earli
postnat
murin
brain
microglia
display
activ
phenotyp
polar
toward
either
classic
proinflammatori
altern
antiinflammatori
activ
state
furthermor
find
age
examin
system
inflamm
induc
intraperiton
inject
lp
lead
widespread
activ
microglia
transient
influx
peripher
macrophag
murin
cn
howev
magnitud
macrophag
influx
cn
development
modul
addit
cnsinfiltr
macrophag
display
polar
proinflammatori
phenotyp
development
period
microgli
activ
associ
high
level
express
multipl
altern
activ
marker
induct
specul
microglialspecif
form
activ
part
serv
compens
higher
level
proinflammatori
macrophag
infiltr
cn
earli
develop
altogeth
data
contribut
grow
literatur
demonstr
brain
may
agespecif
suscept
insult
associ
develop
treatment
neurodevelopment
disord
immun
surveil
cn
new
concept
new
target
cleveland
clinic
oh
usa
propos
hypothesi
health
central
nervou
system
cn
permit
immun
cell
entri
across
bloodbrain
barrier
immunosurveil
take
place
within
subarachnoid
space
leav
cn
parenchyma
untouch
concept
base
descript
studi
human
csf
analyt
studi
subarachnoid
space
murin
eae
normal
human
csf
contain
cell
major
central
memori
cell
half
cell
routin
travers
choroid
plexu
stromal
vessel
epithelium
enter
exit
csf
approxim
twice
per
day
provid
continu
suppli
lymphocyt
novel
antigen
specif
csf
cell
enorm
enrich
activ
central
memori
cell
compar
circul
blood
constitut
leukocyt
lumbar
ventricular
csf
patient
without
cn
inflamm
contain
similar
cellular
compon
support
propos
mani
csf
cell
enter
across
choroid
plexu
commit
tissu
specif
memori
cell
repres
csf
equal
proport
found
blood
healthi
mice
cell
subarachnoid
space
perform
serial
scan
encount
mhc
class
ii
apc
eae
antigen
recognit
clonal
expans
occur
subarachnoid
space
day
event
spinal
cord
parenchyma
integr
observ
experiment
studi
show
subarachnoid
space
inflamm
coupl
parenchym
vascular
activ
well
invas
parenchyma
hematogen
cell
final
novel
find
subpial
demyelin
earli
cours
ms
suggest
ms
diseas
process
may
part
proceed
outsid
cortic
demyelin
mening
inflamm
set
stage
white
matter
lesion
persist
diseas
process
whitacr
carolin
william
jl
cox
gm
smith
km
kithcart
shawler
satoskar
ohio
state
univers
columbu
oh
usa
multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
cn
affect
nearli
million
peopl
worldwid
known
autoreact
cell
subtyp
involv
ms
pathogenesi
current
licens
therapi
ms
includ
form
interferon
beta
well
specif
target
agent
direct
adhes
molecul
antigen
receptor
complex
search
addit
therapi
focus
hormon
cytokin
genet
approach
treatment
ms
use
model
system
experiment
autoimmun
encephalomyel
eae
hormon
studi
foundat
observ
women
ms
exhibit
markedli
fewer
relaps
pregnanc
show
relaps
diseas
postpartum
studi
shown
eae
clinic
sign
markedli
reduc
pregnanc
induc
ongo
eae
accompani
decreas
cn
histopatholog
chang
suppress
inflammatori
cytokin
product
identifi
serum
exosom
mediat
diseas
suppress
analyz
content
exosom
differenti
gel
electrophoresi
mass
spectrometri
result
analys
suggest
exosom
protein
act
decreas
inflamm
well
enhanc
neural
regener
cytokin
approach
therapi
ms
focus
macrophag
migrat
inhibitori
factor
mif
sinc
level
cytokin
shown
increas
relaps
diseas
shown
mifdefici
mice
exhibit
reduc
clinic
sign
eae
cn
inflammatori
infiltr
small
molecul
inhibitor
mif
design
cytokin
pharmasci
also
shown
efficaci
treatment
eae
even
treatment
begun
appear
eae
clinic
sign
shown
treatment
microgli
cultur
mif
upregul
ino
level
moreov
microinject
rmif
vivo
spinal
cord
shown
transient
microgli
reactiv
cellular
accumul
within
cn
thu
inhibit
mif
could
well
serv
import
therapeut
approach
cn
inflamm
genet
approach
therapi
center
microrna
mir
small
noncod
rna
neg
regul
posttranscript
gene
express
identifi
target
tbet
interferon
gamma
import
studi
ms
reason
ms
patient
might
alter
level
mir
inde
found
purifi
cell
ms
patient
lower
basal
level
rel
control
patient
result
identifi
potenti
biomark
ms
futur
candid
therapi
studi
support
nih
grant
nation
ms
societi
grant
stanford
univers
stanford
unit
state
institut
molecular
regen
medicin
paracelsu
medic
univers
strubergass
salzburg
austria
depart
neurolog
neurolog
scienc
stanford
univers
school
medicin
stanford
unit
state
stem
cell
activ
brain
decreas
dramat
age
given
perturb
system
milieu
organ
induc
exercis
enhanc
neural
stem
cell
frequenc
improv
learn
memori
age
mice
hypothes
system
molecular
chang
could
caus
declin
neurogenesi
age
examin
effect
system
factor
adult
neurogenesi
util
model
parabiosi
circulatori
system
share
young
old
mice
heterochron
parabiosi
exposur
young
brain
age
system
environ
result
decreas
neurogenesi
exposur
old
brain
young
system
environ
increas
neurogenesi
use
target
proteom
screen
identifi
conserv
subset
blood
born
chemokinesinclud
plasma
level
correl
reduc
neurogenesi
observ
normal
age
heterochron
parabiosi
function
demonstr
mimick
age
system
environ
increas
level
peripheri
young
adult
mice
result
decreas
neurogenesi
vivo
addit
show
decreas
progenitor
frequenc
neuron
differenti
vitro
use
pharmacolog
approach
also
demonstr
inhibitori
effect
system
administ
mitig
neutral
either
system
directli
within
central
nervou
system
cumul
result
indic
declin
adult
neurogenesi
observ
age
attribut
part
chang
level
immunerel
factor
within
age
system
milieu
mesenchym
stem
cell
msc
promis
vehicl
treatment
neurodegen
diseas
multipl
sclerosi
ms
part
due
broad
immunomodulatori
properti
abil
home
site
tissu
inflamm
injuri
previous
investig
therapeut
potenti
human
msc
amelior
mslike
diseas
mice
experiment
autoimmun
encephalomyel
eae
comparison
msc
three
differ
tissu
sourc
reveal
therapeut
efficaci
adiposederiv
msc
admsc
greater
msc
test
term
suppress
clinic
patholog
sign
diseas
antiinflammatori
cytokin
extens
studi
eae
model
found
play
import
immunoregulatori
role
howev
treatment
eae
system
administr
yield
contradictori
result
suggest
time
mode
deliveri
may
crucial
effect
treatment
present
studi
aim
explor
use
admsc
vehicl
deliveri
mice
eae
transduc
admsc
lentivir
vector
encod
human
track
cell
vector
incorpor
enhanc
green
fluoresc
protein
egfp
sequenc
translat
intern
ribosom
entri
site
sequenc
control
cell
transduc
vector
engin
express
egfp
alon
transgen
egfp
express
maintain
number
passag
assess
flow
cytometri
elisa
importantli
cell
surfac
phenotyp
differenti
potenti
express
chemokin
receptor
admsc
unaffect
transduct
process
vivo
transplant
studi
show
system
administr
express
admsc
either
intraven
intraperiton
inject
initi
phase
diseas
could
prevent
significantli
delay
develop
myelin
oligodendrocyt
glycoprotein
mog
induc
eae
protect
mice
tcell
prolif
respons
mog
found
dramat
reduc
comparison
control
unprotect
mice
current
investig
possibl
mechan
action
includ
product
regulatori
cell
addit
suppress
antigen
present
cell
cell
result
show
msc
modifi
overexpress
suppress
eae
msc
may
use
tool
deliv
therapeut
molecul
previous
lab
shown
human
bone
marrow
deriv
stemprogenitor
cell
msc
enhanc
repair
damag
brain
follow
transient
global
cerebr
ischemia
part
modul
microgli
activ
studi
aim
confirm
find
hmsc
inhibit
activ
microglia
identifi
specif
mechan
underli
effect
assess
effect
inflamm
neuron
surviv
microgli
cell
organotyp
hippocamp
slice
ohc
use
vitro
cocultur
msc
experi
microglia
stimul
bacteri
protein
lipopolysaccharid
lp
treatment
msc
cocultur
either
directli
microglia
transwel
cultur
slice
find
confirm
msc
attenu
activ
microglia
cell
tissu
cultur
parallel
experi
treat
activ
microglia
recombin
antiinflammatori
antiapoptot
protein
express
msc
show
significantli
inhibit
inflammatori
respons
microglia
data
indic
msc
activ
produc
solubl
antiinflammatori
factor
capabl
reduc
microglia
activ
roy
kristin
peitz
michael
oliv
neumann
harald
institut
reconstruct
neurobiolog
univers
hospit
bonn
herti
foundat
univers
bonn
bonn
germani
microglia
resid
immun
cell
central
nervou
system
respons
innat
immun
defenc
upon
injuri
inflamm
becom
activ
migrat
within
lesion
site
microglia
caus
ambival
effect
releas
neurotroph
neurotox
factor
observ
differ
neurodegen
diseas
therefor
detail
studi
concern
function
microglia
neurodegen
diseas
crucial
howev
limit
number
human
microglia
possibl
obtain
complic
investig
new
therapeut
approach
establish
protocol
differenti
human
induc
pluripot
stem
cell
hip
microgli
precursor
ipsdm
method
encompass
differenti
embryoid
bodi
prolifer
microgli
precursor
within
mix
cultur
neuron
astrocyt
oligodendrocyt
obtain
ipsdm
posit
stain
marker
wide
express
microglia
moreov
flow
cytometri
confirm
express
microgli
marker
wherea
cell
larg
neg
stem
cell
marker
furthermor
ipsdm
display
chemokinedirect
migrat
toward
fractalkin
phagocytosi
microspher
bead
similar
primari
murin
microglia
thu
abl
differenti
human
ip
microgli
precursor
effici
suitabl
studi
role
microglia
normal
neuroinflammatori
condit
oxid
stress
os
caus
reactiv
oxygen
speci
ro
exampl
hydrogen
peroxid
hydroxyl
radic
superoxid
os
caus
lipid
peroxid
dna
damag
cell
death
thought
involv
pathogenesi
varieti
neurodegen
diseas
adult
neuralprogenitor
cell
npc
put
sourc
regener
condit
aim
studi
therefor
investig
os
administ
affect
properti
adult
npc
primari
npc
cultur
isol
brain
adult
da
rat
propag
vitro
second
passag
expos
differ
time
period
exposur
cell
differenti
day
fix
immunolabel
neuron
galc
oligodendrocyt
percentag
variou
cell
type
calcul
prolifer
measur
use
tritium
label
thymidin
express
known
fate
determin
gene
expos
control
npc
cultur
investig
use
realtim
rtpcr
result
reveal
signific
dosedepend
increas
percentag
neuron
npc
cultur
compar
control
cultur
effect
determin
immunosytochem
analysi
neuron
marker
realtim
rt
pcr
neuron
gene
betaiitubulin
proneron
gene
neurogenin
interestingli
expos
cultur
also
elev
gene
express
vascular
endotheli
growth
factor
vegfa
receptor
vascular
endotheli
growth
factor
receptor
gene
report
part
nsc
nich
also
affect
nsc
prolifer
differenti
identifi
inflammationinduc
gene
express
pattern
adult
neural
stem
cell
covacu
ruxandra
arvidsson
lisa
perez
estrada
cynthia
svensson
multipl
sclerosi
ms
inflammatori
lesion
often
locat
close
vicin
area
harbor
neural
stem
cell
nsc
subventricular
zone
svz
central
canal
spinal
cord
aim
studi
investig
inflammationinduc
chang
gene
express
profil
nsc
dark
agouti
rat
immun
develop
experiment
autoimmun
encephalomyel
eae
mslike
diseas
model
total
rna
extract
freshfrozen
svz
biopsi
nsc
cultur
isol
svz
spinal
cord
nsc
propag
vitro
use
rna
isol
either
directli
second
passag
differenti
five
day
experiment
group
consist
separ
culturestissu
three
anim
purifi
amplifi
rna
appli
rat
gene
array
affymetrix
data
present
fold
chang
eae
versu
control
statist
analysi
use
unpair
ttest
data
sort
involv
exclus
pvalu
higher
remov
nois
signal
ie
signal
analysi
perform
use
ingenu
pathway
analysi
databas
promin
express
pattern
differentiationrel
gene
display
opposit
chang
svzderiv
cultur
compar
spinal
cordderiv
one
exampl
differenti
svz
cell
show
upregul
gene
involv
astrogliogenesi
astrogli
marker
betaiiitubulin
neuron
marker
spinal
cord
cell
show
downregul
gene
gfap
astrogli
marker
proneuron
gene
oligodendrogli
differenti
neuron
marker
moreov
express
pattern
display
trend
ie
upregul
svz
cultur
downregul
spinal
cord
cultur
differenti
similar
chang
detect
downstream
signal
mediat
smad
also
result
suggest
inflamm
differ
effect
differ
nsc
pool
central
nervou
system
might
impli
nsc
pool
differ
intrins
properti
induc
pluripot
stem
cell
potenti
sourc
autolog
neural
stem
cell
multipl
sclerosi
therapi
vitasalut
san
raffael
univers
milan
itali
stem
cell
neurogenesi
unit
divis
neurosci
san
raffael
scientif
institut
milan
itali
multipl
sclerosi
ms
acquir
inflammatori
neurodegen
immunemedi
disord
central
nervou
system
cn
character
inflamm
demyelin
axon
degener
recent
year
other
accumul
preclin
data
experiment
model
demyelin
suggest
therapi
base
transplant
neural
stemprecursor
cell
npc
contribut
prevent
repair
cn
damag
immunomodul
remyelin
translat
preclin
data
clinic
use
therapeut
protocol
larg
number
expand
autolog
human
precursor
obtain
induc
pluripot
stem
ip
cellsa
new
sourc
pluripot
stem
cell
recent
obtain
genet
reprogram
somat
cellsmay
repres
appropri
tool
reach
abovement
aim
project
aim
obtain
npc
opc
human
mous
ip
cell
test
first
vitro
vivo
anim
model
mstheir
therapeut
efficaci
promot
neural
repair
via
immunomodul
remyelin
due
fact
aim
autolog
sourc
npc
opc
cure
ms
also
assess
exist
therapeut
differ
ip
cell
deriv
healthi
control
vs
ms
patient
may
hamper
expans
capabl
termin
differenti
differ
ip
cell
line
gener
ms
patient
fibroblast
healthi
control
moreov
pluripot
state
confirm
rtpcr
non
viral
pluripot
associ
gene
immunocytochemistri
assay
pluripot
marker
es
celllik
morpholog
capabl
gener
teratoma
inject
scid
mice
induc
ip
cell
neural
oligogli
commit
test
varieti
protocol
previous
valid
es
cell
slight
modif
recent
accumul
solid
data
show
possibl
induc
vitro
neural
commit
eg
npc
human
well
mous
ip
cell
differenti
opc
confirm
immunostain
experi
rtpcrbase
analysi
develop
strategi
promot
neural
repair
via
remyelin
immunmodul
use
ip
cell
might
repres
step
toward
human
applic
stem
cellbas
therapi
chronic
demyelin
cn
disord
irrevers
neurolog
damag
occur
neuroimmunolog
unit
depart
neurosci
ophthalmolog
genet
univers
genoa
genoa
itali
univers
genoa
genoa
itali
disem
section
neuropharmacolog
univers
genoa
itali
mesenchym
stem
cell
msc
bone
marrowderiv
type
adult
stem
cell
demonstr
regul
immun
respons
amelior
experiment
autoimmun
encephalomyel
howev
abil
transdifferenti
neuron
upon
vivo
administr
proven
thu
use
neurodegen
diseas
still
debat
studi
intraven
administ
msc
transgen
model
amyotroph
later
sclerosi
al
administr
mice
deriv
msc
day
time
first
appear
clinic
symptom
day
first
sign
degener
motoneuron
result
signific
improv
behavior
motor
test
increas
surviv
compar
control
anim
luciferaseposit
msc
could
detect
cn
transgen
mice
demonstr
msc
significantli
reduc
astrogliosi
microglia
activ
central
nervou
system
treat
mice
depict
decreas
express
treat
mice
gfap
respect
show
msc
administr
decreas
express
stressassoci
protein
associ
oxid
insult
mutant
mice
last
observ
signific
decreas
releas
glutam
synaptosom
prepar
treat
mice
compar
control
result
suggest
iv
administr
msc
amen
approach
treat
yet
incur
diseas
al
mesenchym
stem
cell
switch
microglia
detriment
protect
phenotyp
giunti
debora
parodi
benedetta
vergani
laura
bruzzon
santina
usai
cesar
mancardi
gianluigi
uccelli
antonio
neuroimmunolog
unit
depart
neurosci
univers
genoa
genova
itali
depart
biolog
genova
itali
disem
section
biochemestri
genova
itali
nation
research
council
section
biophys
genova
itali
inflamm
cn
close
associ
pathogenesi
neural
damag
result
cerebr
ischemia
neurodegen
diseas
therefor
effect
control
microgli
activ
regard
import
therapeut
target
neurolog
diseas
recent
report
shown
neuroprotect
effect
therapeut
mesenchym
stem
cell
msc
may
mediat
abil
inhibit
immun
respons
target
central
nervou
system
also
capac
produc
trophic
factor
may
contribut
function
recoveri
neuron
surviv
stimul
endogen
neural
precursor
studi
role
msc
effector
function
rest
activ
microglia
show
msc
transwel
cultur
inhibit
activ
microglia
reduc
product
express
tnfa
ino
wherea
msc
effect
microgli
prolifer
msc
significantli
increas
microglia
product
neurotrophin
neuroprotect
molecul
also
observ
msc
follow
ifn
stimul
express
high
level
chemokin
mediat
neuronmicrogli
interact
synapt
transmiss
neuron
protect
toxic
insult
presenc
msc
microglia
increas
express
receptor
knockdown
msc
abolish
upregul
result
suggest
msc
exert
neuroprotect
role
microglia
augment
express
releas
final
show
msc
induc
increas
microglia
express
receptor
associ
increas
phagocyt
activ
inde
msc
induc
increas
intracellular
calcium
concentr
lead
enhanc
phagocytosi
result
suggest
msc
affect
microglia
cell
popul
innat
immun
induc
switch
detriment
neuroprotect
phenotyp
mesenchym
stem
cell
msc
consid
new
therapeut
option
treat
autoimmun
diseas
includ
multipl
sclerosi
ms
msc
shown
potent
inhibit
peripher
murin
cell
activ
cellcel
contact
product
solubl
factor
recent
found
solubl
product
human
msc
hmsc
decreas
human
surprisingli
increas
respons
vitro
aim
dissect
mechan
human
msc
reciproc
regul
respons
focus
molecul
known
increas
respons
produc
msc
hmsc
purifi
normal
human
bone
marrow
expand
vitro
valid
phenotyp
differenti
capac
parallel
condit
msc
preactiv
proinflammatori
cytokin
msccondit
supernat
collect
introduc
human
differenti
assay
use
normal
subject
peripher
blood
mononuclear
cell
pbmc
blockad
found
polar
pbmc
mixtur
ifng
cell
express
cytokin
refer
msccondit
supernat
decreas
frequenc
cell
ifng
increas
frequenc
cell
secret
p
without
affect
subset
pretreat
msc
caus
greater
increas
decreas
found
msc
secret
larg
amount
ngml
se
pretreat
msc
secret
compar
untreat
msc
p
b
moreov
exogen
caus
reciproc
regul
respons
consist
observ
msc
effect
data
implic
secret
hmsc
mechan
enhanc
propos
inhibit
minim
potenti
harm
effect
enhanc
hmsc
therapi
mesenchym
stem
cell
msc
repres
promis
therapeut
approach
autoimmun
degen
diseas
central
nervou
system
cn
coupl
immunesuppress
properti
multidifferenti
potenti
previou
studi
shown
prevent
treatment
bone
marrowderiv
msc
bmmsc
reduc
diseas
sever
experiment
autoimmun
encephalomyel
eae
anim
model
multipl
sclerosi
well
famili
model
amyotroph
later
sclerosi
fal
studi
show
intraven
administr
adiposederiv
msc
asc
eae
anim
chronic
establish
diseas
significantli
amelior
diseas
cours
reduc
demyelin
axon
loss
also
induc
cytokin
shift
antigenspecif
cell
subset
asc
express
activ
integrin
adher
inflam
brain
venul
intravit
microscopi
experi
bioluminesc
imag
confirm
integrin
mediat
asc
accumul
inflam
cn
penetr
asc
induc
signific
increas
number
endogen
oligodendrocyt
progenitor
mechan
respons
effect
found
asc
cultur
produc
number
neural
growth
factor
vegf
igfi
bfgf
bdnf
pdgfab
involv
prolifer
oligodendrocyt
precursor
asc
conclus
show
asc
display
clear
therapeut
effect
anim
establish
diseas
bimod
mechan
suppress
autoimmun
respons
well
induc
local
neuroregener
activ
endogen
progenitor
also
evalu
effect
administr
asc
fal
preliminari
result
show
anim
inject
asc
diseas
onset
signific
higher
behavior
perform
compar
control
almost
week
asc
penetr
surviv
spinal
cord
month
sinc
observ
express
neural
glial
marker
specul
neuroprotect
role
asc
may
mediat
releas
neural
trophic
factor
like
vegf
igfi
bdnf
convinc
result
obtain
eae
encourag
data
fal
indic
asc
may
repres
valuabl
therapeut
approach
autoimmun
also
neurodegen
disord
cn
could
consid
elect
strategi
futur
clinic
trial
human
patient
affect
wide
rang
neurolog
disord
investig
vitro
prostaglandin
product
differ
cell
cultur
estim
inhibitori
effect
myelinstimul
tcell
prolifer
follow
cocultiv
autologousallogen
bmsc
peripher
blood
mononuclear
cell
pbmc
ms
patient
bmsc
ms
patient
well
phenotyp
character
confirm
pluripot
pbmc
ms
patient
stimul
pha
myelin
antigen
recombin
myelin
oligodendrocyt
glycoprotein
mog
synthet
peptid
presenc
msc
ad
supernat
confluent
msc
cultur
cocultur
mitogenantigensstimul
pbmc
presenc
msc
detect
cfda
se
label
cell
prolifer
flow
cytometri
use
quantit
cell
cultur
supernat
elisa
kit
parametertm
use
result
find
signific
differ
spontan
product
pbmc
ms
patient
follow
pbmc
stimul
pha
myelin
antigen
addit
supernat
confluent
msc
cultur
presenc
autolog
well
allogen
msc
pbmc
result
increas
product
cocultur
irrespect
antigen
cultiv
condit
p
time
show
msc
ms
patient
well
supernat
cocultur
msc
pbmc
significantli
reduc
myelinstimul
tcell
prolifer
vitro
inhibit
vari
highli
correl
concentr
cell
supernat
r
p
b
constitut
produc
msc
requir
paracrin
signal
lymphocyt
antigen
stimul
affect
product
follow
cocultiv
msc
pbmc
presenc
msc
cell
cultur
lead
signific
increas
simultan
express
suppress
myelinstimul
cell
prolifer
ms
patient
understand
mechan
mscmediat
antiprolif
effect
crucial
use
msc
research
ms
treatment
neuromyel
optica
nmo
also
known
devic
syndrom
immunemedi
neurolog
diseas
involv
spinal
cord
optic
nerv
serum
immunoglobulin
g
autoantibodi
nmo
igg
shown
specif
marker
nmo
water
channel
aquaporin
identifi
target
nmo
igg
measur
autoantibodi
ab
aid
diagnosi
neuromyel
optica
spectrum
disord
nmosd
describ
new
elisa
depend
act
dival
form
bridg
immobil
coat
elisa
plate
well
liquidphas
assay
serum
sampl
togeth
incub
elisa
plate
well
wash
step
bound
quantit
addit
streptavidin
peroxidas
follow
substrat
tetramethylbenzidin
higher
concentr
test
serum
greater
amount
bound
result
increas
thu
provid
quantit
elisa
concentr
patient
sera
express
arbitrari
unitsml
use
calibr
curv
cut
posit
unitsml
healthi
blood
donor
sera
test
neg
elisa
detect
nmo
sera
posit
immunofluoresc
nmosd
sera
neg
rang
unitsml
unitsml
posit
sampl
mean
unitsml
median
unit
ml
furthermor
none
multipl
sclerosi
patient
patient
variou
control
autoimmun
diseas
seroposit
one
sampl
patient
grave
diseas
trab
posit
posit
elisa
unitsml
elisa
interassay
coeffici
variat
n
unitsml
respect
overal
conveni
elisa
show
compar
better
perform
gold
standard
immunofluoresec
test
also
good
precis
easi
handl
characterist
suitabl
routin
laboratori
use
worldwid
subset
patient
multipl
sclerosi
develop
pathogen
autoantibodi
respons
neurofascin
elliott
christina
arthur
ariel
derfuss
tobia
brennan
kathryn
meinl
edgar
olsson
thoma
jariu
sven
barnett
sue
linington
christoph
univers
glasgow
glasgow
unit
kingdom
maxplank
institut
neurobiolog
munich
germani
karolinska
institut
stockholm
sweden
univers
heidelberg
heidelberg
germani
antibodi
long
implic
pathogenesi
multipl
sclerosi
ms
howev
specif
target
remain
illdefin
highli
controversi
order
investig
pathogen
potenti
autoantibodi
present
patient
ms
develop
vitro
screen
strategi
use
myelin
cultur
system
deriv
rat
embryon
spinal
cord
quantifi
antibodi
mediat
effect
axon
myelin
plasma
sampl
taken
cohort
patient
either
ms
n
peripher
neuropathi
n
healthi
control
n
total
immunoglobulin
g
igg
fraction
purifi
patient
sampl
via
protein
g
affin
chromatographi
ad
highli
myelin
cultur
fresh
sera
sourc
complement
reveal
major
patient
ms
demyelin
autoantibodi
respons
within
total
igg
fraction
contrast
demyelin
activ
observ
use
igg
prepar
patient
peripher
neuropathi
healthi
control
group
potenti
specif
autoantibodi
may
axogli
protein
neurofascin
nfasc
test
purifi
nfasc
specif
immunoglobulin
immunoaffin
chromatographi
ms
peripher
neuropathi
control
group
presenc
complement
nfascspecif
autoantibodi
prepar
obtain
ms
patient
found
mediat
rapid
select
destruct
myelin
vitro
addit
half
ms
sampl
also
mediat
signific
loss
axon
axopath
respons
uniqu
ms
sampl
demyelin
observ
two
ten
peripher
neuropathi
control
sampl
investig
whether
deplet
plasma
nfasc
specif
antibodi
repertoir
would
diminish
observ
pathogen
activ
purifi
igg
flow
nfasc
antibodi
purif
reveal
one
ms
case
nfasc
domin
autoantigen
remov
nfasc
specif
compon
abolish
pathogen
activ
use
model
system
abl
formal
demonstr
ms
associ
pathogen
autoantibodi
respons
nfasc
mediat
axon
injuri
andor
disrupt
myelin
indic
respons
may
play
signific
role
drive
lesion
format
vivo
acetylcholin
receptor
musk
antibodi
mother
babi
arthrogryposi
jacobson
lesli
leit
maria
isabel
vincent
angela
univers
oxford
oxford
unit
kingdom
myasthenia
gravi
mg
associ
antibodi
acetylcholin
receptor
achr
muscl
specif
kinas
musk
local
neuromuscular
junction
nmj
achr
exist
two
form
fetal
life
fetalspecif
gamma
subunit
replac
adultspecif
epsilon
subunit
arthrogryposi
multiplex
congenit
amc
defin
multipl
fix
joint
usual
result
lack
movement
utero
caus
mani
differ
known
unknown
genet
environment
factor
high
level
matern
antibodi
fetal
achr
identifi
rare
case
amc
vincent
et
al
often
recur
success
pregnanc
alway
associ
matern
evid
mg
recent
establish
sensit
cellbas
assay
antibodi
achr
musk
use
human
embryon
kidney
cell
transfect
plasmid
encod
achr
subunit
musk
leit
et
al
use
improv
assay
look
antibodi
bind
specif
extracellular
epitop
fetal
adult
achr
musk
studi
total
sera
six
matern
sera
known
achr
posit
seven
achr
antibodymusk
antibodi
neg
mother
amc
babi
previous
studi
dalton
et
al
seven
mother
matern
antibodi
suspect
human
embryon
kidney
cell
transfect
cdna
either
fetal
adult
achr
cluster
protein
rapsyn
musk
matern
serum
test
dilut
bind
igg
detect
secondari
antibodi
conjug
alexa
fluor
red
five
seven
new
case
found
achr
antibodi
posit
routin
test
neg
musk
antibodi
routin
test
eleven
achr
antibodi
posit
matern
sera
bound
achr
cellbas
assay
case
show
greater
reactiv
fetal
adult
achr
one
mother
evid
muscl
weak
two
minim
sign
nine
without
achr
antibodi
one
posit
musk
antibodi
use
cellbas
assay
clinic
data
describ
result
confirm
matern
antibodi
achr
rare
potenti
import
caus
amc
sensit
assay
potenti
fetalpathogen
antibodi
help
identifi
mother
risk
gener
uniqu
bival
monoclon
recombin
ab
rab
coexpress
pair
heavyand
lightchain
v
region
sequenc
amplifi
ms
csf
plasma
cell
singl
cell
pcr
human
tissu
cultur
cell
studi
rab
assay
bind
glia
oligodendrocyt
includ
astrocytoma
cell
line
fetal
astrocyt
differenti
rat
oligodendrocyt
identifi
subset
ms
rab
demonstr
punctat
stain
human
astrocyt
cell
although
deriv
human
astrocytoma
cell
express
gfap
instead
express
proteolipid
protein
cnpase
marker
characterist
oligodendrocyt
lineag
explor
bind
oligodendrocyt
ab
use
stain
differenti
rat
cell
conjunct
stagespecif
marker
mbp
approxim
rab
identifi
display
clear
vesicular
stain
rat
cell
immunoposit
rab
stain
pronounc
mbpposit
cell
none
reactiv
ms
csf
rab
recogn
protein
denatur
condit
identifi
subset
ms
csf
rab
bind
antigen
express
fetal
astrocyt
oligodendroglia
base
absenc
stain
protein
glial
cell
lysat
epitop
like
conform
natur
epitop
may
also
locat
within
lipid
raft
base
pattern
stain
sensit
deterg
studi
show
bind
ms
csf
rab
heteromer
myelin
lipid
complex
contain
sulfatid
galactocerebrosid
see
poster
present
kathryn
brennan
et
al
molecular
ident
antigen
associ
diseas
preval
pathogenesi
pursu
antibodi
voltageg
potassium
channelassoci
complex
antigen
target
central
peripher
nervou
system
immunotherapyrespons
diseas
irani
sarosh
r
water
patrick
pettingil
philippa
zuliani
luigi
buckley
camilla
lang
bethan
vincent
angela
patient
sera
immunoprecipit
vgkc
digitonin
extract
rabbit
brain
tissu
defin
voltageg
potassium
channel
antibodi
vgkcab
vgkcab
associ
peripher
nerv
diseas
neuromyotonia
nmt
central
nervou
system
diseas
limbic
enceph
le
morvan
syndrom
mo
involv
peripher
central
nervou
system
immunotherapyrespons
condit
adendrotoxin
bind
three
vgkc
aim
determin
bound
vgkcab
posit
serum
initi
extract
hek
cell
digitonin
label
extract
howev
three
sera
precipit
signific
level
suggest
patient
sera
bind
directli
instead
protein
complex
digitoninsolubilis
rabbit
brain
extract
inde
small
amount
harsher
deterg
sd
ad
rabbit
brain
digitonin
extract
antigen
target
patient
sera
could
dissoci
pb
sd
test
immunoprecipit
brain
tissu
digitonin
extract
use
commerci
antibodi
protein
report
complex
vgkc
antibodi
precipit
around
respect
therefor
express
hek
cell
incub
patient
sera
unpermeabilis
cell
sera
bound
surfac
cell
respect
sera
also
bound
surfac
live
rat
hippocamp
neuron
final
found
present
mo
nmt
le
case
strike
contrast
detect
le
mo
none
nmt
case
find
defin
new
target
immunemedi
neurolog
syndrom
suggest
molecular
basi
heterogen
clinic
syndrom
ngamli
fewou
simon
rupp
angelika
franc
nickolay
lauren
emma
carrick
kathryn
willison
hugh
j
syndrom
gb
prototyp
postinfecti
disord
peripher
nervou
system
gb
often
associ
pathogen
antigangliosid
antibodi
agab
target
specif
peripher
nerv
compart
node
ranvier
neuromuscular
junction
nmj
site
enrich
sever
gangliosid
speci
distal
motor
nerv
especi
vulner
lack
function
blood
nerv
barrier
despit
strong
experiment
evid
littl
clinic
data
support
vulner
nmj
gb
sever
injuri
determin
concentr
membranebound
agab
therefor
hypothes
antibodi
intern
presynapt
nmj
plasma
membran
rel
desensitis
compart
compar
other
complementmedi
attack
studi
use
mous
monoclon
agab
differenti
cell
mous
triangular
sterni
ts
vitro
nerv
muscl
prepar
test
hypothesi
preincub
agab
cell
follow
exposur
normal
human
serum
nh
complement
sourc
drastic
reduc
cytotox
effect
mediat
complement
ts
prepar
plasma
membran
gangliosid
immunoreact
significantli
reduc
follow
agab
incub
compar
likewis
immunohistolog
analysi
show
signific
reduct
deposit
nmj
ts
prepar
incub
agab
exposur
nh
similarli
number
injur
junction
reduc
mous
sternomastoid
muscl
label
vivo
agab
expos
nh
studi
use
cell
show
intern
agab
partial
recycl
back
cell
surfac
partial
degrad
lysosom
result
demonstr
intern
agab
attenu
nmj
injuri
murin
experiment
model
gb
myasthenia
gravi
mg
bcell
mediat
diseas
bcell
activ
factor
baff
play
essenti
role
bcell
homeostasi
overexpress
baff
protect
bcell
apoptosi
therebi
contribut
autoimmun
patient
mg
higher
level
baff
circul
compar
healthi
subject
baffr
taci
transmembran
activ
cyclophilin
ligand
interactor
two
cellsurfac
receptor
bind
baff
ligand
bcell
baffr
main
receptor
mediat
baff
signal
activ
bcell
downregul
baffr
upregul
taci
express
postul
ratio
baffr
taci
might
alter
patient
mg
aim
determin
frequenc
bcell
express
baffr
taci
determin
intens
express
receptor
bcell
surfac
mg
patient
n
compar
healthi
control
subject
n
cellsurfac
express
baffr
taci
determin
immunofluoresc
stain
peripher
blood
mononuclear
cell
flow
cytometri
analysi
determin
frequenc
bcell
express
baffr
taci
mean
fluoresc
intens
mfi
express
frequenc
bcell
express
baffr
control
mg
patient
mfi
baffr
express
control
mg
patient
frequenc
bcell
express
taci
control
mg
patient
mfi
taci
express
control
mg
patient
baffr
taci
mfi
ratio
control
mg
patient
data
show
major
circul
human
bcell
express
cellsurfac
baffr
differ
healthi
subject
mg
patient
frequenc
bcell
express
baffr
mg
patient
high
frequenc
bcell
express
taci
data
also
show
patient
mg
intens
baffr
express
lower
intens
taci
express
higher
healthi
subject
frequenc
intens
analys
show
lower
ratio
baffr
taci
mg
patient
data
suggest
higher
frequenc
activ
bcell
patient
mg
studi
support
muscular
dystrophi
associ
mda
hertzenberg
deetj
betz
martina
lehmannhorn
klau
zamvil
scott
laliv
patric
hemmer
bernhard
weber
martin
technisch
universitaet
muenchen
munich
germani
univers
california
san
francisco
san
francisco
unit
state
univers
geneva
geneva
switzerland
b
cell
may
dual
role
pathogenesi
multipl
sclerosi
ms
serv
sourc
antibodysecret
plasma
cell
well
act
antigen
present
cell
apc
activ
selfreact
tcell
base
assumpt
b
cell
deplet
gain
substanti
interest
potenti
therapi
evid
suggest
howev
certain
b
cell
subset
regulatori
properti
centralnervoussystem
cn
autoimmun
investig
whether
glatiram
acet
may
specif
modul
proinflammatori
b
cell
function
experiment
autoimmun
encephalomyel
eae
first
mice
inject
subcutan
ga
pb
day
follow
immun
mog
b
cell
isol
secondari
lymphoid
organ
prior
day
immun
immun
gatreat
mice
b
cell
express
lower
level
activ
marker
wherea
express
costimulatori
molecul
reduc
express
enhanc
surfac
level
mhc
ii
remain
unchang
vivo
gatreat
b
cell
secret
less
proinflammatori
tnf
antiinflammatori
use
apc
b
cell
isol
gatreat
mice
reveal
decreas
capabl
promot
differenti
naiv
mog
specif
tcell
encephalitogen
cell
second
mice
inject
b
celldeplet
murin
isotyp
prior
mog
immun
upon
diseas
onset
mice
treat
daili
ga
independ
pretreat
isotyp
ga
treatment
amelior
eae
sever
associ
develop
regulatori
type
ii
monocyt
secret
less
tnf
gatreat
reduc
abil
b
cell
promot
develop
cell
immun
modul
b
cell
apc
function
may
valuabl
approach
select
target
proinflammatori
b
cell
properti
without
abrog
b
cell
regul
b
despit
immunomodulatori
effect
b
cell
clinic
benefit
mediat
ga
reli
presenc
b
cell
find
suggest
combin
ga
may
promis
therapeut
strategi
may
also
enhanc
sustain
clinic
benefit
cessat
therapeut
b
cell
deplet
although
studi
focus
attent
parenchym
lesion
plaqu
sever
evid
impli
primari
role
extraparenchym
structur
mening
central
damag
central
issu
relat
role
recent
describ
mening
b
cell
aggreg
ms
cn
whether
relat
b
cell
infiltr
found
site
parenchym
lesion
ms
brain
address
question
character
b
cell
repertoir
deriv
mening
aggreg
correspond
parenchym
lesion
three
ms
brain
sequenc
variabl
region
b
cell
receptor
heavi
chain
bcr
vh
region
two
ms
brain
expand
antigenexperienc
b
cell
deriv
mening
aggreg
present
plaqu
well
extend
analysi
b
cell
repertoir
deriv
differ
area
addit
eleven
ms
brain
includ
mening
plaqu
nawm
csf
major
b
cell
clone
exclus
locat
howev
sever
antigen
experienc
clone
share
among
differ
anatom
area
detect
studi
highlight
direct
contribut
extraparenchym
site
mening
aggreg
parenchym
infiltr
moreov
defin
extens
network
antigen
experienc
b
cell
popul
within
ms
cn
area
character
molecular
pattern
involv
migrat
specif
b
cell
subpopul
among
differ
site
inflamm
might
provid
crucial
insight
patholog
mechan
diseas
circul
immun
complex
patient
treat
multipl
sclerosi
iuliano
gerardo
cinquanta
luigi
napoletano
rosa
ferruzzi
annamaria
circul
immun
complex
cic
patient
multipl
sclarosi
ms
studi
interest
uncertain
result
preval
acut
progress
remiss
stabl
ms
calcul
respect
howev
literatur
data
season
studi
immunomodul
treatment
contrast
steroid
cyclophosphamid
paper
frequenc
cic
elev
assess
ms
patient
differ
therapi
cohort
ms
treat
patient
test
yearli
autoantibodi
test
complement
cic
cic
assay
nephelometri
normal
cutoff
mcgml
collect
data
includ
ms
male
femal
age
onset
year
mean
relapsingremit
diseas
secondari
progress
phase
treatment
intramuscular
interferon
ifn
week
subcutan
full
dose
ifn
copolim
cop
mitoxantron
mix
azathioprin
aza
ifn
aza
associ
therapi
calcul
also
personyear
data
crude
total
personyear
main
outcom
frequenc
cic
patient
group
sex
ms
clinic
paramet
relaps
edss
score
mri
featur
therapi
preval
incid
calcul
crosstabul
odd
ratio
chisquar
use
test
frequenc
preval
calcul
presenc
one
posit
three
year
follow
overal
slightli
higher
patient
cop
low
dose
ifn
slightli
lower
full
dose
ifn
significantli
lower
immunosuppress
mix
incid
calcul
positiv
test
second
year
overal
slightli
higher
femal
patient
cop
patient
mix
incid
yearperson
method
enhanc
statist
though
immnunosuppress
mix
aza
combin
ifnaza
show
significantli
lower
risk
high
preval
cic
confirm
impress
humor
immun
play
key
role
ms
differ
among
therapi
could
interpret
relat
specif
pharmacodynam
immunosuppress
mythoxantron
fake
antigen
copolym
differ
decreas
differ
dose
interferon
myasthenia
gravi
mg
heterogen
antireceptor
autoimmun
diseas
character
autoantibodi
ab
nicotin
acetylcholin
receptor
achr
neuromuscular
junction
patient
achr
ab
posit
ap
ab
musclespecif
kinas
musk
musk
posit
mp
antiachr
neg
patient
seroneg
sn
autoantibodi
relat
mechan
lead
impair
neuromuscular
transmiss
muscl
weak
differ
subgroup
diseas
differenti
cytokin
express
mg
compar
rheumatoid
arthriti
ra
patient
healthi
control
con
studi
cell
magnet
isol
mac
peripher
blood
mg
median
age
year
women
ap
mp
neg
ab
sn
ra
year
patient
con
year
mg
patient
corticosteroid
express
b
ifng
cell
determin
use
semiquantit
rtpcr
sybr
green
express
level
evalu
gapdh
gene
compar
dd
ct
analyz
nonparametr
test
gene
express
cell
lower
mg
p
ra
p
con
find
also
held
true
patient
without
corticosteroid
treatment
p
p
respect
subgroup
mg
ap
mp
sn
lower
gene
express
con
p
p
p
respect
differ
hand
mg
patient
rel
higher
level
gene
express
ra
group
p
b
cell
cytokin
gene
express
differ
group
rel
lower
express
cell
without
differ
ifng
make
differenti
effect
cell
regul
ab
product
unlik
mg
subgroup
studi
support
tubitak
epilepsi
autoimmun
diseas
brenner
tanja
investig
whether
potenti
pathogen
autoantibodi
present
certain
form
epilepsi
sera
collect
newlydiagnos
epilepsi
patient
taken
start
clinic
treatment
trial
n
cohort
consecut
epilepsi
patient
attend
specialist
clinic
n
sera
screen
antibodi
voltageg
potassium
channel
vgkc
voltageg
calcium
channel
vgcc
glutam
acid
decarboxylas
gad
nmethyldaspart
receptor
nmdar
glycin
receptor
glyr
compar
sera
healthi
diseas
control
n
increas
vgkc
antibodi
titr
found
newlydiagnos
patient
compar
consecut
patient
group
control
vgcc
antibodi
detect
either
cohort
wherea
high
titr
gad
antibodi
uml
found
patient
group
interestingli
proport
patient
nmdar
antibodi
markedli
higher
newli
diagnos
patient
compar
consecut
patient
respons
newlydiagnos
epilepsi
patient
without
antibodi
treatment
antiepilept
drug
a
compar
result
show
tendenc
antibodyposit
patient
less
well
a
treatment
seroneg
patient
howev
due
low
number
patient
result
reach
signific
chisquar
p
result
suggest
immunemedi
compon
form
epilepsi
although
studi
requir
establish
whether
antibodi
directli
pathogen
mere
marker
secondari
immun
respons
character
bcell
phenotyp
ectop
folliclelik
structur
multipl
sclerosi
brain
magliozzi
roberta
serafini
barbara
rosicarelli
barbara
reynold
rychard
aloisi
francesca
istituto
superior
di
rome
itali
imperi
colleg
london
unit
kingdom
bcell
folliclelik
structur
detect
postmortem
cerebr
mening
approxim
examin
patient
secondari
progress
multipl
sclerosi
spm
presenc
associ
extens
cortic
damag
sever
diseas
clinic
cours
although
structur
show
featur
germin
center
gc
follicular
dendrit
cell
prolifer
bcell
plasma
cell
express
activationinduc
cytidin
deaminas
role
support
true
gc
reaction
still
unclear
furthermor
find
ectop
lymphoid
structur
compris
high
frequenc
b
cell
infect
epsteinbarr
viru
ebv
rais
suspicion
format
might
result
abil
viru
induc
bcell
prolifer
matur
latenc
protein
independ
antigen
tcell
help
studi
select
brain
tissu
block
spm
case
contain
mening
bcell
folliclelik
structur
analyz
express
use
immunohistochem
techniqu
first
appear
prob
cell
lymphocyt
differenti
lost
matur
b
cell
reappear
cell
surfac
antigendepend
gc
matur
found
abundantli
express
lymph
node
gc
detect
express
cell
bcell
folliclelik
structur
ms
cerebr
mening
parallel
demonstr
intrafollicular
b
cell
ms
brain
express
memori
marker
despit
express
gc
featur
ectop
bcell
folliclelik
structur
develop
ms
brain
mainli
compris
antigenexperienc
b
cell
find
suggest
mechan
respons
format
mainten
atyp
structur
might
ebvassoci
canon
antigendriven
bcell
activ
work
support
eu
neuropromis
italian
multipl
sclerosi
foundat
mog
local
surfac
myelin
sheath
therefor
access
antibodi
bind
antimog
antibodi
link
myelin
damag
ms
lesion
report
higher
serum
csf
ms
patient
rel
control
addit
antimog
antibodi
capabl
induc
demyelin
vitro
vivo
defin
genet
regul
antimog
igg
eae
start
point
dissect
caus
diseas
pathway
involv
antibodi
respons
three
differ
popul
deriv
suscept
da
resist
pvg
rat
use
daxpvg
daxpvg
daxpvg
advanc
intercross
line
ail
rat
induc
eae
genotyp
perform
use
microsatellit
marker
serum
antimog
igg
isotyp
total
igg
evalu
onset
late
stage
diseas
use
elisa
method
linkag
analysi
backcross
reveal
multipl
iggregul
loci
demonstr
polygen
control
antimog
antibodi
respons
also
observ
distinct
loci
regul
igg
level
onset
diseas
compar
late
stage
exampl
product
onset
regul
locu
chromosom
wherea
region
chromosom
determin
late
stage
respons
strike
influenc
almost
igg
isotyp
confer
locu
chromosom
pvg
allel
drive
higher
igg
level
use
ail
significantli
reduc
confid
interv
locu
mb
mb
contain
gene
includ
antigen
present
lectinlik
type
receptor
complex
congen
strain
carri
pvg
allel
locu
suscept
da
background
confirm
locu
regul
eae
b
cell
number
igg
level
igg
level
higher
congen
rat
compar
da
control
interestingli
correl
less
sever
diseas
distinct
genet
regul
product
differ
igg
isotyp
onset
late
phase
diseas
gene
chromosom
major
regul
antimog
igg
level
examin
larg
cohort
patient
includ
univers
heidelberg
diagnos
stiff
person
syndrom
sp
perm
hyperekplexia
hypex
sera
refer
routin
analysi
patient
possibl
diagnosi
perm
sp
healthi
diseas
control
use
cellbas
indirect
immunofluoresc
assay
cba
use
glyr
hek
cell
sera
dilut
csf
measur
undilut
test
result
score
accord
visual
score
describ
previous
achr
antibodi
leit
et
al
glyrab
healthi
individu
n
neurolog
diseas
n
includ
ms
mg
vgkcab
tsp
nmdaab
neg
patient
posit
serum
valu
detect
patient
diagnos
either
perm
hyperekplexia
sp
one
patient
glyr
gad
antibodi
patient
avail
sera
csf
produc
similar
score
serum
dilut
csf
undilut
five
individu
undilut
csf
posit
time
sera
neg
posit
result
also
found
sera
patient
symptom
suggest
perm
sp
syndrom
retin
brainstem
spinal
cord
disturb
patient
histori
suggest
acquir
autoimmun
disord
found
glyrab
show
variabl
often
high
intrathec
synthesi
clinic
manifest
respons
immunotherapi
compar
patient
without
glyrab
conclud
glyrab
posit
patient
perm
stiff
person
syndrom
acquir
hyperekplexia
also
condit
glyr
may
implic
glyrab
part
grow
number
predominantli
nonparaneoplast
antibodi
cn
channel
receptor
potenti
immunotherapyrespons
neurolog
disord
moment
ongo
need
earli
diagnosi
multipl
sclerosi
ms
may
accomplish
identif
msspecif
biomark
aim
studi
identifi
panel
earli
msassoci
antigen
target
suitabl
biomark
sinc
cerebrospin
fluid
csf
ms
patient
character
presenc
oligoclon
band
antibodi
suitabl
sourc
purpos
identifi
marker
earli
diseas
autoantibodi
profil
perform
phage
display
techniqu
call
serolog
antigen
select
sa
pool
csf
clinic
isol
syndrom
ci
patient
n
develop
definit
ms
earli
relaps
remit
rr
ms
n
primari
progress
pp
ms
n
patient
procedur
base
express
cdna
librari
fuse
filament
phage
protein
vi
interact
expos
protein
immunoglobulin
g
igg
antibodi
produc
two
cdna
display
librari
first
normal
cdna
librari
deriv
activ
chronic
ms
plaqu
vari
degre
demyelin
inflammatori
activ
primari
recombin
use
second
cdna
librari
use
construct
normal
brain
primari
divers
recombin
cdna
insert
librari
clone
pvi
phage
display
vector
system
result
librari
size
coloni
form
unit
cfu
cfu
respect
result
sa
procedur
character
pcr
restrict
digest
analysi
subsequ
enrich
put
antigen
target
display
phage
identifi
sequenc
analysi
led
identif
csf
candid
antigen
ci
rrm
ppm
enrich
clone
identifi
ident
although
deriv
separ
sa
procedur
two
cdna
librari
indic
specif
antibodi
respons
clone
identifi
show
also
homolog
msrelat
protein
howev
antibodi
reactiv
target
describ
far
identifi
sever
candid
marker
ms
confirm
specif
immunoreact
phage
elisa
perform
csf
serum
individu
patient
use
sa
procedur
addit
ms
patient
control
neurolog
diseas
eventu
identif
msassoci
antigen
target
may
help
earli
diagnosi
predict
futur
diseas
progress
yu
xiaoli
green
miyoko
lam
chiwah
bautista
katherin
gilden
donald
bennett
jeffrey
l
neuromyel
optica
nmo
sever
inflammatori
demyelin
diseas
predominantli
affect
optic
nerv
spinal
cord
first
cn
demyelin
diseas
antibodi
direct
autoantigen
aquaporin
play
role
pathogenesi
diseas
nmo
igg
autoantibodi
bind
extracellular
epitop
protein
previous
demonstr
recombin
antibodi
rab
gener
clonal
expand
plasma
cell
cerebrospin
fluid
csf
seroposit
nmo
patient
direct
reproduc
nmo
patholog
eae
model
goal
present
studi
identifi
epitopesmimotop
csf
nmo
rab
screen
linear
circular
phagedisplay
random
peptid
librari
eight
nmo
rab
gener
singl
patient
potenti
target
peptid
isol
phage
peptid
librari
three
five
round
pan
nmo
rab
bound
protein
acoat
microtit
plate
three
nmo
rab
select
total
high
affin
phage
linear
peptid
one
rab
identifi
circular
peptid
affin
select
peptid
defin
doserespons
inhibit
immunoassay
western
blot
demonstr
peptid
recogn
two
nmo
rab
repres
linear
epitop
sequenc
align
result
show
share
sequenc
homolog
nmo
autoantigen
extracellular
loopa
region
identifi
sever
peptid
bind
rab
gener
clonal
expand
nmo
csf
plasma
cell
peptid
homolog
protein
sequenc
extracellular
surfac
peptid
epitopesmimotop
may
potenti
use
diseas
prognosi
monitor
therapi
peripher
blood
mononuclear
cell
pbmc
isol
peripher
immunoglobulin
g
igg
b
cell
csf
cell
infect
epsteinbarr
viru
ebv
presenc
irradi
allogen
pbmc
b
cell
stimul
factor
obtain
continu
divid
b
cell
line
b
cell
immort
verifi
screen
cultur
supernat
antibodi
product
use
dot
blot
clonal
immort
b
cell
line
verifi
use
b
cell
spectratyp
procedur
screen
autoreact
bind
produc
antibodi
human
oligodendroglioma
hog
cell
line
pbmc
epitheli
alveolar
carcinoma
cell
line
analyz
flow
cytometr
analysi
obtain
immort
b
cell
line
ms
patient
b
cell
line
patient
nonor
inflammatori
neurolog
diseas
nindoind
b
cell
line
patient
clinic
isol
syndrom
ci
b
cell
line
obtain
pbmc
although
b
cell
line
isol
csf
ms
patient
nind
patient
b
cell
spectratyp
analysi
indic
immort
b
cell
line
monoclon
elimin
need
clone
hogspecif
intracellular
bind
shown
antibodi
immort
b
cell
line
gener
pbmc
ms
patient
intracellular
bind
hog
cell
pbmc
demonstr
b
cell
line
bind
examin
cell
type
found
immort
b
cell
line
intracellular
bind
hog
cell
confirm
sever
immort
b
cell
line
immunocytochemistri
b
cell
immort
prove
use
method
product
antibodi
autoreact
gener
monoclon
antibodi
demonstr
examin
detect
antibodi
bind
healthi
diseas
brain
tissu
human
rhesu
monkey
moreov
character
obtain
b
cell
line
base
divers
current
progress
sequenc
immunoglobulin
heavi
chain
gene
hashimoto
encephalopathi
steroidrespons
neurolog
disord
associ
elev
serum
thyroid
antibodi
thi
ab
concentr
previou
report
suggest
presenc
antibodi
neuron
protein
could
potenti
pathogen
assess
relev
antineuron
antibodi
investig
sera
five
acut
onset
encephalopathi
patient
elev
serum
thi
ab
identifi
etiolog
sera
thi
ab
posit
neg
patient
acut
chronic
neurolog
diseas
includ
multipl
sclerosi
thi
ab
posit
neg
healthi
individu
serv
control
sera
examin
immunohistochemistri
use
frozen
rat
brain
section
immunocytochemistri
use
cultur
rat
hippocamp
cell
radioimmunoassay
voltageg
potassium
channel
vgkc
voltageg
calcium
channel
glutam
acid
decarboxylas
antibodi
cell
base
assay
nmethyldaspart
receptor
antibodi
paraneoplast
antibodi
use
commerci
kit
strikingli
high
proport
thi
ab
posit
patient
thi
ab
posit
healthi
individu
antineuron
antibodi
oppos
thi
ab
neg
case
immunohistochemistri
fail
identifi
distinct
immunoreact
pattern
uniqu
patient
three
five
case
show
evid
antibodi
cellsurfac
antigen
could
pathogen
although
one
defin
antigen
vgkc
none
sera
examin
show
antibodi
defin
cell
surfac
paraneoplast
antigen
antibodi
found
serum
patient
may
mere
reflect
increas
suscept
antineuron
autoimmun
patient
suscept
autoimmun
thyroid
diseas
work
requir
tri
identifi
specif
neuron
target
condit
see
whether
antibodi
specif
diseas
altern
may
mere
repres
heterogen
group
encephalopathi
mediat
divers
antibodymedi
mechan
clinic
trial
bcell
deplet
antibodi
rituximab
support
critic
pathogen
role
bcell
multipl
sclerosi
ms
howev
immunopathogen
mechan
bcell
involv
current
unknown
investig
effect
bcell
deplet
central
nervou
system
cn
patholog
cellular
humor
immun
mechan
preclin
ms
model
ie
experiment
autoimmun
encephalomyel
eae
common
marmoset
use
humanantihuman
antibodi
crossreact
marmoset
eae
induc
thirteen
marmoset
immun
recombin
human
myelin
oligodendrocyt
glycoprotein
rhmog
cfa
day
seven
anim
receiv
intraven
load
dose
mgkg
antibodi
follow
weekli
intraven
dose
mgkg
antibodi
induc
profound
longlast
bcell
deplet
pbmc
lymphoid
organ
throughout
observ
period
day
wherea
placebotr
control
monkey
develop
clinic
evid
eae
overt
neurolog
deficit
substanti
reduc
three
antibodi
treat
monkey
four
antibodi
treat
monkey
remain
complet
asymptomat
bcell
deplet
reduc
inflamm
demyelin
brain
spinal
cord
optic
nerv
strikingli
none
antibodytr
anim
contain
grey
matter
lesion
contrast
five
six
control
anim
immunoglobulin
level
specif
rhmog
reduc
treat
monkey
furthermor
bcell
deplet
led
alter
distribut
monocyt
activ
tcell
ie
increas
number
monocyt
blood
increas
tcell
prolifer
blood
reduc
tcell
prolifer
il
product
lymphoid
organ
conclus
bcell
deplet
prevent
develop
clinic
patholog
sign
eae
associ
alter
locat
activ
mogreact
tcell
novel
highli
sensit
laboratori
diagnosi
myasthenia
gravi
neuromyel
optica
routin
use
tzarto
socrat
traka
nikolao
tzarto
john
stergiou
christo
zisimopoul
paraskevi
detect
autoantibodi
acetylcholin
receptor
achr
muscl
specif
kinas
musk
radioimmunoprecipit
assay
probabl
best
avail
diagnosi
myasthenia
gravi
similarli
detect
autoantibodi
variou
approach
strongli
indic
presenc
neuromyel
optica
nmo
howev
autoantibodi
detect
mg
nmo
patient
sera
probabl
due
limit
sensit
avail
techniqu
bind
produc
autoantibodi
target
autoantigen
thu
leav
autoantibodi
circul
despit
fact
radioimmunoprecipit
assay
quit
sensit
limit
deriv
fact
small
amount
test
sera
may
use
increas
serum
volum
usual
result
excess
background
radioact
overcam
problem
novel
twostep
radioimmunoprecipit
assay
allow
use
high
volum
patient
sera
background
radioact
remain
low
method
sensit
increas
compar
regular
assay
sera
previous
ambigu
titer
bound
radioact
valu
low
signific
antiachr
antimusk
antibodi
found
clearli
either
posit
neg
moreov
sera
previous
character
neg
found
posit
assay
import
treatment
patient
highli
sensit
radioimmunoassay
invalu
diagnosi
mg
nmo
patient
minut
amount
circul
autoantibodi
assay
current
routin
use
institut
pathogen
antibodi
neuromyel
optica
increas
sensit
cellbas
assay
cluster
water
patrick
vincent
angela
leit
isabel
cellbas
assay
nativ
antigen
express
surfac
transfect
cell
line
often
human
embryon
kidney
hek
cell
prove
best
approach
detect
potenti
pathogen
autoantibodi
membran
protein
neuromyel
optica
nmo
seriou
inflammatori
demyelin
diseas
central
nervou
system
cn
antibodi
predomin
water
channel
cn
implic
diseas
pathogenesi
detect
varieti
assay
water
et
al
around
clinicallydefinit
nmo
patient
previous
show
sera
myasthenia
gravi
patient
neg
bind
acetylcholin
receptor
solut
could
bind
strongli
acetylcholin
receptor
cluster
surfac
hek
cell
leit
et
al
ask
whether
cluster
would
also
increas
sensit
test
antibodi
nmo
express
two
major
isoform
form
tetram
isoform
produc
larg
orthogon
array
hundr
tetram
vivo
transfect
hek
cell
found
antibodi
detect
mani
nmo
sera
use
either
fac
analysi
bind
cluster
isoform
substanti
increas
compar
bind
mfi
v
control
sera
v
result
found
increas
number
posit
result
one
month
routin
serolog
test
seven
eight
sera
posit
cell
patient
nmospectrum
disord
one
diagnos
ademm
clinic
diagnosi
ninth
yet
avail
thu
use
transfect
cell
provid
sensit
assay
antibodi
cluster
antigen
like
help
detect
autoantibodi
specif
membran
protein
eg
nmda
receptor
antibodi
plasma
celllik
b
cell
produc
autoantibodi
neuromyel
optica
norio
chihara
toshimasa
aranami
wakiro
sato
yusei
miyazaki
sachiko
miyak
tomoko
okamoto
masafumi
ogawa
tatsushi
toda
takashi
yamamura
kobe
univers
graduat
school
medicin
kobe
japan
nation
institut
neurosci
ncnp
tokyo
japan
nation
center
hospit
ncnp
tokyo
japan
neuromyel
optica
nmo
inflammatori
diseas
primarili
affect
optic
nerv
spinal
cord
serum
autoantibodi
shown
diseasespecif
nmo
marker
increas
evid
suggest
autoantibodi
may
play
pathogen
role
nmo
sourc
autoantibodi
therapeut
target
diseas
howev
identifi
yet
proport
nmo
patient
report
autoantibodi
antinuclear
antissassb
antibodi
nmo
might
share
autoantibodi
produc
mechan
autoimmun
diseas
b
cell
lack
report
produc
autoantibodi
autoimmun
diseas
member
leucinerich
repeat
famili
molecul
highli
express
memori
b
cell
plasma
cell
purpos
studi
investig
characterist
aqpab
produc
nmo
twentyfour
patient
seroposit
healthi
subject
hs
convent
multipl
sclerosi
cm
patient
enrol
studi
patient
b
cell
subpopul
peripher
blood
enumer
flow
cytometri
purifi
cell
sorter
assess
b
cell
associ
gene
express
product
titer
supernat
purifi
b
cell
subpopul
measur
immunofluoresc
assay
use
human
transfect
effect
cytokin
surviv
activ
produc
cell
analyz
vitro
report
small
b
cell
subpopul
lack
exhibit
sever
similar
plasma
cell
significantli
increas
peripher
blood
seroposit
patient
compar
hs
cm
patient
p
b
frequenc
plasma
celllik
b
cell
pcb
remark
increas
relaps
nmo
patient
notabl
pcb
spontan
produc
wherea
b
cell
subpopul
also
found
interleukin
proinflammatori
cytokin
increas
nmo
patient
enhanc
surviv
pcb
secret
result
provid
novel
therapeut
strategi
nmo
specif
target
pcb
voltageg
potassium
channel
antibodi
vgkcab
associ
limbic
enceph
le
immunerespons
larg
nonparaneoplast
diseas
case
malign
tumour
usual
thymoma
lung
cancer
describ
case
vgkcabl
associ
thymic
hyperplasia
woman
present
subacut
histori
shortterm
memori
loss
tempor
lobe
seizur
psychot
featur
brain
mri
show
bilater
mediotempor
lobe
hyperintens
screen
occult
tumour
includ
metabol
total
bodi
pet
scan
onconeur
ab
prove
neg
vgkcab
highli
rais
pm
treatment
high
dose
steroid
follow
monthli
plasmaexchang
associ
oral
immunosuppress
result
mark
improv
nine
month
onset
vgkcab
titr
declin
pm
sampl
obtain
month
onset
surprisingli
reveal
increas
antibodi
titr
pm
even
though
patient
remain
clinic
remiss
screen
reveal
enlarg
thymu
patient
underw
thymectomi
patholog
reveal
thymic
hyperplasia
bcellcontain
germin
centr
vgkcle
associ
thymoma
also
hyperplast
thymu
similarli
wellknown
find
myasthenia
gravi
persist
high
vgkcab
titr
prompt
search
enlarg
thymu
thymectomi
consid
prevent
possibl
malign
evolut
case
collect
patholog
studi
possibl
reveal
role
thymu
vgkcab
product
reactiv
human
antigen
antibodi
produc
multipl
sclerosi
plaqu
burgoon
mark
p
anderson
sarah
w
miller
breanna
yu
xiaoli
bennett
jeffrey
l
gilden
owen
gregori
p
antigen
target
intrathec
b
cell
respons
patient
multipl
sclerosi
ms
unknown
examin
respons
potenti
role
b
cell
pathogenesi
ms
character
reactiv
individu
clonal
expand
antibodi
express
demyelin
lesion
ms
brain
laser
captur
microdissect
use
isol
singl
plasma
cell
demyelin
lesion
postmortem
relapsingremit
ms
brain
heavi
light
chain
igg
express
plasma
cell
identifi
rtpcr
sequenc
analysi
reveal
restrict
express
clonal
expand
clone
exhibit
somat
mutat
germlin
molecular
featur
antigendriven
respons
four
expand
clone
subclon
mammalian
express
vector
produc
bival
function
igg
analyz
specif
immunoassay
sever
recombin
antibodi
rab
immunostain
one
human
cell
line
deriv
astrocyt
oligodendrocyt
neuron
fibroblast
b
cell
embryon
kidney
cell
one
rab
nonspecif
stain
cell
line
sever
other
specif
stain
distinct
cell
line
cn
noncn
origin
compar
breadth
respons
specif
antibodi
inflammatori
cn
diseas
known
caus
also
perform
ident
immunoassay
rab
produc
brain
patient
subacut
scleros
panenceph
sspe
three
sspe
rab
examin
stain
human
cell
line
deriv
astrocyt
oligodendrocyt
fibroblast
two
three
sspe
rab
also
recogn
measl
viru
caus
agent
sspe
result
reveal
subset
intrathec
synthes
antibodi
ms
plaqu
well
sspe
brain
react
autoantigen
cn
univers
queensland
brisban
australia
previous
describ
atyp
form
experiment
autoimmun
encephalomyel
eae
activ
induc
mice
inject
myelin
proteolipid
protein
plp
peptid
adjuv
result
develop
lesion
restrict
predominantli
brainstem
cerebellum
mice
subsequ
use
cell
passiv
induc
eae
surpris
mice
consist
develop
lesion
brainstem
never
develop
lesion
cerebellum
sinc
mice
activ
induc
eae
produc
cell
antibodi
investig
role
antibodi
develop
cerebellar
lesion
model
eae
induc
passiv
transfer
cell
immunoaffinitypurifi
specif
antibodi
irrelev
antibodi
control
within
day
onset
neurolog
sign
mice
perfus
one
micron
section
cut
everi
brainstem
cerebellum
stain
cresyl
violet
assess
lesion
whole
crosssect
photograph
percentag
area
cerebellum
cover
lesion
determin
use
nih
imag
softwar
assess
role
complement
eae
activ
induc
mice
treat
daili
inject
cobra
venom
factor
cvf
inhibit
complement
mice
develop
eae
assess
cvf
short
halflif
serum
therefor
mice
cvf
treatment
stop
eae
onset
day
later
mice
assess
lesion
cerebellum
mice
passiv
transfer
eae
induc
cell
alon
n
develop
eae
lesion
brainstem
cerebellum
contrast
mice
receiv
cell
antibodi
develop
lesion
cerebellum
activ
immun
mice
receiv
cvf
develop
lesion
cerebellum
howev
day
stop
cvf
treatment
lesion
could
observ
cerebellum
find
strongli
suggest
plpspecif
antibodi
play
role
determin
locat
lesion
anim
model
ms
antibodi
effect
complementmedi
suggest
retarget
lesion
distribut
antibodi
could
potenti
clinic
import
previous
unappreci
element
antibodi
action
ms
requir
investig
signal
kainat
receptor
enhanc
murin
b
cell
prolifer
ig
product
chaimowitz
natalia
daniel
conrad
abund
evid
indic
interplay
immun
nervou
system
alter
plasma
glutam
level
exampl
strongli
correl
immunodefici
state
aid
malign
suggest
glutam
capabl
act
immunomodul
glutam
receptor
signal
examin
immun
cell
eg
cell
effect
glutamaterg
stimuli
b
lymphocyt
remain
unknown
determin
glutam
capabl
modul
b
cell
function
first
examin
mous
b
cell
glutam
receptor
express
furthermor
mous
splenocyt
cultur
glutamateenrich
media
prolifer
antibodi
product
determin
fac
analysi
show
splenic
b
cell
express
receptor
subunit
compris
kainat
receptor
kar
specif
subtyp
ionotrop
glutam
receptor
kar
surfac
express
found
upregul
upon
b
cell
stimul
moreov
splenocyt
b
cell
stimul
ligand
glutam
enrich
media
signific
increas
cellular
prolifer
antibodi
ige
product
kar
specif
antagonist
use
confirm
effect
mediat
kar
data
also
suggest
requir
prolif
enhanc
activ
glutam
result
suggest
glutam
capabl
enhanc
b
cell
function
previou
studi
aim
highthroughput
profil
autoantibodi
present
within
multipl
sclerosi
ms
cerebrospin
fluid
csf
identifi
novel
ms
csf
autoantibodi
target
sperm
associ
antigen
isoform
tissu
express
protein
function
diseasecontribut
role
unknown
investig
candid
ms
autoantigen
warrant
studi
aim
character
novel
candid
ms
autoantigen
analyz
presenc
biomark
potenti
antibodi
ms
serum
recombin
protein
elisa
use
immunoreact
screen
sera
ms
patient
n
control
healthi
control
n
inflammatori
noninflammatori
neurolog
diseas
n
elev
serum
antibodi
detect
significantli
larger
proport
ms
patient
compar
control
p
specif
level
control
elev
antibodi
level
demonstr
ms
patient
give
rise
sensit
addit
investig
biolog
relev
ms
tissu
express
antigen
ms
control
brain
analyz
immunohistochem
approach
demonstr
increas
express
center
ms
brain
lesion
n
detect
stain
seen
within
normal
appear
white
matter
ms
control
brain
tissu
n
moreov
passiv
antibodytransf
experi
monoclon
antibodi
mogpeptid
induc
experiment
autoimmun
encephalomyel
eae
anim
model
ms
indic
diseaseexacerb
effect
antibodi
mice
receiv
antibodi
n
higher
diseas
burden
indic
significantli
higher
diseas
score
compar
anim
inject
isotyp
control
antibodi
n
p
b
spinal
cord
mice
inject
antibodi
character
increas
macrophag
infiltr
without
obviou
effect
demyelin
current
investig
antibodi
exert
pathogen
effect
conclus
find
studi
indic
isoform
constitut
novel
candid
ms
autoantigen
futur
experi
aim
elucid
function
protein
role
autoantibodi
reactiv
ms
brenner
tanja
suleiman
jehan
gill
deepak
brilot
fabienn
antoni
jayn
dale
russel
c
previou
studi
adult
patient
epilepsi
encephalit
disord
antibodi
report
voltageg
potassium
channel
vgkc
well
cn
target
eg
nmethyldaspart
receptor
nmdar
glutam
acid
decarboxylas
gad
vgkc
antibodi
associ
limbic
enceph
adult
vincent
et
al
childhood
case
report
test
sampl
children
statu
epilepticu
mean
age
year
rang
year
includ
enceph
aetiolog
antibodi
vgkc
nmdar
gad
routin
serolog
techniqu
result
compar
paediatr
control
includ
healthi
control
enceph
lethargica
nmdar
enceph
other
children
statu
epilepticu
se
posit
vgkc
antibodi
titr
pm
cutoff
routin
use
adult
patient
compar
healthi
diseas
control
se
patient
enceph
test
posit
vgkc
antibodiesthey
previous
normal
acut
encephalopathi
refractori
seizur
cognit
impair
limbic
enceph
patient
aetiolog
posit
vgkc
antibodi
immunotherapi
variabl
outcom
includ
complet
recoveri
cognit
impair
refractori
epilepsi
mesial
tempor
sclerosi
antibodi
nmdar
gad
detect
se
patient
high
proport
rais
vgkc
antibodi
children
statu
epilepticu
suggest
vgkcantibodi
limbic
enceph
present
paediatr
popul
adult
sometim
associ
hippocamp
sclerosi
bien
et
al
poor
recoveri
follow
central
nervou
system
cn
injuri
gener
attribut
format
glial
scar
well
infiltr
activ
immun
cell
howev
well
control
two
phenomena
actual
essenti
repair
process
aim
studi
reciproc
relationship
bloodderiv
macrophag
one
predomin
immun
popul
lesion
site
glial
scar
matrix
goal
employ
invivo
manipul
separ
target
one
process
inhibit
product
chondroitin
sulfat
proteoglycan
cspg
major
compon
glial
scar
demonstr
commonli
view
obstacl
regener
necessari
templat
dictat
antiinflammatori
natur
infiltr
monocyt
encount
therebi
promot
resolut
local
inflamm
reciproc
condit
ablat
monocytederiv
macrophag
diphtheria
toxin
show
macrophag
use
scar
educ
one
eventu
degrad
although
insuffici
complet
repair
bloodderiv
macrophag
glial
scar
matrix
compris
feedback
loop
enhanc
benefici
properti
restrict
potenti
harm
effect
therefor
refin
endogen
crosstalk
potenti
selfcontain
respons
may
open
new
therapeut
avenu
treatment
spinal
cord
injuri
cn
patholog
new
role
adenosin
receptor
chronic
neuroinflamm
van
der
putten
celin
zuiderwijksick
ella
microglia
activ
promin
featur
mani
neuroinflammatori
disord
sinc
unrestrain
activ
gener
chronic
inflammatori
environ
might
lead
neurodegener
regulatori
mechan
essenti
extracellular
adenosin
modul
cellular
activ
adenosin
receptor
adora
mediat
signal
four
adora
subtyp
describ
either
increas
receptor
decreas
receptor
intracellular
cyclic
amp
level
cellular
respons
extracellular
adenosin
thu
orchestr
express
pattern
differ
adora
subtyp
studi
investig
adoramedi
signal
modul
microgli
tlrinduc
cytokin
product
chronic
inflammatori
condit
use
primari
rhesu
monkey
microglia
character
express
profil
adora
subtyp
unstimul
tlractiv
microglia
tlrmediat
activ
microglia
result
dramat
alter
adora
express
profil
character
simultan
upregul
downregul
express
level
consequ
alter
express
profil
activ
microglia
highli
sensit
adenosinemedi
inhibit
subsequ
tlrinduc
cytokin
respons
enhanc
inhibitori
effect
could
attribut
increas
signal
demonstr
involv
suppress
nfkappab
activ
importantli
use
combin
subtypespecif
agonist
antagonist
show
unstimul
microglia
inhibitori
signal
effect
counteract
signal
activ
microglia
decreas
signal
shift
balanc
toward
signal
sensit
cell
inhibitori
signal
conclus
report
differenti
activ
statespecif
express
adora
microglia
uncov
new
role
dynam
regul
suppressor
inhibit
tlrinduc
proinflammatori
cytokin
respons
therefor
data
would
suggest
explor
combin
agonist
antagonist
dampen
microgli
activ
chronic
neuroinflammatori
condit
activ
innat
immun
respons
hallmark
activ
lesion
multipl
sclerosi
multipl
sclerosi
ms
chronic
neuroinflammatori
diseas
central
nervou
system
cn
numer
infecti
trigger
implic
ms
pathogenesi
conclus
evid
miss
show
interferonalpha
ifnalpha
innat
cytokin
produc
upon
viral
infect
overexpress
activ
area
ms
lesion
inact
ms
lesion
normal
appear
white
matter
healthi
control
brain
detect
ifnalpha
specif
express
mhcclass
ii
express
cell
eg
microglia
macrophag
within
perivascular
parenchym
area
ms
lesion
ifnalpha
present
predominantli
activ
ms
lesionsbord
suggest
local
product
part
acut
inflammatori
process
interestingli
found
ifnalpha
express
hek
cell
cultur
transfect
epsteinbarr
virusencod
small
rna
eber
highli
abund
ebv
infect
cell
also
detect
eber
preselect
activ
ms
lesion
situ
hybrid
area
ifnalpha
overexpress
neurolog
control
case
hypothes
ifnalpha
product
within
cn
might
driven
viral
rna
eber
lead
activ
innat
immun
respons
creat
antivir
state
also
ignit
neuroinflamm
multipl
sclerosi
ms
chronic
neuroinflammatori
diseas
central
nervou
system
cn
numer
infecti
trigger
implic
ms
pathogenesi
conclus
evid
miss
show
interferonalpha
ifnalpha
innat
cytokin
produc
upon
viral
infect
overexpress
activ
area
postmortem
ms
lesion
inact
ms
lesion
normal
appear
white
matter
healthi
control
brain
detect
ifnalpha
specif
express
mhcclass
ii
express
cell
eg
microglia
macrophag
within
perivascular
parenchym
area
ms
lesion
ifnalpha
present
predominantli
activ
ms
lesionsbord
suggest
local
product
part
acut
inflammatori
process
interestingli
found
ifnalpha
express
hek
cell
cultur
upon
transfect
epsteinbarr
virusencod
small
rna
eber
highli
abund
ebv
infect
cell
also
detect
eber
preselect
activ
ms
lesion
situ
hybrid
area
ifnalpha
overexpress
neurolog
control
case
hypothes
ifnalpha
product
within
cn
might
driven
viral
rna
eber
lead
activ
innat
immun
respons
creat
antivir
state
also
contribut
neuroinflamm
age
innat
immun
nondement
alzheim
diseas
brain
cribb
david
berchtold
nicol
cotman
carl
univers
california
irvin
irvin
unit
state
previou
microarray
analysi
reveal
gene
relat
immuneinflammatori
function
undergo
promin
chang
brain
cognit
normal
age
extend
find
ad
analyz
immunerel
gene
express
modul
age
ad
apo
import
ad
risk
factor
use
data
genomewid
transcriptom
studi
human
tissu
sampl
three
brain
region
affect
ad
hippocampu
entorhin
cortex
superior
frontal
gyru
one
region
rel
spare
ad
postcentr
somatosensori
gyru
obtain
autopsi
normal
control
age
year
ad
subject
year
age
four
brain
region
assess
three
vulner
declin
accumul
patholog
age
ad
hippocampu
entorhin
cortex
superior
frontal
gyru
one
region
develop
minim
patholog
postcentr
gyru
age
associ
robust
gene
respons
across
brain
region
immunerel
probeset
show
alter
express
advanc
age
predominantli
undergo
upregul
express
decad
show
gene
chang
rel
littl
chang
preced
subsequ
decad
surprisingli
transit
ad
induc
far
less
extens
chang
immunerel
gene
observ
age
probeset
apo
genotyp
strongli
affect
extent
gene
respons
cognit
normal
age
ad
associ
extens
respons
particularli
age
region
analysi
reveal
brain
region
vulner
ad
hippocampu
entorhin
cortex
superior
frontal
gyru
underw
agerel
increas
immunegen
involv
age
ad
postcentr
gyru
show
extens
agerel
chang
chang
ad
age
two
power
predictor
develop
ad
induc
profound
chang
express
gene
relat
innat
immun
extens
chang
class
gene
occur
cours
cognit
normal
age
transit
ad
data
may
provid
insight
epidemiolog
studi
consist
find
protect
effect
antiinflammatori
drug
taken
normal
age
drug
ad
patient
typic
fail
previous
describ
bloodbrain
barrier
bbb
breakdown
lead
serumprotein
leakag
hippocampu
patient
intract
tempor
lobe
epilepsi
tle
bbb
disrupt
induc
accumul
immunoglobulin
g
igg
parenchyma
surprisingli
pyramid
neuron
postul
igg
leakag
contribut
immun
activ
toxic
epileptogenesi
studi
correl
bbb
damag
serum
protein
leakag
epilept
non
epilept
tissu
epilept
e
tissu
hippocampi
tempor
cortex
obtain
surgeri
patient
suffer
intract
tle
control
ct
piec
tempor
cortex
obtain
autopsi
patient
without
histori
seizur
neurolog
diseas
die
multipl
injuri
sampl
collect
consent
patient
accord
helsinki
declar
immunohistochemistri
evalu
tight
junction
integr
express
protein
bbb
permeabl
igg
leakag
complement
activ
express
hla
protein
e
tissu
observ
bbb
disrupt
igg
diffus
parenchyma
ii
igg
accumul
pyramid
neuron
astrocyt
iii
abund
immunoreact
hla
protein
macrophagelik
cell
local
around
blood
vessel
iv
presenc
posit
perivascular
infiltr
v
mac
deposit
cell
display
microgliamacrophag
morpholog
ct
tissu
bbb
present
damag
igg
found
neuron
studi
describ
chronic
epilept
focu
differ
degre
bbb
permeabl
probabl
induc
angiogen
process
report
tle
team
rigau
et
al
ct
tissu
bbb
preserv
spite
igg
presenc
parenchyma
neuron
suggest
transient
disrupt
tight
junction
presenc
biolog
activ
fragment
indic
activ
complement
cascad
express
observ
cell
morpholog
microgliamacrophag
show
activ
termin
pathway
format
complement
membran
attack
complex
mac
toxic
neuron
xiong
et
al
futur
investig
immun
dysregul
determin
mechan
igg
uptak
particip
epileptogenesi
character
genet
regul
function
complement
activ
traumat
cn
complement
system
play
import
role
innat
immun
defenc
also
believ
activ
neurodegen
condit
recent
role
complement
synapt
strip
develop
also
suggest
studi
address
genet
influenc
local
express
complement
factor
central
nervou
system
cn
use
well
character
nerv
injuri
model
rat
potenti
effect
synapt
plastic
occur
injuri
first
tempor
profil
express
character
inbr
da
pvg
strain
show
significantli
higher
express
da
rat
contrast
express
membran
attack
complex
mac
inhibitor
similar
lower
da
strain
evid
mac
activ
neutrophil
infiltr
use
immunohistochemistri
next
assess
degre
synapt
loss
measur
synaptophysin
immunolabel
demonstr
increas
loss
termin
ventral
horn
da
rat
suggest
role
complement
activ
elimin
synaps
injuri
final
order
map
express
differ
local
express
complement
compon
whole
genom
level
microarray
studi
done
daxpvg
cohort
multipl
express
quantit
trait
loci
eqtl
identifi
reveal
specif
genet
region
regul
express
sever
import
complement
protein
includ
well
strong
genet
influenc
express
complement
receptor
data
constitut
import
find
understand
potenti
effect
complement
activ
complement
regul
traumat
cn
also
implic
interpret
role
complement
system
relat
whole
genom
scan
neurodegen
diseas
microglia
profession
phagocyt
clearanc
microb
apoptot
cell
within
central
nervou
system
cn
differ
type
microgli
phagocyt
receptor
involv
microgli
clearanc
function
like
trigger
receptor
express
myeloid
associ
adaptor
molecul
anoth
phagocyt
receptor
suggest
signal
via
complement
investig
involv
complement
complement
mediat
phagocytosi
microglia
first
protein
classic
complement
cascad
express
rna
microglia
neuron
demonstr
rtpcr
immunohistochem
analysi
reveal
bind
protein
neurit
enzymat
remov
sialic
acid
residu
glycocalyx
neuron
moreov
microglianeuron
cocultur
experi
show
neuron
display
less
sialic
acid
glycocalyx
led
remov
microglia
intact
process
remain
untouch
neuron
process
mark
phagocytoz
microglia
within
h
first
block
experi
antibodi
direct
indic
involv
mircogli
complement
process
data
illustr
neuron
structur
opson
complement
bind
asialyd
glycocalyx
recogn
remov
microglia
bridg
innat
adapt
immun
becom
increasingli
evid
dc
subset
show
specif
distinct
pattern
express
tolllik
receptor
tlr
effector
function
vari
accord
host
statu
health
diseas
recent
studi
demonstr
improp
activ
tlr
lead
local
system
autoimmun
process
addit
circumst
function
numer
impair
specif
dc
subset
associ
autoimmun
role
dc
pathogenesi
multipl
sclerosi
ms
recent
receiv
great
attent
sinc
cell
found
increas
perivascular
cuff
activ
lesion
cerebrospin
fluid
ms
patient
view
scenario
search
abnorm
dc
ms
patient
compar
healthi
subject
evaluatedth
absolut
count
major
circul
myeloid
plasmacytoid
dc
mean
ninecolour
flow
cytometri
singleplatform
assay
base
publish
clinic
guidelin
absolut
count
rare
popul
allow
measur
absolut
number
differ
dc
subset
singl
tube
avoid
sampl
process
variabl
ensur
accuraci
determin
balanc
subset
also
set
evalu
cytokin
profil
upon
stimul
differ
tlr
agonist
multiparametr
flow
cytometri
allow
us
evalu
simultan
differ
dc
subset
three
cytokin
respons
tlr
agonist
data
show
frequenc
calcul
absolut
number
per
whole
blood
plasmacytoid
dc
myeloid
dc
subset
slightli
reduc
blood
ms
patient
compar
healthi
individu
plasmacytoid
dc
obtain
ms
patient
also
show
decreas
abil
product
interferon
alpha
respons
compar
healthi
donor
conclus
result
suggest
alter
dc
function
multipl
sclerosi
overal
believ
analysi
could
help
understand
big
pictur
regard
innat
immun
respons
ms
immunopathogenesi
differenti
respons
human
microglia
blood
deriv
myeloid
cell
durafourt
bryce
lambert
carolin
johnson
trina
blain
manon
baror
amit
antel
jack
p
myeloid
cell
within
central
nervou
system
cn
compris
resid
parenchym
microglia
bloodderiv
dendrit
cell
dc
macrophag
serv
immun
regulatori
effector
function
contribut
cours
multipl
sclerosi
ms
receptor
agonist
cross
blood
brain
barrier
examin
potenti
impact
properti
myeloid
cell
use
realtim
polymeras
chain
reaction
rtpcr
observ
human
adult
fetal
cnsderiv
microglia
express
similar
pattern
receptor
express
monocytederiv
dc
macrophag
receptor
mrna
level
higher
lower
compar
monocyt
mrna
detect
macrophag
fetal
microglia
lowintermedi
transcript
level
detect
cell
type
monocyt
ms
patient
undergo
treatment
fingolimod
show
alter
rel
express
pattern
compar
untreat
healthi
donor
dc
macrophag
gener
vitro
presenc
activ
phosphoryl
form
express
similar
pattern
vehicletr
cell
despit
similar
receptor
express
observ
distinct
intracellular
signal
event
differ
cell
subtyp
follow
shortterm
vitro
exposur
treatment
macrophag
dc
led
decreas
phosphoryl
erk
concomit
induct
myosin
light
chain
mlc
ii
phosphoryl
wherea
respons
absent
microglia
contrast
induc
robust
erk
phosphoryl
human
fetal
astrocyt
abil
modul
cytokin
product
myeloid
cell
also
examin
treatment
inhibit
product
dc
macrophag
induc
microglia
level
secret
induc
poli
c
modul
level
secret
tnfalpha
remain
unaffect
treatment
cell
type
demonstr
distinct
myeloid
cell
popul
present
human
cn
steadyst
inflammatori
condit
exhibit
similar
pattern
express
distinct
signal
cytokin
modul
respons
result
suggest
may
potenti
select
bia
inflammatori
microenviron
cn
background
interleukin
il
cytokin
produc
antigen
present
cell
multipl
role
induct
well
regul
immun
respons
howev
effect
natur
killer
nk
cell
well
defin
nk
cell
particularli
subset
play
signific
role
immun
regul
might
play
protect
function
autoimmun
object
investig
possibl
effect
human
nk
cell
phenotyp
function
method
nk
cell
isol
buffi
coat
healthi
individu
use
mitenyi
bead
sort
nk
cell
cultur
differ
condit
without
addit
studi
potenti
effect
prolifer
express
surfac
marker
transcript
factor
cytokin
secret
treat
nk
cell
stimul
nk
cell
cocultur
autolog
cell
investig
regulatori
function
treat
nk
cell
addit
stimul
nk
cell
studi
induct
cytotox
function
target
cell
line
result
phenotyp
character
suggest
express
exvivo
isol
nk
cell
subset
markedli
increas
express
among
nk
cell
treatment
decreas
prolifer
nk
cell
decreas
prolifer
nk
subset
correl
increas
express
stimul
nk
cell
subset
moreov
treat
nk
suppress
autolog
cell
prolifer
contact
depend
mechan
suppress
abil
seem
depend
upon
express
perforin
among
treat
nk
cell
contrast
treatment
nk
cell
chang
cytotox
suppress
function
nk
cell
gain
immunoregulatori
function
enhanc
stimul
phagocytosi
e
coli
murin
microglia
combin
muramyl
dipeptid
one
tlr
agonist
ribe
sandra
adam
nina
ebert
sandra
nau
roland
depart
neurolog
univers
germani
depart
geriatr
evangelisch
krankenhau
parenchym
microglia
mg
express
tolllik
receptor
tlr
nodlik
nod
receptor
recogn
microbi
stimuli
mediat
respons
contribut
clearanc
infecti
agent
brain
hypothes
combin
nod
tlr
agonist
might
stimul
mg
therebi
increas
abil
phagocytos
e
coli
primari
cultur
mous
mg
expos
muramyl
dipeptid
mdp
polyinosinepolycytidyl
acid
poli
c
endotoxin
lp
oligonucleotid
contain
unmethyl
cytosinguanosin
motif
cpg
control
group
unstimul
cell
includ
experi
stimul
cell
challeng
e
coli
ratio
bacteria
per
cell
phagocytosi
left
proceed
min
phagocytosi
inhibit
studi
cytochalasin
cd
final
concentr
ad
cell
cultur
min
prior
bacteri
addit
remain
present
throughout
experi
monitor
intracellular
kill
insid
mg
cell
allow
phagocytos
bacteria
min
bacteri
exposur
mg
wash
incub
medium
contain
gentamicin
mgl
kill
extracellular
bacteria
thereaft
cell
wash
lyse
distil
water
viabl
intracellular
bacteria
enumer
quantit
plate
serial
dilut
anova
follow
bonferroni
multipl
comparison
test
perform
analys
differ
group
n
p
b
consid
statist
signific
interplay
mdp
ligand
one
tlr
agonist
enhanc
abil
mg
phagocytos
intracellularli
kill
pathogen
strain
e
coli
approach
could
improv
brain
resist
immunocompromis
patient
infect
caus
gramneg
bacteria
jiang
wenzheng
bielekova
bibiana
ms
tcell
mediat
demyelin
diseas
central
nervou
system
ms
research
focus
adapt
immun
respons
becom
clear
function
abnorm
innat
immun
system
lead
dysregul
adapt
immun
eg
activ
nk
cell
inhibit
autolog
cell
viral
infect
multipl
model
autoimmun
moreov
nk
cell
defici
report
mani
human
autoimmun
diseas
includ
ms
previou
data
laboratori
demonstr
therapeut
effect
daclizumab
human
mab
link
druginduc
expans
nk
cell
cell
kill
autolog
activ
cell
goal
current
studi
identifi
mechan
util
nk
cell
cytotox
polyclon
activ
cell
effect
kill
autolog
nk
cell
physiolog
ratio
e
ratio
modifi
flowcytometri
base
kill
assay
also
demonstr
predomin
degranul
oppos
nk
cell
nkmediat
kill
strongli
inhibit
egda
block
degranul
nk
cell
pancaspas
inhibitor
zvadfmk
fasor
trailinhibit
reagent
consist
granul
exocytosisdepend
pathway
cytotox
observ
confoc
microscopi
transfer
granzym
gzmknanb
nk
cell
activ
cell
amount
transfer
granzym
target
cell
quantifi
flow
cytometri
found
greatest
gzmk
moreov
efficaci
gzmkmediat
transfer
target
cell
significantli
greater
nk
cell
isol
daclizumabtr
patient
compar
untreat
ms
control
gzmk
gzma
kill
induc
mitochondri
dysfunct
reactiv
oxygen
speci
ro
measur
mitochondri
transmembran
potenti
intracellular
ro
format
found
significantli
impair
activ
rest
cell
upon
cocultur
nk
cell
final
confirm
nkmediat
kill
activ
cell
potent
inhibit
antioxid
gzmk
limit
express
human
immun
cell
constitut
express
nk
cell
knowledg
data
repres
first
physiolog
evid
import
role
gzmk
human
immun
system
macrophag
recruit
brain
follow
traumat
brain
injuri
partiallydepend
hsieh
christin
niemi
eren
nakamura
mari
seaman
william
traumat
brain
injuri
tbi
major
health
problem
number
one
caus
death
children
unit
state
initi
injuri
brain
follow
inflammatori
immun
respons
inflamm
may
protect
qualiti
particularli
infect
may
also
worsen
brain
injuri
increas
neuron
cell
death
natur
inflammatori
respons
howev
still
poorli
defin
difficult
distinguish
role
macrophag
resid
immun
cell
especi
microglia
inflammatori
cell
neutrophil
furthermor
light
evid
suggest
immun
cell
includ
macrophag
may
promot
recoveri
cn
injuri
import
understand
role
cell
tbi
studi
inflammatori
respons
mice
follow
tbi
induc
control
cortic
impact
use
multicolor
flow
cytometri
character
macrophag
microglia
neutrophil
find
macrophag
injur
half
brain
increas
four
day
follow
tbi
macrophag
express
mhcii
indic
activ
capac
antigen
present
contrast
microglia
express
littl
none
antigen
present
molecul
also
find
almost
macrophag
injur
brain
express
chemokin
receptor
mice
signific
reduct
number
brain
macrophag
follow
tbi
indic
macrophag
recruit
injur
brain
least
part
interestingli
preliminari
studi
also
reveal
subset
infiltr
macrophag
express
marker
altern
activ
macrophag
describ
import
tissu
repair
recoveri
sum
tbi
model
follow
larg
influx
activ
peripher
macrophag
recruit
macrophag
part
depend
least
subset
may
involv
brain
repair
molecular
basi
induct
protect
type
interferon
within
central
nervou
system
sever
neurotrop
virus
vesicular
stomat
viru
vsv
induc
peripher
neutral
antibodi
respons
still
infect
cell
within
central
nervou
system
cn
recent
show
intranas
vsv
instil
mice
select
lack
type
interferon
receptor
ifnar
neuroectoderm
cell
cn
result
sever
enceph
death
wherea
control
mice
show
sign
diseas
detj
et
al
although
condit
ifnar
trigger
instrument
constrain
viru
spread
within
cn
remain
unclear
whether
protect
type
interferon
ifni
induc
local
within
brain
upon
intranas
vsv
challeng
plaqueform
unit
pfu
dose
well
toler
wildtyp
mice
defici
mice
succumb
infect
within
day
although
day
infect
wildtyp
mice
show
similar
viru
clearanc
day
viru
level
continu
increas
cn
mice
note
mice
show
similar
resist
intraven
vsv
challeng
compar
wildtyp
mice
data
suggest
alon
critic
requir
promot
viru
arrest
within
cn
wherea
peripheri
complement
analysi
report
mice
express
luciferas
control
promot
show
h
post
intranas
infect
express
found
nasal
area
olfactori
bulb
collect
data
compat
model
upon
intranas
intraven
infect
protect
ifni
differenti
induc
notion
support
observ
similar
defici
mice
anim
devoid
tolllik
receptor
tlr
signal
rigilik
receptor
rlr
signal
succumb
intranas
infect
wherea
strain
well
toler
intraven
infect
current
test
whether
tlr
rlr
signal
activ
order
mediat
protect
within
cn
whether
mechan
complement
peripheri
netrin
famili
secret
protein
direct
migrat
cell
axon
growth
cone
neural
develop
neuron
migrat
modul
balanc
chemoattract
chemorepuls
signal
besid
neuron
guidanc
involv
function
aspect
may
includ
antiinflamm
aim
studi
examin
express
local
cn
eae
irradi
injuri
western
blot
analysi
reveal
significantli
increas
content
spinal
cord
rat
peak
stage
eae
compar
level
normal
control
anim
pb
maintain
recoveri
stage
eae
immunohistochemistri
detect
protein
neuron
gliocyt
vascular
endotheli
cell
spinal
cord
normal
control
eaeaffect
spinal
cord
immunoreact
increas
mainli
infiltr
inflammatori
cell
peak
stage
also
normal
intens
immunostain
gray
matter
neuron
white
matter
gliocyt
chang
irradi
injuri
also
compar
result
suggest
endogen
increas
cn
inflamm
includ
eae
radiat
contribut
modul
cn
inflamm
research
perform
program
basic
atom
energi
research
institut
baeri
nuclear
r
program
fund
ministri
scienc
technolog
korea
kosef
neuroprotect
function
microgli
immunoreceptor
tyrosinebas
inhibitori
motifsign
receptor
wang
yiner
claud
janin
linnartz
bettina
neumann
harald
sialic
acidbind
immunoglobulin
superfamili
lectin
siglec
member
immunoglobulin
superfamili
recogn
sialic
acid
residu
form
cap
glycocalyx
recent
identifi
microgli
humanspecif
siglec
without
counterpart
mice
contain
two
immunoreceptor
tyrosinebas
inhibitori
motif
itim
polysialyl
neuron
cell
adhes
molecul
psancam
put
ligand
observ
gene
transcript
protein
express
splice
variant
human
brain
tissu
sampl
rtpcr
western
blot
specif
express
microglia
human
brain
tissu
determin
immunohistochemistri
cultur
murin
microgli
cell
genet
modifi
express
human
splice
variant
stimul
crosslink
antibodi
suppress
lipopolysaccharid
lp
induc
gene
transcript
proinflammatori
mediat
nitric
oxid
microglia
moreov
phagocytosi
apoptot
neuron
materi
fibrillari
amyloidbeta
reduc
transduc
microglia
express
psancam
detect
microglia
neuron
immunohistochemistri
rtpcr
cocultur
microglia
transduc
neuron
demonstr
neuroprotect
function
depend
polysial
acid
psa
residu
neuron
independ
psa
microglia
data
demonstr
human
express
murin
microglia
interact
glycocalyx
neuron
reduc
microgli
lpsinduc
gene
transcript
proinflammatori
mediat
impair
phagocytosi
prevent
microgli
neurotox
multipl
sclerosi
ms
regard
autoimmun
disord
central
nervou
system
extens
data
support
role
adapt
immun
mechan
ms
pathogenesi
evid
involv
innat
immun
particularli
neutrophil
still
scarc
goal
project
provid
systemat
analysi
phenotyp
function
marker
neutrophil
ms
patient
whole
blood
ms
patient
healthi
control
analyz
flow
cytometri
express
follow
phenotyp
functionaland
activ
marker
fmlpr
mhcclass
ii
parallel
whole
blood
count
obtain
coulter
count
point
flow
cytometr
data
healthi
control
untreat
ms
patient
avail
ci
rrm
remiss
rrm
relaps
spm
ppm
current
analys
show
surfac
marker
differ
significantli
group
gener
neutrophil
rrm
patient
show
trend
toward
higher
activ
compar
healthi
control
upregul
addit
neutrophil
rrm
patient
tend
demonstr
increas
express
molecul
involv
antigen
present
hlaclass
ii
granulocyt
count
significantli
higher
rrm
patient
relaps
compar
patient
remiss
p
mannwhitney
test
spm
ppm
patient
compar
healthi
donor
p
p
respect
conclus
neutrophil
ms
patient
seem
differ
significantli
respect
surfac
phenotyp
compar
healthi
control
elev
granulocyt
count
might
reflect
ongo
inflammatori
activ
current
studi
pursu
put
function
role
class
ii
express
neutrophil
well
factor
underli
granulophilia
observ
ms
patient
innat
immun
system
detect
onset
infect
presenc
divers
sens
molecul
term
pattern
recognit
receptor
prr
recogn
pathogenassoci
molecular
patter
pamp
well
endogen
ligand
deriv
host
prr
stimul
induc
express
proinflammatori
cytokin
interferon
ifn
costimulatori
molecul
connect
innat
acquir
immun
tolllik
receptor
helicas
rigi
transmembran
cytosol
prr
respect
detect
dsrna
rna
viru
cytomegaloviru
epsteinbarr
viru
among
other
rigi
engag
activ
nfkappab
transcript
factor
induc
product
inflammatori
cytokin
also
activ
lead
type
ifn
product
rheumatoid
arthriti
ra
develop
result
complex
interplay
genet
environment
factor
deregul
immun
respons
exogen
ligand
rigi
cytomegaloviru
epsteinbarr
viru
parvoviru
describ
joint
ra
patient
well
endogen
ligand
host
rna
deriv
necrot
cell
damag
joint
vasoact
intestin
peptid
vip
receptor
express
fibroblastlik
synoviocyt
fl
osteoarthrosi
oa
ra
patient
differenti
express
patholog
vip
exert
antiinflammatori
effect
anim
model
human
ra
aim
present
studi
test
presenc
dsrna
receptor
fl
studi
effect
vip
result
demonstr
basal
express
rna
sensor
rigi
mrna
protein
level
sensor
significantli
express
rafl
oafl
studi
effect
vip
signal
pathway
rigi
stimul
dsrna
synthet
ligand
polyi
c
vip
prevent
transloc
nucleu
oaand
rafl
wherea
nfkappab
activ
prevent
vip
oafl
result
valid
role
vip
neg
regul
proinflammatori
type
ifn
pathway
corrobor
potenti
therapeut
agent
statin
enhanc
tlrinduc
proinflammatori
respons
rhesu
monkey
microglia
van
der
putten
celin
kuiper
hedwich
f
statin
inhibitor
endogen
mevalon
pathway
direct
biosynthesi
cholesterol
isoprenoid
sinc
statin
also
immunomodulatori
capac
consid
co
therapi
inflammatori
disord
includ
multipl
sclerosi
ms
howev
differ
studi
report
contradict
find
statin
influenc
respons
innat
immun
system
particular
tolllik
receptor
tlr
mediat
respons
discrep
could
least
part
attribut
use
differ
type
statin
differ
cell
type
speci
use
studi
studi
investig
effect
differ
statin
tlrmediat
respons
microglia
compar
effect
bonemarrow
bm
deriv
macrophag
donor
unexpectedli
found
simvastatin
lovastatin
atorvastatin
strongli
enhanc
microgli
proinflammatori
cytokin
product
respons
enhanc
statintr
microglia
analysi
cytokin
reveal
tlrinduc
product
gmcsf
strongli
enhanc
wherea
induc
express
immunomodulatori
molecul
antagonist
unaffect
secondli
compar
effect
statin
microglia
bmderiv
macrophag
donor
interestingli
microglia
found
sensit
statinmedi
proinflammatori
effect
experi
use
combin
specif
inhibitor
downstream
pathway
affect
statin
reveal
inhibit
cholesterol
biosynthesi
mainli
respons
observ
effect
microglia
bmderiv
macrophag
preliminari
result
realtim
rtpcr
analys
suggest
microglia
express
lower
intrins
level
key
enzym
involv
mevalon
pathway
bmderiv
macrophag
might
well
underli
enhanc
sensit
microglia
statin
conclus
studi
report
tlrinduc
proinflammatori
respons
microglia
similarli
enhanc
differ
type
statin
microglia
particularli
sensit
statinmedi
effect
compar
macrophag
observ
suggest
statin
might
aggrav
rather
dampen
innat
immun
respons
particularli
cn
could
therebi
possibl
contribut
advers
effect
ms
patient
use
statin
would
suffer
bacteri
viral
infect
multipl
sclerosi
suscept
allel
creat
new
rna
isoform
result
truncat
protein
multipl
sclerosi
inflammatori
neurodegen
diseas
import
genet
compon
metaanalysi
genomewid
associ
scan
gwa
ms
identifi
novel
suscept
locu
p
disrupt
tnf
signal
sever
affect
human
murin
demyelin
neuroinflammatori
diseas
polymorph
intron
locat
near
exonintron
boundari
found
polymorph
give
rise
new
splice
variant
isoform
lack
exon
predict
produc
truncat
protein
defici
transmembran
intracellular
compon
level
rna
express
truncat
isoform
delta
measur
pbmc
genotyp
healthi
subject
phenogenet
project
display
robust
linear
correl
frequenc
suscept
allel
use
plink
analysi
toolkit
fulllength
isoform
present
individu
delta
isoform
found
presenc
ms
suscept
allel
level
express
novel
isoform
also
upregul
pbmc
subject
one
two
copi
risk
allel
pma
stimul
delta
isoform
appear
affect
either
level
solubl
serum
sampl
healthi
n
ms
subject
n
surfac
express
monocyt
granulocyt
assess
flow
cytometri
vitro
experi
show
cytoplasm
intracellular
express
secret
delta
isoform
present
evid
one
function
consequ
high
frequenc
ms
suscept
allel
within
variant
lead
product
novel
rna
isoform
product
truncat
protein
role
activ
microglia
lpsinduc
neuroprotect
asept
brain
injuri
model
chen
zhihong
jalabi
walid
dutta
ranjan
trapp
bruce
therapeut
protect
neuron
death
mani
applic
treat
acut
chronic
diseas
central
nervou
system
cn
neurodegen
diseas
includ
multipl
sclerosi
ms
previous
demonstr
multipl
low
dose
ip
inject
lp
lipopolysaccharid
mice
lead
global
activ
microglia
reduc
inhibitori
gabaerg
presynapt
compon
induct
prosurviv
signal
pathway
neuron
use
asept
cryogen
brain
injuri
model
studi
contribut
neuroprotect
effect
offer
microglia
immunohistochemistri
show
lpsactiv
microgli
cell
gather
around
penumbra
lesion
caus
experiment
brain
injuri
cell
demonstr
phagocyt
capabl
activ
particip
clear
hemorrhag
debri
characterist
antiinflammatori
tissuerepair
phenotyp
macrophag
analysi
dataset
obtain
use
dna
microarray
technolog
reveal
cluster
gene
relat
subtyp
inde
increas
transcript
lp
inject
addit
lp
precondit
mice
reduc
volum
lesion
size
brain
injuri
anim
correspondingli
perform
better
rotarod
equip
use
test
locomotor
behavior
function
conclus
demonstr
lp
precondit
lead
increas
decreas
neuron
loss
brain
damag
molecular
event
elicit
neuroprotect
action
possibl
proffer
activ
microglia
investig
activ
induc
lewi
rat
experiment
autoimmun
encephalomyel
eae
highli
reproduc
model
investig
cellular
molecular
mechan
involv
leukocyt
central
nervou
system
invas
diseas
induc
subcutan
inject
guinea
pig
myelin
basic
protein
gpmbp
resuspend
incomplet
freund
adjuv
ad
mycobacterium
tuberculosi
cfa
diseas
becom
clinic
evid
day
post
eae
induct
pi
neurolog
sign
peak
day
extens
leukocyt
inflamm
mainli
locat
spinal
cord
sc
day
pi
previous
observ
flow
cytometri
massiv
presenc
cellular
popul
lymphocyt
sc
ie
target
organ
well
spleen
ie
imunoregulatori
organ
eae
rat
hypothes
popul
could
compos
polymorphonuclear
cell
wonder
presenc
relat
cfa
use
refer
diseas
thu
focus
attent
character
immun
system
cellular
compon
present
sc
spleen
cfa
eae
anim
day
pi
demonstr
cell
popul
observ
sc
mainli
compos
neutrophil
invad
central
nervou
system
togeth
lymphocyt
eae
anim
fact
leukocyt
infiltr
observ
cfa
treat
rat
remain
cellular
chang
could
observ
extent
cfa
eae
anim
spleen
fact
cfa
eae
spleen
observ
red
pulp
hyperplasia
togeth
white
pulp
lymphoid
hypoplasia
flow
cytometri
confirm
decreas
cell
relev
cellular
popul
previous
observ
mainli
compos
neutrophil
also
observ
cfa
administr
eae
induct
similarli
increas
neutrophil
monocyt
absolut
number
vs
control
signific
reduct
circul
lymphocyt
report
eae
anim
vs
cfa
treat
one
cfa
clearli
respons
spleen
cellular
chang
well
neutrophil
monocyt
number
increas
among
circul
cell
nevertheless
presenc
infiltr
leukocyt
spinal
cord
differ
circul
lymphocyt
cfa
eae
anim
peculiar
event
occur
eae
investig
neutrophil
function
role
eae
develop
futur
endpoint
natur
occur
regulatori
cell
treg
thought
suppress
activ
pathogen
cell
autoimmun
diseas
multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
tolllik
receptor
tlr
key
compon
innat
immun
system
detect
treg
recent
data
point
direct
indirect
involv
tlr
modul
function
treg
test
hypothesi
stimul
reduc
suppress
function
human
treg
show
preferenti
express
human
treg
compar
effector
cell
also
show
triacetyl
lipopeptid
ligand
requir
heterodim
recognit
reduc
suppress
activ
human
treg
contrast
suppress
function
treg
reduc
diacyl
ligand
recognis
heterodim
preliminari
data
show
enhanc
secret
treg
tresp
addit
stimul
agonist
enhanc
express
treg
suggest
activ
may
promot
cell
differenti
data
support
hypothesi
ms
potenti
immunemedi
diseas
infect
may
lead
exacerb
diseas
activ
caus
reduct
treg
suppress
differenti
pathogen
cell
report
stimul
imiquimod
synthet
analog
ssrna
suppress
diseas
sever
chronic
murin
eae
model
preliminari
studi
also
found
stimul
agonist
cpg
type
also
result
suppress
chronic
eae
case
diseas
suppress
associ
expans
plasmacytoid
dendrit
cell
pdc
cn
shown
express
experi
found
increas
product
ifnbeta
spleen
mice
treat
imiquimod
measur
rtpcr
also
gener
pdc
vitro
found
imiquimod
induc
expans
pdc
also
product
ifnbeta
expans
pdc
respons
imiquimod
depend
type
interferon
receptor
ifnar
mice
lack
receptor
expand
pdc
vivo
deplet
pdc
found
reduc
eae
sever
interestingli
preliminari
experi
shown
imiquimod
exacerb
eae
absenc
pdc
indic
protect
effect
imiquimod
depend
pdc
data
demonstr
agonist
imiquimod
agonist
cpg
type
reduc
eae
diseas
sever
potenti
immunotherapi
ms
induc
expans
plasmacytoid
dendrit
cell
produc
ifnbeta
current
use
treatment
ms
theiler
murin
encephalomyel
viru
tmev
singlestrand
rna
viru
caus
chronic
progress
cell
mediat
induc
demyelin
diseas
tmevidd
suscept
mous
strain
serv
virallyinduc
murin
model
human
diseas
multipl
sclerosi
innat
immun
system
serv
first
line
host
defens
pathogen
virus
tolllik
receptor
tlr
member
pattern
recognit
receptor
prr
famili
recogn
pathogen
associ
molecular
pattern
pamp
ligand
bind
activ
proinflammatori
antivir
respons
apc
central
nervou
system
cn
resid
cell
microglia
isol
human
neonat
murin
tissu
express
multipl
tlr
vitro
situ
therefor
examin
tlrstimul
microglia
macrophag
immun
function
murin
cn
respons
tmev
infect
follow
tmev
infect
express
significantli
upregul
day
postinfect
pi
suggest
tlr
dynam
regul
acut
theiler
viru
infect
use
quantit
realtim
pcr
express
recogn
viral
doublestrand
rna
highli
induc
facssort
microglia
respons
tmevinfect
day
pi
data
suggest
virus
may
select
upregul
express
mount
antivir
respons
necessari
tmev
viral
clearanc
cn
elucid
role
tmevidd
examin
develop
induc
demyelin
diseas
absenc
sjl
compar
wildtyp
sjl
mice
sjl
mice
hypersuscept
diseas
exhibit
increas
demyelin
suggest
protect
tmevidd
addit
sjl
mice
defect
tmev
clearanc
cn
measur
increas
viral
titer
mice
compar
wildtyp
control
sjl
mice
defici
total
cn
cell
number
day
pi
also
reflect
reduc
total
cell
percentag
cell
number
would
affect
tmev
clearanc
futur
experi
focus
understand
role
effector
function
cnsresid
cell
acut
infect
studi
support
reactiv
astrocyt
regul
inflamm
promot
tissu
repair
injur
cn
neuroprotect
action
mediat
neurotrophin
nt
brain
deriv
neurotroph
factor
bdnf
act
neuron
express
bdnf
receptor
trkb
aim
work
understand
whether
nt
promot
neuroinflammatori
neuroprotect
side
astrocyt
reactiv
observ
bdnftrkb
axi
predomin
nt
pathway
cultur
human
astrocyt
trkb
strongli
upregul
reactiv
astrocyt
multipl
sclerosi
ms
lesion
astrocyt
respons
bdnf
function
consequ
neuron
cell
investig
vitro
observ
similarli
inflammatori
mediat
bdnf
activ
astrocyt
releas
solubl
factor
induc
degener
rat
spinal
neuron
appropri
experiment
set
led
identif
releas
factor
final
analys
clinic
express
experiment
autoimmun
encephalomyel
eae
doubl
transgen
mice
trkb
select
deplet
gfap
posit
cell
demonstr
blockad
bdnftrkb
axi
astrocyt
protect
anim
eae
develop
overal
identifi
novel
neurodegen
pathway
trigger
astrocyt
respons
bdnf
contribut
ms
patholog
experiment
neuroinflamm
studi
support
fism
fondazion
italiana
sclerosi
multipla
trigger
receptor
express
myeloid
microgli
cell
surfac
receptor
signal
via
immunoreceptor
tyrosinebas
activ
motif
itam
associ
common
adaptor
molecul
human
loss
function
mutat
either
lead
chronic
neurodegener
format
bone
cyst
hallmark
nasuhakola
diseas
demonstr
defici
ko
mice
even
absenc
treatment
present
mild
sign
increas
microgli
activ
sever
brain
region
ventral
tegment
area
substantia
nigra
hypothalamu
cortex
dopaminerg
neuron
degener
nigrostriat
system
sinc
chronic
system
inflamm
postul
promot
neurodegen
process
challeng
mice
intraperiton
lipopolysaccharid
lp
four
intraperiton
lp
challeng
four
day
ko
mice
show
signific
p
b
upregul
microgli
marker
protein
ventral
tegment
area
substantia
nigra
hypothalamu
cortex
compar
untreat
ko
mice
consequ
sign
dopaminerg
neuron
degener
increas
substantia
nigra
lp
challeng
ko
mice
compar
untreat
ko
mice
data
reveal
mild
spontan
neuroinflamm
neurodegener
defici
mice
amplifi
system
inflammatori
challeng
lp
recent
demonstr
monocytederiv
macrophag
support
motor
function
recoveri
follow
spinal
cord
injuri
heal
follow
damag
central
nervou
system
cn
gener
inner
retina
particular
depend
rescu
neuron
escap
lesion
regener
cell
renew
therefor
hypothes
bloodborn
macrophag
directli
involv
heal
process
henc
essenti
follow
insult
visual
system
reli
function
retin
ganglion
cell
rgc
use
bone
marrow
chimer
mice
found
bloodborn
macrophag
infiltr
damag
ganglion
cell
layer
follow
glutam
intox
ablat
monocyt
peripher
blood
result
impair
surviv
rgc
reduc
retin
progenitor
cell
rpc
renew
ciliari
bodi
accord
enhanc
monocyt
popul
augment
surviv
rgc
increas
rpc
prolifer
use
experiment
tool
found
monocytederiv
macrophag
contribut
antiinflammatori
neuroprotect
milieu
injur
retina
thu
find
identifi
novel
fundament
role
monocytederiv
macrophag
regul
immun
respons
follow
retin
injuri
contribut
neuroprotect
cell
renew
neuroprotect
potenti
cell
might
farreach
implic
regard
retin
neuropathi
neurodegen
disord
cn
pathogenesi
alzheim
diseas
ad
gener
attribut
increas
product
accumul
protein
result
direct
neuron
toxic
microgli
activ
product
inflammatori
mediat
contribut
neuron
damag
amyloid
plaqu
contain
increas
number
molecul
whose
signific
clearli
character
among
deposit
autopt
ad
brain
strictli
associ
chitin
insolubl
polym
nacetylglucosamin
detect
calcofluor
stain
amyloid
plaqu
within
cytoplasm
surround
microglia
aim
studi
assess
whether
chitin
could
contribut
pathogenesi
ad
investig
biolog
effect
neuron
microglia
first
demonstr
product
microgli
cultur
chitotriosidas
enzym
degrad
chitin
whose
level
increas
inflammatori
stimuli
lp
ifng
andor
tnfa
primari
microgli
cultur
expos
exogen
chitin
cell
abl
phagocyt
smallsiz
chitin
deposit
mannos
receptor
process
significantli
inhibit
similarli
describ
phagocyt
chitin
induc
mark
prolifer
activ
microgli
cell
consequ
product
proinflammatori
cytokin
reactiv
oxygen
speci
activ
effect
chitin
significantli
attenu
central
point
concern
product
chitin
mammalian
cell
lack
chitin
synthas
demonstr
presenc
excess
nacetylglucosamin
murin
microgli
cell
fibroblast
abl
produc
calcofluorposit
chitinlik
deposit
releas
medium
result
indic
particular
condit
alter
glucos
metabol
hexosamin
pathway
microgli
cell
produc
chitinlik
deposit
releas
extracellular
space
endogen
exogen
chitin
activ
microglia
process
may
contribut
neuron
toxic
inflammatori
mediat
modul
chitin
pathway
influenc
uptak
degrad
data
suggest
chitin
may
play
role
pathogenesi
ad
microglia
fundament
product
degrad
earli
microgli
activ
bloodretin
barrier
breakdown
autoimmun
optic
neuriti
fairless
richard
william
sarah
hoffmann
dorit
diem
ricarda
optic
neuriti
common
earli
symptom
patient
multipl
sclerosi
ms
also
occur
one
symptom
experiment
autoimmun
encephalomyel
eae
brown
norway
bn
rat
immunis
myelin
oligodendrocyt
glycoprotein
mog
result
axon
degener
demyelin
inflammatori
infiltr
optic
nerv
howev
model
prior
onset
clinic
eae
symptom
infiltr
immun
cell
spinal
cord
optic
nerv
report
earli
degener
retin
ganglion
cell
rgc
aim
project
investig
earli
chang
retina
optic
nerv
onset
optic
neuriti
respect
activ
innat
immun
system
order
identifi
caus
earli
neurodegener
monitor
neurodegener
rgc
retrogradelylabel
fluorogold
retina
excis
induct
phase
optic
neuriti
rgc
begin
degener
day
postimmunis
pi
wherea
histopatholog
analys
optic
nerv
confirm
optic
neuriti
begin
approxim
day
pi
addit
frozen
section
retina
optic
nerv
analys
immunohistochemistri
evid
microgli
activ
integr
bloodbrain
bloodretin
barrier
investig
immunofluoresc
evan
blue
extravas
use
method
found
microgli
activ
occur
retina
optic
nerv
earli
day
p
addit
although
bloodretin
barrier
disturb
timepoint
bloodopt
nerv
barrier
remain
intact
onset
optic
neuriti
howev
agreement
studi
found
bloodbrain
barrier
optic
nerv
head
incomplet
healthi
immunis
anim
addit
activ
microglia
distribut
throughout
optic
nerv
frequenc
invers
proport
distanc
optic
nerv
head
propos
follow
immunis
bn
rat
mog
vulner
bloodretin
barrier
permeabl
optic
nerv
head
may
act
entri
point
microglialactiv
potenti
neurotox
factor
peripheri
turn
earli
microgli
activ
model
may
factor
explain
earli
neurodegener
rgc
may
also
explain
visual
disturb
common
earli
symptom
patient
go
develop
ms
express
tnfa
alzheim
patholog
mice
endotoxin
challeng
ilkjaer
laura
babcock
alicia
ann
finsen
bent
chronic
activ
microglia
possibl
amyloid
beta
plaqu
signific
alzheim
diseas
ad
might
play
central
role
pathogenesi
activ
microglia
produc
potenti
neurotox
substanc
includ
cytokin
tumour
necrosi
factor
tnfa
investig
mrna
level
tnfa
neocortex
doubl
transgen
tg
mous
model
ad
wild
type
wt
mice
age
group
month
qpcr
also
number
percentag
tnfa
produc
microglia
macrophag
month
old
wt
tg
mice
investig
flow
cytometri
sinc
system
infectioninflamm
believ
aggrav
ad
patholog
also
investig
effect
treat
month
old
mice
weekli
endotoxin
month
respect
age
depend
amyloid
plaqu
accumul
tg
mice
investig
stereolog
month
old
mice
stain
microgliamacrophag
show
ageand
transgenedepend
activ
microglia
consist
fac
data
month
old
mice
appear
correl
agedepend
increas
amyloid
plaqu
densiti
level
tnfa
mrna
increas
significantli
age
tg
mice
wherea
observ
close
baselin
level
mrna
fac
data
show
signific
increas
number
tnfa
microglia
tg
mice
follow
treatment
endotoxin
level
mrna
tg
mice
rose
significantli
compar
pb
treat
mice
fold
also
compar
wt
mice
receiv
treatment
tnfa
mrna
level
also
increas
endotoxin
treatment
extent
conclus
result
point
continu
plaqu
deposit
induc
chronic
lowgrad
microglialdriven
inflammatori
reaction
age
tg
mice
longterm
inflammatori
challeng
might
induc
enhanc
product
potenti
neurotox
substanc
tnfa
research
institut
environment
medicin
nagoya
univers
nagoya
japan
sever
neurodegen
disord
associ
microgli
accumul
activ
microglia
protect
toxic
effect
neuron
product
variou
cytokin
chemokin
solubl
factor
glutamatemedi
excitotox
contribut
neuron
damag
variou
neurolog
disord
degener
neuron
produc
variou
signal
molecul
regul
microgli
function
studi
identifi
role
fractalkin
fkn
degener
neuron
microglia
particularli
perspect
neuron
surviv
microgli
phagocytosi
secret
solubl
form
fkn
mous
primari
microglia
cortic
neuron
measur
elisa
effect
fkn
treatment
express
variou
cytokin
phagocytosisrel
factor
antioxid
enzym
heme
microglia
assess
rtpcr
elisa
phagocytosi
neuron
debir
evalu
uptak
fluoresc
dyestain
mous
primari
cortic
neuron
microglia
use
sever
specif
inhibitor
western
blot
intracellular
signal
pathway
involv
clearanc
degener
neuron
product
examin
fkn
secret
neuron
affect
glutam
toxic
promot
microgli
phagocytosi
neuron
debri
releas
also
known
mediat
apoptot
cell
clearanc
fkn
induc
antioxid
enzym
microglia
without
produc
neurotox
molecul
nitric
oxid
tumor
necrosi
factor
glutam
consequ
treatment
fkn
significantli
repress
neuron
cell
death
glutam
primari
neuronmicroglia
cocultur
use
sever
specif
mapk
inhibitor
fkninduc
express
neuroprotect
action
mediat
extracellular
signalregul
kinas
cjun
ntermin
kinas
signal
pathway
moreov
induct
associ
activ
factor
transcript
factor
involv
antioxid
respons
element
pathway
secret
fkn
glutamateexpos
neuron
may
act
helpm
signal
neuroprotect
activ
phagocytosi
unwant
debri
express
antioxid
microglia
cerebr
ischemia
accompani
acut
inflamm
involv
activ
microglia
infiltr
neutrophil
granulocyt
monocyt
brain
differ
immun
cell
type
contribut
neuron
outcom
cerebr
ischemia
still
discuss
variou
signific
action
immun
cell
reveal
imag
either
vitroex
vivo
vivo
develop
postischem
ex
vivo
model
immun
cell
fluoresc
label
applic
hippocamp
slice
eyfp
express
neuron
observ
two
signific
mechan
microglia
protect
neuron
ischemia
one
hand
microglia
found
ischem
induc
close
proxim
physic
cellcel
contact
neuron
hand
microglia
elimin
infiltr
neutrophil
granulocyt
fast
effici
block
properti
yield
exacerb
neuron
damag
test
hypothesi
vivo
gener
mous
transgen
neutrophil
lysegfp
microglia
experiment
cerebr
ischemia
use
model
perman
middl
cerebr
arteri
occlus
combin
occlus
common
carotid
arteri
min
intracrani
twophoton
microscopi
tpm
abl
imag
cell
depth
vivo
ischem
lesion
date
observ
rapid
infiltr
neutrophil
fast
respons
microglia
damag
vessel
ischemia
detail
neutrophil
granulocyt
adher
promptli
vessel
subsequ
invad
cerebr
parenchyma
furthermor
microglia
seem
shield
inflam
vessel
send
process
approach
suitabl
answer
wide
rang
question
immun
cell
respond
cerebr
ischem
event
might
contribut
gain
intellig
develop
suitabl
therapeut
strategi
cuban
multipl
sclerosi
ms
patient
evalu
intrathec
measl
rubella
r
varicella
zoster
z
antibodi
synthesi
nflai
sinc
report
countri
yet
compar
distinct
also
report
consid
differ
epidemiolog
tropic
untrop
region
cuban
ms
patient
repres
age
distribut
gender
ratio
analys
csf
neurotroph
viru
protein
neurofila
light
subunit
nfl
antibodi
reaction
use
elisa
assay
evalu
specif
antibodi
index
normal
valu
ai
median
ai
lower
frequenc
intrathec
rubella
antibodi
synthesi
rubellaai
observ
cuban
patient
case
gender
ratio
rubellaai
posit
f
compar
german
patient
gender
ratio
f
could
explain
low
incid
rubella
infect
cuba
nflai
increas
ai
low
number
case
rang
ai
median
ai
nevertheless
signific
correl
observ
nflai
relaps
ms
patient
p
b
number
ms
case
investig
increas
nflai
combin
one
antibodi
speci
intrathec
synthes
neurotroph
viru
frequent
seen
ms
intrathec
antibodi
synthesi
ms
correl
fraction
seroposit
popul
natur
infect
vaccin
may
precondit
intrathec
antibodi
synthesi
neurotrop
virus
ms
differ
nfl
autoantibodi
level
observ
group
ms
patient
confirm
result
previou
report
relationship
util
nflpai
axon
damag
marker
addit
signific
relationship
observ
relaps
subgroup
patient
promot
probabl
relev
marker
subrog
marker
ms
vivo
imag
stroke
investig
intracrani
microscopi
riekburchardt
monika
neumann
jen
orlando
gabriella
gunzer
matthia
reymann
klau
g
leibniz
institut
neurobiolog
project
group
neuropharmacolog
magdeburg
germani
ottovonguerickeunivers
magdeburg
depart
neurolog
magdeburg
germani
ottovonguerickeunivers
magdeburg
institut
molecular
clinic
immunolog
magdeburg
germani
institut
appli
neurosci
ggmbh
magdeburg
germani
cn
damag
caus
stroke
accompani
acut
inflammatori
respons
inflammatori
process
stroke
consist
activ
resid
brain
microglia
recruit
leucocyt
name
neutrophil
monocytesmacrophag
howev
sampl
microgli
process
demonstr
vivo
natur
function
interact
microglia
invad
immun
cell
incomplet
understood
recent
could
identifi
new
neuroprotect
mechan
cn
wherebi
microglia
guard
neuron
engulf
toxic
neutrophil
granulocyt
invad
brain
slice
situ
stroke
model
current
work
investig
vivo
relev
find
induct
cerebr
ischemia
use
model
perman
middl
cerebr
arteri
occlus
combin
occlus
common
carotid
arteri
min
cross
lysegfp
green
fluoresc
neutrophil
mice
green
fluoresc
microglia
mice
allow
visual
cell
type
anim
use
larg
differ
morpholog
migrat
characterist
marker
identif
despit
similar
colour
investig
postischem
chang
microglianeutrophil
morpholog
behaviour
use
intracrani
live
imag
via
twophoton
microscopi
differ
time
point
h
insult
technic
possibl
twophoton
fluoresc
microscopi
enabl
look
live
tissu
examin
demonstr
describ
method
power
investig
vivo
situat
postischem
microgli
activ
neuroimmun
crosstalk
observ
earli
extravas
neutrophil
ischemia
first
h
local
microglia
chang
morpholog
dramat
present
first
postischem
vivo
studi
differ
microgli
activ
phase
timelaps
movi
directli
infarct
area
intracrani
vivo
microscopi
use
method
investig
immun
cell
interact
directli
within
vital
tissu
impli
new
qualiti
new
possibl
examin
inflamm
process
brain
cerebr
ischemia
stroke
character
inflamm
intens
lymphocyt
infiltr
lot
recent
studi
suggest
lymphocyt
recruit
particular
cell
fundament
progress
cerebr
ischemia
lesion
howev
role
differ
helper
cell
subset
stroke
unknown
use
organotyp
hippocamp
slice
cultur
ohc
contain
differ
cn
cell
type
retain
complex
organ
nervou
tissu
induct
experiment
stroke
ohc
expos
oxygen
glucos
depriv
ogd
vitro
model
discov
effect
helper
cell
specif
cytokin
ifngamma
neuron
cell
death
ogd
result
show
h
ogd
neuron
cell
death
significantli
decreas
treatment
nm
applic
nm
nm
ifngamma
neuroprotect
find
indic
main
cytokin
helper
cell
type
may
benefici
effect
ischem
brain
injuri
therefor
suppos
cell
potenti
support
neuroprotect
effect
stroke
monitor
degener
retin
nerv
fiber
layer
optic
coher
tomographi
rat
autoimmun
optic
neuriti
hein
katharina
gadjanski
ivana
muriel
kretzschmar
benedikt
diem
ricarda
mathia
dept
neurolog
germani
dept
neurolog
homburg
saar
germani
multipl
sclerosi
chronic
autoimmun
diseas
frequent
manifest
optic
neuriti
axon
loss
thought
major
patholog
featur
perman
disabl
disord
sinc
retin
nerv
fiber
layer
rnfl
compos
larg
unmyelin
axon
retin
ganglion
cell
measur
rnfl
thick
repres
promis
tool
monitor
axon
loss
patient
optic
neuriti
present
studi
evalu
accuraci
spectral
domain
oct
rat
model
myelin
oligodendrocyt
glycoproteininduc
optic
neuriti
rnfl
thick
measur
perform
period
imag
diseas
develop
progress
result
show
rnfl
thick
declin
significantli
clinic
manifest
diseas
progress
continu
diseas
cours
rnfl
thick
measur
oct
good
repeat
reproduc
also
correspond
histomorphometr
measur
furthermor
high
correl
decreas
rnfl
retin
ganglion
cell
densiti
found
summari
show
first
time
oct
reliabl
monitor
neurodegener
experiment
model
autoimmun
optic
neuriti
rodent
moreov
compar
rnfl
thick
declin
histopatholog
analysi
optic
nerv
result
suggest
earli
part
inflamm
independ
process
rnfl
degener
autoimmun
optic
neuriti
multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
cn
remyelin
ms
ultim
fail
although
strategi
promot
myelin
repair
eagerli
sought
mechan
underli
remyelin
vivo
elus
express
neutrophil
oligodendrocyt
lineag
cell
central
nervou
system
cn
posit
neutrophil
facilit
inflammatori
demyelin
demyelin
model
experiment
autoimmun
encephalomyel
eae
cuprizon
intox
system
inject
small
molecul
antagonist
onset
eae
decreas
demyelin
lesion
result
left
cellular
target
antagonist
uncertain
clarifi
whether
blockad
prevent
demyelin
promot
remyelin
show
action
nonhematopoiet
cell
unexpectedli
delay
myelin
repair
bone
marrow
chimer
mice
subject
two
distinct
model
myelin
injuri
case
myelin
repair
effici
anim
oligodendrocyt
progenitor
cell
opc
demyelin
lesion
mice
prolifer
earlier
vigor
tissu
anim
vitro
demyelin
cn
slice
cultur
also
show
better
myelin
repair
block
neutral
antibodi
genet
delet
result
suggest
inactiv
permit
optim
spatiotempor
posit
opc
demyelin
lesion
receiv
local
prolif
differenti
signal
given
exert
dual
function
promot
demyelin
decreas
remyelin
action
toward
hematopoiet
cell
nonhematopoiet
cell
respect
find
identifi
promis
drug
target
clinic
demyelin
disord
suggest
small
moleculemildron
propion
dehydr
repres
azabutyrobetain
classmay
suitabl
regul
crosstalk
immun
nervou
system
process
impair
parkinson
diseas
pd
previous
found
mitochondriaregul
activ
pupur
et
al
neuroprotect
action
antihiv
drug
azidothymidin
neurotox
model
mice
pupur
et
al
present
studi
model
pd
rat
unilater
intrastriat
inject
rat
pretreat
mildron
mgkg
ip
daili
two
week
evalu
behavior
apomorphin
rotat
rat
sacrif
frozen
striatum
str
substantia
nigra
sn
cut
section
examin
immunohistochem
assess
marker
neuron
macromicrogli
cell
tyrosin
hydroxylas
th
neuron
marker
ubiquitin
regulatori
peptid
involv
ubiquitinproteasom
degrad
system
ioniz
calcium
bind
adaptor
molecul
glial
fibrillari
acid
protein
gfap
induc
nitric
oxid
synthas
ino
glial
cell
linederiv
neurotroph
factor
gdnf
str
follow
result
obtain
loss
th
posit
cell
increas
express
ubiquitin
ino
gfap
gdnf
express
influenc
mildron
str
complet
revers
control
csf
instead
level
number
th
posit
cell
prevent
overexpress
ubiquitin
gfap
ino
tendenc
elev
gdnf
str
decreas
sn
express
found
data
convincingli
demonstr
abil
mildron
protect
nigrostriat
dopamin
cell
destruct
action
th
normal
mildron
also
capabl
regul
improv
ubiquitinproteasom
pathway
reduc
inflamm
ino
reactiv
macrogliaastrocytosi
normal
gfap
express
one
may
suggest
structur
peculiar
charg
moieti
allow
refer
mildron
privileg
small
molecul
regulatori
profil
provid
multifacet
neuroimmunoregul
neuroprotect
univers
saarland
homburgsaar
germani
twincorecent
experiment
clinic
infect
research
hannov
germani
georgaugust
univers
goettingen
goettingen
germani
although
patholog
role
prion
protein
transmiss
spongiform
encephalopathi
wide
investig
physiolog
role
cellular
prion
protein
prpc
remain
elus
amongst
mani
function
attribut
prpc
increas
evid
prpc
involv
cell
surviv
mediat
neuroprotect
addit
potenti
role
immun
respons
also
suggest
aim
studi
determin
two
function
interplay
autoimmun
diseas
firstli
induc
experiment
autoimmun
encephalomyel
eae
commonli
use
model
multipl
sclerosi
mice
immun
myelin
oligodendrocyt
glycoprotein
mog
mice
optic
neuriti
characteris
demyelin
inflammatori
infiltr
axon
degener
optic
nerv
present
western
blot
observ
upregul
prpc
protein
cn
compart
analys
throughout
diseas
cours
next
induc
eae
transgen
mice
defici
overexpress
prpc
mice
defici
prpc
found
exacerb
eae
diseas
cours
comparison
wild
type
mice
howev
histopatholog
analys
reveal
optic
neuriti
exacerb
mous
strain
compar
wild
type
anim
show
increas
number
infiltr
cell
demyelin
axon
degener
order
dissect
role
prpc
neurodegener
anim
fluorogold
label
retin
ganglion
cell
rgc
neuron
whose
axon
form
optic
nerv
perform
prior
immunis
quantif
surviv
rgc
anim
eae
reveal
signific
neuroprotect
rgc
prpc
overexpress
mice
wherea
mice
lack
prpc
reduc
number
data
show
strong
correl
level
prpc
express
surviv
rgc
furthermor
neuroprotect
function
prpc
shown
independ
role
regul
immun
respons
nuclear
enzym
poli
adpribos
activ
neuron
glia
respons
oxid
dna
damag
result
cerebr
ischemiareperfus
sinc
compartment
nucleu
critic
unansw
question
nuclear
send
death
signal
mitochondria
despit
intrigu
recent
find
signal
pathway
remain
poorli
understood
famili
proapoptot
protein
caus
neuron
death
manner
share
sever
common
featur
neuron
death
studi
link
attract
base
common
test
hypothesi
activ
increas
express
neuron
death
two
model
use
activ
paradigm
hypoxia
h
determin
whether
requir
upregul
establish
method
activ
mnng
dnaalkyl
agent
potent
activ
elicit
cytotox
primari
mous
cortic
neuron
cultur
wildtyp
mice
expos
hypoxia
h
mnng
min
neuron
viabil
visual
use
calceinethidium
assay
live
dead
cell
hypoxia
caus
signific
neuron
death
h
reduc
surviv
less
h
cell
death
surviv
significantli
enhanc
genotyp
parp
inhibitor
n
ndimethylacetamidehcl
hypoxia
h
also
enhanc
protein
express
nearli
manner
abolish
delet
treatment
indic
hypox
express
depend
use
direct
activ
mnng
normal
oxygen
found
reduc
neuron
surviv
concentr
timedepend
importantli
signific
neuron
death
first
seen
h
mnng
preced
increas
protein
express
h
block
genet
delet
experi
show
hypox
express
beclin
protein
play
critic
role
gener
matur
autophag
vesicl
subsequ
involv
clearanc
protein
aggreg
beclin
reduc
affect
brain
region
alzheim
diseas
ad
patient
associ
accumul
amyloid
aggreg
recent
studi
suggest
reduc
beclin
level
neuron
impair
autophagi
promot
amyloid
accumul
howev
microglia
also
capabl
regul
clearanc
aggreg
phagocytosi
despit
emerg
link
autophagi
phagosom
matur
role
beclin
microglia
remain
unclear
therefor
sought
determin
whether
beclin
regul
microgli
phagocytosi
use
lentiviru
encod
beclin
shrna
reduc
beclin
level
microgli
cell
ie
cell
assess
whether
reduc
beclin
impair
phagocytosi
amyloid
beta
ab
clearanc
measur
phagocytosi
util
latex
bead
rapidli
phagocytos
ad
microgli
cultur
use
model
find
reduc
beclin
level
microglia
decreas
number
cell
phagocytos
bead
number
intern
bead
per
cell
impair
intern
bead
beclin
defici
microglia
appear
specif
result
defect
phagocytosi
sinc
endocytosi
transferrin
receptor
impair
importantli
phagocyt
defect
beclin
defici
microglia
revers
rescu
beclin
level
via
beclin
overexpress
lentiviru
use
exvivo
amyloid
precursor
protein
app
brain
slice
model
also
find
beclin
defici
microglia
less
effici
degrad
cortic
hippocamp
ab
impair
ab
clearanc
beclin
defici
microglia
explain
deficit
lysosom
function
cellular
migrat
compar
control
cell
suggest
beclin
regul
intrins
cellular
machineri
requir
phagocytosi
togeth
data
suggest
reduc
beclin
level
ad
brain
may
allow
enhanc
diseas
progress
impair
microgli
phagocytosi
therefor
strategi
enhanc
beclin
level
may
provid
novel
approach
treatment
ad
protein
member
granin
famili
exert
import
role
sort
aggreg
secretori
product
subsequ
granul
biogenesi
regul
secretori
pathway
addit
intracellular
function
intact
granin
proteolyticderiv
peptid
mediat
celltocel
signal
includ
homeostat
process
inflammatori
reaction
innat
immun
sgiii
littl
known
granin
express
endocrin
cell
platelet
mast
cell
rodent
cn
neuron
astrogli
cell
abundantli
express
sgiii
synthesi
upregul
traumat
injuri
reactiv
astrocyt
present
studi
examin
distribut
express
level
sgiii
cerebr
cortex
alzheim
diseas
neuropatholog
typic
associ
synapt
dysfunct
inflammatori
chang
transgen
mice
express
mohu
construct
conjunct
variant
human
intens
sgiii
immunolabel
detect
vicin
amyloidbeta
plaqu
neocortex
hippocampu
cerebellum
control
human
hippocampu
sgiii
locat
mainli
neuron
somata
process
scatter
glial
cell
bodi
alzheim
diseas
betaamyloid
plaqu
surround
strong
sgiii
immunostain
present
studi
show
first
time
distribut
sgiii
human
brain
demonstr
dramat
accumul
protein
close
amyloidbeta
plaqu
alzheim
diseas
involv
sgiii
inflammatori
mechan
found
alzheim
diseas
remain
evalu
neuroprotect
role
oligomer
amyloid
beta
toxic
mizuno
tetsuya
doi
yukiko
jin
shiji
mizoguchi
hiroyuki
takeuchi
hideyuki
suzumura
akio
neuroimmunolgi
riem
nagoya
univers
nagoya
japan
futurist
environment
simul
center
riem
nagoya
univers
nagoya
japan
newli
discov
induc
prolifer
monocyt
macrophag
similari
macrophagecoloni
stimulatig
factor
express
brain
howev
produc
cell
function
remain
uncertain
solubl
oligomer
amyloid
beta
oabeta
contribut
neurotox
synapt
dysfunct
alzheim
diseas
ad
microglia
macrophagelik
resid
immun
cell
brain
accumul
senil
plaqu
ad
neurotox
neuroprotect
properti
studi
found
neuron
cell
astrocyt
brain
endotheli
cell
produc
microglia
express
receptor
microglia
activ
attenu
oabeta
neurotox
primari
neuronmicroglia
cocultur
enhanc
microgli
prolifer
clearanc
oabeta
induc
antioxid
enzym
heme
microglia
furthermor
intracerebroventricular
administr
amelior
impair
associ
learn
mous
model
ad
data
support
idea
enhanc
microgli
neuroprotect
properti
may
effect
therapeut
strategi
limit
oabeta
neurotox
ad
role
cytosol
phospholipas
alpha
neuron
degener
sagybross
chen
hadad
nurit
levi
rachel
bengurion
univers
negev
beersheva
israel
bengurion
univers
negev
beersheva
israel
alzheim
diseas
ad
clinic
character
dementia
patholog
progress
loss
neuron
senil
plaqu
neurofibrillari
tangl
vascular
deposit
amyloidbeta
peptid
recent
evid
indic
inflamm
occur
patholog
vulner
region
ad
brain
recent
studi
show
aggreg
ab
may
caus
direct
neuron
damag
death
cytosol
phospholipas
alpha
requisit
compon
cascad
event
lead
product
eicosanoid
acut
chronic
inflamm
aim
present
studi
examin
whether
particip
cortic
neuron
damag
induc
ab
addit
ab
primari
cortic
neuron
caus
decreas
neuron
viabil
determin
cell
count
mtt
reduct
induc
immedi
activ
detect
phosphoryl
serin
upregul
detect
h
presenc
specif
antisens
prevent
upregul
also
prevent
neuron
death
induc
ab
like
wise
ab
induc
activ
nadph
oxidas
releas
intern
superoxid
inhibit
presenc
diphenyliodonium
apocyanin
presenc
nadph
oxidas
inhibitor
prevent
activ
indic
stream
oxidas
neuron
cell
death
result
necrosi
determin
ldh
releas
probabl
apoptosi
indic
caspas
cleavag
dapi
tunel
stain
cleav
caspas
detect
prior
cleav
caspas
prevent
presenc
exposur
neuron
ab
h
induc
product
amyloid
precursor
protein
app
may
result
higher
accumul
ab
enhanc
toxic
effect
result
suggest
involv
ab
induct
neuron
apoptosi
via
activ
caspas
product
app
thu
may
serv
therapeut
target
ad
investig
rate
time
gener
childhood
ocular
myasthenia
gravi
omg
studi
whether
regular
immunosuppress
treatment
prevent
progress
omg
gener
myasthenia
gravi
gmg
retrospect
analysi
perform
data
bank
mg
patient
diagnos
treat
mg
clinic
hospit
childhood
mg
defin
onset
mg
yearsold
omg
defin
present
symptom
confin
ocular
movement
function
ptosi
dipoplia
strabismu
medic
data
patient
childhood
omg
adult
whose
age
onset
year
omg
followup
period
least
one
year
includ
medic
data
childhood
omg
patient
review
compar
data
adult
omg
patient
period
consecut
enrol
patient
follow
year
mean
year
childhood
adult
patient
lost
followup
follow
less
one
year
exclud
gener
rate
childhood
omg
adult
omg
respect
p
b
childhood
omg
patient
progress
gmg
patient
develop
gmg
within
first
year
onset
adult
omg
patient
progress
gmg
patient
develop
gmg
within
first
year
p
b
gener
rate
childhood
omg
patient
receiv
regular
mediumdos
glucocorticoid
base
scheme
treat
concomitantli
immunosuppress
drug
intraven
immunoglobulin
least
six
month
childhood
omg
patient
receiv
regular
immunosuppress
treatment
treat
less
six
month
respect
p
b
childhood
omg
patient
male
femal
progress
gmg
p
n
gener
rate
childhood
omg
significantli
lower
adult
omg
chanc
gener
childhood
omg
within
first
year
onset
significantli
lower
adult
omg
regular
immunosuppress
treatment
may
prevent
gener
childhood
omg
patient
acetylcholin
receptor
antibodi
myasthenia
gravi
studi
north
chines
patient
myasthenia
gravi
mg
autoimmun
disord
mainli
caus
antibodi
acetylcholin
receptor
achr
autoantibodi
absolut
specif
diseas
detect
major
mg
patient
lack
literatur
serolog
statu
chines
mg
patient
studi
attempt
made
determin
achr
antibodi
posit
cohort
mg
patient
north
china
possibl
relationship
serolog
clinic
statu
definit
mg
patient
north
china
recruit
beij
friendship
hospit
affili
hospit
medic
colleg
qingdao
univers
demograph
data
gender
age
diagnosi
onset
clinic
featur
record
complet
blood
taken
acut
phase
recurr
phase
achr
antibodi
test
done
medic
diagnost
institut
laboratori
berlin
germani
use
receptor
assay
rra
kit
valu
nmoll
consid
posit
patient
taken
thymu
examin
includ
ct
scan
andor
patholog
exam
thymusectomi
mg
patient
thymoma
patient
antibodi
patient
without
thymoma
antibodi
posit
rate
seem
higher
thymoma
group
differ
statist
signific
thirtyeight
patient
symptom
limit
ocular
muscl
antibodi
fortysix
gener
group
patient
also
antibodi
differ
two
clinic
type
achr
antibodi
posit
rate
higher
gener
group
ocular
group
group
mg
patient
thymoma
mayb
higher
achr
antibodi
posit
rate
need
case
surpport
antibodi
posit
rate
similar
two
gender
ralationship
age
onset
antibodi
citrullin
peptid
ccp
childhood
autoimmmun
neurolog
disord
anlar
banu
sonmez
mujgan
anlar
f
yasar
hacettep
univers
ankara
turkey
bayindir
medic
center
citrullin
peptid
ccp
recogn
target
autoimmun
respons
certain
disord
particularli
rheumatoid
arthriti
ra
citrullin
deimin
posttransl
modif
arginin
residu
reduc
net
charg
protein
chang
ionic
interact
alter
threedimension
structur
function
protein
central
nervou
system
cn
physiolog
citrullin
myelin
basic
protein
mbp
ensur
function
myelin
total
mbp
citrullinatedpatholog
citrullin
mbp
result
open
conform
increas
suscept
cleavag
expos
epitop
immun
system
citrullin
mbp
demonstr
degen
cn
diseas
scrapieif
caus
citrullin
mbp
may
facilit
epitop
spread
worsen
multipl
sclerosi
ms
cell
respons
citrullin
mbp
stronger
ms
compar
control
subject
thu
citrullin
mbp
may
import
demyelin
diseas
howev
adult
ms
patient
test
anticcp
found
neg
childhood
ms
differ
adult
ms
environmant
genet
immunolog
aspect
investig
children
adolesc
autoimmun
cn
disord
presenc
seroposit
citrullin
peptid
sera
children
male
femal
age
year
autoimmun
neurolog
condit
test
anticcp
use
immunoscan
kit
eurodiagnostica
sweden
diagnos
ms
n
sydenham
chorea
n
optic
neuriti
n
clinic
isol
syndrom
n
acut
dissemin
encephalomyel
n
other
cerebel
limbic
enceph
myeliti
sampl
neg
accord
cutoff
valu
determin
ra
four
sampl
low
titer
uml
neg
control
uml
anticcp
antibodi
belong
three
patient
ms
age
girl
one
boy
one
yearold
girl
sydenham
chorea
antibodi
random
citrullin
peptid
absent
lowtit
childhood
autoimmun
neurolog
disord
describ
childhood
ra
howev
cutoff
valu
might
need
revis
neurolog
disord
develop
pratic
method
test
anticitrullin
mbp
would
interest
antiphosphacan
antibodi
cidp
kusunoki
susumu
aomatsu
hiromi
moris
jyoji
oka
shogo
kinki
univers
osakasayama
japan
kyoto
univers
kyoto
japan
antiglycolipid
antibodi
frequent
present
acutephas
sera
patient
syndrom
contrast
specif
autoantibodi
unknown
chronic
inflammatori
demyelin
polyneuropathi
cidp
igm
paraproteinem
neuropathi
half
igm
mprotein
specif
bind
epitop
myelinassoci
glycoprotein
mag
sulfat
glucuronyl
paraglobosid
sgpg
sever
glycoconjug
epitop
serum
antibodi
antigen
investig
investig
antibodi
activ
epitop
phosphacan
chondroitin
sulfat
proteoglycan
serum
sampl
cidp
patient
investig
patient
met
diagnost
criteria
report
j
periph
nerv
syst
sera
normal
control
patient
antimag
igm
mprotein
igmn
also
examin
phosphacan
epitop
prepar
transfect
phosphacan
synthes
enzym
glcatp
cell
follow
purif
cell
cultur
supernat
phosphacan
without
epitop
also
prepar
antiphosphacan
antibodi
examin
elisa
sera
od
higher
mean
normal
control
sera
consid
positivesera
three
cidp
patient
elev
titer
igm
antiphosphacan
antibodi
none
sera
show
igm
antibodi
activ
phosphacan
without
epitop
six
igmn
patient
igm
antiphosphacan
antibodi
three
antiphosphacan
igmposit
cidp
patient
ataxia
none
antimag
antibodi
cidp
patient
without
antimag
antibodi
elev
titer
antiphosphacan
igm
antibodi
epitop
target
antibodi
antiphosphacan
antibodi
may
associ
ataxia
cidp
examin
differenti
antibodi
activ
sever
glycoconjug
epitop
warrant
respect
frequent
one
everi
locu
mg
group
healthi
control
associ
hla
allel
profil
mg
frequenc
p
b
significantli
higher
patient
control
associ
hla
haplotyp
profil
mg
identifi
ab
twolocushaplotyp
twolocu
haploty
twolocu
haploty
abdrb
threelocu
haplotyp
evid
import
circadian
rhythm
neuroimmunoendocrin
commun
specif
immun
system
rapidli
increas
recent
year
addit
rise
number
data
support
relationship
somat
dysfunct
regulatori
system
name
nervou
immun
endocrin
system
context
aim
present
work
confirm
whether
osteopath
manipul
treatment
omt
spinal
somat
dysfunct
could
exert
influenc
circadian
rhythm
sever
function
peripher
blood
human
neutrophil
blood
sampl
obtain
group
young
healthi
women
men
spinal
pain
symptom
afterward
volunt
randomli
divid
two
group
one
group
n
perform
omt
group
maintain
without
treatment
control
n
pm
second
blood
sampl
ml
obtain
donor
group
blood
sampl
sever
neutrophil
function
phagocyt
process
studi
endotheli
adhes
capac
spontan
mobil
chemotaxi
phagocytosi
inert
particl
phagocyt
effici
basal
stimul
superoxid
anion
level
result
control
group
show
signific
function
decreas
neutrophil
pm
paramet
spontan
mobil
chemotaxi
basal
superoxid
anion
level
circadian
rhythm
modifi
omt
sinc
function
control
group
chang
pm
experienc
decreas
endotheli
adhes
capac
increas
phagocytosi
stimul
superoxid
anion
level
treat
group
moreov
function
decreas
pm
control
group
stimul
time
omt
group
reach
similar
higher
level
conclus
result
show
omt
modifi
circadian
rhythm
function
studi
neutrophil
improv
immun
respons
within
physiolog
limit
better
immun
perform
could
contribut
mainten
appropri
immun
system
activ
infect
homeostat
chang
time
day
function
begin
declin
financi
support
mcinn
ucm
research
group
reticef
investig
clinic
characterist
elderlyonset
myasthenia
gravi
mg
older
onset
china
method
mg
recruit
studi
follow
june
may
identifi
case
onset
diseas
age
elderlyonset
mg
eomg
case
onset
diseas
adultonset
mg
aomg
patient
demograph
data
gender
age
diagnosi
age
onset
diseas
cours
diagnosi
clinic
featur
mg
osserman
classif
diseas
sever
accord
recommend
clinic
research
standard
presenc
associ
disord
choic
therapi
record
result
eomg
patient
seri
malefemal
ratio
age
onset
rang
year
first
complaint
eomg
patient
commonli
extraocular
paralysi
maximum
sever
diseas
eomg
patient
gener
mg
gmg
proport
gmg
eomg
patient
less
aomg
patient
maximum
sever
diseas
p
b
ct
scan
thymu
eomg
patient
reveal
thymoma
patient
eomg
group
less
thymoma
aomg
group
fiftyon
eomg
patient
associ
medic
diseas
compar
case
aomg
group
p
b
twentyeight
eomg
patient
treat
pyridostigmin
glucocorticoid
use
eomg
patient
significantli
less
aomg
group
p
b
immunosuppress
azathioprin
cyclophosphamid
cyclosporin
tacrolimu
use
eomg
patient
thymectomi
perform
eomg
patient
significantli
less
aomg
group
p
b
conclus
characterist
eomg
compris
higher
frequenc
ocular
form
onset
less
proport
gmg
maximum
sever
diseas
proport
associ
medic
diseas
limit
usag
glucocorticoid
thymectomi
usag
immunosuppress
medic
univers
ishikawa
japan
ms
center
utano
nation
hospit
kyoto
japan
brain
research
institut
niigata
univers
niigata
japan
neuromyel
optica
spectrum
disord
nmosd
group
inflammatori
demyelin
diseas
associ
autoantibodi
popul
preval
nmosd
firmli
establish
variou
clinic
featur
nmosd
report
aspect
clinic
cours
anatom
distribut
demyelinationg
lesion
studi
investig
clinicoepidemiolog
featur
posit
patient
larg
japanes
cohort
test
serum
sampl
japanes
patient
diagnos
inflammatori
demyelin
disord
central
nervou
system
whose
serum
sampl
sent
institut
test
clinic
inform
patient
obtain
refer
physician
measur
indirect
immunofluoresc
stain
use
human
hek
cell
sensit
test
specif
base
popul
longitudin
extens
spinal
cord
lesion
lescl
mri
andor
sever
visual
disturb
patient
posit
femal
ratio
none
present
primari
secondari
progress
cours
averag
age
onset
yearold
mri
spinal
cord
lesion
detect
includ
lescl
cerebr
lesion
unilater
bilater
blind
notic
patient
accompani
sjogren
syndrom
ss
thyroid
diseas
myelin
basic
protein
mbp
cerebrospin
fluid
csf
posit
male
patient
present
higher
onset
age
frequent
brainstem
lesion
mri
posit
mbp
csf
patient
child
onset
present
optic
neuriti
first
symptom
nmo
type
patient
lescl
sever
visual
disturb
includ
neg
nmo
type
neg
patient
show
lower
femal
ratio
lower
onset
age
posit
patient
confirm
show
femal
preponder
higher
onset
age
lescl
sever
visual
disturb
main
clinic
featur
high
preval
ss
thyroid
diseas
child
onset
patient
tend
suffer
optic
neuriti
posit
neg
nmo
type
patient
show
differ
epidemiolog
featur
clinic
spectrum
antinmda
receptor
antibodi
relat
enceph
diagnos
cellbas
immunofluorescens
detect
system
tanaka
keiko
nakata
michiyo
matsui
makoto
sakimura
kenji
kanazawa
medic
univers
ishikawa
japan
niigata
univers
niigata
japan
sever
enceph
favor
outcom
predominantli
affect
young
women
ovarian
teratoma
increasingli
recogn
japan
preval
appear
signific
establish
detect
system
antibodi
nmda
receptor
use
cotransfect
hek
cell
cultur
hippocamp
neuron
antibodyposit
patient
show
characterist
clinic
featur
describ
jdalmau
pennsylvania
univ
howev
antibodyposit
patient
show
atyp
featur
occasion
cluster
convuls
plasmapheresi
methylprednisolon
puls
therapi
amelior
diseas
cours
lower
antibodi
titer
establish
antinmda
receptor
antibodydetect
system
clone
cdna
encod
nmdar
insert
express
vector
transfect
hek
cell
patient
sera
cerebrospin
fluid
csf
appli
antibodybind
detect
use
fluorescencelabel
antihuman
igg
rabbit
antibodi
also
use
determin
coloc
among
patient
examin
antibodyposit
compris
femal
patient
mean
age
onset
start
psychiatr
symptom
half
show
convuls
involuntari
movement
autonom
disord
hypoventil
antibodyposit
patient
show
occasion
convuls
fifti
three
percent
antibodyposit
patient
ovarian
teratoma
improv
short
period
tumor
remov
immunotherapi
establish
cellbas
assay
antinmda
receptor
antibodi
use
immiunofluorescens
stain
nmda
receptor
cotransfect
hek
cell
cultur
hippocamp
neuron
antinmda
receptor
antibodyposit
patient
show
characterist
clinic
featur
describ
nmdarrel
enceph
jdalmau
howev
clinic
varieti
monosymptom
epilepsi
psychiatr
disord
chronic
cours
also
exist
lamberteaton
myasthen
syndrom
lem
autoimmun
disord
neuromuscular
transmiss
caus
weak
absent
reflex
autonom
dysfunct
lem
thought
caus
autoantibodi
voltageg
calcium
channel
vgcc
control
releas
acetylcholin
motor
nerv
current
autoantibodi
bind
specif
pqtype
vgcc
detect
patient
radioimmunoprecipit
assay
use
neurotoxin
conotoxin
mviic
cmtx
mviic
assay
avail
mani
centr
worldwid
develop
method
label
complex
protein
use
enhanc
green
fluoresc
protein
egfp
incorpor
protein
littl
effect
confirm
water
et
al
wang
et
al
fluorescenttag
protein
express
mammalian
cell
use
either
cellbas
assay
solubilis
use
immunoprecipit
establish
nonradioact
assay
vgcc
antibodi
produc
fluorescenttag
vgcc
subunit
pore
form
subunit
subunit
identifi
surfac
express
egfptaggedvgcc
human
cell
line
use
mviic
commerci
avail
antibodi
human
vgcc
bound
surfac
cell
egfptag
vgcc
immunoprecipit
antiegfp
antibodi
test
use
egfpvgcc
cell
extract
immunoprecipit
assay
compar
result
standard
radioimmunoassay
develop
assay
lem
may
allow
greater
access
diagnost
assay
speed
diagnosi
result
improv
health
care
may
especi
valuabl
patient
suspect
carcinoma
rapid
identif
treatment
result
improv
prognosi
multipl
sclerosi
ms
patient
respond
standard
treatment
receptor
alpha
monoclon
antibodi
daclizumab
basilixumab
constitut
innov
therapeut
strategi
patient
respond
daclizumab
reduct
new
contrastenhanc
lesion
correl
expans
subset
nk
cell
bielekova
mechan
expans
immunoregulatori
effect
well
understood
object
work
analyz
mechan
action
receptor
alpha
block
antibodi
ms
patient
identifi
marker
predict
outcom
treatment
individu
patient
follow
longitudin
small
cohort
ms
patient
treat
antibodi
analyz
nk
cell
subset
express
activ
marker
adhes
molecul
select
chemokin
cytokin
receptor
flow
cytometri
patient
treat
antibodi
show
slight
decreas
absolut
number
nkt
nk
cell
expect
subpopul
increas
nk
cell
respond
patient
expand
cell
express
higher
level
receptor
beta
popul
untreat
patient
healthi
donor
order
understand
mechan
expans
cell
ad
antibodi
bulk
cultur
peripher
blood
mononuclear
cell
stimul
analyz
prolifer
differ
nk
cell
subset
independ
treatment
antibodi
result
reduc
prolifer
nkt
nk
cell
nk
show
enhanc
prolifer
hypothes
block
high
affin
receptor
trimer
complex
compris
alpha
beta
gamma
subunit
receptor
cell
result
higher
avail
intermedi
affin
receptor
beta
gamma
subunit
nk
cell
high
receptor
block
cell
summari
show
vitro
vivo
nk
cell
prolifer
presenc
block
antibodi
cell
express
differenti
surfac
marker
compar
nk
cell
untreat
ms
patient
healthi
donor
variat
matrix
metalloproteinas
mmp
gene
relat
presenc
sever
atherosclerosi
purpos
studi
investig
effect
angiotensin
ii
ang
ii
matrix
metalloproteinas
mmp
vascular
smooth
muscl
cell
vsmc
compar
effect
captopril
losartan
maip
ang
iimedi
mmp
express
rtpcr
use
measur
chang
vsmc
treat
angiotensin
ii
differ
concentr
differ
time
point
vsmc
pretreat
captopril
losartan
maip
manner
compar
effect
three
drug
ang
iimedi
mmp
express
ang
ii
increas
mrna
express
dosedepend
timedepend
way
mrna
level
induc
ang
ii
increas
earlier
either
pretreat
vsmc
captopril
losartan
maip
respect
ang
iiinduc
mmp
express
significantli
inhibit
signific
differ
among
three
drugtreat
group
term
chang
mmp
observ
result
suggest
maip
inhibitori
effect
ang
iiinduc
express
mmp
vsmc
compar
captopril
losartan
thought
somat
dysfunct
concret
vertebr
somat
dysfunct
vsd
would
potenti
damag
nervou
system
trigger
metamer
wind
leucocyt
local
activ
stimul
allostat
system
distort
spine
root
transmiss
caus
backneck
pain
context
neuroimmunoendocrin
commun
aim
present
work
studi
whether
osteopath
manipul
treatment
omt
abl
control
symptom
patient
vsd
improv
lymphocyt
function
young
men
women
year
age
suffer
backneck
symptom
associ
vsd
develop
diagnostictherapeut
osteopath
protocol
spinal
facilit
segment
segment
facilitationhypersensit
previous
identifi
palpat
test
particip
randomli
dividev
two
group
similar
age
omttreat
nontreat
group
pain
test
three
hour
treatment
use
analog
visual
scale
av
second
av
evalu
made
sampl
peripher
blood
subject
group
obtain
evalu
sever
lymphocyt
function
endotheli
adhes
capac
spontan
mobil
chemotaxi
prolifer
respons
mitogen
pha
cell
viabil
result
obtain
show
spinal
pain
reduct
treat
group
also
improv
lymphocyt
function
evalu
conclus
spinal
omt
could
use
diminish
vertebr
somat
pain
improv
immun
respons
could
ultim
reduc
preval
infecti
diseas
chronic
inflammatori
demyelin
polyneuropathi
cidp
syndrom
gb
autoimmun
diseas
peripher
nervou
system
pn
clinic
hallmark
cidp
gb
albuminocytolog
dissoci
cerebrospin
fluid
csf
chang
csf
level
protein
albumin
patient
cidp
gb
well
studi
howev
aberr
level
protein
render
possibl
search
use
biomark
cidp
gb
sandwich
enzymelink
immunosorb
assay
elisa
use
measur
level
prealbumin
haptoglobin
fibrinogen
csf
plasma
sampl
patient
cidp
gb
well
control
consist
patient
neurolog
disord
ond
multipl
sclerosi
ms
level
csf
prealbumin
fibrinogen
measur
csf
index
protein
lower
patient
cidp
gb
control
csf
haptoglobin
index
elev
patient
cidp
ms
gb
compar
control
ond
data
provid
preliminari
evid
concentr
prealbumin
fibrinogen
decreas
csf
patient
cidp
gb
although
mechan
remain
clarifi
reduc
rate
product
altern
increas
rate
degrad
protein
within
csf
might
partli
explain
reduct
prealbumin
fibrinogen
might
serv
promis
candid
biomark
cidp
gb
evalu
qol
patient
myasthenia
gravi
use
nemoto
yuko
chiba
univers
chiba
japan
tool
object
evalu
qol
eight
subscal
physic
function
pf
rolephys
rf
bodili
pain
bp
gener
health
gh
vital
vt
social
function
sf
roleemot
mental
health
mh
use
evalu
qol
patient
myasthenia
gravi
mg
studi
popul
compris
ambulatori
mg
patient
femal
male
undergon
thymectomi
posit
antiacetylcholin
receptor
antibodi
mean
age
year
rang
mean
durat
ill
year
mean
time
thymectomi
year
histolog
examin
thymu
reveal
hyperplasia
patient
noninvas
thymoma
invas
thymoma
normal
type
unknown
type
chemotherapeut
drug
use
includ
steroid
patient
tacrolimu
cyclosporin
survey
time
breakdown
subject
mgfa
class
patient
iia
iib
iiia
iiib
mgadl
scale
rate
survey
time
averag
rang
subject
investig
three
viewpoint
rate
eight
subscal
base
nation
standard
valu
postop
chang
physic
compon
summari
pc
score
mental
compon
summari
mc
score
correl
pc
mc
score
concurr
mgadl
rate
pf
surgeri
reason
level
pc
mc
maintain
long
time
mc
level
higher
pc
level
pc
mc
score
correl
mgadl
scale
rate
elderli
patient
lower
score
due
complic
although
subject
rel
mildli
affect
outpati
ambulatori
treatment
qol
level
lower
standard
level
thymectomi
immunosuppress
therapi
combin
good
qol
maintain
long
time
mg
patient
without
complic
mgadl
scale
provid
rate
correl
rate
use
conveni
tool
evalu
qol
mg
patient
schizophrenia
one
abund
psychiatr
diseas
preval
popul
bangladesh
threaten
abnorm
elat
mental
state
typic
character
feel
euphoria
lack
inhibit
race
thought
diminish
need
sleep
talk
risk
talk
irrit
laboratori
test
schizophrenia
current
exist
hair
concentr
zinc
zn
calcium
ca
manganes
mn
schizophren
patient
normal
healthi
subject
analyz
flame
atom
absorpt
spectroscopi
faa
data
express
mean
standard
deviat
sd
analyz
statist
softwar
statist
packag
social
scienc
spss
person
comput
pc
window
version
comparison
patient
control
group
made
use
independ
sampl
ttest
group
interview
ask
complet
questionnair
concern
use
drug
includ
use
diabet
medic
steroid
smoke
habit
could
affect
outcom
result
concentr
mn
schizophren
patient
chang
significantli
p
n
compar
control
concentr
zn
decreas
significantli
schizophren
patient
p
b
compar
control
group
ca
level
also
lower
schizophren
patient
p
b
chang
hair
concentr
zn
ca
mn
may
prognost
signific
diagnosi
schizophrenia
socioeconom
data
reveal
patient
poor
middleag
divorc
mean
bodi
mass
index
bmi
control
group
patient
group
within
normal
rang
pearson
correl
analysi
suggest
ca
concentr
patient
signific
invers
correl
bmi
r
p
justifi
regress
analysi
p
oneway
analysi
varianc
anova
test
f
p
may
conclud
zn
ca
concentr
scalp
hair
control
schizophren
patient
chang
compar
control
also
signific
relationship
bmi
ca
level
schizophren
patient
observ
howev
work
larg
popul
suggest
examin
exact
correl
trace
element
level
degre
disord
investig
incid
extrathym
malign
myasthenia
gravi
mg
patient
retrospect
hospitalbas
cohort
clinicopatholog
featur
mg
patient
extrathym
malign
describ
analyz
examin
whether
gender
age
onset
osserman
type
maxim
sever
associ
thymoma
stage
thymoma
immunosuppress
therapi
would
determin
increas
risk
extrathym
malign
cohort
consecut
enrol
mg
patient
regularli
follow
least
six
month
mean
time
followsup
year
fiftyon
patient
develop
extrathym
tumor
develop
extrathym
malign
incid
malign
cohort
significantli
higher
common
chines
popul
men
p
b
women
p
b
malign
includ
lung
cancer
breast
cancer
liver
cancer
gastric
cancer
brain
glioma
solid
malign
tumor
metastat
tumor
undetermin
sourc
tumor
diagnos
year
prior
diagnosi
mg
patient
year
diagnosi
mg
patient
concurr
diagnosi
mg
patient
thymoma
found
patient
incid
significantli
higher
male
femal
p
b
incid
significantli
higher
patient
higher
age
onset
p
b
incid
significantli
lower
ocular
mg
group
gener
group
p
b
differ
among
osserman
ii
iii
iv
type
p
n
incid
significantli
higher
patient
thymoma
patient
without
thymoma
p
b
signific
differ
incid
among
subgroup
differ
thymoma
stage
p
n
incid
patient
treat
glucocorticoid
significantli
differ
incid
treat
combin
therapi
p
n
occurr
extrathym
malign
preval
mg
patient
common
popul
extrathym
malign
male
patient
higher
age
onset
gener
mg
patient
patient
thymoma
osserman
type
stage
thymoma
therapi
mg
relat
incid
extrathym
malign
mg
patient
multipl
sclerosi
ms
inflammatori
autoimmun
diseas
lead
demyelin
neurodegener
central
nervou
system
signific
herit
compon
recent
genomewid
associ
studi
identifi
sever
singl
nucleotid
polymorph
snp
multipl
sclerosi
riskconf
gene
variant
besid
haplotyp
among
other
snp
gene
encod
alphachain
receptor
associ
ms
risk
four
snp
includ
suffici
describ
common
haplotyp
snp
affect
splice
lead
chang
ratio
membranebound
solubl
isoform
specul
chang
affect
function
interact
ie
support
homeostat
prolifer
cell
protect
apoptosi
exact
function
consequ
contribut
ms
risk
larg
unknown
order
dissect
latter
genotyp
ms
patient
hamburg
cohort
basi
function
studi
thu
far
examin
geneand
protein
express
taqman
pcr
elisa
respect
data
support
serum
level
mrna
express
correl
haplotyp
investig
find
associ
differ
cell
surfac
express
analys
variou
cell
popul
previous
associ
pathogenesi
ms
regard
result
show
haplotyp
influenc
three
aspect
studi
address
mechan
differenti
express
chain
translat
autoimmun
inflamm
ms
underway
present
primari
progress
pp
nonact
phase
ill
select
chp
clinic
immunolog
unit
neuroimmunolog
outpati
clinic
particip
underw
neurolog
examin
answer
hospit
anxieti
depress
scale
perform
briefsmel
identif
test
bsit
cutoff
score
ie
percentil
healthi
demograph
match
subject
use
classifi
hyposmia
nonparametr
test
ie
fisher
exact
mannwhitney
use
analyz
resultsresult
impair
odor
identif
found
sle
ms
patient
sle
patient
hyposmia
higher
level
depress
p
anxieti
p
impair
odor
identif
sle
associ
current
intak
benzodiazepin
vs
p
antidepress
prednison
therapi
age
educ
diseas
durat
overt
cn
involv
ms
patient
hyposmia
higher
level
depress
p
increas
anxieti
p
hyposmia
ms
relat
higher
age
p
lower
educ
p
longer
diseas
durat
p
higher
disabl
edss
p
faster
diseas
progress
msss
p
cours
diseas
rr
sp
pp
p
b
signific
associ
found
antidepress
benzodiazepin
prednison
therapi
conclus
present
studi
document
odor
identif
deficit
sle
ms
patient
provid
evid
associ
hyposmia
depress
diseas
find
consist
literatur
paus
colleagu
report
patient
major
depress
low
olfactori
threshold
resect
olfactori
bulb
rodent
found
result
depressionlik
behavior
kelli
et
al
song
leonard
assess
preval
characterist
mild
cognit
impair
mci
primari
syndrom
pss
compar
system
lupu
erythematosu
sle
concept
mild
cognit
impair
mci
refer
transit
state
cognit
normal
age
mild
dementia
also
defin
mild
impair
multipl
cognit
domain
ie
impair
cognit
function
fall
within
lower
spectrum
testnorm
none
suffici
sever
constitut
dementia
mci
may
sometim
progress
form
definit
dementia
sixtyeight
patient
fulfil
revis
acr
criteria
sle
patient
fulfil
europeanamerican
criteria
pss
particip
popul
base
studi
neuropsycholog
test
provid
composit
zscore
memori
verbal
reason
visuospati
executiveattent
function
adjust
age
sex
educ
base
perform
healthi
subject
zscore
sd
least
one
domain
qualifi
mci
seventeen
multivari
analysi
varianc
follow
tukey
hsd
correct
posthoc
multipl
comparison
reveal
groupdiffer
cognit
wilk
lambda
p
b
signific
differ
pss
sle
sle
pss
wors
executiveattent
function
control
p
b
sle
wors
visuospati
function
p
analysi
covari
depress
bdi
fatigu
fss
group
adher
covari
reveal
group
differ
memori
executiveattent
function
could
explain
variat
level
fatigu
fss
effect
group
evid
visuospati
function
control
depress
fatigu
p
b
impair
visuospati
function
sle
group
could
explain
rel
contribut
fatigu
depress
executiveattent
impair
pss
sle
patient
may
share
common
pathogenet
mechan
may
tie
level
fatigu
certain
relationship
causal
direct
may
impli
impair
visuospati
function
sle
patient
explain
rel
contribut
fatigu
may
therefor
due
possibl
slespecif
diseas
mechan
associ
brain
magnet
reson
mr
imag
find
clinic
disabl
patient
suffer
multipl
sclerosi
ms
gener
weak
known
clinicoradiolog
paradox
present
studi
investig
much
inform
structur
mri
pattern
contain
clinic
disabl
ms
patient
tri
predict
sever
marker
symptom
sever
marker
includ
expand
disabl
statu
scale
edss
peg
test
hpt
time
walk
test
twt
measur
motor
disabl
pace
auditori
serial
addit
task
pasat
measur
cognit
dysfunct
diseas
durat
structur
weight
mr
imag
fortyon
patient
clinic
definit
ms
enter
analysi
normal
mr
imag
conduct
local
patternbas
regress
analysi
marker
analys
local
pattern
extract
given
mr
imag
use
searchlight
approach
searchlight
posit
voxel
intens
within
searchlight
use
canon
correl
analysi
predict
symptom
sever
marker
assess
generaliz
regress
perform
perform
leaveoneout
crossvalid
result
given
correl
predict
true
clinic
score
turn
edss
could
predict
neither
basi
basi
weight
imag
howev
hpt
twt
could
well
predict
supplementari
motor
area
base
weight
imag
region
found
weight
imag
pasat
score
mainli
assess
auditori
process
speed
work
memori
function
could
decod
mani
taskrel
region
eg
prefront
cortex
angular
gyru
fusiform
parahippocampu
weight
imag
inferior
pariet
lobe
prefront
cortex
parahippocampu
weight
imag
diseas
durat
could
predict
inferior
occipit
lobe
weight
imag
find
provid
evid
structur
mri
pattern
disabilityrel
region
contain
inform
diseas
durat
motor
disabl
cognit
dysfunct
howev
edss
global
marker
clinic
disabl
could
predict
altogeth
regress
analys
base
weight
imag
superior
analys
base
weight
imag
argu
relev
weight
imag
understand
clinic
disabl
ms
chronic
kidney
diseas
ckd
receiv
particular
attent
year
preced
stage
endstag
renal
diseas
nephrotox
one
wellknown
side
effect
immunosuppress
use
myasthenia
gravi
mg
steroidspar
agent
treat
refractori
gener
diseas
howev
studi
renal
function
mg
patient
therefor
examin
preval
risk
factor
ckd
mg
patient
estim
glomerular
filtrat
rate
gfr
mg
patient
serum
creatinin
scr
measur
least
april
april
examin
relationship
ckd
stage
estim
gfr
egfr
age
histori
diabet
mellitu
dm
hypertens
ht
use
chemotherapi
regular
nsaid
use
iodin
contrast
materi
use
gfr
estim
use
modifi
egfr
egfr
scr
age
femal
propos
japanes
societi
nephrolog
ckd
present
patient
stage
three
stage
mean
age
increas
year
stage
year
stage
ht
present
overal
increas
stage
stage
number
patient
histori
use
chemotherapi
increas
stage
stage
ckd
patient
without
risk
factor
year
old
ht
dm
believ
decreas
gfr
may
caus
use
chemotherapi
onset
exacerb
dm
ht
found
patient
use
cyclospolin
patient
use
tacrolimu
hand
regular
nsaid
use
iodin
contrast
materi
use
associ
gfr
decreas
ckd
highli
preval
mg
patient
rel
gener
japanes
popul
age
year
addit
gener
ckd
risk
factor
nephrotox
complic
due
chemotherapi
consider
influenc
gfr
mg
decreas
patient
neuromyel
optica
nmo
neurolog
diseas
character
optic
neuriti
transvers
myeliti
long
spinal
cord
lesion
lcl
recent
nmoigg
recogn
aquaporin
aqp
water
channel
locat
astrocyt
foot
process
identifi
sera
nmo
patient
order
detect
antibodi
previous
use
immunofluoresc
method
human
embryon
kidney
hek
cell
line
howev
method
labori
time
consum
quantit
analysi
titer
difficult
present
studi
compar
previou
immunofluoresc
detect
system
new
elisa
method
perform
quantit
analysi
level
nmo
patient
use
criteria
wingerchuk
diagnosi
nmo
mcdonald
criteria
multipl
sclerosi
ms
serum
sampl
obtain
patient
shown
posit
antibodi
use
immunofluoresc
method
ms
control
patient
quantit
analysi
perform
use
autoantibodi
elisa
kit
patient
shown
posit
antibodi
immunofluoresc
method
posit
use
elisa
uml
ms
control
patient
found
neg
elisa
two
nmo
spectrum
patient
optic
neuriti
show
high
titer
uml
respect
signific
differ
titer
lcl
optic
neuriti
lcl
without
optic
neuriti
group
quantit
analysi
antibodi
use
elisa
effect
determin
titer
two
optic
neuriti
patient
without
histori
transvers
myeliti
high
titer
chiba
atsuro
uchibori
ayumi
ohishi
chizuko
miyazaki
tai
kyorin
univers
tokyo
japan
autoantibodi
becom
practic
marker
distinguish
clinic
subgroup
diseas
base
immunolog
mechan
studi
search
novel
autoantibodi
patient
multipl
sclerosi
investig
target
tissu
antigen
protein
search
serum
autoantibodi
patient
multipl
sclerosi
western
blot
use
total
protein
fraction
extract
variou
tissu
posit
case
examin
distribut
antigen
immunohistochemistri
chronolog
chang
antibodi
titer
along
treatment
presenc
antibodi
cerebrospin
fluid
found
igg
antibodi
strongli
react
protein
approxim
kda
molecular
mass
extract
cerebr
tissu
serum
male
patient
diagnos
primari
progress
multipl
sclerosi
show
cerebr
white
matter
lesion
magnet
reson
imag
mri
without
spinal
cord
lesion
western
blot
use
variou
tissu
protein
extract
strongest
reaction
protein
seen
cerebr
tissu
rel
weak
one
cerebellar
cortex
reaction
observ
spinal
cord
nonneuron
tissu
liver
kidney
muscl
immunohistochem
studi
use
rat
cerebr
section
patient
igg
strongli
react
blood
vessel
especi
endothelium
also
react
neural
cell
rel
weakli
intrathec
antibodi
product
suggest
patient
neurolog
manifest
improv
methylprednisolon
puls
therapi
serum
antibodi
titer
decreas
treatment
liquid
chromatographi
mass
spectrometr
analysi
band
identifi
peptid
sever
protein
candid
antigen
includ
synapsin
isoform
highest
score
peptid
match
protein
databas
search
correspond
distribut
lesion
mri
distribut
antigen
observ
western
blot
chronolog
chang
antibodi
titer
clinic
manifest
suggest
relationship
igg
antibodi
patholog
process
patient
immunohistochem
find
suggest
vascular
antigen
neural
antigen
also
might
involv
serum
diagnost
marker
multipl
sclerosi
reflect
shift
pbmc
nakatsuji
yuji
okuno
tatsusada
moriya
masayuki
sugimoto
tomoyuki
kinoshita
makoto
nakano
misa
kikutani
hitoshi
sakoda
saburo
kumanogoh
atsushi
osaka
univers
suita
japan
toyonaka
municip
hospit
toyonaka
japan
toneyama
nation
hospit
toyonaka
japan
variabl
role
semaphorin
immun
system
emerg
membranebound
class
semaphorin
enhanc
cell
activ
sinc
treatment
antibodi
amelior
experiment
autoimmun
encephalomyel
eae
suggest
involv
pathogenesi
multipl
sclerosi
ms
establish
elisa
system
assay
serum
level
ms
patient
remiss
phase
ageand
gendermatch
patient
neurolog
diseas
ond
level
significantli
higher
ms
patient
ond
patient
diseas
sensit
specif
respect
addit
patient
ci
exhibit
high
level
ms
patient
thu
elisa
system
help
earli
diagnosi
examin
proport
ifngamma
cell
cell
fac
analysi
peripher
blood
mononuclear
cell
onethird
ms
patient
exhibit
high
level
proport
cell
significantli
higher
ms
patient
high
level
low
level
ond
patient
elucid
mechan
skew
cell
cocultur
bone
marrow
deriv
dendrit
cell
bmdc
wild
type
ko
mice
produc
cell
significantli
reduc
cocultur
bmdc
suggest
express
dc
import
differenti
although
ko
mice
exhibit
milder
clinic
symptom
eae
induc
administr
recombin
exacerb
eae
thu
dc
deriv
suggest
particip
skew
exacerb
diseas
conclus
elev
serum
support
clinic
diagnosi
earli
phase
ms
involv
pathogenesi
skew
cell
toward
cell
multipl
sclerosi
autoimmun
demyelin
diseas
central
nervou
system
complex
network
interact
proinflammatori
antiinflammatori
cytokin
play
import
role
pathogenesi
aim
studi
analyz
relat
serum
level
tnfalfa
ifngamma
phase
msexacerb
remiss
method
studi
women
age
year
relapsingremit
ms
accord
mcdonald
criteria
thirteen
treat
control
group
includ
healthi
women
age
serum
tnfalfa
ifngamma
quantifi
elisa
result
tnfalfaconcentr
significantli
higher
relaps
remiss
reciproc
chang
found
concentr
increas
serum
level
remiss
compar
exacerb
women
ms
higher
relaps
lower
tnfalfa
remiss
control
cytokin
profil
patient
treat
significantli
differ
untreat
group
patient
lower
level
tnfalfa
ifngamma
relaps
higher
level
tnfalfa
remiss
compar
untreat
one
correl
tnfalfa
ifngamma
edss
score
conclus
serum
concentr
tnfalfa
object
reflect
activ
immun
system
clinic
period
msexacerb
remiss
treatment
chang
serum
cytokin
profil
ms
patient
degre
disabl
measur
edss
depend
serum
level
tnfalfa
ifngamma
substrat
reduct
therapi
novel
therapeut
strategi
syndrom
greenshield
kay
wallom
kerrile
riddel
john
edgar
julia
platt
franc
willison
hugh
univers
glasgow
glasgow
unit
kingdom
oxford
univers
oxford
unit
kingdom
syndrom
gb
world
lead
caus
neuromuscular
paralysi
autoimmun
pathophysiolog
autoantibodi
glycolipid
agab
result
complement
mediat
destruct
peripher
nerv
compart
target
glycolipid
identifi
gangliosid
exist
lipid
raft
highli
enrich
neuron
membran
level
gangliosid
critic
determin
factor
mediat
degre
injuri
induc
agab
current
clinic
manag
remain
unrefin
reli
remov
antibodi
via
plasma
exchang
intraven
immunoglobulin
therapi
current
investig
novel
therapi
base
antigen
deplet
use
iminosugar
inhibit
gangliosid
biosynthesi
pharmacolog
reduc
amount
gangliosid
synthesis
therebi
membran
concentr
may
possibl
amelior
level
agab
bind
lessen
avert
patholog
furthermor
level
effect
gangliosid
deplet
offer
insight
recyclingresynthesi
rate
gangliosid
function
mainten
steadi
state
nerv
crucial
develop
regener
nerv
import
consider
drug
would
ideal
target
patient
follow
acut
gb
regener
nerv
may
vulner
agab
attack
patient
chronic
disord
associ
agab
adult
weanl
mice
dose
iminosugar
nbdnj
develop
deplet
total
ganglisoid
content
peripher
nerv
shown
hplc
immunofluoresc
analys
latter
use
monoclon
antibodi
specif
gangliosid
electron
microscopi
show
gross
morpholog
abnorm
either
adult
develop
nerv
particular
node
ranvier
appear
normal
electrophysiolog
behaviour
investig
mice
ideint
normal
control
importantli
follow
sciatic
nerv
crush
nbdnj
effect
rate
reinnerv
neuromuscular
junction
data
confirm
safeti
use
inhibitor
regener
nerv
model
nbdnj
dose
use
achiev
gsl
deplet
level
signific
enough
reduc
agab
bind
subsequ
complement
activ
current
studi
altern
inhibitor
higher
potenc
result
higher
level
gangliosid
synthesi
inhibit
pbmc
patient
rrm
untreat
patient
patient
treat
ifn
match
healthi
control
hc
cultur
differ
time
period
without
stimul
antibodi
isotyp
control
ic
express
noggin
mrna
also
studi
separ
tcell
monocyt
use
mac
secret
level
follistatin
measur
elisa
h
incub
express
follistatin
mrna
studi
quantit
realtim
pcr
express
level
standard
express
gapdh
mrna
basal
level
follistatin
mrna
express
without
stimul
lower
untreat
patient
compar
hc
p
differ
found
untreat
patient
treat
patient
similarli
secret
level
follistatin
higher
hc
compar
untreat
rrm
patient
p
signific
differ
found
untreat
patient
treat
patient
stimul
antibodi
increas
follistatin
express
untreat
patient
ratio
stimul
anti
ab
vs
ic
hc
p
ns
follistatin
mrna
express
predominantli
separ
cell
rrm
patient
cell
cell
hc
similarli
express
cell
type
cell
cell
immun
cell
may
particip
neurogenesi
induct
product
follistatin
cell
stimul
via
upregul
follistatin
express
immun
mediat
neurogenesi
may
defect
rrm
due
low
level
follistatin
product
may
relat
loss
express
monocyt
macrophag
studi
express
regul
noggin
mrna
pbmc
patient
rrm
compar
healthi
control
pbmc
patient
rrm
untreat
patient
patient
treat
match
healthi
control
hc
incub
h
human
antibodi
isotyp
control
ic
express
noggin
mrna
also
studi
separ
tcell
monocyt
use
mac
effect
cytokin
also
studi
express
noggin
mrna
studi
quantit
realtim
pcr
result
standard
express
gapdh
mrna
basal
level
noggin
mrna
express
without
stimul
lower
untreat
patient
compar
hc
p
b
differ
found
untreat
patient
treat
patient
stimul
antibodi
increas
noggin
express
untreat
patient
ratio
stimul
anti
ab
vs
ic
hc
p
howev
stimul
effect
pbmc
untreat
patient
reach
level
hc
without
stimul
p
b
noggin
mrna
express
predominantli
separ
cell
hc
rrm
patient
hc
cell
cell
rrm
patient
cell
cell
pattern
appear
also
protein
noggin
test
western
blot
stimul
increas
noggin
express
hc
group
tcell
may
potenti
particip
induct
neurogener
product
noggin
potenti
seem
defect
immun
cell
patient
rrm
reduc
express
level
noggin
mrna
insuffici
stimulatori
effect
stimul
non
respons
patient
reduct
noggin
express
may
link
ineffici
neuroregener
remyelin
relat
clinic
progress
diseas
antiyo
antibodi
reactiv
purkinj
cell
associ
exclus
paraneoplast
cerebellar
degener
contrast
antihu
antibodi
react
antigen
found
neuron
associ
multipl
paraneoplast
neurolog
disord
role
two
antibodi
caus
paraneoplast
neuron
injuri
known
howev
investig
anim
model
made
difficult
presenc
bloodbrain
barrier
complic
exposur
neuron
antibodi
time
altern
approach
studi
interact
paraneoplast
autoantibodi
target
neuron
popul
use
cerebellar
slice
organotyp
cultur
sinc
cultur
system
preserv
anatom
relationship
present
vivo
allow
exposur
neuron
antibodi
without
interposit
bloodbrain
barrier
goal
studi
compar
effect
antiyo
antihu
antibodi
organotyp
cultur
rat
cerebellum
rat
cerebellar
slice
cultur
incub
antiyo
antihu
antibodi
present
serum
cerebrospin
fluid
purifi
igg
antiyo
antihu
posit
patient
cultur
follow
time
use
confoc
microscopi
neuron
death
determin
uptak
viabil
stain
sytox
green
apoptosi
determin
flica
stain
tunel
method
antiyo
antibodi
accumul
purkinj
cell
caus
widespread
purkinj
cell
death
antihu
antibodi
accumul
essenti
neuron
caus
scatter
neuron
death
molecular
purkinj
cell
granul
cell
layer
initi
uptak
antiyo
antihu
antibodi
occur
cell
shown
viabl
exclus
sytox
green
widespread
within
hour
die
neuron
cultur
incub
antiyo
antibodi
neg
flica
tunel
method
indic
nonapoptot
cell
death
contrast
die
neuron
cultur
incub
antihu
antibodi
posit
marker
apoptosi
antiyo
antibodi
induc
nonapoptot
purkinj
cell
death
wherea
antihu
antibodi
caus
apoptot
death
multipl
neuron
popul
data
suggest
paraneoplast
autoantibodi
may
caus
cell
death
differ
mechan
neuron
gener
may
abl
intern
antibodi
neuron
antibodi
accumul
may
determin
reactiv
intracellular
antigen
ex
vivo
cultur
lpsifngstimul
microglia
display
increas
lytic
activ
glioblastoma
vitro
vivo
glioblastoma
multiform
common
parenchym
brain
tumour
aggress
phenotyp
poor
prognosi
even
treatment
surgeri
radiat
andor
chemotherapi
although
microglia
main
immuneeffector
cell
central
nervou
system
cn
abundantli
present
within
murin
glioblastoma
immun
effector
function
appear
inhibit
tumour
cell
studi
aim
investig
capac
ex
vivo
cultur
microglia
exert
lytic
activ
cell
vitro
well
vivo
primari
cultur
microglia
initi
neonat
brain
mice
characteris
low
flow
cytometr
analysi
addit
immun
respons
confirm
secret
high
amount
tnfa
follow
stimul
lpsifng
moreov
vitro
cocultur
experi
lpsifngstimul
microglia
cell
ratio
result
tumour
cell
kill
within
hour
compar
tumour
cell
kill
upon
cocultur
nonstimul
microglia
n
next
aim
investig
whether
ex
vivo
cultur
lp
ifngstimul
microglia
could
exert
similar
lytic
activ
vivo
first
inocul
cell
cn
adult
mice
result
reproduc
tumour
growth
mean
surviv
time
day
n
immunohistolog
analysi
tumour
confirm
presenc
microglia
surround
tumour
howev
tumourassoci
microglia
costain
activ
marker
compar
phenotyp
allograftinfiltr
microglia
suggest
immunesuppress
statu
tumourassoci
microglia
next
base
abovedescrib
vitro
result
coinocul
lpsifngstimul
microglia
cell
cn
adult
mice
although
anim
becom
tumourfre
significantli
p
b
prolong
surviv
day
observ
n
ongo
studi
aim
visualis
fate
function
graft
lpsifngstimul
microglia
summari
data
demonstr
ex
vivo
cultur
lpsifngstimul
microglia
display
increas
lytic
activ
tumour
cell
vitro
vivo
support
potenti
novel
adjuv
therapi
exist
glioma
treatment
frequenc
gabab
receptor
antibodi
limbic
enceph
gad
antibodyassoci
neurolog
disord
gabab
receptor
antibodi
gababrab
recent
describ
patient
limbic
enceph
le
associ
small
cell
lung
cancer
sclc
concurr
glutam
acid
decarboxylas
gad
antibodi
present
studi
analyz
frequenc
gababrab
two
clinic
set
gababrab
detect
immunofluoresc
hek
cell
transfect
subunit
gabab
receptor
use
serum
dilut
csf
dilut
avail
posit
sampl
react
vivo
neuron
surfac
primari
cell
cultur
fetal
rat
hippocamp
neuron
examin
le
patient
paraneoplast
le
onconeuron
antibodi
huab
amphyphisin
antibodi
paraneoplast
le
without
onconeuron
antibodi
idiopath
le
without
antibodi
le
gadab
patient
gadab
associ
neurolog
syndrom
le
stiffperson
syndrom
sp
cerebellar
ataxia
epilepsi
paraneoplast
cerebellar
ataxia
gababrab
detect
le
patient
five
sclc
two
idiopath
three
paraneoplast
patient
antibodi
intracellular
antigen
two
one
also
gadab
one
huab
gababrab
found
patient
gadab
sp
cerebellar
ataxia
epilepsi
howev
two
six
patient
gadab
paraneoplast
cerebellar
ataxia
also
present
gababrab
set
pancreat
neuroendocrin
tumor
carcinoid
thymu
le
associ
gababrab
usual
relat
sclc
one
patient
concurr
wellcharacter
onconeuron
antibodi
hu
patient
gadab
frequenc
gababrab
low
observ
context
paraneoplast
neurolog
syndrom
human
glioblastoma
multiform
cell
releas
immunogen
signal
treatment
ionis
radiat
chemotherapeut
agent
glioblastoma
multiform
aggress
primari
brain
tumour
carri
surviv
rate
surgeri
adjuv
radio
rt
andor
chemotherapi
ct
standard
therapi
new
therapeut
option
deeper
knowledg
appli
therapi
modul
tumour
cell
urgent
need
sinc
patient
develop
relaps
immunotherapi
induct
immunogen
glioblastoma
cell
standard
therapi
could
promis
strategi
prevent
tumour
recurr
high
degre
select
longlast
memori
immun
system
malign
cancer
cell
respond
rt
andor
ct
distinct
form
cell
death
may
lead
specif
activ
immun
system
due
exposur
immunogen
factor
cell
surfac
releas
immunogen
signal
extracellular
space
factor
elicit
immun
activ
foster
uptak
tumour
cell
dendrit
cell
dc
consecut
contact
cell
may
lead
specif
importantli
longlast
antitumour
immun
fact
antitumour
immun
kill
cancer
stem
cell
resist
rt
micro
metastas
keep
residu
tumour
cell
check
ident
presenc
amount
immunogen
signal
well
tumour
cell
immunogen
determin
molecul
glioblastoma
still
known
aim
work
studi
glioblastoma
cell
line
immunogen
danger
signal
involv
activ
immun
cell
high
mobil
group
protein
heatshock
protein
calreticulin
observ
presenc
releas
exposur
surfac
human
glioblastoma
cell
differ
dose
gamma
radiat
therapeut
relev
concentr
temozolomid
western
blot
immunocytochemistri
data
suggest
modul
express
danger
molecul
standard
treatment
glioblastoma
cell
suggest
signal
play
crucial
role
radiat
chemotherapeut
respons
lead
specif
long
last
antiglioma
immun
respons
although
present
less
lem
patient
almost
exclus
relat
sclclem
rapidli
progress
cours
diseas
onset
lem
patient
rais
high
suspicion
sclc
special
attent
paid
earli
involv
upper
extrem
distal
muscl
bulbar
muscl
male
sexual
impot
order
discrimin
sclclem
ntlem
acquir
neuromyotonia
also
call
isaac
syndrom
characterist
clinic
manifest
antivgkc
ab
may
access
motor
nerv
termin
caus
motor
nerv
hyperexcit
instanc
pseudomyotonia
muscl
cramp
addit
motor
nerv
hyperexcit
antivgkc
ab
particip
morvan
syndrom
induc
variou
autonom
nerv
symptom
sleepless
hallucin
furthermor
case
antivgkc
ab
particip
part
nonherpet
limbic
enceph
nhle
immunemedi
k
channel
diseas
wide
diseas
spectrum
way
mani
patient
sensori
symptom
variou
sensori
disturb
numb
pain
suggest
sensori
nerv
system
also
show
hyperexcit
examin
relationship
antivgkc
ab
sensori
disturb
numb
pain
time
measur
sera
antivgkc
ab
base
radioimmunoassay
use
ialphadendrotoxin
rabbit
brain
homogen
exampl
sera
obtain
follow
patient
nhle
patient
fibromyalgia
fm
patient
myokymia
andor
muscl
cramp
patient
case
antibodyposit
well
muscl
cramp
core
symptom
recogn
numb
pain
limb
approxim
absposit
patient
notabl
found
two
patient
characterist
clinic
featur
sensori
nerv
hyperexcit
develop
complex
region
pain
syndrom
crp
like
symptom
one
case
immunotherapi
made
improv
sensori
symptomsin
nhle
patient
case
antibodyposit
interest
half
patient
evalu
associ
neoplasm
present
initi
four
limb
numb
fm
myokymia
four
case
antibodyposit
protein
level
main
antigen
higher
dorsal
root
ventral
root
addit
antivgkc
ab
could
easili
access
dorsal
root
ganglion
neuron
bloodnervebarri
weak
well
nerv
terminalstherefor
may
account
patient
show
stronger
manifest
hyperexcit
sensori
nerv
motor
nerv
antivgkc
absposit
exampl
exist
among
pain
diseas
crp
erythromelalgia
fibromyalgia
immunemedi
k
channel
diseas
necessari
pay
attent
sensori
symptom
includ
numb
pain
state
protein
normal
tumor
brain
cell
vladimirova
natalya
potapenko
natalya
sizenova
julya
zharskaya
oxana
zatsepina
olga
volpina
olga
shemyakinovchinnikov
institut
bioorgan
chemistri
russian
academi
scienc
moscow
russia
nucleophosmin
major
nucleolar
phosphoprotein
play
crucial
role
cell
prolifer
death
accord
latest
literatur
data
malign
cell
lead
overexpress
nucleophosmin
chang
subcellular
local
induc
appear
abnorm
protein
structur
form
mutant
chimer
truncat
presenc
tumorspecif
oligom
preserv
sdspage
metabotrop
glutam
receptor
involv
decad
ago
paraneoplast
pictur
descript
cerebel
hodgkin
diseas
develop
correl
cerebellitisanti
mglu
reassess
recent
without
underli
neoplasm
caus
condit
hand
glutam
receptor
describ
classic
find
relat
rassmussen
enceph
find
controversi
definit
diagnost
result
preval
focal
epilepsi
specif
rassmussen
enceph
serial
categori
sampl
seri
consid
three
case
paraneoplast
cerebel
sampl
antibodi
or
preval
independ
variabl
linear
mix
prototyp
assum
role
complenet
descript
cofactor
cap
complement
activ
product
consid
activ
section
clinic
diagnos
would
describ
follow
sle
categor
assess
vascul
altern
activ
rassmussen
enceph
cerebel
paraneoplast
or
prevalec
result
consid
autoantibodi
glutam
receptor
invok
system
lupu
erythematosu
enceph
epilepsi
correl
anaphylatoxin
tradit
describ
sle
exacerb
cerebr
occlus
vasculopathi
lupu
cerebr
similar
may
observ
autoantibodi
mechan
action
consid
complement
activ
role
c
regulatori
protein
identif
autoantigen
recogn
autoantibodi
provid
conclus
result
neurolog
autoimmun
diseas
bidimension
immunom
may
repres
use
tool
regard
applic
may
limit
denatur
condit
target
protein
compar
capac
autoantibodi
sera
mice
affect
experiment
autoimmun
encephalomyel
eae
recogn
neural
autoantigen
two
differ
assay
elisa
immunom
induc
diseas
myelin
basic
protein
mbp
total
mbp
spinal
cord
homogen
sch
verifi
whether
complex
autoantigen
quantit
influenc
autoimmun
respons
concord
result
obtain
techniqu
show
presenc
antimbp
igg
mice
immun
total
mbp
apart
mbp
immunom
reveal
presenc
eae
mice
seric
autoantibodi
target
neural
protein
myelin
oligodendrocyt
glycoprotein
nucleotid
presenc
epitop
partial
sequenc
homolog
among
protein
mbp
may
suggest
process
intermolecular
mimicri
find
immunom
multipl
neural
protein
target
autoantibodi
gener
singl
antigen
may
help
explain
complex
autoimmun
respons
observ
multipl
sclerosi
acut
dissemin
encephalomyel
adem
monophas
autoimmun
inflammatori
diseas
central
nervou
system
cn
adem
common
demyelin
disord
childhood
illn
incomplet
understood
serbian
pediatr
popul
describ
epidemiolog
clinic
neuroimag
laboratori
featur
treatment
outcom
group
children
acut
dissemin
encephalomyel
adem
evalu
prognost
factor
outcom
well
prognost
factor
relaps
retrospectiveprospect
review
conduct
children
diagnosi
adem
hospit
institut
mother
child
health
protect
belgrad
wich
tertiari
pediatr
hospit
final
outcom
assess
use
kurtzk
expand
disabl
statu
scale
edss
sexteen
patient
evalu
mean
age
onset
year
within
rang
year
ten
children
preced
infect
month
onset
five
patient
recent
upper
respiratori
tract
illn
often
patient
present
motor
deficit
ataxia
cranial
nerv
abnorm
headach
fever
vomit
intrathec
oligoclon
band
note
three
children
magnet
reson
mri
identifi
lesion
subcort
white
matter
brainstem
periventricular
white
matter
cerebellum
spinal
cord
deep
gray
matter
cortic
gray
matter
patient
twelv
children
treat
corticosteroid
three
children
treat
intraven
immunoglobulin
final
outcom
adem
favour
eleven
patient
good
outcom
three
patient
neurolog
sequela
one
child
die
one
child
develop
multipl
sclerosi
die
clinic
featur
encephalopathi
multipl
neurolog
deficit
mri
identifi
demyelin
lesion
cn
crucial
estabilish
diagnosi
degre
disturb
conscious
size
mri
lesion
influenc
outcom
prognosi
surviv
outcom
excel
long
term
followup
necessari
estim
potenti
risk
convers
multipl
sclerosi
addit
studi
requir
understand
worldwid
epidemiolog
distribut
adem
wich
may
give
insight
diseas
potenti
prevent
measur
african
american
develop
multipl
sclerosi
ms
less
frequent
compar
northern
european
greater
risk
ambulatori
disabl
differ
african
american
white
may
repres
differ
genet
suscept
andor
environment
factor
differ
linkag
disequilibrium
pattern
ancestr
group
may
help
refin
causal
variant
share
ms
patient
northern
european
descent
african
american
object
studi
wellcharacter
african
american
ms
cohort
frequenc
distribut
suscept
snp
previous
identifi
valid
patient
northern
european
ancestri
addit
appli
nextgener
sequenc
assess
contribut
lowfrequ
polymorph
allel
heterogen
diseas
suscept
african
american
case
african
american
case
recruit
use
stringent
well
establish
inclus
criteria
snp
genotyp
use
valid
taqman
snp
genotyp
assay
resequenc
dna
specimen
individu
pool
group
african
american
case
african
american
control
northern
european
case
northern
european
control
candid
gene
amplifi
group
use
exon
specif
primer
sequenc
perform
use
illumina
gaii
dna
sequenc
platform
test
snp
gene
report
associ
ms
suscept
northern
european
contain
snp
associ
diseas
african
american
addit
associ
age
onset
associ
diseas
progress
ba
johnson
et
al
associ
signal
fail
replic
may
result
decreas
power
detect
associ
african
american
due
lower
minor
allel
frequenc
altern
genet
heterogen
may
exist
across
popul
address
question
perform
high
coverag
resequenc
valid
diseas
gene
african
american
northern
european
affect
control
avail
data
consist
common
genet
architectur
ms
among
individu
european
african
ancestri
highcoverag
sequenc
diseas
gene
may
lead
identif
caus
allel
transcript
factor
known
play
promin
role
regul
inflammatori
process
central
nervou
system
astrocyt
key
mediat
neuroinflamm
sever
studi
impli
activ
gfapposit
cell
central
step
promot
neuroinflamm
howev
clear
whether
astrocyt
suffici
drive
neuroinflammatori
process
modul
enhanc
inflammatori
respons
neuropatholog
insult
furthermor
function
astrocyt
neural
develop
well
defin
address
issu
gener
mous
model
allow
condit
express
domin
neg
act
constitut
activ
allel
astrocyt
could
show
model
constitut
activ
allel
express
astrocyt
ependym
cell
express
suffici
induc
neuroinflamm
earli
postnat
phase
accompani
multipl
development
defect
final
lead
postnat
lethal
promin
anim
develop
hydrocephalu
frequent
malform
human
children
often
link
neuroinflammatori
insult
earli
childhood
addit
anim
show
impair
postnat
brain
develop
includ
matur
defect
dentat
gyru
retard
cerebellar
develop
neuroinflammatori
phenotyp
transgen
mous
model
character
massiv
activ
ventricular
mening
macrophag
microglia
could
detect
minor
infiltr
peripher
immun
cell
furthermor
mice
show
promin
astrogliosi
strong
upregul
sever
proinflammatori
target
gene
especi
chemokin
chemokin
import
guidanc
molecul
neural
progenitor
cell
deregul
might
provid
mechan
observ
development
defect
notabl
express
shut
wean
anim
surviv
despit
develop
persist
neuroinflammatori
phenotyp
thu
mous
model
provid
use
tool
studi
impact
neuroinflamm
brain
cancer
develop
neurodegen
diseas
studi
support
dfg
bb
crucial
step
initi
neuroinflammatori
cascad
chemokinemedi
migrat
leukocyt
peripheri
central
nervou
system
cn
understand
player
involv
leukocyt
penetr
cn
particularli
import
modul
may
offer
therapeut
altern
chronic
neuroinflammatori
disord
multipl
sclerosi
ms
anim
model
ms
experiment
autoimmun
encephalomyel
eae
system
seem
critic
mediat
traffick
nk
cell
cn
interestingli
mice
defici
chemokin
receptor
suffer
sever
form
diseas
show
reduc
infiltr
nk
cell
cn
therefor
aim
elucid
role
nk
cell
eae
investig
whether
express
particular
nk
cell
critic
modul
eae
cours
gener
bone
marrow
chimer
mice
ko
wild
type
wt
mice
ko
wt
wt
ko
chimera
preliminari
data
indic
mice
lack
receptor
peripher
leukocyt
ko
wt
chimera
develop
sever
eae
cours
show
reduc
infiltr
nk
cell
compar
mice
express
receptor
cn
wt
ko
chimera
thu
migrat
nk
cell
cn
eae
seem
crucial
control
autoimmun
attack
verifi
transfer
wild
type
nk
cell
mice
one
day
prior
eae
induct
data
far
show
transfer
wild
type
nk
cell
protect
effect
eae
demonstr
milder
diseas
cours
lower
eae
incid
mice
compar
control
mice
mice
transfer
nk
cell
data
suggest
protectiveregulatori
role
nk
cell
neuroinflamm
immunomodul
nk
cell
eae
might
occur
insid
cn
sinc
migrat
nk
cell
cn
appear
requisit
regul
autoimmun
attack
glial
innat
immun
gener
nonaggreg
alphasynuclein
differ
wildtyp
parkinson
diseaselink
mutant
roodveldt
cintia
labradorgarrido
adahir
gonzalezrey
elena
fernandezmontesino
rafael
caro
marta
lachaud
christian
c
parkinson
diseas
pd
progress
neurodegen
disord
character
patholog
presenc
brain
intracellular
protein
inclus
highli
enrich
aggreg
alphasynuclein
although
establish
progress
diseas
accompani
sustain
activ
microglia
underli
molecul
factor
involv
immunetrigg
mechan
remain
larg
unexplor
late
accumul
evid
shown
presenc
extracellular
aggreg
monomer
form
cerebrospin
fluid
blood
plasma
howev
effect
extracellular
cellular
activ
immun
mediat
well
impact
famili
pdlink
mutant
stimul
remain
larg
unknown
work
first
time
studi
activ
profil
monomer
extracellular
primari
glial
microgli
cell
cultur
cell
measur
releas
cytokin
well
chemokin
contrari
observ
use
cell
line
case
aggreg
found
strong
differ
immun
respons
gener
wildtyp
famili
pd
mutant
might
explain
differ
onset
progress
highli
debilit
diseas
axon
damag
consid
major
caus
chronic
disabl
ms
underli
patholog
mechan
poorli
understood
similar
immunemedi
myelin
destruct
autoimmun
neuron
axon
antigen
may
play
import
role
recent
studi
mice
reveal
experiment
autoimmun
axon
protein
neurofila
light
nfl
induc
spastic
paresi
axon
damag
neurodegener
huizinga
et
al
huizinga
et
al
model
grey
matter
lesion
frequent
observ
ms
interestingli
immunoglobulin
ig
deposit
occur
insid
neuron
axon
like
ms
grey
matter
lesion
cell
infiltr
cn
nfl
immunis
mice
rare
goal
research
examin
whether
similar
phagocytosi
myelin
antigen
macrophag
microglia
abl
phagocytos
neuron
antigen
key
step
gener
autoreact
neuron
antigen
human
microglia
monocytederiv
macrophag
mous
cell
line
cultur
either
human
grey
matter
recombin
neurofila
light
variou
time
point
phagocytosi
cell
examin
immunohistochemistri
confoc
microscopi
presenc
neuron
antigen
studi
demonstr
well
myelin
basic
protein
macrophag
microglia
phagocytos
degrad
nfl
asynuclein
microtubul
associ
protein
amyloid
precursor
protein
current
studi
underway
examin
impact
phagocytosi
whether
neuron
antigen
trigger
proinflammatori
antiinflammatori
respons
also
report
whether
autoantibodi
neuron
antigen
augment
uptak
neuron
protein
whether
macrophag
microglia
respond
degrad
neuron
similar
myelin
moreov
current
studi
determin
phagocytosi
neuron
antigen
suffici
activ
nfl
specif
cell
present
human
studi
reveal
extent
macrophag
microglia
phagocytos
neuron
antigen
whether
uptak
suffici
activ
cell
thu
activ
part
pathogen
process
rather
mere
surrog
marker
diseas
ms
patient
mariani
monica
kielian
tammi
dept
patholog
microbiolog
univers
nebraska
medic
center
omaha
usa
brain
abscess
seriou
neurolog
diseas
elicit
pyogen
bacteria
staphylococcu
aureu
typifi
inflamm
edema
often
result
multitud
longterm
health
problem
despit
recent
advanc
defin
innat
immun
pathway
elicit
brain
abscess
develop
littl
inform
current
avail
regard
function
import
adapt
immun
aureu
infect
central
nervou
system
cn
kinet
gd
cell
nkt
cell
infiltr
brain
abscess
mice
examin
use
communityassoci
methicillinresist
aureu
camrsa
isol
recov
otherwis
healthi
patient
die
brain
abscess
ifng
produc
cell
nkt
cell
promin
cours
infect
wherea
rel
gd
cell
detect
investig
function
import
cell
diseas
progress
brain
abscess
induc
tcr
knockout
ko
mice
bacteri
burden
significantli
elev
tcr
ko
anim
later
stage
infect
compar
wt
mice
loss
tcr
cell
also
impact
profil
infiltr
innat
immun
cell
primarili
late
phase
infect
specif
neutrophil
gd
cell
infiltr
significantli
increas
brain
abscess
tcr
ko
mice
compar
wt
anim
wherea
macrophag
infiltr
reduc
tcr
ko
mice
follow
aureu
infect
express
lower
level
mhc
class
ii
costimulatori
molecul
adopt
transfer
purifi
th
cell
tcr
ko
mice
abl
restor
defect
bacteri
clearanc
immun
cell
recruit
level
typic
observ
wt
anim
magnet
reson
imag
mri
studi
reveal
dramat
reduct
brain
abscess
volum
tcr
ko
mice
suggest
pivot
role
tcr
cell
mediat
tissu
injuri
collect
studi
demonstr
import
role
tcr
cell
regul
bacteri
clearanc
innat
immun
infiltr
tissu
injuri
brain
abscess
develop
demonstr
direct
link
innat
adapt
immun
cn
abscess
format
neurotrophin
receptor
regul
human
skelet
muscl
differenti
matur
surviv
upon
inflammatori
stress
recent
studi
anim
model
indic
neurotrophin
receptor
may
express
muscl
satellit
cell
particip
tissu
regener
howev
littl
known
express
human
skelet
muscl
purpos
analys
transcript
protein
level
infant
adult
non
myopath
muscl
inflammatori
myopathi
polymyos
dermatomyos
inclus
bodi
myositi
muscl
degener
mediat
immun
cell
infiltr
becker
muscular
dystrophi
bmd
degener
due
genet
defect
histolog
analys
show
physiolog
condit
neurotrophin
receptor
display
vivo
great
major
satellit
cell
indic
novel
marker
cell
type
furthermor
present
regener
fiber
inflam
dystroph
muscl
suggest
involv
myogenesi
sever
vitro
experi
receptor
blockad
gene
silenc
myoblast
demonstr
necessari
differenti
human
muscl
precursor
cell
regul
dystrophin
induct
myotub
inde
transcriptom
analys
posit
vs
neg
myoblast
show
marker
precursor
cell
popul
bear
transcript
repertoir
associ
muscl
develop
matur
moreov
molecular
immunohistochem
experi
highlight
enhanc
express
three
inflammatori
myopathi
bmd
distinct
cell
type
includ
immun
cell
matur
skelet
muscl
fiber
stain
posit
inde
inflammatori
cytokin
reinforc
level
myotub
vitro
rna
interfer
differenti
cell
demonstr
neurotrophin
receptor
fundament
myofib
surviv
inflammatori
stress
upregul
myofib
inflam
muscl
might
therefor
repres
protect
tissu
respons
inflammationinduc
injuri
conclus
data
demonstr
profoundli
involv
muscl
cell
differenti
matur
surviv
inflammatori
stress
work
support
italian
ministri
health
associ
contr
le
myopathi
project
cf
molecular
mechan
nsaid
deriv
compound
model
alzheim
diseas
kummer
christian
griep
angelika
heneka
michael
alzheim
diseas
character
progress
deposit
within
brain
parenchyma
ineffici
clearanc
solubl
insolubl
peptid
brain
microglia
report
mediat
clearanc
fibrillar
receptormedi
phagocytosi
howev
molecular
mechan
larg
unknown
base
previou
observ
non
steroid
anti
inflammarori
drug
nsaid
peroxisom
prolifer
activ
receptor
gamma
ppar
agonist
pioglitazon
decreas
load
app
transgen
mice
postul
nsaid
pioglitazon
increas
microgli
clearanc
function
motil
ppar
depend
mechan
report
primari
rat
mous
microglia
neonat
anim
intern
fibrillar
vitro
intern
increas
microglia
incub
pioglitazon
nsaid
full
activ
ppar
requir
heterodimer
retinoidxreceptor
rxr
receptor
retino
acid
ra
pparrxr
heterodim
bind
promot
region
target
gene
specif
dna
sequenc
term
peroxisom
prolifer
respons
element
ppre
demonstr
uptak
microglia
enhanc
incub
pioglitazon
nsaid
combin
rxr
agonist
role
pparg
microglia
phagocytosi
assess
use
specif
sirna
suppress
pparg
express
primari
microglia
vitro
phagocytosi
assay
pioglitazon
nsaid
treatment
microglia
additionlli
determin
activ
state
microglia
vivo
treatment
pioglitazon
nsaid
compar
untreat
control
mice
use
protocol
microglia
isol
flow
cytometri
studi
suggest
benefici
role
pparg
pathogenesi
ad
patient
diagnos
acut
dissemin
encephalomyel
adem
divers
outcom
limit
data
predict
factor
prognosi
adem
signific
portion
subsequ
diagnos
multipl
sclerosi
ms
neuromyel
optica
nmo
method
perform
retrospect
review
patient
diagnos
adem
john
hopkin
hospit
feb
search
term
adem
postinfecti
enceph
postvaccin
enceph
clinic
statu
outcom
collect
chart
review
telephon
followup
result
twentyfour
patient
initi
diagnos
adem
averag
time
followup
month
rang
month
median
age
year
old
rang
year
old
pediatr
patient
year
old
five
patient
ultim
diagnos
revis
either
ms
nmo
five
nineteen
patient
histopatholog
confirm
adem
brain
biopsi
autopsi
signific
differ
clinic
present
adem
msnmo
group
includ
presenc
encephalopathi
deep
grey
matter
involv
neuroimag
present
adem
none
msnmo
periventricular
involv
similar
group
nineteen
adem
patient
dichotom
good
outcom
achiev
edss
thirteen
patient
poor
outcom
six
patient
strikingli
patient
poor
outcom
group
edss
mean
age
good
outcom
patient
vs
year
poor
outcom
p
sever
obtund
note
vs
p
differ
white
matter
involv
group
extent
csf
pleocytosi
predict
outcom
treatment
differ
group
two
patient
receiv
treatment
dramat
resolut
symptom
improv
neuroimag
abnorm
three
patient
recurr
adem
one
patient
autopsi
confirm
ademacut
hemorrhag
leukoencephalopathi
adem
protean
diseas
present
outcom
younger
age
present
mild
encephalopathi
associ
better
outcom
involv
deep
grey
matter
may
help
distinguish
adem
first
present
msnmo
amyloid
precursor
protein
modul
eae
effect
neuroinflamm
grant
jacquelin
l
bhat
roopa
steinman
lawrenc
multipl
sclerosi
ms
devast
autoimmun
disord
central
nervou
system
mediat
part
proinflammatori
lymphocyt
enter
cn
blood
attack
myelin
sheath
encas
neuron
axon
amyloid
precursor
protein
app
broadli
express
integr
membran
glycoprotein
proteolyt
process
anterograd
axon
transport
neuron
yield
variou
peptid
subunit
app
use
earli
sensit
marker
axon
damag
immunohistochem
studi
posttransl
product
app
associ
differ
physiolog
function
one
well
studi
role
senil
plaqu
alzheim
diseas
neurotox
caus
oxid
stress
inhibit
synapt
function
like
longterm
potenti
express
neuron
glia
rapidli
induc
mani
neurolog
insult
includ
neurodegener
inflamm
yet
known
app
play
role
pathogenesi
ms
histopatholog
evalu
ms
lesion
reveal
app
immunoreact
increas
activ
demyelin
plaqu
compar
control
patient
without
neurolog
diseas
app
induc
reactiv
glial
cell
neuron
lymphocyt
demyelin
gehrmann
et
al
glia
statist
analysi
myelin
antigen
array
perform
csf
relaps
remit
ms
rrm
neurolog
diseas
patient
shown
rrm
patient
signific
increas
autoantibodi
specif
residu
ousman
et
al
natur
use
experiment
autoimmun
encephalomyel
eae
anim
model
ms
determin
role
app
product
contribut
diseas
pathogenesi
show
mrna
express
level
app
significantli
increas
eae
acut
diseas
app
mrna
level
increas
brain
spinal
cord
compar
control
remiss
chronic
diseas
signific
chang
naiv
control
also
shown
variou
cellular
activ
prolifer
assay
associ
increas
proinflammatori
cytokin
studi
role
app
immun
activ
acut
axon
injuri
ms
eae
puent
fabiola
amor
sandra
centr
neurosci
trauma
london
unit
kingdom
vu
medic
center
amsterdam
netherland
axon
damag
major
caus
irrevers
disabl
multipl
sclerosi
ms
howev
mechan
underl
damag
whether
secondari
myelin
damag
unknown
preliminari
studi
show
axon
protein
neurofila
light
nfl
induc
spastic
neurolog
diseas
mice
extens
axon
damag
neurodegener
occur
key
research
propos
idea
autoimmun
axon
antigen
play
import
role
axon
damag
neurolog
disabl
observ
ms
therebi
provid
target
therapi
treat
axon
damag
neurodegener
diseas
object
investig
mechan
antibodi
cell
nfl
gener
mice
induc
axon
damag
vivo
determin
relationship
autoimmun
cell
respons
antibodi
nfl
diseas
type
activ
progress
ms
nfl
cell
antibodi
respons
overlap
synthet
peptid
cover
sequenc
nfl
protein
design
cell
respons
mice
immun
rmnfl
overlap
peptid
test
prolifer
assay
preliminari
result
show
two
peptid
residu
induc
specif
prolif
respons
intracellular
stain
show
nfl
specif
cell
vitro
stimul
produc
interferongamma
ifng
monoclon
antibodi
design
produc
nfl
protein
antibodi
purifi
use
hitrap
protein
g
affin
column
specif
antibodi
determin
western
blot
use
spinal
cord
brain
homogen
preliminari
result
show
synthet
peptid
repres
amino
termin
region
mous
nfl
induc
specif
cell
respons
base
result
cellepitop
use
immun
mice
pathogen
effect
test
eae
model
also
determin
peptid
also
immunodomin
epitop
cerebrospin
fluid
csf
pbmc
peopl
ms
studi
role
b
cell
ig
axon
damag
nfl
monoclon
antibodi
gener
specif
test
particular
examin
ig
deposit
determin
colocalis
axon
damag
track
nfl
specif
ig
rhuman
nfl
label
use
probe
antibodi
nfl
cn
pn
tissu
section
due
identif
diseas
specif
autoantibodi
ab
bind
water
channel
astrocyt
also
recent
find
experiment
allergen
enceph
eae
disrupt
blood
brain
barrier
bbb
suppos
play
role
pathogenesi
neuromyel
optica
nmo
howev
clinic
signific
bbb
integr
pathogenesi
nmo
still
unclear
aim
investig
csf
profil
evalu
correl
clinic
characterist
patient
nmo
retrospect
analysi
clinic
characterist
acut
stage
csf
studi
result
relaps
patient
definit
nmo
posit
myeliti
posit
optic
neuriti
nmo
spectrum
disord
nmosd
disrupt
bbb
measur
csfserum
albumin
ratio
bivari
partial
correl
assay
use
statist
csfserum
albumin
ration
patient
nmosd
significantli
correl
clinic
edss
r
p
radiolog
sever
length
myeliti
r
p
also
white
blood
cell
count
csf
r
p
level
immunoglobulin
g
igg
csf
also
correl
well
level
serum
igg
r
p
control
csfserum
albumin
ratio
diseas
sever
inflamm
central
nervou
system
cn
patient
nmosd
associ
disrupt
blood
brain
barrier
disrupt
bbb
seem
play
role
migrat
immunoglobulin
system
circul
csf
might
caus
worsen
inflamm
cn
mainten
bbb
integr
patient
nmo
consid
potenti
treatment
target
patient
complement
activ
autoantibodi
bind
nmdar
cluster
nmdarantibodi
enceph
bera
katarzyna
water
patrick
irani
sarosh
jacobson
lesli
spearman
hayley
beeson
david
vincent
angela
univers
oxford
oxford
unit
kingdom
nmethyl
daspart
receptor
nmdar
enceph
sever
autoimmun
encephalopathi
characteris
autoantibodi
subunit
nmda
receptor
nmdar
enceph
subacut
onset
cognit
dysfunct
seizur
psychiatr
sleep
disord
often
progress
dyskinesia
reduct
conscious
level
hypoventil
autoantibodi
bind
live
cultur
neuron
extracellular
epitop
subunit
express
hek
cell
antibodi
shown
reduc
number
nmdar
cluster
hippocamp
neuron
thought
directli
pathogen
dalmau
et
al
explor
pathogen
mechan
look
igg
subclass
abil
antibodi
activ
complement
first
show
antibodi
predominantli
main
complementactiv
subclass
human
igg
form
nmdar
cluster
hek
cell
cotransfect
enhanc
green
fluoresc
protein
egfp
intracellular
protein
cluster
nmdar
glutaminerg
synaps
via
subunit
igg
patient
nmdarab
enceph
bound
strongli
nmdar
cluster
determin
whether
could
activ
complement
ad
fresh
healthi
human
serum
sourc
complement
look
igg
attack
complex
mac
deposit
hek
cell
also
hippocamp
neuron
cultur
strong
weak
detect
surfac
hek
cell
express
nmdar
cluster
presenc
complement
nmdarantibodi
posit
patient
sera
addit
strong
weak
detect
surfac
primari
hippocamp
neuron
deposit
colocalis
igg
none
healthi
control
sera
posit
deposit
hek
cell
hippocamp
neuron
result
suggest
well
antibodyinduc
nmdar
loss
complementmedi
damag
need
consid
potenti
pathogen
mechan
nmdarantibodi
enceph
epidemiolog
studi
shown
diabet
independ
risk
factor
ischem
stroke
diabet
also
strong
predictor
wors
longterm
outcom
stroke
object
present
studi
evalu
effect
escin
cerebr
ischemiareperfus
injuri
diabet
rat
diabet
induc
singl
intraperiton
inject
streptozotocin
mgkg
bodi
weight
male
wistar
rat
anim
blood
glucos
level
exceed
mmoll
select
diabet
rat
rat
hous
addit
week
without
insulin
supplement
diabet
anim
receiv
inject
escin
dose
mgkg
day
prior
subject
cerebr
ischemiareperfus
injuri
infarct
volum
brain
assess
brain
slice
stain
solut
triphenyltetrazolium
chlorid
behavior
test
use
evalu
damag
central
nervou
system
tnfa
content
level
cerebrum
assay
western
blot
use
analyz
express
cerebrumth
result
show
escin
dose
mgkg
significantli
reduc
infarct
volum
decreas
neurolog
deficit
score
treatment
escin
dose
mgkg
reduc
tnfa
content
also
express
level
find
indic
inflamm
implic
aggrav
cerebr
ischem
injuri
diabet
also
suggest
escin
appear
neuroprotect
cerebr
ischemia
reduct
inflammatori
reaction
diabet
rat
studi
support
intern
cooper
program
china
fractalkin
fkn
chemokin
exclus
ligand
receptor
recent
identifi
key
neuroimmun
regulatori
molecul
chemokin
express
neuron
found
microglia
interact
fkn
thought
maintain
microglia
rest
state
therebi
suppress
neurotox
activ
cell
decreas
protein
level
fkn
found
age
brain
well
plasma
patient
alzheim
diseas
hypothesi
disrupt
signal
key
trigger
microglia
activ
age
lead
cognit
impair
suppress
neurogenesi
recent
shown
null
mice
decreas
hippocamp
neurogenesi
compar
control
suggest
agerel
decreas
hippocamp
neurogenesi
togeth
declin
type
synapt
plastic
contribut
disrupt
memori
function
alter
microgli
function
may
play
caus
role
nuerodegener
age
diseas
investig
whether
defici
lead
impair
synapt
plastic
analyz
induct
mainten
ltp
region
null
mice
old
follow
hf
record
fepsp
half
max
addit
minut
data
reveal
knockout
caus
signific
decreas
ltp
compar
wt
examin
defici
result
cognit
deficit
test
mice
number
behavior
task
includ
contextu
fear
condit
compar
wt
null
mice
show
reduc
freez
context
normal
freez
cue
normal
open
field
behavior
normal
behavior
elev
plu
maze
suggest
select
loss
hippocamp
depend
memori
function
test
loss
result
similar
deficit
found
receptor
null
mice
inject
fkn
null
mice
brdu
mgkg
threeday
period
analyz
prolifer
cell
sgz
data
studi
show
signific
reduct
brdu
cell
fkn
null
mice
compar
wt
summari
loss
lead
decreas
neurogenesi
ltp
contextu
fear
condit
initi
studi
suggest
loss
ligand
result
similar
loss
hippocamp
synapt
plastic
genet
dissect
mhc
class
ii
upregul
traumat
brain
injuri
use
congen
strain
al
nimer
faiez
lidman
oll
lindblom
rickard
piehl
fredrik
karolinska
institut
stockholm
sweden
well
known
mhc
class
ii
upregul
occur
perilesion
area
traumat
brain
injuri
tbi
specul
could
import
adapt
immun
respons
tradit
autoimmun
regard
detriment
prototyp
exampl
immun
mediat
diseas
cn
multipl
sclerosi
howev
emerg
data
clearli
demonstr
autoimmun
may
exert
neuroprotect
effect
mechan
nerv
injuri
previous
group
abl
map
strain
differ
mhc
class
ii
express
model
nerv
axotomi
mhc
class
ii
transactiv
ciita
gene
studi
examin
two
inbr
rat
strain
da
pvg
congen
dapvg
ciita
strain
mhc
congen
strain
dissect
genet
effect
mhc
class
ii
present
experiment
model
tbi
use
qrtpcr
day
tbi
found
allel
differ
ciita
gene
regul
invari
chain
mhc
express
mrna
level
mhc
complex
exert
signific
effect
mrna
level
notabl
howev
protein
level
strain
display
much
lower
mhc
ii
label
use
antibodi
pvg
strain
dwarf
effect
express
tcell
rtpcr
day
tbi
higher
howev
significantli
pvg
strain
compar
da
strain
correl
strongli
express
genet
effect
express
inflammatori
mediat
also
seen
addit
character
use
flow
cytometri
underway
find
suggest
allel
differ
ciita
gene
regul
mhc
invari
chain
mrna
express
tbi
addit
mhc
complex
exert
strong
influenc
mhc
present
posttranscript
level
sever
signal
pathway
could
account
regul
mhc
present
combin
genet
effect
ciita
mhc
recent
suggest
import
determin
suscept
autoimmun
neuroinflamm
eg
multipl
sclerosi
studi
need
address
function
consequ
possibl
neuroprotect
detriment
immun
respons
tbi
human
immunodefici
viru
type
patient
present
reduc
synapt
densiti
cognit
impair
consequ
chronic
viral
infect
glycoprotein
neural
cell
adhes
molecul
glycoprotein
involv
neural
plastic
axon
elong
neurogenesi
memori
format
alpha
chemokin
coreceptor
express
neuron
glia
chemokin
glycoprotein
iii
beta
bind
receptor
differ
signal
consequ
ligand
alpha
chemokin
exclus
bind
regul
microgli
activ
neuropatholog
condit
includ
dementia
damag
cortic
hippocamp
neuron
alter
neurogenesi
interact
chemokin
receptor
brain
aim
whether
synerg
human
recombin
growth
hormon
hgh
neuroprotect
hormon
stromal
cell
factor
alpha
fractalkin
combin
would
prevent
gp
iii
betainduc
dendrit
retract
associ
psancam
modul
ii
whether
gh
induc
neuroprotect
iii
beta
glycoprotein
cortic
neuron
regul
ncam
level
absencepres
combin
chemokin
treatment
alphafractalkin
cortic
neuron
obtain
brain
day
old
rat
embryo
feeder
layer
astrocyt
face
neuron
use
support
growth
differenti
pm
h
ad
cell
presenc
hgh
ngm
hour
addit
alpha
nm
andor
fractalkin
nm
treatment
ad
either
absenc
presenc
serumfre
supplement
ncam
level
test
immunofluoresc
div
found
gh
prevent
dendrit
retract
cortic
neuron
expos
iii
beta
modul
ncam
synapt
level
damag
neuron
addit
gh
exert
neuroprotect
neurotox
fractalkinetr
cell
limit
dendrit
degener
associ
psancam
level
result
along
previou
find
neuroprotect
role
neurohormon
chemokin
neuron
cell
suggest
ncam
would
target
gh
andor
chemokin
could
prevent
neuron
loss
dementia
merino
et
al
submit
ramon
cajal
program
protect
neurotox
play
neuroprotect
role
cell
mediat
neurotox
turner
dian
kinsey
robyn
pasichnyk
dion
giuliani
fabrizio
seek
investig
protect
effect
interleukin
il
cell
mediat
neurotox
antiinflammatori
cytokin
enhanc
lymphocyt
helper
cell
type
respons
induc
antiinflammatori
immun
state
demonstr
protect
ms
diseas
progress
exogen
treatment
mice
prior
induct
eae
shown
reduc
durat
sever
eae
symptom
human
fetal
neuron
cocultur
unactiv
activ
treat
activ
cell
neuron
also
cocultur
ovalbumin
specif
cell
line
surviv
assay
quantifi
stain
addit
immunohistochemistri
elisa
assay
flow
cytometri
perform
neuron
cocultur
activ
cell
cocultur
specif
cell
line
show
protect
qualiti
surviv
activ
surviv
treat
line
untreat
treatment
chang
ratio
cell
popul
intracellular
level
fasl
express
cytokin
secret
profil
also
remain
unchang
respect
ifng
lymphocyt
functionassoci
antigen
lfa
found
regul
treatment
taken
togeth
result
indic
neuroprotect
abil
ad
cell
regul
within
immun
synaps
may
contribut
mechan
action
explor
employ
potenti
therapi
ms
patient
microgli
activ
plaqu
load
transgen
mice
treat
select
serotonin
reuptak
inhibitor
ssri
paroxetin
severino
maurizio
manzoor
asif
k
b
finsen
bent
diseas
incid
femal
male
linkag
analysi
identifi
one
main
region
rat
chromosom
regul
suscept
hse
male
femal
fine
map
use
addit
individu
recombin
region
haplotyp
map
express
analysi
identifi
one
candid
gene
calcitonin
receptor
allel
variant
gene
underli
differ
viru
spread
trigemin
ganglia
seen
da
data
demonstr
novel
observ
allel
variant
calcitonin
receptor
contribut
differ
properti
host
nerv
perineuri
cell
innat
immun
respons
whisker
area
defin
suscept
entri
nervou
system
spaciotempor
distribut
ligand
adult
develop
mice
brain
shrivastava
kalpana
gonzalez
pau
acarin
laia
medic
histolog
neurosci
institut
universitat
autonoma
barcelona
bellaterra
barcelona
spain
signal
highlight
contribut
immun
privileg
statu
cn
develop
brain
exhibit
distinct
characterist
along
exacerb
inflammatori
respons
henc
aim
studi
character
express
pattern
develop
adult
mice
brain
wildtyp
mice
postnat
adult
perfus
paraformaldehyd
intracardi
anaesthesia
sacrif
brain
remov
cryoprotect
frozen
cut
section
immunohistochemistri
anim
perfus
pb
brain
dissect
freez
liquid
n
store
till
use
immunoblot
highli
express
gray
matter
region
cerebr
cortex
hippocampu
striatum
immunoreact
appear
surround
neuron
age
group
display
age
depend
decreas
intens
increas
age
blood
vessel
bv
label
tomato
lectin
express
age
pronounc
adult
distinct
label
observ
hippocamp
fissur
hf
along
mening
age
decreas
intens
adult
mani
oval
round
meagr
ramifi
neun
cell
gfap
present
across
hf
earli
postnat
age
much
reduc
absent
adult
adult
hippocamp
mainli
found
stronger
label
inner
commissuralassoci
zone
molecular
layer
dg
western
blot
show
gradual
decreas
express
increas
age
immunolabel
mainli
observ
macrophag
present
mening
later
dorsal
ventricl
line
mainli
drastic
reduct
cell
region
parallel
increas
densiti
primari
ramifi
microgli
cell
parenchyma
moreov
ameboid
microgli
cell
also
seen
cingulum
bundl
brain
close
opposit
laminin
basal
lamina
bv
locat
hf
adulthood
larg
cortic
bv
adult
brain
doublestain
suggest
physic
bind
bv
wall
mainli
hf
cortex
data
indic
signal
might
play
role
modul
microgli
develop
migrat
mediat
immun
regul
neonat
hendrickx
debbi
melief
jeroen
van
eden
corbert
hamann
jorg
hoek
robert
huitinga
ing
netherland
insitut
neurosci
amsterdam
netherland
academ
medic
centr
amsterdam
netherland
microglia
resid
macrophag
brain
phagocyt
myelin
multipl
sclerosi
ms
mean
yet
complet
understood
literatur
suggest
role
autoantibodi
myelin
protein
possibl
concert
complement
receptor
recent
scaveng
receptor
express
microglia
plasma
membran
also
consid
potenti
candid
bind
posttransl
modif
myelin
protein
lipid
present
studi
use
rapid
procedur
isol
sort
cultur
microglia
ms
healthi
control
brain
donor
high
puriti
human
postmortem
brain
tissu
base
densiti
gradient
cell
surfac
express
myelin
isol
tissu
use
sucros
gradient
label
dii
comparison
use
macrophag
cell
line
macrophag
expos
hour
myelin
uptak
quantifi
use
fac
analysi
express
sever
scaveng
receptor
rna
evalu
ms
brain
tissu
use
qpcr
reveal
put
differ
scaveng
receptor
express
ms
tissu
identifi
pathway
myelin
phagocytosi
ms
block
studi
use
either
sirna
block
antibodi
receptor
ultim
identifi
receptor
macrophag
involv
enhanc
uptak
ms
myelin
first
result
show
increas
phagocytosi
myelin
isol
ms
brain
compar
control
myelin
indic
myelin
inde
alter
ms
result
enhanc
suscept
phagocytosi
tissu
obtain
netherland
brain
bank
www
hersenbanknl
studi
support
grant
ms
research
ms
dhendrickx
ninknawnl
evalu
multipl
sclerosi
patient
tumefact
brain
lesion
altinta
ays
tavsanli
mustafa
emir
bolukbasi
feray
saip
sabahattin
siva
aksel
multipl
sclerosi
ms
inflammatori
demyelin
neurodegen
diseas
central
nervou
system
cn
acut
clinic
exacerb
correl
magnet
reson
imag
mri
exhibit
small
asymmetr
multifoc
lesion
predilect
periventricular
subcort
white
matter
lesion
greater
equal
cm
size
refer
tumefact
demyelin
lesion
lesion
hard
distinguish
tumor
often
show
gadolinium
enhanc
may
mass
effect
differenti
diagnosi
includ
parasit
infect
abscess
besid
tumor
cerebr
biopsi
may
requir
verifi
exact
diagnosi
symptom
variabl
includ
headach
cognit
abnorm
mental
confus
aphasia
apraxia
andor
seizur
tumefact
lesion
rare
radiolog
present
inflammatori
demyelin
diseas
cn
like
multipl
sclerosi
limit
data
avail
subject
studi
retrospect
evalu
patient
tumefact
cranial
lesion
diagnos
definit
possibl
ms
clinic
radiolog
cerebrospin
fluid
csf
variabl
report
studi
conduct
cerrahpasa
medic
school
neuroimmunolog
unit
patient
evalu
respect
age
gender
diseas
onset
tumefactiveles
develop
cours
diseas
edss
treatment
respons
radiolog
csf
find
includ
oligoclon
band
patient
femal
mean
age
year
patient
diagnos
definit
msage
first
tumefact
attack
year
mean
patient
tumefact
lesion
develop
follow
howev
patient
present
tumefact
lesion
onset
oligoclon
band
ocb
posit
perform
found
neg
patient
contrast
enhanc
present
patient
mean
edss
tumefact
attack
found
edss
last
follow
mean
durat
follow
found
month
result
suggest
cours
demyelin
diseas
tumefact
brain
lesion
could
favor
multipl
sclerosi
ms
chronic
inflammatori
neurodegen
diseas
product
adamt
disintegrin
metalloproteinas
thrombospondin
motif
may
contribut
axon
damag
convers
promot
neuron
regener
mrna
protein
express
observ
human
central
nervou
system
cn
immunohistochem
studi
laboratori
demonstr
increas
within
ms
lesion
adamtss
also
call
aggrecanas
degrad
chondroitin
sulphat
proteoglycan
cspg
key
compon
cn
extracellular
matrix
ecm
aggrecan
brevican
versican
produc
neoepitop
indic
aggrecanas
activ
aim
project
determin
whether
neuron
cell
produc
adamtss
whether
adamtss
involv
turnov
cn
ecm
evidenc
presenc
versican
neoepitop
cn
tissu
product
studi
human
neuroblastoma
cell
line
undifferenti
differenti
neuron
phenotyp
use
retino
acid
cell
untreat
treat
cytokin
tnf
involv
pathogenesi
ms
mrna
express
determin
realtim
rtpcr
also
investig
express
neoepitop
versican
cryostat
section
white
matter
normal
ms
cn
tissu
immunohistochemistri
fluoresc
microscopi
neuroblastoma
cell
express
mrna
mrna
upregul
retino
acid
treatment
retino
acid
also
morpholog
effect
cell
produc
neuritelik
extens
signific
effect
tnf
adamt
mrna
express
versican
neoepitop
observ
normal
ms
tissu
differenti
express
normal
ms
tissu
investig
work
shown
constitut
express
cell
model
neuron
cell
express
versican
neoepitop
cn
tissu
suggest
role
adamtss
ecm
turnov
multipl
sclerosi
ms
anim
model
experiment
autoimmun
encephalomyel
eae
circul
immun
cell
gain
access
central
nervou
system
cn
caus
inflamm
bloodbrain
barrier
bbb
breakdown
demyelin
inflammatori
cell
recruit
across
bbb
recogn
major
pathophysiolog
hallmark
ms
block
leukocyteendotheli
interact
proven
benefici
treatment
disabl
diseas
junction
adhes
molecul
jama
transmembran
glycoprotein
express
endotheli
epitheli
cell
platelet
leukocyt
subset
shown
mediat
leukocyt
extravas
across
endothelium
therefor
address
role
jama
immunopathogenesi
eae
special
focu
leukocyt
traffick
across
bbb
use
mice
immunofluoresc
stain
brain
cryosect
wildtyp
mice
confirm
local
jama
within
also
outsid
tight
junction
brain
endotheli
cell
mice
found
develop
amelior
moginduc
eae
compar
wildtyp
litterm
perform
vitro
prolifer
assay
could
exclud
role
jama
mogspecif
cell
prime
drain
lymph
node
detect
time
howev
higher
mogspecif
prolifer
rate
peripher
blood
mice
onset
eae
flow
cytometri
cell
isol
cn
mice
onset
eae
show
greatli
reduc
number
inflammatori
cell
cn
mice
observ
suggest
impair
immun
cell
entri
cn
mice
current
investig
potenti
role
jama
bbb
mediat
cell
arrest
cell
crawl
cell
diapedesi
use
vitro
bbb
model
establish
either
wildtyp
mice
intracerebr
infect
suscept
mous
strain
theiler
murin
encephalomyel
viru
tmev
result
immun
mediat
demyelin
diseas
similar
human
multipl
sclerosi
ms
persist
central
nervou
system
cn
viru
infect
suscept
mous
strain
trigger
clonal
expans
differenti
tmevspecif
mhc
class
iirestrict
effector
dth
cell
poorli
control
normal
immunoregulatori
mechan
proinflammatori
cytokin
produc
virusspecif
cell
lead
recruit
accumul
activ
addit
monocyt
macrophag
within
cn
caus
demyelin
termin
nonspecif
bystand
respons
program
death
demonstr
play
crucial
role
develop
mainten
peripher
toler
ms
patient
polymorph
determin
associ
diseas
progress
possibl
partial
defect
inhibit
tcell
activ
studi
examin
regulatori
role
pathway
develop
tmevinduc
demylin
diseas
tmevidd
express
mrna
increas
spleen
spinal
cord
mice
tmevidd
compar
control
investig
vitro
mrna
express
bone
marrowderiv
dc
bmdc
realtim
rt
pcr
analys
tmev
primarili
induc
upregul
mrna
express
compar
uninfect
dc
treatment
monoclon
antibodi
mab
especi
effector
phase
result
signific
deterior
develop
diseas
clinic
histolog
number
infiltr
mononuclear
inflammatori
cell
spinal
cord
also
increas
mice
treat
monoclon
anti
antibodi
flow
cytometr
analysi
cytokin
stain
reveal
signific
increas
number
cytokin
produc
cell
ifngamma
anti
mab
treat
mice
spleen
spinal
cord
result
suggest
pathway
may
critic
involv
process
tmevidd
play
pivot
regulatori
role
develop
tmevidd
result
signific
implic
context
ms
pathogenesi
multipl
sclerosi
ms
inflamatori
demyelin
neurodegen
diseas
central
nervou
system
common
neurolog
diseas
young
adult
western
world
follow
advanc
understand
immunolog
mechan
underli
pathogenesi
ms
cannabinoid
arisen
one
possibl
immunomodulatori
agent
avail
immun
cell
neuron
tissu
express
receptor
compound
present
studi
investig
effect
cannabidiol
cbd
non
psychoact
compon
cannabi
sativa
viral
model
ms
theiler
viru
induc
demyelin
diseas
result
show
therapeut
time
window
presyntomat
phase
cbd
treatment
improv
neurolog
deficit
benefit
associ
decreas
gene
express
proinflammatori
cytokin
well
reduc
microglia
activ
spinal
cord
tmevinfect
mice
primari
cell
cultur
oligodendrocyt
progenitor
cell
cbd
exert
benefici
effect
protect
inflammatori
oxid
death
mechan
involv
decreas
reactiv
oxid
speci
product
experi
progress
order
identifi
intracellular
pathway
mechan
involv
immunomodulatori
protect
action
cbd
solid
evid
genet
influenc
multipl
sclerosi
deciph
caus
gene
could
reveal
key
pathway
influenc
diseas
genom
region
rat
chromosom
name
regul
experiment
autoimmun
encephalomyel
eae
model
multipl
sclerosi
ms
collabor
team
pr
toma
olsson
karolinska
institut
sweden
identifi
major
gene
underli
effect
use
intervalspecif
congen
rat
line
rat
variant
associ
control
protein
level
proinflammatori
lymphocyt
activ
neuroinflamm
analysi
seven
human
cohort
individu
demonstr
associ
ca
haplotyp
first
intron
ms
risk
ca
haplotyp
also
predispos
higher
messeng
rna
express
correl
tumor
necrosi
factor
interferong
express
peripher
blood
cerebrospin
fluid
cell
direct
proof
role
mutat
suscept
eae
rat
provid
use
passiv
transfer
model
inde
antimbp
cell
line
rat
bear
variant
encephalitogen
passiv
transfer
rat
transduct
lentiviru
bear
variant
lentivir
control
prepar
render
pathogen
moreov
demonstr
resist
rat
variant
regulatori
cell
treg
suscept
rat
challeng
relationship
high
proport
treg
protect
eae
observ
resist
congen
rat
purpos
treg
deplet
resist
rat
eae
induct
expect
treg
deplet
revers
resist
eae
thu
ad
support
role
variant
eae
suscept
control
treg
pathway
togeth
data
demonstr
influenc
suscept
central
nervou
system
inflamm
treg
develop
gener
knockin
mous
help
us
deciph
cellular
molecular
level
mechan
pathway
direct
function
cell
dysfunct
lead
immun
diseas
viral
persist
associ
mutat
surfac
protein
human
coronaviru
modul
diseas
mice
enceph
flaccid
paralysi
inflammatori
demyelin
talbot
pierr
j
stjean
julien
r
brison
elodi
marceau
gabriel
desforg
marc
jacomi
helen
etiolog
neurodegen
diseas
central
nervou
system
cn
remain
unknown
like
involv
combin
genet
suscept
environment
trigger
factor
given
exposur
numer
infecti
pathogen
occur
childhood
viral
infect
lead
neurodegener
demyelin
conceiv
virus
may
act
trigger
factor
pathogenesi
neurolog
diseas
multipl
sclerosi
ms
previous
shown
prototyp
strain
common
coldassoci
human
respiratori
coronaviru
infect
human
neuron
glial
cell
persist
human
brain
moreov
neuroinvas
properti
suscept
balbc
mice
lead
chronic
enceph
accompani
disabl
aim
character
neuropatholog
induc
viru
isol
persist
infect
human
neural
cell
cultur
bear
point
mutat
viral
surfac
protein
mutat
viral
surfac
protein
insert
infecti
viral
clone
recombin
mutat
viru
led
drastic
modifi
virusinduc
neuropatholog
balbc
mice
character
flaccid
paralysi
inflammatori
demyelin
even
though
infect
mutat
wildtyp
virus
led
neuroinflamm
modifi
neuropathogenesi
induc
mutat
viru
associ
increas
viral
spread
significantli
tlymphocyt
infiltr
central
nervou
system
well
significantli
increas
level
proinflammatori
cytokin
il
chemokin
trend
toward
increas
cytokin
tnfalpha
ifngamma
chemokin
rant
moreov
recombin
viru
harbor
glycoprotein
mutat
retain
neurotrop
product
infect
neuron
interact
human
respiratori
coronaviru
cn
may
modul
viru
host
factor
result
modifi
neuropathogenesi
genet
suscept
individu
may
relev
neuroinflammatori
diseas
multipl
sclerosi
support
grant
institut
infect
immun
canadian
institut
health
research
canada
research
chair
neuroimmunovirolog
pjt
studentship
fond
de
recherch
sur
la
natur
et
le
technolog
jr
multipl
sclerosi
societi
canada
gm
protein
found
weakli
express
healthi
human
mous
cn
note
mark
upregul
bbbendotheli
cell
infiltr
apc
microglia
cours
eae
activ
ms
lesion
freshli
isol
human
peripher
blood
immun
cell
predominantli
express
monocyt
wherea
bare
detect
b
lymphocyt
addit
found
treatment
bbbendotheli
cell
block
peptid
neutral
antibodi
direct
specif
abrog
adhes
migrat
human
monocyt
across
bbb
endothelium
without
affect
lymphocyt
recruit
final
neutral
cours
eae
either
block
peptid
neutral
antibodi
reduc
clinic
diseas
activ
histopatholog
indic
eae
decreas
infiltr
macrophag
dendrit
cell
inflammatori
apc
cn
studi
uncov
import
cellspecif
role
transmigr
inflammatori
apc
across
bbb
endothelium
emphas
import
myeloid
cell
recruit
cn
develop
neuroinflammatori
lesion
muscl
fiber
damag
hallmark
autoimmun
myositi
known
multinucl
cell
myocyt
rel
resist
classic
form
apoptosi
factor
initi
celldeath
myositi
well
defin
therefor
propos
autophag
oppos
apoptot
cell
death
may
play
role
muscl
fiber
damag
recent
literatur
indic
tumornecrosisfactoralpha
relat
apoptosi
induc
ligand
trail
may
induc
nuclear
factor
kappalightchainenhanc
activ
b
cell
activ
also
autophag
cell
death
cultur
model
system
investig
role
trail
cell
death
pathogenesi
vitro
cell
cultur
vivo
human
muscl
biopsi
mous
muscl
tissu
gene
express
profil
multipl
human
myopathi
indic
express
trail
sever
marker
autophagi
specif
upregul
myositi
muscl
tissu
result
confirm
immunohistochemistri
immunoblot
also
analyz
trail
induc
cell
death
apoptosi
autophagi
activ
vitro
cultur
cell
found
trail
express
predominantli
myositi
muscl
fiber
biopsi
normal
dystroph
diseas
muscl
likewis
autophagi
marker
beclin
upregul
human
mous
model
myositi
trail
express
restrict
regeneratingatroph
area
muscl
fascicl
blood
vessel
infiltr
lymphocyt
trail
induc
activ
degrad
cultur
cell
resist
trailinduc
apoptosi
undergo
autophag
cell
death
small
molecul
inhibitor
effici
block
trailinduc
nuclear
transloc
cultur
cell
data
demonstr
trail
express
autoimmun
myositi
muscl
muscl
diseas
biopsi
trail
express
restrict
regener
muscl
fiber
may
like
mediat
activ
myositi
autophag
cell
death
multinucl
muscl
cell
trail
may
attract
target
therapeut
intervent
autoimmun
myositi
select
blockad
solubl
tumour
necrosi
factor
signal
amelior
experiment
autoimmun
encephalomyel
mice
taoufik
era
tseveleki
vivian
lassman
han
szymkowski
david
probert
lesley
laboratori
molecular
genet
hellen
pasteur
institut
hella
greec
divis
neuroimmunolog
brain
research
institut
vienna
austria
xencor
inc
monrovia
ca
usa
tnf
receptor
wide
express
cn
cell
express
induc
inflammatori
neurodegen
diseas
tnf
synthes
type
ii
transmembran
trimer
protein
cleav
solubl
form
aggarw
et
al
solubl
tnf
sol
tnf
transduc
inflammatori
stimuli
tnfri
also
shown
induc
neuroprotect
vitro
vivo
ischem
condit
mattson
et
al
taoufik
et
al
role
transmembran
tnf
tmtnf
less
well
understood
mediat
prosurviv
effect
cortic
hippocamp
neuron
marchetti
et
al
studi
aim
defin
contribut
tmtnf
protect
cn
neuron
evalu
therapeut
potenti
solubl
tnfspecif
reagent
therapi
multipl
sclerosi
effect
tnf
variant
steed
et
al
engin
select
inhibit
biolog
activ
nativ
soltnf
tmtnf
non
select
agent
etanercept
test
experiment
mous
model
ms
eae
administr
significantli
amelior
eae
mice
compar
nontreat
etanercept
treat
mice
use
prophylact
therapeut
administr
protocol
cell
respons
antigen
prime
cytokin
product
peak
diseas
ifng
equival
group
howev
treatment
induc
signific
induct
express
neuroprotect
molecul
flip
vegf
result
suggest
select
blockad
soltnf
suffici
protect
mice
moginduc
eae
directli
protect
cn
neuron
damag
inflammatori
environ
tmtnf
signal
induc
direct
neuroprotect
cn
inflamm
death
receptor
ligand
constitut
express
develop
adult
brain
often
upregul
patholog
condit
includ
epilepsia
recent
shown
cn
neuron
express
compon
death
receptor
signal
cascad
faddcaspas
pathway
activ
mediat
neuron
death
ischem
injuri
similarli
multipl
dr
signal
molecul
includ
caspas
activ
hippocamp
neuron
follow
kainat
induc
seizur
howev
involv
caspas
neuron
fate
excitotox
injuri
yet
establish
investig
role
caspas
neuron
death
excitotox
injuri
use
vitro
vivo
model
kainateinduc
damag
mice
defici
caspas
specif
cn
neuron
neuron
like
cell
transfect
domin
neg
mutant
murin
caspas
respect
show
mutant
mice
significantli
less
sever
kainicacid
induc
seizur
decreas
neuron
death
activ
caspas
moreov
absenc
caspas
effect
activ
led
sustain
increas
phosphoryl
level
cjun
jnk
hippocampi
mutant
mice
similarli
neuron
cell
defici
caspas
resist
kainat
nmdainduc
cell
death
overal
result
suggest
activ
role
caspas
mediat
excitotox
neuron
death
identifi
potenti
new
target
neurodegen
diseas
tnf
pleiotrop
cytokin
involv
regul
numer
physiolog
patholog
process
inflamm
cancer
autoimmun
tnf
exist
two
biolog
activ
form
solubl
tnf
soltnf
transmembran
tnf
tmtnf
signal
preferenti
respect
often
mediat
oppos
function
effect
tnf
link
pathophysiolog
variou
neurodegen
disord
includ
multipl
sclerosi
ms
howev
specif
role
two
form
tnf
diseas
greatli
underappreci
goal
studi
dissect
function
soltnf
tmtnf
develop
progress
experiment
autoimmun
encephalomyel
eae
wide
use
model
ms
find
select
inhibit
soltnf
therapeut
moginduc
eae
inde
treatment
select
inhibitor
soltnf
improv
clinic
outcom
nonselect
inhibit
form
tnf
etanercept
result
protect
contrari
associ
chronic
exacerb
diseas
sinc
etanercepttr
mice
display
signific
reduct
express
proinflammatori
molecul
eg
cytokin
chemokin
therapeut
effect
sole
attribut
reduct
immuneinflammatori
respons
eae
rather
associ
signific
axon
preserv
shown
increas
number
myelin
axon
spinal
cord
white
matter
highli
improv
myelin
compact
indic
properli
function
axon
accompani
increas
gene
protein
express
axonspecif
molecul
neurofilamenth
significantli
reduc
express
nonphosphoryl
neurofilamenth
associ
axon
damag
furthermor
mice
show
significantli
increas
number
remyelin
axon
parallel
elev
express
myelinspecif
gene
increas
number
oligodendrocyt
precursor
spinal
cord
white
matter
taken
togeth
data
show
select
inhibit
soltnf
promot
function
recoveri
follow
eae
signal
mediat
tmtnf
essenti
axon
myelin
preserv
well
remyelin
evid
open
excit
possibl
futur
clinic
use
select
inhibitor
soltnf
interfer
protect
function
tmtnf
treatment
ms
methylthioadenosin
mta
antioxid
antiprolif
properti
shown
induc
cell
protect
hepat
cell
previous
demonstr
exert
immunomodulatori
effect
anim
model
ms
main
goal
project
assess
neuroprotect
effect
mta
model
ms
parkinson
diseas
stroke
epilepsi
perform
toxicityexcitox
vitro
assay
primari
neuron
olygodendrocyt
neuronastrocyt
cultur
optic
nerv
cerebellar
organotyp
cultur
differ
dose
mta
also
assess
abil
mta
prevent
axon
loss
neuron
death
anim
model
ms
eae
csfgfp
tg
mice
axon
count
motor
evok
potenti
mep
stroke
middl
cerebr
arteri
occlus
mcao
transient
forebrain
ischemia
tfi
parkinson
diseas
mptp
mice
epilepsi
pilocarpin
tempor
lobe
epilepsi
tle
vitro
studi
reveal
mta
protect
neuron
glutam
excitotoc
inde
mta
prevent
excitotox
olygodendrocyt
loss
vitro
cultur
cerebellar
organotyp
cultur
stimul
lp
mta
reduc
myelin
loss
decreas
axon
transect
ms
model
reduc
axon
loss
recov
mep
stroke
model
mta
unabl
increas
neuron
surviv
mcao
model
protect
partial
neuron
death
tfi
mptp
model
high
dose
mta
mgkg
day
reduc
thneuron
loss
substantia
nigra
tle
model
mta
decreas
neunneuron
loss
hilu
region
mta
neuroprotect
model
ms
diseas
deserv
clinic
studi
treat
brain
diseas
vascular
inflammatori
event
respons
sideeffect
associ
abeta
immunotherapi
alzheim
diseas
first
abeta
immunotherapi
trial
alzheim
diseas
ad
use
activ
immunis
peptid
elan
pharmaceut
effect
remov
plaqu
encount
sideeffect
associ
focal
cerebr
white
matter
abnorm
inflamm
neurolog
dysfunct
subsequ
passiv
immunotherapi
shown
similar
chang
bapineuzimab
elan
pharmaceut
rais
possibl
may
gener
complic
abeta
immunotherapi
hypothes
immunis
prompt
solubilis
abeta
plaqu
reloc
solubilis
abeta
cerebr
vasculatur
result
increas
sever
cerebr
amyloid
angiopathi
caa
associ
inflamm
may
exacerb
problem
perform
clinic
neuropatholog
follow
patient
immunis
one
side
effect
rel
distribut
abeta
plaqu
cerebr
vasculatur
caa
well
microgli
inflammatori
marker
lymphocyt
assess
compar
unimmunis
ad
case
immunis
case
observ
plaqu
reduct
associ
increas
sever
caa
ii
increas
phagocyt
activ
microglia
iii
lymphocyt
correl
caa
sever
studi
suggest
abeta
abetatarget
immunolog
respons
converg
cerebr
vasculatur
caus
problem
sideeffect
thought
specif
activ
abeta
immunis
still
seem
observ
current
passiv
immunotherapi
trial
thorough
understand
pathophysiolog
process
identifi
risk
factor
prime
immun
system
preexist
sever
caa
featur
vascular
age
genet
variat
includ
apo
genotyp
may
aid
better
select
ad
patient
abeta
immunotherapi
immunotherapi
stroke
cognit
cerebrovascular
amyloidosi
model
lifshitz
veronica
benromano
tali
kfir
einat
blumenfeldkatzir
tamar
tempelbrami
catherin
assaf
yaniv
xia
weim
wysscoray
toni
weiner
howard
l
frenkel
dan
tel
aviv
univers
tel
aviv
israel
harvard
univers
boston
unit
state
stanford
univers
school
medicin
stanford
unit
state
cerebr
amyloid
angiopathi
caa
due
amyloid
accumul
vessel
wall
lead
hemorrhag
stroke
cognit
impair
avail
treatment
specif
reduc
risk
caa
research
aim
assess
brain
tissu
damag
cognit
impair
result
caa
anim
model
investig
novel
approach
immun
therapi
shown
nasal
vaccin
proteosom
adjuv
protollin
well
toler
human
decreas
amyloid
plaqu
alzheim
diseas
mous
model
recent
report
overexpress
control
astrocyt
promot
gfap
mice
result
caa
mice
nasal
treat
protollin
weekli
basi
start
age
month
three
month
show
nasal
protollin
activ
macrophag
potent
decreas
vascular
amyloid
mice
use
mri
found
pb
treat
anim
show
signific
enlarg
later
ventricl
area
protollin
prevent
brain
damag
prevent
patholog
chang
bbb
vascular
risk
factor
found
associ
vascular
dementia
use
object
recognit
test
ymaze
found
signific
improv
cognit
protollin
treat
group
studi
demonstr
activ
macrophag
protollin
novel
approach
reduc
microhemorrhag
prevent
stroke
improv
cognit
model
cerebr
amyloid
angiopathi
oral
administr
nitroxid
radic
tempol
protect
diseas
anim
model
ms
quandt
jacquelin
huh
jaebong
munasingh
jeeva
hyodo
therapi
immunomodulatori
neuroprotect
potenti
thought
greatest
promis
reduc
sever
progress
multipl
sclerosi
ms
sever
reactiv
oxygen
ro
nitrogen
speci
rn
implic
inflammatorymedi
damag
central
nervou
system
cn
ms
anim
model
experiment
autoimmun
encephalomyel
eae
tempol
stabl
nitroxid
radic
pleuripot
antioxid
activ
report
react
sever
ro
rn
implic
pathogenesi
ms
goal
studi
investig
therapeut
potenti
tempol
character
antiinflammatori
neuroprotect
effect
anim
model
ms
oral
deliveri
tempol
test
efficaci
activ
passiv
model
chronic
relapsingremit
ms
anim
receiv
tempol
feed
ad
libitum
week
prior
induct
activ
eae
show
delay
onset
reduc
incid
diseas
compar
control
fed
anim
milder
diseas
associ
limit
microgli
activ
fewer
inflammatori
infiltr
ex
vivo
analysi
show
frequenc
autoreact
cell
product
diseaseassoci
cytokin
ifngamma
similar
control
tempolf
anim
tempol
also
reduc
sever
clinic
diseas
administ
onset
clinic
symptom
diminish
relaps
enhanc
recoveri
chronic
model
exclud
effect
upon
cell
prime
vivo
tempol
test
passiv
eae
found
reduc
incid
peak
sever
diseas
tempol
lower
cumul
diseas
score
half
correl
spare
neurofila
spinal
cord
detect
elisa
reduc
leukocyt
infiltr
consist
reduct
inflammatori
edema
magnet
reson
imag
mri
anim
peak
diseas
show
lower
relax
time
spinal
cord
tempolf
eae
mice
compar
control
eae
mice
oral
deliveri
tempol
effect
prophylact
therapeut
agent
treatment
autoimmun
demyelin
diseas
abil
tempol
reduc
inflamm
axon
damag
loss
demonstr
antiinflammatori
neuroprotect
properti
signific
promis
treatment
ms
relat
neurolog
disord
metabol
intervent
pantethin
inhibit
experiment
autoimmun
encephalomyel
angiari
stefano
bach
simon
budui
simona
rossi
barbara
zenaro
elena
pietronigro
enrica
battistella
alessandro
della
bianca
vittorina
constantin
gabriela
possibl
antigen
target
test
sampl
antibodi
demonstr
sampl
posit
show
first
time
proport
patient
cerebellar
ataxia
autoimmun
diseas
associ
autoantibodi
surfac
membran
protein
screen
clarifi
pathogen
role
antibodi
surfac
protein
cerebellar
syndrom
detect
antibodi
secret
plasma
cell
asc
antibodi
central
nervou
system
cn
common
hallmark
viral
infect
autoimmun
mediat
disord
despit
increas
evid
plasma
cell
accumul
surviv
cn
littl
known
signal
recruit
asc
brain
use
neurotrop
coronaviru
demonstr
nonredund
role
chemokin
receptor
mediat
asc
accumul
cn
asc
measur
flow
cytometri
elispot
immunohistochemistri
infect
cn
tissu
infect
defici
mice
exhibit
reduct
total
virusspecif
asc
brain
spinal
cord
support
role
sustain
elev
express
ligand
persist
infect
cn
contrast
peripher
asc
respons
accumul
asc
bone
marrow
impair
even
enhanc
rel
wt
mice
furthermor
virusspecif
serum
antibodi
level
includ
neutral
antibodi
similar
wt
control
confirm
primarili
result
migratori
defect
site
inflamm
although
cell
infiltr
cn
transient
reduc
earli
infect
number
local
cell
spinal
cord
similar
wt
mice
time
correspond
peak
asc
accumul
impair
asc
recruit
coincid
elev
level
persist
viral
rna
increas
clinic
diseas
mortal
result
highlight
indispens
protect
role
mediat
asc
recruit
local
antibodi
product
control
persist
infect
cn
multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
cn
perman
neurolog
impair
typic
ms
due
axon
loss
result
recurr
episod
immunemedi
demyelin
endogen
neural
stemprecursor
cell
npc
consid
function
reservoir
promot
tissu
homeostasi
repair
injuri
recent
evid
inflammatori
anim
model
demyelin
suggest
subventricular
zone
svz
deriv
npc
might
contribut
remyelin
investig
role
npc
inflammatori
neurodegen
disord
develop
transgen
mous
line
nestfloxgfpfloxtkireslacz
loxp
flank
gfp
herp
simplex
viru
thymidin
kinas
tk
gene
place
control
nestin
regulatori
region
mice
gfp
cell
detect
svz
ependym
layer
olfactori
bulb
order
induc
activ
tk
gene
svz
cell
select
ablat
endogen
npc
cross
mice
cmvcre
mice
doubl
transgen
mice
call
nesttk
treatment
mice
day
antivir
drug
ganciclovir
gcv
deplet
nestinexpress
brdu
label
cell
subventricular
zone
howev
although
brdu
dcx
psancamlabel
cell
decreas
end
gcv
treatment
neurogenesi
promptli
reconstitut
follow
week
gcv
administr
result
suggest
exist
pool
cell
surviv
short
gcv
administr
reconstitut
svz
test
whether
npc
ablat
influenc
experiment
autoimmun
encephalomyel
eae
experiment
model
ms
nesttk
wild
type
wt
mice
treat
day
either
intraperiton
gcv
salin
obtain
transitori
ablat
npc
nesttk
mous
influenc
diseas
onset
sever
compar
gcv
treat
wt
mice
nevertheless
gcv
administr
induc
wt
nesttk
mice
delay
eae
onset
compar
salin
treat
mice
might
due
interfer
gcv
immun
cell
develop
mous
model
might
inde
contribut
precis
understand
role
neural
stemprecursor
cell
inflammatori
degen
cn
disord
optim
gcv
administr
obtain
perman
ablat
endogen
npc
aspm
neural
stem
cell
nich
embryon
adult
brain
marinaro
cinzia
butti
erica
bergamaschi
andrea
comi
giancarlo
martino
gianvito
muzio
luca
multipl
sclerosi
character
multifoc
inflammatori
demyel
deriv
immunemedi
event
lead
oligodendrocyt
cell
death
axon
injuri
experiment
demyelin
rodent
recent
highlight
involv
subventricular
zone
svz
deriv
neural
precursor
cell
npc
remyelin
order
dissect
kind
repair
mechan
gener
transgen
mous
line
tamoxifen
tam
induc
gene
clone
control
aspm
cisact
region
mice
cross
report
mice
inject
twice
tam
trace
aspm
descend
develop
post
natal
brain
yfp
cell
detect
prolifer
nich
brain
express
npc
lineag
commit
marker
yfp
cell
also
visual
cn
parenchyma
approxim
neuron
remain
express
differ
oligodendrogli
lineag
apc
tam
inject
protocol
use
gener
adult
svz
npc
cultur
neurospher
deriv
svz
contain
mani
yfp
cell
limit
dilut
assay
demonstr
inde
multipot
next
test
whether
post
natal
aspm
cell
svz
may
belong
npc
cell
lineag
mice
chronic
inject
tam
day
wash
day
appli
one
week
last
tam
inject
yfp
cell
detect
svz
mani
express
npc
molecular
marker
moreov
yfp
cell
also
capabl
migrat
along
rostral
migratori
stream
rm
found
wash
day
final
assess
relev
aspm
express
npc
forebrain
matur
cross
nestinfloxgfpfloxtk
obtain
express
suicid
thymidin
kinas
gene
aspmnestin
doubl
posit
cell
mice
inject
tam
administ
gcv
birth
cortic
prolifer
sever
impair
doubl
transgen
mice
also
show
dramat
reduct
brain
size
taken
togeth
data
suggest
aspm
function
lineag
marker
develop
post
natal
npc
furthermor
aspm
express
cell
repres
relev
cell
popul
develop
brain
ablat
result
massiv
reduct
forebrain
prolifer
cell
seri
observ
rodent
primat
model
suggest
potenti
therapi
ischemia
central
nervou
system
administr
adult
stemprogenitor
cell
human
bone
marrow
refer
mesenchym
stem
cell
multipot
mesenchym
stromal
cell
hmsc
result
howev
establish
molecular
cellular
mechan
msc
produc
benefici
effect
recent
carri
experi
mous
model
global
ischemia
assess
neuroprotect
effect
hmsc
administr
hmsc
cell
hemispher
dentat
gyru
hippocampu
day
min
transient
common
carotid
arteri
occlus
tccao
improv
neurolog
function
evalu
openfield
behavior
test
decreas
delay
neuron
cell
death
detect
fluorojad
b
stain
day
tccao
mice
hippocampu
transplant
hmsc
increas
level
antiinflamatori
cytokin
mous
decreas
proinflamatori
cytokin
mous
interferongamma
tumor
necrosi
factoralpha
moreov
hmsc
transplant
significantli
increas
level
mous
insulinlik
growth
cytokin
assay
indic
hmsc
shift
immun
balanc
immun
bia
analys
indic
effect
part
mediat
altern
activ
microglia
andor
macrophag
hmsc
also
increas
hippocamp
microglialmacrophag
level
activ
microgli
marker
mhc
ii
antigen
present
cell
marker
perform
vitro
studi
determin
commun
hmsc
microgli
cell
hmsc
mous
microgli
line
cell
cultur
togeth
presenc
ifngamma
cell
releas
nitric
oxid
metabolit
nox
tnfalpha
media
express
ino
arginas
activ
charact
consist
microgli
classic
activ
medium
mix
cultur
hmsc
decreas
nox
product
hmsc
numberdepend
manner
nonviabl
hmsc
show
suppress
mix
cultur
human
skin
fibroblast
reproduc
suppress
result
strongli
suggest
benefici
effect
hmsc
larg
explain
modul
inflammatori
immun
reaction
support
part
ncrrnih
grant
rr
weizmann
institut
scienc
rehovot
israel
san
raffael
scientif
institut
milan
itali
although
macrophag
known
essenti
player
wound
heal
peripher
tissu
contribut
recoveri
central
nervou
system
cn
immun
privileg
organ
subject
debat
difficulti
distinguish
differ
macrophag
subpopul
lesion
site
contribut
controversi
led
common
view
macrophag
function
homogen
howev
given
massiv
accumul
injur
spinal
cord
activ
resid
microglia
nativ
immun
occup
cn
recruit
addit
infiltr
monocyt
peripher
blood
seem
puzzl
dissect
specif
contribut
infiltr
monocytederiv
popul
recoveri
follow
spinal
cord
injuri
perform
seri
experi
allow
us
function
distinguish
brainresid
macrophag
microglia
infiltr
bloodborn
macrophag
antibodymedi
deplet
condit
ablat
diphtheria
toxin
infiltr
monocytederiv
macrophag
spare
resid
microglia
impair
recoveri
follow
spinal
cord
injuri
lost
motor
function
could
restor
reconstitut
circulatingmonocyt
pool
infiltr
monocytederiv
macrophag
display
uniqu
local
immunoregulatori
role
critic
depend
upon
express
antiinflammatori
cytokin
interleukin
importantli
novel
function
could
provid
resid
counterpart
microglia
fact
immunoregulatori
role
provid
bloodderiv
cell
found
essenti
microgli
respons
termin
notabl
therapeut
relev
enhanc
recoveri
could
achiev
adopt
transfer
monocyt
result
studi
demonstr
infiltr
monocytederiv
cell
function
distinct
inflammatori
resid
microglia
essenti
recoveri
thu
studi
shed
new
light
longheld
debat
regard
contribut
macrophag
recoveri
cn
injuri
potenti
farreach
therapeut
implic
cn
degen
patholog
neutrophil
essenti
effector
cell
first
line
defenc
invad
microorgan
encount
kill
microb
intracellularli
phagocytosi
extracellularli
degranul
recent
format
neutrophil
extracellular
trap
net
discov
new
kill
mechan
net
extracellular
fibr
compos
chromatin
granul
protein
abl
catch
kill
microb
net
format
requir
chromatin
decondens
histon
citrullin
mediat
deiminas
despit
benefici
role
net
infect
composit
includ
tlr
ligand
autolog
dna
bacteri
compound
togeth
self
protein
histon
neutrophil
compound
could
also
harm
effect
facilit
autoimmun
sever
autoimmun
diseas
includ
multipl
sclerosi
ms
higher
preval
femal
compar
male
suggest
role
femal
sex
hormon
develop
diseas
women
also
higher
system
neutrophil
count
correl
estradiol
level
menstruat
moreov
estradiol
appear
influenc
neutrophil
apoptosi
interestingli
role
estradiol
regul
express
cell
line
also
report
studi
examin
whether
estradiol
regul
express
net
format
human
neutrophil
whether
sex
differ
net
format
could
underli
femal
preval
observ
multipl
sclerosi
autoimmun
diseas
studi
express
western
blot
net
format
use
myeloperoxidas
mpo
dnaspecif
elisa
neutrophil
incub
differ
concentr
estradiol
could
demonstr
effect
estradiol
express
net
format
vitro
compar
net
product
neutrophil
male
femal
natur
fluctuat
estradiol
concentr
fail
observ
estradiolassoci
differ
gender
differ
neutrophil
function
ie
phagocytosi
apoptosi
also
analyz
studi
confirm
previous
describ
effect
estradiol
neutrophil
apoptosi
although
could
demonstr
gender
differ
net
format
studi
need
elucid
whether
net
involv
ms
autoimmun
diseas
support
herti
stiftung
adenosin
receptormedi
signal
requir
trigger
tlrinduc
product
microglia
van
der
putten
celin
veth
jennif
zuiderwijksick
ella
microglia
express
wide
rang
tolllik
receptor
tlr
potent
respond
innat
immun
stimuli
tlrmediat
activ
enhanc
cell
surfac
express
costimulatori
molecul
induc
product
varieti
proinflammatori
cytokin
extracellular
adenosin
modul
tlrinduc
product
proinflammatori
cytokin
adenosin
receptor
adora
mediat
signal
four
adora
subtyp
describ
either
increas
decreas
intracellular
camp
level
previous
report
tlrmediat
activ
dramat
alter
adora
express
pattern
primari
microglia
result
strongli
enhanc
sensit
inhibitori
effect
extracellular
adenosin
tlrinduc
cytokin
product
signal
found
respons
inhibitori
effect
import
new
counteract
role
signal
also
identifi
investig
contribut
signal
induc
endogen
produc
adenosin
tlrinduc
cytokin
product
microglia
use
three
chemic
distinct
differ
antagonist
demonstr
protein
product
primari
rhesu
monkey
microglia
strongli
impair
signal
inhibit
wherea
tnfalpha
product
less
affect
preliminari
result
use
short
interfer
rna
reduc
protein
confirm
necess
signal
product
interestingli
analysi
bone
marrowderiv
macrophag
human
monocyt
macrophag
dendrit
cell
show
similar
result
suggest
propos
effect
exclus
microglia
current
investig
signal
pathway
affect
signal
preliminari
result
present
meet
conclus
describ
new
role
tlrinduc
product
propos
tlrinduc
rapid
rise
endogen
produc
extracellular
adenosin
level
provid
microglia
second
signal
necessari
trigger
product
novel
failsaf
mechan
therebi
close
resembl
two
signal
ie
tlr
stimulu
rise
extracellular
atp
signal
need
trigger
inflammasomemedi
product
theiler
murin
encephalomyel
viru
tmev
singlestrand
rna
viru
caus
chronic
progress
cell
mediat
induc
demyelin
diseas
tmevidd
suscept
mous
strain
serv
virallyinduc
murin
model
human
diseas
multipl
sclerosi
innat
immun
system
serv
first
line
host
defens
pathogen
virus
tolllik
receptor
tlr
member
pattern
recognit
receptor
prr
famili
recogn
pathogen
associ
molecular
pattern
pamp
ligand
bind
activ
proinflammatori
antivir
respons
apc
central
nervou
system
cn
resid
cell
microglia
isol
human
neonat
murin
tissu
express
multipl
tlr
vitro
situ
therefor
examin
tlrstimul
microglia
macrophag
immun
function
murin
cn
respons
tmev
infect
follow
tmev
infect
express
significantli
upregul
day
postinfect
pi
suggest
tlr
dynam
regul
acut
theiler
viru
infect
use
quantit
realtim
pcr
express
recogn
viral
doublestrand
rna
highli
induc
facssort
microglia
respons
tmevinfect
day
pi
data
suggest
virus
may
select
upregul
express
mount
antivir
respons
necessari
tmev
viral
clearanc
cn
elucid
role
tmevidd
examin
develop
induc
demyelin
diseas
absenc
compar
wildtyp
sjl
mice
mice
hypersuscept
diseas
exhibit
increas
demyelin
suggest
protect
tmevidd
addit
mice
defect
tmev
clearanc
cn
measur
increas
viral
titer
mice
compar
wildtyp
control
mice
defici
total
cn
cell
number
day
pi
also
reflect
reduc
total
cell
percentag
cell
number
would
affect
tmev
clearanc
futur
experi
focus
understand
role
effector
function
cnsresid
cell
acut
infect
support
estrogen
brain
inflamm
vegeto
e
maggi
clinic
evid
suggest
decreas
level
circul
estrogen
hormon
occur
women
menopaus
associ
higher
incid
inflammatori
disord
accordingli
estrogen
administr
correl
protect
effect
inflammatori
patholog
thu
hypothes
estrogen
exert
benefici
effect
act
antiinflammatori
agent
initi
show
inflammatori
cell
includ
microglia
express
estrogen
receptor
eralpha
erbeta
estrogen
inhibit
transcript
inflammatori
gene
use
experiment
model
acut
brain
inflamm
demonstr
reduc
activ
brain
inflammatori
cell
vivo
effect
specif
mediat
eralpha
recent
data
hormon
withdraw
replac
select
estrogen
receptor
modul
serm
show
estrogen
antiinflammatori
activ
reproduc
serm
gener
use
clinic
practic
parallel
use
mice
anim
model
alzheim
diseas
observ
endogen
estrogen
statu
clearli
regul
brain
inflammatori
respons
associ
chronic
neuroinflammatori
diseas
recent
data
neuroinflamm
age
brain
role
experiment
menopaus
discuss
altogeth
studi
show
estrogen
act
antiinflammatori
signal
brain
result
may
use
identifi
select
ligand
appropri
therapeut
intervent
prevent
neuroinflammatori
patholog
age
women
nerv
growth
factor
ngf
like
molecul
small
stabl
peptid
abl
bind
select
ngfreceptor
mimick
action
nativ
neurotrophin
applic
molecul
consid
possibl
approach
treatment
mani
neurodegen
disord
assess
capac
induc
neuron
differenti
surviv
activ
ngfreceptor
pathway
vitro
applic
ngflike
molecul
two
differ
cell
line
test
express
ngfreceptor
trka
express
ngfreceptor
vivo
model
multipl
sclerosi
eae
experiment
autoimmun
encephalomyel
also
use
test
capac
ngflike
small
molecul
induc
neuroprotect
immunomodul
ngflike
molecul
induc
neuron
differenti
cell
line
promot
surviv
stress
induct
also
cell
line
peptid
induc
trka
ikba
sap
jnk
phosphoryl
ngflike
molecul
improv
clinic
score
anim
affect
eae
peptidetr
anim
also
detect
decreas
level
demyelin
inflammatori
infiltr
compar
control
proinflammatori
cytokin
express
also
modul
peptid
applic
detect
realtim
pcr
small
ngflike
molecul
benefici
effect
neuron
surviv
anim
model
multipl
sclerosi
suggest
possibl
applic
molecul
treatment
differ
neurodegen
disord
utano
nation
hospit
kyoto
japan
tokyo
metropolitan
institut
gerontolog
tokyo
japan
kobe
pharmaceut
univers
kobe
japan
tri
clarifi
clinic
signific
antialkalin
phosphatas
antibodi
ap
ab
serum
patient
myasthenia
gravi
mg
serum
sampl
obtain
seroposit
sp
mg
seroneg
sn
mg
patient
patient
neurolog
immunolog
diseas
lamberteaton
myasthen
syndrom
polymyos
multipl
sclerosi
spinal
progress
muscular
atrophi
chronic
inflammatori
demyelin
polyneuropathi
al
epilepsi
progress
muscular
dystrophi
thyroid
type
diabet
mellitu
rheumatoid
arthriti
control
popul
compris
healthi
volunt
recombin
muscl
specif
kinas
musk
protein
construct
extracellular
domain
human
musk
aptagmusk
fusion
protein
musk
human
placent
alkalin
phosphatas
ap
antiap
ab
measur
radioimmunoprecipit
method
identifi
immunolog
radioimmunoassay
western
blot
analysi
presenc
antibodi
direct
ap
ap
ab
specif
antiacetylcholin
receptor
achr
abposit
myasthenia
gravi
spmg
patient
crossreact
signific
titer
correl
found
ap
ab
achr
ab
signific
titer
correl
observ
among
serum
alkalinephosphatas
ap
ab
ap
abposit
spmg
patient
character
clinic
femal
predomin
sever
form
gener
mg
ap
abneg
spmg
patient
half
requir
artifici
ventil
maximum
sever
ap
ab
pathogen
role
mg
yet
unclarifi
find
show
ap
novel
antigen
among
variou
autoantigen
present
mg
patient
infect
jc
viru
jcv
common
kept
latent
state
immunocompet
individu
usual
jcv
caus
progress
multifoc
leukoencephalopathi
pml
sever
immunocompromis
individu
like
e
g
aid
patient
pml
consid
opportunist
infect
cn
context
multipl
sclerosi
ms
pml
recent
consider
interest
sinc
also
occur
treatment
natalizumab
order
understand
better
role
jcvspecif
cell
healthi
control
ms
patient
without
therapi
natalizumab
character
antigen
specif
phenotyp
function
natalizumab
therapi
seri
overlap
peptid
span
open
read
frame
jcv
design
use
togeth
jcv
protein
assess
presenc
magnitud
specif
jcvspecif
cell
respons
incorpor
assay
serum
csfand
urinari
jcv
viral
load
determin
pcr
natalizumab
therapi
seroposit
assess
elisa
function
aspect
examin
cytokin
secret
elispot
assay
surfac
marker
use
method
observ
posit
jcvspecif
cell
respons
healthi
control
ms
patient
sever
immunodomin
peptid
map
jcv
peptidespecif
cell
respons
increas
natalizumab
therapi
urinari
jcv
viral
load
factor
might
increas
risk
develop
pml
accompani
less
stringent
immun
control
latent
jcv
infect
present
discuss
multipl
sclerosi
ms
pediatr
age
group
increasingli
recogn
adult
complex
interact
genet
environment
factor
contribut
ms
risk
major
genet
compon
ms
suscept
localis
major
histocompat
complex
whether
hla
allel
predict
ms
risk
children
present
acquir
cn
demyelin
syndrom
ad
unknown
hla
allel
type
use
allelespecif
pcr
amplif
method
sampl
children
present
ad
enrol
prospect
canadian
pediatr
demyelin
diseas
studi
unrel
healthi
caucasian
control
thirti
children
ad
diagnos
ms
mean
follow
year
children
present
ad
harbour
allel
significantli
like
diagnos
ms
vs
p
observ
primarili
driven
children
european
ancestri
vs
p
proport
children
noneuropean
ancestri
diagnos
ms
influenc
statu
allel
confer
increas
suscept
pediatriconset
ms
support
fundament
similar
genet
contribut
ms
risk
pediatricand
adultonset
diseas
specif
risk
allel
ad
children
subsequ
ms
diagnosi
ad
children
indic
risk
convey
relat
chronic
cn
autoimmun
diseas
ms
rather
acquir
demyelin
gener
brain
tumor
paraneoplast
syndrom
chair
r
hintzen
van
gool
antivir
nk
respons
limit
efficaci
oncolyt
viral
therapi
glioblastoma
alvarezbreckenridg
christoph
yu
jianhua
moretta
alessandro
kaur
balveen
caligiuri
michael
chiocca
ennio
antonio
ohio
state
univers
columbu
unit
state
univers
genova
genova
itali
oncolyt
viral
ov
therapi
promis
treatment
approach
glioblastoma
test
safeti
efficaci
natur
killer
cell
nk
limit
viral
infect
previou
work
suggest
may
similarli
attenu
virotherapi
object
studi
uncov
role
nk
cell
limit
factor
therapeut
modal
use
flow
cytometri
evalu
tempor
pattern
phenotyp
characterist
nk
cell
recruit
intracrani
ic
xenograft
tumor
human
glioma
treat
oncolyt
herp
viru
pb
quantif
nk
recruit
ic
tumor
treat
reveal
signific
enrich
cell
tumor
hemispher
earli
time
point
continu
hour
p
follow
ov
infect
moreov
nk
cell
recruit
site
inocul
exhibit
activ
phenotyp
includ
enhanc
stain
compar
pb
treat
mice
robust
nk
respons
confirm
detriment
ov
efficaci
enhanc
surviv
nk
deplet
mice
inocul
ov
compar
ov
treat
mice
possess
nk
cell
median
surviv
day
compar
median
surviv
day
p
interestingli
ov
treat
mice
exhibit
robust
induct
macrophag
microgli
deriv
gene
express
tnfa
ino
howev
mice
deplet
nk
cell
express
gene
reduc
basal
level
due
preferenti
nk
mediat
clearanc
ov
infect
glioma
attempt
deciph
critic
nk
activ
ligand
mediat
respons
follow
viral
infect
cultur
glioma
observ
ligand
upregul
nk
activ
receptor
p
p
p
addit
block
antibodi
either
abrog
nk
mediat
clearanc
ov
infect
glioma
find
suggest
nk
cell
preferenti
clear
ov
infect
cell
depend
manner
first
studi
investig
mechanist
chang
nk
cell
activ
recruit
glioma
follow
ov
treatment
futur
work
attempt
identifi
pharmacolog
agent
select
block
nk
activ
ligand
lead
improv
clinic
success
ov
therapi
due
enhanc
viral
propag
tumor
clearanc
multipl
sclerosi
ms
chronic
inflammatori
diseas
central
nervou
system
lead
focal
destruct
myelin
earliest
chang
caus
lesion
format
still
known
studi
pathogen
mechan
involv
lesion
format
complex
due
multifactori
natur
diseas
suscept
heterogen
clinic
diseas
cours
divers
cellular
patholog
recent
studi
activ
demyelin
ms
lesion
reveal
profound
heterogen
immunopatholog
pattern
demyelin
hypothesi
interindividu
heterogen
challeng
descript
stagedepend
sequenc
patholog
featur
small
sampl
ms
autopsi
case
although
similar
lesion
featur
observ
ms
patient
cohort
sever
argument
support
hypothesi
intraindividu
homogen
interindividu
heterogen
includ
patholog
radiolog
data
well
respons
therapi
basi
interindividu
heterogen
may
presenc
distinct
molecular
immunolog
effector
mechan
ms
lesion
normal
appear
white
matter
sinc
initi
event
ms
lesion
format
yet
defin
elucid
molecular
mechan
import
establish
new
therapeut
regimen
specif
interfer
process
patholog
heterogen
well
correl
radiolog
clinic
data
present
bien
christian
univers
bonn
dept
epileptolog
bonn
germani
epilept
seizur
induc
varieti
underli
diseas
one
caus
brain
inflamm
enceph
three
well
defin
chronic
inflammatori
syndrom
regularli
associ
recurr
seizur
rasmussen
enceph
limbic
enceph
antinmethyldaspart
receptor
nmdar
enceph
pathogen
similar
differ
immunolog
respons
cell
death
central
nervou
system
three
type
enceph
discuss
special
emphasi
laid
distinct
antibodydefin
form
chronic
encephalitid
patient
antibodi
intracellular
antigen
onconeur
antibodi
antibodi
glutam
acid
decarboxylas
enceph
domin
cell
hand
patient
harbor
antibodi
membran
antigen
like
voltag
gate
potassium
channel
associ
protein
nmdar
seem
disord
pathogenet
link
antibodi
patholog
autoimmun
lucchinetti
claudia
f
neuromyel
optica
nmo
cn
autoimmun
demyelin
disord
preferenti
affect
optic
nerv
spinal
cord
clinic
patholog
serolog
featur
includ
presenc
nmoigg
target
domin
cn
water
channel
distinguish
nmo
ms
concentr
plasma
membran
astrocyt
endfeet
abut
capillari
pia
brain
spinal
cord
particularli
subpial
subependym
zone
well
glial
lamella
supraopt
nucleu
hypothalamu
site
distinct
brain
mri
abnorm
observ
subset
nmo
patient
nmo
patholog
demonstr
variabl
demyelin
axon
injuri
eosinophilneutrophil
infiltr
well
uniqu
vasculocentr
pattern
immun
complex
deposit
local
astrocyt
endfeet
perivascular
glia
limitan
reflect
region
densiti
molecul
contrast
stagedepend
loss
ms
lesion
nmo
lesion
demonstr
loss
regardless
stage
demyelin
activ
loss
also
observ
site
vasculocentr
ig
deposit
complement
activ
nmo
lesion
larg
lack
demyelin
inflammatori
lesion
predilect
periventricular
region
especi
medullari
floor
fourth
ventricl
adjac
area
postrema
region
lack
bloodbrain
barrier
bbb
rich
osmoreceptor
lesion
like
repres
patholog
substrat
intract
revers
nausea
vomit
report
nmo
patient
supratentori
mri
brain
lesion
also
describ
nmo
either
nonspecif
mslike
appear
supratentori
nmo
lesion
patholog
resembl
nmo
opticospin
lesion
respect
type
inflamm
presenc
perivascular
immun
complex
deposit
loss
pattern
distinct
observ
ms
adem
support
overlap
nmo
either
ms
adem
suggest
studi
paradox
cortic
demyelin
absent
nmo
despit
abund
express
region
region
differ
concentr
could
contribut
paradox
well
region
differ
spatial
distribut
molecular
orient
epitop
astrocyt
endfeet
might
preclud
effici
complement
activ
intermolecular
crosslink
site
keep
vitro
studi
demonstr
exposur
nmo
patient
serum
activ
complement
compromis
membran
integr
cnsderiv
astrocyt
nmo
lesion
character
loss
astrocyt
nmo
lesion
also
demonstr
mark
reduct
coloc
region
loss
patholog
find
coupl
observ
endocytos
follow
bind
nmoigg
concomit
loss
nadepend
glutam
transport
loss
excitatori
transport
suggest
exist
astrocyt
membran
macromolecular
complex
bind
nmoigg
astrocyt
could
therefor
expect
disrupt
glutam
homeostasi
lead
injuri
oligodendrocyt
express
calciumperm
glutam
receptor
summari
clinic
patholog
observ
support
pathogen
role
autoantibodi
specif
nmo
patient
acut
nmo
respond
favor
antibodydeplet
saturday
octob
th
concurr
symposia
therapi
brain
mri
lesion
surround
ventricl
typic
nmo
local
site
high
express
cn
lesion
nmo
exhibit
deposit
immunogloblulin
product
complement
activ
vasculocentr
pattern
coincid
normal
distribut
cn
lesion
nmo
exhibit
loss
immunoreact
wherea
activ
ms
lesion
demonstr
upregul
serum
igg
patient
nmo
bind
extracellular
domain
predominantli
igg
initi
two
potenti
compet
outcom
endocytosisdegrad
complement
activ
paranod
astrocyt
endfeet
highli
express
bind
nmoigg
astrocyt
lead
downregul
disrupt
glutam
homeostasi
recent
experiment
anim
model
recapitul
aspect
nmo
patholog
data
strongli
support
pathogen
role
complement
activ
autoantibodi
initi
nmo
lesion
distinguish
nmo
ms
igg
contact
astrocyt
endfeet
could
impact
astrogli
polar
would
expect
compromis
endfoot
membran
integr
osmot
regul
bbb
function
mainten
paranod
synapt
microenviron
result
irrevers
tissu
damag
neurobiolog
lectur
glial
support
axon
function
relev
diseas
max
planck
institut
experiment
medicin
goettingen
germani
glial
cell
engag
long
axon
featur
virtual
nervou
system
howev
mechan
neuron
glia
commun
troughout
life
well
understood
cn
increas
evid
oligodendrocyt
support
longterm
axon
function
surviv
relev
human
myelin
diseas
patient
multipl
sclerosi
ms
suffer
slowli
progress
loss
axon
inflammatori
demyelin
lesion
rais
question
whether
inflamm
demyelin
oligodendrocyt
dysfunct
combin
thereof
underli
caus
axon
failur
trapp
nave
annu
rev
neurosci
acut
inflamm
eae
mice
perturb
energi
balanc
demyelin
axon
howev
genet
observ
suggest
oligodendrocyt
maintain
longterm
axon
integr
independ
myelin
inflamm
moreov
genet
defect
oligodendrocyt
caus
axon
loss
trigger
secondari
inflamm
includ
invas
activ
cell
white
matter
kassmann
et
al
nat
genet
molecular
mechan
oligodendrocyt
support
axon
function
well
understood
phenotyp
axon
swell
wallerian
degener
mous
model
resembl
patient
mitochondri
defect
studi
possibl
contribut
oligodendrocyt
maintain
axon
energi
balanc
myelin
fiber
nave
nat
rev
neurosci
creat
novel
mous
model
lack
mitochondri
respir
support
ela
neuropromis
leukotreat
bmbf
leukonet
plenari
symposium
autoimmun
respons
neuron
receptor
chair
j
dalmau
neuron
acetylcholin
receptor
autoimmun
vernino
steven
neurolog
autoantibodi
may
help
identifi
treatabl
autoimmun
disord
inform
diseas
pathophysiolog
wellrecogn
antibodymedi
neurolog
disord
associ
autoantibodi
membran
receptor
ion
channel
myasthenia
gravi
mg
protyp
autoimmun
antibodymedi
neurolog
disord
antibodi
specif
nicotin
acetylcholin
receptor
achr
skelet
muscl
caus
mg
muscl
acetylcholin
receptor
one
member
famili
ligandg
ion
channel
homolog
nicotin
achr
also
express
neuron
throughout
central
peripher
nervou
system
mani
patient
autoimmun
autonom
ganglionopathi
aag
serum
autoantibodi
specif
neuron
nicotin
achr
autonom
ganglia
gnachr
aag
classic
subacut
ill
sever
autonom
failur
cours
week
patient
develop
sympathet
failur
parasympathet
failur
impair
pupil
respons
gastrointestin
dysmotil
patient
show
dramat
respons
immunomodulatori
therapi
autoantibodi
aag
patient
inhibit
ganglion
synapt
transmiss
experiment
aag
induc
experiment
anim
thu
aag
antibodymedi
disord
synapt
transmiss
neuron
nicotin
achr
express
central
neuron
receptor
may
also
target
autoimmun
although
evid
confin
clinic
case
report
time
antibodi
neuron
achr
detect
patient
subacut
encephalopathi
case
cognit
symptom
respond
immunomodulatori
treatment
suggest
autoimmun
pathogenesi
antibodi
neuron
muscarin
achr
gprotein
coupl
receptor
also
identifi
serum
patient
includ
sjogren
syndrom
signific
muscarin
achr
antibodi
still
uncertain
neuron
achr
clearli
target
neurolog
autoimmun
case
autoimmun
autonom
ganglionopathi
well
establish
antibodymedi
disord
ganglion
synapt
transmiss
disord
associ
neuron
achr
autoimmun
like
defin
near
futur
clinic
spectrum
autoimmun
nmda
synapt
receptor
encephalitid
seizur
disord
thought
idiopath
appear
immun
mediat
target
antigen
cell
surfac
synapt
receptor
critic
role
synapt
transmiss
plastic
excitatori
glutam
receptor
nmdar
ampar
inhibitori
gabab
receptor
spectrum
associ
symptom
vari
target
antigen
may
includ
alter
memori
behavior
cognit
psychosi
seizur
dyskinesia
part
antinmdar
enceph
recognit
disord
import
affect
children
young
adult
may
occur
without
cancer
associ
frequent
respond
immunotherapi
antibodi
defin
new
syndrom
antinmdar
enceph
latter
multistag
develop
symptom
progress
improv
result
syndrom
characterist
patient
diagnos
clinic
ground
antinmdar
enceph
wide
recogn
children
adult
frequenc
tumor
associ
usual
teratoma
vari
accord
age
children
rare
tumor
gender
ethnic
contrast
autoimmun
ampar
gaba
b
receptor
associ
classic
pictur
limbic
enceph
pure
psychiatr
manifest
frequent
trigger
underli
cancer
immunolog
disord
character
featur
target
epitop
extracellular
antibodyreceptor
bind
visibl
cell
transfect
express
target
receptor
antibodi
alter
structur
function
target
receptor
clinic
pictur
resembl
pharmacolog
genet
model
receptor
disrupt
given
syndrom
attribut
voltagelectur
plenari
symposium
gate
potassium
channel
vgkc
fulfil
criteria
recent
conduct
studi
isol
real
target
antigen
result
isol
epilepsi
relat
gene
product
secret
neuron
protein
main
antigen
limbic
enceph
previous
attribut
vgkc
antigen
form
enceph
sometim
defin
morvan
syndrom
subgroup
patient
neuromyotonia
find
reveal
term
vgkc
antibodi
associ
syndrom
broad
spectrum
clinic
immunolog
disord
start
expos
implic
find
discuss
talk
focu
work
two
recent
discov
human
autoimmun
disord
memori
learn
cognit
psychosi
function
nmda
receptor
ampa
receptor
directli
affect
patient
antibodi
direct
extracellular
epitop
specif
receptor
subunit
disord
natur
occur
model
human
memori
dysfunct
uniqu
rel
frequent
caus
sever
memori
loss
lethal
potenti
treatabl
often
affect
children
caus
serum
cerebrospin
fluid
antibodi
extracellular
domain
nmda
ampa
receptor
subunit
bind
preferenti
hippocampu
surround
cortex
gener
equal
brain
region
accompani
acuteonset
psychosi
hallmark
schizophrenia
discuss
recent
publish
work
unpublish
result
establish
cellular
synapt
mechan
underli
novel
lifethreaten
antiglutam
receptor
encephalopathi
present
unpublish
data
demonstr
patient
antibodi
pathogen
caus
dramat
dosedepend
decreas
densiti
surfac
total
glutam
receptor
cluster
synapt
local
independ
complement
revers
antibodi
remov
antibodi
affect
densiti
synaps
synapt
protein
cluster
dendrit
branchingspin
densiti
cell
surviv
result
support
conclus
antibodi
patient
antiglutam
receptor
enceph
revers
alter
densiti
synapt
local
nmda
ampa
receptor
effect
mediat
primarili
cap
crosslink
intern
receptor
also
discuss
vivo
work
rodent
model
disord
effect
patient
antibodi
synaps
circuit
vivo
use
approach
goal
connect
synapt
circuit
dysfunct
behavior
abnorm
cognit
memori
hallmark
disord
